Citrus Sinensis ID: 022479
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | 2.2.26 [Sep-21-2011] | |||||||
| Q6ICW6 | 314 | Probable serine/threonine | yes | no | 0.945 | 0.891 | 0.775 | 1e-134 | |
| Q0D541 | 327 | Probable serine/threonine | yes | no | 0.925 | 0.837 | 0.690 | 1e-118 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.905 | 0.519 | 0.664 | 1e-106 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.929 | 0.442 | 0.608 | 1e-101 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.939 | 0.397 | 0.609 | 8e-99 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.949 | 0.399 | 0.590 | 6e-97 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.949 | 0.399 | 0.590 | 7e-97 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.918 | 0.552 | 0.586 | 4e-95 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.939 | 0.489 | 0.573 | 5e-95 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.902 | 0.470 | 0.589 | 8e-94 |
| >sp|Q6ICW6|WNK11_ARATH Probable serine/threonine-protein kinase WNK11 OS=Arabidopsis thaliana GN=WNK11 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 479 bits (1233), Expect = e-134, Method: Compositional matrix adjust.
Identities = 217/280 (77%), Positives = 255/280 (91%)
Query: 5 NSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE 64
N + D+D E FVEVDP+GR+GRY +LLGSGAVKKVYRAFDQEEGIEVAWNQV+L FS+
Sbjct: 10 NESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSD 69
Query: 65 DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV 124
DP + RL+SEV+LL+ LKN II Y VW D+++NTLNFITE+CTSGNLR YRKKHRHV
Sbjct: 70 DPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHV 129
Query: 125 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184
S++ALKKWSKQ+L+GL+YLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVG++H
Sbjct: 130 SMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNH 189
Query: 185 AAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
AHSI+GTPE+MAPELYEE+YTEMVDIYS+G+C+LE+V++EIPYSECDSVAKIYK+V+ G
Sbjct: 190 LAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKG 249
Query: 245 VKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
+KP+ALNKV DPE KAFIEKCIAQPRARPSA+ELL DPFF
Sbjct: 250 LKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFF 289
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D541|WNK5_ORYSJ Probable serine/threonine-protein kinase WNK5 OS=Oryza sativa subsp. japonica GN=WNK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 190/275 (69%), Positives = 237/275 (86%), Gaps = 1/275 (0%)
Query: 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQ 77
VDP+GRFGRY+D+LG G+VKKVYR FDQEEGIEVAWN+VRL ++ DP +V RLH+EV+
Sbjct: 48 VDPTGRFGRYADVLGLGSVKKVYRGFDQEEGIEVAWNRVRLRALADRDPAMVERLHAEVR 107
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 137
LLR+L +++II + VWLD LNFITEVCTSG+LR YR +HRHVS+KALKKW++Q+L
Sbjct: 108 LLRSLHHEHIIGFHKVWLDRDAGVLNFITEVCTSGSLREYRDRHRHVSVKALKKWARQIL 167
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
GL++LHTH+PCIIHRDLNCSN+FINGN GQVKIGDLG AAIV ++H AH+I+GTPE+MA
Sbjct: 168 LGLDHLHTHDPCIIHRDLNCSNVFINGNTGQVKIGDLGLAAIVDKTHVAHTILGTPEFMA 227
Query: 198 PELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
PELY E YTE VDIYS+G+C+LEMVT E+PY+ECDSV +IY VT GV P AL +++DPE
Sbjct: 228 PELYTETYTESVDIYSYGMCVLEMVTREMPYAECDSVVQIYHSVTRGVPPAALKRIRDPE 287
Query: 258 VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292
++AFIE+CI QPR RPSA+ELL+DPFF+ ++DDDS
Sbjct: 288 LRAFIERCIGQPRNRPSAAELLRDPFFAGIDDDDS 322
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (987), Expect = e-106, Method: Compositional matrix adjust.
Identities = 182/274 (66%), Positives = 222/274 (81%), Gaps = 6/274 (2%)
Query: 14 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH---FSEDPVLVN 70
E FVE+DP+GR+GRY ++LG GA K+VYRAFDQ EGIEVAWNQV+L SED ++
Sbjct: 10 EEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSED---LD 66
Query: 71 RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 130
RL+SEV LL+TLK+K II Y+ W+D QH T+N ITEV TSGNLR YRKKH+ V ++ALK
Sbjct: 67 RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
KWS+Q+LEGL YLH+H+P +IHRDL C NIFINGN G+VKIGDLG AAI+ R+ +AHS+I
Sbjct: 127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186
Query: 191 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
GTPE+MAPELYEEDY +VDIY+FG+CLLE+VT E PYSEC + A+IY+KVT G+KP AL
Sbjct: 187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246
Query: 251 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
V DP+V+AFIEKCIA+ R SA ELL DPF
Sbjct: 247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-101, Method: Compositional matrix adjust.
Identities = 168/276 (60%), Positives = 216/276 (78%), Gaps = 1/276 (0%)
Query: 12 DGEP-FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 70
D EP F EVDP+ R+GRY+++LG GA K VY+AFDQ EG+EVAWNQ+++ + +
Sbjct: 13 DTEPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLE 72
Query: 71 RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 130
RL SEV+LL+TLK+K II Y+ WLD ++N +NFITEV TSG LR YR KH+ V ++ALK
Sbjct: 73 RLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALK 132
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
KWS+Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG A I+ + +AHSII
Sbjct: 133 KWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSII 192
Query: 191 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
GTPE+MAPELY+E+Y E+VDIY+FG+CLLE+VT E PY EC + A+IYKKV+ G KP +L
Sbjct: 193 GTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSL 252
Query: 251 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE 286
K++DPEV+ FIEKCIA+ R SA ELL DPF +
Sbjct: 253 AKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRD 288
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 8e-99, Method: Compositional matrix adjust.
Identities = 172/282 (60%), Positives = 215/282 (76%), Gaps = 4/282 (1%)
Query: 12 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 71
D FVEVDP+GR+GRY+++LG GA K VYRAFD+ EGIEVAWNQV+L F + P + R
Sbjct: 10 DYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
L+ E+ LL+TLK+K I+ Y+ W+D + +NF+TE+ TSG LR YR +H+ V+I+A+K
Sbjct: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKH 129
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
W +Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG AAI+ +SHAAH +G
Sbjct: 130 WCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVG 188
Query: 192 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251
TPE+MAPE+YEE Y E+VDIYSFG+C+LEMVT + PYSEC A+IYKKV G KP AL
Sbjct: 189 TPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALY 248
Query: 252 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 293
KVKDPEVK FIEKC+A R SA ELL DPF L DD E
Sbjct: 249 KVKDPEVKCFIEKCLATVSLRVSARELLDDPF---LRIDDGE 287
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 167/283 (59%), Positives = 213/283 (75%), Gaps = 2/283 (0%)
Query: 2 PAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH 61
P AN+ + D + EVDP+GR+GRY+D+LG GA K VYRAFD+ +G+EVAWNQV+L
Sbjct: 4 PKANAAAAG-DLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHD 62
Query: 62 FSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 121
F + P + RL+ E+ LL+TLK++ I+ Y+ W+D +NFITE+ TSG LR YR+KH
Sbjct: 63 FLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKH 122
Query: 122 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181
V+I A+K W +Q+L GL YLH+H+P IIHRDL C NIF+NGN G+VKIGDLG AAI+
Sbjct: 123 MRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 182
Query: 182 RSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241
+SHA H +GTPE+MAPE+YEE+Y E+VDIYSFG+C+LEMVT E PYSEC +IYKKV
Sbjct: 183 KSHAVH-CVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKV 241
Query: 242 TGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
G KP+AL KVKDP V+ F+EKC+A R SA ELLKDPF
Sbjct: 242 ISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFL 284
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 7e-97, Method: Compositional matrix adjust.
Identities = 167/283 (59%), Positives = 213/283 (75%), Gaps = 2/283 (0%)
Query: 2 PAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH 61
P AN+ + D + EVDP+GR+GRY+D+LG GA K VYRAFD+ +G+EVAWNQV+L
Sbjct: 4 PKANAAAAG-DLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHD 62
Query: 62 FSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 121
F + P + RL+ E+ LL+TLK++ I+ Y+ W+D +NFITE+ TSG LR YR+KH
Sbjct: 63 FLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKH 122
Query: 122 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181
V+I A+K W +Q+L GL YLH+H+P IIHRDL C NIF+NGN G+VKIGDLG AAI+
Sbjct: 123 MRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 182
Query: 182 RSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241
+SHA H +GTPE+MAPE+YEE+Y E+VDIYSFG+C+LEMVT E PYSEC +IYKKV
Sbjct: 183 KSHAVH-CVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKV 241
Query: 242 TGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
G KP+AL KVKDP V+ F+EKC+A R SA ELLKDPF
Sbjct: 242 ISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFL 284
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 160/273 (58%), Positives = 208/273 (76%), Gaps = 1/273 (0%)
Query: 12 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 71
D +VEVDP+GR+GRY+++LG G+ K VYR FD+ +GIEVAWNQV+L F + P + R
Sbjct: 11 DYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELER 70
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
L+ E+ LL+TLK+K I+ Y+ W+D + +NF+TE+ TSG LR YR KH+ V+I+A+K
Sbjct: 71 LYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKN 130
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
W +Q+L GL YLHTH+P +IHRDL C NIFINGN G+VKIGDLG AA + SHAAH +G
Sbjct: 131 WCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHC-VG 189
Query: 192 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251
TPE+MAPE+Y+E+Y ++VDIYSFG+C+LEMVT + PYSEC A+IYK+V G KP L+
Sbjct: 190 TPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLD 249
Query: 252 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
KVKDPEV+ FIEKC+A R SA ELL D F
Sbjct: 250 KVKDPEVRGFIEKCLATVSLRLSACELLDDHFL 282
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 160/279 (57%), Positives = 213/279 (76%), Gaps = 1/279 (0%)
Query: 12 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 71
D FVE+DPSGR+GRY ++LG GA K VYRAFD+ EGIEVAWNQV+L +F+ +P + +
Sbjct: 10 DCSVFVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEK 69
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
E+ LL+TL ++ I+ Y+ W+D + ++NF+TE+ TSG LR YR +HR V+I+A+K+
Sbjct: 70 FFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQ 129
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
W KQ+L+GL YLH+ P IIHRDL C NIFINGN G+VKIGDLG AAI+ +SHA +G
Sbjct: 130 WCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRC-VG 188
Query: 192 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251
TPE+MAPE+Y+E+Y E+VD+Y+FG+C+LEMVT + PYSEC A+IYKKVT G KP+A
Sbjct: 189 TPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFY 248
Query: 252 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDD 290
VKDPEV+ F+EKC+A R +A ELL+DPF + N D
Sbjct: 249 LVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMD 287
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (880), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 158/268 (58%), Positives = 210/268 (78%), Gaps = 1/268 (0%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
+EVDP+ R+ RY +++G GA K VY+AFD+ +GIEVAWNQVR+ + P + RL+SEV
Sbjct: 19 LEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEV 78
Query: 77 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 136
+LL++LK+ II Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct: 79 RLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQI 138
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 196
L GL YLH EP IIHRDL C NIFINGN G+VKIGDLG A ++ +++A S+IGTPE+M
Sbjct: 139 LMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197
Query: 197 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
APELY+E+Y E+ DIYSFG+C+LEMVT + PY EC + A+IYKKV+ G+KP +L++VKDP
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDP 257
Query: 257 EVKAFIEKCIAQPRARPSASELLKDPFF 284
EVK FIEKC+ R SA ELL DPF
Sbjct: 258 EVKQFIEKCLLPASERLSAKELLLDPFL 285
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| 449444502 | 296 | PREDICTED: probable serine/threonine-pro | 0.996 | 0.996 | 0.881 | 1e-154 | |
| 224131782 | 297 | predicted protein [Populus trichocarpa] | 0.996 | 0.993 | 0.857 | 1e-153 | |
| 356501717 | 297 | PREDICTED: probable serine/threonine-pro | 0.996 | 0.993 | 0.847 | 1e-148 | |
| 356551711 | 297 | PREDICTED: probable serine/threonine-pro | 0.996 | 0.993 | 0.841 | 1e-147 | |
| 359485884 | 301 | PREDICTED: probable serine/threonine-pro | 0.986 | 0.970 | 0.839 | 1e-146 | |
| 357495365 | 294 | MAP kinase-like protein [Medicago trunca | 0.972 | 0.979 | 0.838 | 1e-145 | |
| 296084996 | 831 | unnamed protein product [Vitis vinifera] | 0.966 | 0.344 | 0.846 | 1e-144 | |
| 356569661 | 298 | PREDICTED: probable serine/threonine-pro | 0.989 | 0.983 | 0.784 | 1e-141 | |
| 356524330 | 298 | PREDICTED: probable serine/threonine-pro | 0.996 | 0.989 | 0.766 | 1e-138 | |
| 255576306 | 298 | ATP binding protein, putative [Ricinus c | 0.959 | 0.953 | 0.788 | 1e-137 |
| >gi|449444502|ref|XP_004140013.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Cucumis sativus] gi|449505109|ref|XP_004162379.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1417), Expect = e-154, Method: Compositional matrix adjust.
Identities = 260/295 (88%), Positives = 273/295 (92%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MPA NS DRD EPFVEVDP+GRFGRY DLLGSGAVKKVYRAFDQEEGIEVAWNQVRL
Sbjct: 1 MPAENSIPYDRDAEPFVEVDPTGRFGRYDDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FS DPV +NRL SEVQLL TL NKYIIVCYSVW DD+HNTLNFITEVCTSGNLR YRKK
Sbjct: 61 NFSGDPVFINRLRSEVQLLSTLNNKYIIVCYSVWNDDEHNTLNFITEVCTSGNLRDYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVSIKALKKWSKQVLEGL+YLHTHEPCIIHRDLNCSNIF+NGNIGQVKIGDLGFAAIV
Sbjct: 121 HRHVSIKALKKWSKQVLEGLDYLHTHEPCIIHRDLNCSNIFVNGNIGQVKIGDLGFAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSF +CLLEMVTMEIPYSECDSVAKIYKK
Sbjct: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFAMCLLEMVTMEIPYSECDSVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 295
VT G+KPQA+ KV D EV+AFIEKCIAQPRARPSASELLKDPFF E+ D+DSE +
Sbjct: 241 VTTGIKPQAITKVTDAEVRAFIEKCIAQPRARPSASELLKDPFFDEVRDEDSEQT 295
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131782|ref|XP_002321177.1| predicted protein [Populus trichocarpa] gi|222861950|gb|EEE99492.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1408), Expect = e-153, Method: Compositional matrix adjust.
Identities = 253/295 (85%), Positives = 278/295 (94%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MPAA SN SDRD EPFVEVDP+GRFGRY+DLLG+GAVKKVYRAFDQ EGIEVAWNQVRL
Sbjct: 1 MPAARSNTSDRDDEPFVEVDPTGRFGRYNDLLGAGAVKKVYRAFDQHEGIEVAWNQVRLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+F EDPVL+NRLHSEVQLLRTLKNKYIIVCYSVWLD++ +LNFITEVCTSGNLR YRKK
Sbjct: 61 NFIEDPVLINRLHSEVQLLRTLKNKYIIVCYSVWLDEEDTSLNFITEVCTSGNLRDYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVS+KALK+WSKQVLEGLE+LHTH+PC+IHRDLNCSNIF+NGN GQVKIGDLGFA IV
Sbjct: 121 HRHVSLKALKRWSKQVLEGLEFLHTHDPCVIHRDLNCSNIFVNGNSGQVKIGDLGFATIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
G+SH AHSI+GTPE+MAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD+VAKIYKK
Sbjct: 181 GKSHTAHSILGTPEFMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 295
VT GVKPQALNKV DPEVKAFI KCIA+PRARPSAS+LLKD FFSE+NDD++ P+
Sbjct: 241 VTSGVKPQALNKVADPEVKAFILKCIAEPRARPSASDLLKDTFFSEVNDDETVPA 295
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501717|ref|XP_003519670.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1365), Expect = e-148, Method: Compositional matrix adjust.
Identities = 251/296 (84%), Positives = 272/296 (91%), Gaps = 1/296 (0%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MPA SN D + E FVEVDP+GRFGRYSDLLG GAVKKVYRAFDQEEGIEVAWNQVRL
Sbjct: 1 MPAEKSNSFDNEVEAFVEVDPTGRFGRYSDLLGCGAVKKVYRAFDQEEGIEVAWNQVRLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FSEDPVL+NRLHSEV LLRTL NKYIIVCYSVW D++ + +NFITEVCTSGNLR YRKK
Sbjct: 61 NFSEDPVLINRLHSEVDLLRTLSNKYIIVCYSVWKDEERHNINFITEVCTSGNLRDYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVSIKA KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIV
Sbjct: 121 HRHVSIKAFKKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
GR+HAAHSI+GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVT EIPYSECDSVAKIYKK
Sbjct: 181 GRNHAAHSILGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTTEIPYSECDSVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP 296
VT G+KP+AL+KV DPEVK FIEKCIAQPRARPSA++LLKDPFF ELN+D+ E +P
Sbjct: 241 VTMGIKPEALSKVTDPEVKEFIEKCIAQPRARPSATDLLKDPFFYELNNDE-ESTP 295
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551711|ref|XP_003544217.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1357), Expect = e-147, Method: Compositional matrix adjust.
Identities = 249/296 (84%), Positives = 271/296 (91%), Gaps = 1/296 (0%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MPA SN D + E FVEVDP+GRFGRYSDLLG GAVKKVY AFDQEEGIEVAWNQVRL
Sbjct: 1 MPAEKSNSCDSEVEAFVEVDPTGRFGRYSDLLGCGAVKKVYSAFDQEEGIEVAWNQVRLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FSEDPVL+NRLHSEV+LLRTL NKYIIVCYSVW D++ + +NFITEVCTSGNLR YRKK
Sbjct: 61 NFSEDPVLINRLHSEVELLRTLSNKYIIVCYSVWKDEERHNINFITEVCTSGNLRDYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVSIK KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIV
Sbjct: 121 HRHVSIKVFKKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
GR+HAAHSI+GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVT EIPYSECDSVAKIYKK
Sbjct: 181 GRNHAAHSILGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTTEIPYSECDSVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP 296
VT G+KP+AL+KV DPEVK FIEKCIAQPRARPSA++LLKDPFF ELN+D+ E +P
Sbjct: 241 VTMGIKPEALSKVTDPEVKEFIEKCIAQPRARPSATDLLKDPFFYELNNDE-ESTP 295
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485884|ref|XP_002270768.2| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 524 bits (1349), Expect = e-146, Method: Compositional matrix adjust.
Identities = 245/292 (83%), Positives = 270/292 (92%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MP+A+ N SD D EPFVEVDP+GR+GRYSDLLG GAVKKVYRAFDQEEGIEVAWNQV+L
Sbjct: 1 MPSASLNSSDHDTEPFVEVDPTGRYGRYSDLLGHGAVKKVYRAFDQEEGIEVAWNQVQLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FSED +V+RLHSEV+LL TLKN+ IIV YSVW D++HNTLNFITEVCTSGNLR YRK+
Sbjct: 61 NFSEDKSMVDRLHSEVKLLSTLKNESIIVLYSVWKDNEHNTLNFITEVCTSGNLRDYRKR 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVSIKALKKWS+QVL+GLEYLHTH+PCIIHRDLNCSNIFINGNIGQVKIGDLG AAIV
Sbjct: 121 HRHVSIKALKKWSRQVLKGLEYLHTHDPCIIHRDLNCSNIFINGNIGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
G++H AHS++GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD++AKIYKK
Sbjct: 181 GKNHLAHSVLGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNIAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292
VT GV P A+NKV DPEVK FIEKCIAQPRARPSASELL DPFFSELND D+
Sbjct: 241 VTSGVGPLAMNKVSDPEVKFFIEKCIAQPRARPSASELLNDPFFSELNDGDA 292
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357495365|ref|XP_003617971.1| MAP kinase-like protein [Medicago truncatula] gi|355519306|gb|AET00930.1| MAP kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 244/291 (83%), Positives = 267/291 (91%), Gaps = 3/291 (1%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MPA N D + EPF EVDP+GR+GRY+DLLGSGAVK+VYR FDQEEGIEVAWNQV+L
Sbjct: 1 MPAENW---DGEVEPFAEVDPTGRYGRYNDLLGSGAVKRVYRGFDQEEGIEVAWNQVKLR 57
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FS DPVL+NRLHSEV+LLR L NKYIIVCYSVW DD+ +NFITEVCTSGNLR YRKK
Sbjct: 58 NFSNDPVLINRLHSEVELLRNLSNKYIIVCYSVWKDDERGNINFITEVCTSGNLRDYRKK 117
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVSIKA KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIV
Sbjct: 118 HRHVSIKAFKKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIV 177
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
GR+HAAHSI+GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECDSVAKIYKK
Sbjct: 178 GRTHAAHSILGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDSVAKIYKK 237
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 291
VT G+KPQAL+ V++PEVKAFIEKCIAQPRARPSA++LLKDPFF ELN D+
Sbjct: 238 VTMGIKPQALSNVREPEVKAFIEKCIAQPRARPSATDLLKDPFFFELNSDE 288
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084996|emb|CBI28411.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 517 bits (1332), Expect = e-144, Method: Compositional matrix adjust.
Identities = 242/286 (84%), Positives = 265/286 (92%)
Query: 7 NMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP 66
N SD D EPFVEVDP+GR+GRYSDLLG GAVKKVYRAFDQEEGIEVAWNQV+L +FSED
Sbjct: 537 NSSDHDTEPFVEVDPTGRYGRYSDLLGHGAVKKVYRAFDQEEGIEVAWNQVQLRNFSEDK 596
Query: 67 VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI 126
+V+RLHSEV+LL TLKN+ IIV YSVW D++HNTLNFITEVCTSGNLR YRK+HRHVSI
Sbjct: 597 SMVDRLHSEVKLLSTLKNESIIVLYSVWKDNEHNTLNFITEVCTSGNLRDYRKRHRHVSI 656
Query: 127 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186
KALKKWS+QVL+GLEYLHTH+PCIIHRDLNCSNIFINGNIGQVKIGDLG AAIVG++H A
Sbjct: 657 KALKKWSRQVLKGLEYLHTHDPCIIHRDLNCSNIFINGNIGQVKIGDLGLAAIVGKNHLA 716
Query: 187 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246
HS++GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD++AKIYKKVT GV
Sbjct: 717 HSVLGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNIAKIYKKVTSGVG 776
Query: 247 PQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292
P A+NKV DPEVK FIEKCIAQPRARPSASELL DPFFSELND D+
Sbjct: 777 PLAMNKVSDPEVKFFIEKCIAQPRARPSASELLNDPFFSELNDGDA 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569661|ref|XP_003553016.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 230/293 (78%), Positives = 271/293 (92%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MP+ S+ SD+D EPFVEVDP+ R+GRYS+LLGSGAVKKVYRAFDQEEGIEVAWNQV+L
Sbjct: 1 MPSVKSDASDKDSEPFVEVDPTRRYGRYSELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FS+DP +++RL+SEV+LLR+L NK II YSVW D++HNTLNFITEVCTSGNLR YRKK
Sbjct: 61 NFSDDPAMLDRLYSEVRLLRSLTNKNIISLYSVWRDEKHNTLNFITEVCTSGNLRKYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVS++ALKKWSKQ+LEGL YLH H+PCIIHRDLNCSN+F+NGN GQVKIGDLG AAIV
Sbjct: 121 HRHVSMRALKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
G+SH+AHSI+GTPE+MAPELY+EDYTEMVDIYSFG+C+LEMVT+EIPYSECDSVAKIYKK
Sbjct: 181 GKSHSAHSILGTPEFMAPELYDEDYTEMVDIYSFGMCVLEMVTLEIPYSECDSVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 293
V+ GV+PQALNK+KD EVKAFIE+C+AQPRARPSA+ELLKDPFF L+ D+++
Sbjct: 241 VSSGVRPQALNKIKDAEVKAFIERCLAQPRARPSAAELLKDPFFDVLDGDEND 293
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524330|ref|XP_003530782.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1280), Expect = e-138, Method: Compositional matrix adjust.
Identities = 226/295 (76%), Positives = 269/295 (91%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MP+ + SD+D EPFVEVDP+ R+GRYS+LLG GAVKKVYRAFDQEEGIEVAWNQV+L
Sbjct: 1 MPSVKPDASDKDSEPFVEVDPTRRYGRYSELLGYGAVKKVYRAFDQEEGIEVAWNQVKLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+FS DP +V+RL+SEV+LLR+L NK II YSVW +++HNTLNFITEVCTSGNLR YRKK
Sbjct: 61 NFSYDPSMVDRLYSEVRLLRSLTNKNIISLYSVWREEKHNTLNFITEVCTSGNLREYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
H+HVS++ALKKWSKQ+LEGL YLH H+PCIIHRDLNCSN+F+NGN GQVKIGDLG AAIV
Sbjct: 121 HKHVSMRALKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
G++H+AHSI+GTPE+MAPELYEEDYTEMVDIYSFG+C+LEMVT+EIPY+ECDSVAKIYKK
Sbjct: 181 GKNHSAHSILGTPEFMAPELYEEDYTEMVDIYSFGMCVLEMVTLEIPYNECDSVAKIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 295
V+ GV+PQALNK+KD EVKAF+E+C+AQPRARPSA+ELLKDPFF L+ D+++ S
Sbjct: 241 VSSGVRPQALNKIKDAEVKAFVERCLAQPRARPSAAELLKDPFFDVLDCDENDDS 295
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576306|ref|XP_002529046.1| ATP binding protein, putative [Ricinus communis] gi|223531526|gb|EEF33357.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1269), Expect = e-137, Method: Compositional matrix adjust.
Identities = 224/284 (78%), Positives = 264/284 (92%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
MP+A + SD + E FVEVDP+GR+GRYS+LLG+GAVKKVYRAFDQEEGIEVAWNQVRL
Sbjct: 1 MPSAKPDPSDTESEHFVEVDPTGRYGRYSELLGTGAVKKVYRAFDQEEGIEVAWNQVRLR 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+F+ DP +++RL++EV+LLR+LKNK II Y+VW D++HNTLNFITEVCTSGNLR YRKK
Sbjct: 61 NFTNDPTIIDRLYAEVRLLRSLKNKNIISFYNVWHDEEHNTLNFITEVCTSGNLREYRKK 120
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
HRHVS+KALKKWSKQ+L+GL YLHTHEPCIIHRDLNCSN+ +NGNIGQVKIGDLG AAIV
Sbjct: 121 HRHVSMKALKKWSKQILKGLNYLHTHEPCIIHRDLNCSNLLVNGNIGQVKIGDLGLAAIV 180
Query: 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
G+SH+AHSI+GTPE+MAPELYEEDYTE+VDIYSFG+C+LEMVT+EIPYSECD+VA+IYKK
Sbjct: 181 GKSHSAHSILGTPEFMAPELYEEDYTEIVDIYSFGMCVLEMVTLEIPYSECDNVARIYKK 240
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 284
V+ G++P ALNKVKDPEVKAFIEKC+AQPR RPSA++LLKDPFF
Sbjct: 241 VSSGIRPLALNKVKDPEVKAFIEKCLAQPRVRPSAADLLKDPFF 284
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.976 | 0.920 | 0.764 | 7e-125 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.902 | 0.517 | 0.670 | 6.6e-97 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.959 | 0.405 | 0.6 | 3e-92 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.959 | 0.577 | 0.565 | 9.6e-89 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.956 | 0.502 | 0.564 | 4.7e-87 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.912 | 0.476 | 0.588 | 2.6e-86 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.905 | 0.481 | 0.572 | 1.7e-84 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.932 | 0.526 | 0.570 | 1.7e-84 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.912 | 0.472 | 0.566 | 1.7e-84 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.972 | 0.524 | 0.546 | 3.4e-84 |
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
Identities = 221/289 (76%), Positives = 260/289 (89%)
Query: 5 NSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE 64
N + D+D E FVEVDP+GR+GRY +LLGSGAVKKVYRAFDQEEGIEVAWNQV+L FS+
Sbjct: 10 NESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSD 69
Query: 65 DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV 124
DP + RL+SEV+LL+ LKN II Y VW D+++NTLNFITE+CTSGNLR YRKKHRHV
Sbjct: 70 DPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHV 129
Query: 125 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184
S++ALKKWSKQ+L+GL+YLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVG++H
Sbjct: 130 SMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNH 189
Query: 185 AAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
AHSI+GTPE+MAPELYEE+YTEMVDIYS+G+C+LE+V++EIPYSECDSVAKIYK+V+ G
Sbjct: 190 LAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKG 249
Query: 245 VKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 293
+KP+ALNKV DPE KAFIEKCIAQPRARPSA+ELL DPFF + DDD E
Sbjct: 250 LKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDE 298
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
Identities = 183/273 (67%), Positives = 223/273 (81%)
Query: 14 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-F--SEDPVLVN 70
E FVE+DP+GR+GRY ++LG GA K+VYRAFDQ EGIEVAWNQV+L F SED ++
Sbjct: 10 EEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSED---LD 66
Query: 71 RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 130
RL+SEV LL+TLK+K II Y+ W+D QH T+N ITEV TSGNLR YRKKH+ V ++ALK
Sbjct: 67 RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
KWS+Q+LEGL YLH+H+P +IHRDL C NIFINGN G+VKIGDLG AAI+ R+ +AHS+I
Sbjct: 127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186
Query: 191 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
GTPE+MAPELYEEDY +VDIY+FG+CLLE+VT E PYSEC + A+IY+KVT G+KP AL
Sbjct: 187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246
Query: 251 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPF 283
V DP+V+AFIEKCIA+ R SA ELL DPF
Sbjct: 247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPF 279
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 919 (328.6 bits), Expect = 3.0e-92, P = 3.0e-92
Identities = 174/290 (60%), Positives = 220/290 (75%)
Query: 6 SNMS--DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS 63
+N+S + D FVEVDP+GR+GRY+++LG GA K VYRAFD+ EGIEVAWNQV+L F
Sbjct: 2 NNLSYLEPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 61
Query: 64 EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH 123
+ P + RL+ E+ LL+TLK+K I+ Y+ W+D + +NF+TE+ TSG LR YR +H+
Sbjct: 62 QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKR 121
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183
V+I+A+K W +Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG AAI+ +S
Sbjct: 122 VNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181
Query: 184 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
HAAH + GTPE+MAPE+YEE Y E+VDIYSFG+C+LEMVT + PYSEC A+IYKKV
Sbjct: 182 HAAHCV-GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMS 240
Query: 244 GVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 293
G KP AL KVKDPEVK FIEKC+A R SA ELL DPF L DD E
Sbjct: 241 GKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPF---LRIDDGE 287
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
Identities = 163/288 (56%), Positives = 217/288 (75%)
Query: 6 SNMS--DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS 63
+N+S + D +VEVDP+GR+GRY+++LG G+ K VYR FD+ +GIEVAWNQV+L F
Sbjct: 3 NNLSHLESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFL 62
Query: 64 EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH 123
+ P + RL+ E+ LL+TLK+K I+ Y+ W+D + +NF+TE+ TSG LR YR KH+
Sbjct: 63 QSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKR 122
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183
V+I+A+K W +Q+L GL YLHTH+P +IHRDL C NIFINGN G+VKIGDLG AA + S
Sbjct: 123 VNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHS 182
Query: 184 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
HAAH + GTPE+MAPE+Y+E+Y ++VDIYSFG+C+LEMVT + PYSEC A+IYK+V
Sbjct: 183 HAAHCV-GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVIS 241
Query: 244 GVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 291
G KP L+KVKDPEV+ FIEKC+A R SA ELL D F +++ D
Sbjct: 242 GKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLC-IDESD 288
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 162/287 (56%), Positives = 213/287 (74%)
Query: 6 SNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED 65
S+M + D F E DPSGR+ RY D+LG GA K VY+AFD+ +GIEVAWN V + +
Sbjct: 12 SSMEEAD---FAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQM 68
Query: 66 PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS 125
P + RL+SEV LL+ LK++ II + W+D+++ T+N ITE+ TSG+LR YRKKHR V
Sbjct: 69 PGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVD 128
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185
KA+K W++Q+L+GL YLH+ P +IHRDL C NIF+NGN G+VKIGDLG A ++ +
Sbjct: 129 PKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVL-QQPT 187
Query: 186 AHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245
A S+IGTPE+MAPELYEE+Y E+VDIYSFG+C+LEMVT E PY+EC + A+IYKKVT +
Sbjct: 188 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNI 247
Query: 246 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292
KPQ+L KV DP+V+ FIEKC+ +RP+A EL KDPF + DS
Sbjct: 248 KPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDS 294
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 160/272 (58%), Positives = 213/272 (78%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
+EVDP+ R+ RY +++G GA K VY+AFD+ +GIEVAWNQVR+ + P + RL+SEV
Sbjct: 19 LEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEV 78
Query: 77 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 136
+LL++LK+ II Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct: 79 RLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQI 138
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 196
L GL YLH EP IIHRDL C NIFINGN G+VKIGDLG A ++ +++A S+IGTPE+M
Sbjct: 139 LMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197
Query: 197 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
APELY+E+Y E+ DIYSFG+C+LEMVT + PY EC + A+IYKKV+ G+KP +L++VKDP
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDP 257
Query: 257 EVKAFIEKCIAQPRARPSASELLKDPFFSELN 288
EVK FIEKC+ R SA ELL DPF +LN
Sbjct: 258 EVKQFIEKCLLPASERLSAKELLLDPFL-QLN 288
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 154/269 (57%), Positives = 211/269 (78%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
+E+DP+ R+ RY +++G GA K V++ FD+ +GIEVAWNQVR+ + P + RL+SEV
Sbjct: 19 LEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEV 78
Query: 77 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 136
+LL++LK+K II Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct: 79 RLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQI 138
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 196
L GL+YLH+ +P IIHRD+ C NIFINGN G+VKIGDLG A ++ +++A S+IGTPE+M
Sbjct: 139 LTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197
Query: 197 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
APELY+E+Y E+ DIYSFG+C+LEMVT E PY EC + A+IYKKV+ G+KP +L+KVKDP
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDP 257
Query: 257 EVKAFIEKCIAQPRARPSASELLKDPFFS 285
EV FIEKC+ R SA ELL D F +
Sbjct: 258 EVMKFIEKCLLPASERLSAEELLLDSFLN 286
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 158/277 (57%), Positives = 208/277 (75%)
Query: 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 75
FV+ DP+GR+ RY+D+LG GA K VY+AFD+ EGIEVAWN + + + P ++RL+SE
Sbjct: 6 FVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSE 65
Query: 76 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 135
V LL +LK+ II + W+DD + ++N ITE+ TSG+L YRKKHR V KA+ W++Q
Sbjct: 66 VHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQ 125
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
+L+GL YLH+ P +IHRDL C NIF+NGN G+VKIGDLG AA++ + A S+IGTPE+
Sbjct: 126 ILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVM-QQPTARSVIGTPEF 184
Query: 196 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255
MAPELYEE+Y E+VDIYSFG+C+LEMVT E PY EC + A+IYKKVT G+KPQ+L+KV D
Sbjct: 185 MAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDD 244
Query: 256 PEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292
P+VK FIEKC+ +RP+A ELLKD + DS
Sbjct: 245 PQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDS 281
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 153/270 (56%), Positives = 204/270 (75%)
Query: 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 75
+VE DP+GR+GR++++LG GA+K VY+A D++ GIEVAW+QV+L V + RL+SE
Sbjct: 9 YVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSE 68
Query: 76 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 135
V LL TL +K II Y+ W+D ++TLNFITE+ TSG LR Y+ K+ + I+A+K W++Q
Sbjct: 69 VHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQ 128
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
+LEGL YLH H+P +IHRDL C NIF+NG++GQVKIGDLG A ++ H+AHSIIGTPE+
Sbjct: 129 ILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEF 188
Query: 196 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255
MAPELYEE+Y E++D+YSFG+C LEM+T E PYSEC+ A+IYKKV GG P A +V D
Sbjct: 189 MAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGD 248
Query: 256 PEVKAFIEKCIAQPRARPSASELLKDPFFS 285
E + FI KC+ R SA ELL+DPF +
Sbjct: 249 IEAQRFIGKCLVSASKRVSAKELLQDPFLA 278
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 158/289 (54%), Positives = 209/289 (72%)
Query: 6 SNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED 65
S+ SD D +VE DPSGR+GR+ ++LG GA+K VY+AFDQ G+EVAWNQV+L+
Sbjct: 6 SSASD-DSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRS 64
Query: 66 PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS 125
P + RL+SEV LL+ L ++ II + W+D T NFITE+ TSG LR YR+K++ V
Sbjct: 65 PEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVD 124
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185
I+A+K W++Q+L GL YLH H+P +IHRDL C NIF+NG++GQVKIGDLG AAI+ S
Sbjct: 125 IRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQN 184
Query: 186 AHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245
AHS+IGTPE+MAPELYEEDY E+VDIYSFG+C+LEM+T E PYSEC + A+IYKKVT G
Sbjct: 185 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGK 244
Query: 246 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEP 294
P + + ++ E + F+ KC+ R A ELL DPF + ++ D P
Sbjct: 245 LPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAP 293
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6ICW6 | WNK11_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.775 | 0.9459 | 0.8917 | yes | no |
| Q0D541 | WNK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6909 | 0.9256 | 0.8379 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 296 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-67 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-48 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-44 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-41 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-40 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-40 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-29 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 208 bits (533), Expect = 6e-67
Identities = 85/258 (32%), Positives = 134/258 (51%), Gaps = 11/258 (4%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ LG G+ KVY A D++ G VA ++ +D R+ E+++L+ LK+ I+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR---ERILREIKILKKLKHPNIVR 61
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y V+ D+ L + E C G+L KK +S + + +Q+L LEYLH+
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK--G 117
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 208
I+HRDL NI ++ + G VK+ D G A + + +GTPEYMAPE L + Y +
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPEVKAFIEKCIA 267
VDI+S G+ L E++T + P+ D + +++KK+ PE K I K +
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 268 Q-PRARPSASELLKDPFF 284
+ P R +A E L+ PFF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-65
Identities = 89/259 (34%), Positives = 142/259 (54%), Gaps = 10/259 (3%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
LLG G+ VY A D++ G +A V LS SE+ + L E+++L +L++ I+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVRY 64
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
Y D++ NTLN E + G+L + KK + ++K+++Q+LEGL YLH++ I
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN--GI 122
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA---HSIIGTPEYMAPELYE-EDYT 206
+HRD+ +NI ++ + G VK+ D G A +G S+ GTP +MAPE+ E+Y
Sbjct: 123 VHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC- 265
DI+S G ++EM T + P+SE + K+ +P + + E K F+ KC
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241
Query: 266 IAQPRARPSASELLKDPFF 284
P+ RP+A ELL+ PF
Sbjct: 242 RRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-57
Identities = 85/261 (32%), Positives = 131/261 (50%), Gaps = 15/261 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSG+ VY+A + G VA ++ E E+++LR L + I+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D H L + E C G+L Y + +S KK + Q+L GLEYLH++ II
Sbjct: 65 DAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--II 120
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE--LYEEDYTEM 208
HRDL NI ++ N G VKI D G A ++ S + + +GTP YMAPE L Y
Sbjct: 121 HRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKV-KDPEVKAFIEK 264
VD++S G+ L E++T + P+S + + I + + ++ E K I+K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 265 CIAQ-PRARPSASELLKDPFF 284
C+ + P RP+A E+L+ P+F
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-55
Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 46/256 (17%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G VY A D++ G +VA ++ S L+ L E+++L+ L + I+ Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLY 57
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
V+ D+ H L + E C G+L+ ++ +S + + Q+LEGLEYLH++ I
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEE--DYTE 207
IHRDL NI ++ + G+VK+ D G + ++ + +I+GTP YMAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
DI+S G+ L E+ PE+K I K +
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 268 Q-PRARPSASELLKDP 282
+ P RPSA E+L+
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 9e-49
Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+ +G G +VY+A + G EVA ++L + ++ +E+Q+L+ K+
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK----EKIINEIQILKKCKHPN 58
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHT 145
I+ Y +L + L + E C+ G+L+ K + + K++L+GLEYLH+
Sbjct: 59 IVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 204
+ IIHRD+ +NI + + G+VK+ D G +A + + A ++++GTP +MAPE + +
Sbjct: 117 NG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 263
Y DI+S G+ +E+ + PYSE + ++K T G P N K E K F++
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLK 232
Query: 264 KC-IAQPRARPSASELLKDPF 283
KC P RP+A +LLK PF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-48
Identities = 70/262 (26%), Positives = 131/262 (50%), Gaps = 16/262 (6%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G+ KVY + +G ++ LS+ SE +EV++L+ L + II
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER--EDALNEVKILKKLNHPNIIK 63
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
Y + + L + E G+L + +K+ + + + W Q+ L+YLH+
Sbjct: 64 YYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED 204
+ I+HRD+ NIF+ N G VK+GD G + ++ + A +++GTP Y++PEL +
Sbjct: 122 RK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 205 -YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263
Y DI+S G L E+ T++ P+ E +++ ++ K+ G + + E++ +
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSELRNLVS 236
Query: 264 KCI-AQPRARPSASELLKDPFF 284
+ P RPS +++L+ PF
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-44
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 18/266 (6%)
Query: 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
+ +G G KVY A + + G +A ++R+ DP + + E+++L LK+ ++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ--DNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
Y V + + E C+ G L + R + ++ ++ Q+LEGL YLH+H
Sbjct: 63 KYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG- 119
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-----HSIIGTPEYMAPELYEE 203
I+HRD+ +NIF++ N G +K+GD G A + + S+ GTP YMAPE+
Sbjct: 120 -IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 204 D----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEV 258
+ DI+S G +LEM T + P+SE D+ +I V G KP + + PE
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPF 283
K F+++C+ P+ RP+ASELL+ PF
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-44
Identities = 87/265 (32%), Positives = 144/265 (54%), Gaps = 13/265 (4%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL-VNRLHSEVQLLRTLKNK 85
R LLG GA +VY +D + G E+A QV S + VN L E+QLL+ L+++
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ Y DD+ L+ E G+++ K + ++ +K+++Q+LEG+EYLH+
Sbjct: 65 RIVQYYGCLRDDET--LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA----AIVGRSHAAHSIIGTPEYMAPELY 201
+ I+HRD+ +NI + G VK+GD G + I S+ GTP +M+PE+
Sbjct: 123 NM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 202 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
E Y D++S G ++EM+T + P++E +++A I+K T PQ + V P+ +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238
Query: 261 FIEKCIAQP-RARPSASELLKDPFF 284
F+ + + + RPSA ELL+ F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-43
Identities = 84/259 (32%), Positives = 131/259 (50%), Gaps = 12/259 (4%)
Query: 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
DL+G GA VY+ + E G VA Q+ L E+ + + E+ LL+ LK+ I+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIV 62
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
++L I E +G+LR KK + + QVL+GL YL HE
Sbjct: 63 KYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL--HEQ 118
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPELYE-EDYT 206
+IHRD+ +NI + G VK+ D G A + S S++GTP +MAPE+ E +
Sbjct: 119 GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266
DI+S G ++E++T PY + + +A +++ V P L + PE+K F+ +C
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCF 235
Query: 267 A-QPRARPSASELLKDPFF 284
P RP+A +LLK P+
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 5e-43
Identities = 84/261 (32%), Positives = 130/261 (49%), Gaps = 10/261 (3%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL-SHFSEDPVLVNRLHSEVQLLRTLKNK 85
R +LLGSG+ VY + ++G A +V L V +L E+ LL L++
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ ++ + L E+ G+L KK+ ++ +++Q+L GLEYLH
Sbjct: 63 NIVQYLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EE 203
+HRD+ +NI ++ N G VK+ D G A V A S G+P +MAPE+ +
Sbjct: 121 RN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263
Y DI+S G +LEM T + P+S+ + VA ++K P + E K FI
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP-PIPDHLSDEAKDFIL 236
Query: 264 KCI-AQPRARPSASELLKDPF 283
KC+ P RP+A+ELL+ PF
Sbjct: 237 KCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 81/259 (31%), Positives = 133/259 (51%), Gaps = 16/259 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G+ VY+ + G A ++ H D +L E++ LR+ ++ Y++ CY
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--HEPC 149
+ + ++ + E G+L KK + L ++Q+L+GL+YLHT H
Sbjct: 66 GAFYKE--GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--- 120
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYEEDYTE 207
IIHRD+ SN+ IN G+VKI D G + ++ + ++ +GT YM+PE + E Y+
Sbjct: 121 IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 208 MVDIYSFGLCLLEMVTMEIPYS--ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265
DI+S GL LLE + P+ S ++ + + G P + PE + FI C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 266 IAQ-PRARPSASELLKDPF 283
+ + P+ RPSA+ELL+ PF
Sbjct: 240 LQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-41
Identities = 87/263 (33%), Positives = 141/263 (53%), Gaps = 10/263 (3%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 85
R LLG GA +VY +D + G E+A QV+ S E VN L E+QLL+ L ++
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ Y D TL+ E G+++ K + ++ +K+++Q+LEG+ YLH+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 201
+ I+HRD+ +NI + ++G VK+GD G I S+ GTP +M+PE+
Sbjct: 125 N--MIVHRDIKGANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 202 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
E Y DI+S G ++EM+T + P++E +++A I+K T P V D +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240
Query: 261 FIEKCIAQPRARPSASELLKDPF 283
F+++ + + RPSA ELL+ F
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 87/268 (32%), Positives = 143/268 (53%), Gaps = 24/268 (8%)
Query: 28 YSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 85
Y +L +G GA +VY+A D+ G EVA ++RL +++ +++N E+ +++ K+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE-LIIN----EILIMKDCKHP 75
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLE 141
I+ Y +L + L + E G+L + I + ++VL+GLE
Sbjct: 76 NIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLE 130
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPEL 200
YLH+ +IHRD+ NI ++ + G VK+ D GFAA + + + +S++GTP +MAPE+
Sbjct: 131 YLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 201 YE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVKDPEV 258
+ +DY VDI+S G+ +EM E PY + ++ T G+ + K PE
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW-SPEF 246
Query: 259 KAFIEKCIA-QPRARPSASELLKDPFFS 285
K F+ KC+ P RPSA ELL+ PF
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-40
Identities = 86/263 (32%), Positives = 141/263 (53%), Gaps = 10/263 (3%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 85
R LLG GA +VY +D + G E+A QV+ S E V+ L E+QLL+ L+++
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ Y D TL E G+++ K + ++ +K+++Q+LEG+ YLH+
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 201
+ I+HRD+ +NI + + G VK+GD G I S+ GTP +M+PE+
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 202 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
E Y D++S G ++EM+T + P++E +++A I+K T PQ + + + +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 261 FIEKCIAQPRARPSASELLKDPF 283
F+ + R RPSA ELL+ PF
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 82/263 (31%), Positives = 140/263 (53%), Gaps = 10/263 (3%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 85
R LLG GA +VY +D + G E+A QV S E VN L E+QLL+ L++
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ Y D + L+ E G+++ K + ++ +++++Q+L+G+ YLH+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 201
+ I+HRD+ +NI + + G VK+GD G I S+ GTP +M+PE+
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
E Y D++S ++EM+T + P++E +++A I+K T KP + V D +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 261 FIEKCIAQPRARPSASELLKDPF 283
F+++ + + RP+A LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-37
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 25/264 (9%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ LG G+ VY+A +E G VA V + ++ + E+ +L+ + YI+
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIVK 62
Query: 90 CYSVWLDDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
Y + ++ L + E C +G+ ++ K I A+ Q L+GLEYLH+
Sbjct: 63 YYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI---LYQTLKGLEYLHS 117
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYEE 203
++ IHRD+ NI +N GQ K+ D G + + + A +++IGTP +MAPE + E
Sbjct: 118 NK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAF 261
Y DI+S G+ +EM + PYS+ + I+ P L+ + PE F
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPPTLSDPEKWSPEFNDF 232
Query: 262 IEKC-IAQPRARPSASELLKDPFF 284
++KC + P RPSA +LL+ PF
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 92/288 (31%), Positives = 133/288 (46%), Gaps = 43/288 (14%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ LG G VY+A D++ G VA ++RL + E+ + L E+ LL+ LK+ I+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTAL-REISLLKELKHPNIVK 62
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 148
V ++ L F E C +L+ Y K +S +K Q+L GL Y H+H
Sbjct: 63 LLDVIHTERKLYLVF--EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH-- 117
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY--EE 203
I+HRDL NI IN + G +K+ D G A G R++ H ++ T Y APE+ +
Sbjct: 118 RILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSK 174
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI--------------------YKK 240
Y+ VDI+S G EM+T + + SE D + KI YK
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234
Query: 241 VTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
P+ L KV DPE + K + P R SA E LK P+F
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 75/256 (29%), Positives = 132/256 (51%), Gaps = 14/256 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ V++ + + A Q+ LS + E ++L L + YII Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS--KQVLEGLEYLHTHEPC 149
+LD LN + E +G+L K R + + W Q+L GL +LH+ +
Sbjct: 66 ESFLDKG--KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK-- 121
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPELYEED-YTE 207
I+HRD+ N+F++ VKIGDLG A ++ ++ A++I+GTP Y++PEL E+ Y E
Sbjct: 122 ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
D+++ G+ L E T + P+ + A I K + G P ++++ ++ I++C+
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP--VSQMYSQQLAQLIDQCLT 238
Query: 268 Q-PRARPSASELLKDP 282
+ R RP +LL++P
Sbjct: 239 KDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 31/270 (11%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
++ L +G G+ +VY+A D+ VA + L ++ + + E+Q L ++
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRS 58
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIKALKKWSKQVLEGL 140
YI Y +L + L I E C G+ L+ + +++ ++VL GL
Sbjct: 59 PYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL-----REVLLGL 111
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE 199
EYLH IHRD+ +NI ++ G VK+ D G + + + + ++ +GTP +MAPE
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 200 LY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVTGGVKPQALNKVK- 254
+ + Y E DI+S G+ +E+ E P S+ + I K P +L K
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-----NPPSLEGNKF 223
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
K F+ C+ + P+ RPSA ELLK F
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 30/273 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWN--QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG GA KVY+A +E G+ A Q+ ED ++ E+ +L K+ I+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV------EIDILSECKHPNIVG 66
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----SIKALKKWSKQVLEGLEYLHT 145
Y + + N L + E C G L + + I+ + +Q+LE L +LH+
Sbjct: 67 LYEAYFYE--NKLWILIEFCDGGALDSIMLELERGLTEPQIRYV---CRQMLEALNFLHS 121
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY--- 201
H+ +IHRDL NI + + G VK+ D G +A + + IGTP +MAPE+
Sbjct: 122 HK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 202 ---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPE 257
+ Y DI+S G+ L+E+ ME P+ E + ++ K+ P K
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSS 237
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPFFSELND 289
F++ C+ + P RP+A+ELLK PF S+ +D
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 15/265 (5%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
Y LG+G V + + G +A +RL + + ++ E+ +L + Y
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPY 60
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHT 145
I+ Y + ++ ++ E G+L K+ + + + L K + VL+GL YLH
Sbjct: 61 IVGFYGAFYNN--GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH- 117
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 204
+ IIHRD+ SNI +N GQ+K+ D G + + S A + +GT YMAPE + D
Sbjct: 118 EKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNS-LAKTFVGTSSYMAPERIQGND 175
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK----IYKKVTGGVKPQALNKVKDPEVKA 260
Y+ DI+S GL L+E+ T PY + + + + P+ + P+ +
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 261 FIEKC-IAQPRARPSASELLKDPFF 284
F+ C I PR RPS ELL+ PF
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-34
Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 29 SDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LG GA +VY+ ++ +EVA V+ + E +++R L +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYL 143
++ V +++ L + E G+L +Y +K+R +S+ L ++ Q+ G+EYL
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---YMAPEL 200
+ IHRDL N + N VKI D G + + G +MAPE
Sbjct: 119 ESK--NFIHRDLAARNCLVGEN-LVVKISDFGL-SRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 201 YEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPE 257
+E +T D++SFG+ L E+ T+ E PY S ++ + + G PQ N PE
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLKNGYRLPQPPNCP--PE 231
Query: 258 VKAFIEKC-IAQPRARPSASELLK 280
+ + +C P RP+ SEL++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 32 LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LG GA +VY+ + +EVA V+ + E +++R L + I
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHT 145
+ V +++ L + E G+L Y +K+R +S+ L ++ Q+ G+EYL +
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE------YMAPE 199
IHRDL N + N VKI D G + R +MAPE
Sbjct: 122 K--NFIHRDLAARNCLVGEN-LVVKISDFGLS----RDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 200 LYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV-TGGVKPQALNKVKDP 256
+E +T D++SFG+ L E+ T+ E PY S A++ + + G P+ N P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYLKKGYRLPKPPNCP--P 231
Query: 257 EVKAFIEKC-IAQPRARPSASELLK 280
E+ + +C P RP+ SEL++
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 14/268 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G +V + + A V+ H E + SE ++L + +I+ Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-QQEHIFSEKEILEECNHPFIVKLY 59
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D ++ + + E C G L T + + + V+ EYLH II
Sbjct: 60 RTFKDKKY--IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 210
+RDL N+ ++ N G VK+ D GFA + + GTPEY+APE+ + Y VD
Sbjct: 116 YRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 211 IYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIAQ 268
+S G+ L E++T P+ E D +IY + G D K I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 269 PRAR-----PSASELLKDPFFSELNDDD 291
P R ++ K +F+ + +
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 34/296 (11%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NK 85
R LG G+ +VY A D++ +V V R E+Q+L +L
Sbjct: 3 RILRKLGEGSFGEVYLARDRKLVA----LKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEY 142
I+ Y + D+ L + E G+L KK +S Q+L LEY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-------HAAHSIIGTPEY 195
LH+ IIHRD+ NI ++ + VK+ D G A ++ + +GTP Y
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 MAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 248
MAPE+ + DI+S G+ L E++T P+ + ++ K + P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 249 ALNKVK-------DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+ + ++K +A P+ R S+S L + L +S+ S
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 30 DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA +VY+ + EVA ++ E+ E ++++ L +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE---RKDFLKEARVMKKLGHPN 57
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------VSIKALKKWSKQVL 137
++ V +++ L + E G+L Y +K R +S+K L ++ Q+
Sbjct: 58 VVRLLGVCTEEEPLYL--VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE--- 194
+G+EYL +HRDL N + + VKI D G + R
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGED-LVVKISDFGLS----RDVYDDDYYRKKTGGK 168
Query: 195 ----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQ 248
+MAPE L + +T D++SFG+ L E+ T+ PY S ++ + + G +
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLP 227
Query: 249 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
D E+ + C P RP+ SEL++
Sbjct: 228 KPEYCPD-ELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 21/267 (7%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP-----VLVNRLHSEVQLLRTLKNK 85
L+GSG+ VY + G +A QV L S +++ L E+ LL+ L+++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ LD H LN E G++ + ++ + +Q+L+GL YLH
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-------IVGRSHAAHSIIGTPEYMAP 198
IIHRD+ +NI ++ N G +KI D G + + A S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 199 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ ++ YT DI+S G ++EM+T + P+ +C + I+ K+ P+ + + E
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 258 VKAFIEKCIA-QPRARPSASELLKDPF 283
F+EK RP+A+ELLK PF
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-32
Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 17/266 (6%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRL--SHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LG+GA Y+A D + G +A QV + SE +V L E++L+ L + +II
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+D H N E G++ K+ + +++Q+L GL YLH ++
Sbjct: 67 RMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAA-----IVGRSHAAHSIIGTPEYMAPE-LYE 202
IIHRD+ +N+ I+ +++I D G AA G ++GT +MAPE L
Sbjct: 124 -IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSE---CDSVAKIYKKVTGGVKPQALNKVKDPEVK 259
E Y D++S G ++EM T + P++ + +A I+ K+ ++ + P ++
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPEHLSPGLR 241
Query: 260 AFIEKCI-AQPRARPSASELLKDPFF 284
+C+ QP RP + ELLK P F
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-32
Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 14/256 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G VY+A +G VA +V++ D E+ LL+ L + +I
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 92 SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ ++++ N LN + E+ +G+L + ++K+ R + + + K+ Q+ LE++H+
Sbjct: 69 ASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 205
I+HRD+ +N+FI G VK+GDLG ++ AAHS++GTP YM+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 206 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
DI+S G L EM ++ P Y + ++ + KK+ P E++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 265 CI-AQPRARPSASELL 279
CI P RP S +L
Sbjct: 244 CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 33 GS-GAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
GS G V+KV R D + + W ++ + +E +L SEV +LR LK+ I+ Y
Sbjct: 11 GSFGTVRKVRRKSDGKI---LVWKEIDYGNMTEKEK--QQLVSEVNILRELKHPNIVRYY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+D + TL + E C G+L + +K+ +++ + + + Q+L L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 148 PC---IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYE 202
++HRDL +NIF++ N VK+GD G A I+G + A + +GTP YM+PE L
Sbjct: 126 DPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH 184
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---PEVK 259
Y E DI+S G + E+ + P++ A+ ++ +K ++ E+
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFT-----ARNQLQLASKIKEGKFRRIPYRYSSELN 239
Query: 260 AFIEKCIA-QPRARPSASELLKDPF 283
I+ + P RPS ELL+ P
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 19/261 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G+ KV ++ G A ++ + V +E +L + + +I+ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLH 59
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ ++ L + E G L ++ K S + + ++ +++ LEYLH+ II
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDYTEMV 209
+RDL NI ++ + G +K+ D G A + ++ GTPEY+APE L + Y + V
Sbjct: 116 YRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 210 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-TGGVK-PQALNKVKDPEVKAFIEKCIA 267
D +S G+ L EM+T + P+ + +IY+K+ ++ P+ L PE + I +
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILKDPLRFPEFL----SPEARDLISGLLQ 229
Query: 268 Q-PRAR---PSASELLKDPFF 284
+ P R A E+ PFF
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-31
Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 30/271 (11%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G GA VY A +VA ++ L V+ L EVQ + + ++ Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS---VDELRKEVQAMSQCNHPNVVKYY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNL-----RTYRKKHRHVSIKA--LKKWSKQVLEGLEYLH 144
+ ++ L + + G+L +Y + +I A LK +VL+GLEYLH
Sbjct: 66 TSFVVGD--ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK----EVLKGLEYLH 119
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI----VGRSHAA-HSIIGTPEYMAPE 199
++ IHRD+ NI + + G VKI D G +A R+ + +GTP +MAPE
Sbjct: 120 SNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 200 LYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKPQALNKVK 254
+ E+ Y DI+SFG+ +E+ T PYS+ + + + ++ A K
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ I C+ + P RP+A ELLK FF
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 21/261 (8%)
Query: 32 LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LG GA +VY+ + +VA ++ E +++ L + I
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKLSHPNI 63
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
+ V + + +TE G+L + RK +++K L + + Q+ +G+EYL +
Sbjct: 64 VRLLGVCTQGEPLYI--VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---YMAPELYEE 203
+HRDL N + N VKI D G + + G +MAPE ++
Sbjct: 122 --NFVHRDLAARNCLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 204 D-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261
+T D++SFG+ L E+ T+ E PY S ++ + + G + + E+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDGYRLPR-PENCPDELYEL 236
Query: 262 IEKCIA-QPRARPSASELLKD 281
+ +C A P RP+ SEL++D
Sbjct: 237 MLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 82/266 (30%), Positives = 127/266 (47%), Gaps = 27/266 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---KY 86
+L+G GA VYR G VA + L +D V+ + EV LL L+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPN 63
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEY 142
I Y +L L I E G++RT K +++S+ ++VL L+Y
Sbjct: 64 ITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVII-----REVLVALKY 116
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELY 201
+H +IHRD+ +NI + N G VK+ D G AA++ ++ + S +GTP +MAPE+
Sbjct: 117 IH-KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 202 EE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDPEV 258
E Y DI+S G+ + EM T PYS+ D+ + + KP L +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKSKPPRLEDNGYSKLL 231
Query: 259 KAFIEKCI-AQPRARPSASELLKDPF 283
+ F+ C+ +P+ R SA ELLK +
Sbjct: 232 REFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS--EVQLLRTLKNKYI 87
LG G+ VY+ + A +V L S+ R + E+++L ++ + I
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNI 61
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-------WSK--QVLE 138
I +LD N L + E G+L K K +K W Q+L
Sbjct: 62 ISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKR-----KKKRKLIPEQEIWRIFIQLLR 114
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 198
GL+ LH + I+HRDL +NI + N VKIGDLG + ++ + + A + IGTP YMAP
Sbjct: 115 GLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVL-KKNMAKTQIGTPHYMAP 170
Query: 199 ELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+++ Y+ DI+S G L EM T P+ E S+ + KV G P + + +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIYSQD 228
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDP 282
++ FI + P+ RP+ ++L P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-30
Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG VY+A D G VA ++L + ++ E+ +L+ ++ I+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKECRHPNIVAYF 66
Query: 92 SVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+L + L + E C G+L+ Y+ +S + ++ L+GL YLH
Sbjct: 67 GSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--K 122
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPELYEE----DY 205
IHRD+ +NI + + G VK+ D G +A + + A S IGTP +MAPE+ Y
Sbjct: 123 IHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIE 263
DI++ G+ +E+ ++ P + + ++ P L +K K P FI+
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241
Query: 264 KC-IAQPRARPSASELLKDPF 283
KC P+ RP+A++LL+ PF
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 81/267 (30%), Positives = 131/267 (49%), Gaps = 21/267 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQLLRTLKNKYI 87
++LG GA VY +G +A QV L + +L EV LL++LK+ I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ LDD NT++ E G++ + + + K++KQ+L+G+ YL H
Sbjct: 65 VQYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL--HN 120
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSII-----GTPEYMAPE 199
C++HRD+ +N+ + N G +K+ D G A A VG H HS + GTP +MAPE
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVG-LHGTHSNMLKSMHGTPYWMAPE 178
Query: 200 LYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-GVKPQALNKVKDPE 257
+ E Y DI+S G + EM T + P + D +A ++ G+ P+ +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238
Query: 258 VKAFIEKCIAQPR-ARPSASELLKDPF 283
+ F+ C+ + + RPSA +LL+ F
Sbjct: 239 ID-FVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 30/276 (10%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ R+ + +G GA VY A D G EVA Q+ L + +++N E+ ++
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN----EILVM 70
Query: 80 RTLKNKYII-------VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 132
R K+ I+ V +W+ ++ +T+V T + I A+
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAV--- 120
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIG 191
++ L+ LE+LH+++ +IHRD+ NI + G G VK+ D GF A + + S ++G
Sbjct: 121 CRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 192 TPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
TP +MAPE+ + Y VDI+S G+ +EMV E PY + + +Y T G P+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQ 236
Query: 251 NKVK-DPEVKAFIEKCI-AQPRARPSASELLKDPFF 284
N K + F+ +C+ R SA ELL+ PF
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G VY+A D+ G VA +++L E + E++LL+ L + II
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
V+ L + E + + + + R + +K + Q+L+GL + H+H I+
Sbjct: 65 DVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEED--YTEM 208
HRDL N+ IN G +K+ D G A G ++ + T Y APEL D Y+
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 209 VDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVK----------- 254
VDI+S G E+++ + SE D + KI+ + G P+ K
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF-RTLGTPDPEVWPKFTSLARNYKFSFP 238
Query: 255 --------------DPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
P+ + + + P R +A + L P+F
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 75/253 (29%), Positives = 134/253 (52%), Gaps = 14/253 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G +VYRA +G+ VA +V++ + + + E+ LL+ L + +I Y
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYY 68
Query: 92 SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ +++D N LN + E+ +G+L + ++K+ R + K + K+ Q+ LE++H+
Sbjct: 69 ASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 205
++HRD+ +N+FI G VK+GDLG ++ AAHS++GTP YM+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 206 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
DI+S G L EM ++ P Y + ++ + KK+ P + E++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 265 CI-AQPRARPSAS 276
CI P RP +
Sbjct: 244 CINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 87/270 (32%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR----LHSEVQLLRTLKNKY 86
+LG G VY A D QVR++ E P +R LH E+ L LK++
Sbjct: 15 VLGKGTYGIVYAARDLS-------TQVRIA-IKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIK--ALKKWSKQVLEGLEYL 143
I V Y + D ++ E G+L R K + + ++KQ+LEGL+YL
Sbjct: 67 I-VQY-LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYE 202
H ++ I+HRD+ N+ +N G VKI D G + + G + + GT +YMAPE+ +
Sbjct: 125 HDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 203 E---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----PQALNKVK 254
+ Y DI+S G ++EM T + P+ E KV G K P++L+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPESLSA-- 239
Query: 255 DPEVKAFIEKCIA-QPRARPSASELLKDPF 283
E K FI +C P R SA +LL+DPF
Sbjct: 240 --EAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 76/268 (28%), Positives = 131/268 (48%), Gaps = 24/268 (8%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG GA V + + G+ A + +P L ++ E+++ ++ K+ YI+ Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNL-RTY---RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+LD+ +++ E C G+L Y +K+ + K L K ++ VL+GL YLH+ +
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 206
IIHRD+ SNI + GQVK+ D G + + S A + GT YMAPE + + Y+
Sbjct: 126 --IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKPYS 181
Query: 207 EMVDIYSFGLCLLEMVTMEIPY--SECDSVAKIYKKVTGGVKPQALNKVKDPEV------ 258
D++S GL LLE+ P+ + I + ++ V +P
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 259 --KAFIEKCIAQ-PRARPSASELLKDPF 283
K FI++C+ + P RP+ ++L+ P+
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G +VY+A +++ G VA ++R+ + E P+ R E++LL+ L++ I+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIVRL 63
Query: 91 YSVWLDDQHNTLNFITEVCT---SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ ++ + E +G L + K + +K + KQ+LEGL+YLH++
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHSNG 120
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHS--IIGTPEYMAPELY--E 202
I+HRD+ SNI IN N G +K+ D G A R+ A ++ +I T Y PEL
Sbjct: 121 --ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK---VTGGVKPQALN----- 251
Y VD++S G L E+ + + +E + + KI++ T P
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236
Query: 252 -----------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
+ DP ++K + P+ R SA + L+ +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 27/273 (9%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRL------SHFSEDPVLVNRLHSEVQLLRTLK 83
+L+G G +VY A + G +A QV L H S +V L SE++ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
+ I+ + L+ E G++ + + + + ++ +++QVLEGL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH------AAHSIIGTPEYMA 197
H+ I+HRDL N+ ++ + G KI D G I +S S+ G+ +MA
Sbjct: 125 HSKG--ILHRDLKADNLLVDAD-GICKISDFG---ISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 198 PE---LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK----KVTGGVKPQAL 250
PE Y + Y+ VDI+S G +LEM P+S+ +++A ++K + + P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 251 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPF 283
+ + P RP+A ELL+ PF
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 82/286 (28%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 16 FVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
F + DP F +DL +G G+ VY A D VA ++ S + +
Sbjct: 8 FSKDDPEKLF---TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW-QDII 63
Query: 74 SEVQLLRTLKNKYII---VCY----SVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRH 123
EV+ L+ L++ I CY + WL + E C S L ++K +
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWL---------VMEYCLGSASDILEVHKKPLQE 114
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183
V I A+ L+GL YLH+H IHRD+ NI + G VK+ D G A++V
Sbjct: 115 VEIAAI---CHGALQGLAYLHSH--ERIHRDIKAGNILLTEP-GTVKLADFGSASLVS-- 166
Query: 184 HAAHSIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 239
A+S +GTP +MAPE+ E Y VD++S G+ +E+ + P ++++ +Y
Sbjct: 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 240 KVTGGVKPQALNKVK-DPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
L+ + F++ C+ + P+ RPS+ ELLK F
Sbjct: 226 IAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-26
Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 16/269 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ RY + G GA V+ A D G EVA Q+ L + +++N E+ ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN----EILVM 70
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
+ LKN I+ +L + L + E G+L T + + ++ L+
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQA 127
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 198
LE+LH ++ +IHRD+ N+ + G G VK+ D GF A + + S ++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 199 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DP 256
E+ + Y VDI+S G+ +EMV E PY + + +Y T G P+ N K P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSP 243
Query: 257 EVKAFIEKCIAQP-RARPSASELLKDPFF 284
+ F+ +C+ R SA ELL+ PF
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG GA KVY+A ++E G A + E + E+++L T + YI+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYMVEIEILATCNHPYIVKLL 75
Query: 92 SVWLDDQHNTLNFITEVCTSGNL-RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ D L + E C G + + R ++ ++ +Q+LE L+YLH+ + I
Sbjct: 76 GAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE------LYEE 203
IHRDL N+ + + G +K+ D G +A V S IGTP +MAPE + +
Sbjct: 132 IHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 262
Y DI+S G+ L+EM +E P+ E + + ++ K+ P K E + F+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQPSKWSMEFRDFL 249
Query: 263 EKCIAQ-PRARPSASELLKDPFFSELN 288
+ + + P RPSA++LL+ PF S +
Sbjct: 250 KTALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 86/310 (27%), Positives = 137/310 (44%), Gaps = 46/310 (14%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY L +GSGA V A D+ G +VA ++S+ +D + R+ E++LLR L++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 85 KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
+ II + N +TE+ + +L K + ++ ++ + Q+L GL+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMA 197
YLH+ +IHRDL SNI +N N +KI D G A V + T Y A
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 198 PE--LYEEDYTEMVDIYSFGLCLLEMVTMEI--------------------PYSE----- 230
PE L YT+ +DI+S G E++T + P E
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234
Query: 231 CDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286
A+ Y K + L+K+ PE +EK + P+ R +A E L P+ ++
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
Query: 287 LNDDDSEPSP 296
L+D + EP
Sbjct: 295 LHDPEDEPVA 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 32 LGSGAVKK--VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL-HSEVQLLRTLKNKYII 88
LG GA + +YR E+ V W +V L+ SE R +E+ +L L++ II
Sbjct: 8 LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNII 62
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
Y+ ++DD NTL E G L + R+K + + + + Q++ + Y+H
Sbjct: 63 AYYNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-- 118
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE-ED 204
+ I+HRD+ NIF+ G +K+GD G + I+G ++ A +++GTP YM+PEL +
Sbjct: 119 KAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP---EVKAF 261
Y DI++ G L E++T++ + + + + K V G P V E+ +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-----VVSVYSSELISL 232
Query: 262 IEKCIAQ-PRARPSASELLKDPF 283
+ + Q P RP+A E+L P
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 13/215 (6%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKW 132
E QLL LK+ I+ W + + L + C G+L + +K + + + +W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFAAIV-GRSHAAHSII 190
Q+ L+YLH E I+HRDL N+F+ NI +K+GDLG A ++ + A ++I
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLI 163
Query: 191 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
GTP YM+PEL+ + Y D+++ G C+ EM T++ ++ D + +Y+ + G + P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-- 221
Query: 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 283
+ K PE+ I ++ +P RPS +L+ P+
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP + + G G+ V A D+ G +VA ++ L +L N EV ++
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN----EVVIM 70
Query: 80 RTLKNKYIIVCYSVWL-DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 138
R ++ I+ YS +L D+ L + E G L T H ++ + + VL+
Sbjct: 71 RDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLK 126
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMA 197
L +LH +IHRD+ +I + + G+VK+ D GF A V + S++GTP +MA
Sbjct: 127 ALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 198 PELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-D 255
PE+ Y VDI+S G+ ++EMV E PY + + K++ + P+ N K
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS 242
Query: 256 PEVKAFIEKCIA-QPRARPSASELLKDPFF 284
P +++F+++ + P R +A+ELL PF
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 28/266 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV------LVNRLHSEVQLLRTLKNK 85
LG G+ VY D++ A + RL E PV + + E QLL L +
Sbjct: 8 LGKGSFGTVYLVKDKK-----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLE 141
I+ ++ +L + + ITE C +L + + +S + +W Q+L G+
Sbjct: 63 AIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE- 199
Y+H I+HRDL NIF+ N+ +KIGD G + ++G A + GTP YM+PE
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPE 257
L + Y DI+S G L EM + + + ++ + + V G P+ ++ +
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 258 VKAFIEKCIAQPRARPSASELLKDPF 283
+++ + K P RPSA+E+L++PF
Sbjct: 237 MQSMLNK---DPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 67/256 (26%), Positives = 125/256 (48%), Gaps = 12/256 (4%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
++G GA V+ + + V Q+ + ++D +E Q+L+ L + II
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEY 64
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI--KALKKWSKQVLEGLEYLHTHEP 148
Y +L+D L + E G L Y +K + + + + Q+L L ++HT
Sbjct: 65 YENFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTE 207
I+HRDL NI ++ + VKIGD G + I+ A++++GTP Y++PEL E + Y +
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
DI++ G L E+ +++ + + A + K ++G P ++ P+++ I +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--ISDRYSPDLRQLILSMLN 238
Query: 268 -QPRARPSASELLKDP 282
P RP S+++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---- 84
+G GA VY+A D G VA +VR+ SE+ + ++ L E+ LL+ L++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRV-PLSEEGIPLSTLR-EIALLKQLESFEHP 61
Query: 85 ---KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEG 139
+ + VC+ D+ L + E +L TY K + + +K +Q+L G
Sbjct: 62 NIVRLLDVCH-GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 199
+++LH+H I+HRDL NI + + GQVKI D G A I A S++ T Y APE
Sbjct: 120 VDFLHSH--RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 200 -LYEEDYTEMVDIYSFGLCLLEMVTMEIP----YSECDSVAKIYKKV------------- 241
L + Y VD++S G E+ P SE D + KI+ +
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRR-PLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235
Query: 242 --------TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
++ E ++K + P R SA E L+ P+F
Sbjct: 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 9e-25
Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNK 85
++G G+ V A ++E E A + V + + L R +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE----VLTRLNGHP 62
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
II Y + D+ N L F+ E +G L Y +K+ + K + ++ ++L LEYLH+
Sbjct: 63 GIIKLYYTF-QDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH------------------ 187
IIHRDL NI ++ + +KI D G A ++ + +
Sbjct: 121 KG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 188 ---SIIGTPEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
S +GT EY++PEL E D+++ G + +M+T + P+ + ++K+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR-GSNEYLTFQKI-- 234
Query: 244 GVKPQALN----KVKDPEVKAFIEK-CIAQPRARPSAS----ELLKDPFF 284
L P+ K IEK + P+ R + EL PFF
Sbjct: 235 ----LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-24
Identities = 82/272 (30%), Positives = 133/272 (48%), Gaps = 22/272 (8%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ R+ + G GA VY A D G EVA Q+ L + +++N E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN----EILVM 70
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
R KN I+ +L + L + E G+L T + + ++ L+
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 127
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 198
L++LH+++ +IHRD+ NI + G G VK+ D GF A + + S ++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 199 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----KPQALNKV 253
E+ + Y VDI+S G+ +EMV E PY + + +Y T G P+ L+ V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244
Query: 254 KDPEVKAFIEKCIAQP-RARPSASELLKDPFF 284
+ F+ +C+ R SA ELL+ PF
Sbjct: 245 ----FRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 20/234 (8%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V+++ +E +L ++ Y++ Y + L + E G+L + + +
Sbjct: 37 VDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDEDV 94
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF--AAIVGR---- 182
+ + +++ LEYLH++ IIHRDL NI I+ N G +K+ D G +V R
Sbjct: 95 ARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINL 151
Query: 183 ---SHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 238
I+GTP+Y+APE + + +++ VD +S G L E + P+ ++ +I+
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIF 210
Query: 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARP---SASELLKDPFFSELN 288
+ + G + E I K + P R S E+ PFF ++
Sbjct: 211 QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 6e-24
Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-LHSEVQLLRTLKNKYII 88
LG G VY+A D+E G VA +++L E +N E++LL+ LK+ II
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHE 147
V+ + +N + E +L K V A +K + L GLEYLH++
Sbjct: 66 GLLDVFGHKSN--INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPELY--EE 203
I+HRDL +N+ I + G +K+ D G A G H ++ T Y APEL
Sbjct: 123 --ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GVK----P 247
Y VD++S G E++ + +P+ S+ D + KI+ + G GV
Sbjct: 179 HYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIF-EALGTPTEENWPGVTSLPDY 236
Query: 248 QALNKVKDPEVKA-----------FIEKCIA-QPRARPSASELLKDPFFSEL 287
+K +++ + P R +A + L+ P+FS
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-24
Identities = 69/257 (26%), Positives = 131/257 (50%), Gaps = 14/257 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G +VYRA + VA +V++ + + + E+ LL+ L + +I
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-KEIDLLKQLNHPNVIKYL 68
Query: 92 SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+++D N LN + E+ +G+L + ++K+ R + + + K+ Q+ +E++H+
Sbjct: 69 DSFIED--NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 205
++HRD+ +N+FI G VK+GDLG ++ AAHS++GTP YM+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 206 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
DI+S G L EM ++ P Y + ++ + +K+ P + +++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 265 CI-AQPRARPSASELLK 280
CI P RP + +
Sbjct: 244 CIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 1e-23
Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ R+ + G GA VY A D G EVA Q+ L + +++N E+ ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
R KN I+ +L + L + E G+L T + + ++ L+
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 128
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 198
LE+LH+++ +IHRD+ NI + G G VK+ D GF A + + S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 199 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ + Y VDI+S G+ +EM+ E PY + + +Y T G P+ N K
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244
Query: 258 V-KAFIEKCI-AQPRARPSASELLKDPFF 284
+ + F+ +C+ R SA ELL+ F
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-23
Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 35/282 (12%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+Y ++LG G VY+A+ +A V++ L ++ SE+++L + Y
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
II Y + + N ++ TE G+L YRK HV L + + V++GL YL +
Sbjct: 61 IIGFYGAFFVE--NRISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
+ I+HRD+ SN+ +N GQVK+ D G + + S A + +GT YMAPE + E Y
Sbjct: 115 K--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY 170
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD--------- 255
D++S G+ +E+ PY + +K G + P Q L + D
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQ-------IQKNQGSLMPLQLLQCIVDEDPPVLPVG 223
Query: 256 ---PEVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSE 293
+ FI +C+ QP+ RP+ L+ PF + ND ++E
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAE 265
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-23
Identities = 61/233 (26%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V + +E ++L+++++ +++ Y + DD + L + E G L ++ +K
Sbjct: 45 VEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPV 102
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAH 187
+ ++ QV+ LEYLH+ + I++RDL N+ ++ + G +KI D GFA V GR +
Sbjct: 103 ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR---TY 156
Query: 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246
++ GTPEY+APE + + Y + VD ++ G+ + EM+ P+ + D+ +IY+K+ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEG-- 213
Query: 247 PQALNKVK-----DPEVKAFIEK-CIAQPRAR-----PSASELLKDPFFSELN 288
KV+ P+ K I R +++ P+F+ ++
Sbjct: 214 -----KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-23
Identities = 72/259 (27%), Positives = 130/259 (50%), Gaps = 15/259 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ K+Y A + + ++ L+ ++ EV LL +K+ I+ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHPNIVTFF 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + ++ L + E C G+L R R++ S + W Q+ GL+ H H+
Sbjct: 66 ASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--HIHDRK 121
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE-EDYTE 207
I+HRD+ NIF++ N K+GD G A + S A++ +GTP Y++PE+ + Y
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-VKPQALNKVKDPEVKAFIEKCI 266
DI+S G L E+ T++ P+ E +++ ++ K+ G P + N +D +++ I +
Sbjct: 182 KTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNFSRD--LRSLISQLF 238
Query: 267 -AQPRARPSASELLKDPFF 284
PR RPS + +LK PF
Sbjct: 239 KVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIKALKK 131
EV+ L+ LK+ I +L + +T + E C S L ++K + V I A+
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-- 126
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+ L+GL YLH+H +IHRD+ NI + GQVK+ D G A+ A+S +G
Sbjct: 127 -THGALQGLAYLHSH--NMIHRDIKAGNILLT-EPGQVKLADFGSASKSS---PANSFVG 179
Query: 192 TPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247
TP +MAPE+ E Y VD++S G+ +E+ + P ++++ +Y
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239
Query: 248 QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
N+ D + F++ C+ + P+ RP+++ELL+ F
Sbjct: 240 LQSNEWTD-SFRGFVDYCLQKIPQERPASAELLRHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-22
Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 20/264 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG GA KVY+A ++E G+ A + SE+ + E+ +L + + I+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEEL--EDYMVEIDILASCDHPNIVKLL 68
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ N L + E C G + + R ++ ++ KQ LE L YLH ++ I
Sbjct: 69 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY------EE 203
IHRDL NI + G +K+ D G +A R+ S IGTP +MAPE+ +
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 262
Y D++S G+ L+EM +E P+ E + + ++ K+ P + E K F+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 263 EKCIAQP-RARPSASELLKDPFFS 285
+KC+ + AR + ++LL+ PF +
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 57/179 (31%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 117 YRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173
Y+K + + L K + +++ LEYLH+ +IHRD+ SN+ IN N GQVK+ D
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRN-GQVKLCD 147
Query: 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPY 228
G + + S A G YMAPE + Y D++S G+ ++E+ T PY
Sbjct: 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
Query: 229 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
+ + K+V PQ + PE + F+ KC+ + + RP+ ELL+ PFF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 30/291 (10%)
Query: 3 AANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF 62
++ S + + E++ R +GSGA VY+ + G A + +H
Sbjct: 60 SSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVIYGNH- 111
Query: 63 SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR 122
ED V ++ E+++LR + + ++ C+ ++ D + + + E G+L
Sbjct: 112 -EDTVR-RQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE 167
Query: 123 HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182
L ++Q+L G+ YLH I+HRD+ SN+ IN VKI D G + I+ +
Sbjct: 168 Q----FLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQ 220
Query: 183 S-HAAHSIIGTPEYMAPELYEEDYTEMV------DIYSFGLCLLEMVTMEIPY--SECDS 233
+ +S +GT YM+PE D DI+S G+ +LE P+
Sbjct: 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
Query: 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
A + + P+A E + FI C+ + P R SA +LL+ PF
Sbjct: 281 WASLMCAICMSQPPEAPATAS-REFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 42/289 (14%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP+G F +++G G KVY+A ++ G VA +++ ED + E +L
Sbjct: 3 DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVA---IKIMDIIED--EEEEIKEEYNIL 56
Query: 80 RTLKN-KYIIVCYSVWL-------DDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIK 127
R N I Y ++ DDQ L + E+C G+ ++ RKK + + +
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQ---LWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAA 186
+ ++ L GL YLH ++ +IHRD+ NI + N +VK+ D G +A + +
Sbjct: 114 WIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRR 170
Query: 187 HSIIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
++ IGTP +MAPE+ + Y D++S G+ +E+ + P + + ++K
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
Query: 241 VTGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPSASELLKDPF 283
P +K PE FI +C I RP ELL+ PF
Sbjct: 231 PRN--PPP---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 75/257 (29%), Positives = 129/257 (50%), Gaps = 15/257 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ V A ++ G +VA + L +L N EV ++R +++ ++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIMRDYQHQNVVEMY 84
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+L + L + E G L + R ++ + + + VL+ L YLH+ +I
Sbjct: 85 KSYLVGEE--LWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED-YTEMV 209
HRD+ +I + + G+VK+ D GF A + + S++GTP +MAPE+ Y V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 210 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIA- 267
DI+S G+ ++EMV E PY DS + K++ P+ N K P ++ F+E+ +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 268 QPRARPSASELLKDPFF 284
+P+ R +A ELL PF
Sbjct: 258 EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 20/265 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G V + G +A V H + ++ E+Q++ ++ YI+ Y
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+L++ + + E G+L KK + ++ L K + V+EGL YL+ + I+
Sbjct: 70 GAFLNENNICM--CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY-NVHRIM 126
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 210
HRD+ SNI +N GQ+K+ D G + + S A + +GT YM+PE + YT D
Sbjct: 127 HRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 211 IYSFGLCLLEMVTMEIPYSE-------CDSVAKIYKKVTGGVK--PQALNKVKDPEV-KA 260
++S G+ ++E+ + P++ D I + V+ P L PE +
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 261 FIEKCIAQ-PRARPSASELLKDPFF 284
F++ C+ + P RP+ +L P F
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 29/295 (9%)
Query: 2 PAANSNMSDRD---GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQ 56
P+ + S +D E F + DP F +DL +G G+ VY A D VA +
Sbjct: 1 PSTSRAGSLKDPEIAELFFKEDPEKLF---TDLREIGHGSFGAVYFARDVRTNEVVAIKK 57
Query: 57 VRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGN 113
+ S + + + EV+ L+ +K+ I +L + +T + E C S
Sbjct: 58 MSYSGKQSNEKWQDII-KEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYCLGSASDL 114
Query: 114 LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173
L ++K + V I A+ + L+GL YLH+H +IHRD+ NI + GQVK+ D
Sbjct: 115 LEVHKKPLQEVEIAAI---THGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD 168
Query: 174 LGFAAIVGRSHAAHSIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYS 229
G A+I A+S +GTP +MAPE+ E Y VD++S G+ +E+ + P
Sbjct: 169 FGSASIAS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225
Query: 230 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
++++ +Y + P + + F++ C+ + P+ RP++ ELLK F
Sbjct: 226 NMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-21
Identities = 86/289 (29%), Positives = 126/289 (43%), Gaps = 44/289 (15%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN------ 84
+G GA VY+A D G VA VR+ + P+ R EV LL+ L+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLEAFDHPNI 64
Query: 85 -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLE 141
+ + VC + D+ + + E +LRTY K + + +K +Q L GL+
Sbjct: 65 VRLMDVCATS-RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 200
+LH + CI+HRDL NI + GQVK+ D G A I A ++ T Y APE L
Sbjct: 123 FLHAN--CIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIY------------KKVT--- 242
+ Y VD++S G EM + + SE D + KI+ + VT
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 243 GGVKPQALNKVKD--PEVKA-----FIEKCIAQPRARPSASELLKDPFF 284
G P+ V+ PE++ +E P R SA L+ PFF
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 73/264 (27%), Positives = 110/264 (41%), Gaps = 42/264 (15%)
Query: 58 RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY 117
+L H P + N++ E+++L + YI+ Y + D ++ E G+L
Sbjct: 32 KLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQV 89
Query: 118 RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177
KK + L K S VL GL YL + I+HRD+ SNI +N G++K+ D G +
Sbjct: 90 LKKAGRIPENILGKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVS 147
Query: 178 AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIP--------- 227
+ S A+S +GT YM+PE L YT DI+S GL L+EM P
Sbjct: 148 GQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
Query: 228 -----YSECDSVAKIYKKVTGGV-----KPQAL----------------NKVKDPEVKAF 261
+ AK + G +P A+ + E + F
Sbjct: 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF 266
Query: 262 IEKC-IAQPRARPSASELLKDPFF 284
++KC P+ R EL K PF
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 70/260 (26%), Positives = 130/260 (50%), Gaps = 17/260 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG VY+A + G A ++L ED +V + E+ +++ K+ I+ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQ---EIIMMKDCKHSNIVAYF 72
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+L + + L E C G+L+ +S + S++ L+GL YLH+ +
Sbjct: 73 GSYL--RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEED----YT 206
HRD+ +NI + N G VK+ D G +A + + A S IGTP +MAPE+ + Y
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIEK 264
++ DI++ G+ +E+ ++ P + + ++ +P L +K+K F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247
Query: 265 CIAQ-PRARPSASELLKDPF 283
+ + P+ RP+A +LL+ PF
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 68/219 (31%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
L +EV ++R +++ ++ Y+ +L + L + E G L T H ++ + +
Sbjct: 64 LFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAA 120
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSII 190
VL+ L LH +IHRD+ +I + + G+VK+ D GF A V + S++
Sbjct: 121 VCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 191 GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
GTP +MAPEL Y VDI+S G+ ++EMV E PY + K K + + P+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKL 236
Query: 250 LNKVK-DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
N K P +K F+++ + + P R +A+ELLK PF ++
Sbjct: 237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-20
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 24 RFGRYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
R ++ LG G KV G +VA L+H E+ + E+++L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQHR-SDFEREIEIL 60
Query: 80 RTLKNKYIIVCYSVWLDDQH-NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVL 137
RTL ++ IV Y + +L I E SG+LR Y ++HR +++K L +S Q+
Sbjct: 61 RTLDHEN-IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE--- 194
+G++YL + IHRDL NI + VKI D G A ++ + + E
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 195 -YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 223
+ APE L ++ D++SFG+ L E+ T
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 77/280 (27%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 13 GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 72
E F + DP F ++ G G+ VY A D VA ++ S + + +
Sbjct: 5 AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIKAL 129
EV+ L+ L++ I +L + +T + E C S L ++K + V I A+
Sbjct: 64 -KEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
+ L+GL YLH+H +IHRD+ NI ++ G VK+GD G A+I+ A+
Sbjct: 121 ---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXF 171
Query: 190 IGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245
+GTP +MAPE+ E Y VD++S G+ +E+ + P ++++ +Y +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNE 230
Query: 246 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
P + + F++ C+ + P+ RP++ LLK F
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 22/277 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D LG G VY+ + G+ +A ++RL D N++ E+ +L + YI+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVD 63
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK---ALKKWSKQVLEGLEYLHTH 146
Y + + E +G+L L++ + V++GL++L
Sbjct: 64 FYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KE 120
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 204
E IIHRD+ +N+ +NGN GQVK+ D G + + S A + IG YMAPE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGP 178
Query: 205 -----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPE 257
YT D++S GL +LEM PY ++ A I+ +++ V P L +
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSE 293
+ F+ KC+ + P RP+ ++LL+ P+ + + D +
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-19
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 15/267 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP F + + +G G+ +VY+ D VA + L ++ + + E+ +L
Sbjct: 1 DPEELFTKL-ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE---IEDIQQEITVL 56
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
+ YI Y +L + L I E G+ K + + +++L+G
Sbjct: 57 SQCDSPYITRYYGSYL--KGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAP 198
L+YLH+ IHRD+ +N+ ++ G VK+ D G A + + ++ +GTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ ++ Y DI+S G+ +E+ E P S+ + ++ + P L
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LIPKNSPPTLEGQYSKP 228
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPF 283
K F+E C+ + PR RP+A ELLK F
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 15/267 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP F + + G G+ +V++ D VA + L ++ + + E+ +L
Sbjct: 1 DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE---IEDIQQEITVL 56
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
+ Y+ Y +L D L I E G+ + + + +++L+G
Sbjct: 57 SQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 198
L+YLH+ + IHRD+ +N+ ++ + G+VK+ D G A + + + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ ++ Y DI+S G+ +E+ E P+SE + ++ + P L
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--LIPKNNPPTLEGNYSKP 228
Query: 258 VKAFIEKCI-AQPRARPSASELLKDPF 283
+K F+E C+ +P RP+A ELLK F
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-19
Identities = 81/294 (27%), Positives = 124/294 (42%), Gaps = 58/294 (19%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLK-NKYII 88
LG G VY A ++E G VA ++ + + E L EV+ LR L + I+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE----CMNLR-EVKSLRKLNEHPNIV 61
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLH 144
V+ ++ L F+ E GNL Y +K + S ++ Q+L+GL ++H
Sbjct: 62 KLKEVFRENDE--LYFVFE-YMEGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPE--LY 201
H HRDL N+ ++G VKI D G A + RS + + T Y APE L
Sbjct: 117 KHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREI-RSRPPYTDYVSTRWYRAPEILLR 172
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ--------- 248
Y+ VDI++ G + E+ T+ P SE D + KI V G Q
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKIC-SVLGTPTKQDWPEGYKLA 230
Query: 249 -ALNKVKDPEVKA----------------FIEKCIA-QPRARPSASELLKDPFF 284
L + P+ I+ + P+ RP+AS+ L+ P+F
Sbjct: 231 SKLG-FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V + +E ++L+ L + +++ + + D+++ + + ++ G+LR + + S +
Sbjct: 44 VRNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQ 101
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188
+K W +++ LEYLH+ IIHRD+ NI ++ G V I D A V S
Sbjct: 102 VKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTS 158
Query: 189 IIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 228
GTP YMAPE+ + Y+ VD +S G+ E + + PY
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
+H+E ++L+ + + +II + D + L + E G L +Y + S
Sbjct: 48 VHNEKRVLKEVSHPFIIRLFWTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLF 105
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 190
++ +++ LEYLH+ E I++RDL NI ++ G +K+ D GFA + R+ ++
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDRTW---TLC 159
Query: 191 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
GTPEY+APE + + + + VD ++ G+ + EM+ P+ + D+ IY+K+ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAG----- 213
Query: 250 LNKVK-----DPEVKAFIEKCIAQPRAR 272
K++ D K I+K + R R
Sbjct: 214 --KLEFPRHLDLYAKDLIKKLLVVDRTR 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-19
Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 15/232 (6%)
Query: 53 AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSG 112
A ++RL S V E LL +K+ I+ + D H L + E C G
Sbjct: 29 AMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAFKESFEADGH--LYIVMEYCDGG 83
Query: 113 NL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170
+L + ++ + + +W Q+ G++ H HE ++HRD+ NIF+ N G+VK
Sbjct: 84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVK 140
Query: 171 IGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPY 228
+GD G A ++ A A + +GTP Y+ PE++E Y DI+S G L E+ T++ P+
Sbjct: 141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
Query: 229 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 279
I K G KP L E+++ I++ + PR+RPSA+ +L
Sbjct: 201 QANSWKNLILKVCQGSYKP--LPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ V A ++ G +VA ++ L +L N EV ++R ++ ++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN----EVVIMRDYHHENVVDMY 85
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ +L + L + E G L T H ++ + + VL L YLH +I
Sbjct: 86 NSYL--VGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEE-DYTEMV 209
HRD+ +I + + G++K+ D GF A V + S++GTP +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 210 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV-KAFIE-KCIA 267
DI+S G+ ++EM+ E PY + + +++ + P+ + K V + F++ +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 268 QPRARPSASELLKDPFF 284
+P R +A ELL+ PF
Sbjct: 259 EPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-19
Identities = 72/284 (25%), Positives = 136/284 (47%), Gaps = 35/284 (12%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP+G F +L+G+G +VY+ + G A + ++ E+ + E+ +L
Sbjct: 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-----KQEINML 56
Query: 80 RTLKNKYIIVCY--------SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
+ + I Y +DDQ L + E C +G++ K + ++K ++
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQ---LWLVMEFCGAGSVTDLIKNTKGNTLK--EE 111
Query: 132 W----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-A 186
W +++L GL +LH H+ +IHRD+ N+ + N +VK+ D G +A + R+
Sbjct: 112 WIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR 168
Query: 187 HSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
++ IGTP +MAPE+ D Y D++S G+ +EM P + + ++
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-L 227
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRA-RPSASELLKDPF 283
+ P+ +K + ++FIE C+ + + RP+ +L+K PF
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 89/306 (29%), Positives = 137/306 (44%), Gaps = 53/306 (17%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY DL +G GA V A DQ G VA ++ + FS PVL R + E++LL+ L++
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFST-PVLAKRTYRELKLLKHLRH 68
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-----WSKQVLEG 139
+ II +++ + + F+TE+ + HR ++ + L+K + Q+L G
Sbjct: 69 ENIISLSDIFISPLED-IYFVTELLGT-------DLHRLLTSRPLEKQFIQYFLYQILRG 120
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 199
L+Y+H+ ++HRDL SNI IN N +KI D G A I + + T Y APE
Sbjct: 121 LKYVHS--AGVVHRDLKPSNILINENC-DLKICDFGLARI--QDPQMTGYVSTRYYRAPE 175
Query: 200 --LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY----------KKVTGGV-- 245
L + Y VDI+S G EM+ + + D V + V +
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235
Query: 246 -------------KPQAL-NKVK--DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288
+P K K DP +EK + P+ R SA+E L P+ + +
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295
Query: 289 DDDSEP 294
D EP
Sbjct: 296 DPTDEP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 70/267 (26%), Positives = 125/267 (46%), Gaps = 15/267 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP F + + +G G+ +V++ D VA + L +ED + + E+ +L
Sbjct: 1 DPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEI--EDIQQEITVL 56
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
+ Y+ Y +L + L I E G+ + + + K++L+G
Sbjct: 57 SQCDSPYVTKYYGSYL--KGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLKEILKG 113
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAP 198
L+YLH+ + IHRD+ +N+ ++ G VK+ D G A + + ++ +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ ++ Y DI+S G+ +E+ E P S+ + ++ + P L
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLTGEFSKP 228
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPF 283
K FI+ C+ + P RP+A ELLK F
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 82/317 (25%), Positives = 137/317 (43%), Gaps = 56/317 (17%)
Query: 26 GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY DL LG G+ V+ A D + VA ++ L+ DP V E++++R L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLD 60
Query: 84 NKYIIVCYSVWLDDQH------------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
+ I+ Y V N++ +I + +L + +S + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSV-YIVQEYMETDLANVLE-QGPLSEEHARL 118
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--SHAAHSI 189
+ Q+L GL+Y+H+ ++HRDL +N+FIN +KIGD G A IV SH +
Sbjct: 119 FMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 190 IG--TPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT----------ME--------IP 227
G T Y +P L +YT+ +D+++ G EM+T +E +P
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 228 Y------SECDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASE 277
+E +V + + GG + L + +PE F+E+ + P R +A E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 278 LLKDPFFSELNDDDSEP 294
L P+ S + EP
Sbjct: 297 ALMHPYMSCYSCPFDEP 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVC 90
+G G KVY+A D+ G VA + RL ++ + E+ LL+ L ++ YI+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 91 YSVWLDDQHN-------TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
V ++ N ++ R R + K +K + Q+L+G+ +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------AHSIIGTPEYMA 197
H H ++HRDL N+ ++ G +KI DLG +GR+ + H I+ T Y A
Sbjct: 127 HKHG--VMHRDLKPQNLLVDKQKGLLKIADLG----LGRAFSIPVKSYTHEIV-TLWYRA 179
Query: 198 PE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-------KVTGGV 245
PE L Y+ VDI+S G EM + + SE + I+K +V GV
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239
Query: 246 ------------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
KPQ L++ PE ++K + P R SA L P+F
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 77/312 (24%), Positives = 135/312 (43%), Gaps = 58/312 (18%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA +V AFD + G +VA +LS + + R + E++LL+ + +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 85 KYIIVCYSVWLDDQHN----TLNFITEVCTS--GN-LRTYRKKHRHVSIKALKKWSKQVL 137
+ +I V+ + +T + + N ++ + H+ Q+L
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY-----QIL 128
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPE 194
GL+Y+H+ IIHRDL SNI +N + ++KI D G A H + G T
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA-----RHTDDEMTGYVATRW 180
Query: 195 YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQAL 250
Y APE L Y + VDI+S G + E++T + + D + ++ + + G + L
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 251 NKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPF 283
K+ + +I+ P+ R +A+E L P+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 284 FSELNDDDSEPS 295
+E +D + EP
Sbjct: 301 LAEYHDPEDEPV 312
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 41/218 (18%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII 88
+G G +VY+A D++ G VA +VRL + E P+ R E+++LR L ++ I+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIV 69
Query: 89 VCYSVWLDDQHNTLNFITE-----------------VCTSGNLRTYRKKHRHVSIKALKK 131
+ D Q + L+F + + SG L + + H +K
Sbjct: 70 NLKEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKS 120
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV----GRSHAAH 187
+ KQ+LEGL Y H +HRD+ CSNI +N N GQ+K+ D G A + R +
Sbjct: 121 FMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 188 SIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT 223
I T Y PEL EE Y +D++S G L E+ T
Sbjct: 178 VI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLK 83
RY L +G GA V++A D+E G VA +V L P R E++ L+ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
+ Y++ V+ L E S R + R + +K + + +L+G+ Y+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVM--EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR------SHAAHSIIGTPEYMA 197
H I+HRDL +N+ I G +KI D G A + SH + T Y A
Sbjct: 116 H--ANGIMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQ----VATRWYRA 168
Query: 198 PELY--EEDYTEMVDIYSFGLCLLEM 221
PEL Y VD+++ G E+
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 79/313 (25%), Positives = 128/313 (40%), Gaps = 68/313 (21%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV-- 89
+GSGA V A D G +VA ++ H + P L R E+++LR K+ II
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 90 ------------CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 137
Y V +D + L+ I + + L H+ + Q+L
Sbjct: 71 DILRPPGADFKDVYVV-MDLMESDLHHI--IHSDQPLTE-----EHIRY-----FLYQLL 117
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGT 192
GL+Y+H+ +IHRDL SN+ +N + +++IGD G A + S H + T
Sbjct: 118 RGLKYIHS--ANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 193 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME--IPYSECDSVAKIYKKVTGGVKPQ 248
Y APEL +YT +D++S G EM+ P K+ V G +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234
Query: 249 ALNKVKDPEVKAFIEKC----------------------IAQ-----PRARPSASELLKD 281
LN++ V+ +I+ ++Q P R + + L+
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 282 PFFSELNDDDSEP 294
PF ++ +D D EP
Sbjct: 295 PFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 85/310 (27%), Positives = 140/310 (45%), Gaps = 56/310 (18%)
Query: 27 RYSDLL--GSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY DL GSGA V A D+ G +VA ++ SE + R + E++LL+ +K+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKH 73
Query: 85 KYIIVCYSVW-----LDDQHNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLE 138
+ +I V+ LD H+ + + T G L KH +S ++ Q+L+
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKL----MKHEKLSEDRIQFLVYQMLK 129
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEY 195
GL+Y+H IIHRDL N+ +N + ++KI D G A + G T Y
Sbjct: 130 GLKYIHA--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA-----RQTDSEMTGYVVTRWY 181
Query: 196 MAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALN 251
APE L YT+ VDI+S G + EM+T + + D + ++ + KVTG + +
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 252 KVKDPEVKAFIEK---------------------------CIAQPRARPSASELLKDPFF 284
K++ + K +++K + +R +A+E L P+F
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
Query: 285 SELNDDDSEP 294
E +D + E
Sbjct: 302 EEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 71/262 (27%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIV 89
+GSG +VY+ ++ G +A Q+R + E+ R+ ++ +L++ YI+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE---NKRILMDLDVVLKSHDCPYIVK 78
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEP 148
CY ++ D + FI S L K+ + + L K + +++ L YL +
Sbjct: 79 CYGYFITD---SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-KH 134
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-----E 203
+IHRD+ SNI ++ + G VK+ D G + + S A G YMAPE +
Sbjct: 135 GVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFI 262
Y D++S G+ L+E+ T + PY C + ++ K+ P N+ P+ +F+
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV 253
Query: 263 EKCIAQ-PRARPSASELLKDPF 283
+ C+ + R RP ELL+ PF
Sbjct: 254 DLCLTKDHRKRPKYRELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G VYRA D G VA +VR+ + D + ++ L E+ LL L++ I+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
V + +++ + E C S +K Q+L GL+YLH + II
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--FII 130
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--EED 204
HRDL SN+ + G +KI D G A G A + TP+ Y APEL
Sbjct: 131 HRDLKVSNLLLTDK-GCLKIADFGLARTYG--LPAKPM--TPKVVTLWYRAPELLLGCTT 185
Query: 205 YTEMVDIYSFGLCLLEMVTME 225
YT +D+++ G L E++ +
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G VY+A ++ G VA ++RL +E P R E+ LL+ L + I+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 64
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
V + N L + E +L+ + + + +K + Q+L+GL + H+H
Sbjct: 65 LDVIHTE--NKLYLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR- 120
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ IN G +K+ D G A G R++ H ++ T Y APE L +
Sbjct: 121 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 176
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-------KVTGGV-------- 245
Y+ VDI+S G EMVT + SE D + +I++ V GV
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236
Query: 246 -----KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
Q +KV D + + + + + P R SA L PFF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 81/289 (28%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G VY+A D+ G VA ++RL E P R E+ LL+ L + I+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLEGLEYLHTHEP 148
V + N L + E +L+ Y + +K + Q+L+G+ Y H+H
Sbjct: 64 LDVVHSE--NKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR- 119
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ I+ G +K+ D G A G R++ H ++ T Y APE L
Sbjct: 120 -VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGSR 175
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG--------GV------- 245
Y+ VDI+S G EMV + SE D + +I+ + G GV
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF-RTLGTPDEDVWPGVTSLPDYK 234
Query: 246 ------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
Q L+KV D + + K + P R SA L+ P+F
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 84/314 (26%), Positives = 137/314 (43%), Gaps = 61/314 (19%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY+ L +GSGA V A D+ G +VA ++ SE + R + E+ LL+ +++
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQH 73
Query: 85 KYIIVCYSVWLDDQ------HNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQV 136
+ +I LD +F ++T +K +S ++ Q+
Sbjct: 74 ENVIG----LLDVFTSAVSGDEFQDF---YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TP 193
L GL+Y+H+ IIHRDL N+ +N + ++KI D G A HA + G T
Sbjct: 127 LCGLKYIHS--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA-----RHADAEMTGYVVTR 178
Query: 194 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 249
Y APE L Y + VDI+S G + EM+T + + D + ++ + KVTG P+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238
Query: 250 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 282
+ K++D K++I+ PR R +A+E L+ P
Sbjct: 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298
Query: 283 FFSELNDDDSEPSP 296
+F D D E
Sbjct: 299 YFDSFRDADEETEQ 312
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 67/257 (26%), Positives = 119/257 (46%), Gaps = 14/257 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ K +E+G + ++ +S S P EV +L +K+ I V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNI-VQY 64
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 149
++ N L + + C G+L R V + W Q+ L+ H H+
Sbjct: 65 QESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--HVHDRK 121
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE-EDYTE 207
I+HRD+ NIF+ + G +K+GD G A ++ + A + IGTP Y++PE+ E Y
Sbjct: 122 ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
DI++ G L EM T++ + + + K + G P + + +++ + +
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH--YSYDLRNLVSQLFK 238
Query: 268 Q-PRARPSASELLKDPF 283
+ PR RPS + +L+ F
Sbjct: 239 RNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G V++ + G+ +A +L H P + N++ E+Q+L + YI+ Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D ++ E G+L KK + + L K S V++GL YL I+
Sbjct: 70 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 210
HRD+ SNI +N G++K+ D G + + S A+S +GT YM+PE L Y+ D
Sbjct: 127 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 211 IYSFGLCLLEMVTMEIPYSECDS 233
I+S GL L+EM P D+
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 80/280 (28%), Positives = 129/280 (46%), Gaps = 44/280 (15%)
Query: 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
S +LGSGA V A +G A V + SE NR +EV L I+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK--NRAQAEVCCLLNCDFFSIV 94
Query: 89 VCYSVWL-DDQHNTLN-----FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE---G 139
C+ + D N N + + +G+LR IK+ K ++ E G
Sbjct: 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ--------EIKSRAKTNRTFREHEAG 146
Query: 140 LEYL-------HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI--------VGRSH 184
L ++ H H +IHRD+ +NI + N G VK+GD GF+ + VGR+
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRT- 204
Query: 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
GTP Y+APE++ Y++ D++S G+ L E++T++ P+ + ++K + G
Sbjct: 205 ----FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260
Query: 244 GVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDP 282
P L PE++ + + + P+ RPS+S+LL P
Sbjct: 261 RYDP--LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-17
Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 14/196 (7%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L + E G+ + K + K++ +V+ G+E LH IIHRD+ N+
Sbjct: 72 LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLL 129
Query: 162 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLE 220
I+ G +K+ D G + +GTP+Y+APE +M D +S G + E
Sbjct: 130 IDQT-GHLKLTDFGLSRNG---LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 221 MVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKCI-AQPRARPSAS- 276
+ P+ ++ ++ + P+ + + PE I + + P R A+
Sbjct: 186 FLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG 244
Query: 277 --ELLKDPFFSELNDD 290
E+ PFF +N D
Sbjct: 245 YQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 77/308 (25%), Positives = 139/308 (45%), Gaps = 52/308 (16%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V AFD + G+ VA +LS + + R + E++LL+ +K+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 85 KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
+ +I V+ ++ N + +T + +L K + ++ ++ Q+L GL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK-LTDDHVQFLIYQILRGL 133
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 197
+Y+H+ + IIHRDL SN+ +N + ++KI D G A H + G T Y A
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTDDEMTGYVATRWYRA 185
Query: 198 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 253
PE+ Y + VDI+S G + E++T + D + K+ ++ G + L K+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 254 KDPEVKAFIEKCIAQPR---------------------------ARPSASELLKDPFFSE 286
+ +I+ P+ R +A++ L +F++
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
Query: 287 LNDDDSEP 294
+D D EP
Sbjct: 306 YHDPDDEP 313
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-17
Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 17/260 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG VY+A + G A ++L +D L+ + E+ +++ K+ I+ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQ---EIFMVKECKHCNIVAYF 72
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+L + L E C G+L+ +S + ++ L+GL YLH+ +
Sbjct: 73 GSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEED----YT 206
HRD+ +NI + N G VK+ D G AA + + A S IGTP +MAPE+ + Y
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIE- 263
++ DI++ G+ +E+ ++ P + + ++ +P L +K K F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 264 KCIAQPRARPSASELLKDPF 283
P+ RP+A LL F
Sbjct: 248 SLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V + E +L L + +I+ + D+ N + F+ E G L T+ +K
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188
K + +++ EYLH+ + II+RDL N+ ++ G VK+ D GFA V +
Sbjct: 120 AKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKV--PDRTFT 174
Query: 189 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
+ GTPEY+APE+ + + + + VD ++ G+ L E + P+ + D+ +IY+K+ G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 35/284 (12%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP+G F +++G+G +VY+ + G A + ++ E+ + E+ +L
Sbjct: 13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI-----KLEINML 66
Query: 80 RTLKN-KYIIVCYSVWL-------DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 131
+ + + I Y ++ DDQ L + E C +G++ K + ++K +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQ---LWLVMEFCGAGSVTDLVKNTKGNALK--ED 121
Query: 132 W----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA- 186
W +++L GL +LH H+ +IHRD+ N+ + N +VK+ D G +A + R+
Sbjct: 122 WIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR 178
Query: 187 HSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
++ IGTP +MAPE+ D Y DI+S G+ +EM P + + ++
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L 237
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPR-ARPSASELLKDPF 283
+ P+ +K + FIE C+ + +RPS +LLK PF
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 8 MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 67
+ D D E E LG+G V + + G+ +A +L H P
Sbjct: 2 LKDDDFERISE-------------LGAGNGGVVTKVQHKPSGLIMA---RKLIHLEIKPA 45
Query: 68 LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 127
+ N++ E+Q+L + YI+ Y + D ++ E G+L K+ + + +
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEE 103
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
L K S VL GL YL I+HRD+ SNI +N G++K+ D G + + S A+
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MAN 160
Query: 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
S +GT YM+PE L Y+ DI+S GL L+E+ P D+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 85/291 (29%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN----- 84
+G GA KV++A D + G VA +VR+ E P+ R EV +LR L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---EVAVLRHLETFEHPN 65
Query: 85 --KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGL 140
+ VC +V D+ L + E +L TY K V + +K Q+L GL
Sbjct: 66 VVRLFDVC-TVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+H ++HRDL NI + + GQ+K+ D G A I A S++ T Y APE
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQAL-NKVKD 255
L + Y VD++S G EM + + S+ D + KI V G + V
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVAL 239
Query: 256 PEV---------------------KAFIEKCIA-QPRARPSASELLKDPFF 284
P K + KC+ P R SA L P+F
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVC 90
+G G +V +A ++ G A ++ HF VN L E+Q LR L + I+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFK-SLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
V D + L + E+ NL + + R + K +K + Q+L+ L+++H +
Sbjct: 64 IEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LYEEDYTE 207
I HRD+ NI I +I +K+ D G + I T Y APE L + Y
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178
Query: 208 MVDIYSFGLCLLEMVTME--IPYS-ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF--- 261
+DI++ G E++++ P + E D +AKI+ V G + L K + +
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD-VLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 262 ------IEKCIAQ----------------PRARPSASELLKDPFF 284
+ K + P R +A + L+ P+F
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 61/234 (26%), Positives = 112/234 (47%), Gaps = 31/234 (13%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL-RTYRKKHR---HVSIKALK 130
EV ++R LK+K I+ +L+ + L + E C +G+L R +K ++ + A+
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 131 KWSKQVLEGLEYLHTHEPC-----IIHRDLNCSNIFINGNIGQV---------------- 169
++Q+L L Y H + ++HRDL NIF++ I +
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEI 226
KIGD G + +G AHS +GTP Y +PEL + Y + D+++ G + E+ + +
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 227 PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELL 279
P+ + ++ +++ ++ G P K K E+ I+ + + RPSA + L
Sbjct: 242 PFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 18/229 (7%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V + +E +L T K+++++ + DD++ L E G+ RT +S
Sbjct: 45 VRHVLTERDILTTTKSEWLVKLLYAFQDDEY--LYLAMEYVPGGDFRTLLNNLGVLSEDH 102
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAH 187
+ + ++ E ++ LH E IHRDL N F+ G +K+ D G + IV A+
Sbjct: 103 ARFYMAEMFEAVDALH--ELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---AN 156
Query: 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYS-----ECDSVAKIYKKV 241
S++G+P+YMAPE L + Y VD +S G L E + P+S E K +K+
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 242 TG-GVKPQALNKVKDPEVKAFIEKCIAQPRAR-PSASELLKDPFFSELN 288
V + D E I K I P R S ++ PFF E++
Sbjct: 217 LQRPVYDDPRFNLSD-EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 55/176 (31%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 117 YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176
Y + + L K + ++ L YL E IIHRD+ SNI ++ N G +K+ D G
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRN-GNIKLCDFGI 154
Query: 177 AAIVGRSHAAHSIIGTPEYMAPEL----YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD 232
+ + S A G YMAPE + Y D++S G+ L E+ T + PY + +
Sbjct: 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
Query: 233 SVAKIYKKVTGGVKPQALN---KVKDPEVKAFIEKC-IAQPRARPSASELLKDPFF 284
SV +V G P N + P FI C I RP ELL+ PF
Sbjct: 215 SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 40/233 (17%)
Query: 75 EVQLLRTLKNKYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKAL 129
E+++L++L++ I+ VCYS L + E G+LR Y +KHR + + L
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSA----GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL 110
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
++ Q+ +G+EYL + +HRDL NI + + +VKIGD G ++ + + +
Sbjct: 111 LLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 190 IGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTG 243
E + APE L E ++ D++SFG+ L E+ T YS+ S + ++ G
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMG 223
Query: 244 GVKPQA------LNKVKD-----------PEVKAFIEKCIA-QPRARPSASEL 278
K + +K+ E+ A +++C P RPS SEL
Sbjct: 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 53/264 (20%), Positives = 107/264 (40%), Gaps = 50/264 (18%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK- 127
+ L E+ R L++ I+ + ++ D L ++ + G+ K H +
Sbjct: 43 LKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLPE 100
Query: 128 -ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHA 185
A+ K VL L+Y+H + I HR + S+I ++G+ G+V + L ++ +++
Sbjct: 101 LAIAFILKDVLNALDYIH-SKGFI-HRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKR 157
Query: 186 AHSIIGTPEY-------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSEC---- 231
+ P+ ++PE+ +++ Y E DIYS G+ E+ +P+ +
Sbjct: 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 232 -----------------------DSVAKIYKKVTGGVKPQAL----NKVKDPEVKAFIEK 264
DS+++ ++ + F+E
Sbjct: 218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL 277
Query: 265 CIAQ-PRARPSASELLKDPFFSEL 287
C+ + P +RPSAS+LL FF +
Sbjct: 278 CLQRDPESRPSASQLLNHSFFKQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 19/258 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIE-VAWNQVRLSH------FSEDPVLVNRLHSEVQLLR-T 81
+ LGSGA VY+ + G +A ++ + + E + + SEV +++
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR----TYRKKHRHVSIKALKKWSKQVL 137
L++ I+ Y +L++ + L + ++ L + ++K + + + + Q++
Sbjct: 66 LRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
L YLH E I+HRDL +NI + G +V I D G A S++GT Y
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 198 PELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
PE+ + E Y E D+++FG L +M T++ P+ + ++ K V +P +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP-EGMYSE 240
Query: 257 EVKAFIEKCIA-QPRARP 273
+V I C+ ARP
Sbjct: 241 DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL-RTYRKKH-RHVSIKALKKW 132
E ++ +L ++ +I Y V L L +TE+ G+L RK H I L +
Sbjct: 46 EAAIMHSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF--AAIVGRSH---AAH 187
+ Q+ G+ YL + IHRDL NI + + +VKIGD G A H H
Sbjct: 103 AVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 245
+ + APE L ++ D++ FG+ L EM T E P++ S ++I KK+
Sbjct: 160 LKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDK-- 215
Query: 246 KPQALNKVKD--PEVKAFIEKCIA-QPRARPSASEL 278
+ + L + + ++ + +C A P RP+ + L
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
+Y L +G G+ V++ ++E G VA + S +DPV+ E+++L+ LK+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKH 59
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
++ V+ + L+ + E C L K R V +KK Q L+ + + H
Sbjct: 60 PNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE 203
H CI HRD+ NI I GQ+K+ D GFA I+ ++ + T Y APEL
Sbjct: 118 KHN-CI-HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 204 D--YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALN------- 251
D Y VD+++ G E++T + + S+ D + I +K G + P+
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI-RKTLGDLIPRHQQIFSTNQF 233
Query: 252 ----KVKDPEVK---------------AFIEKCIA-QPRARPSASELLKDPFF 284
+ +PE + +F++ C+ P R S ELL+ P+F
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVR---------LSH-FSEDPVLVNRLHSEVQLLR 80
LLG G KV ++ G A +R ++H +E VL N H L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP---FLT 58
Query: 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
LK + H+ L F+ E G L + + R + + + + +++ L
Sbjct: 59 ALKYAF----------QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 108
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAP 198
EYLH+ + +++RD+ N+ ++ + G +KI D G G S A + GTPEY+AP
Sbjct: 109 EYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164
Query: 199 ELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP 256
E+ E+ DY VD + G+ + EM+ +P+ D + ++ P+ L+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS----P 220
Query: 257 EVKAFIEKCIAQ-PRAR----PS-ASELLKDPFFSELNDDD 291
E K+ + + + P+ R PS A E+++ FF +N D
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 51/312 (16%)
Query: 27 RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR--LSHFSEDPVLVNRLHSEVQLLRTL 82
RY +++G G+ V A D G +VA ++ H S+ R+ E++LLR L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLL 56
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEV--CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
++ I+ + L I V +L K + ++ + + + Q+L L
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGTPEY 195
+Y+HT + HRDL NI N + ++KI D G A V + +I + T Y
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADC-KLKICDFGLAR-VAFNDTPTAIFWTDYVATRWY 172
Query: 196 MAPEL---YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--IYKKVTGGVKPQAL 250
APEL + YT +DI+S G E++T + + + V + + + G P+ +
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 251 NKVK--------------------------DPEVKAFIEKCIA-QPRARPSASELLKDPF 283
++V+ DP +E+ +A P+ RP+A E L DP+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 284 FSELNDDDSEPS 295
F L + EPS
Sbjct: 293 FKGLAKVEREPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 43/289 (14%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
++G GA V + ++ G VA + + S +D + EV++LR L+++ I+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ L + E L + A++ + Q+L+ + Y H+H I
Sbjct: 66 KEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--I 121
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPELYEED--YT 206
IHRD+ NI ++ + G +K+ D GFA + A+ + T Y APEL D Y
Sbjct: 122 IHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 207 EMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---------LNKVK 254
+ VD+++ G + E++ E + S+ D + I +K G + P V
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI-QKCLGPLPPSHQELFSSNPRFAGVA 239
Query: 255 DPEVK------------------AFIEKCIA-QPRARPSASELLKDPFF 284
PE F++ C+ P+ R + ELL+ P+F
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 39/192 (20%)
Query: 127 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186
++K+ Q+L G+E+ H+H IIHRD+ NI ++ + G VK+ D GFA +
Sbjct: 100 SRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV 156
Query: 187 HS-IIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYK 239
++ + T Y APEL D Y VDI++ G + EM+T E P S+ D + I K
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIK 215
Query: 240 KVTGGVKPQ--------------ALNKVKDPE------------VKAFIEKCIA-QPRAR 272
+ G + P+ L +VK+ E V ++C+ P R
Sbjct: 216 CL-GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274
Query: 273 PSASELLKDPFF 284
PS+S+LL FF
Sbjct: 275 PSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G V++A ++E VA +VRL +D + + E+ LL+ LK+K I+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCI 150
V D+ TL F E C +L+ Y + + +K + Q+L+GL + H+H +
Sbjct: 66 DVLHSDKKLTLVF--EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--V 120
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEEDY 205
+HRDL N+ IN N G++K+ D G A G R ++A + T Y P+ + Y
Sbjct: 121 LHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 177
Query: 206 TEMVDIYSFGLCLLEMVTMEIP----YSECDSVAKIYK 239
+ +D++S G E+ P D + +I++
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-15
Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
++ Q++ GLE H H+ I++RDL N+ ++ + G V+I DLG A + G
Sbjct: 100 YAAQIICGLE--HLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAG 156
Query: 192 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVKPQA 249
TP YMAPE L E Y VD ++ G L EM+ P+ K+ K+ + A
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR--QRKEKVEKEELKRRTLEMA 214
Query: 250 LNKVKD--PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 288
+ PE K E + + P R SA E+ + P F +LN
Sbjct: 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 46/278 (16%)
Query: 25 FGRYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLS-HFSEDPVLVNRLHSEVQL 78
FG+ LG+GA KV A + ++VA ++ + H SE L+ SE+++
Sbjct: 39 FGK---TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALM----SELKI 91
Query: 79 LRTLKNKYIIV-----CYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKK 131
+ L N IV C + ITE C G+L + RK+ ++++ L
Sbjct: 92 MSHLGNHENIVNLLGAC------TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSII 190
+S QV +G+ +L + + C IHRDL N+ + +G I VKI D G A + + + + +
Sbjct: 146 FSYQVAKGMAFLAS-KNC-IHRDLAARNVLLTHGKI--VKICDFGLARDI-MNDSNYVVK 200
Query: 191 GTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGG 244
G ++MAPE ++ YT D++S+G+ L E+ ++ PY +K YK + G
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260
Query: 245 ---VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
+P+ E+ ++ C P RP+ ++
Sbjct: 261 YRMAQPEHAPA----EIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 5/133 (3%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + + + ++ +++ GL++LH II+RDL N+
Sbjct: 71 LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLL 219
++ + G +KI D G + A + GTP+Y+APE+ + + Y E VD +SFG+ L
Sbjct: 129 LDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187
Query: 220 EMVTMEIPYSECD 232
EM+ + P+ D
Sbjct: 188 EMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 71/291 (24%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQ 77
DP+ + + +G G KVY+ ++++G A + DP+ + + +E
Sbjct: 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYN 70
Query: 78 LLRTLKNKYIIV-CYSVWLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 133
+L++L N +V Y ++ L + E+C G++ +K L
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--------VKGLLICG 122
Query: 134 KQVLE------------GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181
+++ E GL++LH + IIHRD+ +NI + G VK+ D G +A +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFGVSAQLT 179
Query: 182 RSH-AAHSIIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234
+ ++ +GTP +MAPE+ Y+ Y D++S G+ +E+ + P + V
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
Query: 235 AKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQP-RARPSASELLKDPF 283
++ K+ P L+ K FI +C+ + ARPS + LL+ PF
Sbjct: 240 KTLF-KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 37/235 (15%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY L+G G + +VY A+D VA ++R SE+P+L R E ++ L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60
Query: 84 NKYIIVCYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKK-------HRHVSIKALKKWSK 134
+ I+ YS+ D + T+ +I L++ +K S+ A
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-------------VG 181
++ +EY+H+ ++HRDL NI + G G+V I D G AAI V
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEEDLLDIDVD 176
Query: 182 RSHAAHS-------IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 228
+ +S I+GTP+YMAPE L +E DIY+ G+ L +M+T+ PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-15
Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 45/276 (16%)
Query: 32 LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKN 84
LG G+ VY E VA V +E+ + R+ +E +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERIEFLNEASVMKEFNC 68
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKK---WSK 134
+++ V Q + + E+ G+L++Y + R + L+K +
Sbjct: 69 HHVVRLLGVVSTGQPTLV--VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT-- 192
++ +G+ YL +HRDL N + + VKIGD G + + G
Sbjct: 127 EIADGMAYLA--AKKFVHRDLAARNCMVAED-LTVKIGDFGMTRDI-YETDYYRKGGKGL 182
Query: 193 -P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS--ECDSVAKIYKKVTGGVK 246
P +MAPE L + +T D++SFG+ L EM T+ E PY + V K GG
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGH- 239
Query: 247 PQALNKVKDPEVK--AFIEKCIA-QPRARPSASELL 279
L+ ++ K + C P+ RP+ E++
Sbjct: 240 ---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 47/171 (27%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIK 127
+ L E+++LR L ++ I+ + +D N + I E SG+L+ Y +++ +++K
Sbjct: 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK 109
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
K++ Q+ +G++YL + + +HRDL N+ + + QVKIGD G + +
Sbjct: 110 QQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYY 166
Query: 188 SI---IGTPEY-MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
++ + +P + APE L + + D++SFG+ L E++T CDS
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY------CDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L+ I + G L T+ + H + ++ + +++ L+ H H+ II+RD+ NI
Sbjct: 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD--HLHQLGIIYRDIKLENIL 137
Query: 162 INGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFGL 216
++ G V + D G + A+S GT EYMAPE+ + + VD +S G+
Sbjct: 138 LDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 217 CLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRAR 272
E++T P++ E +S ++I +++ P K E + FI+K + + P+ R
Sbjct: 197 LTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKR 254
Query: 273 ---PSASELLKDPFFSELNDDD 291
A E+ PFF ++ DD
Sbjct: 255 LGANGADEIKNHPFFQGIDWDD 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 74/223 (33%), Positives = 97/223 (43%), Gaps = 51/223 (22%)
Query: 111 SGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169
S +L TY K+ R + I KQ+LEGL YLH IIHRD+ NIFIN ++ QV
Sbjct: 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQV 196
Query: 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT----- 223
IGDLG A + A + GT E APE+ D Y DI+S G+ L EM+
Sbjct: 197 CIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
Query: 224 MEIPYSECDSVAK-----IYKKVTG-GVKPQALNKVKDPE---VKAFIE--KCIAQPRA- 271
E P S + K + K ++ V P+ +DP V+ FIE QP
Sbjct: 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP--RDPGSRLVRGFIEYASLERQPYTR 314
Query: 272 ---------------------------RPSASELLKDPFFSEL 287
RPSA E+L P F++L
Sbjct: 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 67/271 (24%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT----YRKKHRHVSIKALK 130
E+ LLR LK++ ++ V+L+ ++ + + + + K + +K
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAA- 186
Q+L G+ YLH++ ++HRDL +NI + G G VKIGDLG A + +A
Sbjct: 112 SLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPL 166
Query: 187 ------HSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME------------- 225
++ T Y APEL YT+ +DI++ G E++T+E
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226
Query: 226 IPYSECDSVAKI--------------------YKKVTGGVKPQA---------LNKVKDP 256
P+ D + +I Y + K + + K K P
Sbjct: 227 NPFQR-DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP 285
Query: 257 EVKAF--IEKCIA-QPRARPSASELLKDPFF 284
+ + F + K + P R +A E L+ P+F
Sbjct: 286 DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 78/309 (25%), Positives = 122/309 (39%), Gaps = 69/309 (22%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 88
LG G +VY+A + G VA ++ + + + P+ R E+++L+ LK+ ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKLKHPNVVPL 72
Query: 89 ----VCYSVWLDDQHNTLNFITEVCT------SGNLRTYRKKHRHVSIKALKKWSKQVLE 138
V D + V SG L K IK + Q+LE
Sbjct: 73 IDMAVERP---DKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC---YMLQLLE 126
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------------GRSHAA 186
G+ YLH + I+HRD+ +NI I+ N G +KI D G A G +
Sbjct: 127 GINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 187 HSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKK 240
+++ T Y PEL E YT VDI+ G EM T P S+ D + I+K
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKL 242
Query: 241 V---------------------TGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSA 275
+ P+ L + PE + K ++ P R +A
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302
Query: 276 SELLKDPFF 284
S+ L+ P+F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 26/264 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G VY+ ++ G VA ++ L P R E+ L++ LK++ I+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH 64
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEP 148
V N L + E +L+ Y H + +K ++ Q+L+G+ + H +
Sbjct: 65 DVI--HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR- 120
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-IGTPEYMAPE--LYEEDY 205
++HRDL N+ IN G++K+ D G A G S + T Y AP+ L Y
Sbjct: 121 -VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 206 TEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKD-PEVKAF 261
+ +DI+S G + EM+T + + D + KI+ ++ G + PE K
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGTPTESTWPGISQLPEYKPT 237
Query: 262 IEKCIAQ------PRARPSASELL 279
+ Q P A P +LL
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLL 261
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L +T+ + G L + +K S K + +++ LE+LH ++ I++RDL NI
Sbjct: 71 LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENIL 128
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCL 218
++ G + + D G + A + + ++ GT EY+APE L E+ YT+ VD +S G+ +
Sbjct: 129 LDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 219 LEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP------EVKAFIEKCIAQ-PRA 271
EM P+ D ++Y+ + A KV+ P E + F++ + + P+
Sbjct: 188 FEMCCGWSPFYAED-TQQMYRNI-------AFGKVRFPKNVLSDEGRQFVKGLLNRNPQH 239
Query: 272 R----PSASELLKDPFFSELNDD 290
R A EL + PFF++++ D
Sbjct: 240 RLGAHRDAVELKEHPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
E+ +L+TL ++ I+ + L I E G+LR Y KH+ +++ L +++
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQ 114
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
Q+ EG+ YLH+ IHRDL N+ ++ N VKIGD G A V H + + +
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 195 ----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
+ A E L E ++ D++SFG+ L E++T CDS
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT------HCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 71/280 (25%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 31 LLGSGAVKKVY---RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
+LG+GA KV+ + + G A ++ + + +E Q+L ++
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 88 IVC--YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
+V Y+ D + L+ I + G L T+ + + ++ +S +++ LE H
Sbjct: 67 LVTLHYAFQTDTK---LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE--HL 121
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPELY-- 201
H+ II+RD+ NI ++ N G V + D G + A+S GT EYMAP++
Sbjct: 122 HKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 202 -EEDYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPE 257
+ + + VD +S G+ + E++T P++ E +S A+I +++ P +
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 238
Query: 258 VKAFIEK-CIAQPRAR----PS-ASELLKDPFFSELNDDD 291
K I++ + P+ R PS A E+ K PFF ++N DD
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-14
Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
IVC S + L+FI ++ G+L + +H S ++ ++ +++ GLE H H
Sbjct: 59 IVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHN 115
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--Y 205
+++RDL +NI ++ + G V+I DLG A + H+ +GT YMAPE+ ++ Y
Sbjct: 116 RFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAY 173
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI-YKKVTGGVKPQALNKVKDPEVKAFIEK 264
D +S G L +++ P+ + + K ++T + + L PE+++ +E
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEG 232
Query: 265 CIAQPRAR------PSASELLKDPFFSELN 288
+ + R A E+ + PFF L+
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D +VA +LS + + R + E++LL+ +K+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 85 KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
+ +I V+ + N + +T + +L K + +S + ++ Q+L GL
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNL-MGADLNNIVKCQK-LSDEHVQFLIYQLLRGL 131
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
+Y+H+ IIHRDL SN+ +N + +++I D G A + + T Y APE
Sbjct: 132 KYIHS--AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADDEMTGY--VATRWYRAPEI 186
Query: 200 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDP 256
L Y + VDI+S G + E++ + + D + ++ + +V G P+ L K+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246
Query: 257 EVKAFIEKCIAQPR---------------------------ARPSASELLKDPFFSELND 289
+ +I+ P+ R SASE L P+FS+ +D
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306
Query: 290 DDSEP 294
+ EP
Sbjct: 307 PEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 39/280 (13%)
Query: 31 LLGSGAVKKVYRAFDQEEGI---------EVAWNQVRLSH-FSEDPVLVNRLHSEVQLLR 80
LLG G KV ++ G EV + ++H +E VL N H L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP---FLT 58
Query: 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
+LK YS D+ L F+ E G L + + R S + + +++ L
Sbjct: 59 SLK-------YSFQTKDR---LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSAL 108
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAP 198
+YLH+ + I++RDL N+ ++ + G +KI D G G + AA + GTPEY+AP
Sbjct: 109 DYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164
Query: 199 ELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP 256
E+ E+ DY VD + G+ + EM+ +P+ D + +K P+ L+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKS 224
Query: 257 EVKAFIEKCIAQPRAR-----PSASELLKDPFFSELNDDD 291
+ + I P R A E+++ FF+ +N D
Sbjct: 225 LLSGLL---IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 36/275 (13%)
Query: 31 LLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQLLR 80
LLG G KV ++ G EV + ++H +E+ VL N H L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP---FLT 58
Query: 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
LK + H+ L F+ E G L + + R S + + +++ L
Sbjct: 59 ALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPE 199
+YLH+ E +++RDL N+ ++ + G +KI D G + A + GTPEY+APE
Sbjct: 109 DYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 200 LYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
+ E+ DY VD + G+ + EM+ +P+ D K+++ + ++ + PE
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLSPEA 223
Query: 259 KAFIEKCIAQ-PRAR-----PSASELLKDPFFSEL 287
K+ + + + P+ R A E+++ FF+ +
Sbjct: 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-14
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 190
++ Q++ GLE+LH II+RDL N+ ++ N G V+I DLG A +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 191 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
GTP +MAPEL + E+Y VD ++ G+ L EM+ P+ A+ K +K +
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR-----ARGEKVENKELKQRI 213
Query: 250 LNK-VKDPE-----VKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 288
LN V P+ K+F E +A+ P R + L P F +LN
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 53/186 (28%), Positives = 80/186 (43%), Gaps = 40/186 (21%)
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGT 192
Q+L G+ +LH + I+HRDL SN+ +N N G +KI D G A G ++ T
Sbjct: 113 LQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVT 169
Query: 193 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG---- 243
Y APEL ++Y+ +D++S G E++T + + SE D + KI+K +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
Query: 244 ---------GVKPQALNKVKDPEV---KAFIEKCIAQ-------------PRARPSASEL 278
G K K P K F ++ P R SA +
Sbjct: 230 IWPGFSELPGAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287
Query: 279 LKDPFF 284
LK P+F
Sbjct: 288 LKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIG 191
Q++ L+ +H+ ++HRDL +NIF+ G +K+GD GF+ S A S G
Sbjct: 177 QIVLALDEVHSR--KMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 192 TPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
TP Y+APEL+E Y++ D++S G+ L E++T+ P+ + S +I ++V G
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYDPFP 292
Query: 251 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
V +KA ++ +++ P RP+ +LL F
Sbjct: 293 CPVSS-GMKALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 65/249 (26%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSG +V+ + + VA ++ S+D + EVQ L+ L++K++I +
Sbjct: 14 LGSGYFGEVWEGL-WKNRVRVAIKILK----SDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V + + ITE+ G+L + + + + + + +L + QV EG+ YL E
Sbjct: 69 AVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQN 124
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPE-LYEEDYTE 207
IHRDL NI + ++ K+ D G A ++ + + ++ APE ++
Sbjct: 125 SIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 208 MVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC- 265
D++SFG+ L EM T ++PY + ++Y ++T G + K E+ + +C
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241
Query: 266 IAQPRARPS 274
A+P RPS
Sbjct: 242 AAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 32 LGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LGSGA VY+ EG I VA +R P + E ++ ++ + ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPHV 71
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTH 146
+ + L Q IT++ G L Y + H+ ++ + L W Q+ +G+ YL
Sbjct: 72 VRLLGICLSSQVQ---LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG--TP-EYMAPE-LYE 202
++HRDL N+ + VKI D G A ++ + G P ++MA E +
Sbjct: 129 R--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 203 EDYTEMVDIYSFGLCLLEMVT 223
YT D++S+G+ + E++T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 104 FITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162
F+ E G+L + H V S ++ V+ GL+YLH ++ I++RDL N+ +
Sbjct: 79 FVMEYAAGGDLMMH--IHTDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL 134
Query: 163 NGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLE 220
+ G VKI D G +G + GTPE++APE L E YT VD + G+ + E
Sbjct: 135 DTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193
Query: 221 MVTMEIPYS 229
M+ E P+
Sbjct: 194 MLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS----------EVQLLRT 81
LG+G +V+ EG+ WN + PV V L E Q+++
Sbjct: 14 LGAGQFGEVW------EGL---WN-------NTTPVAVKTLKPGTMDPKDFLAEAQIMKK 57
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEG 139
L++ +I Y+V ++ + +TE+ G+L Y R + + L + QV G
Sbjct: 58 LRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115
Query: 140 LEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTP-EYM 196
+ YL IHRDL N+ + NI K+ D G A ++ + A P ++
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 197 APE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS 229
APE LY ++ D++SFG+ L E+VT +PY
Sbjct: 172 APEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 45/288 (15%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G VY+ +++ G VA ++RL SE+ + + E+ LL+ L++ I+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
V + Q + L I E S +L+ Y K +++ + +K + Q+L+G+ + H+
Sbjct: 66 DVLM--QESRLYLIFEF-LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ I+ G +K+ D G A G R + H ++ T Y APE L
Sbjct: 122 -VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVY-THEVV-TLWYRAPEVLLGSP 177
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI--------------------YKK 240
Y+ VDI+S G EM T + + SE D + +I YK
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237
Query: 241 VTGGVKPQAL-NKVKDPEVKAF--IEKC-IAQPRARPSASELLKDPFF 284
K +L + VK+ + +EK I P R SA + L P+F
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +G GA V A + G++VA ++S F E R E+++LR K+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPF-EHQTFCQRTLREIKILRRFKH 62
Query: 85 KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
+ II + + N + E+ + + + +H +S ++ + Q+L GL+
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGLK 120
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGTPEYM 196
Y+H+ ++HRDL SN+ +N N +KI D G A I H H+ + T Y
Sbjct: 121 YIHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH-DHTGFLTEYVATRWYR 176
Query: 197 APE--LYEEDYTEMVDIYSFGLCLLEMV-------------------------TMEIPYS 229
APE L + YT+ +DI+S G L EM+ + E
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 230 ECDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285
A+ Y K NK+ DP+ ++K + P R + E L P+
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
Query: 286 ELNDDDSEP 294
+ +D EP
Sbjct: 297 QYHDPSDEP 305
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ + ++ +++ GL++LH II+RDL N+
Sbjct: 71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 218
++ G +KI D G I+G + + GTP+Y+APE L + Y VD ++ G+ L
Sbjct: 129 LDSE-GHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEILSYQPYGPAVDWWALGVLL 186
Query: 219 LEMVTMEIPY 228
EM+ + P+
Sbjct: 187 YEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 36/252 (14%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL----- 72
S R+ + LG G KV +A+D G VA +V++ S D +L
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 73 -H----SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 127
H E++++ +K++ I+ V++ + + +N + ++ S + +K R ++
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV--EGDFINLVMDIMASDLKKVVDRKIR-LTES 119
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG------ 181
+K Q+L GL LH +HRDL+ +NIFIN + G KI D G A G
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 182 ----RSHAAHSIIGTPE-----YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY-- 228
T + Y APEL E Y VD++S G E++T + +
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 229 -SECDSVAKIYK 239
+E D + +I++
Sbjct: 237 ENEIDQLGRIFE 248
|
Length = 335 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 43/149 (28%), Positives = 80/149 (53%), Gaps = 9/149 (6%)
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 142
+N ++ Y + +H L F+ E G+L + + + ++ +++ GL++
Sbjct: 54 ENPFLTHLYCTFQTKEH--LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQF 111
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPEL 200
LH+ II+RDL N+ ++ + G +KI D G + G + A+ + GTP+Y+APE+
Sbjct: 112 LHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS-TFCGTPDYIAPEI 167
Query: 201 YE-EDYTEMVDIYSFGLCLLEMVTMEIPY 228
+ YT VD +SFG+ L EM+ + P+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158
H+ L F+ E G L + + R S + + +++ L YLH+ + +++RDL
Sbjct: 67 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLE 124
Query: 159 NIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFG 215
N+ ++ + G +KI D G G S A + GTPEY+APE+ E+ DY VD + G
Sbjct: 125 NLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 216 LCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCIAQ-PRAR- 272
+ + EM+ +P+ D + ++ P+ L+ PE K+ + + + P+ R
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQRL 238
Query: 273 ----PSASELLKDPFFSELNDDD 291
A E+++ FF+ +N D
Sbjct: 239 GGGPEDAKEIMEHRFFASINWQD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHS 188
+ ++ ++L LE LH +I+RDL NI ++ G + + D G + + ++
Sbjct: 96 RFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNT 152
Query: 189 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247
GTPEY+APEL YT+ VD ++ G+ L EM+T P+ + ++V ++Y+K+ +P
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKIL--QEP 209
Query: 248 QALNKVKDPEVKAFIEKCIAQ-PRAR---PSASELLKDPFFSELN 288
D + K + +++ P R A E+ PFFS+L+
Sbjct: 210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 81/327 (24%), Positives = 141/327 (43%), Gaps = 52/327 (15%)
Query: 5 NSNMS-DRDGEPFVEVD---PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
N+N D D E ++ D + + +++G+G+ VY A + +VA +V
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-- 100
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIV------CYSVWLDDQHNTLNFITEV---CTS 111
+DP NR E+ +++ L + II ++++ LN + E
Sbjct: 101 ---QDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVH 154
Query: 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171
++ Y + + + + +K +S Q+ L Y+H+ C HRDL N+ I+ N +K+
Sbjct: 155 KYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC--HRDLKPQNLLIDPNTHTLKL 212
Query: 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYS 229
D G A + + S I + Y APEL +YT +D++S G + EM+ +S
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272
Query: 230 ECDSVAKIYK--KVTG--------------------GVKPQALNKV----KDPEVKAFIE 263
SV ++ + +V G VKP+ L KV + FI
Sbjct: 273 GQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS 332
Query: 264 KCIA-QPRARPSASELLKDPFFSELND 289
+ + +P R + E L DPFF +L D
Sbjct: 333 QFLKYEPLKRLNPIEALADPFFDDLRD 359
|
Length = 440 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 65/287 (22%), Positives = 132/287 (45%), Gaps = 39/287 (13%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQ 77
DPS + + +G G KV++ +++ G + A V++ DP+ + + +E
Sbjct: 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAA---VKIL----DPIHDIDEEIEAEYN 66
Query: 78 LLRTLKNKYIIV-CYSVWLDDQHNT---LNFITEVCTSGNL----RTYRKKHRHVSIKAL 129
+L+ L + +V Y ++ L + E+C G++ + + K+ + +
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHS 188
+ L GL++LH ++ IHRD+ +NI + G VK+ D G +A + ++
Sbjct: 127 AYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNT 183
Query: 189 IIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 242
+GTP +MAPE+ + Y D++S G+ +E+ + P ++ + ++K
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK--- 240
Query: 243 GGVKPQALNKVKDPEVKA-----FIEKCIAQP-RARPSASELLKDPF 283
+ + PE+ + FI KC+ + RP+ S+LL+ F
Sbjct: 241 --IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D LG G+ VY+ + G VA ++RL H P R E LL+ LK+ I+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 90 CYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTH 146
+ D H TL + E + +L+ Y +S+ ++ + Q+L GL Y H
Sbjct: 68 LH----DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ I+ G++K+ D G A A S + + T Y P+ L
Sbjct: 123 R--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 204 DYTEMVDIYSFGLCLLEMVT 223
+Y+ +D++ G EM T
Sbjct: 180 EYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 31 LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+LGSGA VY+ EG I VA ++R + P + E ++ ++ N +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPH 70
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+ + L +T+ IT++ G L Y ++H+ ++ + L W Q+ +G+ YL
Sbjct: 71 VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 201
E ++HRDL N+ + VKI D G A ++G + G ++MA E +
Sbjct: 127 -ERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 202 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255
YT D++S+G+ + E++T IP SE S+ + G PQ +
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 237
Query: 256 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
+V + KC + +RP EL+ + FS++ D
Sbjct: 238 IDVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 11/147 (7%)
Query: 88 IVC--YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
IVC Y+ D+ L FI ++ G+L + +H S K ++ ++ +++ GLE H
Sbjct: 59 IVCMTYAFHTPDK---LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HM 113
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED- 204
H +++RDL +NI ++ + G V+I DLG A + H+ +GT YMAPE+ ++
Sbjct: 114 HNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGT 171
Query: 205 -YTEMVDIYSFGLCLLEMVTMEIPYSE 230
Y D +S G L +++ P+ +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + + + ++ +++ GL++LH+ I++RDL NI
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNIL 128
Query: 162 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 218
++ + G +KI D G ++G + + GTP+Y+APE L + Y VD +SFG+ L
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTC-TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186
Query: 219 LEMVTMEIPYSECDSVAKIYK-KVTGGVKPQALNK-VKDPEVKAFIEKCIAQPRARPSA- 275
EM+ + P+ D ++ P+ L + KD VK F+ +P R
Sbjct: 187 YEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVR----EPERRLGVK 242
Query: 276 SELLKDPFFSELN 288
++ + PFF E++
Sbjct: 243 GDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G VY+A D+ +A ++RL ED + + E+ LL+ +++ I+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS------IKALKKWSKQVLEGLEYLHT 145
V ++ L F L KKH S + +K + Q+L G+ Y H+
Sbjct: 68 DVVHSEKRLYLVF-------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--L 200
H ++HRDL N+ I+ +K+ D G A G R+ H ++ T Y APE L
Sbjct: 121 HR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-THEVV-TLWYRAPEILL 176
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK 239
Y+ VDI+S G EMV + + SE D + KI++
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218
|
Length = 294 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 53/308 (17%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-----LHSEVQLLRTLKN 84
++G GA +V+ D++ G A +R S ++ R + +E +L +
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS------DMIKRNQIAHVRAERDILADADS 60
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
+I+ Y + D++H L + E G+L + + + + +++ L+ +H
Sbjct: 61 PWIVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------- 185
+ IHRD+ NI I G +K+ D G + ++
Sbjct: 119 --KLGFIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 186 -----------AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
A+S +GTP+Y+APE L Y D +S G+ L EM+ P+ D+
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS-DT 234
Query: 234 VAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKCIAQPRAR-PSASELLKDPFFS--ELN 288
+ + Y K+ + PE I + + P R S E+ PFF +
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294
Query: 289 DDDSEPSP 296
+ P
Sbjct: 295 NLRETKPP 302
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 61/274 (22%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 31 LLGSGAVKKVY---RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
+LG+GA KV+ + + G A ++ + + V +E +L ++
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+V + L+ I + + G + T+ + + S ++ +S +++ LE H H+
Sbjct: 67 LVTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE--HLHK 123
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPELY--EE 203
I++RD+ NI ++ G V + D G + + +S GT EYMAPE+ +
Sbjct: 124 LGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
+ + VD +S G+ + E++T P++ E ++ +++ +++ P PE +
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQD 240
Query: 261 FIEKCIAQ-PRAR-----PSASELLKDPFFSELN 288
+ K + + P+ R ASE+ + PFF L+
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 12/185 (6%)
Query: 99 HNTLNFITEVCTSGNLRTY-RKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 156
HN L + E+ + GNL + R + R VS+ L ++S V EG+EYL + + ++HRDL
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLA 127
Query: 157 CSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFG 215
NI ++ + G K+ D G A VG +S + ++ APE L + ++ D++S+G
Sbjct: 128 ARNILVSED-GVAKVSDFGLAR-VGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYG 184
Query: 216 LCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARP 273
+ L E+ + PY + S+ ++ + V G + + +V + C +P+ RP
Sbjct: 185 VLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRMEPPEGCP-ADVYVLMTSCWETEPKKRP 242
Query: 274 SASEL 278
S +L
Sbjct: 243 SFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L ++ R + ++ +V L +LH H +I+RDL NI
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNIL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G K+ D G + + GTP+Y+APE L E +Y VD ++ G+ +
Sbjct: 129 LDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKVKDPEVKAFIEK-------CIAQPR 270
EM+ + P+ E D+ +++ + + P L+K +KAF+ K C+A
Sbjct: 188 EMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVA--- 243
Query: 271 ARPSASELLKDPFFSELNDDDSE 293
++ + + PFF E++ E
Sbjct: 244 SQGGEDAIKQHPFFKEIDWVLLE 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-12
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKA-LKKW 132
E ++ TL++ ++ V L L +TE G+L Y R + R V A +
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+ V EG+EYL +HRDL N+ ++ + K+ D G A + + +
Sbjct: 108 ALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQDSGKL--- 161
Query: 193 P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQA 249
P ++ APE L E+ ++ D++SFG+ L E+ + +PY + + V G + +A
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEA 220
Query: 250 LNKVKDPEVKAFIEKCI-AQPRARPSASELL 279
PEV ++ C P RP+ +L
Sbjct: 221 PEGCP-PEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 45/269 (16%)
Query: 32 LGSG----AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LG G VK VY +E +EVA V+ E ++ L + I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE-VEVA---VKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ V + L + E+ G L Y KK R + + LK+ + QV G+ YL E
Sbjct: 59 VRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL---E 112
Query: 148 PC-IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----------- 195
+HRDL N+ + N Q KI D G + +G G+ Y
Sbjct: 113 SKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALG--------AGSDYYRATTAGRWPLK 163
Query: 196 -MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNK 252
APE + ++ D++S+G+ L E + PY E A++ + G + L +
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESG---ERLPR 219
Query: 253 VKD--PEVKAFIEKC-IAQPRARPSASEL 278
++ E+ + + C +P RP+ SEL
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 72/296 (24%)
Query: 31 LLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KN 84
LG GA +V +A + E VA ++ +D ++ L SE+++++ + K+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGKH 75
Query: 85 KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HV 124
K II VC Q L + E GNLR + + R +
Sbjct: 76 KNIINLLGVC------TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 125 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184
+ K L ++ QV G+E+L + + IHRDL N+ + + +KI D G A +
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDI---- 182
Query: 185 AAHSIIGTPEY-------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTME-IPYS 229
H I +Y MAPE L++ YT D++SFG+ L E+ T+ PY
Sbjct: 183 --HHI----DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 230 ECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 281
V +++K + G KPQ + E+ + C P RP+ +L++D
Sbjct: 237 GI-PVEELFKLLKEGYRMEKPQNCTQ----ELYHLMRDCWHEVPSQRPTFKQLVED 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 67/275 (24%), Positives = 128/275 (46%), Gaps = 25/275 (9%)
Query: 31 LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
++G G+ KV A + +G ++V ++ L+ + ++ R LL+ +K+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPF 57
Query: 87 II-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
++ + YS ++ L F+ + G L + ++ R + ++ ++ L YLH+
Sbjct: 58 LVGLHYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEE 203
I++RDL NI ++ + G V + D G + +S + GTPEY+APE + ++
Sbjct: 115 IN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263
Y VD + G L EM+ P+ C VA++Y + KP L + +E
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILH--KPLVLRPGASLTAWSILE 228
Query: 264 KCIAQPR-----ARPSASELLKDPFFSELNDDDSE 293
+ + + R A+ E+ + PFF L+ D E
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLE 263
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 40/130 (30%), Positives = 58/130 (44%), Gaps = 17/130 (13%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAA------ 186
QVL+ L H I+HRDL NI ++ G K+ D G ++ A
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 187 --HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
++GTP Y APE L E T D+Y++GL LE +T + + SVA+I +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQQLS 203
Query: 244 GVK---PQAL 250
V P +
Sbjct: 204 PVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 51/219 (23%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL----VNRLHSEVQLLRTLKNKYI 87
LG+G+ +V A + E + V + F + ++ V+ + SE ++L + + +
Sbjct: 38 LGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ Y + D+ + L + E G T+ ++++ ++ Q++ EYL +
Sbjct: 94 VNLYGSFKDESY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 206
I++RDL N+ ++ + G +K+ D GFA +V +++ GTPEY+APE L +
Sbjct: 152 --IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245
+ D ++ G+ + E++ P+ + + IY+K+ G+
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-L 200
H H+ II+RDL NI ++ G VK+ D G +I + H+ GT EYMAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
+ + VD +S G + +M+T P++ + I K + G + L PE +
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLPPYLTPEARD 229
Query: 261 FIEKCIA-QPRAR----PS-ASELLKDPFFSELNDDD 291
++K + P +R P A+E+ PFF +N DD
Sbjct: 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D LG G V++ + VA ++RL H P R EV LL+ LK+ I+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVT 67
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 148
+ + ++ TL F E S +L+ Y ++ S+ +K + Q+L GL Y H +
Sbjct: 68 LHDIIHTERCLTLVF--EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 203
I+HRDL N+ IN G++K+ D G A ++ ++++ + T Y P+ L
Sbjct: 124 -ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGST 179
Query: 204 DYTEMVDIYSFGLCLLEMVT 223
+Y+ +D++ G L EM T
Sbjct: 180 EYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 73/299 (24%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 89
LG G KV +A + V + E+ + L SE LL+ + + ++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV------------------------S 125
Y D L I E G+LR++ ++ R V +
Sbjct: 68 LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFA------- 177
+ L ++ Q+ G++YL E ++HRDL N+ + G +KI D G +
Sbjct: 126 MGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEED 181
Query: 178 AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 235
+ V RS + ++MA E L++ YT D++SFG+ L E+VT+ PY
Sbjct: 182 SYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP------ 231
Query: 236 KIYKKVTGGVKPQAL-------NKVKDPE-----VKAFIEKCIAQ-PRARPSASELLKD 281
G+ P+ L +++ PE + + C Q P RP+ +++ K+
Sbjct: 232 --------GIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 77/319 (24%), Positives = 134/319 (42%), Gaps = 63/319 (19%)
Query: 15 PFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNR 71
PF + +Y L +G G +V++A ++ VA +V + + E P+ R
Sbjct: 6 PFCDEV-----SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 72 LHSEVQLLRTLKNKYII----VCYSVWLDDQHN----TLNFITEVCTSGNLRTYRKKHRH 123
E+++L+ LK++ ++ +C + +N + + E C K+
Sbjct: 61 ---EIKILQLLKHENVVNLIEICRT--KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-----A 178
++ +KK K +L GL Y+H ++ I+HRD+ +NI I + G +K+ D G A +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLS 172
Query: 179 IVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT----MEIPYSE-- 230
+ + + + T Y PEL E DY +D++ G + EM T M+ +E
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ-GNTEQH 231
Query: 231 --------CDSVAK----------IYKKV---TGG---VKPQALNKVKDPEVKAFIEKCI 266
C S+ ++KK+ G VK + VKDP I+K +
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291
Query: 267 A-QPRARPSASELLKDPFF 284
P R A L FF
Sbjct: 292 VLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
LLG G V +V+ + G A + + V R+ +E ++L TL + ++
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTL 66
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEP 148
Y+ + + + L + + C G L ++ + +S + + ++ +VL LEYLH
Sbjct: 67 YASFQTETY--LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG- 123
Query: 149 CIIHRDLNCSNIFI--NGNI--------------GQVKIGDLGFAAIVGRSHA------- 185
I++RDL NI + +G+I L + ++
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 186 ------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMV 222
++S +GT EY+APE+ D + VD ++ G+ L EM+
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D VA +LS ++ R + E+ L++ + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 85 KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
K II +V+ ++ + + E+ + + + + H + L Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY---QMLCGI 132
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+ IIHRDL SNI + + +KI D G A G S + T Y APE
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQALNKVKDPE 257
+ Y E VDI+S G + EMV +I + D + + K + G P+ + K++ P
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 258 VKAFIE 263
V+ ++E
Sbjct: 249 VRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY L +GSGA V AFD GI VA +LS ++ R + E+ LL+ + +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 85 KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
K II +V+ ++ + + E+ + + + H + L Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL---LYQMLCGI 136
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+ IIHRDL SNI + + +KI D G A + + T Y APE
Sbjct: 137 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPE 257
+ Y E VDI+S G + E+V + + D + + K + G + +N+++ P
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 258 VKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 291
V+ ++E P S EL D F ++ D
Sbjct: 253 VRNYVENRPQYPGI--SFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D VA +LS ++ R + E+ L++ + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 85 KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
K II +V+ ++ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+ IIHRDL SNI + + +KI D G A G S + T Y APE
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQALNKVKDPE 257
+ Y E VDI+S G + EM+ + + D + + K + G P+ + K++ P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 258 VKAFIE 263
V+ ++E
Sbjct: 256 VRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 35/96 (36%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIG 191
KQ+L +EY+H + +IHRD+ NIF+N + G++ +GD G A + A + +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 192 TPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEI 226
T +PE+ D Y E+ DI+S GL LL+M++ +
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 42/114 (36%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 113 NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172
+L Y R+++I + + VL ++YLH + IIHRD+ NIFIN + G V +G
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLG 224
Query: 173 DLGFAA--IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT 223
D G A + ++ + GT APEL D Y VDI+S G+ L EM T
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 13/197 (6%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ + G L + ++ R + ++ ++ L YLH+ II+RDL NI
Sbjct: 71 LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENIL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G V + D G + S + GTPEY+APE L ++ Y VD + G L
Sbjct: 129 LDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRA-RPSASEL 278
EM+ P+ A++Y + KP L + +E + + R R A +
Sbjct: 188 EMLYGLPPFY-SRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDD 244
Query: 279 LKD----PFFSELNDDD 291
+ FFS +N DD
Sbjct: 245 FLEIKNHVFFSSINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + +K R + ++ ++ L +LH + II+RDL N+
Sbjct: 71 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G K+ D G + + GTP+Y+APE L E Y VD ++ G+ L
Sbjct: 129 LDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLY 187
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKVKDPEVKAFIEKCIAQPRARPSA-- 275
EM+ P+ E ++ +++ + V P L++ +KAF+ K P R +
Sbjct: 188 EMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK---NPTMRLGSLT 243
Query: 276 ----SELLKDPFFSELN 288
+L+ PFF EL+
Sbjct: 244 LGGEEAILRHPFFKELD 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ R + + + +S ++ L YL HE II+RDL N+
Sbjct: 71 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPELYE-EDYTEMVDIYSFGLCLL 219
++ G +K+ D G R S GTP Y+APE+ EDY VD ++ G+ +
Sbjct: 129 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARP-SASEL 278
EM+ P+ D V G +D + +EK I PR+ A+ +
Sbjct: 188 EMMAGRSPF---DIV---------GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235
Query: 279 LKDPFFSELNDDDSE 293
LK S LN D E
Sbjct: 236 LK----SFLNKDPKE 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 138 EGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI--IGTPE 194
E + +H+ H+ +HRD+ N+ I+ G +K+ D G AA + + +S +GTP+
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 195 YMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247
Y+APE+ Y D +S G+ EM+ P+ E + AK Y +
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQ 225
Query: 248 QALNKVKDPEV----KAFIEKCIAQPRARPSASELLKDPFFSEL--NDDDSEPSP 296
+ L +DP+V I+ + + R L PFFS++ N+ + P
Sbjct: 226 RFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 29/261 (11%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG V+ + E+ +VA +R SE+ + E Q++ L + ++ Y
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSEEDFI-----EEAQVMMKLSHPKLVQLY 65
Query: 92 SVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
V + L F+ C S LR R K S + L V EG+ YL
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLE--SSN 120
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDY 205
+IHRDL N + N VK+ D G V S GT ++ +PE++ Y
Sbjct: 121 VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKY 178
Query: 206 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAF 261
+ D++SFG+ + E+ + + PY E S +++ + + G KP ++ V
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAGFRLYKP----RLASQSVYEL 233
Query: 262 IEKCIAQ-PRARPSASELLKD 281
++ C + P RPS S LL
Sbjct: 234 MQHCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 58/239 (24%), Positives = 111/239 (46%), Gaps = 26/239 (10%)
Query: 51 EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCT 110
+VA ++ SED + E +++ L ++ ++ Y V + + +TE +
Sbjct: 30 DVAIKMIKEGSMSEDEFI-----EEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTEYMS 82
Query: 111 SGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169
+G L Y ++H + L + K V EG+ YL + + IHRDL N ++ G V
Sbjct: 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCV 139
Query: 170 KIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM- 224
K+ D G + V S +G+ + PE L ++ D+++FG+ + E+ ++
Sbjct: 140 KVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 225 EIPYSECDSVAKIYKKVTGGV---KPQ-ALNKVKDPEVKAFIEKCIAQPRARPSASELL 279
++PY ++ ++ +KV+ G+ +P A KV + EK RP+ +LL
Sbjct: 199 KMPYERFNN-SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEK----AEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D LG G VY+ + VA ++RL H P R EV LL+ LK+ I+
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ + ++ TL F +L+ Y +++ +K + Q+L GL Y H +
Sbjct: 69 LHDIIHTEKSLTLVFEY---LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK- 124
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ IN G++K+ D G A +I ++++ + T Y P+ L
Sbjct: 125 -VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 204 DYTEMVDIYSFGLCLLEMVT 223
DY+ +D++ G EM T
Sbjct: 181 DYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 32 LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 86
LG G +V A D+E+ V V++ ++ L SE+++++ + K+K
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 130
II D L I E + GNLR Y + R +S K L
Sbjct: 86 IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
+ QV G+EYL + + IHRDL N+ + + +KI D G A + H +
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDI--HHIDYYKK 198
Query: 191 GTP-----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM---EIPYSECDSVAKIYKKV 241
T ++MAPE L++ YT D++SFG+ L E+ T+ P + + K+ K+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258
Query: 242 TGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 281
KP E+ + C A P RP+ +L++D
Sbjct: 259 HRMDKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 65/226 (28%)
Query: 123 HVSIKA--LKKWSK-----QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175
H I+A L+ K Q+L+ L+Y+H+ +IHRDL SNI +N + +VK+ D G
Sbjct: 96 HAVIRANILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDC-RVKLADFG 152
Query: 176 FAAIVGRSHAAHSI----------IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 223
A RS + + T Y APE L YT+ VD++S G L EM+
Sbjct: 153 LA----RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 224 -------------------------------MEIPYSE--CDSVAKIYKKVTGGVKPQAL 250
++ P++ DS+ +K L
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK-----PLDEL 263
Query: 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 295
+ ++K + P R +A E L+ P+ ++ ++ EP
Sbjct: 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 21/170 (12%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
++ ++ GLE LH I++RDL NI ++ + G ++I DLG A V +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 192 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSE------CDSVAKIYKKVTGG 244
T YMAPE+ + E YT D ++ G L EM+ + P+ + + V ++ K+V
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 220
Query: 245 VKPQALNKVKDPEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 288
+ ++ P+ ++ + + + P+ R A E+ + P F ++N
Sbjct: 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR--TYRKKHRHVSIKALKKW 132
E ++L + + +I+ + H L + + G+L+ Y R + ++ + +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY 100
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
S Q+ G+ LH H I++RD+ N+ ++ G ++ DLG A + GT
Sbjct: 101 SAQITCGI--LHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157
Query: 193 PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 230
YMAPE L EE Y+ VD ++ G + EMV P+ +
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 8/113 (7%)
Query: 113 NLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171
+L TY + R + + + ++Q+L ++Y+H IIHRD+ N+ +NG + +
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICL 301
Query: 172 GDLGFAAIV--GRSHAAH-SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLE 220
GD G A S H I GT + APE+ D YT VDI+S GL + E
Sbjct: 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ LG G V++ + VA ++RL H P R EV LL+ LK+ I+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 148
+ + D+ TL F +L+ Y ++ S+ +K + Q+L GL Y H +
Sbjct: 69 LHDIVHTDKSLTLVFEY---LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 203
++HRDL N+ IN G++K+ D G A ++ ++++ + T Y P+ L
Sbjct: 125 -VLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSS 180
Query: 204 DYTEMVDIYSFGLCLLEMVT 223
+Y+ +D++ G EM +
Sbjct: 181 EYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 18/156 (11%)
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELY- 201
H H II+RDL NI ++ G +K+ D G + + A+S GT EYMAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEV 258
+T+ D +SFG+ + EM+T +P+ D ++ I K G PQ L+ PE
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLS----PEA 225
Query: 259 KAFIEKCIAQ-PRARPSAS-----ELLKDPFFSELN 288
++ + + P R A E+ + PFFS ++
Sbjct: 226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 20 DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 68
DP F R LG G +V A D++ E + VA ++ +D
Sbjct: 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--- 63
Query: 69 VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 122
++ L SE+++++ + K+K II D L I E + GNLR Y + R
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 121
Query: 123 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171
++ K L + QV G+EYL + + IHRDL N+ + N +KI
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 178
Query: 172 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 224
D G A V + + G ++MAPE L++ YT D++SFG+ + E+ T+
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238
Query: 225 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 281
P + + K+ K+ KP E+ + C A P RP+ +L++D
Sbjct: 239 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 65/259 (25%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSG V+ + + I+VA +R SED + E +++ L + ++ Y
Sbjct: 12 LGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFI-----EEAKVMMKLSHPNLVQLY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHEPCI 150
V + + +TE +G L Y ++ + L V E +EYL ++
Sbjct: 66 GVCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--GF 121
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDYT 206
IHRDL N + + VK+ D G A V S GT ++ PE+++ ++
Sbjct: 122 IHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFS 179
Query: 207 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFI 262
D++SFG+ + E+ + ++PY E S +++ + V+ G +P K+ EV +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVSAGYRLYRP----KLAPTEVYTIM 234
Query: 263 EKC-IAQPRARPSASELLK 280
C +P RP+ +LL
Sbjct: 235 YSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 59/193 (30%), Positives = 85/193 (44%), Gaps = 46/193 (23%)
Query: 72 LHSEVQLLRTL-KNKYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR---- 122
L SE++L++ + K+K II VC Q L I E GNLR + + R
Sbjct: 64 LISEMELMKLIGKHKNIINLLGVC------TQEGPLYVIVEYAAKGNLREFLRARRPPGP 117
Query: 123 ------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170
+S K L + QV G+EYL + CI HRDL N+ + + +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CI-HRDLAARNVLVTED-NVMK 174
Query: 171 IGDLGFAAIVGRSHAAHSIIGTP------EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 223
I D G A V H T ++MAPE L++ YT D++SFG+ + E+ T
Sbjct: 175 IADFGLARGV---HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
Query: 224 ME------IPYSE 230
+ IP E
Sbjct: 232 LGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 23 GRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR 80
G+ Y L LG G+ VY+ + G VA +RL P R E LL+
Sbjct: 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLK 58
Query: 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEG 139
LK+ I++ + + + TL + E + +L Y KH + + +K + Q+L G
Sbjct: 59 GLKHANIVLLHDIIHTKE--TLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAP 198
L Y+H + I+HRDL N+ I+ + G++K+ D G A A SH + + T Y P
Sbjct: 116 LSYIH--QRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 199 E--LYEEDYTEMVDIYSFGLCLLEMV 222
+ L +Y+ +D++ G +EM+
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 32 LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G VY+A D ++ E A Q+ + S E+ LLR LK+ +I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC------REIALLRELKHPNVIA 62
Query: 90 CYSVWLD--DQHNTLNF------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
V+L D+ L F + + KK + +K Q+L+G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 142 YLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRSHAAHS----IIGTPE 194
YLH + ++HRDL +NI + G G+VKI D+GFA + + ++ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 195 YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 231
Y APEL YT+ +DI++ G E++T E P C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 28/172 (16%)
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183
++++ L +S QV G+E+L + + CI HRDL NI ++ N VKI D G A
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRK-CI-HRDLAARNILLSEN-NVVKICDFGLA------ 221
Query: 184 HAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS 229
I P+Y MAPE ++++ YT D++SFG+ L E+ ++ PY
Sbjct: 222 ---RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278
Query: 230 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 280
+ +++ G + +A + PE+ + C P+ RP+ S L++
Sbjct: 279 GVQINEEFCQRLKDGTRMRA-PENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 35/193 (18%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTP 193
Q+L GL+Y+H+ ++HRDL SN+ +N N +KI D G A + + T
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTR 172
Query: 194 EYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME--IPYSECDSVAKIYKKVTGGVKPQA 249
Y APEL +YT +D++S G E++ + P + K+ ++ G +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232
Query: 250 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 282
L +++ + + +I PR R + E L P
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 283 FFSELNDDDSEPS 295
+ + L+D EP
Sbjct: 293 YLASLHDPSDEPV 305
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 133
E+ +L+T+ ++ II + +T+ + +L TY + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSII 190
+++LE L YLH IIHRD+ NIF++ +GD G A + +
Sbjct: 192 RRLLEALAYLH--GRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 191 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIP 227
GT E +PEL D Y DI+S GL L EM +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 65/300 (21%), Positives = 124/300 (41%), Gaps = 64/300 (21%)
Query: 36 AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY---- 91
A+KK+ F ++ +L R E++LLR + I C
Sbjct: 31 AIKKITNVFSKK-------------------ILAKRALRELKLLRHFRGHKNITCLYDMD 71
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
V+ N L ++ E +L + + ++ + + Q+L GL+Y+H+ ++
Sbjct: 72 IVF-PGNFNEL-YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VL 127
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----IIGTPEYMAPE--LYEED 204
HRDL N+ +N + ++KI D G A + ++ + T Y APE L +
Sbjct: 128 HRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 262
YT+ +D++S G L E++ + + D V ++ + +V G + L+++ P+ + +I
Sbjct: 187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246
Query: 263 EKCIAQPR---------ARPSASELLKD------------------PFFSELNDDDSEPS 295
P+ A P A +LL+ P+ + +D D EP
Sbjct: 247 RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 35/129 (27%), Positives = 66/129 (51%), Gaps = 5/129 (3%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L + E G+L + ++ R + + + ++ ++ L +LH E II+RDL N+
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLL 219
++ + G +K+ D G +G + GTP Y+APE+ E+Y VD ++ G+ +
Sbjct: 129 LDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMF 187
Query: 220 EMVTMEIPY 228
EM+ P+
Sbjct: 188 EMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 9/97 (9%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIG 191
Q+L GL+YLH+ I+HRD+ N+ +N N +KI D G A + H ++
Sbjct: 111 QILRGLKYLHSAG--ILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVV- 166
Query: 192 TPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEI 226
T Y APE+ YT VDI+S G E++ I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSI 189
++ ++ GL +LH+ II+RDL N+ ++ G +KI D G I G +
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFG-GKTTRTF 161
Query: 190 IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-- 245
GTP+Y+APE Y+ Y + VD ++FG+ L EM+ + P+ D ++++ +
Sbjct: 162 CGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVS 219
Query: 246 KPQALNKVKDPEVKAFIEKCIAQPRAR----PSASELLKD-PFF 284
P++L+K K + K P R P+ +++ FF
Sbjct: 220 YPKSLSKEAVSICKGLLTK---HPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 26/278 (9%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D G VA +LS ++ R + E+ L++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 85 KYIIVCYSVWLDDQHNTLNFITEV-----CTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
K II +V+ + +L +V NL + + + + Q+L G
Sbjct: 75 KNIIGLLNVFTPQK--SLEEFQDVYLVMELMDANL--CQVIQMDLDHERMSYLLYQMLCG 130
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 199
+++LH+ IIHRDL SNI + + +KI D G A G S + T Y APE
Sbjct: 131 IKHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
Query: 200 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKD 255
+ Y E VDI+S G + EM+ + + D + KI +++ G
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL--GTPSDEFMSRLQ 245
Query: 256 PEVKAFIEKCIAQPRARP-SASELLKDPFFSELNDDDS 292
P V+ ++E +P+ S EL D F ++ +
Sbjct: 246 PTVRNYVEN---RPKYAGYSFEELFPDVLFPPDSESHN 280
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E + G+L + ++ R + + + +S ++ L +LH E II+RDL N+
Sbjct: 71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVL 128
Query: 162 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G +K+ D G + + GTP Y+APE L EDY VD ++ G+ +
Sbjct: 129 LDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARP-SASEL 278
EM+ P+ D V G+ +D + +EK I PR+ AS +
Sbjct: 188 EMMAGRSPF---DIV---------GMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235
Query: 279 LKDPFFSELNDDDSE 293
LK LN D E
Sbjct: 236 LK----GFLNKDPKE 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 38/135 (28%), Positives = 71/135 (52%), Gaps = 9/135 (6%)
Query: 101 TLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 159
+L +T++ G+L + ++HR + + L W Q+ +G+ YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARN 139
Query: 160 IFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFG 215
I + + V+I D G A ++ +S TP ++MA E + YT D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 216 LCLLEMVTMEI-PYS 229
+ + EM++ PY+
Sbjct: 199 VTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 50 IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109
I+VA + SE+ + E +++ L + ++ Y V Q L +TE
Sbjct: 29 IKVAIKAINEGAMSEEDFI-----EEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFM 81
Query: 110 TSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168
+G L Y R++ +S L + V EG+EYL + IHRDL N ++ + G
Sbjct: 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGV 138
Query: 169 VKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM- 224
VK+ D G V + + S P ++ PE++ Y+ D++SFG+ + E+ T
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
Query: 225 EIPYSECDSVAKIYKKVTGG---VKPQ-ALNKVKDPEVKAFIEKCIAQPRARPSASELLK 280
++P+ E S ++ + ++ G +P+ A V + + EK P RP+ +ELL+
Sbjct: 199 KMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEK----PEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
++ ++ GLE LH I++RDL NI ++ + G ++I DLG A + +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 192 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPY 228
T YMAPE+ + E YT D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G +V+ + +VA ++ S V E L++TL++ ++ Y
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS-----VQAFLEEANLMKTLQHDKLVRLY 67
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V ++ + ITE G+L + K V + L +S Q+ EG+ Y+
Sbjct: 68 AVVTKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPELYE- 202
IHRDL +N+ ++ ++ KI D G A ++ R A I ++ APE
Sbjct: 124 YIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINF 178
Query: 203 EDYTEMVDIYSFGLCLLEMVTM-EIPY 228
+T D++SFG+ L E+VT +IPY
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 25/273 (9%)
Query: 31 LLGSGAVKKVYRAFDQEE----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
++G G+ KV A + E ++V + L E ++ R LL+ +K+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSER----NVLLKNVKHPF 57
Query: 87 II-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
++ + +S D+ L F+ + G L + ++ R + ++ ++ L YLH+
Sbjct: 58 LVGLHFSFQTADK---LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 114
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEE 203
I++RDL NI ++ G + + D G + + + GTPEY+APE L+++
Sbjct: 115 LN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263
Y VD + G L EM+ P+ ++ A++Y + KP L + +E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILN--KPLQLKPNITNSARHLLE 228
Query: 264 KCIAQPR-----ARPSASELLKDPFFSELNDDD 291
+ + R A+ E+ FFS +N DD
Sbjct: 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 50/203 (24%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 31 LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+LGSGA VY+ EG I VA +++ + + P E ++ ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHPH 70
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
++ V L T+ +T++ G L Y +H+ ++ + L W Q+ +G+ YL
Sbjct: 71 LVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE- 126
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 201
E ++HRDL N+ + + VKI D G A ++ ++ G ++MA E ++
Sbjct: 127 -ERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 202 EEDYTEMVDIYSFGLCLLEMVTM 224
+T D++S+G+ + E++T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 40/119 (33%), Positives = 61/119 (51%), Gaps = 8/119 (6%)
Query: 186 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
AHS++GTP Y+APE L + YT++ D +S G+ L EM+ + P+ K +
Sbjct: 205 AHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264
Query: 245 VKPQALNKVK-DPEVKAFIEK--CIAQPR-ARPSASELLKDPFFSELN---DDDSEPSP 296
+VK PE I K C A+ R R A ++ PFFSE++ D ++P+P
Sbjct: 265 NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 132
E Q+++ L++ ++ Y+V + + +TE + G+L + K + + + L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVC--SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH-AAHSII 190
+ Q+ EG+ YL + IHRDL NI + + KI D G A ++ A
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAREGA 164
Query: 191 GTP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
P ++ APE Y +T D++SFG+ L E+VT +PY
Sbjct: 165 KFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 132
E Q+++ L++ ++ Y+V ++ + +TE G+L + K+ +++ + L
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 191
+ Q+ +G+ Y+ IHRDL +NI + N+ KI D G A ++ + A
Sbjct: 108 AAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAK 164
Query: 192 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
P ++ APE LY +T D++SFG+ L E+VT +PY
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 16/230 (6%)
Query: 59 LSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLR 115
F + VL++ +E++ LR + + I+ Y +D D L+ I E CT G LR
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLR 110
Query: 116 TYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--EPCIIHRDLNCSNIFINGNIGQVKIGD 173
K + +S K + +GL L+ + +P +++L + + N ++KI
Sbjct: 111 EVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIIC 166
Query: 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSE 230
G I+ S + Y + ++ +YT DIYS G+ L E+ T +IP+
Sbjct: 167 HGLEKIL--SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
Query: 231 CDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELL 279
+ +IY + L E+K +E C + RP+ E+L
Sbjct: 225 LTT-KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 32 LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G VY+A D ++ + A Q+ + S E+ LLR LK+ +I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC------REIALLRELKHPNVIS 62
Query: 90 CYSVWLD--DQHNTLNF------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
V+L D+ L F + + KK + +K Q+L+G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 142 YLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRSHAAHS----IIGTPE 194
YLH + ++HRDL +NI + G G+VKI D+GFA + + ++ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 195 YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 231
Y APEL YT+ +DI++ G E++T E P C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 44/244 (18%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII--- 88
LGSG V + + + E L + + DP L + L E +++ L N YI+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 -VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+C + + + E+ G L + +K++HV+ K + + QV G++YL
Sbjct: 63 GIC-------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 148 PCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-L 200
+HRDL N+ + + Q KI D G + +G + ++ APE +
Sbjct: 116 --FVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
++ D++SFG+ + E + Y + K YK + G EV
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS----YGQ-----KPYKGMKGN------------EVTQ 209
Query: 261 FIEK 264
IE
Sbjct: 210 MIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 78 LLRTLKNKYII-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 136
LL+ LK+ +++ + YS ++ L F+ + G L + ++ R + ++ +V
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEK---LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV 105
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEY 195
+ YLH+ II+RDL NI ++ G V + D G V + GTPEY
Sbjct: 106 ASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEY 162
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254
+APE L +E Y VD + G L EM+ P+ D V+++Y + KP L K
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILH--KPLQLPGGK 219
Query: 255 DPEVKAFIEKCIAQPRARPSAS-----ELLKDPFFSELNDDD 291
+ + + + R + E+ FFS +N DD
Sbjct: 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKW 132
E Q+++ L++ ++ Y+V ++ + +TE + G+L + K + R + + L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAA 186
+ QV G+ Y+ IHRDL +NI + + KI D G A ++ R A
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAK 164
Query: 187 HSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY------SECDSVAKI 237
I ++ APE LY +T D++SFG+ L E+VT +PY + V +
Sbjct: 165 FPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219
Query: 238 YKKVTGGVKPQALNKV------KDPEVKAFIE 263
Y+ P +L+++ KDPE + E
Sbjct: 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 34/235 (14%)
Query: 72 LHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------- 122
L SE+++++ + K+K II D L + E + GNLR Y + R
Sbjct: 64 LVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 123 --------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174
++ K L + QV G+EYL + + IHRDL N+ + + +KI D
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKIADF 178
Query: 175 GFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM---EIP 227
G A V + + G ++MAPE L++ YT D++SFG+ L E+ T+ P
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 228 YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 281
+ + K+ K+ KP E+ + +C A P RP+ +L++D
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 69/304 (22%)
Query: 9 SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 68
RD ++ G FGR ++ + E+ V
Sbjct: 3 ISRDRVTLSDLLQEGTFGR------------IFYG---------ILIDEKPG--KEEEVF 39
Query: 69 VNRLH---SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS-------------- 111
V + SE+Q+ L+ ++ Y + H + I VC
Sbjct: 40 VKTVKDHASEIQVTLLLQESCLL--YGL----SHQNILPILHVCIEDGEPPFVLYPYMNW 93
Query: 112 GNLRTYRKKHRHVSIKALKKWSK--------QVLEGLEYLHTHEPCIIHRDLNCSNIFIN 163
GNL+ + ++ R + S Q+ G+ YLH +IH+D+ N I+
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151
Query: 164 GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY-----MAPE-LYEEDYTEMVDIYSFGLC 217
+ QVKI D + + + +G E MA E L ++Y+ D++SFG+
Sbjct: 152 EEL-QVKITDNALSRDLFPMD--YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208
Query: 218 LLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSA 275
L E++T+ + PY E D ++ + G + D E+ A + C A P RPS
Sbjct: 209 LWELMTLGQTPYVEIDPF-EMAAYLKDGYRLAQPINCPD-ELFAVMACCWALDPEERPSF 266
Query: 276 SELL 279
S+L+
Sbjct: 267 SQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 24/273 (8%)
Query: 31 LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+LGSGA VY+ +G I VA +++ + P + E ++ + + Y
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+ + L +T+ +T++ G L Y ++++ + + L W Q+ +G+ YL
Sbjct: 71 VCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE- 126
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 201
E ++HRDL N+ + + VKI D G A ++ + G ++MA E +
Sbjct: 127 -EVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKA 260
+T D++S+G+ + E++T + +I + G + PQ D V
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID--VYM 242
Query: 261 FIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
+ KC + RP EL+ + FS + D S
Sbjct: 243 IMVKCWMIDSECRPRFRELVDE--FSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 44/249 (17%)
Query: 64 EDPVLVNRLHS------------EVQLLRTLKNKYIIVCYSVWLD-DQHNTLNFITEVCT 110
E VLV L E+ + R L +K ++ + + + H I E
Sbjct: 35 ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY---MILEYTD 91
Query: 111 SGNLRTY---------RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
G+L+ + + K +S K Q+ G+++L +HRDL N
Sbjct: 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCL 149
Query: 162 INGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 218
++ +VK+ L + V S + + + ++APE + E+D++ D++SFG+ +
Sbjct: 150 VSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208
Query: 219 LEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE-----VKAFIEKCIA-QPRA 271
E+ T E+P+ ++V ++ L ++ PE + + +C A P+
Sbjct: 209 WEVFTQGELPFYGLSD-----EEVLNRLQAGKL-ELPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 272 RPSASELLK 280
RPS SEL+
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 50/224 (22%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-WSKQVLEGLEY 142
N++I + + D+ N L + + G+L T K + + + + +++ ++
Sbjct: 60 NQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPEL 200
+H +HRD+ NI ++ N G +++ D G + S +GTP+Y++PE+
Sbjct: 118 VHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 201 YE--ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQAL 250
+ ED Y D +S G+C+ EM+ E P+ +S+ + Y K+ + P +
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQV 233
Query: 251 NKVKDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELNDDD 291
V + + K I + I R + + + PFF+ ++ D+
Sbjct: 234 TDVSE-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
++ ++L GLE LH ++RDL NI ++ + G ++I DLG A + + +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 192 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 228
T YMAPE L + YT D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G+ VY+ + G VA + + P R E LL+ LK+ I++ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVLLH 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ TL F+ E + +L Y +H + ++ + Q+L GL Y+H I
Sbjct: 70 DII--HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--I 124
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEEDY 205
+HRDL N+ I+ +G++K+ D G A +I +++++ + T Y P+ L DY
Sbjct: 125 LHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181
Query: 206 TEMVDIYSFGLCLLEMV 222
+ +DI+ G +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 16 FVEVDPSGRFGR--YSDLLGSG---AVKKVYR-AFDQEEGIEVAWNQVRLSHFSEDPVLV 69
F+ V G FG+ ++ G+ A+K + + Q++ +E + R+ + P +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 70 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 129
+LHS Q + + L F+ E G+L + ++
Sbjct: 64 TQLHSCFQTV--------------------DRLYFVMEYVNGGDLMYHIQQVGKFKEPQA 103
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH----- 184
++ ++ GL +LH II+RDL N+ ++ G +KI D G + H
Sbjct: 104 VFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSE-GHIKIADFGMC----KEHMVDGV 156
Query: 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPY 228
+ GTP+Y+APE+ + Y + VD +++G+ L EM+ + P+
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
+++ + + DD++ L + E G+L + V K K ++ +V+ L+ +H+
Sbjct: 104 WVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS 160
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPELYEE 203
+IHRD+ N+ ++ + G +K+ D G + + + +GTP+Y++PE+ +
Sbjct: 161 MG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 204 D-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
Y D +S G+ L EM+ + P+ DS+ Y K+ +LN +D E+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMD--HKNSLNFPEDVEI 274
Query: 259 KAFIEKCIAQ-------PRARPSASELLKDPFF 284
+ I R E+ + PFF
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 202
H+ +HRD+ N+ ++ N G +++ D G + + S +GTP+Y++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 203 -ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQALNKV 253
ED Y D +S G+C+ EM+ E P+ +S+ + Y K+ + P + V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHITDV 236
Query: 254 KDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELNDDD 291
+ E K I++ I R + + K FF ++ ++
Sbjct: 237 SE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 35/190 (18%)
Query: 46 QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105
Q++ +E + R+ S P + +LHS Q + + L F+
Sbjct: 40 QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--------------------DRLYFV 79
Query: 106 TEVCTSGNL-----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160
E G+L + R K H ++ ++ GL +LH+ II+RDL N+
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIGLFFLHSKG--IIYRDLKLDNV 132
Query: 161 FINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCL 218
++ G +KI D G + + GTP+Y+APE+ + Y + VD ++FG+ L
Sbjct: 133 MLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 219 LEMVTMEIPY 228
EM+ + P+
Sbjct: 192 YEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 34/272 (12%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----------PVLVNRLHSE--VQ 77
D++G G +V +A +++G+ + R+ ++ VL H +
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 78 LLRTLKNK---YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH---RHVSIKALKK 131
LL +++ Y+ + Y+ N L+F+ + + + +S + L
Sbjct: 61 LLGACEHRGYLYLAIEYAPH----GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
++ V G++YL + IHRDL NI + N KI D G + G+ +G
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSR--GQEVYVKKTMG 171
Query: 192 --TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKP 247
+MA E L YT D++S+G+ L E+V++ PY + A++Y+K+ G +
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRL 230
Query: 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
+ D EV + +C +P RPS +++
Sbjct: 231 EKPLNCDD-EVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 50/274 (18%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----- 84
+ +G G VY+ + EVA R + + +Q LK
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKF------LQEAEILKQYDHPN 53
Query: 85 --KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 141
K I VC Q + + E+ G+L T+ RKK +++K L + S G+E
Sbjct: 54 IVKLIGVCV------QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGME 107
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-----AIVGRSHAAHSIIGTP-EY 195
YL + IHRDL N + N +KI D G + I S I P ++
Sbjct: 108 YLESK--NCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQI---PIKW 161
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSEC------DSVAKIYKKVTGGVKP 247
APE L YT D++S+G+ L E ++ + PY + + Y+ + P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP 221
Query: 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280
+ + ++ + +C A P RPS SE+
Sbjct: 222 EEIYRL--------MLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKW 132
E +++TL++ ++ ++V + + ITE G+L + K + L +
Sbjct: 51 EANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI------VGRSHAA 186
S Q+ EG+ ++ IHRDL +NI ++ ++ KI D G A + R A
Sbjct: 108 SAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAK 164
Query: 187 HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
I ++ APE + +T D++SFG+ L+E+VT IPY + ++ + + G
Sbjct: 165 FPI----KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALERG 219
Query: 245 VKPQALNKVKDPEVKAFIEKCIAQPRARPS 274
+ + + +P RP+
Sbjct: 220 YRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 56 QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSV-WLDDQHNTLNFITEVCTSGN 113
++ +F+ +V H QL++ N I + YSV L +++I + G+
Sbjct: 48 IIKAKNFNAIEPMV---H---QLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKD----GD 95
Query: 114 LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173
L KK +S +KK +Q++E L LH H IIH D+ N+ + ++ + D
Sbjct: 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCD 153
Query: 174 LGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 230
G I+G S GT +Y +PE + +Y D ++ G+ E++T + P+ E
Sbjct: 154 YGLCKIIG----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----------EDPVLVNRLHSE- 75
++ D++G G +V RA +++G+++ L F+ E VL H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 76 -VQLLRTLKNK---YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KA 128
+ LL +N+ YI + Y+ + N L+F+ + + K+H S +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPY----GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188
L +++ V G++YL + IHRDL N+ + N+ KI D G + G
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS-KIADFGLSR--GEEVYVKK 175
Query: 189 IIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
+G +MA E L YT D++SFG+ L E+V++ PY + A++Y+K+ G
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKLPQG 234
Query: 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
+ + D EV + +C +P RP +++
Sbjct: 235 YRMEKPRNCDD-EVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH---AAH 187
+S QV G+E+L + C+ HRDL N+ I G + VKI D G A + R +
Sbjct: 244 FSYQVANGMEFLASKN-CV-HRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKG 299
Query: 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 245
S ++MAPE ++ YT + D++SFG+ L E+ T+ PY E + Y + G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359
Query: 246 KPQALNKVKDPEVKAFIEKCIAQP-RARPSASELL 279
+ D E+ ++KC + RP S+L+
Sbjct: 360 RMAKPAHASD-EIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 27 RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
R+ + LG GA KVY+ ++ VA ++ + +P + E +L+
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSD 64
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSK---- 134
L++ I+ V +Q + F E G+L + H V ++ + K
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLF--EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 135 ---------QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185
Q+ G+EYL +H +HRDL N + + VKI D G + + S
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL-TVKISDFGLSRDI-YSAD 178
Query: 186 AHSIIGTP----EYMAPE--LYEEDYTEMVDIYSFGLCLLEM 221
+ + +M PE LY + +T DI+SFG+ L E+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 36/269 (13%)
Query: 31 LLGSGAVKKVYRA------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LGSGA +VY I VA +R ++ E L+ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK---EFLKEAHLMSNFNH 58
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVL 137
I+ V L ++ + I E+ G+L +Y + R +++K L V
Sbjct: 59 PNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 138 EGLEYLH-THEPCIIHRDLNCSNIFINGNIGQ----VKIGDLGFAAIVGRSH----AAHS 188
+G YL H IHRDL N ++ VKIGD G A + +S
Sbjct: 117 KGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 189 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 246
++ +MAPE L + +T D++SFG+ + E++T+ + PY ++ ++ + VT G +
Sbjct: 174 LLPV-RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHVTAGGR 231
Query: 247 PQALNKVKDPEVKAFIEKCIAQ-PRARPS 274
Q D ++ + C AQ P RP+
Sbjct: 232 LQKPENCPD-KIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 112 GNLRTYRKKHR------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165
G+L ++ R + ++ L K+ + G+EYL IHRDL N + +
Sbjct: 92 GDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED 149
Query: 166 IGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEM 221
+ V + D G + + G + I P +++A E L + YT D+++FG+ + E+
Sbjct: 150 M-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
Query: 222 VTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPS 274
T + PY ++ +IY + G N++K PE + + C A P+ RP+
Sbjct: 209 ATRGQTPYPGVEN-HEIYDYLRHG------NRLKQPEDCLDELYDLMYSCWRADPKDRPT 261
Query: 275 ASEL 278
++L
Sbjct: 262 FTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 28/164 (17%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+S QV +G+E+L + + CI HRDL NI ++ N VKI D G A I
Sbjct: 184 YSFQVAKGMEFLASRK-CI-HRDLAARNILLSEN-NVVKICDFGLA---------RDIYK 231
Query: 192 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 237
P+Y MAPE +++ YT D++SFG+ L E+ ++ PY +
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
Query: 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 280
+++ G + +A + PE+ + C +P RP+ SEL++
Sbjct: 292 CRRLKEGTRMRAPD-YTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-08
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKA----L 129
EVQ R L + ++ C ++ L E C G+L+ Y + +R V+ A L
Sbjct: 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVL--EFCPLGDLKNYLRSNRGMVAQMAQKDVL 102
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
++ + +V GL L H+ IH DL N + ++ VKIGD G +
Sbjct: 103 QRMACEVASGL--LWLHQADFIHSDLALRNCQLTADL-SVKIGDYG----LALEQYPEDY 155
Query: 190 IGTPE-------YMAPELYEE--------DYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 233
T + ++APEL E D T+ +I+S G+ + E+ T + PY + S
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-S 214
Query: 234 VAKIYKKV-----TGGVKPQALNKVKDP--EVKAFIEKCIAQPRARPSASEL 278
++ K+V KPQ K D EV F C P RP+A E+
Sbjct: 215 DEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF---CWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWN---QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LG G +V+ WN +V + + E Q+++ L+++ ++
Sbjct: 14 LGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH 146
Y+V ++ + +TE + G+L + K +++ + L + Q+ G+ Y+
Sbjct: 65 QLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE--LYE 202
+HRDL +NI + N+ K+ D G A ++ + A P ++ APE LY
Sbjct: 122 N--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 203 EDYTEMVDIYSFGLCLLEMVTM-EIPY 228
+T D++SFG+ L E+ T +PY
Sbjct: 179 R-FTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-08
Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 29/264 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKN--- 84
+LLG G +V++ +++ V + ED L + SE ++L+ +
Sbjct: 1 ELLGKGNFGEVFKGTLKDK------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54
Query: 85 -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 142
K I VC Q + + E+ G+ ++ RKK + K L K++ G+ Y
Sbjct: 55 VKLIGVC------TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE- 199
L + IHRDL N + N +KI D G + +++ + P ++ APE
Sbjct: 109 LESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEA 165
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
L Y+ D++S+G+ L E ++ + PY + + ++V G + K D +V
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPD-DV 223
Query: 259 KAFIEKCIA-QPRARPSASELLKD 281
+++C +P RP SEL K+
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-08
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV-SIKALKK 131
+E ++ L++ ++ V ++++ L +TE G+L Y R + R V L K
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFAAIVGRSHAAHSII 190
+S V E +EYL + +HRDL N+ ++ N+ K+ D G + +
Sbjct: 107 FSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVA--KVSDFGLTKEASSTQDTGKL- 161
Query: 191 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQ 248
++ APE L E+ ++ D++SFG+ L E+ + +PY + + +V G K
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMD 219
Query: 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
A + P V +++C RPS +L
Sbjct: 220 APDGCP-PVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA----- 128
E Q R+L++ ++ C + L + E C G+L+ Y + R +
Sbjct: 44 EEAQPYRSLQHSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTT 101
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---A 185
L++ + ++ GL +LH + IH DL N + ++ VKIGD G + +
Sbjct: 102 LQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVT 158
Query: 186 AHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 236
+ ++APEL +E D T+ +++S G+ + E+ + PY
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--- 215
Query: 237 IYKKVTGGVKPQALNKVKDPEVK--------AFIEKCIAQPRARPSASEL 278
+ +T V+ Q L K+ P +K ++ C QP RPSA E+
Sbjct: 216 -EQVLTYTVREQQL-KLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGR 182
++ L ++ QV G+E+L + +HRDL N+ + G I VKI D G A +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKI--VKICDFGLARDIMH 289
Query: 183 SH---AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 237
+ S ++MAPE +++ YT + D++S+G+ L E+ ++ PY +
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349
Query: 238 YKKVTGG---VKPQ-ALNKVKDPEVKAFIEKCIAQPRARPS 274
Y K+ G KP A +V D VK + ++P RPS
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCW----NSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 198
GLE L I++RDL NI ++ + G ++I DLG A + +GT YMAP
Sbjct: 114 GLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 228
E + E YT D + G + EM+ + P+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 21/166 (12%)
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--G 181
+ ++ L ++ + G+EYL + IHRDL N +N N+ V + D G + + G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSG 166
Query: 182 RSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 238
+ P +++A E L + YT D+++FG+ + E++T + PY+ ++ ++IY
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIY 225
Query: 239 KKVTGGVKPQALNKVKDP-----EVKAFIEKC-IAQPRARPSASEL 278
+ G N++K P +V + +C +P+ RPS L
Sbjct: 226 NYLIKG------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 131
+E L++ L++ ++ Y+V + + ITE +G+L + K ++I L
Sbjct: 50 AEANLMKQLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 185
+ Q+ EG+ ++ IHRDL +NI ++ + KI D G A ++ R A
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGA 163
Query: 186 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
I ++ APE + +T D++SFG+ L E+VT IPY
Sbjct: 164 KFPI----KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 14/223 (6%)
Query: 66 PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV 124
P L + E ++L+ + I+ V Q + + E+ G+ T+ R + +
Sbjct: 34 PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 125 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA--AIVGR 182
+K L + + G+EYL + IHRDL N + +KI D G + G
Sbjct: 92 KVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGV 148
Query: 183 SHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYK 239
+ + P ++ APE L Y+ D++SFG+ L E ++ +PY+ S + +
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTRE 207
Query: 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281
+ GV+ D V +E+C P RPS S + ++
Sbjct: 208 AIEQGVRLPCPELCPD-AVYRLMERCWEYDPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 112 GNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170
G+LR + R + + ++K L + QV +G+EYL + + +HRDL N ++ + VK
Sbjct: 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESF-TVK 138
Query: 171 IGDLGFAAIVGR----SHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM 224
+ D G A + S H+ P ++MA E L + +T D++SFG+ L E++T
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198
Query: 225 EI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKD 281
PY + DS + G Q DP + + +P RP+ SEL+
Sbjct: 199 GAPPYPDVDSFDITVYLLQGRRLLQP-EYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNK 85
++ D++G G +V +A +++G+ + R+ + S+D E+++L L +
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHH 67
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKAL 129
I+ + + L E GNL + +K R +S + L
Sbjct: 68 PNII-NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
++ V G++YL + IHRDL NI + N KI D G + G+
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSR--GQEVYVKKT 181
Query: 190 IG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 245
+G +MA E L YT D++S+G+ L E+V++ PY + A++Y+K+ G
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGY 240
Query: 246 K-PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 279
+ + LN D EV + +C + P RPS +++L
Sbjct: 241 RLEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 20/106 (18%)
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI----------------VGRS 183
LEYLH + I+HRDL N+ I ++G +K+ D G + I R
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 184 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 228
+ GTPEY+APE + + Y + VD ++ G+ L E + +P+
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 14/122 (11%)
Query: 186 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-K 240
AHS++GTP Y+APE L YT++ D +S G+ L EM+ + P+ + ++ K+ +
Sbjct: 205 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ 264
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQPR---ARPSASELLKDPFFSELN---DDDSEP 294
+ + PQA K+ PE I K P + A E+ PFF ++ D +
Sbjct: 265 TSLHIPPQA--KLS-PEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQS 321
Query: 295 SP 296
+P
Sbjct: 322 AP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 28/164 (17%)
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+S QV G+E+L + + CI HRDL NI ++ N VKI D G A I
Sbjct: 178 YSFQVARGMEFLASRK-CI-HRDLAARNILLSEN-NVVKICDFGLA---------RDIYK 225
Query: 192 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 237
P+Y MAPE ++++ YT D++SFG+ L E+ ++ PY +
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
Query: 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 280
+++ G + +A PE+ + + C P RP+ SEL++
Sbjct: 286 CRRLKEGTRMRAPEYAT-PEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 186 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--- 241
AHS++GTP Y+APE L YT++ D +S G+ L EM+ + P+ D+ A+ KV
Sbjct: 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA-DTPAETQLKVINW 259
Query: 242 --TGGVKPQALNKVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFF 284
T + QA K+ E I + R A E+ PFF
Sbjct: 260 ETTLHIPSQA--KLS-REASDLILRLCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 53/196 (27%)
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-------------- 185
++ +H IHRD+ N+ ++ G +K+ D G + +SH
Sbjct: 114 IDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 186 -------------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLL 219
A+S +GTP+Y+APE++ + Y + D +S G+ +
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGG----VKPQALNKVKDPEVKAFIEK--CIAQPR-AR 272
EM+ P+ D+ + Y+K+ P + PE K I++ C A+ R
Sbjct: 231 EMLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLCCEAERRLGN 287
Query: 273 PSASELLKDPFFSELN 288
+E+ PFF ++
Sbjct: 288 NGVNEIKSHPFFKGVD 303
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 29 SDLLGSGAVKKVYRAF--DQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 85
+G G VY+ E E I VA V+ P + + E ++R +
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 86 YII----VCYS--VWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLE 138
+I+ V VW+ + E+ G LR+Y + +++ + + +L +S Q+
Sbjct: 68 HIVKLIGVITENPVWI---------VMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYM 196
L YL + +HRD+ N+ + + VK+GD G + + S+ S P ++M
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLV-SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 197 APE-LYEEDYTEMVDIYSFGLCLLEM 221
APE + +T D++ FG+C+ E+
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 31/184 (16%)
Query: 64 EDPVLVNR--LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 121
+DP L R E +LL L++++I+ Y V D + L + E G+L + + H
Sbjct: 44 KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAH 101
Query: 122 R----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165
+ + + + Q+ G+ YL + +HRDL N + N
Sbjct: 102 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN 159
Query: 166 IGQVKIGDLGFAAIVGRSH----AAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLL 219
+ VKIGD G + V + H+++ +M PE +Y + TE D++SFG+ L
Sbjct: 160 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTES-DVWSFGVILW 216
Query: 220 EMVT 223
E+ T
Sbjct: 217 EIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 60/217 (27%)
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL---------GFAAIVGRSHAA 186
VL+ L+Y+H +HR + S+I I+ + G+V + L G V
Sbjct: 110 VLKALDYIH--HMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRVVHDFPK 166
Query: 187 HSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
+S+ P +++PE+ +++ Y DIYS G+ E+ +P+ + + + +K+ G
Sbjct: 167 YSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225
Query: 244 GV----------------KP---------------------------QALNKVKDPEVKA 260
V KP N+ P
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285
Query: 261 FIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
F+E+C+ + P ARPSAS LL FF ++ SE P
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 59/210 (28%)
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG-FAAIVGRSHAAHSIIGTPEY 195
L GL YLH + IHR++ S+I I+G+ G V + L ++V A + P++
Sbjct: 111 LRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 196 -------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-- 243
++PEL +D Y DIYS G+ E+ T +P+ + + +K+ G
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227
Query: 244 ------GVKPQALNKVKD-----------------------------PEVKAF------- 261
P +++K+ P K F
Sbjct: 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287
Query: 262 IEKCIAQ-PRARPSASELLKDPFFSELNDD 290
+E C+ Q P RPSAS LL FF ++ +
Sbjct: 288 VELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)
Query: 127 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSH 184
+ L K+ + G+EYL + IHRDL N +N N+ V + D G + + G +
Sbjct: 112 QMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYY 168
Query: 185 AAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 241
I P +++A E L + YT D++SFG+ + E+ T + PY ++ ++IY +
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYL 227
Query: 242 TGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPSASELLKD 281
G N++K P + + + C + P+ RPS L +
Sbjct: 228 RQG------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH 184
+ L +S QV +G+ +L + CI HRDL NI + +G I KI D G A + R+
Sbjct: 213 TEDLLSFSYQVAKGMSFL-ASKNCI-HRDLAARNILLTHGRI--TKICDFGLARDI-RND 267
Query: 185 AAHSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 238
+ + + G ++MAPE ++ YT D++S+G+ L E+ ++ PY +K Y
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327
Query: 239 KKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 280
K + G + + + E+ ++ C A P RP+ ++++
Sbjct: 328 KMIKEGYRMLS-PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 53/192 (27%)
Query: 122 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181
R++S + +K + + + L +LH CS + GN+ KI I+
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCR----------CSPAVVVGNLSPEKI-------IID 817
Query: 182 RSHAAHSIIGTPE-------------YMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIP 227
H + P Y+APE E +D TE DIY FGL L+E++T + P
Sbjct: 818 GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
Query: 228 ------------------YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q 268
YS+C I + G V ++N+ + EV C A
Sbjct: 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATD 934
Query: 269 PRARPSASELLK 280
P ARP A+++LK
Sbjct: 935 PTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 66/241 (27%), Positives = 99/241 (41%), Gaps = 52/241 (21%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV--------------NRL 72
R + LG G +V+ + EG+ + F PVLV N
Sbjct: 8 RLKEKLGEGQFGEVHLC--EAEGLA-EFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL------RTYRKKHRH--- 123
E++++ LKN II V + D + L ITE +G+L R H
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 124 ---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG----- 175
VSI L + Q+ G++YL + +HRDL N + GN +KI D G
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNL 179
Query: 176 ----FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--EIPY 228
+ I GR+ + +MA E + +T D+++FG+ L EM T+ E PY
Sbjct: 180 YSGDYYRIQGRA------VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233
Query: 229 S 229
S
Sbjct: 234 S 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA KV+ + + VA V+ + E +LL +++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--------------RKKHRHVSIKALKKW 132
I+ Y V + + + E G+L + +++ L +
Sbjct: 70 IVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+ Q+ G+ YL + +HRDL N + ++ VKIGD G + V + + + G
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLVGYDL-VVKIGDFGMSRDV-YTTDYYRVGGH 183
Query: 193 P----EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 223
+M PE +Y + TE D++SFG+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 53/267 (19%)
Query: 32 LGSG---AVKK-VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LGSG VKK VY+ +++ I+VA +++ + + + + E +++ L N YI
Sbjct: 3 LGSGNFGCVKKGVYKM--RKKQIDVA---IKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 88 I----VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 142
+ VC + L + E+ + G L + K +++ + + QV G++Y
Sbjct: 58 VRMIGVC-------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 198
L +HRDL N+ + N KI D G + +G + A S P ++ AP
Sbjct: 111 LE--GKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E + ++ D++S+G +TM ++ + G KP K+K PE
Sbjct: 168 ECINFRKFSSRSDVWSYG------ITM-------------WEAFSYGQKP--YKKMKGPE 206
Query: 258 VKAFIE--KCIAQPRARPSA-SELLKD 281
V +FIE K + P P L+KD
Sbjct: 207 VMSFIEQGKRLDCPAECPPEMYALMKD 233
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 202
H+ +HRD+ N+ ++ N G +++ D G + S +GTP+Y++PE+ +
Sbjct: 119 HQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 203 -ED----YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVK----PQALNK 252
ED Y D +S G+C+ EM+ E P Y+E S+ + Y K+ + P +
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTD 235
Query: 253 VKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELNDD---DSEP 294
V + E K I + I P R + PFF ++ D +S
Sbjct: 236 VSE-EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTA 282
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/123 (26%), Positives = 62/123 (50%), Gaps = 15/123 (12%)
Query: 130 KKWSK----QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185
+KW++ +V+ L+ +H+ IHRD+ N+ ++ + G +K+ D G + +
Sbjct: 141 EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGM 197
Query: 186 AHS--IIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 238
+GTP+Y++PE+ + Y D +S G+ L EM+ + P+ DS+ Y
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 256
Query: 239 KKV 241
K+
Sbjct: 257 SKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 41/182 (22%), Positives = 80/182 (43%), Gaps = 42/182 (23%)
Query: 97 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 156
D+ N L I E G++ T K +S +A + + + + ++ +H + IHRD+
Sbjct: 72 DKRN-LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIK 128
Query: 157 CSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------------------- 185
N+ ++ G VK+ D G + ++H
Sbjct: 129 PDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 186 -----AHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 239
A+S +GTP+Y+APE++ + Y ++ D +S G+ + EM+ P+ ++ + Y+
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYR 246
Query: 240 KV 241
KV
Sbjct: 247 KV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH---------- 121
H E +LL L++++I+ Y V ++ + L + E G+L + + H
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 122 ---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178
++ + ++Q+ G+ YL + +HRDL N + N+ VKIGD G +
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL-LVKIGDFGMSR 168
Query: 179 IVGRSH----AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 223
V + H+++ +M PE + +T D++S G+ L E+ T
Sbjct: 169 DVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 54/207 (26%)
Query: 107 EVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162
E C G+L++Y + R+ + L++ + ++ G+ ++H H +H DL N F+
Sbjct: 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL 132
Query: 163 NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-------YMAPELYEE--------DYTE 207
++ VK+GD G +G S I T + ++APEL E + T+
Sbjct: 133 TSDL-TVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTK 187
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEVKAF----- 261
++++ G+ L E+ ++ A+ Y ++ + LN V KD +VK F
Sbjct: 188 PSNVWALGVTLWELF---------ENAAQPYSHLS---DREVLNHVIKDQQVKLFKPQLE 235
Query: 262 ----------IEKCIAQPRARPSASEL 278
++ C P R +A E+
Sbjct: 236 LPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
KYI+ SV+L QH G L ++ K ++ + +K+W+ +++ L+ L
Sbjct: 52 KYIVSEDSVFLVLQH---------AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDAL- 101
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE---LY 201
H I+ RDLN +NI ++ + G +++ + V S ++ Y APE +
Sbjct: 102 -HREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGIS 157
Query: 202 EEDYTEMVDIYSFGLCLLEMVT 223
EE TE D +S G L E++T
Sbjct: 158 EE--TEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 9/130 (6%)
Query: 105 ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 163
ITE +G+L + +++ ++ L + + G++YL +HRDL NI +N
Sbjct: 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--NYVHRDLAARNILVN 140
Query: 164 GNIGQVKIGDLGFAAIVGRSHAAHSIIG--TP-EYMAPE-LYEEDYTEMVDIYSFGLCLL 219
N+ K+ D G + + S A ++ G P + APE + +T D++SFG+ +
Sbjct: 141 SNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 199
Query: 220 EMVTM-EIPY 228
E+++ E PY
Sbjct: 200 EVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 42/187 (22%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------ 122
EV++L LK+ II V +D+ + L ITE +G+L + H
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 123 -------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175
+S +L + Q+ G++YL + +HRDL N + N+ +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183
Query: 176 ---------FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM- 224
+ I GR+ + +MA E + +T D+++FG+ L E++ +
Sbjct: 184 MSRNLYAGDYYRIQGRA------VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237
Query: 225 -EIPYSE 230
E PY E
Sbjct: 238 KEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 39/174 (22%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
E ++ + +++ + + DD++ L + E G+L + V K + ++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 149
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 192
+V+ L+ +H+ IHRD+ N+ ++ + G +K+ D G + + + +GT
Sbjct: 150 EVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 193 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241
P+Y++PE+ + Y D +S G+ L EM+ + P+ DS+ Y K+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 50/248 (20%), Positives = 104/248 (41%), Gaps = 44/248 (17%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
++G GA +V ++ G A +R + E V + +E +L + +++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSLWVVKM 66
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ + D + L I E G++ T K ++ + + + + + ++ +H +
Sbjct: 67 FYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH--QLGF 122
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------------- 185
IHRD+ N+ ++ G VK+ D G + ++H
Sbjct: 123 IHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 186 -----------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
A S +GTP+Y+APE++ + Y ++ D +S G+ + EM+ P+ ++
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ET 240
Query: 234 VAKIYKKV 241
+ YKKV
Sbjct: 241 PQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 105 ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 163
+TE +G+L + +KH ++ L + + G++YL + +HRDL NI +N
Sbjct: 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVN 140
Query: 164 GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCL 218
N+ K+ D G + ++ AA++ G + APE + +T D++S+G+ +
Sbjct: 141 SNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 199
Query: 219 LEMVTM-EIPYSE 230
E+++ E PY E
Sbjct: 200 WEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 18/139 (12%)
Query: 105 ITEVCTSGNLRTY----RKKHRHVSIKALKKWSK------QVLEGLEYLHTHEPCIIHRD 154
I E+ T G+L++Y R + + ++A K ++ +G+ YL+ ++ +HRD
Sbjct: 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRD 144
Query: 155 LNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPE-LYEEDYTEMVD 210
L N + + VKIGD G + + + +M+PE L + +T D
Sbjct: 145 LAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 203
Query: 211 IYSFGLCLLEMVTM-EIPY 228
++SFG+ L E+ T+ E PY
Sbjct: 204 VWSFGVVLWEIATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 46/159 (28%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAA-IVGRSHAA 186
L ++S QV +G+++L + CI HRD+ N+ + +G + KI D G A I+ S+
Sbjct: 214 LLRFSSQVAQGMDFLASKN-CI-HRDVAARNVLLTDGRV--AKICDFGLARDIMNDSN-- 267
Query: 187 HSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKK 240
+ + G ++MAPE +++ YT D++S+G+ L E+ ++ + PY +K YK
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
V G + + PE+ + ++ C +P RP+ S++
Sbjct: 328 VKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 34/184 (18%)
Query: 70 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------- 122
N E++++ LK+ II +V + + L ITE +G+L + +H
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 123 ----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG--- 175
+S L + Q+ G++YL + +HRDL N + N +KI D G
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY-TIKIADFGMSR 178
Query: 176 ------FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--EI 226
+ I GR A I +M+ E + +T D+++FG+ L E++T+ E
Sbjct: 179 NLYSGDYYRIQGR--AVLPI----RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 227 PYSE 230
PYS+
Sbjct: 233 PYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 27/114 (23%)
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIG 191
+Q+L L+ LH+ I+HRD+ NI + G KI DLG AA VG ++ +
Sbjct: 262 RQILFALDGLHS--TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319
Query: 192 TPEYMAPE-----------------------LYEEDYTEMVDIYSFGLCLLEMV 222
P Y APE L++ + + DIYS GL L+M
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373
|
Length = 566 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
++G GA V + +E VA + + S +E+ + E+++LRTLK + I+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE--VKETTLRELKMLRTLKQENIVEL 65
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ + L + E L + V + ++ + Q+++ + + H ++ I
Sbjct: 66 KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPE-LYEEDYTE 207
+HRD+ N+ I+ N +K+ D GFA + A+ + T Y +PE L Y +
Sbjct: 122 VHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 208 MVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQAL 250
VD++S G C+L ++ P SE D + I +KV G + + +
Sbjct: 181 AVDMWSVG-CILGELSDGQPLFPGESEIDQLFTI-QKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 105 ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 163
ITE +G L Y + H S L + + G++YL + +HRDL NI +N
Sbjct: 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVN 141
Query: 164 GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCL 218
N+ + K+ D G + ++ ++ G + APE + +T D++SFG+ +
Sbjct: 142 SNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200
Query: 219 LEMVTM-EIPYSECDSVAKIYKKVTGGVK-------PQALNKVKDPEVKAFIEKCIAQPR 270
E+++ E PY + S ++ K + G + P A+ ++ + +C Q R
Sbjct: 201 WEVMSFGERPYWDM-SNHEVMKAINDGFRLPAPMDCPSAVYQL--------MLQCWQQDR 251
Query: 271 AR 272
AR
Sbjct: 252 AR 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 26/110 (23%)
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+KQV G+ YL E +HRDL N + N+ VKI D G + +I
Sbjct: 136 AKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGL---------SRNIYSA 183
Query: 193 PEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PY 228
Y M PE ++ YT D++++G+ L E+ + + PY
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA KV+ A +++ + VA L SE E +LL L++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQ--DFQREAELLTVLQHQH 68
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR---------------HVSIKALKK 131
I+ Y V + + L + E G+L + + H +++ +
Sbjct: 69 IVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+ Q+ G+ YL + +HRDL N + + VKIGD G + + S + + G
Sbjct: 127 IASQIASGMVYLASLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGG 182
Query: 192 TP----EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 223
+M PE LY + TE DI+SFG+ L E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTES-DIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 24/158 (15%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
Q L L LH R NI + + G + F ++ P
Sbjct: 25 QCLGALRELH--------RQAKSGNILLTWDGLLKLDGSVAF-----KTPEQS--RPDPY 69
Query: 195 YMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------ 247
+MAPE+ + YTE DIYS G+ L E + E+PY+E ++ I + + G+
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129
Query: 248 QALNKVKD-PEVKAFIEKCIAQ-PRARPSASELLKDPF 283
L V + F+ C ++ P+ R +A+ L
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSI 189
K+ +V L+YLH H IIHRDL N+ I+ N G +K+ D G + + + R I
Sbjct: 108 KYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKVTLNRELNMMDI 164
Query: 190 IGTPEYMAP 198
+ TP P
Sbjct: 165 LTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 107 EVCTSGNLRTYRKKHR-------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 159
E+ G+L+++ +++R +++K L ++ V +G +YL + IHRD+ N
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARN 146
Query: 160 IFIN--GNIGQVKIGDLGFAAIVGRS-------HAAHSIIGTPEYMAPELYEED-YTEMV 209
+ G KI D G A + R+ A I ++M PE + + +T
Sbjct: 147 CLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI----KWMPPEAFLDGIFTSKT 202
Query: 210 DIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 268
D++SFG+ L E+ ++ +PY + ++ + VTGG + P + +
Sbjct: 203 DVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHT 261
Query: 269 PRARPSASELLK 280
P RP+ + +L+
Sbjct: 262 PEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 17/43 (39%), Positives = 29/43 (67%), Gaps = 1/43 (2%)
Query: 189 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 230
I+GTP+Y+APE L + + VD ++ G+CL E +T P+++
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND 582
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.04 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.75 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.46 | |
| PLN02236 | 344 | choline kinase | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.06 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.63 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.46 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.08 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.08 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.58 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.48 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.33 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.98 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.82 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=370.58 Aligned_cols=256 Identities=31% Similarity=0.560 Sum_probs=231.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+....||+|..|+||+|.|+.+++.+|+|++... .+....+++.+|++++++++||||+.++|.|..+.. .++++|
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~m 157 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICM 157 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeeh
Confidence 3468899999999999999999999999999533 367888999999999999999999999999988753 699999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+|||.+++...+++++..+..++.++++||.|||. ++ |+||||||+|||++.. |.+||||||.+..+.+. .
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-I 233 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhh-h
Confidence 999999999999998999999999999999999999995 78 9999999999999999 99999999999988665 5
Q ss_pred cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 186 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
..+..||..|||||.+.++ ++.++||||||+.++|+++|+.||... ...-.+...+..+.+|..+....++++++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 6778899999999988865 999999999999999999999999763 45666777777777777777768999999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
|+.+||+ ||.+|||+.|+++|||+++....
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 9999997 99999999999999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-58 Score=378.77 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=228.6
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP---VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
...+|.+.+.||+|+||.|-+|..+.+|+.||||++......... .....+++|+++|++++||+|++++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 345557899999999999999999999999999999875543211 1234467999999999999999999999655
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCC
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGF 176 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~ 176 (296)
+..|+|+||+.||.|.+++..++.+.+...+.+++||+.|+.|||+.| |+||||||+|||++.+. =.+|+.|||+
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 788999999999999999999999999999999999999999999999 99999999999998872 2689999999
Q ss_pred ccccCCCcccccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--C
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--L 250 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 250 (296)
|...++..-....||||.|.|||++.+. +..+.|+|||||++|-+++|.+||++......+.+++..+.-... .
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9999888888899999999999987643 334789999999999999999999987666667777777655433 3
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+..++++..+||..||. ||+.|||+.++|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 44568999999999998 999999999999999999766
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-56 Score=381.42 Aligned_cols=269 Identities=30% Similarity=0.521 Sum_probs=232.7
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
+-...|+...+|+.+++||+|||+++|.+.+..+|+.||+|++..+... .....+.+.+|+++.++|+|||||+++++|
T Consensus 9 p~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 9 PEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred CCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 4444554556667899999999999999999999999999999875543 355678899999999999999999999999
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
.+. +.+|+|.|.|..++|..+++..+.++|.+++.+++||+.||.|||+++ |+|||||..|+|++.+ .++||+||
T Consensus 88 EDs--~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDF 162 (592)
T KOG0575|consen 88 EDS--NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDF 162 (592)
T ss_pred ecC--CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEeccc
Confidence 655 899999999999999999999999999999999999999999999999 9999999999999999 69999999
Q ss_pred CCccccCCC-cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 175 GFAAIVGRS-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 175 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
|+|+.+... ......||||.|.|||++.+ .++..+||||+||++|.|+.|++||.. ....+.++.+..+. ...+.
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~--Y~~P~ 239 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNE--YSMPS 239 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcC--ccccc
Confidence 999998754 55677899999999998775 499999999999999999999999976 44455555444432 23344
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+.+.++||.+||+ ||.+|||++++|.|+||+.=..++.
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 679999999999998 9999999999999999955444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-54 Score=350.44 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=228.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
..| ++.++||+|+||.||.+..+++++.||+|++++...... ...+....|..+|.+++||+|++++-.|.+. ..+
T Consensus 25 ~dF-~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~kL 100 (357)
T KOG0598|consen 25 DDF-EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTE--EKL 100 (357)
T ss_pred hhe-eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccC--CeE
Confidence 345 689999999999999999999999999999987765443 4567888999999999999999999999665 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-C
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-G 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~ 181 (296)
|+|+||+.||.|.-.+++.+.+++..++-++..|+.||.|||++| |+||||||+|||++.+ |.++|+|||+++.. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhccc
Confidence 999999999999999999999999999999999999999999999 9999999999999999 99999999999854 4
Q ss_pred CCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
....+...|||+.|+|||++. ..++.++|.||||+++|+|++|.+||.+.+.......+... . ....+...+.+.++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-k-~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-K-LPLPPGYLSEEARD 255 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-c-CCCCCccCCHHHHH
Confidence 445577789999999999765 55999999999999999999999999886554444444443 3 23445556899999
Q ss_pred HHHHHHh-CCCCCC----CHHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRARP----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~Rp----s~~~ll~hp~~~~~~~~~ 291 (296)
++.++|+ ||++|. ++.++-+||||+.++|++
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 9999997 999995 899999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=345.52 Aligned_cols=267 Identities=25% Similarity=0.464 Sum_probs=234.0
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
..+..+.| .+++.||+|+||+||+|.++.++..||||.+.+... .....+.+..|+.+|+.++|+||+.++++...+
T Consensus 5 ~~~~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 5 SMRVVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 34556677 578889999999999999999999999999987765 677788899999999999999999999999655
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC-----CceEEe
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-----GQVKIG 172 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~-----~~~~l~ 172 (296)
+.+|+|||||.||+|.+++...+.+++..++.++.||+.||++||+++ |+||||||+|||++.+. -.+||+
T Consensus 82 --~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 82 --DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred --CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEec
Confidence 799999999999999999999999999999999999999999999999 99999999999998751 258999
Q ss_pred ccCCccccCCCcccccCCCCCCccCcccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
|||+++.+.........||+|.|||||++ .++|+-++|+||+|+|+|++++|+.||......+-+.....+.......+
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 99999999988889999999999999987 46799999999999999999999999987665555554444444455556
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...+....+|+...++ +|++|.+..+-+.|+++..-..+.
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~ 278 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR 278 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence 6667778899999887 999999999999999987655443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=366.25 Aligned_cols=276 Identities=61% Similarity=1.086 Sum_probs=262.1
Q ss_pred CCCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEE
Q 022479 11 RDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90 (296)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 90 (296)
.+.....+.++.+||.++..+||+|+|-+||+|.+..+|..||.-.++......+....++|..|+.+|+.|+|+||+++
T Consensus 27 ~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirf 106 (632)
T KOG0584|consen 27 PDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRF 106 (632)
T ss_pred cccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeee
Confidence 45667889999999999999999999999999999999999999999888888888889999999999999999999999
Q ss_pred eeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
+..|.+...+++.+|+|.+.+|+|+.|+++.++++...++.|++||++||.|||++.|||+|||||.+||||+.+.|.||
T Consensus 107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 99999888889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
|+|+|+|+......... ..|||.|||||++...|.+..||||||+.+.||+|+.-||+...+..+++..+..+..|..+
T Consensus 187 IGDLGLAtl~r~s~aks-vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHAKS-VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred ecchhHHHHhhccccce-eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 99999999886654433 78999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCHHHHhcCcccccc
Q 022479 251 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~~p~~Rps~~~ll~hp~~~~~ 287 (296)
.....++++++|.+||.-...|+|+.+||.||||+.=
T Consensus 266 ~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDED 302 (632)
T ss_pred hccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence 9999999999999999879999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=354.95 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=224.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++++.||+|+|++|++|.++.+++.||||++....... +.-.+-+.+|-..|.+| .||.|++++-.|.++ ..+|+|
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~sLYFv 152 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ESLYFV 152 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cceEEE
Confidence 78999999999999999999999999999997654422 22235577888999999 899999999999877 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+||.++|.|.+++.+-+.|++...+.++.+|+.||+|||++| |+||||||+|||++.+ ++++|.|||.+..+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 9999999999999999 8999999999987742111
Q ss_pred ----------c----ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 186 ----------A----HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 186 ----------~----~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
. .+..||-.|.+||++. +..++++|+|+||||+|.|+.|.+||.+.+..-.++.++.-.. .+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y---~f 306 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY---EF 306 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc---cC
Confidence 1 3356888999999776 4589999999999999999999999998888777777766533 34
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+...++.+++||+++|. ||.+|+++.++-+||||.+++|++
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 44568999999999997 999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=335.52 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=216.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+...++|+|+||+||+|.+++||+-||||++.-+ .+++...+-..+|+++|++++|+|++.+.++|. ..+.+++|+
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLVF 80 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLVF 80 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEEe
Confidence 4478899999999999999999999999999754 447888888999999999999999999999994 448999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~ 185 (296)
||+...-|.++-.....++...+++++.|++.|+.|+|+++ ++||||||+|||++.+ |.+||||||.|+.+. ....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence 99999666655555556899999999999999999999999 9999999999999999 899999999999886 4444
Q ss_pred cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCC--------------
Q 022479 186 AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKP-------------- 247 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~-------------- 247 (296)
...+..|..|+|||.+.+ ++..+.|||++||++.||++|.+.|++..+.++++-+... ...+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 555678889999997765 4999999999999999999999999999999988744432 1111
Q ss_pred ---CCCCC---------CCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 248 ---QALNK---------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 248 ---~~~~~---------~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
....+ ..+..+-+|++.||+ ||++|++.+++|.||||+.+.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 00000 114567799999998 999999999999999997653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=333.27 Aligned_cols=246 Identities=28% Similarity=0.513 Sum_probs=217.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||.|.||.||++++..+|+.+|.|.++.... +....+....|+.+|++++||||++.+++-..++...++++
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4789999999999999999999999999999986655 67778889999999999999999999996666665669999
Q ss_pred eeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC--CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 106 TEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTH--EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 106 ~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~--~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
||++.+|.|...++ ++..+++..+|.++.||+.||.++|++ +..++||||||.|||++.+ |.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhH
Confidence 99999999988776 467899999999999999999999993 3239999999999999999 8999999999998
Q ss_pred cCCCcc-cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGRSHA-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
+..... ..+..|||.|++||++. ..++.++|||||||++|||+.-..||.+. +...+...+.++-.+..+...+|..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 865433 56678999999999665 56999999999999999999999999985 6677777777776665666778999
Q ss_pred HHHHHHHHHh-CCCCCCCH
Q 022479 258 VKAFIEKCIA-QPRARPSA 275 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~ 275 (296)
++.||..|+. ||+.||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999998 99999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=340.23 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=218.1
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+..++.||+|+||+||++.++++|...|+|.+..... ...+.+.+|+.+|++++||+||+.+|.....+...+++.
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3568999999999999999999999999999986622 126789999999999999999999997543332479999
Q ss_pred eeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC-CCCceEEeccCCccccCC-
Q 022479 106 TEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAIVGR- 182 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~-~~~~~~l~dfg~~~~~~~- 182 (296)
|||+++|+|.+++...+ .++++.++.+.+|+++||+|||++| ++|+||||+|||++. + +.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~-~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSN-GDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCC-CeEEeccCccccccccc
Confidence 99999999999999766 8999999999999999999999999 999999999999999 6 7999999999987653
Q ss_pred ---CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 ---SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSE-CDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ---~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
........+|+.|+|||++... ...++|||||||++.||+||+.||.+ ....+.+..+......| ..+...++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~ 250 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSD 250 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCH
Confidence 2334567899999999988743 33599999999999999999999987 45555556665555444 44555799
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+.++++.+|++ ||+.||||+++|.|||.+....
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999997 9999999999999999876443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=345.99 Aligned_cols=258 Identities=27% Similarity=0.510 Sum_probs=221.1
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-HHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQ 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 98 (296)
..++| ++++.||+|+||+|+++.+..++..||+|++........ ....+.+.+|+.++++++ ||||+++++++..+
T Consensus 15 ~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 15 SIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred ccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 34455 789999999999999999999999999997765422211 244567779999999999 99999999999655
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.||.|.+++...+++++.++..++.|++.|++|||++| |+||||||+||+++.+.+++||+|||++.
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 569999999999999999999999999999999999999999999999 99999999999999985699999999999
Q ss_pred cc-CCCcccccCCCCCCccCccccccC--C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 179 IV-GRSHAAHSIIGTPEYMAPELYEED--Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 179 ~~-~~~~~~~~~~~~~~~~aPE~~~~~--~-~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
.. .........||++.|+|||++.+. + ..++||||+|+++|.|++|..||.+.+.......+.... ...+...
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---~~~p~~~ 246 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---FKIPSYL 246 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC---ccCCCCc
Confidence 88 466678889999999999988764 3 578999999999999999999998854444444433332 2334444
Q ss_pred -ChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 255 -DPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 255 -~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+.+.+.|+.+||. ||.+|+++.+++.||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 8999999999998 9999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=322.65 Aligned_cols=258 Identities=24% Similarity=0.455 Sum_probs=228.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
...| ++.+.||.|+||.|.++.++.+|..+|+|+++..... .-...+...+|.++|+.+.||+++++++.+.+. ..
T Consensus 43 l~df-e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ 118 (355)
T KOG0616|consen 43 LQDF-ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SN 118 (355)
T ss_pred hhhh-hheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--Ce
Confidence 3455 5689999999999999999999999999999865443 234566788999999999999999999999766 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||.+||.|..++...+++++..++-++.|++.||+|||+++ +++|||||+|||++.+ |.+|++|||.+....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEec
Confidence 9999999999999999999999999999999999999999999999 9999999999999999 999999999998875
Q ss_pred CCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.. +...||||.|+|||++. +.+..++|-|+||+++|||+.|.+||...........++.+.. ..+...++++++
T Consensus 196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---~fP~~fs~~~kd 270 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---KFPSYFSSDAKD 270 (355)
T ss_pred Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---cCCcccCHHHHH
Confidence 44 78899999999999766 5699999999999999999999999998777665555555533 345556899999
Q ss_pred HHHHHHh-CCCCC-----CCHHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRAR-----PSASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~R-----ps~~~ll~hp~~~~~~~~~ 291 (296)
|+.++|+ |-.+| .-..++-.||||+.++|.+
T Consensus 271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 9999998 99999 4678999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=346.19 Aligned_cols=263 Identities=30% Similarity=0.418 Sum_probs=222.6
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH 99 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 99 (296)
-..|| .+.++||.|.||.||+|+.+.+|+.||||.++....... .-.=.||++.|++++ ||||+++.+++.+..
T Consensus 8 ~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e---e~~nLREvksL~kln~hpniikL~Evi~d~~- 82 (538)
T KOG0661|consen 8 FMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNPHPNIIKLKEVIRDND- 82 (538)
T ss_pred HHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH---HHHHHHHHHHHHhcCCCCcchhhHHHhhccC-
Confidence 34566 578999999999999999999999999999987654221 112358999999998 999999999998774
Q ss_pred CeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+.+|+||||+.. +|.++++. +..|++..++.|+.||++||+|+|++| ++|||+||+|||+..+ ..+||+|||+|+
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLAR 158 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAR 158 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEeccccccc
Confidence 389999999987 89998875 567999999999999999999999999 9999999999999987 599999999999
Q ss_pred ccCCCcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCC---
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALN--- 251 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~--- 251 (296)
..........+..|..|+|||++- +.++.+.|+|++|||++|+.+-++.|+|.+..++++.+..--..|. .+.
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 987777777788899999999654 3499999999999999999999999999999998876655432221 111
Q ss_pred ----------------------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 252 ----------------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 252 ----------------------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
...+++..+||.+|++ ||++||||.++|+||||+.-.....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~ 302 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS 302 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence 1126788899999998 9999999999999999987655433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=336.66 Aligned_cols=258 Identities=27% Similarity=0.343 Sum_probs=220.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+..++||+|.||.||+|.+..+|+.||+|++..... .........+|+.+|++|+||||+++.++..+.....+|+|+
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 346899999999999999999999999999987643 445566778999999999999999999999887667999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.. .|..++.. +-.|++.+++.++.||+.||+|||++| |.|||||.+|||++.+ |.+||+|||+|+++....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEeccccceeeccCCCC
Confidence 99998 67777765 568999999999999999999999999 9999999999999999 999999999999875433
Q ss_pred -ccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCC-----C--
Q 022479 185 -AAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALN-----K-- 252 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~-----~-- 252 (296)
...+...|..|+|||++-+. |+.+.|+||.|||+.||++|++.|.+....+++..+...+..|. .++ .
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 35566778999999977654 99999999999999999999999999988888877766654331 111 0
Q ss_pred -----------------CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 253 -----------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 253 -----------------~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..+....+|+..||. ||.+|.||.++|+|+||..-..+
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 115677899999998 99999999999999999544433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=346.31 Aligned_cols=266 Identities=23% Similarity=0.428 Sum_probs=234.3
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
.....|-+ ++++.||.|+.|.|-+|.+..||+..|||++....- -.......+.+|+-+|+.+.|||+++++++|..
T Consensus 7 ~~~tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~- 83 (786)
T KOG0588|consen 7 HKNTIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN- 83 (786)
T ss_pred ccccccce-eccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeecc-
Confidence 33444554 899999999999999999999999999999976521 133345667789999999999999999999944
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+|+|.||++||.|++++-..+++++.+...++.||+.|+.|+|..+ ||||||||+|++++.. +++|++|||+|
T Consensus 84 -~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMA 159 (786)
T KOG0588|consen 84 -KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMA 159 (786)
T ss_pred -CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeecccee
Confidence 4789999999999999999999999999999999999999999999999 9999999999999999 67999999999
Q ss_pred cccCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
..-.........||.|.|++||++.+. ...++||||-|+|+|.|+||++||++ ++...+...+..+. ..++..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~--f~MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGV--FEMPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCc--ccCCCcCC
Confidence 998888889999999999999988876 56689999999999999999999985 66677776666654 34557789
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.+.++|+.+|+. ||.+|.|.+++++|||+.++.-....
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 999999999998 99999999999999999998766544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=343.42 Aligned_cols=257 Identities=30% Similarity=0.527 Sum_probs=232.1
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.++...|. --++||+|+.|.||.|....+++.||+|.+....... .+.+.+|+.+++..+|+||+.+++.|...
T Consensus 269 ~dP~~~y~-~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~----keLilnEi~Vm~~~~H~NiVnfl~Sylv~- 342 (550)
T KOG0578|consen 269 GDPRSKYT-DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK----KELLLNEILVMRDLHHPNIVNFLDSYLVG- 342 (550)
T ss_pred CChhhhhc-chhhhccccccceeeeeeccCCceEEEEEEEeccCCc----hhhhHHHHHHHHhccchHHHHHHHHhccc-
Confidence 45555664 4789999999999999999999999999998765433 46788999999999999999999998766
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+.+|+||||+.||+|.+.+.... +++.++..+++.++.||+|||.+| |+|||||.+||++..+ |.+||+|||++.
T Consensus 343 -deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGFca 417 (550)
T KOG0578|consen 343 -DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGFCA 417 (550)
T ss_pred -ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeeeee
Confidence 78999999999999999887655 999999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCc-ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 179 IVGRSH-AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 179 ~~~~~~-~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.+.... ......|||.|+|||++. ..+.++.||||||++++||+.|++||-..++...++-+...+.+....+...+.
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 775443 566778999999999776 569999999999999999999999999888888999999998888888888999
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
++++|+.+||+ |+++|++|.+||+||||+.
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999998 9999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=308.98 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=217.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+|. ..++||+|.||+||+|.+..+|+.||||+++.... ..-......+|++.|+.++|+||+.+.++| +....+
T Consensus 2 ~rY~-~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~--kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l 76 (318)
T KOG0659|consen 2 DRYE-KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA--KDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNL 76 (318)
T ss_pred chhh-hhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc--ccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCce
Confidence 3564 48999999999999999999999999999987654 223345678999999999999999999999 555789
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.+|+||++. +|+..++. ...++..+++.++.+++.||+|||++. |.||||||.|+|++.+ |.+|++|||+++.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccC
Confidence 999999987 78888874 567999999999999999999999999 9999999999999999 899999999999986
Q ss_pred CCcccc-cCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCCCCCC----
Q 022479 182 RSHAAH-SIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQALNK---- 252 (296)
Q Consensus 182 ~~~~~~-~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~---- 252 (296)
...... ....|..|+|||.+.+. +....||||.|||+.||+.|.+.|.+..+.+++..+... .+.+..++.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 554432 33678899999988754 888999999999999999999999999888887655443 222222221
Q ss_pred -------------------CCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 253 -------------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 253 -------------------~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
..++..-+|+.+|+. ||.+|+++.|+|+|+||+..+
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 125667899999999 999999999999999999643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=321.64 Aligned_cols=267 Identities=28% Similarity=0.431 Sum_probs=223.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee---CCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD---DQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~ 99 (296)
.+++...+.||.|+||.|+.+.++.+|+.||+|++..... +.-..++..+|+++|++++|+||+.+.+++.. +.-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3343447999999999999999999999999999974433 55667889999999999999999999999876 234
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+-+|+|+|++.. .|...++.+..+++..++.++.|++.||.|+|+.+ ++||||||+|++++.+ -.+|++|||+|+.
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceee
Confidence 678999999954 89999998888999999999999999999999999 9999999999999999 5899999999998
Q ss_pred cCC---CcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------
Q 022479 180 VGR---SHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------- 247 (296)
Q Consensus 180 ~~~---~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 247 (296)
... ......+..|..|+|||++. ..++.+.||||+|||+.||++|++.|.+.+...++.-+..-...+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 754 33334566788999999654 459999999999999999999999999887766654333322211
Q ss_pred --------------C-------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCCC
Q 022479 248 --------------Q-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 295 (296)
Q Consensus 248 --------------~-------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 295 (296)
. ......++...+|+++||. ||.+|+|++++|.||||..+..++.+|+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~ 324 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV 324 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence 0 0011236788899999999 9999999999999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=323.62 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=226.9
Q ss_pred ceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
-.....+..-|++.++||.|..++||+|.+..+++.||||.+....... ..+.+++|+..++.++||||++.+..|.
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 3344445555678999999999999999999999999999998765532 2788999999999999999999999997
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
.+ ..+|+||.++.+||+.+.++.. ..+++..+..+++++++||.|||++| .+|||+|+.|||++.+ |.|+|+|
T Consensus 95 v~--~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLad 169 (516)
T KOG0582|consen 95 VD--SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLAD 169 (516)
T ss_pred ec--ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcC
Confidence 66 7899999999999999998852 34999999999999999999999999 9999999999999999 9999999
Q ss_pred cCCccccCCCcc-----cccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 022479 174 LGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 174 fg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
||.+-.+..... +....++++|+|||++.+ +|+.++||||||+.+.|+.+|..||....+...+...+.+.+
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 998755432111 134578999999998543 499999999999999999999999999999988888777655
Q ss_pred C-------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 246 K-------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 246 ~-------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
+ +.......+..++.++..||+ ||++|||++++|+|+||+.....
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 4 122222346789999999997 99999999999999999987654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=331.06 Aligned_cols=246 Identities=32% Similarity=0.557 Sum_probs=214.2
Q ss_pred cceeeecccCcceEEEeeecCCCcE-EEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+.||+|+||+||++... |.. +|+|.+..... +....+.|.+|+.+|++++||||++++|.+.++. ..+++|
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iV 118 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIV 118 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEE
Confidence 34677999999999999877 556 99999986554 2333789999999999999999999999997663 279999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC-ceEEeccCCccccCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGR 182 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~-~~~l~dfg~~~~~~~ 182 (296)
|||+++|+|.+++.. ...++...+..++.+|+.||.|||+++| |+|||||++|||++.+ + ++||+|||+++....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~-~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLK-GKTLKIADFGLSREKVI 196 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCC-CCEEEECCCccceeecc
Confidence 999999999999987 6889999999999999999999999998 8999999999999999 6 999999999988765
Q ss_pred C-cccccCCCCCCccCccccccC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 183 S-HAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 183 ~-~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
. .......||..|+|||++.+. ++.++||||||+++|||+||+.||.+.............+..+..... ++..+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~-~~~~l 275 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE-CPPHL 275 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc-CCHHH
Confidence 4 334447899999999998843 999999999999999999999999998886666666667666655544 79999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhc
Q 022479 259 KAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..|+..||. ||.+||++.+++.
T Consensus 276 ~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 276 SSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999997 9999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=334.45 Aligned_cols=253 Identities=24% Similarity=0.423 Sum_probs=213.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||+|+||.||+|.++.+|+.||+|+++..... .......+.+|+.++++++|+||+++++.+... +.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999999999999999854321 233456678899999999999999999888554 7899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCccccc
Q 022479 110 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHS 188 (296)
Q Consensus 110 ~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~~ 188 (296)
.+++|.+++...+.+++.++..++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++.... .......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence 99999999998888999999999999999999999999 9999999999999998 899999999987542 2223344
Q ss_pred CCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh
Q 022479 189 IIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (296)
..+++.|+|||++.+ .++.++|+|||||++|+|++|..||...+............ ...+...+.++.+|+.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHcc
Confidence 578999999997764 48999999999999999999999998755444333333322 22334568999999999997
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 268 -QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 268 -~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
||++|| ++.++++||||+.++|..
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999 899999999999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=330.64 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=215.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+++.+|+|++...... .....+.+.+|+.++++++||||+++++.+.+. ..++++|
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 80 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYMLM 80 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEEEE
Confidence 5789999999999999999999999999999754321 223456788999999999999999999887544 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+.+++|.+++...+.+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC--c
Confidence 99999999999998888999999999999999999999999 9999999999999988 89999999998765432 2
Q ss_pred ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+.......... ..+...+..+++|+++|
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---EFPRHLDLYAKDLIKKL 232 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---CCCccCCHHHHHHHHHH
Confidence 33568899999997664 488999999999999999999999987665544444443322 22334588999999999
Q ss_pred Hh-CCCCCCC-----HHHHhcCcccccccCCC
Q 022479 266 IA-QPRARPS-----ASELLKDPFFSELNDDD 291 (296)
Q Consensus 266 l~-~p~~Rps-----~~~ll~hp~~~~~~~~~ 291 (296)
|+ ||.+||+ ++++++||||+.++|..
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 98 9999995 99999999999888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=331.03 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=221.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+-| ++.++||+|+||.||+|+-+.||+.+|+|+++.+.... .....-++.|..+|....++++|+++-.|.+. .++
T Consensus 141 ~DF-e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~L 216 (550)
T KOG0605|consen 141 DDF-ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYL 216 (550)
T ss_pred ccc-hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--Cee
Confidence 345 67899999999999999999999999999999876543 34457788999999999999999999999666 799
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
||||||++||.+..+|...+.+++..++.++.+++-|+..||+.| ++||||||+|+|++.. |++||.|||+++-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhhh
Confidence 999999999999999999999999999999999999999999999 9999999999999999 9999999999843210
Q ss_pred ------------------------Cc----c--------------------cccCCCCCCccCcccccc-CCCcchhHHH
Q 022479 183 ------------------------SH----A--------------------AHSIIGTPEYMAPELYEE-DYTEMVDIYS 213 (296)
Q Consensus 183 ------------------------~~----~--------------------~~~~~~~~~~~aPE~~~~-~~~~~~Di~s 213 (296)
.. . ..+..|||.|+|||++.+ .+....|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0 112348899999997765 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-CCCCChHHHHHHHHHHhCCCCCC---CHHHHhcCcccccccC
Q 022479 214 FGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELND 289 (296)
Q Consensus 214 lG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~p~~Rp---s~~~ll~hp~~~~~~~ 289 (296)
||||+||||.|.+||.+..+.+....++.-......+ ....+++.++||.+|+-||++|. .++||-+||||+.++|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999999999877666555444332112222 23357999999999999999996 7999999999999999
Q ss_pred CC
Q 022479 290 DD 291 (296)
Q Consensus 290 ~~ 291 (296)
+.
T Consensus 454 ~~ 455 (550)
T KOG0605|consen 454 DH 455 (550)
T ss_pred ch
Confidence 85
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=321.79 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=218.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC---eEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN---TLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~ 103 (296)
.-.+++|+|+||+||.+....+++.+|||++-.+.... .+|+.+|++++||||+++.-.|...... ++.
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 44799999999999999999999999999997665433 2699999999999999998888755444 667
Q ss_pred EEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 104 FITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+|+||++. +|...++. +..++.-.++-+..||++||+|||+.| ||||||||.|+|++.+.|.+||||||.|..
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999998 88877774 677999999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----------
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------- 247 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 247 (296)
........++..+..|+|||.+.+ .++.+.||||.||++.||+-|++.|.+.+..+++..++.--..|
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 987777788888999999997765 49999999999999999999999999987777766544332111
Q ss_pred ----------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 248 ----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 248 ----------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.......+++..+|+.++|+ +|++|.++.++|.||||+....++-
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~ 317 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT 317 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence 11233457899999999999 9999999999999999999887743
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=313.74 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=216.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+....|++|.||+||+|.++.+++.||+|.++...- . .-.--.-.+|+.+|.+++|+||+.+-.+.+...-+.+|+||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-K-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccc-c-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 346889999999999999999999999999987541 1 22223456899999999999999999999887778899999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||++. .|+..+...+ +|+..+++.++.|++.|++|||.+. |+|||||++|+|++.. |.+|++|||+|+.++.+..
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccchhhhhcCCcc
Confidence 99998 7888887644 8999999999999999999999999 9999999999999999 9999999999999876533
Q ss_pred -cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCC-------
Q 022479 186 -AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKV------- 253 (296)
Q Consensus 186 -~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~------- 253 (296)
.....-|..|+|||++-+ .++++.|+||+|||+.+++++++.|++....+++..+...-..| ..++..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 444567889999997654 39999999999999999999999999988777776554432111 111110
Q ss_pred --------------------CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 254 --------------------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 254 --------------------~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.++...+|+..+|. ||++|.||++.|+|+||.+.+.+.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 24678899999998 999999999999999999865443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=333.33 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=216.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+.| ++.+.||+|+||.||+|.++.+++.+|+|+++..... .....+.+.+|+.++++++|+||+++++.+.+. +.+
T Consensus 18 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 93 (329)
T PTZ00263 18 SDF-EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRV 93 (329)
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEE
Confidence 345 6789999999999999999999999999999754321 223456788999999999999999999988655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++|||+.+++|.+++...+.+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999999987643
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. .....+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+........... ... ...+...+..+++|
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~--~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGR--LKFPNWFDGRARDL 245 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCC--cCCCCCCCHHHHHH
Confidence 3 234568899999997764 48899999999999999999999998765544444333 322 12334468899999
Q ss_pred HHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 262 IEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 262 i~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
+.+||+ ||.+|++ +.++++||||++.+|+
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 999997 9999986 7999999999987665
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=334.79 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=221.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+-+.||+|.||.||++..+.+.+.||+|.+.+... .+...+.+++|+++++.++||||+.++++| +....+++|+
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vVt 80 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVVT 80 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEEe
Confidence 578899999999999999999999999999976533 667788999999999999999999999999 5558999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~ 185 (296)
||+.| +|+..+...+.++++.++.++.+++.||.|||+++ |.|+|+||.||++..+ |.+|+||||+++.+.. ...
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence 99998 99999999999999999999999999999999999 9999999999999999 8999999999998754 334
Q ss_pred cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....|||.|+|||.+.+. ++..+|+||||||+||+++|++||... ....+...+.. .+..++...+..+..|++.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~I~~--d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKSILK--DPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHHHhc--CCCCCcccccHHHHHHHHH
Confidence 5667899999999977754 999999999999999999999999753 33333333333 3334444678999999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+|. ||.+|.+-.+++.|||.++-..-++
T Consensus 234 LL~kdP~~RltW~~Ll~HpF~k~~~~~~~ 262 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGHPFWKGKINIAE 262 (808)
T ss_pred HhhcChhhcccHHHHhcChHHhhhhhhhc
Confidence 996 9999999999999999887544333
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=333.89 Aligned_cols=261 Identities=29% Similarity=0.527 Sum_probs=229.7
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
...++...|.+ .+.||.|.||.||+|++..+++.||+|++.... ..+.++.+++|+.+|.+++++||.+.++.+..
T Consensus 7 ~~~~~~~~~~~-~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 7 LKIDPELLYTK-LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred hcCCccccccc-chhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheee
Confidence 44566667765 699999999999999999999999999998654 46668899999999999999999999999987
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
+ ..++++|||+.||++.+.++.++.+++..+..+++++..|+.|||..+ .+|+|||+.||++..+ |.++|+|||+
T Consensus 83 g--~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgV 157 (467)
T KOG0201|consen 83 G--TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGV 157 (467)
T ss_pred c--ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecce
Confidence 7 689999999999999999999998899999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 177 AAIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 177 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
+-....... .....|||.|||||++.+ .++.++||||||++++||++|.+|+....++..++.+-.. .|..+....
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~--~PP~L~~~~ 235 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS--APPRLDGDF 235 (467)
T ss_pred eeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--CCCcccccc
Confidence 987755433 366789999999998876 5999999999999999999999999987775555444333 233445577
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
++.+++|+..||+ ||+.||||.++|+|+|++...
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 8999999999997 999999999999999998843
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=330.89 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=214.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||+|.+..+++.||+|+++..... .......+.+|+.++++++|+||+++++.+... ..+|+||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 80 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYLAM 80 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEEEE
Confidence 6799999999999999999999999999999854321 223456788999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+++++|.+++...+.+++..+..++.|++.||.+||++| ++||||+|+||+++.+ +.++|+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc--cc
Confidence 99999999999998888999999999999999999999999 9999999999999998 8999999999976543 23
Q ss_pred ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC---C--CCCCCCCChHHHH
Q 022479 187 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---P--QALNKVKDPEVKA 260 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~l~~ 260 (296)
....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||......+........... + .......++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 44568899999997664 5889999999999999999999999876554443333221111 1 1111234789999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
|+.+||. +|.+||++.++++||||++++|+
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 9999997 99999999999999999988663
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=322.71 Aligned_cols=257 Identities=19% Similarity=0.347 Sum_probs=211.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||++.+..+++.||+|++...... .......+.+|+.++++++|++++++.+.+.+. +.+++++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEE
Confidence 5689999999999999999999999999998754332 122334677899999999999999999888554 6899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence 99999999887754 346899999999999999999999999 9999999999999988 799999999998764433
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......++..|+|||.+.+ .++.++||||||+++|+|++|+.||....... .....+.. .........+..+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHH
Confidence 3444568899999997764 58999999999999999999999998654322 22222222 112233446889999
Q ss_pred HHHHHHh-CCCCCCC-----HHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRARPS-----ASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~~ 291 (296)
|+.+||+ ||++||+ ++++++||||++++|+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 9999998 9999997 89999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=328.17 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=213.2
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||+|+||.||++.++.+|+.||+|+++..... .......+.+|++++++++||||+++++.+... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence 4799999999999999999999999999854321 234456778899999999999999999988655 6899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Cccccc
Q 022479 110 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS 188 (296)
Q Consensus 110 ~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~~ 188 (296)
.+++|..++.....+++..++.++.||+.||+|||++| ++|+||||+||+++.+ +.++|+|||++..... ......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence 99999999988888999999999999999999999999 9999999999999998 8999999999875322 222344
Q ss_pred CCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh
Q 022479 189 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 189 ~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (296)
..+++.|+|||++. +.++.++|+|||||++|+|++|+.||...+............. ..+...++++++++.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcc
Confidence 56889999999776 4589999999999999999999999987655444444433322 2334568999999999997
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 268 -QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 268 -~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
||++|+ ++.++++||||.+..|..
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999998 999999999999887643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=332.56 Aligned_cols=259 Identities=20% Similarity=0.367 Sum_probs=212.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+.++++++|++|+++++.+.+. ..+|+||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEE
Confidence 5789999999999999999999999999999754321 233456788999999999999999999998654 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||++|++|.+++...+.+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCcccccccccc
Confidence 99999999999998888999999999999999999999999 9999999999999998 8999999999875432110
Q ss_pred -----------------------------------cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCC
Q 022479 186 -----------------------------------AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 186 -----------------------------------~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~ 229 (296)
....++|+.|+|||++. ..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 12346899999999765 458999999999999999999999998
Q ss_pred CCChHHHHHHHHhCCCCCCCCC-CCCChHHHHHHHHHHh---CCCCCCCHHHHhcCcccccccCCC
Q 022479 230 ECDSVAKIYKKVTGGVKPQALN-KVKDPEVKAFIEKCIA---QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~---~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+....+....+........... ...++++++++.+|+. ++..||+++++++||||+.++|+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 7665554444433222211221 2357899999998764 445679999999999999998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=335.53 Aligned_cols=259 Identities=23% Similarity=0.404 Sum_probs=215.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+.+++.++|+||+++++.+.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEE
Confidence 6789999999999999999999999999999754321 233456788999999999999999999998655 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc--
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-- 184 (296)
||+.+++|.+++...+.+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceeccccccc
Confidence 99999999999988888999999999999999999999999 9999999999999998 899999999986542111
Q ss_pred -------------------------------------ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 022479 185 -------------------------------------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEI 226 (296)
Q Consensus 185 -------------------------------------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~ 226 (296)
......+|+.|+|||++. ..++.++|+|||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 011235889999999765 458999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCC-CCCCChHHHHHHHHHHhCCCCCCC---HHHHhcCcccccccCCC
Q 022479 227 PYSECDSVAKIYKKVTGGVKPQAL-NKVKDPEVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDDD 291 (296)
Q Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~p~~Rps---~~~ll~hp~~~~~~~~~ 291 (296)
||.+....+............... ....++++.+||.+|+.+|.+|++ +.+++.||||+.++|+.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 998766655544443322221111 223578999999999999999987 99999999999988754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=334.90 Aligned_cols=260 Identities=23% Similarity=0.412 Sum_probs=218.2
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.+..+++.||+|+++..... .......+.+|++++..++|+|++++++.+.+. +.++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (350)
T cd05573 2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLY 77 (350)
T ss_pred Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEE
Confidence 45 6799999999999999999999999999999854331 223456788999999999999999999888654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+.+++|.+++...+.+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCccc
Confidence 99999999999999988888999999999999999999999999 9999999999999998 89999999999766433
Q ss_pred c------------------------------ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 022479 184 H------------------------------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD 232 (296)
Q Consensus 184 ~------------------------------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 232 (296)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 2334568899999997664 48999999999999999999999998766
Q ss_pred hHHHHHHHHh--CCCCCCCCCCCCChHHHHHHHHHHhCCCCCCC-HHHHhcCcccccccCCC
Q 022479 233 SVAKIYKKVT--GGVKPQALNKVKDPEVKAFIEKCIAQPRARPS-ASELLKDPFFSELNDDD 291 (296)
Q Consensus 233 ~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~p~~Rps-~~~ll~hp~~~~~~~~~ 291 (296)
.......... ..... ......++++.+||.+|+.||.+||+ +.++++||||++++|+.
T Consensus 235 ~~~~~~~i~~~~~~~~~-p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 235 LQETYNKIINWKESLRF-PPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHHHHHHHhccCCcccC-CCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 5544444433 11111 11122589999999999999999999 99999999999988754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=324.78 Aligned_cols=266 Identities=25% Similarity=0.423 Sum_probs=231.5
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQ 98 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 98 (296)
.....+|.+++.||.|.||.||++.++.+|+.+|+|++....... ......+.+|+.+|+++. ||||+.+.+.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~- 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP- 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-
Confidence 444456688999999999999999999999999999998765533 224578899999999998 99999999999655
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC---CceEEeccC
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLG 175 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~---~~~~l~dfg 175 (296)
..+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| ++|+||||+|+|+.... +.++++|||
T Consensus 109 -~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 -DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 7899999999999999998876 4999999999999999999999999 99999999999997653 479999999
Q ss_pred CccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCC
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKV 253 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 253 (296)
++............+||+.|+|||++. ..++...|+||+|+++|.|++|..||.+.........+...... ....+..
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999987766788889999999999888 67999999999999999999999999988777777766666442 2333455
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.+..++++|.+|+. ||.+|+|+.++|+|||++......
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 68999999999997 999999999999999998864443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=301.00 Aligned_cols=268 Identities=21% Similarity=0.364 Sum_probs=232.4
Q ss_pred CCCCCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee
Q 022479 9 SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88 (296)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 88 (296)
..+.+.+....-..+.| ++++.||.|-||.||.|..++++--+|+||+..++.. ......++.+|+++.+.++||||+
T Consensus 8 ~~~~~~~~~~~~~l~df-eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnil 85 (281)
T KOG0580|consen 8 VNPFGSRATKTWTLDDF-EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNIL 85 (281)
T ss_pred cCCcccccccccchhhc-cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHH
Confidence 34445555566667777 6899999999999999999999999999999877643 345567899999999999999999
Q ss_pred EEeeeeeeCCCCeEEEEeeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC
Q 022479 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI 166 (296)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~ 166 (296)
+++++|.+. ..+|+++||...|++...++ ...++++.....++.|++.|+.|+|.++ ++||||||+|+|++.+
T Consensus 86 rlY~~fhd~--~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~- 160 (281)
T KOG0580|consen 86 RLYGYFHDS--KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA- 160 (281)
T ss_pred hhhhheecc--ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-
Confidence 999999877 78999999999999999999 6678999999999999999999999999 9999999999999999
Q ss_pred CceEEeccCCccccCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 022479 167 GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
|.++++|||.+...+ .+.....|+|..|.+||...+. ++...|+|++|++.|+++.|..||.... .++.+..+...
T Consensus 161 ~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~- 237 (281)
T KOG0580|consen 161 GELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV- 237 (281)
T ss_pred CCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc-
Confidence 899999999997765 5567778999999999987754 9999999999999999999999998766 44444444442
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
....+..++.+.+++|..|+. +|.+|.+..+++.|||+.+.
T Consensus 238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 223346679999999999997 99999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=328.63 Aligned_cols=258 Identities=22% Similarity=0.400 Sum_probs=216.6
Q ss_pred CCCcccceeeecccCcceEEEeeecCCC-cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.+.| .+.++||+|+||.||+|.++.++ ..+|+|++...... .......+.+|+.+++.++||||+++++.+.+. .
T Consensus 29 ~~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 29 YEDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred hhhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 3445 67899999999999999876654 68999999754321 233456788999999999999999999998655 6
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++||||+.+++|.+++.....+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeec
Confidence 89999999999999999998888999999999999999999999999 9999999999999988 89999999999876
Q ss_pred CCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
... .....+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+............... ..+...++.++
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---YFPKFLDNNCK 256 (340)
T ss_pred CCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHH
Confidence 432 234568899999997764 488999999999999999999999987655444444433321 23445688999
Q ss_pred HHHHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+++++||+ ||++|+ +++++++||||++++|..
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99999998 999995 999999999999988753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=327.08 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=212.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||+|+||.||++.++.+++.||+|++...... .......+.+|+.+++.++|+||+++.+.+... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999999999999999754322 234456788899999999999999999888554 7899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Cccccc
Q 022479 110 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS 188 (296)
Q Consensus 110 ~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~~ 188 (296)
.+++|..++.....+++.++..++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++..... ......
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence 99999999988888999999999999999999999999 9999999999999988 8999999999875422 222344
Q ss_pred CCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh
Q 022479 189 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 189 ~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (296)
..+++.|+|||.+. ..++.++|+||||+++|+|++|..||...+..+......... ...+...+.++.+|+.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---IKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---ccCCCCCCHHHHHHHHHHcC
Confidence 57899999999776 458899999999999999999999998755444333332221 22334568899999999997
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCC
Q 022479 268 -QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 268 -~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
||++|+ ++.++++||||...+|.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999999999988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=306.12 Aligned_cols=264 Identities=25% Similarity=0.435 Sum_probs=228.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC----CCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
..|+ -++.||.|..++|-++.++.+|+.+|+|++...... ......+.-.+|+++|+++ .||+|+++.+.+.
T Consensus 17 ~~y~-pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-- 93 (411)
T KOG0599|consen 17 AKYE-PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-- 93 (411)
T ss_pred hhcC-hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--
Confidence 3443 479999999999999999999999999999764432 2345666778999999999 5999999999994
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
....+++|+|.++.|.|.+++...-.+++...+++++|++++++|||.++ ||||||||+|||++++ .+++|.|||.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEecccee
Confidence 44789999999999999999999999999999999999999999999999 9999999999999999 79999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc-------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 249 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 249 (296)
..+.........||||+|.|||.+.. +++...|+|+.|+|+|.++.|.+||......-.+..+..+...-..
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 99999888999999999999997652 3788899999999999999999999877666666666555433211
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
-+...++..++||.+||+ ||++|.|++++|.||||..+.+...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 123457899999999998 9999999999999999977765544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=321.39 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=205.8
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..++| ++.++||+|+||+||+|.++.+++.+|+|++...... .....+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 76 (303)
T cd07869 3 KADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTK--E 76 (303)
T ss_pred ccccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--C
Confidence 34566 6799999999999999999999999999999754321 1234567899999999999999999998654 6
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 77 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 152 (303)
T cd07869 77 TLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARA 152 (303)
T ss_pred eEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCccee
Confidence 89999999975 66666654 456899999999999999999999999 9999999999999988 8999999999875
Q ss_pred cCCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---CCCCC------
Q 022479 180 VGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---GGVKP------ 247 (296)
Q Consensus 180 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~------ 247 (296)
.... .......+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+..+.......+. .....
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 4322 22334567889999997653 478899999999999999999999987554433222211 11000
Q ss_pred --------CC-------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 248 --------QA-------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 248 --------~~-------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.. .....+..+.+|+.+||+ ||++|||+.++++||||+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence 00 000124678899999998 99999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=325.80 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=208.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC---CeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---NTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~ 103 (296)
++.++||+|+||.||++.++.+++.||+|.+..... ......++.+|++++++++||||+++++++..... ..+|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 679999999999999999999999999999874322 22234568899999999999999999998764432 3589
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+. ++|.+++.....+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCccccccccc
Confidence 9999996 589999988888999999999999999999999999 9999999999999998 89999999999764322
Q ss_pred c----ccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---------------
Q 022479 184 H----AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--------------- 241 (296)
Q Consensus 184 ~----~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~--------------- 241 (296)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+...........
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 1233568899999997653 58889999999999999999999997654332211100
Q ss_pred -----------hCCCCCC--CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 242 -----------TGGVKPQ--ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 242 -----------~~~~~~~--~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
....... ......++.+.+++.+||+ ||++|||++++++||||+.+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~ 302 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE 302 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence 0000000 0011246788999999998 99999999999999999988876654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=335.27 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=224.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 101 (296)
..| ++.++||+|.||+|+++..+.+++.||||++++..... .+..+....|-+++...+ ||.++.++.+|... .+
T Consensus 368 ~~F-~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~ 443 (694)
T KOG0694|consen 368 DDF-RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EH 443 (694)
T ss_pred cce-EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--Ce
Confidence 345 67899999999999999999999999999999877654 344688888999998885 99999999999554 79
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.||.+. .+++.+.+++..+.-++..++.||.|||++| |++||||.+|||++.. |.+||+|||+++..-
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccC
Confidence 99999999999943 3445567999999999999999999999999 9999999999999999 999999999998653
Q ss_pred -CCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 -RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 -~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
....++..||||.|+|||++.+. |+.+.|.|+||+++|+||.|..||.+.+..+..-+++... ..++-..+.+..
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~---~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE---VRYPRFLSKEAI 596 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCcccHHHH
Confidence 56678899999999999987754 9999999999999999999999999866655555555543 345556789999
Q ss_pred HHHHHHHh-CCCCCCC-----HHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARPS-----ASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~~ 291 (296)
++++++|. +|++|.- ++++..||||+.++|++
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 99999996 9999973 79999999999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=305.54 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=221.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
..| .+.++||+|.|+.|+++.+..+|+.+|+|.+....+.. ...+.+.+|+++-+.++||||+++...+.+. ...
T Consensus 11 d~y-~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~ 85 (355)
T KOG0033|consen 11 DNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFH 85 (355)
T ss_pred hhh-hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhccc--cee
Confidence 445 57899999999999999999999999999997665532 2467788999999999999999999988554 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~ 180 (296)
|+|+|++.|+.|..-+-....+++..+-..++||++||.|+|.++ |+|||+||.|+++.... .-+||+|||++...
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999998665555566889899999999999999999999 99999999999996542 36999999999988
Q ss_pred CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 258 (296)
+.........|+|.|+|||++.++ ++..+|||+-|+|+|-++.|.+||++.+......++..+.... ...+...+++.
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 877677788999999999988765 8999999999999999999999999866555444444443332 22345568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
++|+.+||. ||.+|+|+.++|+|||+++...-+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~A 277 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVA 277 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcchHHHH
Confidence 999999997 999999999999999998765433
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=324.07 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=210.1
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|+||+||+|.+..+++.||+|+++..... .......+.+|+.++++++|+||+++++.+... ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 79999999999999999999999999754321 233456788899999999999999999888544 789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-CcccccCC
Q 022479 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSII 190 (296)
Q Consensus 112 ~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 190 (296)
++|.+++...+.+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++..... ........
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence 999999988888999999999999999999999999 9999999999999998 8999999999875422 22334456
Q ss_pred CCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-C
Q 022479 191 GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q 268 (296)
Q Consensus 191 ~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~ 268 (296)
+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+........ +...+...++++++|+.+||+ |
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---CCCCCCcCCHHHHHHHHHHcCCC
Confidence 8999999997764 4889999999999999999999999876554444433332 223345568999999999998 9
Q ss_pred CCCCC---CHHHHhcCcccccccC
Q 022479 269 PRARP---SASELLKDPFFSELND 289 (296)
Q Consensus 269 p~~Rp---s~~~ll~hp~~~~~~~ 289 (296)
|.+|| ++.+++.||||.+..+
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99997 5899999999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=333.78 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=211.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||++.++.+++.||+|++...... .......+.+|++++++++|+||+++++.+.+. ..+|+||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 80 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLIM 80 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEEEE
Confidence 5789999999999999999999999999999754321 234457788999999999999999999998654 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc--
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-- 184 (296)
||+++++|.+++...+.+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeeccccccccccccc
Confidence 99999999999988888999999999999999999999999 9999999999999988 899999999986321100
Q ss_pred ----------------------------------------------ccccCCCCCCccCcccccc-CCCcchhHHHHHHH
Q 022479 185 ----------------------------------------------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLC 217 (296)
Q Consensus 185 ----------------------------------------------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i 217 (296)
......+++.|+|||++.+ .++.++|+|||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012358899999997654 48999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC-CCCChHHHHHHHHHHhCCCC---CCCHHHHhcCcccccccCCC
Q 022479 218 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDPEVKAFIEKCIAQPRA---RPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 218 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~p~~---Rps~~~ll~hp~~~~~~~~~ 291 (296)
+|+|++|..||.+....+....+........... ...+.++++|+.+||.+|.+ |+++.+++.||||++++|+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999987655444444332211111111 23578999999999986555 56999999999999887643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=318.61 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=206.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||+|+||+||++.++.+++.+|+|+++.... .....+.+.+|+.++++++|+||+++++.+... ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (287)
T cd07848 2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLY 76 (287)
T ss_pred Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEE
Confidence 44 689999999999999999999999999999975433 233456788899999999999999999988544 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+.++++..+......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccc
Confidence 99999999877766666667999999999999999999999999 9999999999999988 89999999999876432
Q ss_pred c--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--C------------
Q 022479 184 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--K------------ 246 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~------------ 246 (296)
. ......+++.|+|||++. ..++.++|+||||+++|+|++|+.||.+....+.......... +
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 122345788999999765 4588999999999999999999999987655444332221100 0
Q ss_pred ------C---------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ------P---------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ------~---------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+ .......+.++.+|+++||+ ||++|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 00011257789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=320.16 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=212.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||.||++.++.++..+|+|++.... .......+.+|++++++++|+|++++++.+... ..+
T Consensus 5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (331)
T cd06649 5 DDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 78 (331)
T ss_pred ccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 455 67899999999999999999999999999997542 345567899999999999999999999998665 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+++|.+++.....+++..+..++.|++.||.|||+. + ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCccccccc
Confidence 99999999999999999888899999999999999999999985 6 9999999999999998 899999999987654
Q ss_pred CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------------------
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV------------------- 241 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~------------------- 241 (296)
.. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||......+ +...+
T Consensus 156 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccc
Confidence 32 2334568899999997764 48899999999999999999999997544322 21111
Q ss_pred ---------------------------hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 242 ---------------------------TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 242 ---------------------------~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.....+.......++++++|+.+||+ ||++|||+.++++||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 11111122223457899999999998 9999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.98 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=213.1
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+.++++++|+||+++++.+.+. ..+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence 36789999999999999999999999999999754322 234456789999999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCcccccccc
Confidence 999999999999998888999999999999999999999999 9999999999999988 899999999875321000
Q ss_pred -----------------------------------------------ccccCCCCCCccCccccc-cCCCcchhHHHHHH
Q 022479 185 -----------------------------------------------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGL 216 (296)
Q Consensus 185 -----------------------------------------------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~ 216 (296)
......+|+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 012346889999999765 44889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCChHHHHHHHHHH--h-CCCCCCCHHHHhcCcccccccCCC
Q 022479 217 CLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEVKAFIEKCI--A-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 217 i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l--~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
++|+|++|..||......+.............. .....++++.+|+.+|+ . +|..|+++.++++||||+.++|..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 999999999999876655554444332222111 12245889999999965 3 666799999999999999988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=324.84 Aligned_cols=253 Identities=20% Similarity=0.394 Sum_probs=210.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||++.++.+++.||+|+++.... ......+.+.+|..+++++ +||||+++++++... ..+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence 479999999999999999999999999986433 2234456788899999998 799999999988654 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-CCCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~~~~~~~ 187 (296)
+++++|..++...+.+++..+..++.|++.||.|||++| ++||||+|+||+++.+ +.++|+|||++... .......
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 89999999998643 2222334
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
...+++.|+|||++.+ .++.++|+||||+++|+|++|+.||... ...+...+.+.... ...+...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence 4678999999997764 4889999999999999999999999621 11222333333322 22344568899
Q ss_pred HHHHHHHHh-CCCCCCC------HHHHhcCcccccccCC
Q 022479 259 KAFIEKCIA-QPRARPS------ASELLKDPFFSELNDD 290 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps------~~~ll~hp~~~~~~~~ 290 (296)
.+++.+||+ ||.+|++ ++++++||||..++|+
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999998 9999987 7899999999988774
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=324.07 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=211.5
Q ss_pred eeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|+||.||++.+. .+++.||+|+++.............+.+|+.++++++||||+++++.+..+ ..+|++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 67999999999999863 468899999998654333334456678899999999999999999988654 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~ 185 (296)
||+.+++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++..... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence 99999999999998888999999999999999999999999 9999999999999998 8999999999875422 222
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||................ ...+...++.+.+++.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK---LNLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHH
Confidence 334568999999997764 47889999999999999999999998766554444443332 12334468899999999
Q ss_pred HHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 265 CIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 265 ~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
||+ ||++|| ++.+++.||||+...|+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 997 999999 89999999999887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=331.27 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=214.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|+||+||+|.++.+++.+|+|++..... ........+.+|++++++++|+||+++++.+.+. +.+|+||
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv~ 80 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVM 80 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEEE
Confidence 578999999999999999999999999999975422 1234456788999999999999999999998655 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC---
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--- 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~--- 183 (296)
||+.+++|.+++...+.+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCccccccccc
Confidence 99999999999988888999999999999999999999999 9999999999999998 89999999997532100
Q ss_pred ---------------------------------------------cccccCCCCCCccCccccc-cCCCcchhHHHHHHH
Q 022479 184 ---------------------------------------------HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLC 217 (296)
Q Consensus 184 ---------------------------------------------~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i 217 (296)
.......+++.|+|||++. ..++.++|+|||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0011235789999999765 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-CCCCChHHHHHHHHHHhCCCCCCC---HHHHhcCcccccccCCC
Q 022479 218 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKDPEVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDDD 291 (296)
Q Consensus 218 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~p~~Rps---~~~ll~hp~~~~~~~~~ 291 (296)
+|+|++|..||.+....+............... ....+++..++|.+|+.+|++|++ +.++++||||+.++|..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 999999999998776665555544332222222 234588999999998889999987 99999999999987754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=323.34 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=210.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||+||+|.++.+++.||+|++...... .....+.+..|..++..+ +|+||+++++.+... ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 4799999999999999999999999999754322 223345667788888776 699999999988554 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+.+++|..++.....+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999987542 222334
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||......+......... ...+...+.++.+++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---VVYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHc
Confidence 4568999999997764 48889999999999999999999998765544444433322 2234456889999999999
Q ss_pred h-CCCCCCCH------HHHhcCcccccccCCC
Q 022479 267 A-QPRARPSA------SELLKDPFFSELNDDD 291 (296)
Q Consensus 267 ~-~p~~Rps~------~~ll~hp~~~~~~~~~ 291 (296)
+ ||++||++ +++++||||+.+.|+.
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~ 263 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 8 99999998 9999999999987744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=327.30 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=217.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|+||+||++.++.+++.+|+|+++.... ........+.+|+.+++.++|++|+++++.+.+. ..+++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVM 80 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEE
Confidence 678999999999999999999999999999986432 1234566788999999999999999999888554 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+ +.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCCCc
Confidence 999999999999875 67999999999999999999999999 9999999999999998 8999999999987643322
Q ss_pred --cccCCCCCCccCccccc-------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-CCCCC
Q 022479 186 --AHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKD 255 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (296)
.....+++.|+|||++. ..++.++||||||+++|+|++|..||...........+.......... ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 22346789999999764 336789999999999999999999998766555554444332221111 12358
Q ss_pred hHHHHHHHHHHhCCCCCCCHHHHhcCcccccccCCCC
Q 022479 256 PEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 256 ~~l~~li~~~l~~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+.+|+.+||.+|.+||++.+++.||||++++|+.-
T Consensus 238 ~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred HHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 8999999999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=323.95 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=206.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHH-HHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV-QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||+||++.++.+|+.||+|++.......... ...+..|. .+++.++|+||+++++.+... ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH-HHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 47999999999999999999999999997543322222 23344444 456889999999999888654 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.+++|..++.....+++..+..++.||+.||.|||++| ++||||+|+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccc
Confidence 999999999998888999999999999999999999999 9999999999999998 8999999999875322 22234
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||++.+ .++.++|+||||+++|+|++|..||...+..+......... .......+..+.+++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---LRLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHh
Confidence 4568999999997664 48889999999999999999999998765444433333322 2233345889999999999
Q ss_pred h-CCCCCCCH----HHHhcCcccccccCCC
Q 022479 267 A-QPRARPSA----SELLKDPFFSELNDDD 291 (296)
Q Consensus 267 ~-~p~~Rps~----~~ll~hp~~~~~~~~~ 291 (296)
+ ||.+||++ .++++||||..+.|++
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 8 99999987 6999999999887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=333.21 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----- 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 97 (296)
.+| +++++||+|+||+||+|.+..+++.||+|++.... ....+|+.++++++|+||+++.+++...
T Consensus 66 ~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 66 KSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 345 78999999999999999999999999999886431 2234699999999999999998876432
Q ss_pred -CCCeEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 98 -QHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 98 -~~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
....+++||||+++ +|.+++. ....+++..++.++.||+.||+|||+++ ++||||||+||+++.+.+.++|+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 12357789999987 6666554 4567999999999999999999999999 99999999999999774579999
Q ss_pred ccCCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--- 247 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--- 247 (296)
|||++.............+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+...+.....+
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999987655444455677899999997654 48899999999999999999999998876655554443211100
Q ss_pred -----------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 248 -----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 248 -----------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
...+...++++.+|+.+||+ ||.+|||+.++|+||||+.+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 00122346789999999998 99999999999999999987654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=324.99 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=211.3
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
+.||+|+||.||++.++.+++.+|+|+++..... .......+..|+++++.++|+||+++.+.+... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 4699999999999999999999999999864332 233456777899999999999999999888554 7899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 110 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 110 ~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
.+++|..++.....+++..+..++.||+.||+|||+ +| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence 999999999888889999999999999999999997 79 9999999999999998 899999999987542 222233
Q ss_pred cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||++. +.++.++|+||||+++|+|++|..||.+.............. ...+...++++.+|+.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHh
Confidence 456899999999775 458999999999999999999999998755444333332222 2234456889999999999
Q ss_pred h-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 267 A-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
+ ||++|+ ++.++++||||+++.|.
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 8 999997 99999999999988765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=313.85 Aligned_cols=251 Identities=22% Similarity=0.448 Sum_probs=220.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
..|++.+.||+|.||.|-+|.....|+.||||.++.+... ++...-.+++|+++++.++||||+.++.+| +..+.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence 3447889999999999999999889999999999877653 444456688999999999999999999999 5558999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||..+|.|.+++...+.+++.+.+.+++||+.|+.|+|+++ ++|||||.+|||++.| +++|++|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence 99999999999999999999999999999999999999999999 9999999999999999 89999999999999888
Q ss_pred cccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.-....||+|-|.+||++.+. ..+..|.||||+++|.++.|..||++.+. ..+..++..+-.. ..--+....-|
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-k~lvrQIs~GaYr---EP~~PSdA~gL 282 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-KRLVRQISRGAYR---EPETPSDASGL 282 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-HHHHHHhhccccc---CCCCCchHHHH
Confidence 888999999999999999876 56789999999999999999999998554 4455544443221 11135678899
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
|+-||. ||++|.|++++-.|=|+
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhee
Confidence 999997 99999999999999773
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=313.96 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=203.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| .+.++||+|+||+||+|.++.+++.||+|+++..... .....+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 78 (288)
T cd07871 5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCL 78 (288)
T ss_pred ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence 455 5789999999999999999999999999999754321 1234567899999999999999999988554 689
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+ +|.+++.. +..+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeecc
Confidence 999999986 88888765 445799999999999999999999999 9999999999999998 899999999987653
Q ss_pred CCc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--C---------
Q 022479 182 RSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--P--------- 247 (296)
Q Consensus 182 ~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~--------- 247 (296)
... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+....+.+......... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 322 2233457889999997653 4789999999999999999999999876554444332211100 0
Q ss_pred ----------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 ----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 ----------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+.+..+|+.+||+ ||.+|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00012346789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=310.03 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=223.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|.-|+||+|..+.++..+|+||+....... ..-..+.+.|.++|++++||.+..+|..+ +..++.|++|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~m 156 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVM 156 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEE
Confidence 66799999999999999999999999999998766533 44567889999999999999999999999 4448999999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC--
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-- 182 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-- 182 (296)
|||+||.|..+++. ++.+++..++-++..++-||+|||..| ||.|||||+||||..+ |++.|.||+++..+..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCCCCC
Confidence 99999999988875 568999999999999999999999999 9999999999999999 9999999998744310
Q ss_pred ---------------------------------C----------------------cccccCCCCCCccCccccccC-CC
Q 022479 183 ---------------------------------S----------------------HAAHSIIGTPEYMAPELYEED-YT 206 (296)
Q Consensus 183 ---------------------------------~----------------------~~~~~~~~~~~~~aPE~~~~~-~~ 206 (296)
. ..+.+..||-.|.|||++.+. ++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 001112356779999988865 99
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCC----HHHHhcC
Q 022479 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPS----ASELLKD 281 (296)
Q Consensus 207 ~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps----~~~ll~h 281 (296)
.+.|.|+||+++|||+.|..||.+.+..+.+.+++.+...-.... ..+...++||+++|. ||.+|.- |.++-+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999999999999988765433322 457899999999995 9999998 9999999
Q ss_pred cccccccCC
Q 022479 282 PFFSELNDD 290 (296)
Q Consensus 282 p~~~~~~~~ 290 (296)
|||+.++|+
T Consensus 393 pFF~gVnWa 401 (459)
T KOG0610|consen 393 PFFEGVNWA 401 (459)
T ss_pred ccccCCChh
Confidence 999999997
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=323.43 Aligned_cols=257 Identities=23% Similarity=0.401 Sum_probs=211.5
Q ss_pred cceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 102 (296)
++.++||+|+||+||++.+. .+++.+|+|++............+.+.+|+.+++++ .|++|+++++.+... ..+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~ 80 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AKL 80 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CEE
Confidence 67899999999999998763 468999999997654433445567788999999999 589999999888544 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++|||+.+++|.+++.....+++.++..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 9999999999999998 8999999999876532
Q ss_pred C--cccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 183 S--HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSEC---DSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 183 ~--~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
. .......+++.|+|||.+.+. .+.++||||||+++|+|++|..||... .....+...+.... ...+...+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCC
Confidence 2 223345689999999977643 688999999999999999999999642 22233333333221 12334468
Q ss_pred hHHHHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 256 PEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
..+.+++.+||+ ||++|| +++++++||||++..|.
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 899999999997 999999 88999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=321.90 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=212.4
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||+|.++.+++.||+|+++..... .......+..|.+++..+ +|++|+++++.+... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence 4699999999999999999999999999754322 233455677788888866 799999999998655 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.+++|...+.....+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence 999999999988888999999999999999999999999 9999999999999998 8999999999875422 22233
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||++.+ .++.++|+||||+++|+|++|+.||......+....+..... ..+...+.++.+++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHh
Confidence 4568899999997764 488999999999999999999999987665555554443322 233446889999999999
Q ss_pred h-CCCCCC-------CHHHHhcCcccccccCCC
Q 022479 267 A-QPRARP-------SASELLKDPFFSELNDDD 291 (296)
Q Consensus 267 ~-~p~~Rp-------s~~~ll~hp~~~~~~~~~ 291 (296)
+ ||++|+ ++.++++||||..++|+.
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~ 264 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence 7 999999 999999999999987764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=322.66 Aligned_cols=262 Identities=26% Similarity=0.366 Sum_probs=207.5
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC-
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH- 99 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 99 (296)
..++| ++.+.||+|+||.||++.+..+|+.+|+|++..... .......+.+|+.+++.++|+||+++++++.....
T Consensus 19 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 34566 679999999999999999999999999999975432 33445677899999999999999999998864421
Q ss_pred ---CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 100 ---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 100 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
..++++|||+.+ +|...+.. .+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCC
Confidence 357999999987 55555532 4889999999999999999999999 9999999999999998 8999999999
Q ss_pred ccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC----------
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------- 245 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------- 245 (296)
+.............+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+..+..........
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 976544444455677899999997764 588999999999999999999999987654332221111100
Q ss_pred -----------CC------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 246 -----------KP------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 246 -----------~~------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.. .......++.+++|+.+||. ||++|||+.++|+||||..+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 00 00111235789999999998 999999999999999998654433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=329.84 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=212.4
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|++++++++|+||+++++.+.+. +.+++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEE
Confidence 36899999999999999999999999999998643221 122346688999999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
|||+++++|.+++...+.+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 999999999999998888999999999999999999999999 9999999999999988 89999999997532100
Q ss_pred ------------------------------------------cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHH
Q 022479 184 ------------------------------------------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLE 220 (296)
Q Consensus 184 ------------------------------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ 220 (296)
.......+++.|+|||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00112468899999997764 48899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHHHHHHHHHHhCCCCCC---CHHHHhcCcccccccCC
Q 022479 221 MVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDD 290 (296)
Q Consensus 221 ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~p~~Rp---s~~~ll~hp~~~~~~~~ 290 (296)
|++|+.||.+....+............. ......+.++.+++.+|+.+|.+|+ ++.++++||||+.+++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 9999999987665554444333221111 1123457899999999888999999 99999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=320.02 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=210.8
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||+||+|.++.+++.||+|+++..... .......+.+|..+++.+ +|+|++++++++... +.+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999999864321 233456677888888888 699999999988654 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+.+++|..++...+.+++.++..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999986532 222233
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
..++++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+............... ..+...+..+.+|+.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCcCCHHHHHHHHHHc
Confidence 4568899999997764 588999999999999999999999987554444333333221 233446889999999999
Q ss_pred h-CCCCCCCH-----HHHhcCcccccccCC
Q 022479 267 A-QPRARPSA-----SELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~-----~~ll~hp~~~~~~~~ 290 (296)
. ||++||++ .+++.||||+.++|.
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 7 99999999 999999999998774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=325.51 Aligned_cols=259 Identities=19% Similarity=0.303 Sum_probs=212.7
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.| ++.++||+|+||+||++.++.+++.||+|++...... .......+.+|+.+++.++|+||+++++.+.++ +.++
T Consensus 44 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~~ 119 (370)
T cd05596 44 DF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLY 119 (370)
T ss_pred Hc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEE
Confidence 44 6789999999999999999999999999999753321 122345577899999999999999999888554 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+++++|.+++... .+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeeccCC
Confidence 999999999999988764 5899999999999999999999999 9999999999999998 89999999999776432
Q ss_pred c--ccccCCCCCCccCcccccc-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC-CCCC
Q 022479 184 H--AAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKD 255 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 255 (296)
. ......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.........+........... ...+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 2 2234568999999997653 378899999999999999999999987665544444443322222222 2358
Q ss_pred hHHHHHHHHHHh-CCCC--CCCHHHHhcCcccccccCC
Q 022479 256 PEVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDD 290 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~--Rps~~~ll~hp~~~~~~~~ 290 (296)
.++.+||.+||+ +|++ |++++++++||||+...|.
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 899999999997 8887 9999999999999987664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=305.64 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=214.9
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCC----CCeE
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY-IIVCYSVWLDDQ----HNTL 102 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----~~~~ 102 (296)
..++||+|.||+||+|.++.+|+.||+|++....-. +-.-....+|+.++++++|+| |+.+++++.... ...+
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 467799999999999999999999999999865431 112345678999999999999 999999987653 2389
Q ss_pred EEEeeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 103 NFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
++|+||... .|.+++.... .++...++.+++||+.||+|||+++ |+||||||+||+++.+ |.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeeeccchHH
Confidence 999999987 8999988654 4777899999999999999999999 9999999999999998 999999999998
Q ss_pred ccCC-CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCC
Q 022479 179 IVGR-SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKV 253 (296)
Q Consensus 179 ~~~~-~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 253 (296)
-+.- .........|..|+|||++.+. ++...||||+|||+.||++++..|.+..+.+++..+...-..| ..++..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 7653 3335556778899999977654 8999999999999999999999999988877777665542222 111111
Q ss_pred C-------------------------ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 254 K-------------------------DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 254 ~-------------------------~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
. +....+++.+||+ +|.+|.|+..+|.||||.......+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 1 2478899999999 99999999999999999998765543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=327.98 Aligned_cols=259 Identities=21% Similarity=0.364 Sum_probs=213.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+.++.+++|++++++++.+.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence 5789999999999999999999999999999753321 234456788999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc--
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-- 184 (296)
||++|++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCccccccccc
Confidence 99999999999988888999999999999999999999999 9999999999999988 899999999986542110
Q ss_pred ----------------------------------ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCC
Q 022479 185 ----------------------------------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 185 ----------------------------------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~ 229 (296)
......+++.|+|||++. ..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 011346889999999765 458899999999999999999999998
Q ss_pred CCChHHHHHHHHhCCCCCCCCC-CCCChHHHHHHHHHHhCCCCCC---CHHHHhcCcccccccCCC
Q 022479 230 ECDSVAKIYKKVTGGVKPQALN-KVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDDD 291 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~p~~Rp---s~~~ll~hp~~~~~~~~~ 291 (296)
+..................... ...++++++||.+|+.||.+|+ +++++++||||++++|..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 7665554444332221111111 2357899999999878999988 589999999999988754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=318.65 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=207.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||+|.+..+++.||+|+++...... ....+.+..|..++... +|+||+++++.+... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 47999999999999999999999999998643222 22334455566666654 899999999888554 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.|++|..++.....+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 8999999999976432 22344
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
..++++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+..+..... .... ...+...+.++.+++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5578999999997764 4889999999999999999999999876654444433 3321 2234456889999999999
Q ss_pred h-CCCCCCCH-HHHhcCcccccccCC
Q 022479 267 A-QPRARPSA-SELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~-~~ll~hp~~~~~~~~ 290 (296)
. ||.+||++ .++++||||+.++|.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHH
Confidence 7 99999986 588899999988764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=320.32 Aligned_cols=253 Identities=20% Similarity=0.389 Sum_probs=208.8
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||+||++.++.+++.+|+|+++..... .......+.+|..++.++ +|+||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence 4799999999999999999999999999865332 334456778888888777 799999999998655 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+.+++|..++.....+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999987532 222234
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
...+++.|+|||++.+ .++.++|+||||+++|+|++|..||... .........+.... ...+...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence 4578999999997764 4888999999999999999999999521 11222333333321 22344568899
Q ss_pred HHHHHHHHh-CCCCCCC------HHHHhcCcccccccCC
Q 022479 259 KAFIEKCIA-QPRARPS------ASELLKDPFFSELNDD 290 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps------~~~ll~hp~~~~~~~~ 290 (296)
.+++.+||+ ||++||+ +.++++||||+.++|+
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999998 9999998 5899999999998774
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=317.75 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=211.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC-ceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK-YIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~lv 105 (296)
++.+.||+|+||.||+|.++.+++.||+|++...... .....+.+..|.+++..+.|+ +++++++.+... +.+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEE
Confidence 6789999999999999999999999999999854322 233456778899999999775 467777777544 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~ 184 (296)
|||+.+++|..++.....+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCC
Confidence 999999999999988888999999999999999999999999 9999999999999998 899999999986532 222
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+.......... ..+...+.++.+++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICK 233 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHH
Confidence 2334568999999997765 488999999999999999999999987665554444433221 233456889999999
Q ss_pred HHHh-CCCCCCCH-----HHHhcCcccccccCC
Q 022479 264 KCIA-QPRARPSA-----SELLKDPFFSELNDD 290 (296)
Q Consensus 264 ~~l~-~p~~Rps~-----~~ll~hp~~~~~~~~ 290 (296)
+||. ||.+|++. .++++||||+.++|.
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9997 99999976 899999999998774
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=318.92 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=208.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHH---HhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL---RTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
++.++||+|+||.||++.++.+++.||+|+++..... .....+.+.+|.+++ +.++|+||+++++++... +.+|
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 5789999999999999999999999999999854321 223345566665554 566899999999988654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR- 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~- 182 (296)
+||||+.+++|...+.. ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCCC
Confidence 99999999999888765 46999999999999999999999999 9999999999999998 8999999999875322
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
........+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+....+.......... ..+...+..+.++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l 231 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSREAISI 231 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHHH
Confidence 222344678899999997664 488899999999999999999999987655544444433322 2334468899999
Q ss_pred HHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 262 IEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 262 i~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+.+||+ ||.+|| ++.++++||||+++.|+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 999998 999999 799999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=320.83 Aligned_cols=263 Identities=26% Similarity=0.359 Sum_probs=210.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.++||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4566 679999999999999999999999999999975432 3344567788999999999999999998875432
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+|+||||+.+ +|...+.. .++...+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCc
Confidence 2468999999987 67666653 4789999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
.............++..|+|||++.+ .++.++|+|||||++|+|++|+.||.+.+..+.....+.....+
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 87655444455678899999997664 48899999999999999999999998766555443332211100
Q ss_pred ------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 ------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 ------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++++++|+.+||+ ||.+|||+.++|+||||..+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 330 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence 00011124678999999998 99999999999999999875444433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=316.96 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=207.4
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||+|.++.+|+.||+|+++...... .........|..++... +|++++++++.+... +.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 47999999999999999999999999998643211 12344566677777654 899999999998654 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.+++|..++.....+++.++..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999998 7999999999865321 22234
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+........ .+.... ...+...+.++++|+.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE-SIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 4568999999997764 58899999999999999999999998755443333 333222 2223446889999999999
Q ss_pred h-CCCCCCCH-HHHhcCcccccccCC
Q 022479 267 A-QPRARPSA-SELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~-~~ll~hp~~~~~~~~ 290 (296)
. ||++||++ +++++||||+.++|.
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 7 99999998 588999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=312.33 Aligned_cols=258 Identities=21% Similarity=0.343 Sum_probs=212.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.+..+++.||+|++...... .......+.+|+.++++++|++++++++.+..+ +.++++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEE
Confidence 5789999999999999999989999999999754331 122345577899999999999999999988544 6899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence 999999999887543 46899999999999999999999999 9999999999999988 899999999998764433
Q ss_pred ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK---IYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......+++.|+|||.+. ..++.++|+||+|+++|++++|..||.+...... ....+... ........+..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHH
Confidence 334456788999999765 4488899999999999999999999986543222 22222221 12233446889999
Q ss_pred HHHHHHh-CCCCCC-----CHHHHhcCcccccccCCCC
Q 022479 261 FIEKCIA-QPRARP-----SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 261 li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~ 292 (296)
|+.+||. ||++|| ++.++++||||.+.+|+.-
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence 9999997 999999 9999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=316.06 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=208.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
+.||+|+||+||+|.++.+++.||+|+++...... .........|..+++.. +||||+++++.+... +.++++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence 46999999999999999999999999998643211 12234556677777764 899999999998655 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.+++|..++.....+++.++..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999998 7999999999875322 22234
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||.+.+ .++.++|+|||||++|+|++|..||......+.......... ..+...+.++++++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP---CYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHHHh
Confidence 4568899999997764 489999999999999999999999987655444433332221 233446889999999999
Q ss_pred h-CCCCCCCHH-HHhcCcccccccCC
Q 022479 267 A-QPRARPSAS-ELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~~-~ll~hp~~~~~~~~ 290 (296)
+ ||++||++. ++++||||+.++|.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHH
Confidence 7 999999996 89999999998875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=321.57 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=209.9
Q ss_pred eeecccCcceEEEeee---cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|+||.||++.+ +.+|+.+|+|+++.... .......+.+|++++++++|+||+++++.+..+ ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5799999999999876 45789999999986433 122345677899999999999999999988654 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-cc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-~~ 185 (296)
||+.+++|.+++.....+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 9999999999999998 89999999998765433 23
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||......+.......... ..+...+..+.+|+.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Confidence 344578899999997764 478899999999999999999999987665544444433222 2234468899999999
Q ss_pred HHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 265 CIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 265 ~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
||+ ||++||+ +.++++||||+.+.|+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 998 9999999 7889999999987664
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=320.52 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=207.6
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
+.||+|+||+||+|.++.+++.+|+|++..............+..+..+++.++|+||+++++.+... +.++++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 46999999999999999999999999998643322222233333444567889999999999888554 7899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCccccc
Q 022479 110 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHS 188 (296)
Q Consensus 110 ~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~~ 188 (296)
.+++|..++.....+++..+..++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++.... .......
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccc
Confidence 99999999988888999999999999999999999999 9999999999999988 899999999987542 2223445
Q ss_pred CCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh
Q 022479 189 IIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (296)
..+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+......... .......+..+.+++.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---cCCCCCCCHHHHHHHHHHcc
Confidence 578999999997664 48889999999999999999999998766555444443322 22233468899999999998
Q ss_pred -CCCCCCCHH----HHhcCcccccccCCC
Q 022479 268 -QPRARPSAS----ELLKDPFFSELNDDD 291 (296)
Q Consensus 268 -~p~~Rps~~----~ll~hp~~~~~~~~~ 291 (296)
||.+|+++. ++++|+||..++|++
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999999876 899999999887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=317.09 Aligned_cols=254 Identities=20% Similarity=0.379 Sum_probs=211.2
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||+|.++.+++.+|+|+++.... .+....+.+.+|..++.++ +|++|+++++++... +.+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence 479999999999999999999999999986433 2334466788899999888 699999999988655 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+.+++|..++...+.+++..+..++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999987532 222344
Q ss_pred cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 188 SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC------DSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
..++++.|+|||.+. ..++.++|+||||+++|+|++|..||... ...+......... +...+...+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 567899999999765 45889999999999999999999999531 2233344444332 22234456889999
Q ss_pred HHHHHHh-CCCCCCC------HHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRARPS------ASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~Rps------~~~ll~hp~~~~~~~~~ 291 (296)
++.+||+ ||++|++ ++++++||||+.++|+.
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 9999997 9999997 57999999999988764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=321.73 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=210.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||.||++.++.+++.+|+|++...... .......+.+|+.+++.++||||+++++.+..+ ..+++|
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv 121 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYLYMV 121 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence 47899999999999999999999999999999753321 222345678899999999999999999988654 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
|||+.+++|.+++... .+++..+..++.||+.||+|||+++ ++||||||+||+++.+ +.++|+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceecccCCc
Confidence 9999999999998765 4899999999999999999999999 9999999999999988 8999999999987643222
Q ss_pred --cccCCCCCCccCcccccc-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC-CCCChH
Q 022479 186 --AHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDPE 257 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 257 (296)
.....+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+........... ...+..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 234568999999997653 267899999999999999999999987665555544444332222222 235888
Q ss_pred HHHHHHHHHh-CCC--CCCCHHHHhcCcccccccC
Q 022479 258 VKAFIEKCIA-QPR--ARPSASELLKDPFFSELND 289 (296)
Q Consensus 258 l~~li~~~l~-~p~--~Rps~~~ll~hp~~~~~~~ 289 (296)
+++++.+|+. ++. .|+++.++++||||+...|
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 9999999997 443 3899999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=314.46 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=210.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||++.++.++..+|+|.+.... .......+.+|++++++++|+||+++++++.+. +.+
T Consensus 5 ~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (333)
T cd06650 5 DDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 78 (333)
T ss_pred hhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEE
Confidence 445 67999999999999999999999999999987542 344567789999999999999999999999765 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++|||+.+++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhh
Confidence 99999999999999999888899999999999999999999974 7 9999999999999988 799999999987653
Q ss_pred CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-----------------------
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI----------------------- 237 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~----------------------- 237 (296)
.. ......++..|+|||.+.+ .++.++|+|||||++|+|++|+.||.........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred hh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 32 2233467889999997764 4888999999999999999999999754322111
Q ss_pred --------------------HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 238 --------------------YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 238 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
...+.....+.......+.++++|+.+||+ ||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 111111111222223356789999999998 999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=303.03 Aligned_cols=252 Identities=34% Similarity=0.590 Sum_probs=213.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.++++||+|++|.||.+.+..+++.+++|++....... .......+.+|+.++++++|+|++++++.+.+. ..++++
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence 67999999999999999999999999999987653321 223456788999999999999999999998655 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+||+++++|.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 9999999999999988 8999999999876533211
Q ss_pred c----ccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 186 A----HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 186 ~----~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
. ....++..|+|||.+.+. .+.++|+||||+++|+|++|+.||................... ..+...+..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP-QLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC-CCCccCCHHHHH
Confidence 1 234567789999977644 8899999999999999999999998766665555544443332 344456889999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
++.+||. +|.+|||+.++++||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999997 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=310.02 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=206.3
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|+||+||++.++.+++.+|+|++...... .....+.+..|++++++++|++++++.+.+... ..++++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 79999999999999999999999999754332 222345677899999999999999999888544 679999999999
Q ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-cc
Q 022479 112 GNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AA 186 (296)
Q Consensus 112 ~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~~ 186 (296)
++|..++. ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccc
Confidence 99988774 3456999999999999999999999999 9999999999999988 899999999987654322 22
Q ss_pred ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 187 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...... ......... .+.......+..+.+++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCCHHHHHHH
Confidence 33467889999997664 4888999999999999999999999754322 122222221 12233345688999999
Q ss_pred HHHHh-CCCCCC-----CHHHHhcCcccccccCCCC
Q 022479 263 EKCIA-QPRARP-----SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 263 ~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~ 292 (296)
.+||+ ||++|| +++++++||||+.+.|..-
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 99997 999999 8899999999999888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=318.27 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=205.7
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHH-HHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV-QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||.||+|.++.+++.+|+|++.......... ...+.+|. .+++.++|+||+++++.+.+. +.+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH-HHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence 47999999999999999999999999997543322222 33344444 467889999999999888554 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+++++|...+.....+++..+..++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999987532 222334
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...+.. .....+.... ...+...+.++.+++.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNILHKP--LQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence 4568899999997764 4888999999999999999999999875543 3444333322 2333456889999999999
Q ss_pred h-CCCCCCCH----HHHhcCcccccccCC
Q 022479 267 A-QPRARPSA----SELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~----~~ll~hp~~~~~~~~ 290 (296)
+ ||.+|+++ .++++|+||..++|.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 8 99999875 599999999987764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=315.02 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=212.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++.++||+|+||.||+|.++.+++.+|+|++...... ..........|..++..+ .|++++++++++... +.+++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEEE
Confidence 5789999999999999999999999999999864322 223345566777788777 578888888888554 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Cc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~ 184 (296)
|||+.+++|..++...+.+++.++..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++..... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCCC
Confidence 999999999999988888999999999999999999999999 9999999999999999 8999999999875432 22
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.....++++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+..... ..+...+.++.+++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~ 233 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVAICK 233 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCcCCHHHHHHHH
Confidence 2344568999999997664 489999999999999999999999987665555544444322 233446889999999
Q ss_pred HHHh-CCCCCCCH-----HHHhcCcccccccCCC
Q 022479 264 KCIA-QPRARPSA-----SELLKDPFFSELNDDD 291 (296)
Q Consensus 264 ~~l~-~p~~Rps~-----~~ll~hp~~~~~~~~~ 291 (296)
+||+ ||.+|+++ .++++||||+.++|..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 9997 99999974 8999999999888654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=319.25 Aligned_cols=261 Identities=27% Similarity=0.376 Sum_probs=208.8
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-- 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 98 (296)
..++| ++.+.||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34566 678999999999999999999999999999875432 3444567888999999999999999999886432
Q ss_pred --CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 99 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 99 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
...++++|||+.+ ++...+.. .++...+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcc
Confidence 2467999999987 56666543 4889999999999999999999999 9999999999999998 8999999999
Q ss_pred ccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 247 (296)
++............+++.|+|||++.+ .++.++|+||||+++|+|++|+.||.+....+.....+.....+
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655444455678899999997664 48899999999999999999999998765444333222110000
Q ss_pred -------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 248 -------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 248 -------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.......+.++++|+.+||+ ||++|||+.++|+||||..+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 00011234678999999998 99999999999999999866433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=309.61 Aligned_cols=254 Identities=30% Similarity=0.438 Sum_probs=201.2
Q ss_pred CcccceeeecccCcceEEEeeecC-CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeeeeeeC--
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDD-- 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~-- 97 (296)
+| ++.+.||+|+||+||+|.+.. +++.+|+|+++...... .....+.+|+.+++++ +||||+++++++...
T Consensus 2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 44 678999999999999999854 46889999987654322 1223344566666655 699999999987532
Q ss_pred -CCCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 98 -QHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 98 -~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
....+++++||+.+ +|.+++.. ...+++.+++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccc
Confidence 23578999999975 88888865 345899999999999999999999999 9999999999999998 89999999
Q ss_pred CCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--C---
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q--- 248 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~--- 248 (296)
|++.............+++.|+|||.+. ..++.++|+||||+++|+|++|..||.+..+.+.+..+......+ .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9998765544445567889999999765 458889999999999999999999998876666555444321100 0
Q ss_pred -------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 249 -------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 249 -------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
......+..+++|+.+||+ ||++|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0011246788999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=308.36 Aligned_cols=255 Identities=21% Similarity=0.341 Sum_probs=204.8
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|+||.||++.++.+|+.+|+|++....... ......+..|++++++++|+|++++.+.+... ..++++|||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 799999999999999999999999997543321 12234456799999999999999999888544 789999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccC
Q 022479 112 GNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189 (296)
Q Consensus 112 ~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~ 189 (296)
++|..++... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.+ +.++|+|||++............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence 9998887543 35888999999999999999999999 9999999999999998 79999999998876544334445
Q ss_pred CCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 190 IGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 190 ~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
.++..|+|||++.+ .++.++|+||||+++|+|++|..||..... ............. .......+.++++|+.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHHHHH
Confidence 68889999997654 488999999999999999999999975432 1222222222111 122234688999999999
Q ss_pred Hh-CCCCCCCH----HHHhcCcccccccCCCCC
Q 022479 266 IA-QPRARPSA----SELLKDPFFSELNDDDSE 293 (296)
Q Consensus 266 l~-~p~~Rps~----~~ll~hp~~~~~~~~~~~ 293 (296)
|+ ||++||++ +++++||||+.++|+..+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~ 266 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE 266 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHHHh
Confidence 98 99999999 778899999998875433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=313.18 Aligned_cols=260 Identities=23% Similarity=0.430 Sum_probs=212.8
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH----------HHHHHHHHHHHHHHhcCCCceeEEe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP----------VLVNRLHSEVQLLRTLKNKYIIVCY 91 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~ 91 (296)
.++| ++.+.||+|.||.|-+|.+..+++.||+|++......... ..+++.++|+.+++++.|+|||+++
T Consensus 96 lNqy-~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQY-ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred hhhe-ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4556 5789999999999999999999999999999875442211 1246899999999999999999999
Q ss_pred eeeeeCCCCeEEEEeeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
++.-++..+.+|+|+||+..|.+. +...... +++.+++.+++.++.||+|||.+| |+||||||+|+|++.+ |.+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEE
Confidence 999888889999999999988775 3333444 999999999999999999999999 9999999999999999 9999
Q ss_pred EeccCCccccCC------CcccccCCCCCCccCccccccC-----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022479 171 IGDLGFAAIVGR------SHAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 239 (296)
Q Consensus 171 l~dfg~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~ 239 (296)
|+|||++..+.. ........|||.|+|||...++ .+.+.|||+||+++|.++-|+.||-+.... .++.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-~l~~ 329 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-ELFD 329 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-HHHH
Confidence 999999987632 2224457899999999965431 567899999999999999999999874443 3444
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+........-..-..+.+++||.+||. ||++|.++-++..|||...-
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 4443322111111247899999999996 99999999999999997644
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=310.63 Aligned_cols=252 Identities=34% Similarity=0.595 Sum_probs=208.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.+.||+|+||+||++.+..+++.+|+|++..... .........+|+.++++++|+||+++++++... ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--cccccc
Confidence 4678999999999999999999999999999986543 223333445699999999999999999999764 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-CCCc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~~~~ 184 (296)
|+++.+++|.+++.....++..++..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||.+... ....
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccc
Confidence 999999999999998788999999999999999999999999 9999999999999988 89999999999763 3334
Q ss_pred ccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCCCCC-CCCCCCCChHH
Q 022479 185 AAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKP-QALNKVKDPEV 258 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l 258 (296)
......+++.|+|||.+. ...+.++|+||||+++++|++|..||.... ............... .......+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 455667888999999876 558999999999999999999999998762 222222222211111 11111123799
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+++.+||. ||++|||+.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999998 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=316.38 Aligned_cols=248 Identities=23% Similarity=0.411 Sum_probs=208.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|.||.||.+..+. ...+|+|.++.... ..+.|.+|++++++++|++|+++++++..+ ..+||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIVt 280 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIVT 280 (468)
T ss_pred HHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEEE
Confidence 566999999999999998873 34899999986433 135677999999999999999999999655 5899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||++.|+|.+|++. +..+...++..++.|||+|++||++++ +|||||-..||||+.+ ..+|++|||+++...+..
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccccCCCc
Confidence 99999999999997 678999999999999999999999999 9999999999999999 799999999999554322
Q ss_pred --ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
..........|.|||.+. +.++.++||||||+++|||+| |+.||.+....+.+.. +..+.....+ ..+|+++.+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P-~~CP~~vY~ 435 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRP-EGCPDEVYE 435 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCC-CCCCHHHHH
Confidence 233444567899999765 669999999999999999999 9999988766555554 4555444444 446999999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
++..||. +|++|||++.+.. ++.++..
T Consensus 436 lM~~CW~~~P~~RPtF~~L~~--~l~~~~~ 463 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLRE--VLEDFFT 463 (468)
T ss_pred HHHHHhhCCcccCCCHHHHHH--HHHHhhh
Confidence 9999997 9999999998876 5555544
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=317.33 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=205.5
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHH-HHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++||+|+||+||+|.++.+|+.+|+|++....... ......+..|.. +++.++|+||+++++.+... +.+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence 46999999999999999999999999997543322 222334444444 57789999999999888654 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~~~ 187 (296)
+.+++|..++.....+++..+..++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++.... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence 999999999988888999999999999999999999999 9999999999999998 899999999987532 222334
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||++.+ .++.++|+|||||++|+|++|..||...+..+.......... ......+..+.+++.+|+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---VLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---cCCCCCCHHHHHHHHHHh
Confidence 4568899999997764 488999999999999999999999987655444444333221 222346889999999999
Q ss_pred h-CCCCCCCH----HHHhcCcccccccCC
Q 022479 267 A-QPRARPSA----SELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rps~----~~ll~hp~~~~~~~~ 290 (296)
+ ||.+||++ .++++||||....|.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence 7 99999876 599999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=316.35 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=203.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||++.+..+++.||+|++.... .......+.+|++++++++|+||+++++++... +.+++++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEE
Confidence 45789999999999999999999999999986432 345567889999999999999999999988544 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-c
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~ 185 (296)
||+.+++|... ...++..+..++.||+.||+|||++| ++|+||||+||+++.+ +.++|+|||++....... .
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceeccccccc
Confidence 99999998643 23577888999999999999999999 9999999999999998 899999999998764322 2
Q ss_pred cccCCCCCCccCccccccC------CCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 186 AHSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~~------~~~~~Di~slG~i~~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.....++..|+|||.+... .+.++|||||||++|+|++|+.||.... +............. .......+.+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-CCCCCccCHH
Confidence 3345688999999976422 4568999999999999999999997322 22222222222222 2233456889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+.+||.+||+ ||++|||+.++++||||..-....
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~ 338 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCCccc
Confidence 9999999998 999999999999999999875443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=304.93 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=215.9
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
.+.+.| ++.++||.|++|.||++.+..+++.+++|++... +......+.+|+.++++++|+|++++++.+..+
T Consensus 9 ~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 81 (292)
T cd06644 9 DPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-- 81 (292)
T ss_pred Ccchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--
Confidence 444555 7899999999999999999999999999998753 445567788999999999999999999988655
Q ss_pred CeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..++++|||+.+++|..++.. ...+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccce
Confidence 689999999999999887754 456899999999999999999999999 9999999999999988 899999999886
Q ss_pred ccCCC-cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 179 IVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 179 ~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
..... .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 54322 1223345678899999763 2367789999999999999999999977555444444433322222233
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...+.++.+++.+||. ||++||+++++++||||..+.++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 4457889999999997 999999999999999999988775
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=318.64 Aligned_cols=251 Identities=27% Similarity=0.352 Sum_probs=200.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| .+.++||+|+||.||+|.+..+++.||+|.... ..+.+|++++++++||||+++++.+... ...
T Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 158 (391)
T PHA03212 92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KFT 158 (391)
T ss_pred CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--Cee
Confidence 345 789999999999999999999999999997541 3456899999999999999999998655 678
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++++|++. ++|..++.....+++.++..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVD 234 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCccccccc
Confidence 99999986 488888888778999999999999999999999999 9999999999999988 8999999999875422
Q ss_pred C--cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhC--C------
Q 022479 183 S--HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS-------VAKIYKKVTG--G------ 244 (296)
Q Consensus 183 ~--~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~-------~~~~~~~~~~--~------ 244 (296)
. .......+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ...+...+.. .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 22334578999999997764 489999999999999999999987743211 1111111100 0
Q ss_pred ------------------C-CCCCC-----CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 245 ------------------V-KPQAL-----NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 245 ------------------~-~~~~~-----~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
. .+... ....+.++.+|+.+||. ||.+|||+.++|+||||+.+..+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0 00000 01135678999999998 99999999999999999987654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=313.88 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=210.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||+||++.++.+++.||+|++...... .....+.+.+|..+++.++|++|+++++.+..+ +.+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLVM 80 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEEE
Confidence 6789999999999999999999999999999753221 223456688899999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCCCC
Confidence 99999999999976 567999999999999999999999999 9999999999999988 8999999999876543222
Q ss_pred --cccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCC
Q 022479 186 --AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALNKVKD 255 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 255 (296)
.....+++.|+|||++. +.++.++|+|||||++|+|++|+.||.+....+............. ......+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 22346899999999775 2367889999999999999999999987555444444333221111 1122368
Q ss_pred hHHHHHHHHHHh---CCCCCCCHHHHhcCcccccccCCC
Q 022479 256 PEVKAFIEKCIA---QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 256 ~~l~~li~~~l~---~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.++++++++|+. ++..|+++.++++||||...+|+.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 899999999985 444489999999999999887643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=336.94 Aligned_cols=263 Identities=24% Similarity=0.446 Sum_probs=220.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+++.+|+|++..... .......+..|+.++++++||||+++++.|.......+
T Consensus 13 ~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 13 NEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345 789999999999999999999999999999986543 34456788999999999999999999999887766789
Q ss_pred EEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCceecCCCCCceEEeCC--------
Q 022479 103 NFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHE-----PCIIHRDLNCSNIFINGN-------- 165 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~-----~~i~h~dl~~~nilv~~~-------- 165 (296)
|+||||+.+++|.+++.. ...+++..++.++.||+.||+|||+.+ .+|+|+||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999998864 357999999999999999999999843 239999999999999642
Q ss_pred --------CCceEEeccCCccccCCCcccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022479 166 --------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234 (296)
Q Consensus 166 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 234 (296)
.+.++|+|||++.............+++.|+|||++.+ .++.++||||||||+|+|++|..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 13589999999987655444455678999999997642 3788999999999999999999999876666
Q ss_pred HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 235 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..+...+..... ......+.++.+||..||. +|.+||++.++|.|||++.+..+
T Consensus 250 ~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 250 SQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred HHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 666665554432 2223458899999999998 99999999999999999977654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.95 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=213.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-- 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 99 (296)
..+| ++.++||+|+||+||++.+..+++.||+|++..... +......+.+|+..+..++|+++++++..+.....
T Consensus 31 ~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 31 AKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred CCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3455 789999999999999999999999999999976543 45556778899999999999999999877653321
Q ss_pred ----CeEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 100 ----NTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 100 ----~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
..+++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.++|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCEEE
Confidence 247899999999999998864 356899999999999999999999999 9999999999999998 89999
Q ss_pred eccCCccccCCC---cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC
Q 022479 172 GDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 172 ~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
+|||+++..... ......++++.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+...........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~- 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD- 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 999999765432 12334578999999997764 4899999999999999999999999876554444443333222
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
..+...++++.+++.+||. ||.+||++.++++|||++.+
T Consensus 264 -~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 -PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 2334568899999999997 99999999999999998764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.87 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=205.6
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
||+|+||+||+|.++.+++.||+|++....... ......+..|..++.+. .||+|++++..+... ..+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 799999999999999999999999997543322 22233445566666655 699999999988554 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Ccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~~~~ 187 (296)
+.+++|..++...+.+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++..... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence 999999999988888999999999999999999999999 9999999999999998 8999999999875422 22334
Q ss_pred cCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
..++++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+....+..... .......++++.+++.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHH
Confidence 5678999999997753 378899999999999999999999987655444443333322 222334688999999999
Q ss_pred Hh-CCCCCC----CHHHHhcCcccccccCCC
Q 022479 266 IA-QPRARP----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 266 l~-~p~~Rp----s~~~ll~hp~~~~~~~~~ 291 (296)
|+ ||.+|| ++.++++||||.+..|+.
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 97 999998 799999999999876543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=304.28 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=216.5
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.++| ++.+.||+|++|+||++.+..+++.+|+|+++.. .....+.+.+|++++++++|+|++++++.+... .
T Consensus 3 ~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 75 (280)
T cd06611 3 PNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--N 75 (280)
T ss_pred chhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--C
Confidence 44566 6899999999999999999888999999999754 344557788999999999999999999998654 6
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.++++|||+.+++|..++.. ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~ 152 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAK 152 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchh
Confidence 89999999999999999876 456999999999999999999999999 9999999999999998 8999999998866
Q ss_pred cCCCc-ccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 180 VGRSH-AAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
..... ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||......................+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (280)
T cd06611 153 NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS 232 (280)
T ss_pred hcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcc
Confidence 53322 223345788899999753 23677899999999999999999999876665555544433332223344
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..+.++.+++.+||+ +|.+||++.++++||||.+...+
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 568899999999997 99999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=317.26 Aligned_cols=259 Identities=19% Similarity=0.291 Sum_probs=210.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.-+++.+.||+|+||.||+|.++.+++.+|+|++...... .......+.+|+.+++.++||||+++++.+... ..++
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~ 119 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLY 119 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEE
Confidence 3447899999999999999999999999999999753321 223345678899999999999999999988654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+++++|.+++... .+++..+..++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcC
Confidence 999999999999998765 4899999999999999999999999 9999999999999998 89999999999876432
Q ss_pred c--ccccCCCCCCccCcccccc-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-CCCCC
Q 022479 184 H--AAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKD 255 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (296)
. ......+++.|+|||++.+ .++.++|+|||||++|+|++|..||...........+.......... ....+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2234568999999997753 26789999999999999999999998766554444444332222111 22468
Q ss_pred hHHHHHHHHHHhCCCC---CCCHHHHhcCcccccccC
Q 022479 256 PEVKAFIEKCIAQPRA---RPSASELLKDPFFSELND 289 (296)
Q Consensus 256 ~~l~~li~~~l~~p~~---Rps~~~ll~hp~~~~~~~ 289 (296)
..++++|.+||.+|.. |++++++++||||++..|
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 8999999999974333 789999999999988554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=300.54 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=212.7
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||.|++|.||++.+..+++.+++|++..... ......+.+.+|+.++++++|+|++++++.+.++ ..+++++||.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 7999999999999998999999999975433 2234457899999999999999999999988654 789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCC
Q 022479 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191 (296)
Q Consensus 112 ~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 191 (296)
++|.+++.....++...+..++.|++.||++||+++ ++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence 999999988878999999999999999999999999 9999999999999998 8999999999987755433444567
Q ss_pred CCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-
Q 022479 192 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA- 267 (296)
Q Consensus 192 ~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~- 267 (296)
++.|++||.+. ..++.++|+||||+++|+|++|..||.... .............. ...+...+.++.+++.+||.
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-CCCCcccCHHHHHHHHHHccC
Confidence 88999999765 458899999999999999999999997655 33333333322222 22333348899999999997
Q ss_pred CCCCCCC-----HHHHhcCcccccccCC
Q 022479 268 QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 268 ~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
+|++||+ +.++++||||++++|+
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 9999999 9999999999999886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=299.84 Aligned_cols=255 Identities=33% Similarity=0.557 Sum_probs=211.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccC-CCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.++||+|++|.||++.+..++..+++|++...... ........+.+|+.++++++|+|++++++.+.......++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 5789999999999999999999999999998754321 233456778999999999999999999998876555789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
+||+.+++|.+++.....++...++.++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccccc
Confidence 999999999999988778999999999999999999999999 9999999999999988 799999999987653211
Q ss_pred ---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 ---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......++..|+|||.+.+ .++.++|+||+|+++|++++|+.||.................. ...+...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-PQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-CCCchhcCHHHHH
Confidence 1122346778999997664 4889999999999999999999999876666555544433332 2334456788999
Q ss_pred HHHHHHhCCCCCCCHHHHhcCcccc
Q 022479 261 FIEKCIAQPRARPSASELLKDPFFS 285 (296)
Q Consensus 261 li~~~l~~p~~Rps~~~ll~hp~~~ 285 (296)
++.+|+.+|++||++.++++||||+
T Consensus 241 li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCChhhCcCHHHHhcCcccc
Confidence 9954445999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=304.45 Aligned_cols=262 Identities=28% Similarity=0.475 Sum_probs=217.1
Q ss_pred ceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
++..++..+| .+.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|+|++++++.+.
T Consensus 13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4555666677 578999999999999999999999999999976433 22466888999999999999999999886
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.. ...++|+||+.+++|.+++... .++..++..++.|++.||+|||+.| ++|+||+|+||+++.+ +.++|+|||
T Consensus 88 ~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg 161 (296)
T cd06654 88 VG--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFG 161 (296)
T ss_pred eC--CEEEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccc
Confidence 54 6899999999999999988654 5899999999999999999999999 9999999999999988 799999999
Q ss_pred CccccCCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 176 FAAIVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 176 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
.+....... ......+++.|+|||.+.+ ..+.++|+||||+++|+|++|+.||.........................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 987653322 2233467789999997664 48899999999999999999999998766555554444333322223344
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.+..+.+++.+||. ||++||++.+++.||||...+
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 67889999999997 999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=313.80 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=223.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| .+.+++|.|+||.++++.++.+++.+++|.+..... .....+...+|+.+++++.||||+...+.|.+.+ ..+
T Consensus 4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l 79 (426)
T KOG0589|consen 4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL 79 (426)
T ss_pred chh-hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence 355 579999999999999999999999999999988765 3444568889999999999999999999997663 449
Q ss_pred EEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++||+|+.||+|.+.+.+ +..++++.+..|+.|++.|+.|||+++ |+|||||+.|||++.+ +.|+|.|||+++.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-Cceeecchhhhhhc
Confidence 999999999999999874 468999999999999999999999999 9999999999999999 78899999999999
Q ss_pred CCCc-ccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
+... ......|||.|++||++.+. +..++|||||||++|||++-+++|...+-..-+..+.... ....+...+.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--YSPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--CCCCCccccHHH
Confidence 7766 67778899999999988765 9999999999999999999999998754444444444433 234456678999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+.||..|++ +|..||++.++|.+|.+..+.
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999997 999999999999998877443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=306.91 Aligned_cols=266 Identities=28% Similarity=0.470 Sum_probs=217.9
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
+..+...+| .+.+.||+|++|.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++.+..
T Consensus 13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 344555666 579999999999999999998999999999975432 224567889999999999999999999865
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
. ..+++|+||+++++|.+++... .+++.++..++.|++.+|.+||+.| ++|+||+|+||+++.+ +.++|+|||.
T Consensus 88 ~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~ 161 (297)
T cd06656 88 G--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF 161 (297)
T ss_pred C--CEEEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCcc
Confidence 4 7899999999999999988654 4899999999999999999999999 9999999999999988 8999999999
Q ss_pred ccccCCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 177 AAIVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 177 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
+....... ......+++.|+|||.+.+ .++.++|+||||+++|++++|..||.................+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 87654322 2233467788999997654 488999999999999999999999977655444443333333333334456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+..+++++.+||. +|++||++.++++||||+......+.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 281 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL 281 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence 7889999999997 99999999999999999877655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=304.94 Aligned_cols=252 Identities=28% Similarity=0.389 Sum_probs=198.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHh---cCCCceeEEeeeeeeC---CCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT---LKNKYIIVCYSVWLDD---QHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~---~~~ 100 (296)
++.+.||+|+||+||+|.++.+++.+|+|.++....... ....+.+|+.++++ ++|+||+++++++... ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 678999999999999999999999999999875432111 11233445555554 4799999999987643 235
Q ss_pred eEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 101 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
.+++++||+.+ +|.+++... ..+++.++..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCccc
Confidence 68999999986 788888653 35899999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--CC--------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KP-------- 247 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~-------- 247 (296)
............++..|+|||.+. ..++.++|+||||+++|+|++|..||.+....+.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 765444444556788999999765 4589999999999999999999999977655444333322100 00
Q ss_pred --------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 --------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+.++.+|+.+||+ ||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112346788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.25 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=206.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC---CeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---NTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~ 103 (296)
.+.++||+|+||.||++.+..+++.||+|++..... +.....++.+|+.+++.++|+||+++++++..... ..+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 468999999999999999999999999999864322 33445678899999999999999999998865421 2689
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+|+||+.+ +|...+.....+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence 99999975 78888887788999999999999999999999999 9999999999999998 89999999999765332
Q ss_pred c--ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC----------------
Q 022479 184 H--AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---------------- 243 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~---------------- 243 (296)
. ......+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+.+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 1223456788999997764 3788999999999999999999999876554433322111
Q ss_pred -------CCCCC------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 244 -------GVKPQ------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 244 -------~~~~~------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
...+. ......++++.+|+.+||+ ||++|||+.++|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 1122347789999999998 999999999999999998843
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=297.75 Aligned_cols=255 Identities=33% Similarity=0.560 Sum_probs=212.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeeccc-CCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++++||+|++|.||++.++.+++.|++|++..... .........+.+|+.+++++.|+|++++++.+.+.....++++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 679999999999999999999999999999865432 2233456788999999999999999999998866555788999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
+||+++++|.+++.....+++..+..++.|++.+|++||+++ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCccccccccccc
Confidence 999999999999988777999999999999999999999999 9999999999999988 89999999998765321
Q ss_pred --cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 184 --HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 184 --~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.......++..|+|||.+. ...+.++|+||||+++|+|++|+.||.................. ...+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC-CCCchhhCHHHHH
Confidence 1122345677899999765 44889999999999999999999999876655555544333222 2233345778999
Q ss_pred HHHHHHhCCCCCCCHHHHhcCcccc
Q 022479 261 FIEKCIAQPRARPSASELLKDPFFS 285 (296)
Q Consensus 261 li~~~l~~p~~Rps~~~ll~hp~~~ 285 (296)
++.+|+.+|++||+++++++|||+.
T Consensus 241 ~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=306.42 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=205.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| .+.++||+|+||.||++.++.+++.+|+|+++...... ....+.+|+.++++++|+|++++++.+..+ +.+
T Consensus 6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 79 (309)
T cd07872 6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL 79 (309)
T ss_pred Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence 456 67899999999999999999999999999997543221 234566899999999999999999998655 689
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++|||+.+ +|.+++.. +..++...+..++.|++.||+|||++| ++||||+|+||+++.+ +.++|+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecC
Confidence 999999987 77777654 456899999999999999999999999 9999999999999998 899999999987653
Q ss_pred CCc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-------------
Q 022479 182 RSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV------------- 245 (296)
Q Consensus 182 ~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------- 245 (296)
... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+....+..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 2233456889999997653 478899999999999999999999987654443332221100
Q ss_pred --------CCC------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 246 --------KPQ------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 246 --------~~~------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
... ......+.++.+|+.+||+ ||.+|||+.++++||||+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 000 0011246789999999998 9999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=317.77 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=209.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-C-----CceeEEeeeeeeCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-N-----KYIIVCYSVWLDDQH 99 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~ 99 (296)
|.+.++||+|.||.|.+|.+..|++.||||+++.. .....+...|+++|.+++ | -|+++++++|.-.
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-- 260 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-- 260 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--
Confidence 36799999999999999999999999999999863 556778889999999997 2 4799999999666
Q ss_pred CeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCC
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGF 176 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~ 176 (296)
+.+|+|+|.+.- +|.++++.+ ..++...++.++.||+.||.+||+.+ |+|+||||+|||+..- ...+|++|||+
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccc
Confidence 789999999976 999999865 35889999999999999999999999 9999999999999643 24899999999
Q ss_pred ccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 247 (296)
+........ .+..+..|+|||++-+ .++.+.||||||||+.||++|.+.|++.+..+++..++.....|
T Consensus 338 Sc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 338 SCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 988765543 5667788999996654 59999999999999999999999999887777665433321110
Q ss_pred --------------------C---------------------CCC-----------CCCChHHHHHHHHHHh-CCCCCCC
Q 022479 248 --------------------Q---------------------ALN-----------KVKDPEVKAFIEKCIA-QPRARPS 274 (296)
Q Consensus 248 --------------------~---------------------~~~-----------~~~~~~l~~li~~~l~-~p~~Rps 274 (296)
. ..+ ......+.+++.+||+ ||..|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 000 0112457899999998 9999999
Q ss_pred HHHHhcCcccccccCCC
Q 022479 275 ASELLKDPFFSELNDDD 291 (296)
Q Consensus 275 ~~~ll~hp~~~~~~~~~ 291 (296)
+.++|+||||.......
T Consensus 496 p~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSLER 512 (586)
T ss_pred HHHHhcCcccccccccc
Confidence 99999999999554443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=322.39 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=197.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC------ceeEEeeeeeeC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK------YIIVCYSVWLDD 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~ 97 (296)
+.|++.++||+|+||+||+|.+..+++.||||+++.. .........|+.+++.+.|. +++++.+++...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3447899999999999999999999999999999642 12234456677777777554 477887777543
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCC---------
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIG--------- 167 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~--------- 167 (296)
...+++|++++ |++|.+++...+.+++..+..++.|++.||.|||+ .| |+||||||+|||++.+..
T Consensus 204 -~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 -TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred -CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccc
Confidence 35788999988 55888888888889999999999999999999998 59 999999999999987621
Q ss_pred ------ceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022479 168 ------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240 (296)
Q Consensus 168 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~ 240 (296)
.+||+|||.+..... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998764322 2334678999999997664 4899999999999999999999999876654433222
Q ss_pred HhC--CCC-----------------------CC--------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 241 VTG--GVK-----------------------PQ--------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 241 ~~~--~~~-----------------------~~--------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
... ..+ +. .......+.+.+||.+||+ ||++|||+.++|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 111 000 00 0000123567899999998 9999999999999
Q ss_pred CcccccccCC
Q 022479 281 DPFFSELNDD 290 (296)
Q Consensus 281 hp~~~~~~~~ 290 (296)
||||.++..+
T Consensus 438 Hp~~~~~~~~ 447 (467)
T PTZ00284 438 HPYVLKYYPE 447 (467)
T ss_pred CccccccCCc
Confidence 9999986543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=308.86 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=210.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 105 (296)
++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+..|..++..+.| ++++++.+++... +.+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEE
Confidence 5789999999999999999999999999999854321 22334567788888888865 5677787777544 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-c
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-H 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-~ 184 (296)
|||+++++|..++...+.+++.++..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++...... .
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCc
Confidence 999999999999998888999999999999999999999999 9999999999999998 89999999998754322 2
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
......+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+............... ..+...+.++.+++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHH
Confidence 2334568899999997764 488999999999999999999999987665554444443322 223446889999999
Q ss_pred HHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 264 KCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 264 ~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
+||+ +|.+|++ ..++++||||+.++|.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 9997 9999997 5799999999998863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=321.01 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=210.8
Q ss_pred ccceeeecccCcceEEEeeecCC-CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
|.+.+.||.|++|.||+|.+..+ +..+|+|.+... +......+.+|+.+++.++||||+++++.+... ..+|+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 57899999999999999998877 788999877533 344456778899999999999999999998665 68999
Q ss_pred EeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 105 ITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
||||+.+++|.+++.. ..++++.++..++.|++.||.|||+++ ++||||||+||+++.+ +.++|+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCceec
Confidence 9999999999887653 456899999999999999999999999 9999999999999998 89999999999876
Q ss_pred CCCc---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.... .....++++.|+|||++.+ .++.++|||||||++|+|++|..||......+...........+ .+...+.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~s~ 297 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCPVSS 297 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCccCCH
Confidence 4322 2334568999999997764 48899999999999999999999998766655555544443322 2334678
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++.+++.+||. ||++||++.+++.|||++..
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999997 99999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=312.44 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=207.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---- 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 98 (296)
.+| .+.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++|+||+++++++....
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 15 ERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 455 678999999999999999999999999999875422 2233456778999999999999999998775332
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...++++++++ +++|..++.. ..+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCccce
Confidence 14578889987 5688877764 45999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
..... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+.........+
T Consensus 167 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 76432 234567889999997764 47889999999999999999999998755444333322111000
Q ss_pred ------------CC-------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 ------------QA-------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 ------------~~-------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.. .....++.+.+|+.+||. ||.+|||+.++|.||||..+..++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~ 310 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE 310 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccc
Confidence 00 001235678899999998 99999999999999999988766543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=303.68 Aligned_cols=256 Identities=21% Similarity=0.366 Sum_probs=209.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.+..+++.+|+|.+...... .......+.+|+.++++++|++++++.+.+... +.++++|
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence 4678999999999999999999999999998754332 223345667899999999999999999888554 6899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence 999999999888643 35899999999999999999999999 9999999999999998 799999999987654433
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......++..|+|||.+.+ .++.++|+||+|+++|+|++|..||...... +......... . .......+.++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~ 234 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-Q-EEYSEKFSPDARS 234 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-h-hhcCccCCHHHHH
Confidence 3344568899999997754 4889999999999999999999999764321 2222221111 1 1233446889999
Q ss_pred HHHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
|+.+||+ ||++||| ++++++||||+.+.+.
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 9999998 9999999 9999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=302.10 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=215.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+.||+|++|.||++.+..+++.+|+|+++..... .....+.+.+|+++++++.|+||+++++.+... ..++++|
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 80 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLVM 80 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEEE
Confidence 5789999999999999999999999999999754331 233457788999999999999999999998655 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+.+++|.+++.....+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--C
Confidence 99999999999998888999999999999999999999999 9999999999999998 89999999999876543 3
Q ss_pred ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
....+++.|+|||.+. ...+.++|+||||+++|+|++|..||............. .+. ...+...+..+++++++|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGK--VRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCC--ccCCccCCHHHHHHHHHH
Confidence 3446788999999765 447889999999999999999999998755433333333 222 122334588999999999
Q ss_pred Hh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 266 IA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 266 l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
|. ||.+|+ ++.++++||||+...|.+
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 97 999999 999999999999988654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.59 Aligned_cols=250 Identities=27% Similarity=0.556 Sum_probs=208.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.++.+++.+++|++..... .....+.+.+|++++++++|+|++++.+.+... ...+++++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 689999999999999999999999999999975443 344456788999999999999999998876432 35789999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS- 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~- 183 (296)
||+++++|.+++.. ...+++.+++.++.|++.++++||+.| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 99999999999875 346899999999999999999999999 9999999999999988 89999999998766432
Q ss_pred cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
.......+++.|+|||.+.+ ..+.++|+||||++++++++|+.||...+............. +. .....++.+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PP-MPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CC-CccccCHHHHHHH
Confidence 22333457889999997654 488899999999999999999999987655444444333322 22 2344688999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+||+ ||++||++.++++||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99997 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=299.21 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=212.4
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||.||++.+..++..+++|.+... .......+.+|+.+++.++|+|++++++.+... ...+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence 46788999999999999999999999999998643 344467788999999999999999999988655 689999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-
Q 022479 106 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS- 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~- 183 (296)
+||+.+++|..++.. ...+++..+..++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence 999999999887754 457999999999999999999999999 9999999999999998 79999999998765332
Q ss_pred cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 184 HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.......++..|+|||.+. ..++.++|+||+|+++|+|++|..||......+...............+...+.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 1223345788999999763 2367899999999999999999999987666555555544333322333446889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+.+++.+||+ ||.+||++.++++||||.....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 9999999997 9999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=310.00 Aligned_cols=259 Identities=20% Similarity=0.331 Sum_probs=210.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.++.+++.+|+|++...... .......+..|+.++..++|++++++++.+.+. ..+++||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEE
Confidence 6789999999999999999999999999999643221 223345678899999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccCCc
Confidence 99999999999976 467899999999999999999999999 9999999999999988 899999999987543222
Q ss_pred -ccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCC
Q 022479 185 -AAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL--NKVKD 255 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 255 (296)
......+++.|+|||++. +.++.++|+||||+++|+|++|+.||......+............... ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 223356899999999764 347889999999999999999999998766555555444332221111 23458
Q ss_pred hHHHHHHHHHHh---CCCCCCCHHHHhcCcccccccCCC
Q 022479 256 PEVKAFIEKCIA---QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 256 ~~l~~li~~~l~---~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.++++|+.+|+. ++..|++++++++||||+.++|+.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 899999999995 344478999999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=307.81 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=204.8
Q ss_pred ceeeeccc--CcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 28 YSDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 28 ~~~~lg~g--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+.++||+| ++++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++.+..+ +..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 56789999 678999999999999999999975533 344566788899999999999999999998765 689999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||+.+++|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.+ +.+++.||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccc
Confidence 999999999999865 345899999999999999999999999 9999999999999998 79999999865432111
Q ss_pred c--------ccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-----
Q 022479 184 H--------AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP----- 247 (296)
Q Consensus 184 ~--------~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----- 247 (296)
. ......++..|+|||++.+ .++.++|+|||||++|+|++|..||.................+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence 0 0112234567999997753 47899999999999999999999997654433333322221100
Q ss_pred --------------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 248 --------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 248 --------------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.......++.+.+|+.+||+ ||++|||+.++++||||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00011235689999999998 999999999999999999876
Q ss_pred CCCC
Q 022479 289 DDDS 292 (296)
Q Consensus 289 ~~~~ 292 (296)
..+.
T Consensus 315 ~~~~ 318 (327)
T cd08227 315 RRAS 318 (327)
T ss_pred hhhh
Confidence 5443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=298.26 Aligned_cols=256 Identities=29% Similarity=0.513 Sum_probs=214.2
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||.|++|.||++.+..+++.+++|++.... .......+.+|+++++.++|+|++++.+.+.++ ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (274)
T cd06609 2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW 75 (274)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence 45 57899999999999999999999999999997543 233346678999999999999999999988665 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+++||+.+++|.+++... ++++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccc
Confidence 999999999999998876 7899999999999999999999999 9999999999999998 89999999999877543
Q ss_pred -cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 -HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||............ .....+.......+.++.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-PKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-hhcCCCCCcccccCHHHHHH
Confidence 22334456778999997664 4899999999999999999999999765544443333 23333333333268899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
+.+||. +|++||+++++++||||.+....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999997 99999999999999999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=300.83 Aligned_cols=259 Identities=21% Similarity=0.344 Sum_probs=211.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+..++||+|+||+||++.+..+++.+|+|.+...... .......+.+|++++++++|++++++.+.+... +.+++++
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 4578899999999999999999999999999754331 223345677899999999999999998888544 7899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|..++.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence 99999999888764 346999999999999999999999999 9999999999999988 799999999987654433
Q ss_pred ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 262 (296)
......++..|+|||.+. ..++.++|+||||+++|+|++|..||.................. ........+.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 334456889999999765 45889999999999999999999999875543332222221111 1223344678899999
Q ss_pred HHHHh-CCCCCCC-----HHHHhcCcccccccCCC
Q 022479 263 EKCIA-QPRARPS-----ASELLKDPFFSELNDDD 291 (296)
Q Consensus 263 ~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~~ 291 (296)
.+||+ ||++||+ +.+++.|+||+.+.++.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence 99998 9999999 89999999999986653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=300.09 Aligned_cols=257 Identities=28% Similarity=0.499 Sum_probs=215.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
..+| .+.++||.|++|+||++.+..+++.+++|.+..... ...+.+.+|+..++.++|+|++++++.+... +.
T Consensus 18 ~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 90 (296)
T cd06655 18 KKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVG--DE 90 (296)
T ss_pred cceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecC--ce
Confidence 3345 678999999999999999999999999999975432 2246778899999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++++||+.+++|..++... .+++.++..++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchhcc
Confidence 99999999999999988764 5899999999999999999999999 9999999999999988 899999999987654
Q ss_pred CCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
... ......++..|+|||.+.+ .++.++|+||||+++|++++|..||..........................+..+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 322 2233457789999997664 48899999999999999999999998876666655544443333334445688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+++.+||. ||.+||++.+++.||||+....
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999997 9999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=296.02 Aligned_cols=251 Identities=30% Similarity=0.543 Sum_probs=209.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-----HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+++.||+|++|.||+|.+..+++.+|+|.+........ ....+.+.+|+.++++++|+|++++++.+... ..
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--DH 80 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--Cc
Confidence 578999999999999999988899999999876543222 23456788999999999999999999988654 68
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.++++||+++++|.+++...+.+++..+..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence 8999999999999999998888999999999999999999999999 9999999999999988 799999999987664
Q ss_pred CCcc-------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 182 RSHA-------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 182 ~~~~-------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
.... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+............. ..+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPE-IPSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCc-CCcc
Confidence 2111 112346778999997654 4788999999999999999999999876655554443332 2222 2334
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+..+.+++++||+ ||.+||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 68899999999998 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=294.72 Aligned_cols=251 Identities=30% Similarity=0.567 Sum_probs=209.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.| .+.++||+|++|.||++.+..+++.+++|.+.... ....+.+|++++++++|+|++++++.+.+. ..
T Consensus 2 ~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~ 72 (256)
T cd06612 2 EEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TD 72 (256)
T ss_pred cccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--Cc
Confidence 3456 57899999999999999999889999999987431 167899999999999999999999998665 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++++||+.+++|.+++.. ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~ 149 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQL 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhc
Confidence 9999999999999999875 567899999999999999999999999 9999999999999998 79999999999876
Q ss_pred CCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
.... ......++..|+|||.+.+ ..+.++|+||||+++|+|++|+.||..........................+..+
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred ccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 5433 2233446788999997664 4888999999999999999999999875554443332222222222233456789
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+++.+||+ ||++|||+.++|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999998 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.41 Aligned_cols=249 Identities=30% Similarity=0.551 Sum_probs=209.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+.||+|++|.||++.++.+++.+++|.+..... .......+.+|++++++++|+|++++++.+... +.+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 467899999999999999999999999999976543 345567889999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++++|.+++... ..++...++.++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCcc
Confidence 999999999998763 57899999999999999999999999 9999999999999998 799999999987664432
Q ss_pred c-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 A-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
. .....+++.|+|||+..+ .++.++|+||||+++++|++|+.||................ .+. .....+..+.+++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC-CccccCHHHHHHH
Confidence 2 223457788999997664 47889999999999999999999998766544444433332 222 2225688999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+||+ +|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99997 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=297.72 Aligned_cols=251 Identities=26% Similarity=0.499 Sum_probs=208.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|++|.||+|.+..+++.+|+|+++... ......+.+|+.+++.++|+|++++++.+... +.+
T Consensus 9 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~ 81 (267)
T cd06645 9 EDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKL 81 (267)
T ss_pred HHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEE
Confidence 455 67899999999999999999999999999997542 22345678899999999999999999988655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++++||+++++|.+++...+.+++.++..++.|++.++.|||+.| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEccC
Confidence 999999999999999988888999999999999999999999999 9999999999999988 7999999999876543
Q ss_pred Cc-ccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC--CCCC
Q 022479 183 SH-AAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN--KVKD 255 (296)
Q Consensus 183 ~~-~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 255 (296)
.. ......++..|+|||.+. +.++.++|+||||+++|+|++|..||..................+.... ...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 21 223446788999999763 3478899999999999999999999976554444443333322222221 1346
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~ 283 (296)
..+.+++.+||+ +|++||++.+++.|||
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 789999999997 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=295.25 Aligned_cols=252 Identities=30% Similarity=0.493 Sum_probs=209.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccC--CCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
++++.||+|+||.||++.+. +++.+|+|.++..... ........+.+|++++++++|+|++++.+.+.+. ..+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEE
Confidence 57899999999999999864 6889999998754321 2234456789999999999999999999998655 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC--
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-- 182 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-- 182 (296)
++||+.+++|.+++.....+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhcc
Confidence 9999999999999988778999999999999999999999999 9999999999999988 8999999999875421
Q ss_pred -----CcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 -----SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 -----~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
........++..|+|||.+.+. .+.++|+||||+++|++++|..||...+......................+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1112234577889999977644 7889999999999999999999998765555444433332222233445689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
++.+++.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999997 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=308.90 Aligned_cols=259 Identities=19% Similarity=0.323 Sum_probs=210.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.++.+++.+|+|++...... .......+.+|..++..++|++|+++++.+.+. +.+|+||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv~ 80 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLVM 80 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence 6789999999999999999999999999999753221 233455688899999999999999999988554 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.|++|.+++.. ...+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCCCc
Confidence 99999999999986 567999999999999999999999999 9999999999999988 8999999999876643322
Q ss_pred --cccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--CCCCC
Q 022479 186 --AHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL--NKVKD 255 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 255 (296)
.....+++.|+|||++.+ .++.++|+||||+++|+|++|+.||......+............... ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 223568999999997653 47889999999999999999999998765554444443322211111 12357
Q ss_pred hHHHHHHHHHHh-CCCC--CCCHHHHhcCcccccccCCC
Q 022479 256 PEVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~--Rps~~~ll~hp~~~~~~~~~ 291 (296)
+++++++.+|+. ++++ |++++++++||||+.++|+.
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 899999999996 4333 57999999999999887643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=300.46 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=209.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.+..++..+|+|.+.... ......++.+|++++++++|+||+++++.+.++ +.+++++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICM 78 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEe
Confidence 67899999999999999999999999999987532 344566788999999999999999999998665 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++.....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCccccccc-c
Confidence 999999999999888889999999999999999999997 58 9999999999999998 79999999998755322 2
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------------
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---------------------- 242 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~---------------------- 242 (296)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...+... ......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCc
Confidence 334567889999997654 47889999999999999999999996433211 111111
Q ss_pred --------------CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 243 --------------GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 243 --------------~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
....+.......+.++++++.+||. ||++||++.++++||||.+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 1111122222357789999999997 99999999999999999875444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=305.67 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=228.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.|.+.+.||+|.|++|-+|.+--+|+.||||++..... +......+.+|++.++.+.||||+++|++. +....+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEE
Confidence 334789999999999999999999999999999987766 455567788999999999999999999987 4447899
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++.|.-.+|.|.+|+-++ ..+.+...++++.||+.|+.|+|+.. +|||||||+|+.+-..-|-+||.|||++..+..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999998654 46999999999999999999999999 999999999999887779999999999999988
Q ss_pred CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.......||...|.|||++-+. -.++.||||||+|+|.+++|++||...++.+.+--++ .+. ...+...+.+-++
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-DCK--YtvPshvS~eCrd 248 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-DCK--YTVPSHVSKECRD 248 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-ccc--ccCchhhhHHHHH
Confidence 8888899999999999977655 4567999999999999999999999877766654433 322 2234556899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
||.+||. ||++|.|.+++..|+|++..+...+-
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 9999997 99999999999999999999887654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=303.04 Aligned_cols=260 Identities=23% Similarity=0.389 Sum_probs=215.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|+||+|.+..+++.+|+|.+...... .....+.+..|++++++++|++++++++.+... ...++++
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 80 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCLVM 80 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEEEE
Confidence 6789999999999999999999999999999865432 234567789999999999999999999988544 7899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 999999999998753 57899999999999999999999999 9999999999999998 899999999886543211
Q ss_pred c------------------------------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022479 185 A------------------------------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233 (296)
Q Consensus 185 ~------------------------------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 233 (296)
. .....++..|+|||.+.+ ..+.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 112245778999997654 488899999999999999999999987666
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCC----HHHHhcCcccccccCCCCC
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPS----ASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps----~~~ll~hp~~~~~~~~~~~ 293 (296)
.............. ......+..+++++.+||. ||++||+ +.+++.||||+..+|..-+
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 238 DETFSNILKKEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred HHHHHHHhcCCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 55555544332221 1122258899999999997 9999999 9999999999999887654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=307.21 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=200.1
Q ss_pred CCcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
++| ++.++||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++++ +|+||+++++.+..
T Consensus 7 ~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 7 DRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 355 7899999999999999975 2345789999987432 233456788999999999 89999999998764
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc-------------------------------------------------------
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH------------------------------------------------------- 121 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------------------------------------- 121 (296)
. ...++++|||+++|+|.+++...
T Consensus 83 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 P-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred C-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 4 35789999999999999988642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc---ccccCCC
Q 022479 122 -------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIG 191 (296)
Q Consensus 122 -------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~ 191 (296)
..+++.++..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||+++...... ......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCC
Confidence 24778888999999999999999999 9999999999999988 799999999997653221 1222334
Q ss_pred CCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-C
Q 022479 192 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q 268 (296)
Q Consensus 192 ~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~ 268 (296)
+..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.....+..+.... .+...++++.+|+.+||+ |
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQGD 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHccCC
Confidence 57899999765 458999999999999999997 9999987654444444444443332 344568899999999997 9
Q ss_pred CCCCCCHHHHhc
Q 022479 269 PRARPSASELLK 280 (296)
Q Consensus 269 p~~Rps~~~ll~ 280 (296)
|++|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=303.33 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=191.2
Q ss_pred ceeeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+++||+|+||+||+|.++ .+++.+|+|.+..... ...+.+|+.++++++|+||+++++.+.......++++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred cccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 3678999999999999965 3678899999874422 2346789999999999999999999876666789999
Q ss_pred eeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC---CCCceEEec
Q 022479 106 TEVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGD 173 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~---~~~~~~l~d 173 (296)
+||+.+ +|..++... ..+++..++.++.|++.||.|||++| ++|+||||+||++.. ..+.++|+|
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 999876 777776532 25899999999999999999999999 999999999999942 226899999
Q ss_pred cCCccccCCCc----ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 022479 174 LGFAAIVGRSH----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---------VAKIY 238 (296)
Q Consensus 174 fg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---------~~~~~ 238 (296)
||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||..... ...+.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 99997764321 2234567889999997754 378899999999999999999999964321 11111
Q ss_pred HHHhCC--CC----------C-----------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCc
Q 022479 239 KKVTGG--VK----------P-----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDP 282 (296)
Q Consensus 239 ~~~~~~--~~----------~-----------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp 282 (296)
...... .. + .......+..+.+|+.+||+ ||++|||++++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 110000 00 0 00001124568899999998 999999999999999
Q ss_pred cc
Q 022479 283 FF 284 (296)
Q Consensus 283 ~~ 284 (296)
||
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=292.92 Aligned_cols=251 Identities=28% Similarity=0.524 Sum_probs=212.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.+..+++.+|+|++..... .....+++.+|++++++++|+|++++++.+.......+++++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 578999999999999999999999999999976543 455567888999999999999999999988766667899999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 107 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLH-----THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 107 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH-----~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
||+.+++|.+++.. ...+++..++.++.|++.||.+|| +.+ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEeccccc
Confidence 99999999998865 467999999999999999999999 888 9999999999999988 89999999999
Q ss_pred cccCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
........ .....+++.|+|||.+.+ ..+.++|+||||+++++|++|..||..... ......+..... .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKF-RRIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHHHhcCCC-CCCccccC
Confidence 87755433 334567889999997664 478899999999999999999999987653 334444433332 23344568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
..+.+++.+||+ +|++||++.++++|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 899999999997 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=297.79 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=206.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.++.+++.+|+|++..... .....+.+.+|+.++++++|+|++++++.+... ..+++++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~ 79 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLVF 79 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEEE
Confidence 678999999999999999999999999999875432 222345678899999999999999999998655 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-c
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~ 185 (296)
||+++++|..+......+++.++..++.|++.+|+|||+.| ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence 99999999888877777999999999999999999999999 9999999999999988 899999999998764433 2
Q ss_pred cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------------------
Q 022479 186 AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV------------------ 245 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------ 245 (296)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+..........
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223446778999997654 378899999999999999999999987665555443322100
Q ss_pred ----CCC------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 246 ----KPQ------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 246 ----~~~------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+. ......+..+.+|+.+||+ +|++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0012246789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=295.91 Aligned_cols=256 Identities=26% Similarity=0.490 Sum_probs=210.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
.+.++| ++.+.||+|++|.||+|.++.+++.+++|++.... ...+.+.+|+.+++++ .|+|++++++.+....
T Consensus 3 ~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred Cchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 345666 68999999999999999999889999999987542 2346788999999999 7999999999987643
Q ss_pred ----CCeEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 99 ----HNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 99 ----~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
...+++++||+.+++|.+++.. +..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEE
Confidence 3568999999999999988764 457999999999999999999999999 9999999999999998 8999
Q ss_pred EeccCCccccCCCc-ccccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 022479 171 IGDLGFAAIVGRSH-AAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 171 l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~ 243 (296)
|+|||.+....... ......++..|+|||.+.. .++.++|+||||++++++++|..||...............
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99999987654322 2233457788999997642 3677899999999999999999999866555555554443
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
...........+.++++|+.+||. ||++|||+.++++|||+
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 322222222356789999999997 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=297.79 Aligned_cols=253 Identities=31% Similarity=0.566 Sum_probs=211.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.++.+++.+++|.+.... .......+.+|++++++++|+|++++++.+... ..+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 56889999999999999999999999999987543 234567788999999999999999999988655 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.++++||+ .+ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhHHHH
Confidence 999999999999875 789999999999999999999999 89 9999999999999998 899999999987653322
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
. ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||... ...............+.......+.++.
T Consensus 156 ~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred h-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 1 12667788999997654 4889999999999999999999999754 2222333333343333333333688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
++|.+||. ||++|||+.+++.||||+.+.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 99999997 999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.12 Aligned_cols=255 Identities=25% Similarity=0.519 Sum_probs=209.0
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
++.++| ++.++||+|+||.||++.++.+++.+|+|++..... ....+.+|+.+++++ +|+|++++.+.+....
T Consensus 3 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred Chhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 456677 578999999999999999999999999999975421 135677899999998 6999999999887542
Q ss_pred ----CCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 99 ----HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 99 ----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
...+++++||+.+++|.+++... ..+++..+..++.|++.|++|||+++ ++|+||+|+||+++.+ +.++|+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEc
Confidence 24689999999999999998863 46899999999999999999999999 9999999999999998 799999
Q ss_pred ccCCccccCCC-cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 022479 173 DLGFAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 173 dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
|||++...... .......++..|+|||++. ..++.++|+||+|+++|+|++|..||.............. ..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-~~ 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NP 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-CC
Confidence 99998765432 2233456788999999764 2377899999999999999999999976554444443322 22
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.........+.++.+|+.+||. ||.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2233334467899999999997 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=295.19 Aligned_cols=251 Identities=29% Similarity=0.529 Sum_probs=206.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.+..+++.+|+|++.... .......+.+|++++++++|+|++++++.+... +..++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 57899999999999999999999999999987542 344556788999999999999999999998765 6889999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+++++|..+ ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cc
Confidence 99999998654 24789999999999999999999999 9999999999999998 89999999999765433 23
Q ss_pred ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV------AKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
....++..|+|||.+. ..++.++|+||||+++|+|++|..||...... ............+.......+.++.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 3456788999999765 45889999999999999999999999642211 1222222222222223334578999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
+++.+||+ +|++||++.++++||||...+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 99999997 99999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=293.74 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=203.2
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHH-HHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
+.||+|++|.||+|.+..+++.+|+|+++...... ......+..|..+ ....+|+|++++++.+... +.+++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 56999999999999999899999999987543211 1222333444444 4455899999999998544 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~ 188 (296)
+.+++|.+++.....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||++..... ...
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~ 152 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKK 152 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc---ccc
Confidence 999999999998888999999999999999999999999 9999999999999998 7999999998876433 223
Q ss_pred CCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChHHHHHHHHHH
Q 022479 189 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 266 (296)
..++..|+|||.+.+. ++.++|+||||+++|+|++|..||.................. +.......+..+.+++.+||
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 4567789999976544 788999999999999999999999876554444333332221 12223346889999999999
Q ss_pred h-CCCCCC---CHHHHhcCcccccccCC
Q 022479 267 A-QPRARP---SASELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rp---s~~~ll~hp~~~~~~~~ 290 (296)
. +|++|| ++++++.||||++++|+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 7 999999 55899999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=292.53 Aligned_cols=251 Identities=27% Similarity=0.509 Sum_probs=210.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| ++.++||+|++|.||+|.+..+++.+++|++..... ...+.+.+|++++++++|+|++++++.+... ..+
T Consensus 3 ~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 75 (262)
T cd06613 3 EDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKL 75 (262)
T ss_pred cce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEE
Confidence 455 678999999999999999998999999999986532 2467888999999999999999999988655 689
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++|||+.+++|.+++... ..+++.++..++.|++.||++||+++ ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~ 152 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhhh
Confidence 9999999999999998775 78999999999999999999999999 9999999999999988 899999999987764
Q ss_pred CCc-ccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCC
Q 022479 182 RSH-AAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKVK 254 (296)
Q Consensus 182 ~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 254 (296)
... ......++..|+|||.+.+ ..+.++|+||||+++|+|++|..||.+................+.. .....
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 332 2233456778999997653 5788999999999999999999999876655555544443222211 12234
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~ 283 (296)
+.++.+++.+||. +|.+|||+.+++.|+|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6789999999997 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=290.91 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=211.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.++.+++.+|+|.+..... .......+.+|++++++++|++++++++.+... ..+++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVM 78 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEE
Confidence 678999999999999999999999999999976543 344567899999999999999999999988544 7899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++++|.+++.. ...+++..+..++.|++.++.+||++| ++|+||+|+||+++.+.+.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999976 345899999999999999999999999 99999999999998764578999999998776554
Q ss_pred ccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
......++..|+|||.+.+. .+.++|+||||+++|+|++|..||...+.............. ......+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 234 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PISDRYSPDLRQLIL 234 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CCCCCcCHHHHHHHH
Confidence 44455678899999977644 788999999999999999999999876555444444333222 223446889999999
Q ss_pred HHHh-CCCCCCCHHHHhcCccc
Q 022479 264 KCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.||. +|.+|||+.+++.||||
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHccCChhhCCCHHHHhhCCCC
Confidence 9997 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=297.27 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=201.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.++.+++.||+|+++.... +......+.+|+.++++++|+|++++++.+.++ ..+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 578999999999999999998999999999875432 223346677899999999999999999998654 6899999
Q ss_pred eccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 107 EVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||+.+ +|.+++.. +..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCCC
Confidence 99985 78888764 256899999999999999999999999 9999999999999998 89999999998765432
Q ss_pred cc-cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--------------
Q 022479 184 HA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-------------- 246 (296)
Q Consensus 184 ~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------- 246 (296)
.. .....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 21 223356788999997654 3688999999999999999999999876554443332211000
Q ss_pred ------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
........+.++.+++.+||. ||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000112357889999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=295.68 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=208.4
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC-
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ- 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~- 98 (296)
+.++| .+.+.||+|+||.||++.++.+++.+|+|++.... .....+.+|+.+++++ +|+|++++++.+....
T Consensus 20 ~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 45566 68999999999999999999999999999986432 2235667889999998 8999999999886542
Q ss_pred --CCeEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 99 --HNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 99 --~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
...+++++||+.+++|.+++. .+..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEe
Confidence 256899999999999998875 3467899999999999999999999999 9999999999999998 799999
Q ss_pred ccCCccccCCCc-ccccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 022479 173 DLGFAAIVGRSH-AAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 173 dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
|||.+....... ......++..|+|||.+.. ..+.++|+||||+++|+|++|+.||........+........
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999987654322 1233457788999997643 257899999999999999999999987665555554433332
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
.........+..+.+++.+||+ +|++||++.++++||||+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2222233356789999999997 999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=297.22 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=207.9
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|+||+||+|.++.+|+.+++|++...... .......+..|++++++++|++++++.+.+... +.+|+++||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 69999999999999999999999999754322 222345667899999999999999999888544 689999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccC
Q 022479 112 GNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189 (296)
Q Consensus 112 ~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~ 189 (296)
++|.+++.... .+++.++..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||.+............
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence 99999987654 7999999999999999999999999 9999999999999998 79999999998776543333445
Q ss_pred CCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 190 IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 190 ~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
.++..|+|||.+. +.++.++|+||||+++++|++|+.||..... ...+...... .+.......++.+.+++.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 5677899999765 4488899999999999999999999976443 1222221111 12233344588999999999
Q ss_pred Hh-CCCCCC-----CHHHHhcCcccccccCCCCC
Q 022479 266 IA-QPRARP-----SASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 266 l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~~ 293 (296)
|+ ||.+|| ++.+++.||||..++|....
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 97 999999 88999999999999985443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=294.89 Aligned_cols=255 Identities=25% Similarity=0.467 Sum_probs=208.0
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
....+.| ++.+.||+|+||.||++.++.+++.+|+|++..... .....+.+|+.++++++|+|++++++.+...
T Consensus 5 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~- 78 (267)
T cd06646 5 RNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR- 78 (267)
T ss_pred cCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Confidence 3444556 689999999999999999999999999999975422 2235677899999999999999999998655
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++++||+.+++|.+++.....+++.++..++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 79 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~ 154 (267)
T cd06646 79 -EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAA 154 (267)
T ss_pred -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccce
Confidence 689999999999999999988788999999999999999999999999 9999999999999988 799999999998
Q ss_pred ccCCCc-ccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC--C
Q 022479 179 IVGRSH-AAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL--N 251 (296)
Q Consensus 179 ~~~~~~-~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 251 (296)
...... ......++..|+|||.+. ...+.++|+||+|+++|+|++|..||..................+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 664322 223345778999999763 337789999999999999999999997554443333222222222111 1
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~ 283 (296)
...+..+.+++.+||. +|++|||++++++|+|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 2347899999999997 9999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=300.53 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=198.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||+|.++.+|+.+|+|.++.... .......+.+|+.++++++|+|++++++.+.+. ..+++++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 578999999999999999999999999999976432 222335677899999999999999999998654 6899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+ +|.+++.. ...+++..++.++.|+++||.+||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence 99986 67776654 567999999999999999999999999 9999999999999998 899999999987654322
Q ss_pred ccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC-C--------------CC-
Q 022479 185 AAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-G--------------VK- 246 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~-~--------------~~- 246 (296)
......++..|+|||.+.+. ++.++|+||||+++|+|++|..|+....+.......+.. . ..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334567889999976543 688999999999999999998886433332222211110 0 00
Q ss_pred ---C--------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ---P--------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ---~--------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+ .......+.++++++.+||+ ||.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112346889999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=288.85 Aligned_cols=249 Identities=28% Similarity=0.503 Sum_probs=212.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||.|+||.||.+.+..+++.+++|.+..... +......+.+|+.++++++|+|++++++.+.+. ..+++++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 678999999999999999999999999999876543 344567788999999999999999999999664 7899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++.++..++.|++.+|++||+.| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEccccc
Confidence 999999999999764 56899999999999999999999999 9999999999999998 799999999987764433
Q ss_pred -ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 -AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......+++.|.|||.+.+ .++.++|+||||+++|+|++|..||......+...........+ .....+.++.+++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i 233 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--VVSVYSSELISLV 233 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CccccCHHHHHHH
Confidence 2334557889999997664 47889999999999999999999998766555555554443332 2245688999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
..||. +|.+||++.++++|||+
T Consensus 234 ~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 234 HSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHcccCcccCCCHHHHhhCcCC
Confidence 99997 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=306.11 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=209.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.+.||+|+||+||++.+..+++.+|+|.+..... +......+.+|+.++++++|+|++++++++....
T Consensus 15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3455 678999999999999999999999999999864322 3344566778999999999999999999875432
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
....++|+||+.+ +|.+.+... +++..+..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccc
Confidence 2457999999976 787777653 899999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
.............++..|+|||.+. ..++.++|+||||+++|+|++|+.||...+..............+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 8765544344456788999999765 458999999999999999999999997655433322221110000
Q ss_pred ------------C-------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 248 ------------Q-------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 248 ------------~-------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
. ......++.+++++.+||+ ||++|||+.++|.||||+.+-++.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~ 324 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVE 324 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCC
Confidence 0 0011235678999999998 999999999999999998766654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=292.30 Aligned_cols=254 Identities=30% Similarity=0.577 Sum_probs=215.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||+|.++.+++.+++|++..... ......+.+|++.+++++|+|++++++.+... ..+++++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 578999999999999999999999999999875432 24567889999999999999999999998655 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++.....+++..+..++.|++.++++||+ .+ ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccCCC
Confidence 999999999999987889999999999999999999999 99 9999999999999998 8999999999987644332
Q ss_pred c-ccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 A-HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 ~-~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ....++..|.|||.+.+. .+.++|+||||+++|+|++|..||.... ........+.....+.......+..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2 234567889999976644 7889999999999999999999997764 44444444444433333333368899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+++||. +|++||++.++++||||+.++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 999997 999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=294.68 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=203.3
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~~lv~e 107 (296)
..||+|+++.||++.. +|+.||+|+++.... ......+.+.+|+.++++++||||+++++++.+ +....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5799999999999977 589999999975432 234556788999999999999999999999877 44467899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
|+.+++|.+++.....++......++.|++.||.+||+. + ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhcccc--
Confidence 999999999999888899999999999999999999985 8 8899999999999998 899999999987654322
Q ss_pred ccCCCCCCccCccccc---cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
....++..|+|||++. +.++.++||||||+++|+|++|..||.+....+............. .+...+.++.+++.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~ 256 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-LPLDCPLEIKCIVE 256 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-CCCcCcHHHHHHHH
Confidence 2345678999999775 3589999999999999999999999987665444444433433332 33346899999999
Q ss_pred HHHh-CCCCCCCHHHHhc
Q 022479 264 KCIA-QPRARPSASELLK 280 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~ 280 (296)
+||+ ||++|||+.++++
T Consensus 257 ~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 257 ACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHhcCCcccCcCHHHHHH
Confidence 9998 9999999999987
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=292.42 Aligned_cols=250 Identities=29% Similarity=0.501 Sum_probs=208.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||.|++|+||++.+..++..+++|++..... ....+.+.+|+..++.++|++++++++.+... +.+++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 679999999999999999988999999999875433 22567889999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 107 EVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|++.+++|.+++... ..+++..+..++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhccC
Confidence 999999999998763 45899999999999999999999999 9999999999999998 79999999998766433
Q ss_pred ccc-----ccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC---CCC
Q 022479 184 HAA-----HSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL---NKV 253 (296)
Q Consensus 184 ~~~-----~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 253 (296)
... ....++..|+|||.+.. ..+.++|+||||+++++|++|+.||...................... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 221 23356788999997654 48899999999999999999999998765555444444432221111 124
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+.++.+++.+||. ||++||++.+++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 57889999999997 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=296.97 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=212.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||.||++.++.+++.|++|.+..... ........+.+|+.+++.++|+||+++++.+..+ ..++++|
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEEE
Confidence 678999999999999999999999999999875432 1233456788999999999999999999888544 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc--
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-- 184 (296)
||+.|++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcCccc
Confidence 99999999999988888999999999999999999999999 9999999999999988 899999999876321000
Q ss_pred --------------ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 185 --------------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 185 --------------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
......++..|+|||.+. +..+.++|+||||+++|++++|..||.+....+..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011124567899999665 45899999999999999999999999876555444444443322222
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCC---HHHHhcCcccccccCCC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPS---ASELLKDPFFSELNDDD 291 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps---~~~ll~hp~~~~~~~~~ 291 (296)
.....+..+.+++.+||+ ||++||+ +.++|+||||...++..
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 233568899999999998 9999997 89999999998887754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=290.15 Aligned_cols=255 Identities=30% Similarity=0.540 Sum_probs=214.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeeccc-CCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
|++.+.||+|++|.||++.++.+++.+++|.+..... .........+.+|+.++++++|+|++++++.+.+.....+++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 3679999999999999999999999999999864321 123455678999999999999999999999887665578899
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
++||+++++|.+++...+.+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcccccccccccc
Confidence 9999999999999988777999999999999999999999999 9999999999999988 799999999997653211
Q ss_pred ----ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 185 ----AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 185 ----~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
......++..|+|||.+.+ ..+.++|+||||+++|++++|..||..........+....... ...+...++++.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-PMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-CCCCcccCHHHH
Confidence 1123456788999997764 4889999999999999999999999877666666655443333 334555688999
Q ss_pred HHHHHHHhCCCCCCCHHHHhcCccc
Q 022479 260 AFIEKCIAQPRARPSASELLKDPFF 284 (296)
Q Consensus 260 ~li~~~l~~p~~Rps~~~ll~hp~~ 284 (296)
+++.+||++|..||++.+++.|||.
T Consensus 240 ~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhcCcccCccHHHHhcCCCC
Confidence 9999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=289.37 Aligned_cols=252 Identities=33% Similarity=0.539 Sum_probs=212.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeeccc-CCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+.+++||+|++|.||+|.++.+++.+++|.+..... .......+.+.+|+.++++++|++++++++.+... ..++++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 80 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIF 80 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEE
Confidence 568999999999999999998899999999976432 12345567899999999999999999999988544 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+||+++++|.+++.....+++..+..++.|++.++++||+.| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence 999999999999988888999999999999999999999999 9999999999999988 7999999999887654443
Q ss_pred cccCCCCCCccCccccc-cC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYE-ED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~-~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.....++..|++||.+. .. ++.++|+||||+++|++++|..||.................. .......+..+.+++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 236 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKDFIL 236 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-CCcCCCcCHHHHHHHH
Confidence 44456788899999654 33 789999999999999999999999776655555444332222 2233446889999999
Q ss_pred HHHh-CCCCCCCHHHHhcCccc
Q 022479 264 KCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+||. +|.+||++.+++.|||+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHhhcCcccCcCHHHHhcCCCC
Confidence 9997 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=298.01 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
..+| .+.++||+|++|.||++.++.+++.||+|.++...... ....+.+|+.++++++|+||+++++.+..+ ..
T Consensus 5 ~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~ 78 (301)
T cd07873 5 LETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTE--KS 78 (301)
T ss_pred ccce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chhHHHHHHHHHHhcCCCCcceEEEEEecC--Ce
Confidence 3456 67899999999999999999999999999997543221 234566899999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++++||+.+ +|..++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAK 154 (301)
T ss_pred EEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhcc
Confidence 9999999985 88887764 456899999999999999999999999 9999999999999998 79999999998765
Q ss_pred CCCc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----------
Q 022479 181 GRSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----------- 246 (296)
Q Consensus 181 ~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------- 246 (296)
.... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+...........
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3322 2233456789999997654 3788999999999999999999999876544333221111000
Q ss_pred ---------CC-------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 247 ---------PQ-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 247 ---------~~-------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+. ......++.+++||.+||. ||.+|||+.++++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0112347789999999998 999999999999999998775
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=293.01 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=207.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC--CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
+.++.||+|++|.||++.+..+++.+|+|++....... .....+.+.+|++++++++|+|++++++.+.+. ..+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEE
Confidence 56899999999999999999999999999997543211 233567899999999999999999999998554 68999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
++||+.+++|.+++....++++..+..++.|++.||++||++| ++|+||+|+||+++.+...++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999988888999999999999999999999999 99999999999998773469999999987764321
Q ss_pred c-----cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCCC
Q 022479 185 A-----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 185 ~-----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
. .....++..|+|||.+.+ .++.++|+||||++++++++|..||..... ........... .....+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-TAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-CCCCCchhhC
Confidence 1 122346778999997654 488999999999999999999999964332 12222222222 2223334567
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
.++.+++.+||. +|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999997 999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=295.08 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=200.5
Q ss_pred eecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHH---HHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ---LLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+||+|+||.||++.+..+++.+|+|++......... ....+.++.. ++...+|++++.+.+.+..+ +..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence 489999999999999999999999999765432221 1222333433 34445799999998888554 67999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccc
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~ 187 (296)
|+.+++|..++...+.+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~ 153 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PH 153 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-cc
Confidence 9999999999988888999999999999999999999999 9999999999999988 799999999987654322 23
Q ss_pred cCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 188 SIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
...++..|+|||.+. ...+.++|+||+|+++|+|++|..||..... ......... . .....+...+.++++++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T-VNVELPDSFSPELKSLLE 231 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-c-CCcCCccccCHHHHHHHH
Confidence 346788999999765 3478999999999999999999999975322 122222211 1 122334456899999999
Q ss_pred HHHh-CCCCCC-----CHHHHhcCcccccccCCCC
Q 022479 264 KCIA-QPRARP-----SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 264 ~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~ 292 (296)
+||+ ||.+|| |+.++++||||+.+.+...
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 9997 999999 6999999999999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=297.04 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=211.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.++||+|++|.||+|.++.+++.|++|.+....... .......+..|++++++++|+|++++++.+.+. ..+++|
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 80 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINLV 80 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEEE
Confidence 56889999999999999999899999999998654421 123445677899999999999999999998664 789999
Q ss_pred eeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|||+ +++|.+++.... .+++..+..++.|+++||.+||++| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCCC
Confidence 9999 889999998765 7999999999999999999999999 9999999999999998 899999999998765432
Q ss_pred -ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------------
Q 022479 185 -AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------------- 247 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 247 (296)
......++..|.|||.+.+ .++.++|+||||+++++|++|..||....+.+...........+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 2223345678999997653 47889999999999999999988887665544433332211000
Q ss_pred -----------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 -----------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 -----------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......+..+.+++.+||+ ||++|||+.+++.||||++...+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 00112236789999999998 99999999999999999998776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=298.16 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=210.7
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
...+| ++.+.||+|++|.||++.++.+|+.||+|+++..... ......+.+|+.++++++|+|++++++.+.+....
T Consensus 5 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 34455 6799999999999999999999999999999765432 12223456799999999999999999998766556
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++|+||+.+ +|.+++.. ...+++.++..++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~ 157 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLART 157 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeee
Confidence 78999999976 78777765 467899999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCCc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 180 VGRSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
..... .......+..|+|||.+.+ .++.++|+||||+++|+|++|..||......+.+.........+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 65432 1222334678999997754 37889999999999999999999998766655544433321100
Q ss_pred ------------CCC------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 248 ------------QAL------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 248 ------------~~~------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
... ....+.++.++|.+||+ ||++|||+++++.||||++..-+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 000 01236788999999998 9999999999999999986655433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=288.02 Aligned_cols=253 Identities=34% Similarity=0.600 Sum_probs=215.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.+..+++.+++|++..... .....+.+.+|+.++++++|++++++++.+.......+++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 568999999999999999998999999999976543 245678899999999999999999999998665447899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|.+++.....+++.+++.++.|++.+|++||+.+ ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEeccccccc
Confidence 99999999999998878999999999999999999999999 9999999999999998 8999999999987755432
Q ss_pred --cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
.....++..|.|||...+. .+.++|+||||+++++|++|..||......................+...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 3445678899999977644 8999999999999999999999998765333333333322233344455689999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+|++ ||.+||++.+++.||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99998 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.97 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=211.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||.|+||.||+|.++.+++.+|+|++..... ......+.+.+|++++++++|||++++++.+.+ ...+++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEEE
Confidence 678999999999999999999999999999985433 223456789999999999999999999988854 37899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+.+++|..++.....+++..+..++.|++++|.+||+++ ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence 99999999999988778999999999999999999999999 9999999999999998 89999999999876544344
Q ss_pred ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
....++..|.|||.+.+ ..+.++|+||||+++|+|++|..||..... .......... .....+...+..+.+++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 45567788999997664 478999999999999999999999986553 3333333332 222233345789999999
Q ss_pred HHHh-CCCCCCCH--HHHhcCccc
Q 022479 264 KCIA-QPRARPSA--SELLKDPFF 284 (296)
Q Consensus 264 ~~l~-~p~~Rps~--~~ll~hp~~ 284 (296)
+||+ ||.+||++ .+++.||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9997 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=298.32 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=217.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|+||.||+|+++.+|+.+|+|.+....- ...+..|+.+++++.++++++.||.+... ..+++||
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD------LQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVM 107 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD------LQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVM 107 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch------HHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeeh
Confidence 678999999999999999999999999999985432 57788899999999999999999999766 5699999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-Cc
Q 022479 107 EVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~-~~ 184 (296)
|||..||..+.+. .+.++++.++..+++..+.+|+|||... -+|||||..|||++.+ |..||+|||++..+.. ..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhhHH
Confidence 9999999999887 4678999999999999999999999999 8999999999999999 9999999999977643 33
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
......|||.|+|||++.. .+...+||||||+...+|..|++||.+..+..-+.-+-...++-...+...++++.++++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 4556789999999998875 499999999999999999999999988666554443333333333334556889999999
Q ss_pred HHHh-CCCCCCCHHHHhcCccccccc
Q 022479 264 KCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+||- +|++|.++.++++|||+++-.
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9995 999999999999999998754
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=293.63 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=206.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||+|.+..+|+.+++|++..... .......+.+|+.++++++|+|++++++.+..+ ..+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 78 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVM 78 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEe
Confidence 678999999999999999998999999999986543 234456788999999999999999999998654 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+ +++|.+++.. ...+++.+++.++.|++.+|++||+.+ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence 999 8999998864 466999999999999999999999999 9999999999999998 899999999988765432
Q ss_pred -ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-------------
Q 022479 185 -AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ------------- 248 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 248 (296)
......++..|+|||.+.+ ..+.++|+||||+++++|++|.+||.+..+.............+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 1333457889999997653 368899999999999999999988877655444433332111000
Q ss_pred --------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 249 --------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 249 --------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
......+.++.+++++||. ||.+||+++++++||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0011236889999999998 999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.91 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=193.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++|+||+++++.+... ...+
T Consensus 67 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 133 (357)
T PHA03209 67 GY-TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITC 133 (357)
T ss_pred Cc-EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeE
Confidence 44 7899999999999999999999999999985432 124588999999999999999998765 6788
Q ss_pred EEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+|++++.+ +|..++. ....+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||.+.....
T Consensus 134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCcccccccc
Confidence 99999976 6777765 4567999999999999999999999999 9999999999999998 7999999999976544
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCC-CCCChH---------HHHHHHHhC-CCCC-CC
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPY-SECDSV---------AKIYKKVTG-GVKP-QA 249 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~-~~~~~~---------~~~~~~~~~-~~~~-~~ 249 (296)
........++..|+|||++.+ .++.++|+|||||++|+|+++..++ ...... ..+...+.. ...+ ..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 333445568899999997764 5899999999999999999855444 321110 111111111 0000 00
Q ss_pred C-----------------------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 250 L-----------------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 250 ~-----------------------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
. ....+..+.+||.+||+ ||++|||+.++|+||||+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0 11235677789999998 99999999999999999864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=314.01 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=226.2
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
+|+|..-||.|+||.||+|.++.++-.-|.|++... +++..+.+.-|+++|..+.||+|+++++.|.-+ +.+++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwi 106 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWI 106 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEE
Confidence 446667789999999999999998888899998744 677789999999999999999999999988766 78999
Q ss_pred EeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-C
Q 022479 105 ITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-R 182 (296)
Q Consensus 105 v~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~ 182 (296)
+.|||.||-....+- -+..+++.++..+++|++.||.|||+++ |+|||||..|||++.+ |.++|+|||++.... .
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKST 183 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchhH
Confidence 999999998877654 5778999999999999999999999999 9999999999999999 999999999986542 2
Q ss_pred CcccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.....+..|||.|+|||++. ..|++++||||||+.+.+|..+.+|-...+++..+..+....++-...+...+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 23356678999999999664 348999999999999999999999999999999988888887766666667788
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.+.+++..||. ||..||++.++|+||||.+++-+
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 99999999996 99999999999999999976543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=318.69 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=206.3
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEee-ee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYS-VW 94 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~ 94 (296)
..+..++...+|.++|.+|||+.||+|++...|..||+|.+... ++...+.+.+|++++++|+ |+|||.+++ ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 33444444457889999999999999999988899999998744 6788899999999999996 999999999 33
Q ss_pred eeC---C-CCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 95 LDD---Q-HNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 95 ~~~---~-~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
... . ...+.|+||||+|++|-+++.+ ...|++.++++|+.++++|+++||...|+++|||||-+|||++.+ |.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~ 184 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GN 184 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CC
Confidence 222 1 2467889999999999999974 456999999999999999999999999999999999999999999 89
Q ss_pred eEEeccCCccccCCCcc----------cccCCCCCCccCccccc---c-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022479 169 VKIGDLGFAAIVGRSHA----------AHSIIGTPEYMAPELYE---E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~---~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 234 (296)
.||||||.++-.-.... .-....|+.|+|||+++ + ..++++|||+|||++|.|+....||++....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999999975422211 11234689999999664 3 3899999999999999999999999864332
Q ss_pred HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 235 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
. ++.+..... .....+..+.+||..||+ ||.+||++-+++.+
T Consensus 265 a----Ilng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 265 A----ILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred e----EEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2 222222111 113468899999999998 99999999999873
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=288.03 Aligned_cols=251 Identities=34% Similarity=0.623 Sum_probs=209.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.+..+++.+++|+++.... .....+.+.+|+.++++++|+||+++++..... ..+++++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFM 78 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEE
Confidence 678999999999999999988999999999986543 245678899999999999999999999987544 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|.+++..+..+++..++.++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCCCCc
Confidence 99999999999998878999999999999999999999999 9999999999999998 8999999999987643322
Q ss_pred ----cccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCCh
Q 022479 186 ----AHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDP 256 (296)
Q Consensus 186 ----~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (296)
.....++..|+|||.+.+. .+.++|+||||++++++++|..||..................+.. .....+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 1124567899999976633 688999999999999999999999765433333322222222211 1222478
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+.+++..||+ +|.+||++.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999997 99999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=292.07 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=208.5
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|++|.||++.+..+|+.+++|++..... ........+.+|++++++++|+|++++++.+.. ...+++++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 6899999999999998999999999975433 224556788899999999999999999988754 3789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-------
Q 022479 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH------- 184 (296)
Q Consensus 112 ~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~------- 184 (296)
++|.+++...+.+++..+..++.|++.+|++||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence 999999988778999999999999999999999999 9999999999999998 899999999987653321
Q ss_pred --ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 185 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
......++..|+|||... ...+.++|+||||++++++++|..||......+............. .....+..+.++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP-EDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC-ccccCCHHHHHH
Confidence 122345677899999665 4488899999999999999999999987655444444333222211 111238899999
Q ss_pred HHHHHh-CCCCCCCH---HHHhcCcccccccC
Q 022479 262 IEKCIA-QPRARPSA---SELLKDPFFSELND 289 (296)
Q Consensus 262 i~~~l~-~p~~Rps~---~~ll~hp~~~~~~~ 289 (296)
+.+||+ +|++|||+ .++|+||||.+++|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999998 99999999 99999999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=292.78 Aligned_cols=256 Identities=26% Similarity=0.504 Sum_probs=209.1
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
.++.+.| ++.++||+|+||.||++.++.+++.+|+|++... ......+..|+.+++++ +|+|++++++.+...
T Consensus 12 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3555666 6789999999999999999999999999998643 23346678899999998 699999999988642
Q ss_pred ----CCCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 98 ----QHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 98 ----~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
....++++|||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEE
Confidence 24688999999999999998875 345888899999999999999999999 9999999999999998 79999
Q ss_pred eccCCccccCCC-cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 022479 172 GDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244 (296)
Q Consensus 172 ~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 244 (296)
+|||.+...... .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||.............. .
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-N 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-C
Confidence 999998765322 1223345788999999764 2377889999999999999999999976655444443322 2
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
..+.......+..+.+|+.+||. ||.+||++.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 22333334468899999999998 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=292.82 Aligned_cols=256 Identities=24% Similarity=0.479 Sum_probs=206.6
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC-
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD- 97 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 97 (296)
+...+| ++.+.||+|++|+||++.++.+++.+|+|++.... .....+.+|+.+++++ +|+|++++++.+...
T Consensus 15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 355566 68999999999999999999999999999886422 1235677899999999 699999999987532
Q ss_pred --CCCeEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 98 --QHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 98 --~~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
.+..++++|||+++++|.+++. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEE
Confidence 3367999999999999998765 3456889999999999999999999999 9999999999999998 79999
Q ss_pred eccCCccccCCCc-ccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 022479 172 GDLGFAAIVGRSH-AAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244 (296)
Q Consensus 172 ~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 244 (296)
+|||.+....... ......++..|+|||.+. ..++.++|+||||+++|+|++|+.||................
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999987654322 223345788999999764 236889999999999999999999998765544443332222
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
..........+..+.+++.+||+ ||++|||+.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22222334457789999999997 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=288.78 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=201.4
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
..+||+|+||.||++.+..++..+++|.+... .....+.+.+|+.++++++|+|++++++.+..+ ..+++++||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence 56899999999999999989999999998754 233456788999999999999999999988654 789999999
Q ss_pred cCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 109 CTSGNLRTYRKKH-RHV--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 109 ~~~~sL~~~l~~~-~~~--~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+.+++|.+++... ..+ ++..+..++.|++.||+|||++| ++|+||+|+||+++.+.+.++|+|||.+........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998754 445 78889999999999999999999 999999999999987547999999999876543222
Q ss_pred -cccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 -AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 -~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....+++.|+|||.+.+ ..+.++|+||||+++|+|++|..||......................+...+++++++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 223456789999997653 2788999999999999999999999764433222221111111222344567899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+.+||. +|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999998 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.83 Aligned_cols=266 Identities=25% Similarity=0.351 Sum_probs=212.5
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH----------HHHHHHHHHHHHHHhcCCCcee
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP----------VLVNRLHSEVQLLRTLKNKYII 88 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~ 88 (296)
-+..++|..+.+.||+|+||+||++.++.+++.||+|+++........ .....+.+|++++++++|+|++
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456778877789999999999999999999999999999765432211 0112467899999999999999
Q ss_pred EEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
++++.+... ...+++|||+.+ +|.+++.....+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.
T Consensus 84 ~~~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~ 157 (335)
T PTZ00024 84 GLVDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GI 157 (335)
T ss_pred eeeEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CC
Confidence 999998654 689999999975 89999988888999999999999999999999999 9999999999999998 89
Q ss_pred eEEeccCCccccCC---------------CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 022479 169 VKIGDLGFAAIVGR---------------SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSEC 231 (296)
Q Consensus 169 ~~l~dfg~~~~~~~---------------~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~ 231 (296)
++|+|||.+..... ........++..|+|||.+.+. .+.++|+||||+++|+|++|..||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876541 1111223456789999977643 688999999999999999999999877
Q ss_pred ChHHHHHHHHhCC--CCCCC-----------------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 232 DSVAKIYKKVTGG--VKPQA-----------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 232 ~~~~~~~~~~~~~--~~~~~-----------------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
+..+....+.... ..... .....+.++.+++.+||+ +|++|||++++|.||||+
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 6655443332211 10000 011236789999999998 999999999999999998
Q ss_pred cccCC
Q 022479 286 ELNDD 290 (296)
Q Consensus 286 ~~~~~ 290 (296)
...-.
T Consensus 318 ~~~~~ 322 (335)
T PTZ00024 318 SDPLP 322 (335)
T ss_pred CCCCC
Confidence 76544
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=293.71 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=206.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
..| ++.+.||+|++|.||+|.++.+++.+++|.++..... ......+.+|+.++++++|+|++++.+.+.......+
T Consensus 5 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEY-EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhh-hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 345 5789999999999999999999999999999865432 2333456789999999999999999998876655789
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+ +|.+++... ..+++.++..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 157 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYG 157 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeecc
Confidence 999999986 888888754 45899999999999999999999999 9999999999999998 899999999988765
Q ss_pred CC-cccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC------------
Q 022479 182 RS-HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------------ 246 (296)
Q Consensus 182 ~~-~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------ 246 (296)
.. .......+++.|+|||.+.+. .+.++|+||||+++|+|++|..||..................
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 43 223334567889999977543 688999999999999999999999866554443322211000
Q ss_pred ----------------CCCCCCC-CChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ----------------PQALNKV-KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ----------------~~~~~~~-~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
....+.. .+..+.+++++||+ ||++|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111 47789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=295.26 Aligned_cols=263 Identities=29% Similarity=0.486 Sum_probs=214.4
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.++.++| ++.+.||+|+||+||++.+..+++.+++|++.... ....+.+.+|+.++++++|+|++++++.+...
T Consensus 15 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~- 88 (293)
T cd06647 15 GDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVG- 88 (293)
T ss_pred cCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeC-
Confidence 4445566 67899999999999999998889999999986432 22346788899999999999999999988665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+..++|+||+.+++|.+++... .+++.++..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~~ 163 (293)
T cd06647 89 -DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCA 163 (293)
T ss_pred -CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCccee
Confidence 6799999999999999998764 4889999999999999999999999 9999999999999988 799999999886
Q ss_pred ccCCCc-ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 179 IVGRSH-AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 179 ~~~~~~-~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
...... ......+++.|+|||.+. +.++.++|+||||+++|++++|..||..........................+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence 554322 223345777899999765 448889999999999999999999998655544433333332222223344578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.+++++.+||. +|.+||++.+++.||||+....-++
T Consensus 244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~ 280 (293)
T cd06647 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280 (293)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence 89999999997 9999999999999999987765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=299.95 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=189.7
Q ss_pred ceeeecccCcceEEEeeecC--CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+||+|+||+||+|.++. ++..+|+|.+..... ...+.+|+.++++++|+|++++++++.......++++
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 36789999999999998654 568899999874322 2356789999999999999999999876666789999
Q ss_pred eeccCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC---CCCceEEec
Q 022479 106 TEVCTSGNLRTYRKK---------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGD 173 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~---------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~---~~~~~~l~d 173 (296)
+||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||++.. ..+.++|+|
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 999886 67666642 125889999999999999999999999 999999999999942 226899999
Q ss_pred cCCccccCCCc----ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 022479 174 LGFAAIVGRSH----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------AKIY 238 (296)
Q Consensus 174 fg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~---------~~~~ 238 (296)
||++....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99998664322 1233456889999997754 3788999999999999999999999642211 0110
Q ss_pred HHHhC--CCC---------------------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCc
Q 022479 239 KKVTG--GVK---------------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDP 282 (296)
Q Consensus 239 ~~~~~--~~~---------------------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp 282 (296)
..... ... ........+..+.+|+.+||+ ||.+|||+.++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 00000 000 000011224568899999998 999999999999999
Q ss_pred cc
Q 022479 283 FF 284 (296)
Q Consensus 283 ~~ 284 (296)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=291.86 Aligned_cols=263 Identities=32% Similarity=0.584 Sum_probs=219.6
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.+....| .+.+.||+|++|.||++.++.+++.+++|++..... ....+.+|++.+++++|+|++++++.+...
T Consensus 15 ~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 87 (286)
T cd06614 15 GDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG- 87 (286)
T ss_pred CCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-
Confidence 4455555 678999999999999999998899999999975432 456788899999999999999999998766
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...++++||+.+++|.+++.... .++...+..++.|++.+|++||+.| ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~ 163 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFA 163 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchh
Confidence 78999999999999999998876 8999999999999999999999999 9999999999999988 89999999988
Q ss_pred cccCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
........ .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||..........................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS 243 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence 76543221 222346778999997654 4889999999999999999999999876665555554444333322233367
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+++++..||+ +|.+||++.+++.|+||++..+..+
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 281 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchHh
Confidence 899999999998 9999999999999999999776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=286.76 Aligned_cols=249 Identities=24% Similarity=0.488 Sum_probs=208.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||++|++.+..+|+.+++|.+..... .....+.+.+|+.++++++|+|++++.+.+... +..++++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIVM 78 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEEE
Confidence 578999999999999999999999999999976433 334456788999999999999999999988544 7899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++.++..++.|++.|+.+||+++ ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcch
Confidence 999999999988653 35789999999999999999999999 9999999999999988 799999999997664432
Q ss_pred c-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 A-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
. .....+++.|+|||.+.+ ..+.++|+||||++++++++|..||......+.......+.... .....+.++.+++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 233 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHYSYDLRNLV 233 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--CcccCCHHHHHHH
Confidence 2 122346778999997654 47889999999999999999999998766655555554443322 2334578999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+||+ +|.+||++.++++||||
T Consensus 234 ~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 234 SQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHhhCChhhCcCHHHHhhCcCC
Confidence 99997 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=289.66 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=207.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC------CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.+.++||+|++|.||++.+..+|+.+|+|.++...... .....+.+.+|+.++++++|+|++++++.+... .
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 81 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE--E 81 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--C
Confidence 56899999999999999999899999999986532211 122345788999999999999999999988544 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++|+||+.+++|.+++...+.+++..+..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence 89999999999999999988888999999999999999999999999 9999999999999988 89999999998765
Q ss_pred CCCc---ccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC---CC
Q 022479 181 GRSH---AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA---LN 251 (296)
Q Consensus 181 ~~~~---~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 251 (296)
.... ......++..|+|||.+.. .++.++|+||||+++|++++|..||..................... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 3321 1223456788999997653 2688999999999999999999999766555554443333222211 22
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
...+.++.+++.+||. +|++|||+.++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2357899999999997 99999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=290.41 Aligned_cols=259 Identities=29% Similarity=0.509 Sum_probs=209.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| +..+.||.|++|.||++.++.+++.+|+|.+.... ......++.+|++++++++|+||+++++.+.+.....++
T Consensus 2 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KI-VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ce-EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 44 56899999999999999999899999999987542 234567789999999999999999999998776667899
Q ss_pred EEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 104 FITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeecccccc
Confidence 99999999999887653 456899999999999999999999999 9999999999999988 7999999999876
Q ss_pred cCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCCCCCCCC---
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD----SVAKIYKKVTGGVKPQALN--- 251 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~--- 251 (296)
..... .....++..|+|||.+. ..++.++|+||||+++|+|++|..||.... ..............+....
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 53322 22345677899999765 448889999999999999999999997541 2222333333322111111
Q ss_pred --CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 252 --KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 252 --~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
...++.+.+++.+||+ +|.+|||+.++++||||++....
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1235789999999997 99999999999999999766543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=308.62 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=226.5
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
-+..-|+...|.. ++-||.|+||.||.|.+..+.+.||||++..+-. .+.+-+.++..|+++|++++|||++..-|+|
T Consensus 18 LF~k~DPEklf~d-LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCy 95 (948)
T KOG0577|consen 18 LFFKDDPEKLFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCY 95 (948)
T ss_pred HHccCCHHHHHHH-HHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence 5667788888876 7899999999999999999999999999986533 3455677889999999999999999999999
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
..+ .+.|+|||||-| |..+.+. ...++.+-++..|+.+.+.||+|||+++ .+|||||..|||++.. |.|||+|
T Consensus 96 Lre--~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~-g~VKLaD 169 (948)
T KOG0577|consen 96 LRE--HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP-GLVKLAD 169 (948)
T ss_pred ecc--chHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC-Ceeeecc
Confidence 876 689999999987 8888776 3457899999999999999999999999 9999999999999999 8999999
Q ss_pred cCCccccCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
||.+..... ..+..|||.|+|||++- ++++.+.||||||++..++...++|+-+.+.+.-++-+..... |.-
T Consensus 170 FGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-PtL 245 (948)
T KOG0577|consen 170 FGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PTL 245 (948)
T ss_pred ccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CCC
Confidence 999988654 45678999999999553 6699999999999999999999999988888888887665543 333
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
...-.++.+++|+.+||+ -|.+|||.+++|+|+|+.-
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 344458999999999997 9999999999999999753
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=291.70 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=202.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHH-HHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+.||+|+||.||++.++.+|+.||+|.++.... ... ..++..|+.. ++..+|+|++++++.+... ..++++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 578999999999999999999999999999875432 222 2344445554 6677999999999998654 679999
Q ss_pred eeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 106 TEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+||+.+ +|.+++.. ...+++..++.++.|++.||+|||++ + ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISGYL 154 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence 999975 77777653 35689999999999999999999997 8 9999999999999998 79999999998866
Q ss_pred CCCcccccCCCCCCccCcccccc-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCC
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
..........++..|+|||.+.+ .++.++|+||||+++|+|++|+.||.... ..+.+.... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKF 233 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCcccc
Confidence 44332333456778999997643 36789999999999999999999997532 333343333 233333334456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
+.++.+++.+||. +|.+||++.+++.||||.+....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 8899999999997 99999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=295.85 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=209.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.....||+|++|.||++.+..+++.+|+|++... .....+.+.+|+.++++++|+|++++++.+... +..++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~ 98 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVM 98 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEE
Confidence 3468899999999999999989999999998643 234456788999999999999999999988654 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-c
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~ 185 (296)
||+++++|.+++... .+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 99 e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 99 EFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred eCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhccccccc
Confidence 999999999988654 5899999999999999999999999 9999999999999998 799999999987553222 1
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||.+.+ ..+.++|+||||+++|++++|+.||..........................+..+.+++.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 233457789999997654 4888999999999999999999999876555444333222212112223457889999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
||. ||.+|||+.++++||||+....+.
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCcc
Confidence 997 999999999999999999766544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=292.43 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=207.6
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|++|.||+|.++.+++.|++|+++.... .....+.+.+|++++++++|+|++++.+.+... +.++
T Consensus 2 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 76 (288)
T cd07833 2 KY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLY 76 (288)
T ss_pred ce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEE
Confidence 44 679999999999999999999999999999875433 334457888999999999999999999998664 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+++||+.++.+..+......+++.+++.++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRAR 153 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCC
Confidence 99999999877777777677999999999999999999999999 9999999999999998 89999999998876543
Q ss_pred c--ccccCCCCCCccCccccc-c-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCC-----------
Q 022479 184 H--AAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVK----------- 246 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~----------- 246 (296)
. ......++..|+|||.+. . .++.++|+||||+++|+|++|..||.+....+.+...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 3 233345677899999765 3 4788999999999999999999999865554443322110 000
Q ss_pred ---------C-------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ---------P-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ---------~-------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
. .......+.++.+|+++||. +|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01122347889999999997 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=290.61 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=210.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
...++||+|+||.||++.++.++..+|+|+++... .......+.+|+.++++++|++++++++.+.+. ..+++||
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIM 81 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEE
Confidence 45788999999999999999899999999987543 234467889999999999999999999998665 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|.+++..+ .+++.++..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++++|||++........
T Consensus 82 e~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 82 EYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCCccc
Confidence 999999999988764 5899999999999999999999999 9999999999999988 7999999999976543221
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|.|||.+.+ ..+.++|+||||+++|+|++|..||............ ..... .......+..+.+++.+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNP-PTLTGEFSKPFKEFIDA 235 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCC-CCCchhhhHHHHHHHHH
Confidence 223356778999997654 4889999999999999999999999876554444332 22222 22333457889999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
||+ +|++||++.++++||||......
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 236 CLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HcccCcccCcCHHHHHhChHhhhcchh
Confidence 997 99999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=289.83 Aligned_cols=254 Identities=23% Similarity=0.406 Sum_probs=201.7
Q ss_pred eecccCcceEEEeeecCCCcEEEeeeeeecccCCCHH--HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
+||+|+||.||++.+..+++.||+|.+.......... ...........++...|++++.+.+.+... ..+++|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 4899999999999999899999999997654322211 111222233445556899999998888544 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~ 188 (296)
+.|++|..++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++...... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcC
Confidence 999999999988888999999999999999999999999 9999999999999998 79999999998765332 2233
Q ss_pred CCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 189 IIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
..++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.+... .......... .. ...+...+..+.+++.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA-VELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-cC-CCCCCcCCHHHHHHHHH
Confidence 467889999997753 378899999999999999999999976522 2222222221 12 22333458899999999
Q ss_pred HHh-CCCCCC-----CHHHHhcCcccccccCCCC
Q 022479 265 CIA-QPRARP-----SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 265 ~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~ 292 (296)
||. +|.+|| ++.++++||||+.+.|+.-
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 997 999999 9999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=289.20 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=208.0
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
-++||+|++|.||++.++.+++.+++|++... .....+.+.+|+.+++.++|+|++++++.+... +..++++||
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~ 97 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF 97 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence 57999999999999999889999999998643 223345678999999999999999999988654 688999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-cccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-~~~~ 187 (296)
+.+++|.+++.. .+++..++..++.|++.+|++||++| ++|+||+|+||+++.+ +.++|+|||.+...... ....
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccc
Confidence 999999999887 56899999999999999999999999 9999999999999998 89999999988654332 1223
Q ss_pred cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
...+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..........................+..+.+++.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 3457889999997664 488899999999999999999999987655444443333322222222235789999999999
Q ss_pred h-CCCCCCCHHHHhcCcccccccC
Q 022479 267 A-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 267 ~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
. +|++||++.++++||||++...
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ccChhhCcCHHHHccCcccccCCC
Confidence 7 9999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=277.95 Aligned_cols=254 Identities=22% Similarity=0.245 Sum_probs=203.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC---CC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---QH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~ 99 (296)
+..|++.+.||+|||+-||++++-.+++.||+|++.+.. .+..+...+|++..++++|||+++++++...+ ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 344489999999999999999999999999999999874 45578889999999999999999998776543 33
Q ss_pred CeEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 100 NTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
...|+++.|+..|||.+.+.. +..+++.++..++.++++||.+||+..|+++|+||||.||+++.. +.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEecc
Confidence 679999999999999988763 558999999999999999999999999999999999999999997 899999999
Q ss_pred CccccCCCcc----------cccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 022479 176 FAAIVGRSHA----------AHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKK 240 (296)
Q Consensus 176 ~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-~~~~~~ 240 (296)
.++...-.-. ......|.-|+|||.+.- ..++++|||||||++|.||-|.-||+..-.. ..+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 9987632111 112345678999997762 3899999999999999999999999521100 000000
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+.............++.+.++|+.|++ ||.+||++.+++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111111112233478999999999998 99999999999873
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.25 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=200.2
Q ss_pred ccceeeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
|++.++||+|+||.||++... .+++.+++|.+... ....+|++++++++|+||+++++.+... ..++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~ 162 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWK--STVC 162 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence 478999999999999999754 35678999988642 2245799999999999999999988654 6899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
++|+++.+ +|.+++.....+++.++..++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 163 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccccCcc
Confidence 99999875 78888887788999999999999999999999999 9999999999999998 89999999998765432
Q ss_pred c---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhC-------------
Q 022479 184 H---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTG------------- 243 (296)
Q Consensus 184 ~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~------------- 243 (296)
. ......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+... ...+..++..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2 2234568899999997764 488999999999999999999999965321 1111111110
Q ss_pred ------------CCCC-CC-----CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 244 ------------GVKP-QA-----LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 244 ------------~~~~-~~-----~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...+ .. .....+.+++++|.+||. ||++|||+.++|.||||.+.+++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 0000 00 011235678899999998 999999999999999999877764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=307.20 Aligned_cols=234 Identities=35% Similarity=0.527 Sum_probs=202.6
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
++-||+|+.|.||+++.. ++.||||+++. .-..+++-|++|+|+||+.+.|+|. +.-.++|+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEf 193 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEF 193 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeeec--CCceeEEeeec
Confidence 467999999999999776 89999999862 1225899999999999999999995 44689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~ 188 (296)
|..|-|...++.+..++...+..|..+|+.++.|||.+. |+|||||.-||||+.+ ..|||+|||-+.........-+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhh
Confidence 999999999999999999999999999999999999999 9999999999999999 6999999999987766555566
Q ss_pred CCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh
Q 022479 189 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (296)
.+||..|+|||++.++ .+++.||||||+++|||+||..||.+.+....+.-.-........ +.-+++.++-|++.||+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv-PstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV-PSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC-cccCchHHHHHHHHHHh
Confidence 8899999999988765 899999999999999999999999876655444432222222233 34468999999999997
Q ss_pred -CCCCCCCHHHHhcC
Q 022479 268 -QPRARPSASELLKD 281 (296)
Q Consensus 268 -~p~~Rps~~~ll~h 281 (296)
.|..|||+.++|.|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 99999999999998
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=299.90 Aligned_cols=263 Identities=30% Similarity=0.440 Sum_probs=215.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---CCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---HNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 103 (296)
++.++||.|++|.||+|.+..+++.+++|++..... +....+.+.+|+.++++++|+|++++.+.+.... ...+|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 678999999999999999998899999999975432 2444577889999999999999999999886542 24789
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
++++|+.+ +|.+++.....+++..++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeeccc
Confidence 99999985 89889888778999999999999999999999999 9999999999999999 89999999999876544
Q ss_pred c----ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---------
Q 022479 184 H----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------- 248 (296)
Q Consensus 184 ~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 248 (296)
. ......++..|+|||.+.+ ..+.++|+||||+++|+|++|..||.+....+...........+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 2333456788999997653 488899999999999999999999987665544433332211100
Q ss_pred -------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCCC
Q 022479 249 -------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 295 (296)
Q Consensus 249 -------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 295 (296)
......+..+.+++.+||+ +|.+||++.+++.||||+.+..+..++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 0011246789999999997 9999999999999999999888766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=290.06 Aligned_cols=257 Identities=25% Similarity=0.467 Sum_probs=211.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|+||++.+..+++.+|+|++.... .......+.+|+++++.++|+|++++++.+... ..+++|+
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 67899999999999999999899999999987542 344567889999999999999999999998665 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+++++|..++...+.+++..+..++.+++.+|.|||+ ++ ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-I 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhhh-c
Confidence 999999999999887889999999999999999999997 58 9999999999999988 89999999998654322 2
Q ss_pred cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----------HHHHHHHhCCCCCCCCCCCC
Q 022479 186 AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV----------AKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 254 (296)
.....++..|+|||.+. +.++.++|+||||+++|++++|..||...... ............+.......
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 23446788999999654 56889999999999999999999999754331 11122222222222222335
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+..+.+|+.+||+ ||++|||+.++++|+||..-..++.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~ 277 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccccc
Confidence 7889999999998 9999999999999999977655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=291.29 Aligned_cols=256 Identities=29% Similarity=0.532 Sum_probs=209.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||.||++.++.+++.+|+|.++... +......+.+|+.++++++|+|++++++.+... +.+++++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 67899999999999999999999999999987432 344457888999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 107 EVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 107 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
||+++++|..++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCcccccC
Confidence 999999999888763 378999999999999999999996 58 9999999999999997 8999999999876533
Q ss_pred CcccccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhCCCCCCCCCCC
Q 022479 183 SHAAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI--YKKVTGGVKPQALNKV 253 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 253 (296)
. ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||......... ...+.....+. ....
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-LPSG 233 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-CCcc
Confidence 2 22334567789999976432 477899999999999999999999754332221 11222222222 2333
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.+.++.+++.+||+ +|++||++.+++.||||......+.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~ 273 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCcc
Confidence 68999999999997 9999999999999999988775543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=292.05 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=202.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
...++||+|+||.||++.+..+++.+|+|.+..... ......+.+|+..+.++. |+|++++++.+..+ ...+++
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 356889999999999999999999999999875432 244567889999999996 99999999988654 678889
Q ss_pred eeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 106 TEVCTSGNLRTYRK-----KHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 106 ~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+||+.. ++.++.. ....+++..+..++.|++.||+|||+. + ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence 999875 5544332 246799999999999999999999975 8 9999999999999988 7999999999976
Q ss_pred cCCCcccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC---C
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN---K 252 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 252 (296)
...........++..|+|||.+.+ .++.++|+||||+++|+|++|+.||..................+.... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 644333344467888999997654 378899999999999999999999976443222222222222222211 2
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..+.++.+|+.+||+ ||.+|||+.+++.||||+...+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 367899999999997 99999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=289.17 Aligned_cols=255 Identities=30% Similarity=0.505 Sum_probs=209.6
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~ 102 (296)
|.+.++||+|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++++. |++++++++.+... ..+
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~ 77 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRL 77 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEE
Confidence 456889999999999999999999999999987542 2334567888999999996 99999999988654 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++++||+.+++|.+++..+ .+++..+..++.|++.+|.+||+.| ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence 9999999999999988764 6899999999999999999999999 9999999999999998 8999999999987644
Q ss_pred Ccc-cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 183 SHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 183 ~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||........... ......+.......+.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcccCCHHHH
Confidence 322 233457788999997653 368899999999999999999999976544333322 2222222222333678999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
+++.+||+ ||++||++.++++|+||++...+
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 99999997 99999999999999999886643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=298.24 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=207.4
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDD 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 97 (296)
+...++-|.+.++||+||.+.||++...+ ...||+|.+..... ++...+-+.+|+..|.+++ |.+|++++++-+.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~--D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEA--DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhc--CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 44556667889999999999999998764 45677777665544 7888999999999999995 88999999987654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
.++|+||||-.. .|..++++... ++.-.++.+..|++.|+.++|++| |||.||||.|+++-. |++||+|||+
T Consensus 433 --~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk--G~LKLIDFGI 505 (677)
T KOG0596|consen 433 --GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK--GRLKLIDFGI 505 (677)
T ss_pred --ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe--eeEEeeeech
Confidence 799999999765 89999987554 333588889999999999999999 999999999999988 5999999999
Q ss_pred ccccCCCc---ccccCCCCCCccCcccccc------------CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHH
Q 022479 177 AAIVGRSH---AAHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKK 240 (296)
Q Consensus 177 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~ 240 (296)
|....... .....+||+.|+|||.+.. ..++++||||||||+|+|+.|+.||.... ....+..+
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 98764432 2445689999999996531 15778999999999999999999996533 22223332
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..-+....+.......++.+++++||+ ||++|||+.+||+|||++-+.-.
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 222232333333334569999999997 99999999999999999875443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=289.04 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=198.1
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.+.| ++.+.||+|+||.||++.+..+++.+++|++....... ....+.+|+.+++.++|+|++++++.+..+ .
T Consensus 3 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~ 76 (291)
T cd07870 3 AATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTK--E 76 (291)
T ss_pred cccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecC--C
Confidence 34556 67999999999999999999999999999997543221 123556899999999999999999988654 6
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..++++||+.+ ++..++.. ...+++..+..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||+++.
T Consensus 77 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~ 152 (291)
T cd07870 77 TLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARA 152 (291)
T ss_pred eEEEEEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccc
Confidence 89999999974 66666543 456788899999999999999999999 9999999999999988 8999999999876
Q ss_pred cCCCc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---CC--------
Q 022479 180 VGRSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GV-------- 245 (296)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~---~~-------- 245 (296)
..... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||............... ..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred cCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 43322 1233446789999997754 3788999999999999999999999765432222111100 00
Q ss_pred ------CCCC-------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 246 ------KPQA-------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 246 ------~~~~-------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+.. .....+..+.+++.+|++ ||++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 000125688999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.78 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=194.6
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
..+| .+.++||+|+||.||++.+..+++.||+|.... ..+.+|++++++++|+||+++++.+... ..
T Consensus 168 ~~gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~ 234 (461)
T PHA03211 168 GLGF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GL 234 (461)
T ss_pred cCCe-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence 3455 689999999999999999999999999996432 2345799999999999999999988655 67
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++++++.+ +|..++.. ...+++.+++.++.|++.||.|||++| |+|+||||+|||++.+ +.++|+|||++...
T Consensus 235 ~~lv~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceec
Confidence 8899999964 77777765 456999999999999999999999999 9999999999999988 79999999999765
Q ss_pred CCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhCCCC---
Q 022479 181 GRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD-------SVAKIYKKVTGGVK--- 246 (296)
Q Consensus 181 ~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~-------~~~~~~~~~~~~~~--- 246 (296)
..... .....++..|+|||++.+ .++.++|||||||++|+|++|..|+.... ....+.+.+.....
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 33211 223468999999997764 48899999999999999999875542211 11222222221100
Q ss_pred --C---------------------CCC------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 247 --P---------------------QAL------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 247 --~---------------------~~~------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+ ... ....+..+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 000 01234578999999998 9999999999999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=291.25 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=202.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||+|.++.+++.+|+|.++.... .......+.+|++++++++|+|++++++.+.+. +..++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVF 78 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEe
Confidence 568999999999999999999999999999875432 223345788899999999999999999998544 7899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+ +|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV 154 (284)
T ss_pred ecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccCc
Confidence 99964 78888764 456899999999999999999999999 9999999999999998 899999999987654322
Q ss_pred c-cccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-------------
Q 022479 185 A-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ------------- 248 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 248 (296)
. .....++..|+|||.+.+. .+.++|+||||+++|+|++|+.||.+....+...........+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1 2233457789999976543 58889999999999999999999987665554443332211100
Q ss_pred -------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 249 -------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 249 -------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
......+.+++++|.+||+ ||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0012346788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=298.23 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=208.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-- 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 99 (296)
.++| .+.+.||.|++|.||+|.++.+++.||+|++..... ...+.+.+|++++++++|+|++++++.+.....
T Consensus 4 ~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred Ccce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4566 679999999999999999999999999999976533 335678889999999999999999877654321
Q ss_pred ----------CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCce
Q 022479 100 ----------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169 (296)
Q Consensus 100 ----------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~ 169 (296)
..+++++||+.+ +|.+++..+ .+++..++.++.|+++||.|||+.| ++|+||+|+||+++...+.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeecccc-cHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceE
Confidence 357899999985 888887654 5899999999999999999999999 99999999999998654689
Q ss_pred EEeccCCccccCCCcc----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 022479 170 KIGDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~ 243 (296)
+|+|||.+........ .....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||......+........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976533211 122346778999996543 4788999999999999999999999876655544433322
Q ss_pred CCC-----------------------CC----CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 244 GVK-----------------------PQ----ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 244 ~~~-----------------------~~----~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
... .. ......+.++.+|+.+||+ ||++|||+.++|.||||+.+..+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~ 312 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDE 312 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccc
Confidence 110 00 0012346789999999998 99999999999999999987666443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=292.85 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=209.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.....||+|+||.||++.++.+++.+|+|++..... ...+.+.+|+.+++.++|+|++++++.+..+ +.+++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~ 97 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLM 97 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEE
Confidence 346789999999999999998999999999875432 2245678899999999999999999988655 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-c
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~ 185 (296)
||+++++|..++.. ..+++..++.++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhccccccc
Confidence 99999999987765 45899999999999999999999999 9999999999999998 899999999987553321 2
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||.+.+ .++.++|+||||+++++|++|+.||......+...................+..+.+++.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 233557889999997764 5888999999999999999999999766555444433222222222233457889999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
||+ +|++||++.++++||||.+-..+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 998 999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=288.42 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=199.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++.++||+|++|.||++.++.+++.+|+|+++.... +... ....+|+..+.++. |+|++++++.+.+...+.++++
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 578999999999999999999999999999875432 2222 23346888888885 9999999999977655789999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
+||+.+ +|.+++.. ...+++.++..++.|++.||++||+++ ++|+||+|+||+++. +.++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCC
Confidence 999986 77777664 457899999999999999999999999 999999999999998 699999999998765443
Q ss_pred ccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC---------------C
Q 022479 185 AAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------------P 247 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------~ 247 (296)
......++..|+|||.+. +..+.++|+||||+++|+|++|..||.+.+..+........... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 334445788999999654 33788999999999999999999999876554433322211000 0
Q ss_pred CC-----------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 QA-----------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 ~~-----------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.. .....+.++.+++.+||. +|.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 012347899999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=292.45 Aligned_cols=253 Identities=26% Similarity=0.488 Sum_probs=209.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
...+.||+|++|.||++.+..+++.+|+|.+.... .....+.+.+|+.++++++|+|++++++.+... ..+++|+
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIM 81 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEE
Confidence 45788999999999999999889999999987442 234567889999999999999999999988654 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|.+++.. ..+++..+..++.|++.|+.+||+++ ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccCcchh
Confidence 99999999998865 45899999999999999999999999 9999999999999988 8999999999876543221
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|..||............ ..... .......+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSP-PTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCC-CCCCcccCHHHHHHHHH
Confidence 223356778999997764 4788999999999999999999999765444433322 22222 22334457889999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
||+ +|++||++.++++||||..+.+.
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred HccCCcccCcCHHHHHHhHHHHHHhhh
Confidence 997 99999999999999999876643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.50 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=212.2
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
...++..+| ++.++||+|++|+||++.+..+++.||+|++..... ........+.+|+++++.++|+|++++.+.+..
T Consensus 9 ~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 9 SKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred cCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 344555666 678999999999999999998999999999864422 234445678899999999999999999999876
Q ss_pred CCCCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
. +..++|+||+.+ ++.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||
T Consensus 87 ~--~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg 160 (307)
T cd06607 87 E--HTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFG 160 (307)
T ss_pred C--CeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecC
Confidence 5 678999999986 6666654 3557999999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
++...... ....++..|+|||.+. +.++.++|+||||+++|+|++|..||.+.............. .+....
T Consensus 161 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~ 236 (307)
T cd06607 161 SASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSS 236 (307)
T ss_pred cceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCc
Confidence 98765432 2335677899999763 347889999999999999999999998766655555443332 222333
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
...+..+.+++.+||. +|++||++.+++.||||..-.
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 3457889999999997 999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=282.78 Aligned_cols=249 Identities=27% Similarity=0.519 Sum_probs=211.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||.|++|.||++.+..+++.+++|++..... +......+.+|++++++++|+|++++.+.+... ...++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 578999999999999999998999999999986543 345567788999999999999999999988655 7899999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 107 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 107 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
||+++++|.+++.. +..+++.++..++.+++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeeccc
Confidence 99999999999876 377999999999999999999999999 9999999999999998 8999999999987654
Q ss_pred Cc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.. ......+++.|+|||...+ ..+.++|+||+|+++++|++|..||......+......... ....+...+.++.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIPSQYSSELRN 233 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CCCCCCCCCHHHHH
Confidence 43 2333467888999996654 48889999999999999999999997655444444433322 22334456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
++..||. +|++||++.++|.||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.06 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=209.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC---
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--- 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 99 (296)
++| ++.++||+|++|+||++.+..+++.||+|.++.... .......+.+|+.++++++|+|++++++++.....
T Consensus 5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 344 679999999999999999999999999999875422 22234567789999999999999999987754322
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++++||+. ++|.+++...+.+++..+..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 45899999997 589889988888999999999999999999999999 9999999999999988 8999999999976
Q ss_pred cCCCc-ccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--CCC---------
Q 022479 180 VGRSH-AAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGV--------- 245 (296)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~--~~~--------- 245 (296)
..... ......++..|+|||.+. ...+.++|+||||+++|+|++|..||.+.+.......... +..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 54331 122345677899999765 3488999999999999999999999976543222111110 000
Q ss_pred ---------------CC--CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 246 ---------------KP--QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 246 ---------------~~--~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.. .......+.++.+++.+||+ +|.+|||+.++++||||..+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00 00112357889999999998 99999999999999999987665544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=280.54 Aligned_cols=248 Identities=32% Similarity=0.594 Sum_probs=209.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+.||+|++|.||++.+..+++.+++|++..... .....+.+|++.+++++|++++++.+.+... ...++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 567899999999999999998899999999975432 3467888999999999999999999988655 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++... ..+++..+..++.|++.+|.+||+.| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeecccccccccccc
Confidence 999999999998876 67999999999999999999999999 9999999999999998 8999999999987654432
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||.+.+ ..+.++|+||||+++++|++|..||..........................+..+.+++..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 344567789999997664 4788999999999999999999999876544444444333222222222237899999999
Q ss_pred HHh-CCCCCCCHHHHhcCcc
Q 022479 265 CIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~ 283 (296)
||+ ||++|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 997 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.70 Aligned_cols=265 Identities=26% Similarity=0.447 Sum_probs=211.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 100 (296)
.+| .+.+.||+|++|.||++.++.+++.||+|++..... .......+.+|+.++++++|+||+++.+++... ...
T Consensus 5 ~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 445 678999999999999999999999999999875422 223456677899999999999999999877533 235
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++|+||+.+ +|.+++.....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 78999999965 89999987788999999999999999999999999 9999999999999998 89999999998765
Q ss_pred CCCcc-----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--C-------
Q 022479 181 GRSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--G------- 244 (296)
Q Consensus 181 ~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~------- 244 (296)
..... .....++..|+|||.+.+ ..+.++|+||||+++|+|++|+.||.+......+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 123356788999997653 4788999999999999999999999765543322211110 0
Q ss_pred -------------CC-CCC-----CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 245 -------------VK-PQA-----LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 245 -------------~~-~~~-----~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
.. ... .....+.++.+++.+||+ +|++||++.+++.||||..+..+..++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~ 307 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP 307 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence 00 000 012247889999999998 999999999999999999888877654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=288.71 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=203.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||.|++|.||++.++.+|..+|+|++..... +......+.+|++++++++|+|++++++.+.+. ...++++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence 568899999999999999999999999999976533 222345677899999999999999999998654 7899999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+. ++|.+++.... .+++..+..++.|++.||++||+++ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCc
Confidence 9996 58999887655 7899999999999999999999999 9999999999999997 899999999997654322
Q ss_pred c-cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------------
Q 022479 185 A-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------------- 247 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 247 (296)
. .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||....+...+.........+
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 222345778999997654 36889999999999999999999998766655544432211100
Q ss_pred ------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 ------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 ------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+.++.+++.+||+ ||.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01122346789999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=287.36 Aligned_cols=257 Identities=23% Similarity=0.435 Sum_probs=221.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.++++||+|.||.|.++..+.+++.||+|+++....- +.+...--..|-++|+..+||.+..+.-.|. ..+++|+||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceEEEEE
Confidence 5789999999999999999999999999999876543 3444555668999999999999988876663 448999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-CCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~~~~~ 185 (296)
||..||.|.-+++..+.+++...+-+...|+.||.|||+.+ ||.||||.+|.+++.+ |.+|+.|||++..- .....
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhcccccce
Confidence 99999999999998888999999999999999999999999 9999999999999999 99999999999753 33455
Q ss_pred cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
+...||||.|+|||++. ..+..+.|.|.+|+++|+|++|++||...+ .+.+...+... ....+...+++.+.|+..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~kLFeLIl~e--d~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HEKLFELILME--DLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-hhHHHHHHHhh--hccCCccCCHHHHHHHHH
Confidence 77899999999999887 559999999999999999999999998754 45555544442 223344468999999999
Q ss_pred HHh-CCCCCC-----CHHHHhcCcccccccCCCC
Q 022479 265 CIA-QPRARP-----SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 265 ~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~ 292 (296)
+|. ||++|. .+.++.+|+||..++|++.
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 996 999996 7999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=288.79 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=205.5
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||+|++|+||++.++.+|+.+|+|.+..... .....+.+.+|++++++++|+|++++++.+.+. ...+
T Consensus 3 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (294)
T PLN00009 3 QY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLY 77 (294)
T ss_pred ce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEE
Confidence 45 578999999999999999999999999999875432 223346678899999999999999999998654 7899
Q ss_pred EEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||+.+ +|.+++.... .+++..++.++.||+.||++||+++ ++|+||+|+||+++.+.+.++|+|||++....
T Consensus 78 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99999975 7777776533 3578889999999999999999999 99999999999998654689999999997654
Q ss_pred CCcc-cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--C--------
Q 022479 182 RSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q-------- 248 (296)
Q Consensus 182 ~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~-------- 248 (296)
.... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+...........+ .
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 3221 223345778999997654 37889999999999999999999998766655554433211000 0
Q ss_pred ----------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 249 ----------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 249 ----------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
......+.++.+++.+|++ +|++||++.+++.||||.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 0012246789999999997 9999999999999999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=280.27 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=213.0
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee--CC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD--DQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~ 98 (296)
..-|..-.++||-|-.|.|-.+.++.+|+++|+|++.-+ ...++|++.--+. .|+||+.++++|.- ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 334433349999999999999999999999999998632 3456677765555 59999999998853 23
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEecc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDL 174 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~df 174 (296)
.+.+.+|||.++||.|...+++.+. +++.++..|+.||..|+.|||+.+ |+||||||+|+|.+.+. -.+||+||
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccc
Confidence 4678889999999999999998664 999999999999999999999999 99999999999997652 37999999
Q ss_pred CCccccCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhCCCC-CC
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS----VAKIYKKVTGGVK-PQ 248 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~-~~ 248 (296)
|++............|.||.|.|||++..+ ++..-|+||+|+++|-|++|.+||..... ...-..+..+... +.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 999988777778888999999999988754 88889999999999999999999975432 1222233333221 33
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.-+++.|++.+++|+++|+ +|++|.|+++++.|||+.....-+.
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 3355678999999999998 9999999999999999877655443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=299.34 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=199.9
Q ss_pred CcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
+| +++++||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+++.+ +||||+++++.+.+.
T Consensus 36 ~~-~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 36 RL-SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred He-ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 44 6899999999999999964 3456789999997432 223356788999999999 899999999998554
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc--------------------------------------------------------
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH-------------------------------------------------------- 121 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------- 121 (296)
...+++|||+++|+|.+++...
T Consensus 112 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 112 --GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred --CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 6789999999999999888642
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 122 -------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 122 -------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
..+++..+..++.|++.||+|||+++ ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccC
Confidence 14678889999999999999999999 9999999999999988 7999999999976543
Q ss_pred Ccc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 183 SHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 183 ~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
... .....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||............+....... .+...+.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 345 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSE 345 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHH
Confidence 221 112234567999997654 58999999999999999998 8999987655555555555543322 23445789
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+++|+..||+ ||++|||+.++++
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.16 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=195.9
Q ss_pred CCcccceeeecccCcceEEEeeecC----------------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE----------------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 86 (296)
++| ++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|+|
T Consensus 5 ~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 5 GHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 455 689999999999999997532 34579999987532 3445677899999999999999
Q ss_pred eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 022479 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-------------------RHVSIKALKKWSKQVLEGLEYLHTHE 147 (296)
Q Consensus 87 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------------~~~~~~~~~~i~~ql~~~l~~LH~~~ 147 (296)
|+++++.+.+. ...+++|||+.+++|.+++... ..++..++..++.|++.||+|||++|
T Consensus 81 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 81 IIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred eeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999998655 6799999999999999988643 23677889999999999999999999
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT 223 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~ 223 (296)
++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+. +.++.++|+||||+++|+|++
T Consensus 159 --ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 159 --FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred --ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999998 899999999997653322 122334467899999765 558999999999999999987
Q ss_pred --CCCCCCCCChHHHHHHHHh---CCC--CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 224 --MEIPYSECDSVAKIYKKVT---GGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 224 --g~~p~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+..||.+....+....... ... ........++..+.+|+.+||+ ||++|||+.++.+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6678876554443332211 111 1111223457899999999998 9999999999965
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=295.35 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=211.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++| .+.++||+|++|.||++.+..+++.+|+|++..... .......+.+|+.+++++ +|+||+++++.+.......
T Consensus 7 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 445 678999999999999999998899999999864322 223345677899999999 9999999999886655567
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++|+||+.+ +|..++..+ .+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 8999999985 898888776 6889999999999999999999999 9999999999999999 899999999987653
Q ss_pred CCc------ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-------
Q 022479 182 RSH------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------- 246 (296)
Q Consensus 182 ~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------- 246 (296)
... ......++..|+|||.+.+ ..+.++|+||||+++|+|++|+.||.+....+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322 1222346778999997643 4788999999999999999999999765544433322211100
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 247 ---------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 247 ---------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
........+.++.+++.+||+ ||.+|||+.++++||||+.+....+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~ 308 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP 308 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence 001111257889999999998 999999999999999999997776653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=283.79 Aligned_cols=245 Identities=18% Similarity=0.276 Sum_probs=199.2
Q ss_pred ccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+++.+.||+|+||.||++.++ ..+..+|+|.++... .......+.+|+..+++++|+|++++++.+... ..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 378999999999999999765 346789999987542 334456788999999999999999999988644 689
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.+ +.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence 999999999999999876 457899999999999999999999999 9999999999999998 799999999876542
Q ss_pred CCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... .....++..|+|||.+. +.++.++||||||+++|++++ |..||.+....+..... ....... .+..++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLP-APRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCC-CCCCCCHH
Confidence 2211 11223456899999765 558899999999999999875 99999876655544443 3332222 23446889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+++.+||+ +|.+||+++++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999998 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.66 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=198.1
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
++.++||+|+||.||+|.+... +..||+|+++... .......+.+|+.+++++ +|+||+++++.+... .
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--~ 115 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG--G 115 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--C
Confidence 6899999999999999986433 4579999997543 234456788999999999 899999999998554 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc-----------------------------------------------------------
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------------------------------------------------------- 121 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 121 (296)
.++++|||+.+++|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 899999999999999987532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc---cc
Q 022479 122 -----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AH 187 (296)
Q Consensus 122 -----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~ 187 (296)
.++++.++..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeecc
Confidence 24788899999999999999999999 9999999999999988 7999999999876533221 11
Q ss_pred cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
...++..|+|||++. +.++.++|+||||+++|+|++ |+.||................... ..+...+.++.+++.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHHHHHH
Confidence 223456799999765 458999999999999999997 999998755544444444443332 22344588999999999
Q ss_pred Hh-CCCCCCCHHHHhc
Q 022479 266 IA-QPRARPSASELLK 280 (296)
Q Consensus 266 l~-~p~~Rps~~~ll~ 280 (296)
|+ ||.+|||+.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 98 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=294.29 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=205.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.++||+|++|.||++.+..+|+.||+|+++... .......+.+|+.++++++|+|++++++++....
T Consensus 4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 3455 68999999999999999999999999999986421 2334566788999999999999999998765432
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...+++++||+.+ +|...+.. ..+++..++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECccccee
Confidence 2468999999976 77776654 45999999999999999999999999 9999999999999998 899999999987
Q ss_pred ccCCCcc----cccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--------
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-------- 244 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~-------- 244 (296)
....... .....+++.|+|||.+. ..++.++|+||||+++|+|++|+.||.+.+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6533221 12245678899999654 348889999999999999999999997654322221111000
Q ss_pred --------------CC--CC----CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 245 --------------VK--PQ----ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 245 --------------~~--~~----~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.. .. ......++++.+++.+||+ ||++|||+.++++||||..+..+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~ 304 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE 304 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence 00 00 0011236789999999998 99999999999999999988766443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=289.77 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=203.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.++.+++.+|+|++..... .....+.+.+|++++++++|+|++++++.+..+ ...++++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 79 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYLVF 79 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEEEE
Confidence 578999999999999999998899999999865432 223456788899999999999999999998543 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|..+......+++.++..++.|++.+|+|||+.+ ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence 99999999888777667999999999999999999999999 9999999999999998 7999999999876543222
Q ss_pred cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--C-----------------
Q 022479 186 AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--G----------------- 244 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~----------------- 244 (296)
.....++..|+|||++.+ ..+.++|+||||+++|+|++|..||......+........ .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 223446778999997654 3678899999999999999999999765543332222210 0
Q ss_pred -CCCC--------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 245 -VKPQ--------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 245 -~~~~--------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
..+. ......+..+.+|+.+||. +|++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 0012346789999999997 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=282.16 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=215.8
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
.+.||+|+|+.|.-+....+|..||||++.+. ......++.+|++++.++ .|+||++++++|.++ ..+|+|+|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEe
Confidence 38999999999999999999999999999865 456688999999999999 599999999999655 78999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccccCC---
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGR--- 182 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~~~--- 182 (296)
-+.||+|...+.+...|++.++..+.+.|+.||.+||.+| |+||||||+|||-..-+ .-+|||||++..-...
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999999999999999999999999999999999 99999999999987542 3589999998764321
Q ss_pred -----CcccccCCCCCCccCccccc---cC---CCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHH
Q 022479 183 -----SHAAHSIIGTPEYMAPELYE---ED---YTEMVDIYSFGLCLLEMVTMEIPYSECDS--------------VAKI 237 (296)
Q Consensus 183 -----~~~~~~~~~~~~~~aPE~~~---~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~~--------------~~~~ 237 (296)
.......+|+-.|||||++. ++ ++.+-|.||||+|+|-|++|.+||.+... -..+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12233345677899999654 33 88899999999999999999999975432 1233
Q ss_pred HHHHhCCCC--CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCCCC
Q 022479 238 YKKVTGGVK--PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296 (296)
Q Consensus 238 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 296 (296)
...+..+.- |..-+..++++.++|++.++. |+.+|.++.++++|||++....+..-|+|
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp 376 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTP 376 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCC
Confidence 333433321 233345578999999999997 99999999999999999988877665655
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=286.00 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=198.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|++|+||++.++.+++.||+|.+....... ....+.+|++++++++|+||+++++.+.+. +.
T Consensus 4 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (291)
T cd07844 4 LETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTK--KT 77 (291)
T ss_pred ccce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecC--Ce
Confidence 4556 57899999999999999999899999999997543221 123456799999999999999999998544 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.++|+||+.+ +|.+++.. ...+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECcccccccc
Confidence 9999999986 88888765 346899999999999999999999999 9999999999999998 89999999998654
Q ss_pred CCCcc-cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---CCCCCC-----
Q 022479 181 GRSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKPQA----- 249 (296)
Q Consensus 181 ~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~----- 249 (296)
..... .....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.+............. ......
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 32211 122345778999997653 3788999999999999999999999765422221111110 000000
Q ss_pred --------------------CCCCCC--hHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 250 --------------------LNKVKD--PEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 250 --------------------~~~~~~--~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.....+ ..+.+++.+||. +|++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000122 678899999998 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=283.71 Aligned_cols=252 Identities=26% Similarity=0.511 Sum_probs=208.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||.||++.+..+++.+|+|.+.... .......+.+|+.++++++|+|++++++.+.+. ..+++|+
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 56889999999999999998899999999986442 234456788999999999999999999998655 6899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-c
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~ 185 (296)
||+.+++|..++..+ .++...+..++.|++.++.+||+.| ++|+||+|+||+++.+ +.++++|||++....... .
T Consensus 82 e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchhh
Confidence 999999999888754 5899999999999999999999999 9999999999999988 899999999987654322 1
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||.+.+ ..+.++|+||||+++|+|++|..||........... +.....+ ......+.++.+++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPP-TLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCC-CCCcccCHHHHHHHHH
Confidence 223456778999997654 478899999999999999999999976554333333 2222222 2334467899999999
Q ss_pred HHh-CCCCCCCHHHHhcCcccccccC
Q 022479 265 CIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
||+ +|.+||++.++++||||.....
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhhhh
Confidence 997 9999999999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=287.92 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=202.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCC---
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH--- 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~--- 99 (296)
+| ++.+.||+|++|.||++.+..+++.||+|+++.... .......+.+|+.+++++. |+|++++++.+.....
T Consensus 2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 44 578999999999999999999999999999875432 2223456778999999995 5999999988865432
Q ss_pred CeEEEEeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 100 NTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
...|+++||+.+ +|.+++.. +..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.+.+.++|+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 237999999987 78887754 235899999999999999999999999 9999999999999984389999999
Q ss_pred CCccccCCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----
Q 022479 175 GFAAIVGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---- 247 (296)
Q Consensus 175 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---- 247 (296)
|.+...... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+................+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 998765332 12223345778999997643 37889999999999999999999998766655554433211000
Q ss_pred ---------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 248 ---------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 248 ---------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
.......+.++.++|.+||. ||.+||++.+++.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00012357889999999997 999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=282.42 Aligned_cols=250 Identities=26% Similarity=0.487 Sum_probs=207.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+.||+|++|.||++.++.+|..+|+|.+..... .....+.+.+|+.++++++|+|++++++.+... ..+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 78 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIVM 78 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEEE
Confidence 578999999999999999999999999999976533 223356778999999999999999999988544 7899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.+...++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999988753 35799999999999999999999999 99999999999999874457999999987764432
Q ss_pred c-cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 A-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
. .....+++.|+|||... ...+.++|+||||++++++++|..||..................+ .....+.++.+++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i 234 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--ISPNFSRDLRSLI 234 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC--CCCCCCHHHHHHH
Confidence 2 22235778899999765 458899999999999999999999998766555555544333221 2234578999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.+||. +|++|||+.++++||||
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 235 SQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHhccChhhCcCHHHHhhCCCC
Confidence 99997 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=286.91 Aligned_cols=250 Identities=28% Similarity=0.459 Sum_probs=206.7
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
..+||+|++|.||++.++.+++.+|+|++... .......+.+|+.++++++|+|++++++.+... +..+++|||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEec
Confidence 47899999999999999999999999998643 233466788999999999999999999998655 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-ccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAH 187 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~~~ 187 (296)
+++++|.+++.. ..+++..+..++.|++.+|++||+.| ++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceeccccccccc
Confidence 999999987754 45899999999999999999999999 9999999999999998 899999999886553321 223
Q ss_pred cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChHHHHHHHHH
Q 022479 188 SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 188 ~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 265 (296)
...++..|+|||.+. ..++.++|+||+|+++|+|++|..||.+......... .....+ ........+..+.+++.+|
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPPKLKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhCCcccCCcccCCHHHHHHHHHH
Confidence 345678899999765 4478899999999999999999999987554443333 222222 2212234578999999999
Q ss_pred Hh-CCCCCCCHHHHhcCcccccccC
Q 022479 266 IA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 266 l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
|+ ||.+||++.+++.||||.+..-
T Consensus 254 l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 254 LVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HhCCcccCcCHHHHhcChHHhccCC
Confidence 97 9999999999999999998774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=282.01 Aligned_cols=250 Identities=27% Similarity=0.490 Sum_probs=205.5
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||.||++.++.+++.+|+|.++.... .+......+.+|+++++.++|+|++++++.+.+. +..+
T Consensus 3 ~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 3 NF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred ce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEE
Confidence 45 689999999999999999999999999999875332 2345567788999999999999999999988665 6889
Q ss_pred EEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 104 FITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+++||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECcccccee
Confidence 99999999999988753 345899999999999999999999999 9999999999999988 7999999999877
Q ss_pred cCCCcc-cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 180 VGRSHA-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
...... .....+++.|+|||.+. ...+.++|+||+|+++|+|++|..||.... +.......+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 643322 22345777899999765 448889999999999999999999996533 223344444443333333445678
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++.+||+ +|.+||++.++++
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHH
Confidence 99999999998 9999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=278.18 Aligned_cols=249 Identities=32% Similarity=0.560 Sum_probs=212.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|++|.||++.+..+++.+++|.+..... .....+.+.+|++++++++|++++++.+.+.+. ..+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 578999999999999999998999999999986543 345567899999999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||+.+++|.+++.....+++..++.++.|++.++.+||++| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCccc
Confidence 99999999999988888999999999999999999999999 9999999999999998 8999999999987654332
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....++..|+|||...+ ..+.++|+|+||+++++|++|..||................ ....+...+..+.+++.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--CCCCCCCCCHHHHHHHHH
Confidence 233456788999997654 37889999999999999999999998766555444443322 223345568899999999
Q ss_pred HHh-CCCCCCCHHHHhcCccc
Q 022479 265 CIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~ 284 (296)
||. +|++||++.++++||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 997 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.07 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=210.4
Q ss_pred ccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
+++.+.||+|+||.||+|.+. .+|+.||+|++............+.+.+|+.+++++ +|++|+++++.+... ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--Ce
Confidence 367899999999999999874 478999999997644333334456788899999999 589999999888544 68
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++|+||+++++|.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 8999999999999999988888999999999999999999999999 9999999999999998 899999999987654
Q ss_pred CCc--ccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCC
Q 022479 182 RSH--AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 182 ~~~--~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 253 (296)
... ......++..|+|||.+.+ ..+.++|+||||+++|+|++|..||..... .............+ .+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCcc
Confidence 322 1223457788999997653 367889999999999999999999964322 22233332222221 2334
Q ss_pred CChHHHHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
.+..+.+++++||+ ||++|| ++++++.||||....|++
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 67899999999998 999997 899999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=285.42 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=205.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.+..+++.+|+|++.... ........+.+|++++++++|+|++++++.+.+.+....++++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 57899999999999999999999999999998654 2333446678899999999999999999998765447899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+ +|..++... ..+++..++.++.|+++||++||+.| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCCc
Confidence 99986 888887654 57999999999999999999999999 9999999999999998 899999999998765432
Q ss_pred -ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------------
Q 022479 185 -AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------------- 247 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 247 (296)
......++..|+|||.+.+ .++.++|+||||+++|+|++|..||........+.........+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1233445778999996653 37889999999999999999999998766544433332211100
Q ss_pred --------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 --------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+.++.+++.+||. +|.+||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111237889999999997 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=285.26 Aligned_cols=243 Identities=30% Similarity=0.530 Sum_probs=195.6
Q ss_pred ceeeecccCcceEEEeeec----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQ----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.+.||+|.||.||+|... ..+..|+||.++.. ......+.+.+|++.+++++|+||+++++++... ..++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccc--cccc
Confidence 5789999999999999987 45678999999542 2455578899999999999999999999999844 5699
Q ss_pred EEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||+++++|.+++... ..++..++..++.|++.||+|||+++ ++|++|+++||+++.+ +.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccc
Confidence 999999999999999886 78999999999999999999999999 9999999999999999 799999999998763
Q ss_pred CCc---ccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 182 RSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 182 ~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
... ..........|+|||.+.+. ++.++||||||+++|+|++ |+.||.+....+.. ..+..+.... .+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 232 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-EKLKQGQRLP-IPDNCPK 232 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-HHHHTTEETT-SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccce-eccchhH
Confidence 221 12333456689999987654 8999999999999999999 78999877554444 4444443333 3445689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++..||. ||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999997 9999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=288.90 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=200.3
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.+..++| ++.++||+|++|.||+|.++.+++.+|+|.+..... .......+.+|+.++++++|+|++++++++....
T Consensus 8 ~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 8 CDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 3455566 579999999999999999999999999999875432 1222344567999999999999999999876542
Q ss_pred ------CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 99 ------HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 99 ------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
....++++||+.+ +|.+++... ..+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl 160 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKL 160 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEE
Confidence 2457999999976 777766643 46899999999999999999999999 9999999999999998 89999
Q ss_pred eccCCccccCCCcc-----cccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHh
Q 022479 172 GDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVT 242 (296)
Q Consensus 172 ~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~--~~~ 242 (296)
+|||.+........ .....++..|+|||.+.+. .+.++|+||||+++|+|++|..||.+......... .+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999976643221 1223456789999976543 67899999999999999999999976544322211 111
Q ss_pred CCCCCC---------------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 243 GGVKPQ---------------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 243 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+..++. ......+..+.++|.+||. ||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 110000 0011235678899999997 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.77 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=225.0
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.....++|.+...||+|.|++|.++.+..++..||+|.++.... +......+.+|+++++.++||||++++.+...+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~- 127 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE- 127 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-
Confidence 34445566889999999999999999999999999999987765 444455699999999999999999999998544
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+|+||||..++.+++++..+++..+.....+..|++.|++|||+++ +||||||++||+++.+ .+++|+|||+++
T Consensus 128 -~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~ 203 (596)
T KOG0586|consen 128 -ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFST 203 (596)
T ss_pred -ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccce
Confidence 899999999999999999999999999999999999999999999999 9999999999999999 689999999999
Q ss_pred ccCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.+.........|+++-|+|||++.+. -.+..|+||||+++|-|++|.+||++..--+-....+.+. ...+...+.
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk---~rIp~~ms~ 280 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK---YRIPFYMSC 280 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee---ecccceeec
Confidence 99988889999999999999988865 6778999999999999999999998743222222222222 223444577
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+-.++|.++|. +|.+|++++++.+|.|.....
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 89999999997 999999999999999976443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=306.10 Aligned_cols=250 Identities=31% Similarity=0.511 Sum_probs=210.5
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
-+||+|.||+||.+.+..+...+|||.+... +....+-+..|+.+-++++|.||++.+|.+.+. ..+-+.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEEeecC
Confidence 5799999999999999999999999999754 333456788999999999999999999998444 6788889999
Q ss_pred CCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-CCcc
Q 022479 110 TSGNLRTYRKKH-RHV--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHA 185 (296)
Q Consensus 110 ~~~sL~~~l~~~-~~~--~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-~~~~ 185 (296)
+||||..++... +++ .+.++--+.+||++||.|||.+. |||||||-+|++|+.-.|.+|+.|||-++++. -+..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999998753 566 78888899999999999999999 99999999999998877999999999998764 4556
Q ss_pred cccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
+....||..|+|||+++. ++..++|||||||.+.||.||++||.+.....-.+-.+---......+...+.+.+.+|
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 778889999999998874 38999999999999999999999997654433322221111122233444578899999
Q ss_pred HHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+|+. ||.+||||.++|..||++.-
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccC
Confidence 99998 99999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=283.97 Aligned_cols=244 Identities=22% Similarity=0.373 Sum_probs=200.9
Q ss_pred cceeeecccCcceEEEeeecCCC-----cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEG-----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++.+.||+|++|.||++.+...+ ..+++|.+.... .......+.+|++++++++|+|++++++.+... ..
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 57899999999999999876554 679999986432 345567789999999999999999999988544 67
Q ss_pred EEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
.++++||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.+
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC
Confidence 89999999999999998754 45788999999999999999999999 9999999999999998
Q ss_pred CCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK 240 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 240 (296)
+.++|+|||++....... ......+++.|+|||.+. +.++.++|+||||+++|+|++ |..||.+....+ ....
T Consensus 161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~~~ 238 (283)
T cd05048 161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIEM 238 (283)
T ss_pred -CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH
Confidence 799999999987643221 122334567899999655 568999999999999999998 999998755543 4444
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+.....+. .+...+.++.+|+.+||+ ||.+||++.++++
T Consensus 239 i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 239 IRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred HHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 44433332 234568999999999997 9999999999988
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.84 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=209.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| .+.+.||+|+||.||++.+..+++.||+|+++.... +....+.+.+|+.++++++|+||+++++.+....
T Consensus 16 ~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3555 679999999999999999998999999999975422 2333566788999999999999999998875432
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...++++++++ +++|.+++... .+++..++.++.|++.||+|||+.| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEeccccc
Confidence 23467788776 66898877654 5999999999999999999999999 9999999999999998 89999999998
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC----------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------- 245 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------- 245 (296)
...... .....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||.................
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 765332 233456788999997654 478899999999999999999999976554433322211100
Q ss_pred ---------------CC---CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCCCC
Q 022479 246 ---------------KP---QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296 (296)
Q Consensus 246 ---------------~~---~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 296 (296)
.. .......++++.+|+..|++ ||.+||++.+++.||||+++..+++.++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~ 315 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 315 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccC
Confidence 00 00011247789999999998 99999999999999999998887776543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=283.64 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=201.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||.|++|.||++.++.+|+.+|+|+++..... .....+.+|+.++++++|+|++++++.+.+. ..+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 5789999999999999999999999999999865332 2235566799999999999999999998665 6789999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 107 EVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||+.+ +|.+++... ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcCC
Confidence 99986 788887653 35899999999999999999999999 9999999999999988 89999999999765332
Q ss_pred c-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------------
Q 022479 184 H-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------------- 247 (296)
Q Consensus 184 ~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------- 247 (296)
. ......++..|++||.+.+ .++.++|+||||+++|++++|..||.+....+...........+
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1223445778999997654 36889999999999999999999998766544433322211000
Q ss_pred -------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 -------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 -------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+..+.+++.+|++ ||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00011246788999999997 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=278.58 Aligned_cols=245 Identities=28% Similarity=0.491 Sum_probs=203.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.++.+++.+|+|.++... .....+.+.+|+.++++++|+|++++.+.+... ..+++++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 67899999999999999999999999999987543 233456788899999999999999999988554 7899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++++|.+++.. ...+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeecccc
Confidence 99999999988864 346899999999999999999999999 9999999999999988 799999999987664332
Q ss_pred c-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 A-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
. .....+++.|+|||.+.+ ..+.++|+||||+++|+|++|..||.................. ..+...+..+.+++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 232 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--PLPSHYSYELRSLI 232 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--CCCcccCHHHHHHH
Confidence 2 223457788999997764 4888999999999999999999999865544444433333222 23344678999999
Q ss_pred HHHHh-CCCCCCCHHHHhcC
Q 022479 263 EKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~h 281 (296)
.+||+ ||++|||+.+++.-
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhCCcccCCCHHHHhhc
Confidence 99997 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=299.47 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=210.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+++.||+|.||+||++.+-. .||||++..... +.+..+.|+.|+.++++-+|-||+-++|++..++ +.+|+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIIT 466 (678)
T ss_pred hccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeee
Confidence 567999999999999998874 499999987654 5668899999999999999999999999998774 59999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
-||+|.+|..++-. ...|...+...|++|+++|+.|||.++ |+|+|||..|||+..+ +.|||+|||+++.....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccceeeeeeecc
Confidence 99999999988752 356899999999999999999999999 9999999999999999 89999999999765432
Q ss_pred -cccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC---CCCCCCCCCCC
Q 022479 184 -HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKVKD 255 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 255 (296)
....-..+...|+|||+++. .++..+|||+||+++|||++|.+||. ....+.+.-.+-.+ .........++
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence 11222345678999997763 38999999999999999999999998 45555554444444 23334445567
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc----C-cccccccCCCCCC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK----D-PFFSELNDDDSEP 294 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~----h-p~~~~~~~~~~~~ 294 (296)
.++++|+..||+ ++++||.+.+||. + +-.-++.+.+++|
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P 667 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEP 667 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCcc
Confidence 899999999998 9999999999987 1 2255666666655
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=279.19 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=208.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.++.+++.+++|++..... .......+.+|++++++++|+|++++.+.+.+. ...++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 578999999999999999999999999999976443 334456778899999999999999999888654 7899999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 107 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 107 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
||+++++|..++.. ...+++..++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhcc
Confidence 99999999998866 456899999999999999999999999 9999999999999998 7999999999987654
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ......++..|+|||.+.+ ..+.++|+||||++++++++|..||...+..+.... ......+ ......+.++.++
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~l 232 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYP-PIPPIYSQDLQNF 232 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCC-CCchhhCHHHHHH
Confidence 4 3333557889999997654 478899999999999999999999987654433333 3332222 2233568899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+.+||. +|++||++.++++||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999997 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=279.71 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred eeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|+||.||++.+... +..+++|.++.... ....+.+.+|++.++.++|+|++++++++.. ...+++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4799999999999999866 88999999976533 2256788999999999999999999998865 47899999
Q ss_pred eccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 107 EVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 107 e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
||+++++|.+++... ..+++.+++.++.|++.||++||+++ ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence 999999999999875 78999999999999999999999999 9999999999999999 89999999999
Q ss_pred cccCCCc---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 178 AIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 178 ~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
....... ......++..|+|||.+.. .++.++|+||||+++|+|++ |..||...... .....+...... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCC-CCCc
Confidence 8765432 2334456788999997664 58899999999999999999 69999876443 344444433322 2334
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
..+.++.+++.+||+ +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 458999999999998 99999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=290.07 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=210.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-- 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 99 (296)
.++| .+.+.||+|++|+||++.+..+++.||+|++.... ........+.+|+.++++++|+||+++.+++.....
T Consensus 14 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 4455 67999999999999999999999999999986432 234445678899999999999999999998864421
Q ss_pred --CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 100 --NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 100 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..++++++|+ +++|..++.. ..+++..++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccc
Confidence 3568999998 6688887764 46999999999999999999999999 9999999999999988 89999999998
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 247 (296)
...... .....+++.|+|||.+.+ ..+.++|+||||+++|++++|..||.+.................
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 765432 223456788999997654 37889999999999999999999998765544433322211100
Q ss_pred --------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 --------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 --------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......+.++.+++.+|+. ||.+|||+.+++.||||+.+..+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~ 310 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence 00112346789999999998 99999999999999999998776655
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=277.80 Aligned_cols=240 Identities=23% Similarity=0.399 Sum_probs=197.4
Q ss_pred eecccCcceEEEeee--cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 31 LLGSGAVKKVYRAFD--QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
.||+|+||.||+|.+ +.+++.+|+|+++... .+....+.+.+|+.+++++.|+|++++++.+.. +..++++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 4568899999987543 245567789999999999999999999988732 467899999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc---
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--- 185 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~--- 185 (296)
+.+++|.+++.....+++..+..++.|++.||++||++| ++|+||+|.||+++.+ +.++|+|||.+........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 9999999999999998 7999999999976643322
Q ss_pred -cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 186 -AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 186 -~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......+..|+|||.+.. ..+.++|+||||+++|+|++ |..||...... .....+.....+. .+...++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 111223468999997664 48889999999999999998 99999875543 3444444433322 3445689999999
Q ss_pred HHHHh-CCCCCCCHHHHhc
Q 022479 263 EKCIA-QPRARPSASELLK 280 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~ 280 (296)
.+||+ ||.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99998 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=279.51 Aligned_cols=239 Identities=22% Similarity=0.311 Sum_probs=191.5
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEeeccC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCT 110 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 110 (296)
||+|+||.||++.++.++..+|+|.+........ |......+ +|+|++++++.+... +.+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---------e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---------EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh---------hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEEcCC
Confidence 5999999999999999999999999975433111 22222222 799999999999765 68999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCC
Q 022479 111 SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190 (296)
Q Consensus 111 ~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (296)
+++|.+++.....+++.++..++.|++.||.+||+.| ++|+||+|+||+++.+.+.++|+|||.+...... ....
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~ 167 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYD 167 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCC
Confidence 9999999988878999999999999999999999999 9999999999999998339999999998765432 2345
Q ss_pred CCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hCCCCCCCCCCCCChHHHHHHHHHHh-
Q 022479 191 GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPEVKAFIEKCIA- 267 (296)
Q Consensus 191 ~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~- 267 (296)
++..|+|||.+.+ .++.++|+||+|+++|+|++|..||............. .............+..+.+++.+||+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence 7789999997764 48889999999999999999999997543222111111 11112222333568999999999998
Q ss_pred CCCCCCC-HHHHhcCccccc
Q 022479 268 QPRARPS-ASELLKDPFFSE 286 (296)
Q Consensus 268 ~p~~Rps-~~~ll~hp~~~~ 286 (296)
+|.+||+ ++++|+||||.+
T Consensus 248 ~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 248 NINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ChhhCCchHHHHhcCCcccC
Confidence 9999996 699999999974
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=284.72 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=208.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+.||+|++|.||++.+..+++.+++|++...... .....+.+.+|..+++++. |+|++++++.+... +.++++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLYFV 80 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEEEE
Confidence 6789999999999999999999999999999764332 2334577889999999998 99999999988544 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||++.+++|.+++...+.++...++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence 999999999999998888999999999999999999999999 9999999999999988 8999999999876543221
Q ss_pred ---------------------cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 022479 186 ---------------------AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 186 ---------------------~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~ 243 (296)
.....++..|+|||... ...+.++|+||||++++++++|..||...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 12234567899999665 44888999999999999999999999876544444443322
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCH----HHHhcCccc
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSA----SELLKDPFF 284 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~----~~ll~hp~~ 284 (296)
. ...+...+..+.+++.+||. +|.+||++ +++++||||
T Consensus 238 ~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 E---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1 12233458899999999997 99999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.23 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=210.3
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-- 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 99 (296)
.++| .+.++||+|++|.||++.+..+++.||+|++..... +......+.+|+.+++++.|+|++++.+.+.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCce-EEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4455 679999999999999999999999999999875422 23345667789999999999999999887754321
Q ss_pred --CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 100 --NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 100 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++++||+ +++|.+++... .+++..++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEcccccc
Confidence 3589999998 45898888764 5999999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ------- 248 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------- 248 (296)
...... .....++..|+|||.+.+ ..+.++|+||||+++|++++|+.||..................+.
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 876433 233456778999997653 478899999999999999999999987665554443322211000
Q ss_pred ---------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 249 ---------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 249 ---------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
......+.++.+++.+||. ||++|||+.+++.||||+++..+..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~ 311 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP 311 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc
Confidence 0011247889999999997 999999999999999999887665443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=290.65 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=200.1
Q ss_pred CCcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
.+| ++.++||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.+++++ +|+||+++++.+..
T Consensus 7 ~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 7 DRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 355 789999999999999997533 45789999987432 233456778899999999 89999999998764
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc-------------------------------------------------------
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH------------------------------------------------------- 121 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------------------------------------- 121 (296)
. ...+++++||+++++|.+++...
T Consensus 83 ~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 P-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred C-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 36788999999999999888532
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc---cccCCCC
Q 022479 122 ------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGT 192 (296)
Q Consensus 122 ------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~ 192 (296)
..++...+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++........ .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999999 9999999999999988 7999999999987532211 2223345
Q ss_pred CCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CC
Q 022479 193 PEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QP 269 (296)
Q Consensus 193 ~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p 269 (296)
..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+.....+........ ....++++.+++.+||+ +|
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA-PEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC-CccCCHHHHHHHHHHccCCh
Confidence 6799999665 558999999999999999998 99999875544444444444333222 33457899999999998 99
Q ss_pred CCCCCHHHHhcC
Q 022479 270 RARPSASELLKD 281 (296)
Q Consensus 270 ~~Rps~~~ll~h 281 (296)
++||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=281.38 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=202.6
Q ss_pred CcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
+| ++.++||+|+||.||+|.++. .+..+|+|.+.... .......+.+|+.++++++|+|++++++.+.+.
T Consensus 7 ~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 7 KI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred Hc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 45 678999999999999987652 34579999876432 233345678899999999999999999988544
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
...+++|||+.+++|.+++... ...+...+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.
T Consensus 82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~~ 157 (288)
T cd05061 82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-FT 157 (288)
T ss_pred -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-Cc
Confidence 6789999999999999998742 23466788899999999999999999 9999999999999998 79
Q ss_pred eEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 022479 169 VKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~ 243 (296)
++|+|||+++....... .....++..|+|||.+. +..+.++|+||||+++|+|++ |..||.+....+..... ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc
Confidence 99999999875432211 11123456799999765 458999999999999999998 78899875554433333 33
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc------CcccccccC
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK------DPFFSELND 289 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~------hp~~~~~~~ 289 (296)
..... .....++.+.+++.+||+ ||++|||+.++++ ||||++++|
T Consensus 237 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 237 GGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 22222 233457899999999997 9999999999987 999999887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=276.73 Aligned_cols=241 Identities=22% Similarity=0.391 Sum_probs=196.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
+.||+|+||.||++.++.+++.+|+|.+.... .......+.+|++++++++|+||+++++++... ..+++|+||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 46999999999999999899999999886432 345567889999999999999999999988554 6899999999
Q ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc--
Q 022479 110 TSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-- 186 (296)
Q Consensus 110 ~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~-- 186 (296)
.+++|.+++.. ...+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence 99999999875 446899999999999999999999999 9999999999999988 79999999998765322111
Q ss_pred -ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 187 -HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 187 -~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.....+..|+|||.+. +..+.++|+||||+++|+|++ |..||....... ........... ......+..+.+++.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 1112235699999765 448889999999999999998 889997654433 33333333222 234456889999999
Q ss_pred HHHh-CCCCCCCHHHHhc
Q 022479 264 KCIA-QPRARPSASELLK 280 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~ 280 (296)
+||+ +|++|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=291.17 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=206.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---- 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 98 (296)
++| .+.+.||+|++|.||+|.++.+|+.+|+|++..... .......+.+|+.++++++|+|++++++++....
T Consensus 15 ~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 455 578999999999999999998999999999875432 2333456788999999999999999999876432
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...++++++|+.. +|..+. +..+++..+..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLAR 165 (342)
T ss_pred CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCCc
Confidence 1356899999875 676654 346899999999999999999999999 9999999999999998 899999999987
Q ss_pred ccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------- 246 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------- 246 (296)
..... .....+++.|+|||.+.+ ..+.++|+||||+++|+|++|+.||.+................
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 65322 223456778999997654 3788999999999999999999999876544443332221100
Q ss_pred -----------CCCC-------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 247 -----------PQAL-------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 247 -----------~~~~-------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
+... ....+..+.+|+.+||+ ||++||++.+++.||||+.+.+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 0000 11246778999999997 999999999999999999998876553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=305.77 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=211.9
Q ss_pred CCCceecCCCCCcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce
Q 022479 13 GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87 (296)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 87 (296)
.....++...+- ++.+.||+|+||.||++.... ....||||.++... +.....+|++|++++..++|+||
T Consensus 477 ~~~~~~i~r~~i--~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 477 DLKVLEIPRSDI--VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ccceeEechhhe--eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCe
Confidence 334444444444 457999999999999997532 24569999998542 45578899999999999999999
Q ss_pred eEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHhhCCCCceec
Q 022479 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH----------R----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHR 153 (296)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~----~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~ 153 (296)
|+++|++.++ +.+++|+||+..|+|.+||... . +++..+...|+.||+.|+.||-++. +|||
T Consensus 552 VrLlGVC~~~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHR 627 (774)
T KOG1026|consen 552 VRLLGVCREG--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHR 627 (774)
T ss_pred EEEEEEEccC--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--cccc
Confidence 9999999655 8899999999999999998742 1 3888999999999999999999999 9999
Q ss_pred CCCCCceEEeCCCCceEEeccCCccccCCC--cc-cccCCCCCCccCcc-ccccCCCcchhHHHHHHHHHHHHh-CCCCC
Q 022479 154 DLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HA-AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-MEIPY 228 (296)
Q Consensus 154 dl~~~nilv~~~~~~~~l~dfg~~~~~~~~--~~-~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 228 (296)
||-..|+||..+ -.|||+|||+++..... .. .+......+||||| ++.+.+++++||||+|+++||+++ |+.||
T Consensus 628 DLATRNCLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 628 DLATRNCLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred chhhhhceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence 999999999999 69999999999865322 11 22344567999999 667889999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 229 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+..+.+.+.-+..+.. .. .+..+|.++.+|+..||+ +|++||++.++=.
T Consensus 707 ~glSn~EVIe~i~~g~l-L~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 707 YGLSNQEVIECIRAGQL-LS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cccchHHHHHHHHcCCc-cc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99877777666655544 33 345569999999999997 9999999999854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=252.78 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=210.2
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
-.++||+|.||+||++.+..+++-||+|.+....- ++-.-....+|+-+++.++|.||++++++.-. ++.+-+|+|
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhs--dkkltlvfe 81 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFE 81 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeHH
Confidence 36899999999999999999999999999987543 33345667899999999999999999998844 478999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 108 VCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 108 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||.. .|..++.. ++.++...+++++.|++.+|.++|+++ +.|||+||.|.+++.| |.+||+|||+++-++-+-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrc 157 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence 9977 78888764 678999999999999999999999999 9999999999999999 9999999999988765442
Q ss_pred cccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC--CCCCC------C-
Q 022479 186 AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP--QALNK------V- 253 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~------~- 253 (296)
.+...-|..|++|.++.+. ++++.|+||.|||+.|+.. |.+.|++.+-.+++..+...-..+ ..++. .
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445568899999988754 9999999999999999988 788888887777776665432211 11111 0
Q ss_pred -----------------CChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 254 -----------------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 254 -----------------~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
....-++|+++++. +|.+|.+++++++||||.+..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 02456789999998 999999999999999998754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=268.32 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=209.9
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEEe
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
....||+|..|+||++..+.+|...|||.+... .+.+..+++...+++..+.. .|+|++++|+|... ..+++.|
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~IcM 170 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFICM 170 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHHH
Confidence 347799999999999999999999999999753 35677788888888887765 89999999999876 4577788
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|.+.- .+..+++. .+++++.-+-++...++.||.||..+ + ++|||+||+|||++.. |++||||||++.++....
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccC-CCEEeecccccceeeccc
Confidence 88754 45555543 46799999999999999999999654 7 9999999999999999 999999999998886655
Q ss_pred ccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC-CCChHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK-VKDPEVK 259 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 259 (296)
......|-+.|+|||.+.- .++.++|+||||+.++++.||.-||.+.+..-.....+....++.-... ..+..++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 5555667788999997762 3888999999999999999999999987666666666666544433332 3689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+++..||. |+.+||...++|+|||+..++.
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 99999997 9999999999999999877654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=310.80 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=199.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||+|.+..+++.||+|++.... .......+++.+|++++++++|||++++++.+.+. +..
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEE
Confidence 456 68999999999999999999999999999997532 23445567899999999999999999999988654 689
Q ss_pred EEEeeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 103 NFITEVCTSGNLRTYRKKH-----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
+++|||++|++|.+++... ...+...+..++.|++.||+|||++| ++||||||+||+++.+ +.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEE
Confidence 9999999999999988631 23566778899999999999999999 9999999999999998 89999
Q ss_pred eccCCccccCCC-------------------cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 022479 172 GDLGFAAIVGRS-------------------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC 231 (296)
Q Consensus 172 ~dfg~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~ 231 (296)
+|||++...... .......+++.|+|||.+.+ ..+.++|+|||||++|+|++|..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999765210 01112458999999997664 4889999999999999999999999764
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 232 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.......................++.+.+++.+||. ||++|++..+.+.
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 443333222222111111223457889999999998 9999987665554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.07 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=206.5
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..++| .+.++||.|+||.||++.++.+++.+|+|.+..... .....+.+.+|++++++++|||++++.+.+.... .
T Consensus 8 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 83 (328)
T cd07856 8 ITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-E 83 (328)
T ss_pred cccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-C
Confidence 44555 689999999999999999999999999999864322 2234566778999999999999999999886533 5
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++++||+. ++|..++... .+++..+..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCcccccccc
Confidence 7889999985 5888877654 4888999999999999999999999 9999999999999988 89999999998765
Q ss_pred CCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---------------- 242 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~---------------- 242 (296)
... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||..............
T Consensus 159 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 159 DPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 332 223456778999997654 478999999999999999999999976543222111110
Q ss_pred -------CCC--CC---CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 243 -------GGV--KP---QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 243 -------~~~--~~---~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
... .+ .......+..+.+++++||+ +|++||++++++.||||.....+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 000 00 00012346889999999998 99999999999999999877766544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.43 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=200.6
Q ss_pred CCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
+||+++.+.||+|+||+||++. ...++..+|+|+++... .......+.+|++++++++|+|++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 5777889999999999998764 34568899999987542 2334567888999999999999999999887665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...++++|||+.+++|.+++... .+++.++..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeeccccc
Confidence 56789999999999999998765 4999999999999999999999999 9999999999999998 799999999998
Q ss_pred ccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHH
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--------------AKIYK 239 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~--------------~~~~~ 239 (296)
....... .....++..|+|||.+. +..+.++|+||||+++|+|++|..||...... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7643221 11223455699999765 45889999999999999999999998543211 11111
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
......... .+...+.++.+++..||+ +|++|||+.+++. +|++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~--~l~~ 280 (283)
T cd05080 236 LLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP--ILKE 280 (283)
T ss_pred hhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH--HHHH
Confidence 111111111 133457899999999998 9999999999997 5544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.36 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=200.9
Q ss_pred eeeeccc--CcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 29 SDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 29 ~~~lg~g--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
...||.| ++|+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++|+||+++++++..+ ..+++++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~ 78 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVIS 78 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEE
Confidence 3457776 899999999999999999999875433 344567889999999999999999999999665 6789999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++++||+.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccC
Confidence 999999999998763 35899999999999999999999999 9999999999999988 799999997653321111
Q ss_pred c--------cccCCCCCCccCccccccC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------
Q 022479 185 A--------AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------ 247 (296)
Q Consensus 185 ~--------~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------ 247 (296)
. .....++..|+|||++.+. ++.++|+||||+++|+|++|..||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 0 0111234569999977643 6889999999999999999999998755444443333221100
Q ss_pred --------------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 248 --------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 248 --------------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.......++.+.+|+.+||+ ||++|||+.++|+||||..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00011235678999999998 999999999999999998876
Q ss_pred CC
Q 022479 289 DD 290 (296)
Q Consensus 289 ~~ 290 (296)
..
T Consensus 316 ~~ 317 (328)
T cd08226 316 EQ 317 (328)
T ss_pred Hh
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=277.49 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=200.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|++|.||++.++.+++.+++|.+... ......+.+|++++++++|++++++++.+... ..+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 81 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEE
Confidence 5689999999999999999989999999998642 22356788999999999999999999988554 6789999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..++...+..++.|++.+|++||+++ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCccccccccce
Confidence 999999999998753 35889999999999999999999999 9999999999999988 899999999997764332
Q ss_pred cc--ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AA--HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~--~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.. .....+..|+|||.+. ...+.++|+||||+++|+|++ |..||.+... +............. .....+.++.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYRME-RPEGCPPKVYE 236 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCCCC-CCCCCCHHHHH
Confidence 21 1222356799999765 458889999999999999998 9999987544 44444454443333 33446899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhc
Q 022479 261 FIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+||+ ||++||++.++++
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 9999998 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.02 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=207.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
...++||+|++|+||++.+..+++.+++|++..... ........+.+|+++++.++|+|++++++.+.+. ...++++
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 346789999999999999998999999999975433 2334456788899999999999999999998665 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+ ++.+++.. ...+++.++..++.|++.++.|||++| ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASKSSP--- 173 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCCcccCC---
Confidence 99976 66666654 557899999999999999999999999 9999999999999988 7999999998865332
Q ss_pred cccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 AHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....++..|+|||.+. +..+.++|+||||+++|+|++|..||................. +.......+..+++|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-PTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCHHHHHH
Confidence 22345678899999763 4478899999999999999999999987666665555544332 223333457789999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+.+||+ +|.+||++.+++.||||...+
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999998 999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=281.96 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=203.4
Q ss_pred ccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.+.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|+.++++++|++++++++.+... .
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 36789999999999999985 234567899988643 344567789999999999999999999998654 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC
Q 022479 101 TLNFITEVCTSGNLRTYRKKHR-------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
.+++++||+.+++|.+++...+ .+++.++..++.|++.||++||++| ++|+||+|+||+++.+ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~-~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-L 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-C
Confidence 8999999999999999987543 4899999999999999999999999 9999999999999998 8
Q ss_pred ceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 022479 168 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT 242 (296)
Q Consensus 168 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~ 242 (296)
.++|+|||.+........ .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+..... .
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-T 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-H
Confidence 999999999876532211 12233466899999766 458899999999999999998 99999876655444443 3
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.+.... .....+.++.+++.+||+ ||.+|||+.+++. .++++...
T Consensus 237 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~~~ 282 (288)
T cd05093 237 QGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLAKA 282 (288)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHHHh
Confidence 332222 233467899999999998 9999999999977 66666543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=284.54 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=201.0
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-------
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ------- 98 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 98 (296)
+.+.++||+|++|+||++.++.+++.+|+|+++.... .......+.+|++++++++|+|++++++.+.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 3678999999999999999999999999999976432 2222346678999999999999999998886542
Q ss_pred -CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
...+++++||+.+ ++..++.. ...+++..+..++.|++.||+|||+.| ++|+||+|+||+++.+ +.++|+|||.
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcccc
Confidence 2378999999987 66666654 346899999999999999999999999 9999999999999998 8999999999
Q ss_pred ccccCCCcc--cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCCC-
Q 022479 177 AAIVGRSHA--AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQA- 249 (296)
Q Consensus 177 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~- 249 (296)
+........ ......+..|+|||.+.+ ..+.++|+||||+++++|++|+.||......+.+...... ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 987643321 122334668999997653 3688999999999999999999999865554443332221 111000
Q ss_pred ------------------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 250 ------------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 250 ------------------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.....+..+.+++..||+ ||.+||++.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112347899999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=287.06 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| .+.++||+|++|.||++.++.+++.+++|++...... ......+.+|++++++++|+||+++++.+.+..
T Consensus 7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 3566 6899999999999999999999999999999764331 112235678999999999999999998776433
Q ss_pred ---CCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 99 ---HNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 99 ---~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
...++++++|+.+ ++...+. ....+++.++..++.|+++||+|||+.| ++|+||+|+||+++.+ +.++|+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcC
Confidence 2367999999987 5655554 4557999999999999999999999999 9999999999999998 89999999
Q ss_pred CCccccCCCccc------------ccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022479 175 GFAAIVGRSHAA------------HSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240 (296)
Q Consensus 175 g~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~ 240 (296)
|++......... ....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+..........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765332211 11234677999997653 3788999999999999999999999876654433322
Q ss_pred HhCCCC--C---------------CCC----------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 241 VTGGVK--P---------------QAL----------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 241 ~~~~~~--~---------------~~~----------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
...... + ... ....+..+.+++.+||+ ||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 211100 0 000 01123678899999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=285.48 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=207.6
Q ss_pred cceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 102 (296)
++.+.||+|++|.||++.+. .+++.+|+|+++...........+.+.+|+.+++++ +|++++++.+.+... ..+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CEE
Confidence 57899999999999998853 457889999997544333344556788999999999 599999999888544 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++|+||+.+++|.+++.....+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence 999999999999999987778999999999999999999999999 9999999999999998 8999999999876533
Q ss_pred Ccc--cccCCCCCCccCccccccC---CCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCCC
Q 022479 183 SHA--AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 183 ~~~--~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
... .....++..|+|||.+.+. .+.++|+||||+++|+|++|..||.... ............. ...+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCccc
Confidence 221 2234578899999976543 6889999999999999999999996322 1222222222221 1223446
Q ss_pred ChHHHHHHHHHHh-CCCCCCC---HHHHhcCcccccccCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPS---ASELLKDPFFSELNDDD 291 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps---~~~ll~hp~~~~~~~~~ 291 (296)
+..+.+++.+||+ ||++||| +.++|+||||+.+.|+.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 7899999999997 9999998 56779999999999973
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=286.87 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=198.0
Q ss_pred cceeeecccCcceEEEeeecC--CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
++.++||+|++|.||+|.++. +++.||+|.+..... ......+.+.+|+.++++++|||++++++.+.+.....+++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 578999999999999999988 799999999986431 12233456778999999999999999999998765578999
Q ss_pred EeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC----CCCceEEeccC
Q 022479 105 ITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----NIGQVKIGDLG 175 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~----~~~~~~l~dfg 175 (296)
|+||+.+ +|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++. + +.++|+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPER-GVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCcc-ceEEECCCc
Confidence 9999986 66666542 236899999999999999999999999 999999999999998 6 799999999
Q ss_pred CccccCCCcc----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q 022479 176 FAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---------KIYKK 240 (296)
Q Consensus 176 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~---------~~~~~ 240 (296)
++........ .....++..|+|||.+.+ .++.++|+||||+++++|++|..||.+..... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886643222 223356788999996654 37889999999999999999999997543211 01000
Q ss_pred HhC-----------------------CCCCCCCC-----------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 241 VTG-----------------------GVKPQALN-----------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 241 ~~~-----------------------~~~~~~~~-----------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
... ........ ...+..+.+++.+||+ ||++|||+.+++.||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00000000 1346789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=282.46 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=204.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.+..+++.+++|.++.... .......+.+|+.++++++|++++++++.+..+ ..+++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence 467889999999999999998999999999876543 223456788899999999999999999988655 7899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+ +|..++.. ...+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcc
Confidence 99986 77777765 467999999999999999999999999 9999999999999988 799999999997765443
Q ss_pred ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------------
Q 022479 185 AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------------- 247 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 247 (296)
......++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+...........+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2223446778999996653 47889999999999999999999998766655544433221110
Q ss_pred ------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 ------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 ------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+.++.++|.+||+ ||.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00112246789999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=275.40 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=198.7
Q ss_pred eeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|+||.||+|....++ ..+|+|.+..... ....+.+.+|+.+++.+.|+|++++++.+.. +.+++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 47999999999999875554 7899999875543 2345678899999999999999999987642 4689999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+.+++|.+++.....+++..+..++.|++.+|++||..+ ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999999 9999999999999998 89999999998766433221
Q ss_pred c----cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 187 H----SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 187 ~----~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
. ...++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+ ....+...... ......+..+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERL-PRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHHcCCcC-CCCCCCCHHHHH
Confidence 1 111235799999765 448889999999999999998 999997755443 33444443322 233446889999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++.+||. +|++||++.++++ .|.++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~--~l~~~ 255 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES--TFRRD 255 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH--HHHhc
Confidence 9999998 9999999999988 55543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=275.52 Aligned_cols=251 Identities=30% Similarity=0.535 Sum_probs=204.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|++|.||+|.+..+|+.+|+|.++.... .+....+.+.+|++++++++|++++++++.+... +..
T Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~ 77 (267)
T cd08224 2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NEL 77 (267)
T ss_pred Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 345 679999999999999999998999999999875432 2334467888999999999999999999998655 688
Q ss_pred EEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 103 NFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
++++||+.+++|..++.. ...++..++..++.|++.+|++||+.| ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceee
Confidence 999999999999998864 345899999999999999999999999 9999999999999988 899999999987
Q ss_pred ccCCCc-ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCC
Q 022479 179 IVGRSH-AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 179 ~~~~~~-~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
...... ......++..|.|||.+. ..++.++|+||||+++|+|++|..||.... +..........+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 654322 223345778899999765 448889999999999999999999996432 22233333333333333333567
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+.+++.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999997 9999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.29 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=214.4
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||+|-||+||-++++++|+.||||++.+..+...+ ..++++|+.+|+++.||.|+.+...+ +..+.+++|||-+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl 645 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKL 645 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhh
Confidence 8999999999999999999999999999887774433 37899999999999999999997666 3448899999999
Q ss_pred CCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccccCCCccc
Q 022479 110 TSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 110 ~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~~~~~~~ 186 (296)
.|.-|+-.+. +.+++++..-+-++.||+.||.|||-++ |+|+||||+|||+.... ..+||||||.++..++..-.
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 9976666665 4678999999999999999999999999 99999999999998653 48999999999999887777
Q ss_pred ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
.+..|||.|+|||++. +.+..+.|+||.|+|+|--++|..||.+..++...++...-- -+..++.-++...-+||..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCCchhhcCHHHHHHHHHH
Confidence 7888999999999776 559999999999999999999999998655544433322222 23334444688899999999
Q ss_pred Hh-CCCCCCCHHHHhcCcccccc
Q 022479 266 IA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 266 l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
|+ .-.+|.|.++.|.|||++++
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHhcchHhhccchhhhcc
Confidence 98 99999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.50 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=213.2
Q ss_pred ceeeecccCcceEEEeeecCCCc---E-EEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGI---E-VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~---~-~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.++||+|+||.||++..+..+. . ||+|..+.+. ....+.+..+.+|++++++++|+||++++|+.... ..++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EPLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CccE
Confidence 45999999999999999876432 3 8999988532 12577788999999999999999999999998766 6899
Q ss_pred EEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+|||++.||+|.++++..+ .++..+...++.+.+.||+|||+++ ++||||-..|+|++.+ +.+|++|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcc
Confidence 9999999999999999876 5999999999999999999999999 9999999999999998 6899999999887653
Q ss_pred Ccccc-cCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 183 SHAAH-SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 183 ~~~~~-~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
..... ......+|+|||.+.. .++.++||||+|+++||+.+ |..||.+....+....+...+..... +...+.++.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-PSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-CCCCHHHHH
Confidence 32222 2235679999997764 59999999999999999999 88899998777666666566555444 446689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.++.+||. +|++||++.++.+ +++.+...
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~ 423 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK--KLEALEKK 423 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH--HHHHHHhc
Confidence 99999997 9999999999988 55554443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=279.63 Aligned_cols=252 Identities=29% Similarity=0.400 Sum_probs=199.6
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeeeeeeCCC---C
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDDQH---N 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---~ 100 (296)
++.++||+|++|.||++.++.+++.+|+|++..... .......+.+|+.+++++ +|+|++++++.+..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 578999999999999999998899999999975533 222234455677766665 59999999999876531 2
Q ss_pred eEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 101 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
.+++++||+.+ +|.+++... ..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcce
Confidence 48999999986 788888763 35899999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------- 247 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 247 (296)
............++..|+|||.+. ..++.++|+||||+++|+|++|..||......+...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 775444334445678899999765 448889999999999999999999998765554444333211100
Q ss_pred -----------CCC---CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 -----------QAL---NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 -----------~~~---~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
... ....+..+.+++.+||+ ||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 01124678899999997 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=275.40 Aligned_cols=244 Identities=27% Similarity=0.469 Sum_probs=205.8
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||.|++|.||++.+..+++.+++|++..... ........+..|+.++++++|++++++++.+.. ...++++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 6999999999999988899999999976543 233456788999999999999999999988854 3789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-cccccCC
Q 022479 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSII 190 (296)
Q Consensus 112 ~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 190 (296)
++|.+++.....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.+ +.++|+|||.+...... .......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence 999999998878999999999999999999999999 9999999999999998 79999999999876443 2234455
Q ss_pred CCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-C
Q 022479 191 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q 268 (296)
Q Consensus 191 ~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~ 268 (296)
++..|+|||...+. .+.++|+||||+++|++++|..||...+. ......+... ....+...+..+.+++.+||. |
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence 67789999976644 78899999999999999999999976554 3333333332 223344458899999999997 9
Q ss_pred CCCCCCH---HHHhcCccc
Q 022479 269 PRARPSA---SELLKDPFF 284 (296)
Q Consensus 269 p~~Rps~---~~ll~hp~~ 284 (296)
|++||++ +++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.71 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=206.0
Q ss_pred cceeeecccCcceEEEeeecCC--CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC--CCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD--QHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 101 (296)
++.+.||+|+||.||++.+..+ +..+|+|++..... .......+.+|+.+++++ .|+||+++++..... ....
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 6789999999999999999888 89999999874322 233456677899999999 599999998865322 2256
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++++++. ++|..++.....+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceecc
Confidence 788888886 489999988888999999999999999999999999 9999999999999998 899999999997654
Q ss_pred CCcc-----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC----------
Q 022479 182 RSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---------- 244 (296)
Q Consensus 182 ~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~---------- 244 (296)
.... .....++..|+|||.+.+ .++.++|+||||+++|++++|..||...+........+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 223457888999996643 47899999999999999999999997655433222211110
Q ss_pred ---------------CCC---CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 245 ---------------VKP---QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 245 ---------------~~~---~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
... .......+..+.+|+.+||+ ||++|||+.+++.||||+.+.++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~ 304 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence 000 01112246789999999998 99999999999999999988776544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=283.66 Aligned_cols=260 Identities=26% Similarity=0.468 Sum_probs=204.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
+.| ++.++||+|++|.||++.++.+++.+|+|.++.... ......+..++.++.+. .|+|++++++.+.+. ..
T Consensus 15 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~ 88 (296)
T cd06618 15 NDL-ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SD 88 (296)
T ss_pred chh-eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--Ce
Confidence 344 678999999999999999998899999999975432 22344555677666666 499999999998654 67
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+++++||+.+ ++..++.. ...+++..+..++.|++.+|+|||+ .+ ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchh
Confidence 9999999865 67666654 4578999999999999999999997 58 9999999999999988 8999999999877
Q ss_pred cCCCcccccCCCCCCccCccccccC-----CCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (296)
...........++..|+|||.+.+. .+.++|+||||+++|+|++|+.||...... +.+................
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 6543333344567789999977533 688999999999999999999999754332 2333333332221112223
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.+.++.+|+.+||. ||.+||++++++.||||.......+
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence 57899999999997 9999999999999999998766544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.02 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=199.8
Q ss_pred cceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.+.||+|+||.||++.+.. +++.+|+|.++... .....+.+.+|++++++++|+|++++++.+... ..
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 578999999999999998743 35789999987542 233567889999999999999999999998655 78
Q ss_pred EEEEeeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH--------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
.+++|||+++++|.+++... ..+++.++..++.|++.++.+||++| ++|+||+|+||+++.+ +
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD-L 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC-C
Confidence 99999999999999998753 34788899999999999999999999 9999999999999999 8
Q ss_pred ceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 022479 168 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT 242 (296)
Q Consensus 168 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~ 242 (296)
.++|+|||++........ ......++.|+|||.+. +.++.++|+||||+++|+|++ |..||.+....+..... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~-~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-T 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-H
Confidence 999999999875432211 22233467899999765 458889999999999999998 99999876555444433 3
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+... ......+..+.+++.+||+ ||++||++.++++
T Consensus 239 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33322 2234568999999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=276.90 Aligned_cols=247 Identities=19% Similarity=0.325 Sum_probs=199.1
Q ss_pred cceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC----
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---- 99 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 99 (296)
+++++||+|+||.||+|.+..+ +..+|+|.++.... .......+.+|+..++.++|+|++++++.+.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5789999999999999987653 47899999875433 34456788999999999999999999998765432
Q ss_pred CeEEEEeeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
...++++||+.+++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEECC
Confidence 3579999999999999887432 36899999999999999999999999 9999999999999998 7999999
Q ss_pred cCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 174 LGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 174 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
||++........ ......+..|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+... .+.......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-YLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCC
Confidence 999876533211 11223456799999765 448999999999999999999 899998765544443 333333322
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+...+..+.+++.+||+ ||++|||+.++++
T Consensus 236 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 236 -QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred -CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234568899999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=290.99 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=197.9
Q ss_pred cceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 100 (296)
.++++||+|+||+||+|.+.. ++..||+|+++... .....+.+.+|+++++++. ||||+++++.+.+. .
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--~ 114 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS--G 114 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--C
Confidence 578999999999999998643 24579999997542 2344567889999999996 99999999998554 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc-----------------------------------------------------------
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------------------------------------------------------- 121 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 121 (296)
.+++||||+++++|.+++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 899999999999999887542
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 122 -------------------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 122 -------------------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~ 272 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeC
Confidence 23778888999999999999999999 999999999999999
Q ss_pred CCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022479 165 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK 239 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~ 239 (296)
+ +.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........
T Consensus 273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 8 7999999999876533221 22234567899999765 458999999999999999997 9999987555455555
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+....... .....+.++.+++.+||+ ||++||++.++.+
T Consensus 352 ~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 555543332 234458899999999998 9999999999877
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=277.40 Aligned_cols=250 Identities=30% Similarity=0.541 Sum_probs=204.3
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||+|++|.||++.++.+++.+++|.+..... ........+.+|+.+++.++|+|++++++.+.+. +.++
T Consensus 3 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 3 NF-RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 78 (267)
T ss_pred hh-hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEE
Confidence 44 578999999999999999998999999999875432 1334456788999999999999999999998665 6899
Q ss_pred EEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 104 FITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+++||+.+++|.+++.. ...+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhc
Confidence 99999999999998763 456899999999999999999999999 9999999999999988 8999999999876
Q ss_pred cCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCCCh
Q 022479 180 VGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS-VAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
...... .....++..|+|||.+.+ ..+.++|+||||+++|+|++|..||.+... .......+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 643322 233467889999997654 488899999999999999999999965332 23333333333333333445688
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++++++.+||+ ||.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999997 9999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=277.00 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=195.9
Q ss_pred ccceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+++.+.||+|++|.||++.++ .++..+|+|++.... .......+.+|+.+++.++|+|++++++.+.+. .
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~ 82 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--Q 82 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--C
Confidence 468999999999999998764 235679999986432 233456688999999999999999999988544 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
..++++||+.+++|.+++... ..++...+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~-~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-CCEE
Confidence 889999999999999998652 23567888999999999999999999 9999999999999998 8999
Q ss_pred EeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 022479 171 IGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 171 l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
|+|||++........ .....++..|+|||.+. +.++.++|+||||+++|+|++ |..||.+........... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875532211 11223467899999766 458999999999999999999 789998765544333333 322
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
. .......++.+.+++.+||+ ||++|||+.+++++
T Consensus 239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22344568899999999998 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=277.12 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=198.9
Q ss_pred ccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.+.++||+|++|.||+|.+.. ++..+++|.+.... .......+.+|+.++++++|+|++++++.+.+. .
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 4678999999999999999976 67889999886432 234456788899999999999999999988654 5
Q ss_pred eEEEEeeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEE
Q 022479 101 TLNFITEVCTSGNLRTYRKKHR-------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKI 171 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l 171 (296)
..++++||+.+++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+. ..++|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 7889999999999999987643 5889999999999999999999999 99999999999998651 26999
Q ss_pred eccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 022479 172 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 172 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+|||++........ ......+..|+|||.+. +.++.++||||||+++|+|++ |..||.+.... .....+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCc
Confidence 99999976532211 11222345799999765 558999999999999999997 99999875543 34444444333
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
... +...+..+.+++.+||+ +|++|||+.++++|
T Consensus 240 ~~~-~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDP-PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 332 34458899999999998 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=275.80 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=197.6
Q ss_pred cceeeecccCcceEEEeeecCCCc--EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----CC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI--EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----HN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 100 (296)
.++++||+|+||.||++.+..++. .+|+|.++.... .....+.+.+|+.+++.++|+|++++++.+.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 368899999999999999877665 689999875432 4455678889999999999999999998764321 23
Q ss_pred eEEEEeeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 101 TLNFITEVCTSGNLRTYRKK------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
..++++||+.+++|..++.. ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.+ +.++|+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCC
Confidence 57889999999999988742 235889999999999999999999999 9999999999999988 79999999
Q ss_pred CCccccCCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 175 GFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 175 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
|++........ ......++.|++||...+ .++.++|+||||+++|+|++ |..||.+....+ ....+..+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCCCC-
Confidence 99987643221 122335668999997654 48899999999999999999 899998755443 334344433222
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.....+..+.+++.+||+ ||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233457889999999997 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.37 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=199.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
..| ++.+.||+|+||+||+|.+..+++ .+|+|+++... .....+++.+|+.+++.++|+||+++++.+...
T Consensus 7 ~~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 345 678999999999999998766555 38999986432 344567788999999999999999999988643
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++++|+.+++|.+++... ..++...+..++.|++.||+|||+++ ++|+||||+||+++.+ +.++|+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a 156 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLA 156 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEcccccc
Confidence 467899999999999998764 46889999999999999999999999 9999999999999998 79999999999
Q ss_pred cccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 178 AIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 178 ~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
........ ......+..|+|||.+. ..++.++|+||||+++|+|++ |..||.+.... .+............ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLPQ-PP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCCCCCC-CC
Confidence 87643222 12223456799999765 458999999999999999998 99999865443 33444444333222 33
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.++..+.+++.+||+ +|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 457899999999997 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=282.34 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=197.8
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+++.+|. .+.||.+.+..+++.+|+|++..... .....+.+.+|++++++++|+||+++++.+.+. +.+++++|
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e 79 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSP 79 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEe
Confidence 3444444 45566666677899999999986532 345567899999999999999999999988655 67899999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 108 VCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 108 ~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccc
Confidence 9999999999875 346899999999999999999999999 9999999999999988 8999999998865432111
Q ss_pred --------cccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------
Q 022479 186 --------AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------- 247 (296)
Q Consensus 186 --------~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 247 (296)
.....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||..........+...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 122335667999997754 37889999999999999999999998765554444433322110
Q ss_pred ------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 248 ------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 248 ------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.......+.++.+|+..||. ||++|||+.++|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 00001113578899999998 9999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=272.89 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=195.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||.||++..+. +..+|+|.+..... ....+.+|+.++++++|+|++++++.+... ..++++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 78 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVT 78 (256)
T ss_pred EEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEE
Confidence 568899999999999998764 56899998864322 135678899999999999999999988544 6899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCCce
Confidence 99999999999874 356899999999999999999999999 9999999999999988 7999999999876532221
Q ss_pred c--ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 A--HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 ~--~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ....++..|+|||.+. ..++.++|+||||+++|+|++ |+.||......+....... +... ..+...+.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~-~~~~~~~~~~~~l 233 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRL-YRPKLASMTVYEV 233 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCC-CCCCCCCHHHHHH
Confidence 1 1223445799999776 458899999999999999999 8999987655444444333 3222 2234457899999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+||+ +|++|||+.++++
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=279.77 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=210.6
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.++...| ...+.||+|+||.||++.+..++..+|+|++..... ........+.+|++++++++|+|++++++.+.+.
T Consensus 21 ~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 97 (317)
T cd06635 21 EDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE- 97 (317)
T ss_pred CCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-
Confidence 3444445 568999999999999999998999999999875432 2344556788999999999999999999998655
Q ss_pred CCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...++++||+.| +|.+.+. ....+++.++..++.|++.+|.+||+++ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 98 -~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg~~ 172 (317)
T cd06635 98 -HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSA 172 (317)
T ss_pred -CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCCCc
Confidence 678999999986 6666654 4567899999999999999999999999 9999999999999988 89999999988
Q ss_pred cccCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
..... .....++..|+|||.+. +..+.++|+||||+++|+|++|..||.................. ......
T Consensus 173 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 248 (317)
T cd06635 173 SIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-TLQSNE 248 (317)
T ss_pred cccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-CCCCcc
Confidence 75432 22345778899999753 34888999999999999999999999876655555555444332 223344
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.+..+++++.+||+ +|.+||++.++++|+|+....
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 57889999999997 999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=324.02 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=225.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
..+.+||.|.||.||-|.+..+|+..|+|-+..... .....+...+|+.++..++|||+++.+|+-+.. ..+++-|
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence 347899999999999999999999999999976543 355567788999999999999999999987655 6788899
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC---
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--- 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~--- 183 (296)
|||.||+|.+.++.++-.++.....+..|+++|++|||++| ||||||||.||+++.+ |.+|++|||.|......
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence 99999999999999887888888888999999999999999 9999999999999999 89999999999766332
Q ss_pred --cccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 184 --HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 184 --~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.......||+-|+|||++-+ +...+.|||||||++.||+||+.||...++.=.++-.+-.+..|+.+.. .+.+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 23456789999999998764 3677999999999999999999999988887777777777777777666 7999
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
-++++..||+ ||++|.++.|+|.|.|-+.-..+++.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s~ 1506 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDSS 1506 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccccccccchh
Confidence 9999999997 99999999999999997765555543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=273.93 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=199.0
Q ss_pred cceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
++.+.||+|+||+||+|.++.+ ...+|+|+++... .......+.+|+.++++++|+|++++++.+... ..++
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVM 81 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceE
Confidence 6789999999999999988654 4579999886432 344566788999999999999999999988544 6799
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++||+.+++|.+++.. .+.++...+..++.|++.|+++||+++ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence 99999999999999875 457899999999999999999999999 9999999999999998 7999999999987642
Q ss_pred Ccc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 183 SHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 183 ~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
... ......+..|+|||.+. ..++.++|+||||+++|++++ |..||......... ..+....... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDGYRLP-PPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHHcCCCCC-CCCCCCHH
Confidence 111 11223456899999766 458899999999999999998 99999765544433 3333332222 22345889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+++..||+ +|++||++.++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=276.16 Aligned_cols=242 Identities=25% Similarity=0.399 Sum_probs=200.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.++||+|++|+||+|.++. +..+++|++.... ......+.+|+.+++.++|+|++++++.+... ..++++|
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 81 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYIIT 81 (261)
T ss_pred HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEEE
Confidence 678999999999999999987 8899999987542 22356788899999999999999999988554 6899999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++.. +..++...+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCCcc
Confidence 99999999999975 456899999999999999999999999 9999999999999998 899999999997654321
Q ss_pred c-cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 185 A-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 185 ~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. .....++..|+|||.+. +.++.++|+||||+++|+|++ |..||......+...... ....... ....+.++.++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~ 236 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPC-PAKCPQEIYKI 236 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCC-CCCCCHHHHHH
Confidence 1 12223456799999665 458889999999999999998 899998765544444433 3332222 34568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+||+ ||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=280.77 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=195.1
Q ss_pred cceeeecccCcceEEEeeecCCCcE--EEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.+.+.||+|+||.||+|.++.++.. +++|.++.. ........+.+|+.++.++ +|+|++++++.+... ..++
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~ 84 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 84 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence 6789999999999999998877765 466665421 2344567788999999999 899999999988544 7899
Q ss_pred EEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC
Q 022479 104 FITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
+++||+++++|.+++... ..+++.+++.++.|++.|++|||++| ++|+||+|+||+++.+ +
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~-~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-Y 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC-C
Confidence 999999999999998643 25789999999999999999999999 9999999999999988 7
Q ss_pred ceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 022479 168 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
.++|+|||++..............+..|+|||.+.+ .++.++|+||||+++|+|++ |..||......+ .........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGY 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcCC
Confidence 999999999864322212222233567999997654 47889999999999999998 999997655443 333333332
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.... ....++.+.+|+.+||+ +|++||++.+++.+
T Consensus 241 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 23357899999999998 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=278.93 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=195.2
Q ss_pred cceeeecccCcceEEEeeecCCCc--EEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI--EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 103 (296)
++.++||+|+||.||++.++.++. .+++|.++... .....+.+.+|+.+++++ +|||++++++.+... ..++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 678999999999999999887765 46788776321 334456788999999999 799999999988544 6789
Q ss_pred EEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC
Q 022479 104 FITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
+++||+++++|.+++... ..+++..+..++.|++.||++||++| ++|+||+|+||+++.+ +
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN-L 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC-C
Confidence 999999999999998653 24888999999999999999999999 9999999999999988 7
Q ss_pred ceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 022479 168 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
.++|+|||++..............+..|+|||.+.+ .++.++|+||||+++|+|++ |..||......+.. .......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-EKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhcCC
Confidence 999999999865432212222223457999997654 48899999999999999997 99999875554433 3333332
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
... .....+.++++|+.+||+ +|.+||+++++++.
T Consensus 236 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222 234468899999999998 99999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=273.47 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=197.4
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|++|.||++.+. ++..+|+|.+.... ...+.+.+|+.++++++|+|++++++.+.+. +..+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 378899999999999999865 46779999876432 2256788999999999999999999888544 678999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||+++++|.+++.. ...++...+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceecCCC
Confidence 999999999999864 456889999999999999999999999 9999999999999998 89999999999876432
Q ss_pred cc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .....++..|+|||.+. +..+.++|+||||+++|+|++ |..||.+......... +........ ....+.++.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPR-MENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCC-CCCCCHHHH
Confidence 21 11223456799999765 458889999999999999998 9999987555444333 333332222 234688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+++.+||. +|++||+++++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=277.94 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=201.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+.||+|++|+||+|....+++.+++|.+...... .......+|+..+++++ |+|++++++.+.+ ....+++
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 76 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFV 76 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEE
Confidence 5788999999999999999988999999998754321 11233456889999999 9999999999865 3789999
Q ss_pred eeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+ +++|.+++.... .+++.++..++.|++.+|.+||+++ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccCC
Confidence 9999 668888887654 7899999999999999999999999 9999999999999998 89999999999876554
Q ss_pred cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------------
Q 022479 184 HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------------- 247 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 247 (296)
.......++..|+|||.+.+ .++.++|+||||+++++|++|+.||......+...........+
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 44444557788999997643 37889999999999999999999997765554443322110000
Q ss_pred -------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 -------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 -------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.......+..+.+++.+||+ ||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00011125789999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=272.51 Aligned_cols=242 Identities=22% Similarity=0.400 Sum_probs=196.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|+||.+..+. +..+|+|.+..... ..+.+.+|+.++++++|||++++++++... ..++++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEE
Confidence 578999999999999997653 45699999874332 135688899999999999999999988544 6789999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++... ..+++.+++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCCCce
Confidence 999999999998763 46899999999999999999999999 9999999999999988 7999999999876533221
Q ss_pred --cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....++..|+|||.+. +.++.++|+||||+++|+|++ |..||......+.... +...... ......+..+.++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-VSQGLRL-YRPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HhcCCCC-CCCCCCCHHHHHH
Confidence 11223456799999776 458889999999999999998 9999976554443333 3333222 2234458899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcC
Q 022479 262 IEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~h 281 (296)
+.+||+ +|.+||++.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999997 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=272.75 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=198.5
Q ss_pred eeecccCcceEEEeeecC-CC--cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQE-EG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|++|+||++.+.. .+ ..+|+|.+...... ...+.+.+|+.++++++|+|++++++.+.+ ..+++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 479999999999999865 33 36899999765432 567889999999999999999999998865 6789999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++.... .+++..++.++.|++.||++||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence 9999999999987653 6899999999999999999999999 9999999999999999 899999999998764321
Q ss_pred c----cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 185 A----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 185 ~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
. .....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||......+........... .......+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-LERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-CCCCccCCHHH
Confidence 1 112345668999997764 58899999999999999999 99999776655544444432222 22233467899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhc
Q 022479 259 KAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+++..||+ +|++|||+.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=276.25 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=199.6
Q ss_pred CCcccceeeecccCcceEEEeee----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
++++++.++||+|+||.||++.. +.++..+|+|.++... .......+.+|+.++++++|+|++++.+.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 56778899999999999999974 4568899999986432 3445677999999999999999999999887665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++++||++|++|.+++... ..+++.++..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCccc
Confidence 57789999999999999998754 46899999999999999999999999 9999999999999998 79999999999
Q ss_pred cccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHH
Q 022479 178 AIVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC--------------DSVAKIY 238 (296)
Q Consensus 178 ~~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~--------------~~~~~~~ 238 (296)
........ .....++..|+|||.+. +.++.++|+||||+++|+++++..|+... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 86643221 12234566799999655 45889999999999999999987654221 1111122
Q ss_pred HHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......... ......+..+.+|+.+||+ ||++|||+.++++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 222222211 1233468899999999998 9999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=272.03 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=195.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.++ ++..+|+|++..... . ...+.+|++++++++|+|++++++.+... ..+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--S---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVT 78 (256)
T ss_pred chhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--C---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEEE
Confidence 57899999999999999876 467899999864332 1 24577899999999999999999987544 6889999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+++++|.+++.. ...+++..+..++.|++.|+++||+.| ++|+||+|+||+++.+ +.++|+|||.++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceecccccc
Confidence 99999999999875 446899999999999999999999999 9999999999999998 8999999999876533211
Q ss_pred c--ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 A--HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 ~--~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. .....+..|+|||.+. +.++.++|+||||+++|++++ |..||......+.. ..+........ +...+.++.++
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l 233 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAGYRLYR-PKLAPTEVYTI 233 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHcCCcCCC-CCCCCHHHHHH
Confidence 1 1112334799999765 458889999999999999999 89999765554443 33333332222 34468999999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+||. +|++|||+.++++
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=279.45 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=209.4
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+..+| ...+.||+|++|.||++.++.+++.+++|.+...... ......++.+|+++++.++|+|++++.+.+... .
T Consensus 13 ~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 88 (308)
T cd06634 13 PEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--H 88 (308)
T ss_pred cHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--C
Confidence 44445 4578899999999999999999999999998753222 334456788899999999999999999988655 6
Q ss_pred eEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..++|+||+.+ ++.+.+. ....+++.++..++.|++.++.+||+++ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 89 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCccccee
Confidence 78999999975 7766664 4556899999999999999999999999 9999999999999988 8999999999876
Q ss_pred cCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
.... ....++..|+|||.+. +..+.++|+||||+++|+|++|..||................ .+.......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWS 240 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCCcCccccc
Confidence 5432 2345677899999753 347889999999999999999999997765555444443332 2333344568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..+.+||.+||+ +|.+||++.++++|||+.....
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 899999999997 9999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=273.77 Aligned_cols=243 Identities=21% Similarity=0.370 Sum_probs=196.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|++|+||+|.+..+ ..+|+|.++.... . .+.+.+|++++++++|+|++++++.+.+ ...
T Consensus 6 ~~~-~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (262)
T cd05071 6 ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 75 (262)
T ss_pred HHe-eEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--C---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCc
Confidence 344 7899999999999999988765 4699999875322 1 3567889999999999999999987632 457
Q ss_pred EEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++|||+.+++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~ 152 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLI 152 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeec
Confidence 899999999999999975 345889999999999999999999999 9999999999999998 79999999999766
Q ss_pred CCCccc--ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHAA--HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~~--~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
...... ....++..|+|||... +.++.++|+||||+++|+|++ |..||.+....+. ...+........ ....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~~ 230 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPC-PPECPE 230 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcCCCCCC-ccccCH
Confidence 433221 2233456799999665 558999999999999999999 8889976554433 333333322222 334588
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++.+|++ ||++||++.+++.
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=284.68 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=198.3
Q ss_pred CCcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
++| ++.++||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.++.++ +|+|++++++.+..
T Consensus 7 ~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 7 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 455 7899999999999999974 3457889999997542 233456788899999999 68999999988764
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc-------------------------------------------------------
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH------------------------------------------------------- 121 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------------------------------------- 121 (296)
.. ..+++++||+.+++|.+++...
T Consensus 83 ~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 PG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred CC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 43 6789999999999999988642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc---c
Q 022479 122 ------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---A 186 (296)
Q Consensus 122 ------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~ 186 (296)
..++...+..++.|++.||+|||+++ ++|+||||+||+++.+ +.++|+|||++........ .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhc
Confidence 23677888899999999999999999 9999999999999988 7999999999876532211 1
Q ss_pred ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
....++..|+|||.+. ..++.++|+||||+++|+|++ |..||..................... +...++++.+++..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 317 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC-CCCCCHHHHHHHHH
Confidence 2223456799999665 458899999999999999997 99999765444444444444333222 33457889999999
Q ss_pred HHh-CCCCCCCHHHHhcC
Q 022479 265 CIA-QPRARPSASELLKD 281 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~h 281 (296)
||+ ||++|||+.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 997 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=275.09 Aligned_cols=245 Identities=22% Similarity=0.362 Sum_probs=197.8
Q ss_pred cceeeecccCcceEEEeee----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFD----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++.+.||+|+||+||+|.+ ..++..+++|.+.... .......+.+|+.++++++|+|++++++.+... ...
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 82 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPV 82 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cce
Confidence 6789999999999999985 3356789999987432 334456788999999999999999999988554 678
Q ss_pred EEEeeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 103 NFITEVCTSGNLRTYRKKH-----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
+++|||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~ 160 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence 9999999999999998532 24788889999999999999999999 9999999999999988
Q ss_pred CCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK 240 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 240 (296)
+.++|+|||+++...... ......++..|+|||.+. +..+.++|+||||+++|+|++ |..||.+... ..+...
T Consensus 161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~ 238 (283)
T cd05090 161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEM 238 (283)
T ss_pred -CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH
Confidence 799999999997653221 122233456799999765 458999999999999999998 9999977554 334444
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+....... .....++.+.+++.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44433322 334568999999999998 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=312.73 Aligned_cols=257 Identities=19% Similarity=0.347 Sum_probs=217.4
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||.|+||.|..+.++.+++.||+|.+..-.... ......|..|..+|..-+.+=|+.++-.|.++ +++|+||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlVM 154 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLVM 154 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEEE
Confidence 68899999999999999999999999999997522211 12246788899999999989999998888666 8999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
||++||.|-.++....++++..++-++..|+-||..||+.| +|||||||+|||++.. |+++|+|||.+-.+...+.
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcE
Confidence 99999999999999889999999999999999999999999 9999999999999999 9999999999987764443
Q ss_pred -cccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCC-CCCCCh
Q 022479 186 -AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QAL-NKVKDP 256 (296)
Q Consensus 186 -~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~ 256 (296)
.....|||.|.|||++. +.+++.-|.||||+++|+|+.|..||....-. .-+..++.-... .++ ...+|+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-eTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-ETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-HHHHHHhchhhhcCCCcccccCH
Confidence 55678999999999774 34888999999999999999999999753333 333333332211 111 234799
Q ss_pred HHHHHHHHHHhCCCCCCC---HHHHhcCcccccccCC
Q 022479 257 EVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDD 290 (296)
Q Consensus 257 ~l~~li~~~l~~p~~Rps---~~~ll~hp~~~~~~~~ 290 (296)
..++||.+++-+|+.|.. ++++-.||||.+++|+
T Consensus 311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred HHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 999999999999999887 9999999999999995
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=274.38 Aligned_cols=246 Identities=24% Similarity=0.418 Sum_probs=198.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
..| ++.++||+|+||+||+|.+..+++ +||+|+++... .......+.+|+.+++.+.|+|++++++.+..
T Consensus 7 ~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 80 (279)
T cd05109 7 TEL-KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-- 80 (279)
T ss_pred hhe-eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--
Confidence 344 678999999999999999876665 48899886432 34556778899999999999999999998854
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++++|+++++|.+++.. ...+++.++..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~ 156 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLA 156 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCce
Confidence 347789999999999999876 456899999999999999999999999 9999999999999888 79999999999
Q ss_pred cccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 178 AIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 178 ~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
+....... ......+..|+|||... +.++.++|+||||+++|+|++ |..||..... ..+...+.....+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~ 234 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEKGERLPQ-PP 234 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCcCCC-Cc
Confidence 87643222 11223456799999765 458899999999999999998 8999976443 334444444333222 33
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+..+.+++.+||. ||++||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 468899999999997 9999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=276.66 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=199.5
Q ss_pred CcccceeeecccCcceEEEeeecCCC----------------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEG----------------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 87 (296)
+| ++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|++++++++|+|+
T Consensus 6 ~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 6 PL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45 68999999999999999876543 457899887542 33556788899999999999999
Q ss_pred eEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCC
Q 022479 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 156 (296)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~ 156 (296)
+++++.+... ..+++++|++.+++|.+++.... .+++..++.++.|++.||++||+++ ++|+||+
T Consensus 82 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred eEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 9999988654 68899999999999999987655 6899999999999999999999999 9999999
Q ss_pred CCceEEeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 022479 157 CSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIPYSE 230 (296)
Q Consensus 157 ~~nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~--g~~p~~~ 230 (296)
|+||+++.+ +.++|+|||.+....... ......++..|+|||.+. +.++.++|+||||+++|+|++ |..||..
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999 899999999987653322 122334567899999765 468999999999999999998 7788876
Q ss_pred CChHHHHHHHHhC-----CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 231 CDSVAKIYKKVTG-----GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 231 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......+...... ...........+.++.+++.+||+ ||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5544443333221 011111223457899999999998 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=274.78 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=197.0
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.++||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++.+... ..
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cc
Confidence 56899999999999999642 34678899987643 345567899999999999999999999988554 67
Q ss_pred EEEEeeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC
Q 022479 102 LNFITEVCTSGNLRTYRKKHR---------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI 166 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~ 166 (296)
.++++||+.+++|.+++.... .+++..+..++.|++.|++|||++| ++|+||+|+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~- 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG- 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC-
Confidence 899999999999999987542 4789999999999999999999999 9999999999999988
Q ss_pred CceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022479 167 GQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 167 ~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~ 241 (296)
+.++|+|||++........ .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||......+......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 7999999999875532211 12223457899999665 458999999999999999998 999997665554444433
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...... .....++.+.+++.+||+ ||.+||++.+++.
T Consensus 239 -~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 -QGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -cCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332222 234568899999999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=278.90 Aligned_cols=250 Identities=31% Similarity=0.467 Sum_probs=203.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.+..+++.+++|++..... .......+.+|+.++++++|++++++.+.+.+. ..+++++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence 457889999999999999999999999999986542 233456677899999999999999999988654 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+ +|.+++... ..+++..+..++.|++.+|.+||+.| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCcc
Confidence 99985 899999876 57999999999999999999999999 9999999999999998 899999999987764432
Q ss_pred ccccCCCCCCccCccccc-c-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----------------
Q 022479 185 AAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------------- 246 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------- 246 (296)
.......+..|+|||.+. . ..+.++|+||||++++++++|..||......+...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 222334567899999664 3 5888999999999999999999999876554443332211000
Q ss_pred ---CC-------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 247 ---PQ-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 247 ---~~-------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+. ......+..+.+++.+||+ ||++||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 0001126789999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=271.09 Aligned_cols=238 Identities=22% Similarity=0.390 Sum_probs=194.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++... |..+++|.++.. ...+.+.+|+.++++++|++++++++.+... ....++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVT 79 (256)
T ss_pred eeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEE
Confidence 67899999999999999665 788999998632 1245788999999999999999999876543 35789999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++++|.+++.... .+++..+..++.|++.+|++||++| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceeccccC
Confidence 9999999999987643 4889999999999999999999999 9999999999999998 899999999987653322
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
.....+..|+|||++.+ .++.++|+||||+++|+|++ |+.||..... ......+.....+ ......+..+.+++
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 22334567999997664 48889999999999999997 9999976443 3344444443332 23345689999999
Q ss_pred HHHHh-CCCCCCCHHHHhc
Q 022479 263 EKCIA-QPRARPSASELLK 280 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~ 280 (296)
.+||+ +|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.52 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=199.4
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.+.||+|+||.||++.+. .++..+++|.++.. .....+.+.+|+..+++++|+|++++++.+... ..
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DP 81 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--Cc
Confidence 56899999999999999753 24556888887643 334456788999999999999999999988544 67
Q ss_pred EEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 102 LNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
.++||||+.+++|.+++.... .+++..++.++.|++.|+++||++| ++|+||+|+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN 159 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC
Confidence 999999999999999987532 3789999999999999999999999 9999999999999998
Q ss_pred CCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK 240 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 240 (296)
+.++|+|||++........ .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+... .
T Consensus 160 -~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~ 237 (291)
T cd05094 160 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-C 237 (291)
T ss_pred -CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-H
Confidence 7999999999876533221 22234567899999665 458889999999999999999 999997655544333 3
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
...+..+ ......+..+.+++.+||+ ||++||++.++++ .+.++
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~--~l~~~ 282 (291)
T cd05094 238 ITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK--ILHAL 282 (291)
T ss_pred HhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH--HHHHH
Confidence 3333222 2334468899999999997 9999999999988 55544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=270.30 Aligned_cols=242 Identities=23% Similarity=0.368 Sum_probs=196.8
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.+.||+|++|.||++.+.. ++.+|+|.++.... ..+.+.+|++++++++|+|++++++.+... +.++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred eeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence 3678999999999999998754 57899999875432 135678899999999999999999987544 678999
Q ss_pred eeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||+.+++|.+++.... .++...+..++.|++.|+.+||++| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEccCC
Confidence 99999999999987643 7899999999999999999999999 9999999999999998 79999999999876532
Q ss_pred ccc--ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HAA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~~--~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
... .....+..|+|||...+ .++.++|+||||+++++|++ |+.||.+....... ..+...... ......+..+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 234 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-QQVDQGYRM-PCPPGCPKELY 234 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCC-CCCCcCCHHHH
Confidence 211 11222357999997654 58889999999999999999 99999875544333 333333222 22334588999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+++.+|++ +|.+||++.++++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHH
Confidence 99999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.22 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=200.2
Q ss_pred cceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
.+.++||+|+||.||++.+ ..++..+|+|+++... .....+.+.+|+.+++++ +|+||+++++.+... .
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 112 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--G 112 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--C
Confidence 6789999999999999975 3346689999987432 234456788999999999 799999999988554 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 101 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
.+++++||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECCCcccc
Confidence 799999999999999998753 33899999999999999999999999 9999999999999988 799999999987
Q ss_pred ccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 179 IVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 179 ~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
....... .....++..|+|||.+. +.++.++|+||||+++|+|++ |..||................... .....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCC
Confidence 6543221 12233466899999665 458899999999999999998 999998766555555555544332 22334
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.++.+++.+||. +|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 57899999999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=273.53 Aligned_cols=244 Identities=21% Similarity=0.351 Sum_probs=198.2
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.+.||+|+||.||++.++.. +..+|+|.+.... .......+.+|+.+++.++|+|++++++.+... ..
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 83 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--QP 83 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--CC
Confidence 6789999999999999987643 4789999986432 234456788899999999999999999998554 78
Q ss_pred EEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 102 LNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CCEEE
Confidence 99999999999999998642 24678899999999999999999999 9999999999999998 89999
Q ss_pred eccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 022479 172 GDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 172 ~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+|||.++...... ......++..|.|||.+. +..+.++|+||||+++|++++ |..||.+....+..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-IDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH-hcCCC
Confidence 9999987653321 122334567899999765 558899999999999999998 99999875554444433 33322
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
. ..+...+.++.+++.+||+ +|++|||+.+++.
T Consensus 240 ~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 2344458999999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=273.98 Aligned_cols=250 Identities=28% Similarity=0.510 Sum_probs=200.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.++||+|++|+||++.+..++..+++|+++...... .......+..|+.++++++|||++++++.+.+. ...+++
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFCII 80 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceEEE
Confidence 57899999999999999988777777777776433211 222334567789999999999999999988554 678999
Q ss_pred eeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 106 TEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+||+++++|.+++.. +..+++.+++.++.|++.||.+||+.| ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeecC
Confidence 999999999888753 457999999999999999999999999 999999999999986 469999999987653
Q ss_pred CC-cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RS-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||............. ....+ ......+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~ 234 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTP-SLPETYSRQLN 234 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCC-CCcchhcHHHH
Confidence 32 22334456788999996653 47889999999999999999999997655444443333 33222 23445688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+++.+||. +|++||++.++++||||
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999997 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.65 Aligned_cols=244 Identities=22% Similarity=0.379 Sum_probs=208.8
Q ss_pred cceeeecccCcceEEEeeecCCCc-----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI-----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.+.||+|.||.||.+....... .||+|.++... +.....+|.+|..++++++||||++++|++.+. ..
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence 467999999999999998765432 38888887543 466678999999999999999999999999874 67
Q ss_pred EEEEeeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 102 LNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
.++++||++||.|..|+++. ..++..++..++.++++|+.||++++ +|||||...|+|++.. ..+|++||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEccc
Confidence 89999999999999999875 46899999999999999999999999 9999999999999999 79999999
Q ss_pred CCccccCCC---cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 175 GFAAIVGRS---HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 175 g~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
|+|+..... ..........+|+|||.+. +.++.++||||||+++||++| |..||.+.++.+.+.....++ .-.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccC
Confidence 999854221 1122234567999999766 669999999999999999999 999999888877777666666 334
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+..+++.+.+++..||+ +|++||++..+++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 556679999999999998 9999999999988
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=269.35 Aligned_cols=239 Identities=21% Similarity=0.389 Sum_probs=193.9
Q ss_pred eecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 31 LLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
.||+|+||.||++.+. ..+..+|+|++.... .....+.+.+|+.++++++|+|++++++.+.. ..+++|+||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 3899999999998765 345679999987542 34456779999999999999999999998732 468999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc--
Q 022479 109 CTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-- 185 (296)
Q Consensus 109 ~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~-- 185 (296)
+++++|.+++.. ...+++.++..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccce
Confidence 999999999874 557899999999999999999999999 9999999999999988 7999999999876533221
Q ss_pred --cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
......+..|+|||.+. +..+.++|+||||+++|++++ |..||.+....+. ...+..+.... .....++++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-MSFIEQGKRLD-CPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHHCCCCCC-CCCCCCHHHHHH
Confidence 11122346899999765 458889999999999999996 9999987655443 34444433332 334568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+||. +|++||++.++.+
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999998 9999999999977
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.35 Aligned_cols=149 Identities=24% Similarity=0.386 Sum_probs=133.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| ++.++||+|+||+||+|.+..+++.||+|+++.... ........+.+|+.+++.++|+||++++..+... ..+
T Consensus 4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 79 (669)
T cd05610 4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV 79 (669)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence 345 679999999999999999999999999999975433 2345567889999999999999999999888554 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
|+||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ +.++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999999999999999988888999999999999999999999999 9999999999999988 899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=268.30 Aligned_cols=240 Identities=23% Similarity=0.392 Sum_probs=199.4
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
.+++.+.||+|++|.||++... |+.+|+|+++.... ..+++.+|+.++++++|+|++++++.+.. ....++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 3478999999999999999765 78999999975421 46778899999999999999999999865 378999
Q ss_pred EeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 105 ITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++||+++++|.+++.... .+++..+..++.|++.||.+||+++ ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEccccccccccc
Confidence 999999999999998655 7999999999999999999999999 9999999999999998 7999999999987633
Q ss_pred CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
... ....+..|+|||.+. +..+.++|+||||++++++++ |..||..... ..+...+........ ....++.+.+
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPHVEKGYRMEA-PEGCPPEVYK 230 (256)
T ss_pred ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhcCCCCCC-ccCCCHHHHH
Confidence 222 233456799999665 458889999999999999997 9999976543 344444444333222 3345899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhc
Q 022479 261 FIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+||+ +|.+|||+.+++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 9999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=282.80 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=194.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++|. -..+||+|+||+||++.... +..||||.+...... . ..+|.+|+.++.+++|+|+++++|+|.+.+. ..
T Consensus 75 ~~Fs-~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~--~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~ 147 (361)
T KOG1187|consen 75 NNFS-ESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ--G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HR 147 (361)
T ss_pred hCCc-hhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc--c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eE
Confidence 3443 36899999999999998875 489999977654321 1 3459999999999999999999999977632 69
Q ss_pred EEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 103 NFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|+||++.|+|.+++.... .+++....+|+..++.||+|||+. .|+|+|||||++|||++.+ ..+||+|||++..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCccc
Confidence 99999999999999987654 899999999999999999999995 4569999999999999999 6999999999966
Q ss_pred cCC-CcccccC-CCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhCC-----C
Q 022479 180 VGR-SHAAHSI-IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD------SVAKIYKKVTGG-----V 245 (296)
Q Consensus 180 ~~~-~~~~~~~-~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~------~~~~~~~~~~~~-----~ 245 (296)
... ....... .+|.+|++||++. +..+.++||||||+++.|+++|+.+.+... ..+.....+... .
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 544 2222222 7899999999776 679999999999999999999998886432 112111222221 1
Q ss_pred CCCCCCCCCC--hH---HHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 246 KPQALNKVKD--PE---VKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 246 ~~~~~~~~~~--~~---l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.......+ .+ +..+...|++ +|+.||++.++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1221112222 23 4567788997 9999999999866
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=298.26 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=187.3
Q ss_pred ccceeeecccCcceEEEeeecCCC-cEEEeeeee-------------ecccCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVR-------------LSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~-~~~avK~~~-------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 91 (296)
|++.++||+|+||+||++..+... ...+.|.+. .............+.+|+.++++++|+||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 478999999999999998764332 222222110 011112334556788999999999999999999
Q ss_pred eeeeeCCCCeEEEEeeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC
Q 022479 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKH-----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI 166 (296)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~ 166 (296)
+++... +..|++++++.+ +|..++... .......+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 230 ~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~- 303 (501)
T PHA03210 230 EILRSE--ANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD- 303 (501)
T ss_pred EEEEEC--CeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-
Confidence 998665 678899999866 666665432 23446678889999999999999999 9999999999999998
Q ss_pred CceEEeccCCccccCCCcc--cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHH
Q 022479 167 GQVKIGDLGFAAIVGRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIP-YSEC--DSVAKIYKK 240 (296)
Q Consensus 167 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p-~~~~--~~~~~~~~~ 240 (296)
+.++|+|||++..+..... .....++..|+|||++.+ .++.++|||||||++|+|++|..+ |... .....+...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 8999999999987644322 233568999999997764 488999999999999999998754 4321 222222222
Q ss_pred HhCCCC-----------------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 241 VTGGVK-----------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 241 ~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+..... ........+..+.+++.+||+ ||++|||+.++|.||||....
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 211000 000011235677888999998 999999999999999998754
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.43 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=198.4
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||+|.++ +++.+|+|.+..... ....+.+|+.++++++|+|++++++.+.. ..++++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred ceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 378899999999999999865 478899999874432 13567889999999999999999987632 468999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||+.+++|.+++.. +..++..++..++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeecCCC
Confidence 999999999998864 346899999999999999999999999 9999999999999998 79999999999765422
Q ss_pred cc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .....++..|+|||.+. ..++.++|+||||+++|++++ |+.||.+....+.... ....... ......+.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~ 233 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRM-PRPDNCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCC-CCCCCCCHHHH
Confidence 11 12233456899999765 447889999999999999999 9999987655444333 3333222 22344678999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+++.+||. +|++||+++++++ ++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~--~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS--VLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH--Hhhc
Confidence 99999997 9999999999988 5543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=272.05 Aligned_cols=241 Identities=26% Similarity=0.391 Sum_probs=191.7
Q ss_pred eeecccCcceEEEeeecCCCc--EEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQEEGI--EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++||+|+||.||++.++.++. .+++|.++... .....+.+.+|+.+++++ +|+|++++++.+... ..++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 469999999999999988775 46778776321 344456788999999999 799999999988544 6789999
Q ss_pred eccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 107 EVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
||+++++|.+++.... .+++.++..++.|++.||+|||++| ++|+||+|+||+++.+ +.++
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEE
Confidence 9999999999987532 4789999999999999999999999 9999999999999998 7999
Q ss_pred EeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
|+|||++..............+..|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+ ....+.......
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~ 231 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLE 231 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-HHHHHhCCCCCC
Confidence 99999986432221122223355799999765 448889999999999999997 999997654433 333333332222
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.....+.++.+++.+||. ||.+|||+.+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 233457899999999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=269.31 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=201.1
Q ss_pred cceeeecccCcceEEEeeecCCC----cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+.+.||.|+||.||++.+..++ ..+|+|++.... .......+.+|+.++++++|+|++++++.+.+. +..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 36788999999999999998766 889999996543 222567889999999999999999999988655 689
Q ss_pred EEEeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++++||+.+++|.+++..... +++.++..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceec
Confidence 999999999999999976544 899999999999999999999999 9999999999999998 79999999999776
Q ss_pred CCCcccc--cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHAAH--SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~~~--~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
....... ...+++.|+|||.+. ...+.++|+||||+++++|++ |..||......... ..+........ ....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~-~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-EYLKKGYRLPK-PENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCC-CCcCCH
Confidence 5432211 223567899999765 448999999999999999998 88898764443333 33333333222 334689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+++.+||. ||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 9999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.45 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCC--------------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEG--------------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~--------------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 88 (296)
++| ++.++||+|+||.||++.+..++ ..+|+|.++... .......+.+|++++++++|+|++
T Consensus 5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 5 QQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred HhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 355 78899999999999999875432 358999987432 344566789999999999999999
Q ss_pred EEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCC
Q 022479 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 156 (296)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~ 156 (296)
++++.+... ...+++|||+.+++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||+
T Consensus 81 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk 156 (295)
T cd05097 81 RLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA 156 (295)
T ss_pred eEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence 999998544 68899999999999999986432 4688899999999999999999999 9999999
Q ss_pred CCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 022479 157 CSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIPYSE 230 (296)
Q Consensus 157 ~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~--g~~p~~~ 230 (296)
|+||+++.+ +.++|+|||++........ .....++..|+|||.+. +.++.++|+||||+++++|++ |..||..
T Consensus 157 p~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 157 TRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999988 7999999999876532211 12223456899999655 558999999999999999988 6788876
Q ss_pred CChHHHHHHHHh-----CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 231 CDSVAKIYKKVT-----GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 231 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
....+.+..... ............++.+.+|+.+||+ ||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 544333322211 0111112233457899999999998 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.73 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=197.7
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
++.+.||+|++|.||++..+.. ...+|+|.+.... .......+.+|+.+++++ +|+|++++++.+... .
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~ 89 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--G 89 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--C
Confidence 6789999999999999987643 3779999987432 233456788999999999 899999999988544 6
Q ss_pred eEEEEeeccCCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 101 TLNFITEVCTSGNLRTYRKK----------------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~----------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
.++++|||+.+++|..++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~ 167 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTE 167 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcC
Confidence 79999999999999999854 346889999999999999999999999 999999999999998
Q ss_pred CCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022479 165 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK 239 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~ 239 (296)
+ +.++|+|||.++....... .....++..|+|||.+. ..++.++|+||||+++|++++ |..||......+ ...
T Consensus 168 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~ 245 (293)
T cd05053 168 D-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFK 245 (293)
T ss_pred C-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-HHH
Confidence 8 8999999999986643221 12223456799999765 458899999999999999998 999998655443 344
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......... .+...+..+.+|+.+||+ ||++|||+.++++
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 246 LLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 444433322 233457899999999998 9999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=271.99 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=195.1
Q ss_pred ccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 26 GRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
+++.++||+|+||.||++. +..+++.||+|.+... .....+.+.+|++++++++|+|++++.+.+.......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 3678999999999999987 3457889999998743 3444677889999999999999999999876555567
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++++||+++++|.+++... ..+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccccc
Confidence 89999999999999998753 56899999999999999999999999 9999999999999998 79999999999876
Q ss_pred CCCccc----ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Q 022479 181 GRSHAA----HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------------AKIYKK 240 (296)
Q Consensus 181 ~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~---------------~~~~~~ 240 (296)
...... .....+..|+|||.+.+ .++.++|+||||+++++|++|..++...... ..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 432211 11223345899997654 4888999999999999999987765432110 111122
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
....... ......+.++.+|+.+||+ +|++|||+.++++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2222211 2233457899999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=268.89 Aligned_cols=244 Identities=23% Similarity=0.405 Sum_probs=196.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|.||++.+..+ ..+|+|.+..... ..+.+.+|++++++++|++++++++.+.. ...+++|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEE
Confidence 6789999999999999987654 4699998764322 23567889999999999999999987732 4578999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEccCCc
Confidence 999999999998753 35889999999999999999999999 9999999999999998 799999999997654322
Q ss_pred c--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 A--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
. .....++..|+|||... +..+.++|+||||+++|+|++ |..||.+..+.+.. ........... ....+..+.+
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~ 234 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQVERGYRMPC-PQGCPESLHE 234 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCC-CcccCHHHHH
Confidence 1 11223456799999665 458899999999999999999 99999876554443 33344333222 2345889999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
++.+||. ||.+||++.++++ +|++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~--~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS--FLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH--HHhc
Confidence 9999997 9999999999988 6554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=269.43 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=197.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|++|+||++.+. .+..+|+|.+..... . .+.+.+|+.++++++|++++++++.+.. ...+++|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEE
Confidence 68899999999999999876 466799999875433 1 3568889999999999999999987632 4578999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++.. ...+++.++..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccCcc
Confidence 99999999999875 345899999999999999999999999 9999999999999998 799999999997654322
Q ss_pred cc--ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AA--HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~--~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.. ....++..|+|||... ..++.++|+||||+++|+|++ |..||.+....+.... +..+.... .+...+..+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~ 234 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMP-CPQDCPISLHE 234 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCC-CCCcCCHHHHH
Confidence 11 1222345799999665 458889999999999999999 8999987655444433 33332222 23445889999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
|+.+||. +|++|||+.+++. ++++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~--~l~~ 259 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS--FLED 259 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH--HHhc
Confidence 9999997 9999999999986 6554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=270.71 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=198.2
Q ss_pred ccceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+++.+.||+|+||.||+|.++.+++ .||+|+++... .......+..|+.++++++|||++++.+.+... ..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 3789999999999999999877664 59999987432 355567899999999999999999999988544 678
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+++|.+++.. .+.++..++..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccccccc
Confidence 999999999999999875 456899999999999999999999999 9999999999999988 799999999987653
Q ss_pred CCccccc------CCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 182 RSHAAHS------IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 182 ~~~~~~~------~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
....... ...+..|+|||.+. +.++.++|+||||+++|++++ |..||......+.... +........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~-~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA-IEQDYRLPP-PMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCcCCC-ccc
Confidence 3221111 11134799999765 458899999999999999887 9999987655443333 333322222 233
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+..+.+++.+||+ +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57899999999998 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=269.66 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=189.7
Q ss_pred eeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.||+|+||.||++... .++..+++|.++... .......+.+|+.++++++|+|++++++.+.+. ..+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEE
Confidence 36999999999999754 345779999886543 233345788899999999999999999988544 67899999
Q ss_pred ccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 108 VCTSGNLRTYRKKH-----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 108 ~~~~~sL~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+++++|.+++... ...+...+..++.|++.|++|||+.+ ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccC
Confidence 99999999998642 24567788899999999999999999 9999999999999998 7999999999865432
Q ss_pred Ccc---cccCCCCCCccCcccccc--------CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC---C
Q 022479 183 SHA---AHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---P 247 (296)
Q Consensus 183 ~~~---~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~---~ 247 (296)
... .....++..|+|||++.+ .++.++|+||||+++|+|++ |..||......+........... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 211 122345678999997753 24779999999999999996 99999876555443332222211 1
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIAQPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~~p~~Rps~~~ll~ 280 (296)
.......++.+.+++++|+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 122234578899999999989999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=268.61 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=199.6
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| .+.++||+|++|+||++.++ ++..+++|.+..... ....+.+|+.++++++|+|++++++.+... ...+
T Consensus 7 ~~-~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (261)
T cd05034 7 SL-KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIY 77 (261)
T ss_pred he-eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceE
Confidence 44 68999999999999999876 457899999875432 235688899999999999999999987543 6789
Q ss_pred EEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++||+.+++|.+++... ..++...+..++.|++.|+.+||+++ ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceecc
Confidence 999999999999999764 46899999999999999999999999 9999999999999999 899999999987764
Q ss_pred CCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... ......+..|+|||.+. +..+.++|+||||++++++++ |+.||.+.......... ........ ....+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~ 232 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPR-PPNCPEE 232 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCC-CCCCCHH
Confidence 3211 11222346799999765 458889999999999999998 99999876554444443 33322222 2234789
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+.+++.+||. +|.+||++.++++ +|++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~--~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS--FLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH--HHhc
Confidence 9999999997 9999999999987 5543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=288.63 Aligned_cols=257 Identities=23% Similarity=0.425 Sum_probs=229.6
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+...||-|+||.|=++..+.....+|+|.++..+..+ ....+-+..|-.++..+++++|+++|..|.+. +++|++||
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvYmLmE 500 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVYMLME 500 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhhhhHH
Confidence 4577999999999999887666679999998877643 45567788999999999999999999999665 89999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccc
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~ 187 (296)
-|-||.|...+...+.|++.+.+-++..+++|++|||++| |+.|||||+|.+++.+ |-+||.|||.+........+.
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCcee
Confidence 9999999999999999999999999999999999999999 9999999999999999 999999999999999999999
Q ss_pred cCCCCCCccCcc-ccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 188 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 188 ~~~~~~~~~aPE-~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
..||||.|.||| ++++.++.+.|.|+||+++||+++|.+||++.+++.. ++.+..+.....++..++....+||.++-
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 999999999999 5667899999999999999999999999999777655 45555555555556677888999999988
Q ss_pred h-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 267 A-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 267 ~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+ +|.+|. .+.++-+|-||..++|+-
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 6 999997 599999999999999973
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.72 Aligned_cols=244 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred cceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++.++||+|+||+||++.+.. .++.+|+|+++... .....+.+..|+.++++++|+||+++++.+... ..
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~ 82 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QP 82 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cc
Confidence 678999999999999998754 35789999997442 344567788999999999999999999988554 57
Q ss_pred EEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
.++++||+.+++|.+++... ..++...+..++.|++.||.|||++| ++|+||||+||+++.+
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDK 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCC
Confidence 89999999999999998532 34788889999999999999999999 9999999999999988
Q ss_pred CCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK 240 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 240 (296)
+.++|+|||++....... ......+++.|+|||.+. +.++.++|+||||+++|+|++ |..||.+....+ ....
T Consensus 161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~ 238 (283)
T cd05091 161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VIEM 238 (283)
T ss_pred -CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH
Confidence 799999999987653221 123334567899999664 568999999999999999998 888987755543 4444
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+...... ......+..+.+|+..||+ +|++||++.+++.
T Consensus 239 i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4443322 2234568899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=270.79 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=200.4
Q ss_pred cccceeeecccCcceEEEeeecC----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQE----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.+++.++||+|+||.||+|.+.. ++..+++|.+... ........+.+|+.++++++|+|++++++.+... ..
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 34689999999999999999876 3578999987632 2455577889999999999999999999987654 36
Q ss_pred eEEEEeeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 101 TLNFITEVCTSGNLRTYRKKH--------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
..+++++|..+++|..++... ..+++.++..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcEEEC
Confidence 788999999999999998753 45899999999999999999999999 9999999999999988 799999
Q ss_pred ccCCccccCCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 022479 173 DLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 173 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
|||+++.+..... .....++..|+|||.+.+ .++.++||||||+++|++++ |+.||......+ ....+......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCCCC
Confidence 9999976532211 112234567999997654 48899999999999999999 999998755433 44444444333
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.. ....++++.+++.+||. ||++|||+.++++
T Consensus 239 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 AQ-PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 23458899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=272.45 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=194.6
Q ss_pred CCCcccceeeecccCcceEEEeeecC----------------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQE----------------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 85 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 85 (296)
.++| ++.++||+|+||+||++.+.. ++..+|+|++.... .......+.+|+.++++++|+
T Consensus 4 ~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 4 RKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred hhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCC
Confidence 3455 689999999999999985432 34568999987442 344567888999999999999
Q ss_pred ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecC
Q 022479 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 154 (296)
Q Consensus 86 ~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~d 154 (296)
|++++++.+... ...++++||+.+++|.+++.... .+++.++..++.|++.||+|||++| ++|+|
T Consensus 80 ~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~d 155 (296)
T cd05095 80 NIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRD 155 (296)
T ss_pred CcceEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence 999999988655 67899999999999999987532 3667889999999999999999999 99999
Q ss_pred CCCCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCcccc-ccCCCcchhHHHHHHHHHHHHh--CCCCC
Q 022479 155 LNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVT--MEIPY 228 (296)
Q Consensus 155 l~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~i~~~ll~--g~~p~ 228 (296)
|+|+||+++.+ +.++|+|||++........ ......+..|++||.. .+.++.++|+||||+++|+|++ |..||
T Consensus 156 lkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 156 LATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred CChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999988 7999999999876533221 1222335679999954 4568999999999999999998 77899
Q ss_pred CCCChHHHHHHHH---hCC--CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 229 SECDSVAKIYKKV---TGG--VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 229 ~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......+...... ... .........+++.+.+|+..||+ ||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7654433322211 111 01111233457899999999998 9999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=274.53 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=198.1
Q ss_pred CCcccceeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
++| .+++.||+|+||.||++.+.. +...+|+|.++... .......+.+|+.+++++ +|+|++++++.+
T Consensus 18 ~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 18 DRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred HHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345 689999999999999997643 23569999987432 233456788899999999 799999999988
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
... ..+++++||+.+++|.+++... ..++..++..++.|++.||+|||++| ++|+||+|+
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 169 (307)
T cd05098 94 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169 (307)
T ss_pred ecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence 554 6899999999999999999753 24788999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++|+|||.+........ ......+..|+|||.+. +.++.++|+||||+++|+|++ |..||....
T Consensus 170 Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~- 247 (307)
T cd05098 170 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247 (307)
T ss_pred heEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 9999988 7999999999876543211 11223346899999765 448899999999999999998 889997644
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.....+....... .....+.++.+|+.+||. +|++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 248 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 444444444443322 234458899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=265.58 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=195.6
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||.|++|.||++.+.. ++.+++|.+..... ......+.+|++++++++|++++++++.+... ...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 479999999999999887 99999999875433 24567789999999999999999999988554 6889999999
Q ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc--
Q 022479 110 TSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-- 186 (296)
Q Consensus 110 ~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~-- 186 (296)
.+++|.+++.. ...++...+..++.+++.+|.+||+++ ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence 99999999865 456899999999999999999999999 9999999999999988 79999999998765422111
Q ss_pred -ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 187 -HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 187 -~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.....+..|+|||.+. +.++.++|+||||+++|+|++ |..||.......... .+...... ..+...+.++.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-RIESGYRM-PAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-HHhcCCCC-CCCccCCHHHHHHHH
Confidence 1122345799999765 458899999999999999999 889997655433333 33322221 223446889999999
Q ss_pred HHHh-CCCCCCCHHHHhc
Q 022479 264 KCIA-QPRARPSASELLK 280 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~ 280 (296)
+||. +|.+||++.++++
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=271.56 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=198.2
Q ss_pred cceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++.++||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 578999999999999998643 23568888876432 234457788999999999999999999988544 67
Q ss_pred EEEEeeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 157 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~ 157 (296)
.++++||+.+++|.+++... ..++...+..++.|++.||.+||+++ ++|+||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 89999999999999987642 24788899999999999999999999 99999999
Q ss_pred CceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022479 158 SNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECD 232 (296)
Q Consensus 158 ~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~ 232 (296)
+||+++.+ +.++|+|||++........ ......+..|+|||.+. ...+.++|+||||+++|+|++ |..||.+..
T Consensus 156 ~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 156 RNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred heEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999988 7999999999876532211 12234456899999655 458899999999999999998 999997654
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 233 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
. ..+.+......... .....+.++.+++.+||+ +|++||++.++++ .|++
T Consensus 235 ~-~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~--~l~~ 285 (290)
T cd05045 235 P-ERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK--ELEK 285 (290)
T ss_pred H-HHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH--HHHH
Confidence 3 44444444433332 234568899999999997 9999999999987 4443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=282.02 Aligned_cols=245 Identities=28% Similarity=0.414 Sum_probs=198.7
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 100 (296)
.++++||+|+||.||+|.+. .+++.||+|+++.... ......+.+|++++.++. |+||+++++.+... .
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR---SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC---hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence 45799999999999999853 3457899999975432 333456889999999997 99999999998654 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc-----------------------------------------------------------
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------------------------------------------------------- 121 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 121 (296)
.+++|+||+.+++|.+++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 799999999999999988542
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE
Q 022479 122 ---------------------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 122 ---------------------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv 162 (296)
..++...+..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 13567778899999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKI 237 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~ 237 (296)
+.+ +.++|+|||++........ .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+..
T Consensus 273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 988 7999999999976532211 22234567899999765 448899999999999999998 89999876665655
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...+..+..+.. +...+.++.+++.+||. +|.+||++.++++
T Consensus 352 ~~~~~~~~~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 352 YNAIKRGYRMAK-PAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555555443332 33458899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=268.77 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=194.8
Q ss_pred cceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++.+.||+|+||+||++.+..+++ .+++|.+... ........+..++..+++++|+||+++++++.. ...
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 568999999999999999877766 4666766422 123445678888889999999999999998743 457
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||.++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence 789999999999999975 457899999999999999999999999 9999999999999988 799999999997653
Q ss_pred CCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 182 RSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 182 ~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.... .....++..|+|||.+. +.++.++|+||||+++|++++ |..||.+... ......+..+.... ....++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 238 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLA-QPQICTI 238 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCcCC-CCCCCCH
Confidence 2211 12233556899999765 558999999999999999998 9999977543 33344444433322 2334578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++.+||. ||.+|||+.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.43 Aligned_cols=267 Identities=20% Similarity=0.312 Sum_probs=226.9
Q ss_pred CccCCCCCCCCCCCceecCCCCCcccceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHH
Q 022479 2 PAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQL 78 (296)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~ 78 (296)
|..+++..++.-+...++|+..- .+.++||.|.||.|+++..+..+ ..||||.++.-. .+.....|..|+.+
T Consensus 609 P~TYEDPnqAvreFakEId~s~i--~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsI 683 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCV--KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASI 683 (996)
T ss_pred CccccCccHHHHHhhhhcChhhe--EEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhh
Confidence 34566666666777788888766 57999999999999999998776 459999998532 46678899999999
Q ss_pred HHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCC
Q 022479 79 LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 157 (296)
Q Consensus 79 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~ 157 (296)
+-+++||||+++.|+.... +.+++++||++.|+|..||.. .+.|+..++.-+++.|+.++.||-..+ +|||||-.
T Consensus 684 MGQFdHPNIIrLEGVVTks--~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAA 759 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKS--KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAA 759 (996)
T ss_pred cccCCCCcEEEEEEEEecC--ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhh
Confidence 9999999999999999544 899999999999999999985 467999999999999999999999999 99999999
Q ss_pred CceEEeCCCCceEEeccCCccccCCCcc----cccCCCCCCccCcccc-ccCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 022479 158 SNIFINGNIGQVKIGDLGFAAIVGRSHA----AHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVT-MEIPYSEC 231 (296)
Q Consensus 158 ~nilv~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~ 231 (296)
.||||+.+ -.+|+.|||+++.+++... +.......+|.|||.+ .+.++.++|+||+|++|||.|+ |+.||.+.
T Consensus 760 RNILVNsn-LvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 760 RNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hheeeccc-eEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 99999999 7999999999998854432 2233456799999955 5789999999999999999988 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 232 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+-+.+..+..+-. ...+.+ +|.++.+|+..||+ |..+||.+.|++.
T Consensus 839 SNQdVIkaIe~gyR-LPpPmD-CP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 839 SNQDVIKAIEQGYR-LPPPMD-CPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred chHHHHHHHHhccC-CCCCCC-CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 77776666655543 333334 59999999999998 9999999999988
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=268.81 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=202.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
+.| ++.++||+|+||+||++.++.+|+ .+|+|+..... .......+.+|+..+++++|+|++++++.+..
T Consensus 7 ~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 7 TEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 344 678999999999999999876664 58888876543 24456778899999999999999999998864
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...++++||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCccc
Confidence 568899999999999999876 456899999999999999999999999 9999999999999988 79999999999
Q ss_pred cccCCCcccc---cCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 178 AIVGRSHAAH---SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 178 ~~~~~~~~~~---~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
.......... ....+..|+|||.+. +.++.++|+||||+++|++++ |..||.+.... .+...+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDLLEKGERL-PQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhCCCCC-CCCC
Confidence 8764322211 122345799999665 558899999999999999998 99999875443 344444443222 2233
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
..+..+.+++.+||. ||..||++.++++ .|..+
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~ 268 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN--EFSKM 268 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 457889999999997 9999999999988 55554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=277.89 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=218.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++.-++||+|+||.||.++.+.||+-||+|++.....-. ..-......|-.+|++++.+.||.+--.| +..+.+++|
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LClV 263 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALCLV 263 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceEEE
Confidence 355689999999999999999999999999986554321 22234567899999999999998886566 445789999
Q ss_pred eeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+..+.||.|.-++.+.+ .+++..+.-++.+|+-+|+|||+.+ ||.|||||+|||+++. |++.|.|+|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH-GHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC-CCeEeeccceEEecCCC
Confidence 99999999988887755 7999999999999999999999999 9999999999999999 99999999999998877
Q ss_pred cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC---DSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.......||.+|+|||++.++ ++.+.|.|+|||++|+|+.|+-||... ...+++.+.+.. .+..+++..+++.+
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 777777999999999988755 999999999999999999999999642 223333333333 34455677799999
Q ss_pred HHHHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+|++.+|. ||.+|. .+.++-+||||++++|.-
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 99999996 999996 678999999999999853
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.20 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=194.4
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeecc
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 109 (296)
++||+|++|.||++... ++..+|+|++.... .......+.+|++++++++|+|++++++.+... ...+++|||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 47999999999999865 58899999987432 344455788999999999999999999988554 6789999999
Q ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc--c
Q 022479 110 TSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--A 186 (296)
Q Consensus 110 ~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~--~ 186 (296)
++++|.+++.. ...+++..+..++.|++.+|.+||++| ++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccccC
Confidence 99999998875 446899999999999999999999999 9999999999999988 7999999999875432211 1
Q ss_pred ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
.....+..|+|||.+. +.++.++|+||||+++|++++ |..||.+......... +........ ....+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSC-PQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCC-CCCCCHHHHHHHHH
Confidence 1223356799999766 448889999999999999998 9999987655444333 333322222 33468899999999
Q ss_pred HHh-CCCCCCCHHHHhc
Q 022479 265 CIA-QPRARPSASELLK 280 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~ 280 (296)
||. +|++||++.++++
T Consensus 230 ~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 230 CWDYKPENRPKFSELQK 246 (250)
T ss_pred HcccCcccCCCHHHHHH
Confidence 997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.39 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=197.1
Q ss_pred CCcccceeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
++| .+.++||+|+||.||++.+.. ....+|+|.++... .......+.+|+.+++++ .|+||+++++++
T Consensus 12 ~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 12 DRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 455 579999999999999997532 34578999887432 234466788999999999 699999999988
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
... ..+++++||+.+++|.+++... ..++..++..++.|++.||.|||++| ++|+||+|+
T Consensus 88 ~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 163 (314)
T cd05099 88 TQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163 (314)
T ss_pred ccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence 554 6789999999999999998653 34888999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++|+|||.++....... ......+..|+|||.+. +.++.++|+||||+++|+|++ |..||.....
T Consensus 164 Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 164 NVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999988 7999999999976543211 11223345799999765 458889999999999999999 8999976543
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......+....... .....+.++.+++.+||. +|++|||+.++++
T Consensus 243 -~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 -EELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 44444444433222 234457899999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=270.45 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=197.8
Q ss_pred CCcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
++| ++.+.||+|+||.||+|.++. ++..+|+|+++... .......+.+|+.++++++|+|++++++.+...
T Consensus 5 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 5 NNI-EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred Hhc-eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 344 678999999999999998753 57889999987432 344567788999999999999999999988544
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH----------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL 155 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl 155 (296)
..+++++||+.+++|.+++... ..+++..++.++.|++.||++||+++ ++|+||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl 156 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDL 156 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccc
Confidence 6789999999999999998643 24778889999999999999999999 999999
Q ss_pred CCCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 022479 156 NCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSE 230 (296)
Q Consensus 156 ~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~ 230 (296)
+|+||+++.+ +.++|+|||.+........ ......+..|+|||.+. +.++.++|+||||+++|+|++ |..||.+
T Consensus 157 ~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 157 ATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred cHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999988 8999999999875432211 12223456799999665 558999999999999999998 8889976
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 231 CDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
....+..... ..+.... .....+.++.+|+.+||+ ||.+|||+.++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYV-RDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHH-hcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554444433 3322222 223457899999999998 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=266.39 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=201.6
Q ss_pred cceeeecccCcceEEEeeecC-CCcEEEeeeeeecccC------CCHHHHHHHHHHHHHHHh-cCCCceeEEeeeeeeCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRT-LKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~ 98 (296)
.+.+.||+|+||.||++.++. +++.+|+|.+...... ........+.+|+.++.+ ++|+|++++++.+.+.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~- 81 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN- 81 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-
Confidence 568899999999999999987 6789999998653221 233455667788888865 7999999999998654
Q ss_pred CCeEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEec
Q 022479 99 HNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
...++++||+.+++|.+++. ....+++..++.++.|++.+|.+||+ .+ ++|+||+|.||+++.+ +.++|+|
T Consensus 82 -~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~d 157 (269)
T cd08528 82 -DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTITD 157 (269)
T ss_pred -CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEec
Confidence 78999999999999988874 34568999999999999999999996 67 9999999999999998 7999999
Q ss_pred cCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
||.+.............++..|++||.+.+ .++.++|+||||+++|+|++|..||................ .......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-YEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc-CCcCCcc
Confidence 999987655544445567888999997654 48899999999999999999999997655444443333332 2222333
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+..+.+++.+||+ ||++||++.++..
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 568899999999997 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.61 Aligned_cols=245 Identities=28% Similarity=0.423 Sum_probs=197.2
Q ss_pred ccceeeecccCcceEEEeeec-------CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
+.+++.||+|+||.||++.+. .++..+|+|++.... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 367899999999999999742 234579999986432 234457788999999999 899999999988654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceE
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nil 161 (296)
..++++|||+.+++|.+++... ..++..++..++.|++.||.|||++| ++|+||+|+||+
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 6889999999999999998753 24778889999999999999999999 999999999999
Q ss_pred EeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022479 162 INGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAK 236 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~ 236 (296)
++.+ +.++|+|||.+........ .....++..|+|||.+.+ .++.++||||||+++|++++ |..||.+.. ...
T Consensus 170 i~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~ 247 (304)
T cd05101 170 VTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247 (304)
T ss_pred EcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHH
Confidence 9988 8999999999987643221 222334567999997654 48899999999999999998 788887654 444
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+...+........ ....+..+.+|+.+||. +|.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 248 LFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 4444444433222 34468899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=265.55 Aligned_cols=244 Identities=22% Similarity=0.353 Sum_probs=197.3
Q ss_pred cceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
...++||+|++|.||+|.++.+++ .+++|.++... .....+.+.+|++++++++|+|++++.+.+... +..+
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 82 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPAM 82 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCcE
Confidence 568999999999999999876654 68888886432 234456788999999999999999999988544 6789
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++|||+++++|.+++.. .+.+++.++..++.|++.|+++||+.| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence 99999999999999875 457899999999999999999999999 9999999999999988 7999999999876643
Q ss_pred Cccc----ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHAA----HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~~----~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.... .....+..|+|||.+. +.++.++|+||||+++|++++ |..||......+ ....+........ ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~~~~~~-~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDGFRLPA-PMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcCCCCCC-CCCCCH
Confidence 2111 1122345799999765 458899999999999999997 999997655544 3333333322222 233578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+++.+||+ +|++||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=266.95 Aligned_cols=243 Identities=25% Similarity=0.380 Sum_probs=190.4
Q ss_pred eeecccCcceEEEeeecC--CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.||+|+||.||++.... ....+++|.+.... .......+.+|+.+++.++|+||+++++.+... ..++++||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEE
Confidence 369999999999996533 34567777765332 344456788899999999999999999988544 67999999
Q ss_pred ccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 108 VCTSGNLRTYRKKHR-----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+.+++|.+++.... ..++..+..++.|++.||+|||+++ ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEecccccccccc
Confidence 999999999987642 2467788899999999999999999 9999999999999998 7999999999865422
Q ss_pred Cc---ccccCCCCCCccCccccc--------cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC---C
Q 022479 183 SH---AAHSIIGTPEYMAPELYE--------EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---P 247 (296)
Q Consensus 183 ~~---~~~~~~~~~~~~aPE~~~--------~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~---~ 247 (296)
.. ......++..|+|||++. ...+.++|+||||+++|+|++ |..||....+.+........... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence 11 122233456799999753 236789999999999999999 78899876666555554444321 1
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIAQPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~~p~~Rps~~~ll~ 280 (296)
.......+..+.+++..||.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 222334678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=271.30 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=200.2
Q ss_pred CcccceeeecccCcceEEEeeec----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQ----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+++++.+.||+|+||.||++... .+++.+|+|+++.... ......+.+|++++++++|+|++++++++.....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 34467899999999999999854 3478999999975433 1456789999999999999999999998876556
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...++++||+.+++|.+++.... .++...+..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEccccccc
Confidence 78999999999999999997644 6899999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHH
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS--------------VAKIYK 239 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~--------------~~~~~~ 239 (296)
....... ......+..|++||... ...+.++|+||||+++++|++|..|+..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7652211 11223345699999665 4588899999999999999999999864321 122222
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+..... ......++.++.+++.+||+ +|++|||+.+++.
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2232222 22234457899999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=267.35 Aligned_cols=249 Identities=23% Similarity=0.414 Sum_probs=199.1
Q ss_pred cceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.+.++||+|++|.||+|.+... ...+++|...... .....+.+.+|+.++++++|+|++++++.+.+ ...+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 5789999999999999987543 3468889886432 24556788999999999999999999998754 4578
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++||+++++|.+++... ..++...+..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceeeeccc
Confidence 999999999999999764 45899999999999999999999999 9999999999999998 7999999999876543
Q ss_pred Ccc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 183 SHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 183 ~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... ......+..|+|||.+. ..++.++|+||||++++++++ |..||.+....+..... ...... ......+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCcC-CCCCCCCHHH
Confidence 221 11222345799999765 458899999999999999986 99999876655444333 332222 2234568899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.+++.+|+. +|.+|||+.+++. .+.++.
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~--~l~~~~ 266 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKA--QLSDIL 266 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH--HHHHHH
Confidence 999999997 9999999999988 444443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.04 Aligned_cols=244 Identities=21% Similarity=0.356 Sum_probs=197.8
Q ss_pred cceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
++.+.||+|+||.||+|.++.++ ..+|+|.++... .....+.+.+|+.++++++|||++++++.+... +.++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVM 81 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccE
Confidence 68899999999999999886544 369999886432 244467889999999999999999999988544 7899
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++|||+++++|.+++... ..++..++..++.|++.||++||+.+ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence 999999999999998764 56899999999999999999999999 9999999999999988 7999999999976643
Q ss_pred Ccc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
... ......+..|+|||.+. +.++.++|+||||+++|++++ |..||.+....+.... +........ ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~ 236 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-IEEGYRLPA-PMDCPA 236 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-HhCCCcCCC-CCCCCH
Confidence 221 11122245799999776 458999999999999999887 9999987655443333 333322222 234578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++.+||+ +|.+||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=264.61 Aligned_cols=227 Identities=20% Similarity=0.304 Sum_probs=185.3
Q ss_pred cCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCH
Q 022479 35 GAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL 114 (296)
Q Consensus 35 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL 114 (296)
|.+|.||+|.++.+++.+|+|++..... ..++...+....|||++++++.+... +..+++|||+.+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 8899999999999999999999975421 22344555566799999999988654 789999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCC
Q 022479 115 RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194 (296)
Q Consensus 115 ~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 194 (296)
.+++.....+++..+..++.|++.||.+||+.| ++|+||+|+||+++.+ +.++++|||.+...... ......+..
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~ 147 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENM 147 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCcc
Confidence 999988778999999999999999999999999 9999999999999998 79999999987665432 223345667
Q ss_pred ccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCC
Q 022479 195 YMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR 272 (296)
Q Consensus 195 ~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~R 272 (296)
|+|||... +..+.++|+||+|+++|+|++|..|+...... .... .....+...++.+++++.+||+ ||.+|
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTH-TTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccc-cccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 99999776 44888999999999999999999887542211 0001 1112234468899999999997 99999
Q ss_pred CCH-----HHHhcCccc
Q 022479 273 PSA-----SELLKDPFF 284 (296)
Q Consensus 273 ps~-----~~ll~hp~~ 284 (296)
|++ +++++||||
T Consensus 221 ~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 221 LGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCCccchHHHHcCCCC
Confidence 986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.75 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=197.7
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++.+.||+|+||.||++..+.+ .+.+++|.+.... .......+.+|++++++++|+|++++++.+.+. ..
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 82 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--EP 82 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--Cc
Confidence 5689999999999999997543 4678888876432 344567899999999999999999999988543 67
Q ss_pred EEEEeeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 102 LNFITEVCTSGNLRTYRKKHR---------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
.++++||+.+++|.+++.... .+++..+..++.|++.+|+|||+++ ++|+||+|+||+++.+ +.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcEEEc
Confidence 899999999999999998655 6899999999999999999999999 9999999999999998 799999
Q ss_pred ccCCccccCCCc--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 173 DLGFAAIVGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 173 dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
|||++....... ......++..|+|||.+. +..+.++|+||||+++|++++ |..||........... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-~~~~~~~~ 238 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-LQAGKLEL 238 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-HHcCCcCC
Confidence 999986542211 122233456799999665 458889999999999999998 8899976554443333 33322222
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......+..+.+++.+||+ +|.+|||+.+++.
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2344568999999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=264.43 Aligned_cols=243 Identities=20% Similarity=0.340 Sum_probs=187.4
Q ss_pred eeecccCcceEEEeeecCC--CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.||+|+||+||++....+ ...+++|.+... ......+.+.+|+.+++.++|||++++++.+... ..++++||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEe
Confidence 3699999999999875432 234555655432 2334567889999999999999999999998654 67899999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 108 VCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 108 ~~~~~sL~~~l~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|+.+++|.+++... ...+...++.++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKE 152 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcc
Confidence 99999999998753 34667788899999999999999999 9999999999999988 89999999987543211
Q ss_pred ---cccccCCCCCCccCcccccc--------CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC---CC
Q 022479 184 ---HAAHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---PQ 248 (296)
Q Consensus 184 ---~~~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~---~~ 248 (296)
.......++..|+|||++.. ..+.++|+||||+++|+|++ |..||....+.+........... ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence 11233456788999997642 25678999999999999997 57788766555544443333221 12
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIAQPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~~p~~Rps~~~ll~ 280 (296)
......++.+.+++..||.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 22334578899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=273.35 Aligned_cols=247 Identities=27% Similarity=0.394 Sum_probs=196.8
Q ss_pred cccceeeecccCcceEEEeeecCC-------CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEE-------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
.+++++.||+|+||.||+|.+... +..+|+|+++... .......+.+|+.+++++ +|+||+++++.+..
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 347899999999999999986432 2368999887432 344567888999999999 79999999999855
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCce
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ni 160 (296)
. ..+++++||+++++|.+++... ..++..++..++.|++.||+|||++| ++|+||+|+||
T Consensus 90 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 165 (334)
T cd05100 90 D--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNV 165 (334)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence 4 6799999999999999998753 24777888999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022479 161 FINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVA 235 (296)
Q Consensus 161 lv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~ 235 (296)
+++.+ +.++|+|||+++....... .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||.+... +
T Consensus 166 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~ 243 (334)
T cd05100 166 LVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-E 243 (334)
T ss_pred EEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-H
Confidence 99988 7999999999876543221 11222345799999765 458899999999999999998 8899977544 4
Q ss_pred HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 236 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.....+........ ....+..+.+++.+||+ +|++|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44444444333222 33457899999999998 99999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=266.62 Aligned_cols=236 Identities=23% Similarity=0.366 Sum_probs=187.0
Q ss_pred eeecccCcceEEEeeecCCCc-------EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 30 DLLGSGAVKKVYRAFDQEEGI-------EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++||+|+||.||++.++..+. .+++|.+... .....+.+.+|+.+++.++|+|++++++.+..+ ...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCc
Confidence 469999999999998865443 3888887533 234456788899999999999999999998765 568
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC-------ceEEecc
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-------QVKIGDL 174 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~-------~~~l~df 174 (296)
++||||+.+++|..++... ..+++..+..++.|++.||+|||++| ++|+||+|+||+++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 8999999999999999764 45899999999999999999999999 999999999999987622 2799999
Q ss_pred CCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
|.+...... ....++..|+|||.+.+ .++.++|+||||+++|+|++|. .||........ ....... ...+
T Consensus 153 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~---~~~~ 225 (258)
T cd05078 153 GISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDR---HQLP 225 (258)
T ss_pred ccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHcc---ccCC
Confidence 988654322 22456778999997764 3788999999999999999984 66655433332 2222221 1223
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...+.++.+|+.+||+ ||++|||+.++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3346789999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=262.46 Aligned_cols=241 Identities=23% Similarity=0.416 Sum_probs=195.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|.||++.+. .+..+|+|.++.... . ...+.+|++++++++|++++++++.+... ..+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--S---EEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--C---HHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEE
Confidence 57899999999999999875 467899999874433 1 34678899999999999999999988544 6789999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+++|.+++.. ...+++..++.++.|++.++++||+.+ ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccCcc
Confidence 99999999999875 356899999999999999999999999 9999999999999988 7999999999876533211
Q ss_pred --cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
......+..|+|||.+. +.++.++|+||||+++|+|++ |..||....... ....+..+... ..+...+..+.+|
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRL-YKPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHhCCCCC-CCCCCCCHHHHHH
Confidence 11223456899999766 558889999999999999998 999997655433 33333333222 2233458899999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+||+ +|++|||+.++++
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHHcccChhhCCCHHHHHH
Confidence 999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=264.55 Aligned_cols=233 Identities=23% Similarity=0.363 Sum_probs=186.5
Q ss_pred eeecccCcceEEEeeecCCC----------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 30 DLLGSGAVKKVYRAFDQEEG----------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+.||+|+||.||++.++.++ ..+++|++..... ....+.+|+.++++++|+|++++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----DSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-----hHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998766 3477777664321 15778899999999999999999998865
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC-------ceEE
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-------QVKI 171 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~-------~~~l 171 (296)
...++++||+.+++|.+++.... .++...+..++.|++.||+|||++| ++|+||+|+||+++.+ + .++|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence 35789999999999999998655 7999999999999999999999999 9999999999999987 5 6999
Q ss_pred eccCCccccCCCcccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
+|||++..... .....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||.......... .....
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~--- 222 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQ--- 222 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcC---
Confidence 99999887543 222334567999997764 48889999999999999999 588886654322222 21111
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..........+.+++.+||. +|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11122224789999999997 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.41 Aligned_cols=241 Identities=26% Similarity=0.401 Sum_probs=192.7
Q ss_pred eeecccCcceEEEeeecCCC------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 30 DLLGSGAVKKVYRAFDQEEG------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.||+|++|.||++.++... +.+++|.+.... .......+.+|+.+++.++|+||+++++.+... ...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeE
Confidence 36999999999999876543 689999986432 223356788899999999999999999988654 6789
Q ss_pred EEeeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC-----ceEE
Q 022479 104 FITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-----QVKI 171 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~-----~~~l 171 (296)
+++||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.+ + .++|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEE
Confidence 999999999999998642 34788999999999999999999999 9999999999999987 5 7999
Q ss_pred eccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 022479 172 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 172 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+|||++........ ......+..|+|||.+. +..+.++|+||||+++|+|++ |..||......+..... .....
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCc
Confidence 99999876532211 22233467899999765 458999999999999999998 99999876555443333 22222
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
. ......+..+.+++.+||+ +|.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 2233458899999999997 9999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=262.50 Aligned_cols=241 Identities=24% Similarity=0.401 Sum_probs=194.8
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||++.+. .+..+++|.+... ....+.+.+|+.++++++|+|++++++.+.. ...+++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred eeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 378999999999999999865 4567999988642 2335678899999999999999999988754 568999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||+.+++|.+++.. +..++..++..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeeccCC
Confidence 999999999999875 446788899999999999999999999 9999999999999998 89999999998765432
Q ss_pred cc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .....++..|+|||.+. +..+.++|+||||+++|++++ |..||......... ..+....... .....+.++.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~ 233 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMP-RPENCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCCCCCC-CcccCCHHHH
Confidence 11 11223446799999766 448889999999999999999 99999875544333 3333333222 2344678999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+++.+||. +|++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 99999997 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=262.32 Aligned_cols=236 Identities=24% Similarity=0.442 Sum_probs=193.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||.||++. .+++.+|+|.++... ....+.+|+.++++++|+|++++++.+.. +..++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~ 77 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVM 77 (254)
T ss_pred eeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEE
Confidence 678999999999999985 468889999986432 24568889999999999999999998754 3478999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVGSMG- 153 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceecccc-
Confidence 999999999998754 35889999999999999999999999 9999999999999998 79999999998764322
Q ss_pred ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......+..|+|||.+. +.++.++|+||||+++|+|++ |..||......+ ............ .....++.+.+++
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li 230 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECVEKGYRME-PPEGCPADVYVLM 230 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhCCCCCC-CCCcCCHHHHHHH
Confidence 11223356799999765 458899999999999999998 999997655433 334444433322 2345688999999
Q ss_pred HHHHh-CCCCCCCHHHHhc
Q 022479 263 EKCIA-QPRARPSASELLK 280 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~ 280 (296)
.+||+ +|+.||++.+++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=263.18 Aligned_cols=236 Identities=22% Similarity=0.369 Sum_probs=184.9
Q ss_pred eeecccCcceEEEeeecCC------------CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 30 DLLGSGAVKKVYRAFDQEE------------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
+.||+|++|.||++..... ...+++|++... .......+.+++.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999985322 335888887643 233456788899999999999999999998654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc-------e
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-------V 169 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~-------~ 169 (296)
...++++||+.+++|..++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +. +
T Consensus 77 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~ 151 (262)
T cd05077 77 --VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFI 151 (262)
T ss_pred --CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCcee
Confidence 567899999999999988875 456999999999999999999999999 9999999999999865 33 8
Q ss_pred EEeccCCccccCCCcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhCCCC
Q 022479 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMV-TMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+++|||++...... ....++..|+|||.+. +.++.++||||||+++|+|+ +|..||......+. ........
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~- 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQC- 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCc-
Confidence 99999998655322 2234567899999765 34888999999999999997 58888876433222 22112111
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
......+.++.+|+.+||+ ||++||++.+++++
T Consensus 227 --~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 --MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 1122235789999999998 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=264.69 Aligned_cols=236 Identities=20% Similarity=0.305 Sum_probs=184.1
Q ss_pred eecccCcceEEEeeecCC------------------------CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc
Q 022479 31 LLGSGAVKKVYRAFDQEE------------------------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 86 (296)
.||+|+||.||++....+ ...+++|++... .......+.+++.++++++|+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 699999999999875321 235888887643 2334567888999999999999
Q ss_pred eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 87 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
|+++++++... ...++||||+.+++|..++.. .+.+++..+..++.|++.||+|||+++ ++|+||+|+||+++..
T Consensus 78 iv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 99999998765 678999999999999998865 567899999999999999999999999 9999999999999754
Q ss_pred C------CceEEeccCCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 022479 166 I------GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMV-TMEIPYSECDSVAK 236 (296)
Q Consensus 166 ~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll-~g~~p~~~~~~~~~ 236 (296)
. ..++++|||.+...... ....++..|+|||.+.+ .++.++|+||||+++|+++ +|..||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 1 24899999987543221 12345677999997753 4789999999999999985 69999976544332
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
. ....... ..+......+.+++.+||+ +|++|||+.++|++
T Consensus 231 ~-~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 E-RFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-HHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 2222111 1122235689999999998 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=260.79 Aligned_cols=242 Identities=22% Similarity=0.362 Sum_probs=189.7
Q ss_pred eeecccCcceEEEeeecC---CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+.||+|+||.||+|.+.. .+..+|+|.+... ......+.+.+|+.+++.++|+|++++++.+.... ...++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998643 3457999987532 13444677889999999999999999999765433 5678999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
||+.+++|.+++... ...+...+..++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence 999999999998753 45678888899999999999999999 9999999999999998 799999999987543211
Q ss_pred ----ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 185 ----AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 185 ----~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
......++..|+|||.+. ..++.++||||||+++|+|++ |.+||......+... .+.....+. .....+..+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCC-CCCcCCHHH
Confidence 111223456899999765 558899999999999999999 566776554444333 333332222 233457899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhc
Q 022479 259 KAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+++.+||+ +|++||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 999999998 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=263.09 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=194.6
Q ss_pred cceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC----
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---- 99 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 99 (296)
++.++||+|+||.||+|.+. .+++.+|+|+++.... .....+++.+|+.++++++|+|++++++.+.....
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 56889999999999999864 3578999999975443 34456778899999999999999999998765422
Q ss_pred CeEEEEeeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
...+++++|..+++|..++... ..++...+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEECc
Confidence 2347889999999998886432 24788999999999999999999999 9999999999999988 7999999
Q ss_pred cCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 174 LGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 174 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
||.+........ ......++.|++||.+. +..+.++|+||||+++|+|++ |..||.+....+ ............
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIKGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHHHHHcCCcCC
Confidence 999886533211 11223456799999765 447889999999999999999 889997655433 333333332222
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.....+..+.+++.+||+ +|++|||+.+++.
T Consensus 236 -~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 -QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223457899999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.39 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=200.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
...| +...+||+|.||.||+|..+.++. .+|+|+++.... ..-......+|+.+++.++|+|++.+..++..-
T Consensus 23 l~~y-e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEY-EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHh-hccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3344 567889999999999997766543 689999986532 112234567899999999999999999988764
Q ss_pred CCCeEEEEeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC---CCce
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---IGQV 169 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~---~~~~ 169 (296)
+..+++++||.+. .|...+.. ...++...+++++.||+.++.|||++- +.||||||.||+|..+ .|+|
T Consensus 100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred -CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 4899999999998 66666653 346889999999999999999999999 9999999999999876 3699
Q ss_pred EEeccCCccccCCCcc----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCC---------hH
Q 022479 170 KIGDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECD---------SV 234 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~---------~~ 234 (296)
|++|+|+++.+.++-. .....-|..|+|||.+-+ .++.+.|+|+.|||+.||++-++.|.+.. ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999999998865422 223345778999997654 48999999999999999999887774311 12
Q ss_pred HHHHHHHh--CCCCCCCCCC--------------------------------CCChHHHHHHHHHHh-CCCCCCCHHHHh
Q 022479 235 AKIYKKVT--GGVKPQALNK--------------------------------VKDPEVKAFIEKCIA-QPRARPSASELL 279 (296)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~--------------------------------~~~~~l~~li~~~l~-~p~~Rps~~~ll 279 (296)
+++..+.. +.+....+++ .-++...+|+.+||. ||.+|.|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 22222221 1111111111 014457789999998 999999999999
Q ss_pred cCcccccccCC
Q 022479 280 KDPFFSELNDD 290 (296)
Q Consensus 280 ~hp~~~~~~~~ 290 (296)
+|+||.+-+-+
T Consensus 336 eh~yF~~d~lp 346 (438)
T KOG0666|consen 336 EHPYFTEDPLP 346 (438)
T ss_pred cccccccCCCC
Confidence 99999887554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=280.25 Aligned_cols=239 Identities=22% Similarity=0.399 Sum_probs=198.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+...+|.|+|+.+-.+.+..+++..++|++...... ..+|+.++... +|+|+++..+.+.+. ...|+|
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v 394 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLV 394 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCC--ceeeee
Confidence 4677899999999999999999999999999865221 23456555555 799999999999554 889999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||.+.|+-+.+.+...+.+. .++..|+.+|+.|+.|||.+| ++||||+|+|||+..+.+.++|+|||.++..+..
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99999998888777766555 777789999999999999999 9999999999999644389999999999876544
Q ss_pred cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (296)
....+.|..|.|||+... +++++.|+||||+++|+|++|+.||.......++...+..+. .....|...++|++.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQ 545 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHH
Confidence 445577889999997764 599999999999999999999999976544434444333322 126779999999999
Q ss_pred HHh-CCCCCCCHHHHhcCccc
Q 022479 265 CIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~ 284 (296)
||+ ||.+|+++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 998 99999999999999999
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=266.57 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=194.6
Q ss_pred cceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+..++||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.++++++|+|++++++.+... ..
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~ 83 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI 83 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence 567899999999999999877775 46888776432 233445688999999999999999999988543 46
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++++|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcccccccccc
Confidence 7889999999999998764 36899999999999999999999999 9999999999999988 799999999998664
Q ss_pred CCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 182 RSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 182 ~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.... ......+..|+|||.+. ..++.++|+||||+++|++++ |..||.+... ......+....... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLEKGERLP-QPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCCCC-CCCCCCH
Confidence 3221 22233456899999765 458899999999999999997 9999976443 33444444433222 2334578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+++..||. +|++||++.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999997 9999999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=264.68 Aligned_cols=253 Identities=20% Similarity=0.212 Sum_probs=185.0
Q ss_pred CCCCcccceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHH-------HHHHHHHHHHHHhcCCCceeEE
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVL-------VNRLHSEVQLLRTLKNKYIIVC 90 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~ 90 (296)
..+..|++.++||+|+||+||+|.+..+ +..+++|+..........+. ......+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3444458899999999999999998877 66777776543221100000 0112233445566789999999
Q ss_pred eeeeeeCCC--CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 91 YSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 91 ~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
++++..... ...+++++++.. ++.+.+......++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~-~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN-NR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-Cc
Confidence 987654432 244667777654 67777776666788999999999999999999999 9999999999999988 79
Q ss_pred eEEeccCCccccCCCc--------ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-
Q 022479 169 VKIGDLGFAAIVGRSH--------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY- 238 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~- 238 (296)
++|+|||+++.+.... ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999997653211 1122458899999997664 48999999999999999999999998653322211
Q ss_pred -------HHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 239 -------KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 239 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+... .......+..+.++++.|++ +|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEG---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhh---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111111 11223347889999999998 9999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=266.44 Aligned_cols=261 Identities=21% Similarity=0.363 Sum_probs=203.9
Q ss_pred ceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC--Cc----eeE
Q 022479 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--KY----IIV 89 (296)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~----i~~ 89 (296)
+...|.....|.+..++|+|.||.|-.+.+..++..+|+|+++.- ....+...-|+++|.++++ |+ +++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 444555344446899999999999999999999999999999853 3334556679999999943 22 456
Q ss_pred EeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--
Q 022479 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-- 165 (296)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-- 165 (296)
+.++| +-.+..++|+|.+. .|+.+|+..+. +++...++.++.||++++++||+.+ ++|.||||+||++...
T Consensus 156 m~~wF--dyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 156 MRDWF--DYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEY 230 (415)
T ss_pred eehhh--hccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccce
Confidence 66667 44578999999884 49999998754 6889999999999999999999999 9999999999998432
Q ss_pred -----------------CCceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 022479 166 -----------------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIP 227 (296)
Q Consensus 166 -----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p 227 (296)
.-.++++|||.++.-.+.. .....|..|+|||++-+ +++.+.|+||+|||++|+.+|...
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1258999999998765443 55678889999997766 599999999999999999999999
Q ss_pred CCCCChHHH--HHHHHhCCCCCCCCCCC-----------------------------------------CChHHHHHHHH
Q 022479 228 YSECDSVAK--IYKKVTGGVKPQALNKV-----------------------------------------KDPEVKAFIEK 264 (296)
Q Consensus 228 ~~~~~~~~~--~~~~~~~~~~~~~~~~~-----------------------------------------~~~~l~~li~~ 264 (296)
|...++.+- .++.+.+..+....... .-..+.+|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 987664442 34444443221111000 01367899999
Q ss_pred HHh-CCCCCCCHHHHhcCccccccc
Q 022479 265 CIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 265 ~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
||. ||.+|+|+.|+|.||||+...
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcCC
Confidence 999 999999999999999998653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=255.87 Aligned_cols=241 Identities=34% Similarity=0.586 Sum_probs=205.3
Q ss_pred CcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHH
Q 022479 36 AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR 115 (296)
Q Consensus 36 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~ 115 (296)
+||.||++.+..+++.+++|++...... ...+.+.+|++.+++++|++++++++.+... ...++++|++.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 5899999999988999999999754331 1157889999999999999999999998654 6889999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCc
Q 022479 116 TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195 (296)
Q Consensus 116 ~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 195 (296)
.++.....++...++.++.+++.++.+||+.+ ++|+||+|+||+++.+ +.++++|||.+.............++..|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence 99987766899999999999999999999999 9999999999999999 89999999999887665455566678899
Q ss_pred cCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC-CChHHHHHHHHHHh-CCCCC
Q 022479 196 MAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEVKAFIEKCIA-QPRAR 272 (296)
Q Consensus 196 ~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~-~p~~R 272 (296)
++||... ...+.++|+|+||++++++++|..||......................... .+.++.+++.+||. +|++|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999765 458889999999999999999999998755556666555554333222221 67899999999997 99999
Q ss_pred CCHHHHhcCccc
Q 022479 273 PSASELLKDPFF 284 (296)
Q Consensus 273 ps~~~ll~hp~~ 284 (296)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=282.53 Aligned_cols=260 Identities=24% Similarity=0.446 Sum_probs=220.6
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee--
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD-- 96 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 96 (296)
++.+.+ ++.++||.|.+|.||++.++.+++..|+|+....... .+....|.++|+.. .|||+..+++.+..
T Consensus 16 dp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 455555 7899999999999999999999999999998765432 24555688888888 59999999998864
Q ss_pred -CCCCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 97 -DQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 97 -~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
..++.+|||||||.|||..++++. +.++.+..+..|++.++.|+.|||.+. ++|||+|-.|||++.+ +.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEee
Confidence 345899999999999999999874 678999999999999999999999999 9999999999999999 8999999
Q ss_pred cCCccccCCC-cccccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 022479 174 LGFAAIVGRS-HAAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 174 fg~~~~~~~~-~~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
||++.....+ .......|||.|+|||++.. .++.++|+||||++..||..|.+|+-+..+..-++.+....++
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 9999877554 33556679999999997753 2677899999999999999999999988877777766555444
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
....+...+.++-++|..||. |.++||+..++|+|||++...
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 444455567899999999995 999999999999999998443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=256.94 Aligned_cols=263 Identities=23% Similarity=0.396 Sum_probs=205.7
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee--
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD-- 96 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 96 (296)
.+..+.|.+ ..+||+|.||.||+|..+.+|+.||+|++-...- .+-.-....+|+++|..++|+|++.+++++..
T Consensus 13 ~~~~~~yek-~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 13 CDEVSKYEK-LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred eecchHHHH-HHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 345566754 8999999999999999999999999988754211 11122446689999999999999988877642
Q ss_pred ----CCCCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 97 ----DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 97 ----~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
....++|+|+++|+. .|...+... .+++..++++++.++.++|.|+|... |+|||+|+.|++++.+ |.++|
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEe
Confidence 122469999999988 788888765 68999999999999999999999999 9999999999999999 89999
Q ss_pred eccCCccccCCCcc-----cccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHh
Q 022479 172 GDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI--YKKVT 242 (296)
Q Consensus 172 ~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~--~~~~~ 242 (296)
+|||+++.+..... .....-|..|++||.+-+ ++.++.|||..|||+.+|.++.+-+.+......+ ++.+.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999976643222 222334778999996654 4999999999999999999999999876544433 33333
Q ss_pred CCCCCCCCCCC------------------------------CChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 243 GGVKPQALNKV------------------------------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 243 ~~~~~~~~~~~------------------------------~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
++..+..++.+ ..++..+|+..|+. ||++|++++++|+|.||.+=.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 33332222221 13467799999999 999999999999999986533
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.68 Aligned_cols=251 Identities=30% Similarity=0.541 Sum_probs=197.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC---------
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--------- 97 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 97 (296)
+..++||+||||.||+|.++-+|..||||++.... +........+|+.+|.+++|||+++.+..|.+.
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 34589999999999999999999999999998654 455677889999999999999999998443321
Q ss_pred --------------------------------------------------------------------------------
Q 022479 98 -------------------------------------------------------------------------------- 97 (296)
Q Consensus 98 -------------------------------------------------------------------------------- 97 (296)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C-------CCeEEEEeeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhCCC
Q 022479 98 ---------------------Q-------HNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 148 (296)
Q Consensus 98 ---------------------~-------~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~ql~~~l~~LH~~~~ 148 (296)
+ ...+||-||||+..++.+++..+... .....|.++++|++||+|+|+.|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc-
Confidence 0 03679999999998888888876655 57788999999999999999999
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccccC-------------------CCcccccCCCCCCccCcccccc----CC
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-------------------RSHAAHSIIGTPEYMAPELYEE----DY 205 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~----~~ 205 (296)
++||||||.|||++.+ +.|||+|||+++... .........||.-|.|||++.+ .+
T Consensus 718 -iIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 -IIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred -eeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999988 799999999998721 0111233467889999998764 37
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCc
Q 022479 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDP 282 (296)
Q Consensus 206 ~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp 282 (296)
+.++||||||+|++||+. ||...-........+..+..|.. +....-+.-..+|+.|++ ||.+||||.++|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 889999999999999987 46543333333333333333322 111123566789999998 999999999999999
Q ss_pred cccc
Q 022479 283 FFSE 286 (296)
Q Consensus 283 ~~~~ 286 (296)
||-.
T Consensus 873 llpp 876 (1351)
T KOG1035|consen 873 LLPP 876 (1351)
T ss_pred CCCc
Confidence 9863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=265.28 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=216.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+..+||+|+||.|-++..+.+.+.||||+++....-++.+ .+.-..|-++|.... -|.++++..+|..- +++|+|
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-vectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-VECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-ccceehhhhheecCCCCchHHHHHHHhhhh--hheeeE
Confidence 57899999999999999999999999999998776543322 344445677776664 45667777777433 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-CCCc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~~~~ 184 (296)
|||+.||.|--.+++-+++.++.+.-++..|+-+|-+||++| |+.||||.+||+++.. |.+||+|||++..- -...
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCc
Confidence 999999999989999999999999999999999999999999 9999999999999999 99999999999753 2334
Q ss_pred ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.+...||||.|.|||++. +.++.+.|.|++|+++|||+.|++||++.+..+...++...+. .++...|.+..+++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---syPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---SYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---cCcccccHHHHHHHH
Confidence 467789999999999654 7799999999999999999999999999766666666555543 355667899999999
Q ss_pred HHHh-CCCCCC-----CHHHHhcCcccccccCCCCC
Q 022479 264 KCIA-QPRARP-----SASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 264 ~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~~~ 293 (296)
..|- .|.+|. .-.++-.||||+.++|+.-+
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E 618 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE 618 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence 9995 999996 34678889999999997543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=243.62 Aligned_cols=259 Identities=18% Similarity=0.347 Sum_probs=213.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 101 (296)
..| ++.+++|.|.|+.||.+.+..++++++||+++.- -.+.+.+|+.+|+.++ ++||++++++..++..++
T Consensus 38 ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 38 DDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred chH-HHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 344 6789999999999999999999999999999843 2477889999999997 999999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
..+++||+.....+.+.. .++...++..+.+++.||.|+|+.| |+|||+||.|++++.....+.|+|+|+|.++-
T Consensus 110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999999998876665555 4889999999999999999999999 99999999999999876789999999999886
Q ss_pred CCcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhCC--------------
Q 022479 182 RSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGG-------------- 244 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~-~~~~~~~~~~~~~~~~-------------- 244 (296)
......-...+..|.-||.+. +.++.+.|+|||||++..|+-.+-|| .+.++.+++..+..--
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 655555556666788999665 45999999999999999999988777 3445555443222110
Q ss_pred ------------CC--------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 245 ------------VK--------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 245 ------------~~--------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
.. ........+++.-+|+.++|. |-.+|+|+.+++.||||..+....+++
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~ 335 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR 335 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence 00 111223346899999999999 999999999999999999887766553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=252.64 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=206.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+..||.|+||+|++..++.+|+..|||.+.... .+....++..|.+...+- +.|||++++|....+ .-.|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHH
Confidence 467999999999999999999999999998643 356677888888876655 689999999988766 45899999
Q ss_pred ccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 108 VCTSGNLRTYRK-----KHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 108 ~~~~~sL~~~l~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.+.- ||..+.+ +...++++-+-.+....+.||.||-.. . ++|||+||+|||++.. |.+||||||++..+.
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~-G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH-GDVKLCDFGICGQLV 219 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC-CCEeeecccchHhHH
Confidence 9864 7765543 356799999999999999999999665 6 9999999999999999 999999999997764
Q ss_pred CCcccccCCCCCCccCccccc---cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC----C
Q 022479 182 RSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV----K 254 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 254 (296)
..-......|-.-|+|||.+. ..++-++|+||||+++||+.||..||.+.+..-+...++..+-++...... .
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 433333334445699999776 338999999999999999999999998877655555555555444333221 4
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+..+..+|..||- |..+||+..+++++||++.+.....
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 7889999999995 9999999999999999998876543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=276.53 Aligned_cols=202 Identities=28% Similarity=0.433 Sum_probs=176.6
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----C
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----H 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 99 (296)
.-+...+.||+|+||.||++.++.+|+.||||++..... ....+.--+|++++++++|+|||+.+++-.+.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 334457999999999999999999999999999986442 223566778999999999999999998754443 4
Q ss_pred CeEEEEeeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC-C--ceEEec
Q 022479 100 NTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-G--QVKIGD 173 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~-~--~~~l~d 173 (296)
+...++||||.||+|+..+.. ...+++.++..++..++.||.|||++| |+||||||.||++..+. | .-||+|
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeec
Confidence 566889999999999999975 346999999999999999999999999 99999999999997653 2 689999
Q ss_pred cCCccccCCCcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSE 230 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~ 230 (296)
||.|+..++.....+..||+.|.+||.+. +.++...|.||+|+++|+.+||..||..
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99999999988999999999999999887 4588889999999999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=253.43 Aligned_cols=269 Identities=19% Similarity=0.357 Sum_probs=224.9
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSV 93 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 93 (296)
+.+.--..+.| ++.++||.|+|+.|-.+.++.+.+-||+|+++..-..+ .+.++.++.|-.+..+- +||.++-+..+
T Consensus 242 ~~~~~l~l~df-~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 242 KISQGLGLQDF-DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccc-eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 33333334455 67899999999999999999999999999999765544 44467888888888777 68999999888
Q ss_pred eeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 94 WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
|..+ .++++|.||++||.|--.+++.+.++++.++-+...|+-||.|||+.| |+.||||.+|++++.. |.+||.|
T Consensus 320 fqte--srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltd 394 (593)
T KOG0695|consen 320 FQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTD 394 (593)
T ss_pred hccc--ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-Cceeecc
Confidence 8555 789999999999999888888889999999999999999999999999 9999999999999999 8999999
Q ss_pred cCCcccc-CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCC-------CCChHHHHHHHHhCC
Q 022479 174 LGFAAIV-GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYS-------ECDSVAKIYKKVTGG 244 (296)
Q Consensus 174 fg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~-------~~~~~~~~~~~~~~~ 244 (296)
||+...- .....++..|+||.|.|||++.++ +..+.|.|+||+++++|+.|+-||. +.+..+-+.+.+...
T Consensus 395 ygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred cchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 9998753 455668889999999999999876 9999999999999999999999994 233455566665552
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CCCCCC------CHHHHhcCcccccccCCCC
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARP------SASELLKDPFFSELNDDDS 292 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p~~Rp------s~~~ll~hp~~~~~~~~~~ 292 (296)
. ...+...+-....+++.-|. ||++|. -+.++-.|+||+.++|+.-
T Consensus 475 q--iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 475 Q--IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred c--ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence 2 22333446678888999996 999985 5789999999999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=273.65 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=209.3
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
+.... ++.++||+|.||.|+++.++..+ ..||||.++.... ..+...|.+|+.++.+|.|+|++++||+..+.
T Consensus 108 pee~i-~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~H~hliRLyGvVl~q 183 (1039)
T KOG0199|consen 108 PEEQI-KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ 183 (1039)
T ss_pred cHHHH-HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhccCcceeEEeeeeccc
Confidence 33444 45789999999999999987643 3489999986544 33789999999999999999999999999763
Q ss_pred CCCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.+.+|+|.+++|||.+.+.. ...|-...+..++.||+.|+.||.+++ +|||||-..|+++..- ..|||+|||
T Consensus 184 ---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~DFG 257 (1039)
T KOG0199|consen 184 ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICDFG 257 (1039)
T ss_pred ---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeeccc
Confidence 58889999999999998875 456888899999999999999999999 9999999999999987 699999999
Q ss_pred CccccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 176 FAAIVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 176 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
+.+-+..... .........|+|||.+. +.++.++|+|++|+.+|||++ |+.||.+......+..+..+.. ..
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--Lp 335 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--LP 335 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--CC
Confidence 9988755433 22334456799999776 569999999999999999999 8999999888888777663332 23
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+..++..+.+++..||. +|.+||++.++...
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 345579999999999999 99999999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.01 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=201.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.++++||+|-||.|.+|+... +.+||+|.++... .......|.+|+++|.+++||||+.++|+|..+ +.+++++
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI~ 614 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMIT 614 (807)
T ss_pred ehhhhhcCcccceeEEEEecC-ceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHHH
Confidence 578999999999999997653 6899999998543 355578999999999999999999999999655 7899999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||++.|.|.+|+..+. .+......+++.||+.|++||.+.+ +|||||.+.|+|++.+ .++|++|||+++.+....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccCC
Confidence 9999999999999874 3345566779999999999999999 9999999999999999 699999999998653322
Q ss_pred ---ccccCCCCCCccCcc-ccccCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhC--CCCC---CCCCCC
Q 022479 185 ---AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--MEIPYSECDSVAKIYKKVTG--GVKP---QALNKV 253 (296)
Q Consensus 185 ---~~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~i~~~ll~--g~~p~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 253 (296)
..+......+|+|+| ++.+++++++|+|++|+.+||+++ ...||++..+.+.+.+.-.- .... ...+..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 123334567999999 677999999999999999999865 78999887665555433221 1111 222455
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.++.+++-+||. |.++|||++++..
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 68899999999998 9999999999976
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.22 Aligned_cols=241 Identities=23% Similarity=0.438 Sum_probs=201.1
Q ss_pred eeeecccCcceEEEeeecC--CC--cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQE--EG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~--~~--~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
+++||.|-||.||.+.... .| --||||+.+... +.+..+.|.+|..++++++||||++++|++.+. ..++
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wi 467 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWI 467 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeE
Confidence 4899999999999988532 23 348888887543 445578899999999999999999999999764 6999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 105 ITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||.++-|.|..|++. ...++...+..++.||+.||+|||+++ +|||||-..||||... ..+||+|||+++-.+..
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhcccc
Confidence 9999999999999986 467999999999999999999999999 9999999999999998 69999999999877543
Q ss_pred cc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .+.......|+|||-++ +.++.++|+|.||+.+||++. |..||.+..+.+.+..+..+... ..+..+|+.+.
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl--P~P~nCPp~LY 622 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL--PCPPNCPPALY 622 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC--CCCCCCChHHH
Confidence 22 22334456899999655 779999999999999999987 99999987776666554444332 33455799999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.|+.+||. +|.+||.+.++..
T Consensus 623 slmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHH
Confidence 99999999 9999998887754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.96 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=174.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCC----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEE----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW--- 94 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--- 94 (296)
.++| .+.++||+|+||.||+|.+..+ +..||+|++..... . +.... +.++...+.++......+
T Consensus 131 ~~~y-~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~----e~~~~--e~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDF-VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V----EIWMN--ERVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred cCCe-EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h----HHHHH--HHHHhhchhhHHHHHHhhhcc
Confidence 3455 6799999999999999999988 89999998763211 1 11111 111222222222111111
Q ss_pred -eeCCCCeEEEEeeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCCCceec
Q 022479 95 -LDDQHNTLNFITEVCTSGNLRTYRKKHRH--------------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHR 153 (296)
Q Consensus 95 -~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~ 153 (296)
.......+++++||+.+++|.+++..... .....+..++.|++.||+|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 11334679999999999999998875321 123456789999999999999999 9999
Q ss_pred CCCCCceEEeCCCCceEEeccCCccccCCC--cccccCCCCCCccCcccccc-C----------------------CCcc
Q 022479 154 DLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPELYEE-D----------------------YTEM 208 (296)
Q Consensus 154 dl~~~nilv~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~----------------------~~~~ 208 (296)
||||+|||++.+.+.++|+|||++...... .......+++.|+|||.+.. . +..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999975479999999999765322 22344567899999995431 1 2235
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC----------CC---------CCCCCCChHHHHHHHHHHh-C
Q 022479 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----------PQ---------ALNKVKDPEVKAFIEKCIA-Q 268 (296)
Q Consensus 209 ~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------~~---------~~~~~~~~~l~~li~~~l~-~ 268 (296)
+|||||||++|+|+++..++.. ....+...+..... .. ...+.......+|+.+||+ |
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 6999999999999998776542 22222222221110 00 0011123345689999998 9
Q ss_pred CCCCCCHHHHhcCcccccccCC
Q 022479 269 PRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 269 p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
|++|||+.++|+||||+.....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999987664
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=264.34 Aligned_cols=240 Identities=24% Similarity=0.406 Sum_probs=207.3
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
..+||.|-||.||.+.+++-.-.||||.++. +....+.|..|+.+++.++|||+++++|+|.-+ -.+||++||
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTEf 344 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITEF 344 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEEec
Confidence 4789999999999999999889999999984 455678999999999999999999999999655 579999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 109 CTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 109 ~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
+..|+|.+++.... .++.-.+..++.||..|+.||..++ ++||||-..|+||..+ ..+|++|||+++++.....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhcCCcee
Confidence 99999999998643 3666677889999999999999999 9999999999999999 7999999999998743322
Q ss_pred -cccCCCCCCccCcc-ccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 186 -AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 186 -~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
.........|.||| +-...++.++|+|+||+++|||.| |.-||.+ -+...++..+..+.....+.. +++.+..|+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~~PeG-CPpkVYeLM 499 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMDGPEG-CPPKVYELM 499 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccccCCCC-CCHHHHHHH
Confidence 22233456899999 445789999999999999999999 8999988 456778888888877666554 599999999
Q ss_pred HHHHh-CCCCCCCHHHHhc
Q 022479 263 EKCIA-QPRARPSASELLK 280 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~ 280 (296)
..||+ .|.+||++.++-+
T Consensus 500 raCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHhcCCcccCccHHHHHH
Confidence 99998 9999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=248.05 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=212.0
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
+......||-. .+.+|.|.- .|..+.+.-.++++|+|++..... +..-.++..+|..++..++|+|+++++.++..
T Consensus 11 s~ftv~~Ry~n-L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 11 STFTVPKRYVN-LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred cceeeeeeeee-ecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 44455567755 789999999 788898999999999999976633 23446788899999999999999999998864
Q ss_pred CC----CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 97 DQ----HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 97 ~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
.. -..+|+|||++.. +|...+. -.++...+..+..|++.|+.|||+.| |+||||||+||++..+ ..+|+.
T Consensus 87 ~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~ 160 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKIL 160 (369)
T ss_pred cccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeec
Confidence 32 1357899999977 7777666 24788899999999999999999999 9999999999999999 799999
Q ss_pred ccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----- 246 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 246 (296)
|||+++.....-....+..+..|.|||++- -.+.+..||||+|||+.+|++|...|.+.+..++.-..+.....
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 999998876654566777888999999654 45999999999999999999999999877665543322221110
Q ss_pred ----------------------------CCCC------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 247 ----------------------------PQAL------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 247 ----------------------------~~~~------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...+ .......+++++.+||. ||++|.|+.++|+|||++-+..++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ 320 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPD 320 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccc
Confidence 0000 01124578899999997 999999999999999999554444
Q ss_pred CC
Q 022479 292 SE 293 (296)
Q Consensus 292 ~~ 293 (296)
+.
T Consensus 321 ev 322 (369)
T KOG0665|consen 321 EV 322 (369)
T ss_pred cc
Confidence 44
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=257.05 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=212.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP---VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
..|| .++.+||.|+|+.||+|.+...++.||+|+-.......++ ..-+-.-+|.++-+.+.||-|+++|+++..+.
T Consensus 462 n~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3455 5789999999999999999999999999986544322221 23345678999999999999999999987654
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCC
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGF 176 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~ 176 (296)
+.+|-|.|||+|..|.-+++++..+++.++++|+.||+.||.||-...|+|+|.||||.|||+-.+. |.+|+.|||+
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 7889999999999999999999999999999999999999999999999999999999999997653 7899999999
Q ss_pred ccccCCCcc--------cccCCCCCCccCccccc-c----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--
Q 022479 177 AAIVGRSHA--------AHSIIGTPEYMAPELYE-E----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-- 241 (296)
Q Consensus 177 ~~~~~~~~~--------~~~~~~~~~~~aPE~~~-~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~-- 241 (296)
+..++.... ++-..||-+|++||.+. + ..+.+.|+||+|+|+|..+.|+.||.....-..+.+-.
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 998854322 33356788899999543 2 27889999999999999999999997543322222211
Q ss_pred hCCCCC-CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 242 TGGVKP-QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 242 ~~~~~~-~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
...... .......+++.+++|++||+ .-++|.+..++-.||||..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111111 22344568999999999999 9999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=273.04 Aligned_cols=240 Identities=28% Similarity=0.427 Sum_probs=192.2
Q ss_pred eeeecccCcceE-EEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEe
Q 022479 29 SDLLGSGAVKKV-YRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 29 ~~~lg~g~~~~v-~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+++|.|+-|++ |++... |+.||||.+-.. .....++|+..|+.- .||||++.++.-. ....+|++.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~--d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQ--DRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeecc--CCceEEEEe
Confidence 488999999775 899765 789999998532 245678899999988 6999999987654 347889999
Q ss_pred eccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----CCceEEeccCCcc
Q 022479 107 EVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIGDLGFAA 178 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~----~~~~~l~dfg~~~ 178 (296)
|.|.. +|.++++... .......+.++.|++.||+|||+.+ ||||||||.|||++.. ..+++|.|||++.
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99987 9999998741 1111344778999999999999999 9999999999999872 2489999999998
Q ss_pred ccCCCcc----cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
.++.... .....||.+|.|||++.+. ...+.|||||||++|+.++| .+||.+ ..++..+++.++.....+..
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLEP 737 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeecc
Confidence 8754322 4455789999999988765 66789999999999999995 899974 44555566666655544444
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
....+..+||.+|+. +|..||+|.++|.||+|
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 333489999999998 99999999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=260.35 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=181.3
Q ss_pred CCCcccceeeecccCcceEEEeeec----------------CCCcEEEeeeeeecccCCCHH----------HHHHHHHH
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVRLSHFSEDPV----------LVNRLHSE 75 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~----------------~~~~~~avK~~~~~~~~~~~~----------~~~~~~~e 75 (296)
.+.| ++.++||+|+||+||++.+. ..++.||||.+.........+ ..+....|
T Consensus 144 ~d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4455 67999999999999998642 235679999987542211111 11223346
Q ss_pred HHHHHhcCCCce-----eEEeeeeeeC------CCCeEEEEeeccCCCCHHHHHHhc-----------------------
Q 022479 76 VQLLRTLKNKYI-----IVCYSVWLDD------QHNTLNFITEVCTSGNLRTYRKKH----------------------- 121 (296)
Q Consensus 76 ~~~l~~l~~~~i-----~~~~~~~~~~------~~~~~~lv~e~~~~~sL~~~l~~~----------------------- 121 (296)
+.++.+++|.++ +++++++... .....++|+||+.+++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 4555554321 124589999999999998887531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccc--cCCCCCCccCc
Q 022479 122 -RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAP 198 (296)
Q Consensus 122 -~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~aP 198 (296)
..++...++.++.|++.+|.|||+.+ ++|+||||+||+++.+ +.++|+|||++.......... ....++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356678889999999999999999 9999999999999998 799999999997653322222 22347899999
Q ss_pred cccccC-----------------------CCcchhHHHHHHHHHHHHhCCC-CCCCCChHHHH----------HHHHhCC
Q 022479 199 ELYEED-----------------------YTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKI----------YKKVTGG 244 (296)
Q Consensus 199 E~~~~~-----------------------~~~~~Di~slG~i~~~ll~g~~-p~~~~~~~~~~----------~~~~~~~ 244 (296)
|.+... ...+.|+||+||++++|++|.. ||.+....... .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 966421 1124699999999999999875 77532211111 1111111
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CC---CCCCCHHHHhcCccccc
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QP---RARPSASELLKDPFFSE 286 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p---~~Rps~~~ll~hp~~~~ 286 (296)
..........++..++|+.+||. +| .+|+|+.++|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11222334468899999999995 54 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=260.92 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC------CceeEEeeeee
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN------KYIIVCYSVWL 95 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~ 95 (296)
.+..|++....|+|=|++|.+|.+...|..||||++... +...+.=..|+++|++|+. -|+++++.+|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 333446667789999999999999999999999999854 3344566789999999963 37888888884
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
..+.+|+|+|.+.- +|.+.++..+ .+....+..++.||+-||.+|-.+| |+|.||||+||||+.+...+|||
T Consensus 505 --hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 --HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred --hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeec
Confidence 44889999999865 8999888643 5888899999999999999999999 99999999999999987899999
Q ss_pred ccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--CCCCCCC
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQA 249 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 249 (296)
|||.|...+.+.. .++.-+..|.|||++-+ .++...|+||+||.+|++.||+..|++..+-.++.-.+. +..+...
T Consensus 580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 580 DFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9999998765543 33445568999997665 499999999999999999999999998765554432211 1111100
Q ss_pred CC-----------CCC--------------------------------------------ChHHHHHHHHHHh-CCCCCC
Q 022479 250 LN-----------KVK--------------------------------------------DPEVKAFIEKCIA-QPRARP 273 (296)
Q Consensus 250 ~~-----------~~~--------------------------------------------~~~l~~li~~~l~-~p~~Rp 273 (296)
+. .+. --.+++|+.+||. ||.+|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00 000 1257889999998 999999
Q ss_pred CHHHHhcCccccc
Q 022479 274 SASELLKDPFFSE 286 (296)
Q Consensus 274 s~~~ll~hp~~~~ 286 (296)
|++++|.||||..
T Consensus 739 t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 739 TVNQALKHPFITE 751 (752)
T ss_pred CHHHHhcCCcccC
Confidence 9999999999974
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.67 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=193.6
Q ss_pred CCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHH--hcCCCceeE
Q 022479 12 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR--TLKNKYIIV 89 (296)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~ 89 (296)
+|-|+-......+=-.+.+.||+|.||.||++... |+.||||+|.-. ++ +...+|.++.+ .++|+||+.
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE---~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DE---RSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----ch---hhhhhHHHHHHHHHhccchhhh
Confidence 34444444444443356799999999999999877 899999999732 21 33445666655 459999999
Q ss_pred EeeeeeeCC--CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh------CCCCceecCCCCCceE
Q 022479 90 CYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT------HEPCIIHRDLNCSNIF 161 (296)
Q Consensus 90 ~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~------~~~~i~h~dl~~~nil 161 (296)
+++.-..+. ...++||++|.+.|||.+|+.. ..++.+....++..++.||+|||. ..|.|+|||||..|||
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 887543322 2579999999999999999998 559999999999999999999994 2344999999999999
Q ss_pred EeCCCCceEEeccCCccccCCC-----cccccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhC-----
Q 022479 162 INGNIGQVKIGDLGFAAIVGRS-----HAAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTM----- 224 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g----- 224 (296)
|..+ +.+.|+|+|+|-..... .......||.+|+|||+++.. .-..+||||||.++||++-.
T Consensus 349 VKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 349 VKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999 89999999999776443 224567899999999998864 23469999999999999762
Q ss_pred -----CCCCCCCC-----hHHHHHHHHhCCCCCCCCCCCC-C---hHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 225 -----EIPYSECD-----SVAKIYKKVTGGVKPQALNKVK-D---PEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 225 -----~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~---~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.+||.+.- ..+...-...+...|..+.... . ..+..|++.||- +|..|.|+..+-+ .++++.
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK--tl~~l~ 504 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK--TLAKLS 504 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH--HHHHHh
Confidence 58885422 2222222222222332222221 2 345677899996 9999999988876 555544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.46 Aligned_cols=140 Identities=26% Similarity=0.351 Sum_probs=116.4
Q ss_pred CceecCCCC-CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC--------CC
Q 022479 15 PFVEVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--------NK 85 (296)
Q Consensus 15 ~~~~~~~~~-~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~ 85 (296)
++...+.-. +.|.+.++||.|.|+|||+|.+..+.+.||+|+++- ++...+....|+++|++++ ..
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 555555543 444689999999999999999999999999999984 4556677788999999985 24
Q ss_pred ceeEEeeeeeeCC--CCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCce
Q 022479 86 YIIVCYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNI 160 (296)
Q Consensus 86 ~i~~~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~ni 160 (296)
+|+++++.|...+ +..+++|+|++.. +|..++... ..++...++.|++|++.||.|||.. | |+|.||||+||
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENv 219 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENV 219 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCccee
Confidence 6999999987543 4688899999865 777777653 4599999999999999999999986 8 99999999999
Q ss_pred EE
Q 022479 161 FI 162 (296)
Q Consensus 161 lv 162 (296)
|+
T Consensus 220 Ll 221 (590)
T KOG1290|consen 220 LL 221 (590)
T ss_pred ee
Confidence 98
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=246.79 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=185.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeCC--CCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYSVWLDDQ--HNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~--~~~~ 102 (296)
.+.++||+|+||.||+|+.. ++.||||++... ....+++|-++.+. +.|+||+++++.-.... ...+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhHHHhhcCccceeehhhcc--CceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45788999999999999765 799999999743 24556666666554 58999999987643222 3478
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------CCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-------HEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-------~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
++|++|.+.|||.++++.+. +++.+..+++..++.||+|||+ ..|+|+|||||..||||..| +...|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccc
Confidence 99999999999999999866 9999999999999999999996 34569999999999999999 899999999
Q ss_pred CccccCCCc---ccccCCCCCCccCccccccCC-------CcchhHHHHHHHHHHHHhC------------CCCCC----
Q 022479 176 FAAIVGRSH---AAHSIIGTPEYMAPELYEEDY-------TEMVDIYSFGLCLLEMVTM------------EIPYS---- 229 (296)
Q Consensus 176 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-------~~~~Di~slG~i~~~ll~g------------~~p~~---- 229 (296)
++.++.... .+-...||.+|+|||++.+-. -.+.||||+|.++|||++. ++||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998875332 234467999999999988642 1358999999999999985 24443
Q ss_pred CCChHHHHHHHHhCCC-CCCCC----CCCCChHHHHHHHHHHh-CCCCCCCHHHH
Q 022479 230 ECDSVAKIYKKVTGGV-KPQAL----NKVKDPEVKAFIEKCIA-QPRARPSASEL 278 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~~l~-~p~~Rps~~~l 278 (296)
.....++.++.+.... .|..+ .......+++.+..||. ||+.|.|+.=+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1223344444443322 22222 22335678899999998 99999998755
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=261.88 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=207.4
Q ss_pred cceeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
.+.+.||+|.||.|+++..+. ....||||..+.... ....+.+..|+++++.+ .|+|++.+.|.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 456799999999999987531 145699999986543 35678899999999999 59999999999966
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv 162 (296)
...+++++||+..|+|..++...+ .++..++..++.||+.|++||++.. ++||||-..|||+
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLI 451 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEe
Confidence 478999999999999999998755 4889999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCcccc--cCC--CCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSHAAH--SII--GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAK 236 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~ 236 (296)
+.+ ..+|++|||+++......... ... ....|+|||.+.. .++.++|+||+|+++|||++ |..||.+......
T Consensus 452 ~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 TKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred cCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 999 699999999998643322211 111 3457999997765 59999999999999999999 8999998664566
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+.+.+..+.....+..+ +.++.++++.||. +|++||++.++.. +|..
T Consensus 531 l~~~l~~G~r~~~P~~c-~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQPEHC-SDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred HHHHHhcCCCCCCCCCC-CHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 67777777766665554 9999999999998 9999999999987 5544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=253.66 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=207.7
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
.+.||=|+||.|.++.-.++...||+|.+.+..... .....-++.|..+|..-.++-||++|-.|.+. +.+|+||||
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYFVMdY 710 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVMDY 710 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEEEEec
Confidence 588999999999999988899999999997654322 22344578899999999999999999999665 789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc---
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--- 185 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~--- 185 (296)
++||.+-.+|...+-|.+..++-++..|.-|+++.|..| ++||||||+|||++.+ |.+||.|||+++-+.+...
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceecccccc
Confidence 999999998888888999999999999999999999999 9999999999999999 9999999999865421100
Q ss_pred ----------------------------------------cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhC
Q 022479 186 ----------------------------------------AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM 224 (296)
Q Consensus 186 ----------------------------------------~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g 224 (296)
.....||+.|.|||++. ..+...-|.||.|+|+|+|+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 11234789999999765 5588899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHh-CCCCCCCCCCCCChHHHHHHHHHHhCCCCCC---CHHHHhcCcccccccCCC
Q 022479 225 EIPYSECDSVAKIYKKVT-GGVKPQALNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDDD 291 (296)
Q Consensus 225 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~p~~Rp---s~~~ll~hp~~~~~~~~~ 291 (296)
+.||-...+.+..+.++. .+.....+....+.+..+||.++..+++.|. -++++-.||||+.|+|.+
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 999965444333222111 1112233344568899999999988787875 677899999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=217.38 Aligned_cols=213 Identities=27% Similarity=0.423 Sum_probs=174.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
..-||.|+||.|-+..+..+|...|+|-+.... +.....++.+|+.+..+. ..|+++.++|.+..+ ..+++.||
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME 125 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICME 125 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHH
Confidence 477999999999999999999999999997543 345567777888877666 689999999988766 56999999
Q ss_pred ccCCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 108 VCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 108 ~~~~~sL~~~----l~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
.+.- ||..| ++.+..+++.-+-+++..++.||.|||++ . ++|||+||+|||++.+ |++|+||||.+..+.+
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYD-GQVKICDFGISGYLVD 201 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccC-CcEEEcccccceeehh
Confidence 9876 77666 45688999999999999999999999998 6 9999999999999999 9999999999987654
Q ss_pred CcccccCCCCCCccCcccccc-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
.-......|-.-|+|||.+.. .++-++||||||+.+.||.+++.||+.....-+...++...+.|.-.
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 433333445567999997763 48889999999999999999999998765555555555555554433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=276.27 Aligned_cols=240 Identities=22% Similarity=0.335 Sum_probs=180.0
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
..++||+|+||.||+|.++.++..||+|.++.... ....|++.+++++||||+++++++.+. ...++|||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~E 763 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHE 763 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEe
Confidence 36789999999999999988999999999864321 112357889999999999999999655 67899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH---THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|+++++|.+++.. +++..+..++.|++.|++||| +.+ ++||||||+||+++.+ +..++. ++.......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCC-CceEEE-ecccccccc--
Confidence 9999999999964 889999999999999999999 456 9999999999999987 566654 554433211
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhCCC------CCCCCCC-
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD----SVAKIYKKVTGGV------KPQALNK- 252 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~----~~~~~~~~~~~~~------~~~~~~~- 252 (296)
.....+++.|+|||++.+ .++.++||||+|+++|||++|+.||.... ............. .+.....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 112356789999997764 48999999999999999999999985321 1111111111000 0100000
Q ss_pred ----CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 253 ----VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 253 ----~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
....++.+++.+||+ ||++||++.++++ .++++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLK--TLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH--HHHHhhc
Confidence 112356788999997 9999999999998 4555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=230.02 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=196.4
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC---eEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN---TLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~lv 105 (296)
.+.||-|+||+||.+.+..+|+.|++|++..-.. +-...+++.+|+++|.-++|.|++..+++...+..+ .+|++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4789999999999999999999999999874332 445678899999999999999999888876544322 35667
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+|.+.. .|...+-....++.+.++.++.||+.+|.|||+.+ |.||||||.|.+|+.| -.+|+||||+++..+....
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhh
Confidence 777765 56666667778999999999999999999999999 9999999999999999 5999999999987643322
Q ss_pred --cccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CC--------------
Q 022479 186 --AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GV-------------- 245 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~-------------- 245 (296)
..-..-|..|+|||++.+. ++.+.||||.|||+.|++..+..|....+.+++.-+..- .+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2223346789999988754 899999999999999999999999766655544322211 11
Q ss_pred -------CCCCCC---CCC-----ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 246 -------KPQALN---KVK-----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 246 -------~~~~~~---~~~-----~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+...+ ... ..+...++..++. ||++|.+.++++.|+++..-
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111110 000 1345567778887 99999999999999997653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=235.30 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=200.4
Q ss_pred CCcccceeeecccCcceEEEeeecC---CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
..+++..++||+|.|++||++.+.. .++.||+|.+...+. ..++.+|++.|..+ .+.||+++.+++.-.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~~~rnn- 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNGCFRNN- 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence 3455778999999999999999887 788999999986543 35688999999999 478999999888444
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+...+|++|++...-.++... ++..++...+..++.||+++|++| |+|||+||+|++.+...++-.|+|||++.
T Consensus 108 -d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 -DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred -CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 789999999999988888876 779999999999999999999999 99999999999999988999999999986
Q ss_pred ccC-----------------C----------------------------CcccccCCCCCCccCccccccC--CCcchhH
Q 022479 179 IVG-----------------R----------------------------SHAAHSIIGTPEYMAPELYEED--YTEMVDI 211 (296)
Q Consensus 179 ~~~-----------------~----------------------------~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di 211 (296)
... . .....+..||++|+|||++.+- .+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 0001123578999999987643 7889999
Q ss_pred HHHHHHHHHHHhCCCCCCCC-ChHHHHHHH--------------HhCC--------------------------------
Q 022479 212 YSFGLCLLEMVTMEIPYSEC-DSVAKIYKK--------------VTGG-------------------------------- 244 (296)
Q Consensus 212 ~slG~i~~~ll~g~~p~~~~-~~~~~~~~~--------------~~~~-------------------------------- 244 (296)
||.|+|+..++++..||-.. ++.+.+.++ ..+.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999321 111111100 0000
Q ss_pred --CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 245 --VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 245 --~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.......+..+..+.+|+.+|+. ||.+|.|++++|+||||.+.+..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 00111122335578899999998 99999999999999999976543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=248.54 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=201.1
Q ss_pred cceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+-.++||+|+||+||++..-..|+ +||+|++.... .......+.+|+.++.++.|+|++++++++... .+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 347999999999999999865554 58888876443 334467788999999999999999999998654 48
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.||++|+++|+|.++++. ...+-...+..|+.||++||.|||.++ ++||||-..||||..- +.+|+.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccC
Confidence 999999999999999985 457889999999999999999999999 9999999999999988 699999999999886
Q ss_pred CCccccc---CCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 182 RSHAAHS---IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 182 ~~~~~~~---~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
....... ..-.+.|+|=|.+. ..++.++||||+|+.+||++| |..|+.+. ..+++...+..+..... +..++-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-~~~eI~dlle~geRLsq-PpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-PAEEIPDLLEKGERLSQ-PPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-CHHHhhHHHhccccCCC-CCCccH
Confidence 5444333 23355788888554 569999999999999999999 99999874 45566666666655444 444688
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++..++.+||- |++.||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999997 9999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=214.16 Aligned_cols=209 Identities=38% Similarity=0.675 Sum_probs=182.9
Q ss_pred ecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCC
Q 022479 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS 111 (296)
Q Consensus 32 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 111 (296)
||+|.+|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++++++++.+... ...++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 689999999999998889999999998543311 457889999999999999999999998654 689999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC-CCCceEEeccCCccccCCCc-cccc
Q 022479 112 GNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAIVGRSH-AAHS 188 (296)
Q Consensus 112 ~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~-~~~~~~l~dfg~~~~~~~~~-~~~~ 188 (296)
++|.+++... ..++...++.++.+++.++.+||+.| ++|+||+|.||+++. + +.++|+||+.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhc
Confidence 9999999875 56899999999999999999999999 999999999999999 6 799999999998764432 1333
Q ss_pred CCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 189 IIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 189 ~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
......|.+||.... ..+.++|+|++|++++++ ..+.+++..|+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l 198 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKML 198 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHh
Confidence 456778999997765 688899999999999999 78999999999
Q ss_pred h-CCCCCCCHHHHhcCc
Q 022479 267 A-QPRARPSASELLKDP 282 (296)
Q Consensus 267 ~-~p~~Rps~~~ll~hp 282 (296)
. +|.+||++.++++|+
T Consensus 199 ~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 199 QKDPEKRPSAKEILEHL 215 (215)
T ss_pred hCCcccCcCHHHHhhCC
Confidence 7 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=248.77 Aligned_cols=260 Identities=27% Similarity=0.505 Sum_probs=223.2
Q ss_pred ceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
++.-++...|+ +.+.+|+|.||.||++.++.+++..|+|+++.... +...-+++|+-+++.++|+||+.+++.+.
T Consensus 8 isrrnP~ddye-llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 8 ISRRNPQDDYE-LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred hhhcCCccchh-heeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhh
Confidence 44457778885 69999999999999999999999999999997643 33566778999999999999999999996
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.. ..++++||||.||+|.+...-.+++++.++..+++..+.+++|||+.| -+|||||-.||++++. |.++++|||
T Consensus 83 r~--dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfg 157 (829)
T KOG0576|consen 83 RR--DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFG 157 (829)
T ss_pred hh--cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccC
Confidence 54 789999999999999987777788999999999999999999999999 8999999999999999 899999999
Q ss_pred CccccCCC-cccccCCCCCCccCcccc----ccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 176 FAAIVGRS-HAAHSIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 176 ~~~~~~~~-~~~~~~~~~~~~~aPE~~----~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
.+..+... ....+..||+.|+|||+- .+.+....|+|++|+...++-.-+.|.-...+...++-....+..+..+
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc
Confidence 98766432 345667899999999943 2558999999999999999999888887777777776666666665555
Q ss_pred C--CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 251 N--KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 251 ~--~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
. ...++.+.+|++.++- +|++||+++.+|.|||..
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 3 3447889999999995 999999999999999965
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=240.06 Aligned_cols=197 Identities=30% Similarity=0.408 Sum_probs=171.1
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHH----HHHHHHHHHHhcC---CCceeEEeeeeeeCCCC
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----RLHSEVQLLRTLK---NKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~----~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~ 100 (296)
..+.+|+|+||.|++|+++.+...|++|.+++.....+....+ .+-.|+++|..++ |+||++++++|.+. +
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd--d 642 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD--D 642 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC--C
Confidence 3699999999999999999999999999998766544333322 2456888888887 99999999999554 7
Q ss_pred eEEEEeeccC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCT-SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|++||... |..|.+++...+.+++.+...|.+|++.|++|||+.| |+|||||-+|++++.+ |.++|+|||.+..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhh
Confidence 9999999874 4489999999999999999999999999999999999 9999999999999999 9999999999875
Q ss_pred cCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSE 230 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~ 230 (296)
.. ...+....||..|+|||++.+. ....-|||+||+++|.++..+.||.+
T Consensus 720 ~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 3346667899999999999876 56678999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=220.58 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=199.3
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
+...++-+|.||.||++++.+. .+.+.+|.++... ++-....+.+|.-.+..+.|+|++++.++..+.. .+
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~ 362 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-AT 362 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-Cc
Confidence 5567888999999999976543 3457788887543 4566778889998999999999999999988765 66
Q ss_pred EEEEeeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 102 LNFITEVCTSGNLRTYRKKH--------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
.++++.+..-++|+.|+... ..++..++..++.|++-|++|||++| ++|.||-..|.++++. -++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeEEecc
Confidence 77788999999999999831 35777788899999999999999999 9999999999999999 7999999
Q ss_pred cCCccccCCC--cc-cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 174 LGFAAIVGRS--HA-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 174 fg~~~~~~~~--~~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
=.+++.+-.. +- -........|+|||.+. ..++.++|+||||+++|||+| |+.||.+.++.+..--. ..+.. .
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kdGyR-l 517 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KDGYR-L 517 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hccce-e
Confidence 9999865322 11 22334566899999655 669999999999999999999 99999987776654444 33433 3
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+..+|+++..++..||. +|++||+++|++.
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3445579999999999998 9999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-30 Score=211.36 Aligned_cols=212 Identities=33% Similarity=0.523 Sum_probs=181.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|++|+||++.+..+++.+++|.+...... ...+.+.+|++.+++++|++++++++.+... ...++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~ 76 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM 76 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence 4688999999999999999988999999999865332 3467888999999999999999999988554 6789999
Q ss_pred eccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 107 EVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
|++.+++|.+++..... +++..+..++.+++.++.+||+++ ++|+|++|.||+++.+ +.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccc
Confidence 99999999999987666 899999999999999999999999 9999999999999998 799999999998775442
Q ss_pred -ccccCCCCCCccCcccc-c-cCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhCCCC
Q 022479 185 -AAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLEMVTMEIPYSE-CDSVAKIYKKVTGGVK 246 (296)
Q Consensus 185 -~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~i~~~ll~g~~p~~~-~~~~~~~~~~~~~~~~ 246 (296)
......++..|++||.. . ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+.+
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23445667789999976 3 3477799999999999999999999977 5666667776666553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=208.46 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=192.3
Q ss_pred CCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEee
Q 022479 14 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYS 92 (296)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 92 (296)
+++..++-.+.| .+.+.||+|.||.+-+|.|+.++..+++|-++.. .-.+..|.+|...--.+ .|.||+..++
T Consensus 15 ~el~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 15 EELKKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred ccccccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHH
Confidence 345555666677 5789999999999999999999999999999854 33467888888777666 4889998888
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe-CCCCceEE
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKI 171 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~-~~~~~~~l 171 (296)
+..... +.+++++||++.|+|..-+...+ +-+...+.++.|++.|+.|+|+++ +||||||.+|||+- .++-++||
T Consensus 89 vaFqt~-d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 89 VAFQTS-DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred HHhhcC-ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEe
Confidence 766554 58888999999999998888766 788888999999999999999999 99999999999984 44459999
Q ss_pred eccCCccccCCCcccccCCCCCCccCccccc----cC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHH
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYE----ED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA----KIYKKV 241 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~----~~~~~~ 241 (296)
||||..+..+..-. .......|.+||... +. ..+.+|+|.||++++.++||..||......+ ...+..
T Consensus 165 cDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred eecccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 99999886543321 112234688898543 22 5778999999999999999999996322111 111221
Q ss_pred hC-CCCCCCCCCCCChHHHHHHHHHHh-CCCCC---CCHHHHhcCccc
Q 022479 242 TG-GVKPQALNKVKDPEVKAFIEKCIA-QPRAR---PSASELLKDPFF 284 (296)
Q Consensus 242 ~~-~~~~~~~~~~~~~~l~~li~~~l~-~p~~R---ps~~~ll~hp~~ 284 (296)
.+ ...........++.+..+.++-|. ++++| .++......-|.
T Consensus 243 ~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 243 KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 11 111111222346777788888886 99999 444444444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=194.77 Aligned_cols=160 Identities=25% Similarity=0.361 Sum_probs=125.4
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCC
Q 022479 112 GNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190 (296)
Q Consensus 112 ~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (296)
|+|.+++.. +..+++.+++.++.|++.||.|||+.+ ||+||+++.+ +.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeecccc----CC
Confidence 588999986 456999999999999999999999888 9999999988 78888 99987764322 25
Q ss_pred CCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC-----CCCCCh--HHHHHH
Q 022479 191 GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-----NKVKDP--EVKAFI 262 (296)
Q Consensus 191 ~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~l~~li 262 (296)
+++.|+|||++.+ .++.++||||||+++|+|++|+.||...................... ....+. .+.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 7899999997764 48899999999999999999999997654433333333222221111 111122 699999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+||. +|++||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 99998 9999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=239.60 Aligned_cols=181 Identities=20% Similarity=0.221 Sum_probs=132.9
Q ss_pred CeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-------------
Q 022479 100 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN------------- 165 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~------------- 165 (296)
..+++++|+.. ++|.+++.. ...+++.+++.++.||+.||+|||++| |+||||||+|||++..
T Consensus 53 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 53 DSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred chhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCc
Confidence 46778889874 499999975 456999999999999999999999999 9999999999999643
Q ss_pred -----CCceEEeccCCccccCCCc-----------------ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHH
Q 022479 166 -----IGQVKIGDLGFAAIVGRSH-----------------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMV 222 (296)
Q Consensus 166 -----~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll 222 (296)
.+.++++|||+++...... ......+|+.|+|||++. ..++.++|||||||++|||+
T Consensus 130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl 209 (793)
T PLN00181 130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF 209 (793)
T ss_pred ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence 1456666777665321100 001134678899999765 45899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 223 TMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 223 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+|..|+..... ..........++... .......+++..||. +|.+||++.++|+||||...
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 210 CPVSSREEKSR--TMSSLRHRVLPPQIL--LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hCCCchhhHHH--HHHHHHHhhcChhhh--hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 99888754221 111111111111111 124556788999997 99999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=218.65 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=198.1
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeec--ccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS--HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.|.+...++|.|++|.++.+......+.++.|.+... ...........+..|+-+-..+.|++++.....+.+. ..
T Consensus 318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~ 395 (601)
T KOG0590|consen 318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DG 395 (601)
T ss_pred ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--cc
Confidence 3556689999999998887777666666666665421 2222233334477888888899999998777666543 23
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
..-.|||+++ .|..++.....++..++..++.||+.|+.|+|+.| +.|+|+|++|++++.+ |.++++|||.+..+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeec
Confidence 3334999999 99999998888999999999999999999999999 9999999999999999 899999999997763
Q ss_pred CC-----cccccCCCCCCccCcccccc-CCCc-chhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHh-----CCCCCC
Q 022479 182 RS-----HAAHSIIGTPEYMAPELYEE-DYTE-MVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVT-----GGVKPQ 248 (296)
Q Consensus 182 ~~-----~~~~~~~~~~~~~aPE~~~~-~~~~-~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~-~~~~-----~~~~~~ 248 (296)
.. ......+++..|.|||.+.+ ++.+ ..||||.|++++.|.+|+.||......+..+ .... ....+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 22 33556778899999997664 4555 4899999999999999999996443332221 1100 011122
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
......+..-+.++.+||+ ||++|.+++++++.+||+.++-
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 2233446788899999998 9999999999999999998763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=183.89 Aligned_cols=201 Identities=18% Similarity=0.259 Sum_probs=167.2
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH 99 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 99 (296)
..|-.|+++++||+|+||.++.+.+--++++||||.-+..+- ..+++.|.+..+.|. .++|..++-+. ..+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYFG--QEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence 455667999999999999999999999999999999875432 467888999998885 56777776444 334
Q ss_pred CeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC----CCCceEEecc
Q 022479 100 NTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----NIGQVKIGDL 174 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~----~~~~~~l~df 174 (296)
.+-.+|+|.+ |.||++++. .+++|+..++..++.|++.-++++|++. ++.|||||+|+||.. +.+.+.++||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence 6677888987 459999887 6788999999999999999999999999 999999999999953 2247999999
Q ss_pred CCccccCCC--------cccccCCCCCCccCcc-ccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 022479 175 GFAAIVGRS--------HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD 232 (296)
Q Consensus 175 g~~~~~~~~--------~~~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 232 (296)
|++..+-.+ ....+..||-+|++-. .+.++-|.+-|+-+||-++++.+-|.+||.+..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 999877432 2344556899999988 556679999999999999999999999998743
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-25 Score=187.82 Aligned_cols=247 Identities=19% Similarity=0.207 Sum_probs=182.6
Q ss_pred cccceeeecccCcceEEEeeecCCC-cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC----CceeEEeeeeeeCCC
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQH 99 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----~~i~~~~~~~~~~~~ 99 (296)
-|++.++||+|+||.||.|.+..++ +.+|+|+......... ..+..|..++..+.. +++..+++.+. ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 3478999999999999999987764 6788888875432111 156678888888863 57777777664 233
Q ss_pred CeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC----CceEEec
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI----GQVKIGD 173 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~----~~~~l~d 173 (296)
..-++||+.+ |.+|.++.... +.++..++..++.|++.+|.+||+.| ++||||||.|+.+.... ..+.|+|
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 6778888877 45999987543 68999999999999999999999999 99999999999998652 3699999
Q ss_pred cCCcc--ccCCCc--------c-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---HH
Q 022479 174 LGFAA--IVGRSH--------A-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK---IY 238 (296)
Q Consensus 174 fg~~~--~~~~~~--------~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~---~~ 238 (296)
||+++ .+.... . .....||.+|+|+....+ +.+++.|+||++.++.+++.|.+||.+...... ..
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 431111 1 123448999999997664 599999999999999999999999976543222 22
Q ss_pred HHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.......... .....+.++.++...+-. +...+|....+..
T Consensus 251 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2111111111 233445677777666666 9999998887754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=191.21 Aligned_cols=173 Identities=16% Similarity=0.158 Sum_probs=130.5
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecC-CCcEEEeeeeeeccc-CCCHHHHHHHHHHHHHHHhcCCCceeEEee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYIIVCYS 92 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 92 (296)
|.+...+....|.+.++||+|+||+||+|.++. +++.+|+|++..... .........+.+|++++++++|+++++.+.
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 444444555555789999999999999999876 677789998752211 113345677999999999999999985332
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCC-CCCceEEeCCCCceEE
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL-NCSNIFINGNIGQVKI 171 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl-~~~nilv~~~~~~~~l 171 (296)
.+ ...|+||||+.|++|... .. .. ...++.|++++|.+||++| ++|||| ||+||+++.+ +.++|
T Consensus 89 ~~-----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikL 153 (365)
T PRK09188 89 AT-----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAV 153 (365)
T ss_pred Ec-----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEE
Confidence 22 347999999999999632 11 11 1467889999999999999 999999 9999999887 79999
Q ss_pred eccCCccccCCCccc---------ccCCCCCCccCccccc
Q 022479 172 GDLGFAAIVGRSHAA---------HSIIGTPEYMAPELYE 202 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~---------~~~~~~~~~~aPE~~~ 202 (296)
+|||+++.+...... ....+++.|.|||.+.
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999876443221 2334677899999775
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-24 Score=180.97 Aligned_cols=257 Identities=29% Similarity=0.405 Sum_probs=205.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC-ceeEEeeeeeeCCCCeEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK-YIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~l 104 (296)
+++.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +++++.+.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 367899999999999999887 788999997654322 23577889999999999988 799999988433 45899
Q ss_pred EeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC-ceEEeccCCcccc
Q 022479 105 ITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV 180 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~-~~~l~dfg~~~~~ 180 (296)
+++++.++++.+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++.. + .++++|||.+...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~-~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRD-GRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCC-CCeEEEeccCcceec
Confidence 999999999997777664 7999999999999999999999999 9999999999999998 5 7999999999765
Q ss_pred CCCc-------ccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCC
Q 022479 181 GRSH-------AAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVK 246 (296)
Q Consensus 181 ~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~ 246 (296)
.... ......++..|.+||.+.+ ..+...|+|++|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4332 2456678999999997664 588899999999999999999999876553 3444444444433
Q ss_pred C-CCCCCCC------ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 247 P-QALNKVK------DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 247 ~-~~~~~~~------~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+ ....... ...+.+++..++. +|..|.+..+...+++........
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~ 285 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence 2 1111111 1578999999997 999999999999887665544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=170.62 Aligned_cols=242 Identities=19% Similarity=0.265 Sum_probs=179.0
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC-ceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK-YIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~ 100 (296)
.+.| ++.++||+|+||.+|.+....+|+.||+|+-+.... -.++..|.++.+.+++. .|..+..+.. +..
T Consensus 14 ~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ 84 (341)
T KOG1163|consen 14 GGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGT--EKD 84 (341)
T ss_pred ccce-EEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhcc--ccc
Confidence 3445 889999999999999999999999999999875433 34577788899888754 4444443332 236
Q ss_pred eEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCc
Q 022479 101 TLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFA 177 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~ 177 (296)
+-.+|||.+ |.||++++. ..+.++..++..++-|++.-++|+|.++ ++||||||+|+++.-+. ..+.|+|||++
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 778899988 459998887 4668999999999999999999999999 99999999999997652 57999999999
Q ss_pred cccCCC--------cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhC---
Q 022479 178 AIVGRS--------HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY--KKVTG--- 243 (296)
Q Consensus 178 ~~~~~~--------~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~--~~~~~--- 243 (296)
..+-.. .......||.+|+|-...- -+.+.+.|+-|+|.+++++.-|.+||.+.......+ +.+.+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 877332 2233456788998877544 457899999999999999999999998865444322 22211
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCH
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSA 275 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~ 275 (296)
..+...+=...|.++.-.+.-|-. --++-|+.
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 112222223346677766666654 44444543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=184.30 Aligned_cols=236 Identities=17% Similarity=0.206 Sum_probs=149.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC----------CceeEEee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----------KYIIVCYS 92 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~~~~ 92 (296)
.+-...++.||.|+++.||.+.+..+|+.+|+|++.... ......++.+++|.-....+.+ -.++..++
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 333456899999999999999999999999999998766 3334456777777655544322 12333333
Q ss_pred eeeeC---------CCC------eEEEEeeccCCCCHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHhhCCCCc
Q 022479 93 VWLDD---------QHN------TLNFITEVCTSGNLRTYRK---KHRH----VSIKALKKWSKQVLEGLEYLHTHEPCI 150 (296)
Q Consensus 93 ~~~~~---------~~~------~~~lv~e~~~~~sL~~~l~---~~~~----~~~~~~~~i~~ql~~~l~~LH~~~~~i 150 (296)
....+ .+. ..+++|.-..+ +|.+++. .... +.......+..|++..+++||..| +
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--l 166 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--L 166 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--e
Confidence 32211 111 22456666644 7777654 2221 222233455689999999999999 9
Q ss_pred eecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCcccccc---------CCCcchhHHHHHHHHHHH
Q 022479 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---------DYTEMVDIYSFGLCLLEM 221 (296)
Q Consensus 151 ~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~Di~slG~i~~~l 221 (296)
+|+||+|+|++++.+ |.++|+||+.....+..... ...+..|.+||.... ..+.+.|.|+||+++|.|
T Consensus 167 VHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EEST-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999 99999999988776553322 334567889995432 268889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCC
Q 022479 222 VTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR 272 (296)
Q Consensus 222 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~R 272 (296)
.++..||........... ...... ..|+.+++||..+|+ ||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999974322111100 111222 468999999999998 99987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=198.73 Aligned_cols=242 Identities=20% Similarity=0.331 Sum_probs=199.7
Q ss_pred eecccCcceEEEee---ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEEe
Q 022479 31 LLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 31 ~lg~g~~~~v~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++|+|.||.|+++. ..+.|..+++|+.+.......... ....|..++..++ ||+++++.-.+..+ ..++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccc--cchhHhh
Confidence 47999999999764 344578899999987654332222 5567888888886 99999998777544 6789999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
++..|+.|...+.....+.+.........++-++.++|+.+ ++++|+|++||+++.+ |.+++.|||.++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc
Confidence 99999999999998888999999999999999999999999 9999999999999999 99999999999876443322
Q ss_pred ccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 266 (296)
||+..|+|||++. ....+.|.||+|+++++|++|..||.+ +....+..... ..+...+..+++++..++
T Consensus 154 ---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---~~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---EMPRELSAEARSLFRQLF 222 (612)
T ss_pred ---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc---CCchhhhHHHHHHHHHHH
Confidence 9999999999988 778899999999999999999999976 33333333222 223334778999999999
Q ss_pred h-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 267 A-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 267 ~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
. +|..|. -+.++++|+||..++|+
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 7 999996 45889999999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=205.17 Aligned_cols=242 Identities=21% Similarity=0.238 Sum_probs=176.8
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+.||++.|=+|.+|++.+ | .|+|||+-.....-+-....+...+++ ...+++||.+++..+.. ..+..|+|-
T Consensus 26 ~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~--t~kAAylvR 100 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV--TDKAAYLVR 100 (1431)
T ss_pred eeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH--hhHHHHHHH
Confidence 568999999999999997763 4 499999965432112222333344555 56778999999877653 336778888
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc--C--C
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--G--R 182 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~--~--~ 182 (296)
.|... +|.+.+...+.+.+-+.+-+++||+.||..+|..| |+|||||.+|||++.= +=+.|.||..-+.. . +
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCCCC
Confidence 89887 89999999999999999999999999999999999 9999999999999987 57999999865432 1 1
Q ss_pred Ccc----cccCCCCCCccCcccccc-----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCC-
Q 022479 183 SHA----AHSIIGTPEYMAPELYEE-----------D-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGG- 244 (296)
Q Consensus 183 ~~~----~~~~~~~~~~~aPE~~~~-----------~-~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~- 244 (296)
+.. +.......+|.|||.+.. . .+++.||||+||++.|+++ |++||.- .++..=..++
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCc
Confidence 111 112233458999996542 1 5678999999999999987 7888841 1111110110
Q ss_pred -CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 245 -VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 245 -~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.....+....+..++.|+..|++ ||.+|.||++.|+.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00011122234579999999998 99999999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=164.48 Aligned_cols=145 Identities=19% Similarity=0.199 Sum_probs=112.4
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH----------------------HHHHHHHHHHHHHHhcCCCc
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP----------------------VLVNRLHSEVQLLRTLKNKY 86 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~~~~ 86 (296)
...||+|++|.||+|.+. +|+.||+|+++........ ........|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999764321111 01123346999999998877
Q ss_pred eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCCCceEEeCC
Q 022479 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 87 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~~nilv~~~ 165 (296)
+........ . ..++||||+.|+++.........++..++..++.|++.+|.++ |+.| ++||||||+||+++.
T Consensus 81 v~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~- 153 (190)
T cd05147 81 IPCPEPILL-K---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCCcEEEe-c---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC-
Confidence 643332221 1 2379999999987765544456799999999999999999999 7999 999999999999984
Q ss_pred CCceEEeccCCccccCC
Q 022479 166 IGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~ 182 (296)
+.++|+|||++...+.
T Consensus 154 -~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 -GKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CcEEEEEccccccCCC
Confidence 6899999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=172.73 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=171.5
Q ss_pred cceeeecccCcceEEEeeecCCCc-----------------------------------EEEeeeeeecc-cCCCHHHHH
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGI-----------------------------------EVAWNQVRLSH-FSEDPVLVN 70 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~-----------------------------------~~avK~~~~~~-~~~~~~~~~ 70 (296)
++++.||+|+.+.||.+..+.+|. +.|+|.+..-. ...+....+
T Consensus 160 eiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~iL~ 239 (598)
T KOG4158|consen 160 EIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAHILK 239 (598)
T ss_pred cccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHHHHH
Confidence 689999999999999987654211 35666654322 222333444
Q ss_pred HHHHHHH------HH--------H-------h-cCCCceeEEeeeeeeC-------------------------CCCeEE
Q 022479 71 RLHSEVQ------LL--------R-------T-LKNKYIIVCYSVWLDD-------------------------QHNTLN 103 (296)
Q Consensus 71 ~~~~e~~------~l--------~-------~-l~~~~i~~~~~~~~~~-------------------------~~~~~~ 103 (296)
...+|.- .+ + + -+||||+.+.+.|.++ ...++|
T Consensus 240 sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tly 319 (598)
T KOG4158|consen 240 SMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLY 319 (598)
T ss_pred HhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEE
Confidence 4433310 00 1 1 2599999998776542 347899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC---CceEEeccCCcccc
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIV 180 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~---~~~~l~dfg~~~~~ 180 (296)
+||..+.. +|.+++.... .+......++.|+++|+.|||++| +.|||+|.+||++..++ ..++++|||.+--.
T Consensus 320 lvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd 395 (598)
T KOG4158|consen 320 LVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD 395 (598)
T ss_pred Eehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeec
Confidence 99999987 9999988655 677788889999999999999999 99999999999996553 25899999976322
Q ss_pred CC------C-cccccCCCCCCccCcccccc---C----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 022479 181 GR------S-HAAHSIIGTPEYMAPELYEE---D----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 181 ~~------~-~~~~~~~~~~~~~aPE~~~~---~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
.. . ......-|+-.-+|||+... . ...++|.|+.|.+.||++....||.+..... +....-+.-.
T Consensus 396 ~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~q 474 (598)
T KOG4158|consen 396 DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQ 474 (598)
T ss_pred cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhh
Confidence 11 0 01112234556789997653 2 3457999999999999999999998622110 0000011112
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHH
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASE 277 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ 277 (296)
...+++.+++.+++|+..+|+ ||.+|+|+.-
T Consensus 475 LPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 475 LPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 345567779999999999998 9999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=166.42 Aligned_cols=249 Identities=18% Similarity=0.308 Sum_probs=197.8
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
+++.++...- .+.-+|.+...|..|++..+ |..+++|++..... +....+.|..|.-.|+-+.||||+++++.+
T Consensus 183 r~~gid~~~l--nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSL--NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhh--hhhhhhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhc
Confidence 3444443333 24577899999999999887 55678888876544 455567788999999999999999999999
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE-
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI- 171 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l- 171 (296)
..+ -.+.++.-|++.+||...+-.. -..+..+..+++..++.+++|||+..|.+--..|+..+++++.+ ...++
T Consensus 257 nsp--pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltaris 333 (448)
T KOG0195|consen 257 NSP--PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARIS 333 (448)
T ss_pred cCC--CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhhee
Confidence 665 4678899999999999988653 34677789999999999999999998866667899999999988 44444
Q ss_pred -eccCCccccCCCcccccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 022479 172 -GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 172 -~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+|-.++.. .......|.|++||.+.+. .-.+.|+|||++++||+.|.+.||.+..+.+--+.+..++..
T Consensus 334 mad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr 407 (448)
T KOG0195|consen 334 MADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR 407 (448)
T ss_pred cccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc
Confidence 34333322 2234567899999976643 456799999999999999999999999999988888888887
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHh
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELL 279 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll 279 (296)
...++. .+..+..|+.-|+. ||.+||.+..++
T Consensus 408 v~ippg-is~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 408 VHIPPG-ISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccCCCC-ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 776655 58889999999997 999999988775
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=160.05 Aligned_cols=145 Identities=21% Similarity=0.222 Sum_probs=113.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----------------------HHHHHHHHHHHHHHHhcCCCc
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----------------------PVLVNRLHSEVQLLRTLKNKY 86 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~~~~ 86 (296)
...||+|++|.||+|.+. +|+.||+|++........ ......+..|.+.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999986521100 011234568899999999988
Q ss_pred eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCC
Q 022479 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 87 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~ 165 (296)
+......... ..++||||+.|+++.........++..+...++.|++.++.++|+ .| ++|+||||+||+++ +
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence 7544333322 247999999998654433334568889999999999999999999 99 99999999999999 5
Q ss_pred CCceEEeccCCccccCC
Q 022479 166 IGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~ 182 (296)
+.++|+|||++.....
T Consensus 154 -~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 -GKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCEEEEEcccceecCC
Confidence 7999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=164.43 Aligned_cols=175 Identities=14% Similarity=0.121 Sum_probs=131.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHH------HHHHHHHHHhcCCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR------LHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
++| ++.++||.|+||.||++.. ++..+|+|++..... ..+..... +.+|+..+.++.|+++..+...+..
T Consensus 31 ~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 31 YNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred Cce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 444 7899999999999999654 477899999975433 23333333 5799999999999999998887664
Q ss_pred CC------CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 97 DQ------HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 97 ~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
.. ....+++|||++|.+|.++.. +++ ....++..++..+|+.| ++|+|++|+||+++.+ | ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-EE
Confidence 32 235789999999999988732 333 34569999999999999 9999999999999988 7 99
Q ss_pred EeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHh
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT 223 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~ 223 (296)
|+|||............. | .+...+..++|+|+||+.+.....
T Consensus 175 liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHHH
Confidence 999998865432111100 0 122335678999999998876654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=183.89 Aligned_cols=222 Identities=25% Similarity=0.434 Sum_probs=163.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
...| +.-+.|..|+||.||.+.|+.+.+.+|+|.=+.. . . +++ ++....+|.++
T Consensus 82 e~df-~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----i---lRn---ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDF-NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----I---LRN---ILTFAGNPFVV------------- 135 (1205)
T ss_pred cccc-ceeEeeccCCCCceeeeeccccccchhhcccccc-h-----h---hhc---cccccCCccee-------------
Confidence 3444 5579999999999999999999999999443311 1 0 000 22222222222
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
|.-.+.++..++++... +.+++|||+.| |+|+|+||+|.+|+.- |++|+.|||+...-.
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGL 194 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhh
Confidence 23334455555555433 88999999999 9999999999999999 999999999875421
Q ss_pred C--------------Ccc--cccCCCCCCccCcccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 022479 182 R--------------SHA--AHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244 (296)
Q Consensus 182 ~--------------~~~--~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 244 (296)
. ... ..-.++||.|.|||++ .+.|....|.|++|+|+|+.+.|..||.+..+.+-+-..+...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1 011 1124799999999965 4669999999999999999999999998866655555554443
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CCCCC---CCHHHHhcCcccccccCC
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QPRAR---PSASELLKDPFFSELNDD 290 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p~~R---ps~~~ll~hp~~~~~~~~ 290 (296)
..+..-....+++.++++..+|+ +|..| ..+.++-+|+||+..+|.
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 33333344568899999999997 99999 578888999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=152.38 Aligned_cols=185 Identities=13% Similarity=0.059 Sum_probs=139.8
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEEe
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+...|++|+||+|+.+.. .+.+++.+.+.........-....+.+|+++|+++.| +++.+++++ +..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 578899999999997754 5788988888765543333334468899999999954 678888775 2368999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCC-CCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL-NCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl-~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
+|+.|.+|...... . ...++.|++.+|.++|++| ++|+|| +|+||+++.+ +.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcch
Confidence 99999998654322 1 1357789999999999999 999999 7999999987 8999999999986543321
Q ss_pred c--------------ccCCCCCCccCccc--cccCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 022479 186 A--------------HSIIGTPEYMAPEL--YEEDYT-EMVDIYSFGLCLLEMVTMEIPYSE 230 (296)
Q Consensus 186 ~--------------~~~~~~~~~~aPE~--~~~~~~-~~~Di~slG~i~~~ll~g~~p~~~ 230 (296)
. .-...++.+++|+. +....+ .+.+.++.|+-+|.++|+..+..+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 01224667777763 223444 567888999999999999988754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-20 Score=147.78 Aligned_cols=137 Identities=18% Similarity=0.128 Sum_probs=106.8
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-----CCCceeEEeeeeeeCCC-Ce-
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-----KNKYIIVCYSVWLDDQH-NT- 101 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~-~~- 101 (296)
.++||+|+++.||. +..++.. +||++..... ...+.+.+|+++++++ .||||+++++++..+.+ ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 57899999999995 7776666 6999875322 2346789999999999 57999999999976532 23
Q ss_pred EEEEeec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhCCCCceecCCCCCceEEeCC---CCceEEeccC
Q 022479 102 LNFITEV--CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL-EYLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLG 175 (296)
Q Consensus 102 ~~lv~e~--~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l-~~LH~~~~~i~h~dl~~~nilv~~~---~~~~~l~dfg 175 (296)
+.+|+|| ..+++|.+++++. .+++. ..++.|++.++ +|||+++ |+|+||||+||+++.+ ...++|+|++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5578999999875 36665 35577777776 9999999 9999999999999853 1379999954
Q ss_pred Cc
Q 022479 176 FA 177 (296)
Q Consensus 176 ~~ 177 (296)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=152.00 Aligned_cols=153 Identities=18% Similarity=0.179 Sum_probs=118.3
Q ss_pred CCCCcccceeeecccCcceEEEee-ecCCCcEEEeeeeeecccCCC--------------------HHHHHHHHHHHHHH
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAF-DQEEGIEVAWNQVRLSHFSED--------------------PVLVNRLHSEVQLL 79 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~avK~~~~~~~~~~--------------------~~~~~~~~~e~~~l 79 (296)
..++.+++.+.||+|++|.||+|. +..+|+.||+|+++....... ......+..|+..+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 456667889999999999999998 667899999999985432100 01223467899999
Q ss_pred HhcCCCc--eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCC
Q 022479 80 RTLKNKY--IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 157 (296)
Q Consensus 80 ~~l~~~~--i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~ 157 (296)
+++.+.. +.+++.. . ..++||||+.|.+|.........+...++..++.|++.++.+||+.|. ++|+||+|
T Consensus 105 ~~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp 177 (237)
T smart00090 105 QRLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE-LVHGDLSE 177 (237)
T ss_pred HHHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC-EEeCCCCh
Confidence 9997533 3333332 2 247999999998887765444557777788999999999999999874 89999999
Q ss_pred CceEEeCCCCceEEeccCCccccCC
Q 022479 158 SNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 158 ~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||+++ + +.++|+|||.+...+.
T Consensus 178 ~NIli~-~-~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-D-GKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-C-CCEEEEEChhhhccCC
Confidence 999999 5 7999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=175.56 Aligned_cols=202 Identities=19% Similarity=0.178 Sum_probs=154.6
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
+.....-.+--+.|.+.||+|+||.||+|.+.. |+.+|+|+-+.....+ --+..++...++ ++ --+.|..+...+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk-~~--~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLK-PQ--MLPSIMHISSAH 763 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhc-hh--hhcchHHHHHHH
Confidence 334444444445688999999999999999887 9999999988664322 222222222222 11 123444454444
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC------CCc
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN------IGQ 168 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~------~~~ 168 (296)
+-. +.-++|++|.+.|+|.+++...+.+++..+..+..|++..+.+||..+ ||||||||+|+++... .--
T Consensus 764 ~~~--~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 764 VFQ--NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred ccC--CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence 333 457789999999999999999889999999999999999999999999 9999999999999532 136
Q ss_pred eEEeccCCcccc---CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCC
Q 022479 169 VKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME 225 (296)
Q Consensus 169 ~~l~dfg~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~ 225 (296)
++|+|||.+-.+ .+.-.+...+.|..+-.+|+..+. |++.+|.|.|+.+++-|+-|+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999999998543 444456677888899999977755 999999999999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=156.99 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=151.4
Q ss_pred HHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCC
Q 022479 79 LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 157 (296)
Q Consensus 79 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~ 157 (296)
|+.+.|.|+.+++|.+.++ ..++.|++|+..|+|.+.+.. .-.++..-...+++.++.+|+|||.... ..|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence 3578899999999999887 678999999999999999986 4457777778889999999999999873 39999999
Q ss_pred CceEEeCCCCceEEeccCCccccCCC---cccccCCCCCCccCccccccC--------CCcchhHHHHHHHHHHHHhCCC
Q 022479 158 SNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEI 226 (296)
Q Consensus 158 ~nilv~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~--------~~~~~Di~slG~i~~~ll~g~~ 226 (296)
.|++++.. ..+|+.|||+....... ..........-|.|||.+... .+.+.|+||+|++++++++...
T Consensus 78 ~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999 79999999998876431 111112233468999977653 4667999999999999999999
Q ss_pred CCCCC----ChHHHHHHHHhC-CCCCCC---C-CCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 227 PYSEC----DSVAKIYKKVTG-GVKPQA---L-NKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 227 p~~~~----~~~~~~~~~~~~-~~~~~~---~-~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
||... .+ +++...+.. ...+.. . .....+++..++..||. +|.+||++.++-.
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99642 22 233333333 222111 1 11234578899999997 9999999999865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=139.41 Aligned_cols=138 Identities=19% Similarity=0.268 Sum_probs=111.6
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++||+|++|.||++.. .|..+++|+......... .....++.+|+.++..+.++++.....++... ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999976 577899998764332111 11234678899999999988877665555444 467889
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
|||++|++|.+++..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ + +.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999999999876432 78899999999999999999 99999999999999 5 6899999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.1e-18 Score=136.02 Aligned_cols=135 Identities=17% Similarity=0.231 Sum_probs=105.6
Q ss_pred eecccCcceEEEeeecCCCcEEEeeeeeecccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.||+|++|.||++.. ++..+++|+......... .....++.+|+++++.+.++++......+... ...+++|
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 489999999999974 578899999654332111 12246678999999999887654443333333 4568999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
||++|++|.+++..... .++.+++.+|.+||+.| ++|+|++|.||+++ + +.++++|||.+...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcCC
Confidence 99999999988765331 78899999999999999 99999999999999 5 79999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-18 Score=136.40 Aligned_cols=145 Identities=22% Similarity=0.209 Sum_probs=110.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC------------------HHHHHHHHHHHHHHHhcC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED------------------PVLVNRLHSEVQLLRTLK 83 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~------------------~~~~~~~~~e~~~l~~l~ 83 (296)
.+..+.+.++||+|++|.||++.+. +|+.+|+|++........ .........|+..+.++.
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3444577899999999999999875 799999999875431000 011224677888999887
Q ss_pred CCc--eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceE
Q 022479 84 NKY--IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 84 ~~~--i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nil 161 (296)
+.+ +...++. ...+++|||+.|++|...... .....++.+++.++.++|+.| ++|+||+|.||+
T Consensus 92 ~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEE
Confidence 764 3333321 345889999999998765331 345678899999999999999 999999999999
Q ss_pred EeCCCCceEEeccCCccccCC
Q 022479 162 INGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~ 182 (296)
++.+ +.++|+|||.+.....
T Consensus 158 l~~~-~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDD-EKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCC-CcEEEEECCccccCCC
Confidence 9987 7999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.5e-19 Score=150.85 Aligned_cols=173 Identities=29% Similarity=0.543 Sum_probs=131.4
Q ss_pred CeEEEEeeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 100 NTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
.++|+.|+++...+|.+|+.. ....+......++.|++.++.| ++ .+|+|++|.||+...+ ..++|.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhh
Confidence 468999999999999999974 3456777888999999999999 88 9999999999999999 6999999999
Q ss_pred ccccCCCc-------ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 022479 177 AAIVGRSH-------AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 177 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
.+...... ......+|..|++||.+. ++++.++|||+||+|+++++. =...+. .......+..+..+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCC
Confidence 98765443 233456899999999777 559999999999999999988 222221 11122222222222
Q ss_pred -CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 248 -QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 248 -~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.++.. -+.-..|+..|+- .|.+||++...-.|+|.
T Consensus 479 ~~~~~d--~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQD--YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhc--CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22222 2455688999996 99999988777777775
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=151.25 Aligned_cols=141 Identities=18% Similarity=0.222 Sum_probs=109.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC----CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE----DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
.++...++||+|+||+||++... +..+++|+........ .....+++.+|++++++++|+++.........+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 33355799999999999998765 3345555432221111 112346788999999999999988766555443
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...+++|||+.|++|.+++. ....++.+++.+|.+||+.+ ++||||+|+||+++ + +.++|+|||++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 45789999999999998876 34678999999999999999 99999999999994 4 6899999999876
Q ss_pred c
Q 022479 180 V 180 (296)
Q Consensus 180 ~ 180 (296)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-19 Score=163.61 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=201.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCC-CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 99 (296)
...| ++.+.||+|.++.+-.+....+ ...+|.|-+.... .+.........|..+.+.++ |.|++.+++.....
T Consensus 19 ~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-- 93 (601)
T KOG0590|consen 19 NSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-- 93 (601)
T ss_pred cccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC--
Confidence 5555 6788899999999998877443 3445666655433 34555666777888888887 99999999988554
Q ss_pred CeEEEEeeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hCCCCceecCCCCCceEEeCCCC-ceEEeccC
Q 022479 100 NTLNFITEVCTSGNLRTYR-KKHR-HVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDLNCSNIFINGNIG-QVKIGDLG 175 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l-~~~~-~~~~~~~~~i~~ql~~~l~~LH-~~~~~i~h~dl~~~nilv~~~~~-~~~l~dfg 175 (296)
...++..++..|+++...+ .... ..+.......+.|+..++.|+| ..+ +.|+|++|+|.+++.. + .+++.|||
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~ 170 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFG 170 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCch
Confidence 6788899999999998888 4443 5777888899999999999999 889 9999999999999998 7 99999999
Q ss_pred CccccCC----CcccccCCC-CCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--C
Q 022479 176 FAAIVGR----SHAAHSIIG-TPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--K 246 (296)
Q Consensus 176 ~~~~~~~----~~~~~~~~~-~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~ 246 (296)
+++.+.. .......++ ++.|.|||...+ ...+..|+||.|+++..+++|..||.........+....... .
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 9987754 222444667 899999997765 478889999999999999999999976444333222222211 1
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
........+....+++.+++. +|..|.+.+++-.+||+..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 233445567888999999996 9999999999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=129.23 Aligned_cols=142 Identities=23% Similarity=0.241 Sum_probs=100.2
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHH--------------------HHHHHHHHHHHHhcCCCc-
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL--------------------VNRLHSEVQLLRTLKNKY- 86 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~--------------------~~~~~~e~~~l~~l~~~~- 86 (296)
+++.||+|++|+||+|.+. +++.||+|++........... ......|...+.++.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999887 789999999875432111100 011245666676665443
Q ss_pred -eeEEeeeeeeCCCCeEEEEeeccCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEe
Q 022479 87 -IIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFIN 163 (296)
Q Consensus 87 -i~~~~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~ 163 (296)
+.++++. ...+++|||++++.+. ..+.... . ......++.+++.++.++|+ .+ ++|+||+|+||+++
T Consensus 80 ~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 3333332 2358999999995332 1122111 1 16778999999999999999 99 99999999999999
Q ss_pred CCCCceEEeccCCccccCC
Q 022479 164 GNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 164 ~~~~~~~l~dfg~~~~~~~ 182 (296)
+ +.++|+|||.+.....
T Consensus 150 -~-~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -D-GKVYIIDVPQAVEIDH 166 (187)
T ss_pred -C-CcEEEEECcccccccC
Confidence 5 7999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-18 Score=140.15 Aligned_cols=264 Identities=32% Similarity=0.570 Sum_probs=177.3
Q ss_pred CceecCCCCCcccceeeecccC---cceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGA---VKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~---~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 91 (296)
.+-+.++.++..+-.+..|+.. .-.||++.+...|..++..-+......+-...-+....-+.-|-++-|.|+++++
T Consensus 54 eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH 133 (458)
T KOG1266|consen 54 EILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFH 133 (458)
T ss_pred hhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4555666677666566666522 2346777777777777766665433211111122233344555566788999988
Q ss_pred eeeeeCC---CCeEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 92 SVWLDDQ---HNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 92 ~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
.+|.+.. .-...+++||+..|+|..|++. +..+......+|+-||..||.|||++.|+++|+++..+.|+++.
T Consensus 134 ~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ 213 (458)
T KOG1266|consen 134 KYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQH 213 (458)
T ss_pred HhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecC
Confidence 7775432 2457888999999999999975 45688888899999999999999999999999999999999998
Q ss_pred CCCceEEeccCCccccCC-----CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HH
Q 022479 165 NIGQVKIGDLGFAAIVGR-----SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VA 235 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~ 235 (296)
+ |-+++..-........ .....-..+.++|.+||.-. .....++|||++|....+|..+..--..... .+
T Consensus 214 n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~e 292 (458)
T KOG1266|consen 214 N-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVE 292 (458)
T ss_pred C-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehh
Confidence 7 7777765443322211 11122234567889998543 3367789999999999999887654221111 11
Q ss_pred HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 236 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
..... ........--+.++.+|++ .|..||++.+++.||-+-++
T Consensus 293 e~ia~--------~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 293 ENIAN--------VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred hhhhh--------heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 11111 1111122345678999998 99999999999999976544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-16 Score=127.38 Aligned_cols=142 Identities=14% Similarity=0.166 Sum_probs=107.1
Q ss_pred eeeec-ccCcceEEEeeecCCCcEEEeeeeeeccc-----C----CCHHHHHHHHHHHHHHHhcCCCce--eEEeeeeee
Q 022479 29 SDLLG-SGAVKKVYRAFDQEEGIEVAWNQVRLSHF-----S----EDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLD 96 (296)
Q Consensus 29 ~~~lg-~g~~~~v~~~~~~~~~~~~avK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~ 96 (296)
+..|| .|+.|++|.+... +..+++|.+..... . .+.....++.+|++++.++.|+++ ...++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 46788 8999999999664 78899998854211 0 112334678899999999998775 555555333
Q ss_pred CCCC--eEEEEeeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 97 DQHN--TLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 97 ~~~~--~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
.... ..++|+|+++| .+|.+++... .+++.. +.+++.+|.+||++| ++|+||+|.|||++.+ +.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEE
Confidence 2211 23599999997 6898887653 455543 568999999999999 9999999999999988 7999999
Q ss_pred cCCcccc
Q 022479 174 LGFAAIV 180 (296)
Q Consensus 174 fg~~~~~ 180 (296)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.1e-15 Score=112.95 Aligned_cols=131 Identities=20% Similarity=0.156 Sum_probs=107.0
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCCCeEEEEe
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--KYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.||+|.++.||++... +..+++|.+..... ...+.+|+..++.+.+ .++.+++...... +..++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 577999999999999875 37899999864321 4567889999999976 4777877666433 6789999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
||+.+.++..+ +......++.+++.+++.||.. + ++|+|++|.||+++.. +.++++||+.+..
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceEEEECC-cEEEEEecccccC
Confidence 99999877654 5566778899999999999984 6 9999999999999987 7999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-14 Score=125.84 Aligned_cols=180 Identities=19% Similarity=0.259 Sum_probs=136.1
Q ss_pred eeecccCcceEE-EeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVY-RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~-~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
+...-++.+ +| .+..+.++.++.|.+.+.+. ........+-++.|+.++||||++++..+..+ .++|+|+|.
T Consensus 18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTEr 90 (690)
T KOG1243|consen 18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTER 90 (690)
T ss_pred ccccCCCcc-cccccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeec
Confidence 334444555 34 46677889999999998653 24456677899999999999999999998555 689999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-c
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-A 186 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~-~ 186 (296)
+. .|..++++ ++...+..-+.||+.||.+|| .++ ++|++|+.++|+|+.. |..+|++|.++........ .
T Consensus 91 V~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 91 VR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred cc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCccc
Confidence 86 57777776 447777788999999999997 567 9999999999999999 8999999999876544332 1
Q ss_pred ccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCC
Q 022479 187 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTME 225 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~ 225 (296)
.....--.|..|+.+... ....|.|.|||++++++.|.
T Consensus 163 ~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence 112222245566543321 14579999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=133.61 Aligned_cols=249 Identities=21% Similarity=0.262 Sum_probs=184.3
Q ss_pred ceeeecc--cCcceEEEeee--cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeE
Q 022479 28 YSDLLGS--GAVKKVYRAFD--QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 28 ~~~~lg~--g~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 102 (296)
+.+-+|. |.+|.+|.+.. ..++..+|+|.-+.... ......+-.+++...+.+ .|.+.++.+..+.+ +...
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~l 193 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGIL 193 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCccccc--CCcc
Confidence 4577899 99999999988 88899999999543322 111122233455555555 48888887777743 4788
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHH----HHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLE----GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~----~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
|+.+|.+.. +|..++.. ...+++..++....+... ||.++|+.+ ++|.|++|.||+...+-...++.|||+.
T Consensus 194 fiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence 889999874 77777665 445899999999999999 999999999 9999999999999988458999999999
Q ss_pred cccCCCccccc------CCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhCCCCCCC
Q 022479 178 AIVGRSHAAHS------IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 178 ~~~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~ 249 (296)
........... ..+...|++||...+.++...|+|+||.++.+..++..+.... ..... +.....+..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----~r~~~ip~e 346 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----LRQGYIPLE 346 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----cccccCchh
Confidence 88755442111 2567789999999999999999999999999998876555321 11111 111111111
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.-...+.++...+..|++ +|..|+++..++.|+++...
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 222236677788999997 99999999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.5e-13 Score=103.73 Aligned_cols=144 Identities=15% Similarity=0.120 Sum_probs=102.0
Q ss_pred eeeecccCcceEEEeeecC------CCcEEEeeeeeeccc--CC-------C---------HHHHHH----HHHHHHHHH
Q 022479 29 SDLLGSGAVKKVYRAFDQE------EGIEVAWNQVRLSHF--SE-------D---------PVLVNR----LHSEVQLLR 80 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~--~~-------~---------~~~~~~----~~~e~~~l~ 80 (296)
...||.|--+.||.|.... .+..+|+|+.+.... .. + ...... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999997653 357899999865321 00 0 011223 338999999
Q ss_pred hcCCC--ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCC
Q 022479 81 TLKNK--YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNC 157 (296)
Q Consensus 81 ~l~~~--~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~ 157 (296)
++... ++..++.. ..-++||||+.+..+....-....++..+...+..+++.+|..| |+.| ++||||++
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 99654 44444443 23677999998754432222223456667778889999999998 8999 99999999
Q ss_pred CceEEeCCCCceEEeccCCccccCC
Q 022479 158 SNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 158 ~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
.||+++. +.+.++|||.+.....
T Consensus 154 ~NIL~~~--~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWHD--GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEEC--CcEEEEECCCceeCCC
Confidence 9999985 5799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-13 Score=118.51 Aligned_cols=144 Identities=20% Similarity=0.188 Sum_probs=98.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCC---C-----------------------H----HHHH------HHH
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE---D-----------------------P----VLVN------RLH 73 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~-----------------------~----~~~~------~~~ 73 (296)
+.||+|++|.||+|..+ +|+.||||+.+...... + . +... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 68999999999999876 68999999986431100 0 0 0001 234
Q ss_pred HHHHHHHhcC----CCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhCC
Q 022479 74 SEVQLLRTLK----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLE-GLEYLHTHE 147 (296)
Q Consensus 74 ~e~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~-~l~~LH~~~ 147 (296)
+|++.+.++. +.+-+.+-.++.+-. ...+++|||+.|.+|.++.... ... ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 4555555542 333344444443322 3468999999999998876532 112 23456666665 467889999
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++|+|++|.||+++.+ +.++++|||++....
T Consensus 278 --~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 9999999999999888 899999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-14 Score=131.77 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=192.6
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.+-+.+|.++.++.+.-..+|...+.|+.......... ..+...++-.++....+|.++...-.+ ......+++++
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-DYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGH 884 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccc-cccccCCccCccccCCCCceecccCCC--CCCCCcchhhH
Confidence 456888999999998877777877777776543211110 112222333333334445555443333 33467899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-----
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR----- 182 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~----- 182 (296)
|..++.|...+...+..+.+-.+..+..++.++++||... +.|+|++|.|++...+ +..++.+|+.......
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccCcC
Confidence 9999999998888888888888888899999999999998 8999999999999999 8999999973321100
Q ss_pred ---------------------------CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022479 183 ---------------------------SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234 (296)
Q Consensus 183 ---------------------------~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 234 (296)
........+++.|.+||... ......+|.|++|+.+++.++|..||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 00112234688999999654 55888999999999999999999999887777
Q ss_pred HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHH---HHhcCcccccccCCC
Q 022479 235 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSAS---ELLKDPFFSELNDDD 291 (296)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~---~ll~hp~~~~~~~~~ 291 (296)
..+.++.....++..-....+...++++..++. +|.+|..+. ++-.||||++++|+.
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 777666666555555566678899999999997 999998777 788899999999974
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-13 Score=103.03 Aligned_cols=129 Identities=19% Similarity=0.130 Sum_probs=93.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEEeec
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e~ 108 (296)
+.|+.|..+.||++... ++.+++|+...... ....+..|+.+++.+.+.+++ +++... . ...++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEe
Confidence 57899999999999764 78899999764321 122456788888888655544 333322 2 234789999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCC---CceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 109 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 109 ~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~---~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|.++... . . .....+.+++++|+.||+.+. +++|+|++|.||+++ + +.++++||+.+..
T Consensus 73 i~G~~l~~~-~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE-D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc-c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence 999887643 0 1 123456789999999999871 249999999999999 4 5899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-12 Score=97.46 Aligned_cols=135 Identities=20% Similarity=0.240 Sum_probs=101.5
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHH-----HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV-----LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
..+++|+-+.++.+... |.++++|.=....+ ..+. ...+..+|++++.++....+-...-+..++ +...+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~Y-R~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRY-RHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCccc-CChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEE
Confidence 45789999999999664 44566665433322 2222 344677899999999766665444444445 45678
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+|||++|..|++.+... ...++..+=.-+..||..| ++||||+++||+++.+ .+.++|||++...
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCccccc
Confidence 99999999999999875 1456677777889999999 9999999999999986 5999999999754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.8e-13 Score=118.75 Aligned_cols=141 Identities=16% Similarity=0.180 Sum_probs=93.6
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccC--------------------------CCH----HHHHH------HH
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--------------------------EDP----VLVNR------LH 73 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------------------------~~~----~~~~~------~~ 73 (296)
+.||+|++|.||+|..+.+|+.||||+.+..... .-. +..+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 7899999999999999988999999999743100 000 11222 33
Q ss_pred HHHHHHHhcC----CCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 022479 74 SEVQLLRTLK----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHR----HVSIKALKKWSKQVLEGLEYL 143 (296)
Q Consensus 74 ~e~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~----~~~~~~~~~i~~ql~~~l~~L 143 (296)
+|+..+.++. +...+.+-.++.+- ....++||||+.|+.+.+. +...+ .+.+..+..++.| +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------i 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------V 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------H
Confidence 4444444442 44445444555432 2457899999999999764 33322 1222223333333 4
Q ss_pred hhCCCCceecCCCCCceEEeCCCC----ceEEeccCCccccC
Q 022479 144 HTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFAAIVG 181 (296)
Q Consensus 144 H~~~~~i~h~dl~~~nilv~~~~~----~~~l~dfg~~~~~~ 181 (296)
...| ++|+|++|.||+++.+ + +++++|||+....+
T Consensus 277 f~~G--ffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 FRDG--FFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HhCC--eeeCCCChHHeEEecC-CCCCCeEEEEecceEEECC
Confidence 4688 9999999999999988 6 99999999987664
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.8e-12 Score=94.64 Aligned_cols=147 Identities=19% Similarity=0.250 Sum_probs=110.5
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccC----CCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
...+|-+|+-+.|+++... |+.++||.=....+. +..-...+..+|++.|.++.--.|.-..-++.+... -.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--Ce
Confidence 3678999999999999665 888888875443332 223456678899999999976666655556666643 45
Q ss_pred EEeeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc--eEEeccCCcc
Q 022479 104 FITEVCTS-GNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAA 178 (296)
Q Consensus 104 lv~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~--~~l~dfg~~~ 178 (296)
+.|||+.| .++++++... ..........++.++=+.+..||.++ ++||||+.+||++..+.+. +.++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 56899988 4778887642 22333344788999999999999999 9999999999999877554 4999999987
Q ss_pred cc
Q 022479 179 IV 180 (296)
Q Consensus 179 ~~ 180 (296)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 64
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.5e-11 Score=104.33 Aligned_cols=220 Identities=17% Similarity=0.236 Sum_probs=155.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~~lv~e 107 (296)
+..+.-...+.|++..+.+|..|++|.++...... ...-...++.++++.|.|++++.+++... ++..+++|++
T Consensus 282 ~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYD 357 (655)
T KOG3741|consen 282 ELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYD 357 (655)
T ss_pred ccccccccceeEeeeeccCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEe
Confidence 33333456788999999999999999995432211 11223568899999999999998887622 2367899999
Q ss_pred ccCCC-CHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 108 VCTSG-NLRTYRK---------------KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 108 ~~~~~-sL~~~l~---------------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
|+++. +|.++.- ++...++..+|.++.||..||.++|+.| ++.+-|.|.+|+++.+ .++++
T Consensus 358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIri 434 (655)
T KOG3741|consen 358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRI 434 (655)
T ss_pred cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEE
Confidence 99875 5655421 2345789999999999999999999999 9999999999999998 69999
Q ss_pred eccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCC
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKKVTGGVKPQAL 250 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 250 (296)
...|.......... +| + +.-.+-|.--||.++..|.||..--...+.. +..... .
T Consensus 435 S~C~i~Dvl~~d~~-----------~~--l--e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I 490 (655)
T KOG3741|consen 435 SGCGIMDVLQEDPT-----------EP--L--ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------I 490 (655)
T ss_pred ecccceeeecCCCC-----------cc--h--hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------h
Confidence 99888876643320 11 0 0133579999999999999985332111111 111111 2
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
....+.++++++.-+.. ++++ -++.+++.+
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 22347788888888876 6665 677777764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.5e-11 Score=100.43 Aligned_cols=237 Identities=14% Similarity=0.197 Sum_probs=157.0
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEe-----eeeeeCCCCe
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCY-----SVWLDDQHNT 101 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~-----~~~~~~~~~~ 101 (296)
.++.||+|+-+.+|..-.- ...+.|++..... .... +....|-.. .||-+-.-. ..+....+..
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPP----AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCc----hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4677999999999976322 2356788765432 1111 123333333 333221101 0111122344
Q ss_pred EEEEeeccCCCC-HHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 102 LNFITEVCTSGN-LRTYR------KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 102 ~~lv~e~~~~~s-L~~~l------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
+-++|..+.|.. ...++ +..+...+.-+.++++.|+.+.+.||.+| .+-||++++|+||+++ +.+.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-SKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-ceEEEEcc
Confidence 777788777752 22222 23456788899999999999999999999 9999999999999999 89999998
Q ss_pred CCccccCCCcccccCCCCCCccCccccc-c-----CCCcchhHHHHHHHHHHHHhC-CCCCCCCC-------hHHHHHH-
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYE-E-----DYTEMVDIYSFGLCLLEMVTM-EIPYSECD-------SVAKIYK- 239 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~-----~~~~~~Di~slG~i~~~ll~g-~~p~~~~~-------~~~~~~~- 239 (296)
+.-....+........+.+.|.+||... + +.+...|.|.||+++++++.| ++||++.. +.+..+.
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 8777766665566677888999999543 2 367789999999999999885 99997522 2221110
Q ss_pred ------HHhC-C---CCCCCCCCCCChHHHHHHHHHHh---CCCCCCCHHH
Q 022479 240 ------KVTG-G---VKPQALNKVKDPEVKAFIEKCIA---QPRARPSASE 277 (296)
Q Consensus 240 ------~~~~-~---~~~~~~~~~~~~~l~~li~~~l~---~p~~Rps~~~ 277 (296)
...+ + .+...+....+++++.|...|+. ++.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0000 0 11123334457899999999995 5778998865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.9e-12 Score=110.38 Aligned_cols=248 Identities=21% Similarity=0.197 Sum_probs=167.9
Q ss_pred CCCcccceeeecccCcceEEEeeec-CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQ-EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 99 (296)
.+.|. ....||.|.++.++.+.-. .++..|++|-..........+ ..-..|+.....+ .|.+++.....|..-
T Consensus 264 ~~df~-~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d--i~sl~ev~l~~~l~~~~~~~g~~~~W~~~-- 338 (524)
T KOG0601|consen 264 LTDFG-LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD--IFSLGEVILEAILGSHLPSVGKNSSWSQL-- 338 (524)
T ss_pred cCCcc-eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh--hcchhhhhHhhHhhcccccCCCCCCcccc--
Confidence 44564 4789999999999987644 567889999887654322211 2223444444444 466776655555322
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...|+--||+.++++.......-.+++...+.+..|++.++.++|+.. ++|+|++|+||++..+++..++.||+..+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence 456688899999988777765556888899999999999999999999 999999999999998656889999999876
Q ss_pred cCCCcccccCCCCCCcc-Ccccccc-C-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 180 VGRSHAAHSIIGTPEYM-APELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~-aPE~~~~-~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
+.-... ......++. .+|++.. . +-.++|+++||.-+.+..++...-........+. .+..+ .... ...
T Consensus 417 ~~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~----~~~~p-~~~~-~~~ 488 (524)
T KOG0601|consen 417 LAFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR----SGDTP-NLPG-LKL 488 (524)
T ss_pred cceecc--cccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee----ccccc-CCCc-hHH
Confidence 432211 111122333 2454433 2 7778999999999999999865433222111111 11111 1112 236
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
.++.+.+.++. ++..||++.++..|.=|
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchh
Confidence 77778888886 99999999999887644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.4e-11 Score=95.23 Aligned_cols=145 Identities=17% Similarity=0.210 Sum_probs=103.9
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeeeeeCC-CCeEEEEe
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVWLDDQ-HNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~-~~~~~lv~ 106 (296)
+.|+.|..+.+|++.... |+.+++|........ .....+.+|.++++.+.+.+ +.+++....... ....+++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 678999999999998753 688999997643221 12456788999999997644 445555443221 12568999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---------------------------------------- 146 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~---------------------------------------- 146 (296)
||++|.++...+.. ..++......++.+++.+|..||+.
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888665432 3466777777777888777777742
Q ss_pred --------------CCCceecCCCCCceEEeCC-CCceEEeccCCccc
Q 022479 147 --------------EPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAI 179 (296)
Q Consensus 147 --------------~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~ 179 (296)
..+++|+|+.+.||+++.+ .+.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 2348999999999999983 25789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.4e-10 Score=92.97 Aligned_cols=143 Identities=15% Similarity=0.090 Sum_probs=98.6
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHH----------HHHHHHHHHHhcCCCce--eEEeeeeeeC
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----------RLHSEVQLLRTLKNKYI--IVCYSVWLDD 97 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~----------~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 97 (296)
+.+-.-....|.++.. .|+.|.||....... ....+ .+.+|...+.++...+| .++..+....
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~---~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~ 102 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGW---GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG 102 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcH---HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence 4444444445666644 477899997643221 01111 36678888877753333 2333333221
Q ss_pred ---CCCeEEEEeeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC------C
Q 022479 98 ---QHNTLNFITEVCTSG-NLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING------N 165 (296)
Q Consensus 98 ---~~~~~~lv~e~~~~~-sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~------~ 165 (296)
....-++|+|++++. +|.+++.. ....+......++.+++..++.||..| ++|+|+++.|||++. +
T Consensus 103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 103 SNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred CCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCC
Confidence 124578999999986 89998864 344667788899999999999999999 999999999999985 1
Q ss_pred CCceEEeccCCccc
Q 022479 166 IGQVKIGDLGFAAI 179 (296)
Q Consensus 166 ~~~~~l~dfg~~~~ 179 (296)
...+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 25899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.1e-10 Score=86.34 Aligned_cols=130 Identities=25% Similarity=0.258 Sum_probs=84.5
Q ss_pred eEEEeeecCCCcEEEeeeeeeccc----------------------CCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeee
Q 022479 39 KVYRAFDQEEGIEVAWNQVRLSHF----------------------SEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVW 94 (296)
Q Consensus 39 ~v~~~~~~~~~~~~avK~~~~~~~----------------------~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~ 94 (296)
.||.|... +|..+|+|..+.... ...........+|.+.|.++...+ +.+++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888764 477899998765211 111234567889999999998764 44554332
Q ss_pred eeCCCCeEEEEeeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 95 LDDQHNTLNFITEVCT--SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY-LHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~-LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
. -++||||+. |..+..+.... ++......++.+++..+.. +|..| ++||||++.||+++.+ .+.+
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i 147 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI 147 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred --C----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence 2 468999999 76665543321 1234556777788885555 57999 9999999999999986 8999
Q ss_pred eccCCccccC
Q 022479 172 GDLGFAAIVG 181 (296)
Q Consensus 172 ~dfg~~~~~~ 181 (296)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.5e-11 Score=107.65 Aligned_cols=151 Identities=19% Similarity=0.340 Sum_probs=110.5
Q ss_pred HHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc----------cccCCCCCCccCccccccC
Q 022479 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA----------AHSIIGTPEYMAPELYEED 204 (296)
Q Consensus 135 ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~ 204 (296)
+.+.|+.++|..-. +||++|.|++|.++.+ +..|++.|+.+........ ......+..|.|||++...
T Consensus 107 ~v~dgl~flh~sAk-~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK-VVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc-eeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34499999998733 9999999999999999 8999999998754432111 1112235679999976654
Q ss_pred -CCcchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 205 -YTEMVDIYSFGLCLLEMVT-MEIPYSECD-SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 205 -~~~~~Di~slG~i~~~ll~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...++|+||+|+++|.+.. |+.-+.... ....-.+....+..........++++++=+.+++. ++.-||++..++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 7889999999999999995 555554322 22222333333333344445668999999999997 9999999999999
Q ss_pred Ccccccc
Q 022479 281 DPFFSEL 287 (296)
Q Consensus 281 hp~~~~~ 287 (296)
.|||.+-
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-09 Score=86.64 Aligned_cols=143 Identities=22% Similarity=0.205 Sum_probs=101.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecc------------------cCCCHHHHHHHHHHHHHHHhcCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH------------------FSEDPVLVNRLHSEVQLLRTLKN 84 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~------------------~~~~~~~~~~~~~e~~~l~~l~~ 84 (296)
+....++.+||-|--|.||.|.+. .|.++|+|.=+.-. ...-.......++|.+.|.++..
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 334578899999999999999987 58899998732210 00112345567889999999975
Q ss_pred C--ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE
Q 022479 85 K--YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 85 ~--~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv 162 (296)
. .+.+.+++ ++-.+|||++.|..|...-- +......++..|++-+..+-..| ++|||+++-||++
T Consensus 169 ~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 169 EGVKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred cCCCCCCcccc------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 4 55555543 45678999999977754321 23344445555555555555778 9999999999999
Q ss_pred eCCCCceEEeccCCcccc
Q 022479 163 NGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~ 180 (296)
+.+ |.++++||--+...
T Consensus 236 ~~d-g~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TED-GDIVVIDWPQAVPI 252 (304)
T ss_pred ecC-CCEEEEeCcccccC
Confidence 999 89999999766544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=1e-08 Score=80.69 Aligned_cols=142 Identities=13% Similarity=0.092 Sum_probs=100.0
Q ss_pred cccCcceEEEeeecCCCcEEEeeeeeecccCC--CHHHHHHHHHHHHHHHhcCCCce--eEEe-e-eeeeCCCCeEEEEe
Q 022479 33 GSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKNKYI--IVCY-S-VWLDDQHNTLNFIT 106 (296)
Q Consensus 33 g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i--~~~~-~-~~~~~~~~~~~lv~ 106 (296)
|.||-+.|++.... |+.+-+|.-...-... -+.-...|.+|...++++..-++ .++. + ....+....-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 34888889998655 4578888765211100 01234668888888888854332 2332 1 11122234578899
Q ss_pred eccCCC-CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc--eEEeccCCccc
Q 022479 107 EVCTSG-NLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAI 179 (296)
Q Consensus 107 e~~~~~-sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~--~~l~dfg~~~~ 179 (296)
|-+.|- +|.+++... .+.+......++.+++.+++.||+.| +.|+|+.+.||+++.+ +. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 977654 898888763 34677888899999999999999999 9999999999999866 56 99999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.5e-08 Score=77.82 Aligned_cols=109 Identities=20% Similarity=0.182 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHHhcCCCce--eEEeeeeeeC--CCCeEEEEeeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 022479 69 VNRLHSEVQLLRTLKNKYI--IVCYSVWLDD--QHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143 (296)
Q Consensus 69 ~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~--~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L 143 (296)
..+..+|...+.++....| .+++.+.... .....++|+|++++. +|.+++......+......++.+++..++.|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3456677777777753333 3344443322 123558899999885 7999998755577888899999999999999
Q ss_pred hhCCCCceecCCCCCceEEeCCCC---ceEEeccCCcccc
Q 022479 144 HTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFAAIV 180 (296)
Q Consensus 144 H~~~~~i~h~dl~~~nilv~~~~~---~~~l~dfg~~~~~ 180 (296)
|..| ++|+|+++.|||++.+ + .+.++||+.+...
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~-~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPD-DGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCC-CCceeEEEEcchhceeC
Confidence 9999 9999999999999988 4 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8e-08 Score=91.23 Aligned_cols=210 Identities=23% Similarity=0.351 Sum_probs=150.7
Q ss_pred HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC--eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 022479 68 LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145 (296)
Q Consensus 68 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~ 145 (296)
.+....-|...+.+..|+|+..++.+..+.... ...+..+++...++...++.-+.++..+.+.+..++.++++++|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344455677788888999999999887765432 234467889999999999999999999999999999999999999
Q ss_pred CCCCceecCCCCC---ceEEeCCCCceEEe--ccCCccccCCCcccccCCCCCCccCccccccC---CCcchhHHHHHHH
Q 022479 146 HEPCIIHRDLNCS---NIFINGNIGQVKIG--DLGFAAIVGRSHAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLC 217 (296)
Q Consensus 146 ~~~~i~h~dl~~~---nilv~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i 217 (296)
.. ..|.-|..+ +.-++.. +.+... ||+.+..+..............+.++|..... .+..+|+|++|..
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 87 677666666 3333333 345555 88888777665554444455566677755433 4455799999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 218 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 218 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
...+..|..+-..... ............+.++..+|+. ++++|+++.+++.|+|.+...+..+
T Consensus 382 ~~~~~~~~~i~~~~~~------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred HhhhhhcCcccccccc------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 9999887655322111 0111111122268888999996 9999999999999999887666554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.1e-07 Score=70.56 Aligned_cols=144 Identities=20% Similarity=0.110 Sum_probs=101.5
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
.++.+.....--++.+.|++|..|.||++... |..+|+|+-..++. ...+..|+++|..++..++.+=.-.+
T Consensus 13 ~i~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~y 84 (201)
T COG2112 13 EILNVEEGKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFY 84 (201)
T ss_pred eeeeeeccchhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEe
Confidence 34444444444467799999999999999765 77899999764433 56788899999999887776443233
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCC-CCceEEeCCCCceEEec
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN-CSNIFINGNIGQVKIGD 173 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~-~~nilv~~~~~~~~l~d 173 (296)
+ .-++.|||+.|-+|.+..... + .+-+..+++.---|...| |-|+.|+ |..+++..+ +.+.|+|
T Consensus 85 --g---~~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~-~~~~iID 149 (201)
T COG2112 85 --G---EDFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVND-RDVYIID 149 (201)
T ss_pred --c---hhhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEecC-CcEEEEE
Confidence 2 234459999998887655432 2 233445666655678889 9999996 455555555 5899999
Q ss_pred cCCccccC
Q 022479 174 LGFAAIVG 181 (296)
Q Consensus 174 fg~~~~~~ 181 (296)
|+.|+...
T Consensus 150 Fd~At~k~ 157 (201)
T COG2112 150 FDSATFKK 157 (201)
T ss_pred ccchhhcc
Confidence 99998543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=75.23 Aligned_cols=144 Identities=18% Similarity=0.174 Sum_probs=97.9
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC--------------------HHHHHHHHHHHHHHHhcCCCce
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--------------------PVLVNRLHSEVQLLRTLKNKYI 87 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~~~i 87 (296)
+.-.|++|--++||+|.. .++..+|+|+++.....-. .........|+.-|+++...++
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345677899999999875 3588999999976433111 1122235577888888855443
Q ss_pred --eEEeeeeeeCCCCeEEEEeeccCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEe
Q 022479 88 --IVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFIN 163 (296)
Q Consensus 88 --~~~~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~ 163 (296)
.+.+.+. .-.++||++...... -.|+. ..+...+...+..++++.+.-|-. .+ +||+||+.-|||+.
T Consensus 131 rvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~ 201 (268)
T COG1718 131 RVPEPIAFR------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH 201 (268)
T ss_pred CCCCceeec------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE
Confidence 3333332 246789998765221 11222 223444677778888888888866 78 99999999999999
Q ss_pred CCCCceEEeccCCccccCCC
Q 022479 164 GNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 164 ~~~~~~~l~dfg~~~~~~~~ 183 (296)
+ +.+.++|++-+....++
T Consensus 202 -~-~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 -D-GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -C-CeEEEEECccccccCCC
Confidence 4 68999999988766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-07 Score=73.79 Aligned_cols=136 Identities=17% Similarity=0.192 Sum_probs=80.1
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce--eEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~lv~e 107 (296)
.+||+|..+.||+. .+..+++|...... . .....+|.++++.+..-.+ .+++.+..+ .+...++|+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---D---KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---C---HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeee
Confidence 57899999999984 25567888886422 1 2346789999988864444 444544422 355778999
Q ss_pred ccCCCC-HHHH--------------HHh-----c----CCCCHHHHHH-HHH----------HHHHH-HHHH--hhCCCC
Q 022479 108 VCTSGN-LRTY--------------RKK-----H----RHVSIKALKK-WSK----------QVLEG-LEYL--HTHEPC 149 (296)
Q Consensus 108 ~~~~~s-L~~~--------------l~~-----~----~~~~~~~~~~-i~~----------ql~~~-l~~L--H~~~~~ 149 (296)
++.|.. +... +.. + .......... +.. .+.+. ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999963 2111 100 0 0111111100 000 01111 1111 223334
Q ss_pred ceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 150 i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|+|+.|.||+++.+ + +.++||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 8999999999999987 6 99999997754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.2e-07 Score=71.49 Aligned_cols=68 Identities=18% Similarity=0.313 Sum_probs=54.1
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...+++|||++|..|.+... +++ .+...+++++..||+.| ++|||..|.|++++.+ .+.++|++....
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEEEECccccc
Confidence 35678999999988876543 333 24456778899999999 9999999999999975 599999976643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.8e-07 Score=80.79 Aligned_cols=149 Identities=18% Similarity=0.220 Sum_probs=96.3
Q ss_pred cccce-eeecccCcceEEEeeecCCCcEEEeeeeeecccC--------------------------CCH----HHHHH--
Q 022479 25 FGRYS-DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--------------------------EDP----VLVNR-- 71 (296)
Q Consensus 25 ~~~~~-~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------------------------~~~----~~~~~-- 71 (296)
|.++. +.|++++-|.||+|..+. |+.||||+....-.. .-. +..+.
T Consensus 125 F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 33444 889999999999999885 999999997652110 000 11112
Q ss_pred ----HHHHHHHHHhc----CCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHH
Q 022479 72 ----LHSEVQLLRTL----KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLE 141 (296)
Q Consensus 72 ----~~~e~~~l~~l----~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~ql~~~l~ 141 (296)
+.+|...+.++ ++..-+.+-.++++-. ..-.++|||+.|..+.+. ++. ..++...+.....++. +.
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~ 279 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LR 279 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc-CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HH
Confidence 33444444444 2333344444554422 456789999999988877 444 3355444333322221 33
Q ss_pred HHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 142 ~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.+-..| ++|+|..|.||+++.+ |++.+.|||+....+
T Consensus 280 q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 344478 9999999999999999 899999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=4e-06 Score=68.26 Aligned_cols=143 Identities=22% Similarity=0.269 Sum_probs=81.3
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeeeeeCC-CCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVWLDDQ-HNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~-~~~~~lv 105 (296)
.+.|+.|..+.+|++.... ..+++|.... ......+.+|..+++.+.... +.+++....... ....+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 3678999999999997764 5899999753 234567778888888885433 345554332222 2457899
Q ss_pred eeccCCCCHHH----------------HHHh---c----CCCCHHH------HHH---H------------HHHHHH-HH
Q 022479 106 TEVCTSGNLRT----------------YRKK---H----RHVSIKA------LKK---W------------SKQVLE-GL 140 (296)
Q Consensus 106 ~e~~~~~sL~~----------------~l~~---~----~~~~~~~------~~~---i------------~~ql~~-~l 140 (296)
|+++.|..+.. .+.. . ..+.... ... . ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987766 1110 0 0001000 000 0 111222 23
Q ss_pred HHHhh-----CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 141 EYLHT-----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 141 ~~LH~-----~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++ ...+++|+|+.+.||+++.+.+.+.++||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33321 2334999999999999993325668999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.5e-08 Score=90.45 Aligned_cols=253 Identities=18% Similarity=0.196 Sum_probs=163.0
Q ss_pred CCCCCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc-e
Q 022479 9 SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY-I 87 (296)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i 87 (296)
..+++.+-......++.+..-.-.++++++.+++.....+.... .+.+... ....-++++|.+++||| .
T Consensus 227 mTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~ 296 (829)
T KOG0576|consen 227 MTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPV 296 (829)
T ss_pred hhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCc
Confidence 34455544555555666677788999999999988665443333 5555433 22345888999999999 4
Q ss_pred eEEeeeeeeCCCCeEEEEeeccCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 88 IVCYSVWLDDQHNTLNFITEVCTSG-NLRTYR-KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l-~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
+..++.+ +...+.++.++++.++ +..... .....+.+-+...+++.-.++++++|+.- -+|+| ||+.+.
T Consensus 297 v~~~~d~--~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~- 367 (829)
T KOG0576|consen 297 VRYLEDY--DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE- 367 (829)
T ss_pred ccccccC--CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-
Confidence 4444443 4447889999999887 222111 11122444455566777788999999986 58888 777766
Q ss_pred CCceEEeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 022479 166 IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 244 (296)
+..++.+|+....+..........+++.++|||+.. +.+..+.|.|++|.-..++.-|.+|-..... ... ..+
T Consensus 368 -~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~---~~g 441 (829)
T KOG0576|consen 368 -EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP---MIG 441 (829)
T ss_pred -cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC---CCC
Confidence 479999999998887766677778899999999655 5588999999999877777777766543100 000 000
Q ss_pred CCC--CCCC---CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 245 VKP--QALN---KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 245 ~~~--~~~~---~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
..+ ..+. ...+..-+++...|+. .|..|+..-.++.|.+|..
T Consensus 442 ~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 442 NGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 000 0000 0001111235566775 7888888888887766653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=74.25 Aligned_cols=144 Identities=16% Similarity=0.193 Sum_probs=93.0
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCC---------------------------CHHHHHHHHHHHH-----
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE---------------------------DPVLVNRLHSEVQ----- 77 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---------------------------~~~~~~~~~~e~~----- 77 (296)
+.||..+.|.|++|..+. |+.|||||-+..-... -.+..+.+..|+.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 889999999999999886 9999999976531100 0111222222222
Q ss_pred -----HHHhcCCCc---eeEEeeeeeeCCCCeEEEEeeccCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHH-HHHhhC
Q 022479 78 -----LLRTLKNKY---IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGL-EYLHTH 146 (296)
Q Consensus 78 -----~l~~l~~~~---i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~ql~~~l-~~LH~~ 146 (296)
+.+.+.|-+ -+.+-.++++-. ....++|||+.|..+.+. +...+ ++...+.. .+.++. .-|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s-t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~---~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS-TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILN---KLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC-cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHH---HHHHHHHHHHHhc
Confidence 223333444 233444444332 467899999999976554 44444 66654444 444432 334567
Q ss_pred CCCceecCCCCCceEEeC---CCCceEEeccCCccccC
Q 022479 147 EPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 147 ~~~i~h~dl~~~nilv~~---~~~~~~l~dfg~~~~~~ 181 (296)
| ++|+|=.|-||+++. +...+.+.|+|+.....
T Consensus 321 G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8 999999999999994 23689999999987653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.1e-06 Score=67.96 Aligned_cols=74 Identities=9% Similarity=0.008 Sum_probs=44.0
Q ss_pred eeecccCcce-EEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC---ceeEEeeeeeeCCC-CeEEE
Q 022479 30 DLLGSGAVKK-VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDDQH-NTLNF 104 (296)
Q Consensus 30 ~~lg~g~~~~-v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~-~~~~l 104 (296)
+.|+.|+... ||++ +..+++|..+.. .....+.+|.+++..+... .+.+++......+. ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 4577777764 8877 235777765421 1245688899999888632 22333332221111 23478
Q ss_pred EeeccCCCCH
Q 022479 105 ITEVCTSGNL 114 (296)
Q Consensus 105 v~e~~~~~sL 114 (296)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 8999999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=66.19 Aligned_cols=138 Identities=16% Similarity=0.116 Sum_probs=79.8
Q ss_pred eeecccCc-ceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAV-KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~-~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.|..|.+ ..||++... +..+++|...... ...+.+|+++++.+.. -.+.+++...... ...++||+
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 34555555 788999653 4678888876332 2345678888888843 2334555544322 45788999
Q ss_pred ccCCCCHHHHH----------------Hh-cC------CCCHH--HHHHHHH--------------------HHHHHHHH
Q 022479 108 VCTSGNLRTYR----------------KK-HR------HVSIK--ALKKWSK--------------------QVLEGLEY 142 (296)
Q Consensus 108 ~~~~~sL~~~l----------------~~-~~------~~~~~--~~~~i~~--------------------ql~~~l~~ 142 (296)
+++|.++.... .. +. .+... ....... .+...+..
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 99998775331 10 00 11100 0000000 01111222
Q ss_pred Hh-----hCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 143 LH-----THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 143 LH-----~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
|- ...++++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~ 193 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPG-KFSGFIDLGRLGV 193 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCC-cEEEEEEcccccc
Confidence 21 123459999999999999987 6788999987754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.5e-05 Score=75.36 Aligned_cols=149 Identities=17% Similarity=0.268 Sum_probs=89.1
Q ss_pred eeeecccCcceEEEeeecCCC--cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCce--eEEeeeeeeCC-CCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYI--IVCYSVWLDDQ-HNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~~-~~~~ 102 (296)
.+.++.|.+..+|++.....+ ..+++|+......... ...+.+|+++++.+. |.++ .+++..+.+.. ....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~---~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS---AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc---HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 577899999999998765432 4677887654322111 346778999999995 5554 55555554321 1356
Q ss_pred EEEeeccCCCCHHH--------------------HHHh-cC------------C---CCHHHHHHHHHH-----------
Q 022479 103 NFITEVCTSGNLRT--------------------YRKK-HR------------H---VSIKALKKWSKQ----------- 135 (296)
Q Consensus 103 ~lv~e~~~~~sL~~--------------------~l~~-~~------------~---~~~~~~~~i~~q----------- 135 (296)
|+||||+.|..+.+ .+.. +. . .-..++..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999875321 1110 00 0 001233222221
Q ss_pred ----HHHHHHHHhhC---------CCCceecCCCCCceEEeCCCC-ceEEeccCCcccc
Q 022479 136 ----VLEGLEYLHTH---------EPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV 180 (296)
Q Consensus 136 ----l~~~l~~LH~~---------~~~i~h~dl~~~nilv~~~~~-~~~l~dfg~~~~~ 180 (296)
+...+.+|..+ .+++||+|+++.|++++.+.+ .+-++|++.++.-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 22334555332 134999999999999986423 4689999987653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.7e-05 Score=59.70 Aligned_cols=137 Identities=22% Similarity=0.276 Sum_probs=90.1
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCC------------CHHHHHHHHHHHHHHHhcC------CCceeEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------------DPVLVNRLHSEVQLLRTLK------NKYIIVC 90 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~------------~~~~~~~~~~e~~~l~~l~------~~~i~~~ 90 (296)
...||+|+.-.||.- .. +...+||+........ .....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 467999999999954 43 5567899997665000 0112455666666666665 7889999
Q ss_pred eeeeeeCCCCeEEEEeeccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 91 YSVWLDDQHNTLNFITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
+|+.... ..+-+|+|.+.. .+|.++++.+. ++. .+...+. +...+|-.++ |+.+|++|.||++..
T Consensus 83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEe
Confidence 9998544 456666666532 26888886655 665 4444444 4455666777 999999999999976
Q ss_pred CCC---ceEEec-cCCc
Q 022479 165 NIG---QVKIGD-LGFA 177 (296)
Q Consensus 165 ~~~---~~~l~d-fg~~ 177 (296)
+.+ .++|+| ||..
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 531 466666 3433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.9e-05 Score=63.50 Aligned_cols=78 Identities=12% Similarity=0.037 Sum_probs=53.2
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC---CceeEEeeeeeeCC-CCeEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---KYIIVCYSVWLDDQ-HNTLNF 104 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~-~~~~~l 104 (296)
.+.||+|..+.||+.... +..+.+|..+... ....+..|.+.|+.+.. -.+.++++.+..+. ...-++
T Consensus 19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS--QGNPMPLMARSFS------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC--CCCEEEEEecccc------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 467999999999998543 3356677754211 12567889999988854 24566776654322 255799
Q ss_pred EeeccCCCCH
Q 022479 105 ITEVCTSGNL 114 (296)
Q Consensus 105 v~e~~~~~sL 114 (296)
|||++.|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.9e-05 Score=65.17 Aligned_cols=145 Identities=18% Similarity=0.226 Sum_probs=102.8
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccC----------------------CCHHHHHHHHHHHHHHHhcCCC
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----------------------EDPVLVNRLHSEVQLLRTLKNK 85 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----------------------~~~~~~~~~~~e~~~l~~l~~~ 85 (296)
+--.|..|--+.||.|... +|..+|||+++-+-.. ......-....|++-|++++..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3455677889999998755 5888999998753210 0112333456788899999877
Q ss_pred ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCCCceEEeC
Q 022479 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 86 ~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~~nilv~~ 164 (296)
.|.-.--+... .-.|||+++....-..-.-....++...+..+-.|++.-+..| +.++ +||.||+--|+|+..
T Consensus 227 GIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 227 GIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC
Confidence 75433323322 2577999987654333333445578888888889999999888 6778 999999999999998
Q ss_pred CCCceEEeccCCccccC
Q 022479 165 NIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~ 181 (296)
|.++++|.+-+...+
T Consensus 301 --G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 --GKLYIIDVSQSVEHD 315 (520)
T ss_pred --CEEEEEEccccccCC
Confidence 589999998765443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.04 E-value=7e-05 Score=61.19 Aligned_cols=74 Identities=14% Similarity=0.170 Sum_probs=46.3
Q ss_pred eeecccCcceEEEeeecC-CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e 107 (296)
+.|..|-...+|++.... .++.+++|+...... . .-...+|+.+++.+....+. +++... .. .+++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~-~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----L-IIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----c-eecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 567788888999996543 357898997753211 1 11234688888888654443 333222 21 26899
Q ss_pred ccCCCCH
Q 022479 108 VCTSGNL 114 (296)
Q Consensus 108 ~~~~~sL 114 (296)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.5e-05 Score=63.26 Aligned_cols=135 Identities=18% Similarity=0.224 Sum_probs=76.1
Q ss_pred eecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEEeecc
Q 022479 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITEVC 109 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e~~ 109 (296)
.+..|-...+|++. .+++.+++|....... ...-...+|.++++.+....+. +++.. .+ -++|++|+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEec
Confidence 35667888899886 4577888987643211 1101246788888888654443 22222 22 25789999
Q ss_pred CCCCHHH--------------HHHh-------cCCCCHH-HHHHHHHHH---------HHHHHHHhh------CCCCcee
Q 022479 110 TSGNLRT--------------YRKK-------HRHVSIK-ALKKWSKQV---------LEGLEYLHT------HEPCIIH 152 (296)
Q Consensus 110 ~~~sL~~--------------~l~~-------~~~~~~~-~~~~i~~ql---------~~~l~~LH~------~~~~i~h 152 (296)
+|..+.. .+.+ ..+++.. .+.....++ ...+..+-. ..++++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 9876531 1111 0111211 111211111 111222211 1235999
Q ss_pred cCCCCCceEEeCCCCceEEeccCCccc
Q 022479 153 RDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 153 ~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+|+.|.||+++.+ + +.++||+.+..
T Consensus 151 ~Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeCC-C-CEEEeccccCc
Confidence 9999999999987 4 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00026 Score=62.07 Aligned_cols=81 Identities=20% Similarity=0.233 Sum_probs=52.7
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeeccc--CCC-HHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SED-PVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~ 102 (296)
.+.||.|....||++.+...++.++||.-..... ... ....++...|.+.|+.+. ..++.+++.+. + ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence 4679999999999999864436899998541110 011 123567778888888863 23455555442 3 446
Q ss_pred EEEeeccCCCC
Q 022479 103 NFITEVCTSGN 113 (296)
Q Consensus 103 ~lv~e~~~~~s 113 (296)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 78999988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00041 Score=54.59 Aligned_cols=128 Identities=18% Similarity=0.266 Sum_probs=83.3
Q ss_pred cceeeecccCc-ceEEEeeecCCCcEEEeeeeee---ccc-------CCC-------HHHHHHHHHHHHHHHhc---CCC
Q 022479 27 RYSDLLGSGAV-KKVYRAFDQEEGIEVAWNQVRL---SHF-------SED-------PVLVNRLHSEVQLLRTL---KNK 85 (296)
Q Consensus 27 ~~~~~lg~g~~-~~v~~~~~~~~~~~~avK~~~~---~~~-------~~~-------~~~~~~~~~e~~~l~~l---~~~ 85 (296)
++.+.||.|.- |.||++... |+.||+|++.. ... ... .....-|..|-+...++ .+.
T Consensus 40 ~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e 117 (207)
T PF13095_consen 40 EFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE 117 (207)
T ss_pred eeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence 67899999999 999999654 88999999433 111 000 02233455565555555 455
Q ss_pred ce--eEEeeeeeeCCC----------------CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 022479 86 YI--IVCYSVWLDDQH----------------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147 (296)
Q Consensus 86 ~i--~~~~~~~~~~~~----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ 147 (296)
++ ++++|+..-... -...||-||..... .++... +.++.+-+..+|+.|
T Consensus 118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILHKLG 184 (207)
T ss_pred CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHHHCC
Confidence 55 889888753310 12245666655433 233333 455777788899999
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
|+-+|+++.|.. .-+|+||+.+
T Consensus 185 --I~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 185 --IVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred --eeeccCcccccc------CCEEEecccC
Confidence 999999998875 3488899854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=6.9e-05 Score=58.87 Aligned_cols=100 Identities=21% Similarity=0.161 Sum_probs=76.5
Q ss_pred HHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEEeeccCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 022479 74 SEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149 (296)
Q Consensus 74 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~---~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 149 (296)
.|.-+++.+.+ +++.+++|.+ + -++++||...+++.. .+.+-...++..+..++.++++.+.+|+..-.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888865 5899999998 3 244679998765531 122222368999999999999999999874211
Q ss_pred -ceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 150 -IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 150 -i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+...|++++|+-++.+ ++++++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 7779999999999988 89999999987554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00057 Score=57.88 Aligned_cols=148 Identities=13% Similarity=0.198 Sum_probs=83.8
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC--ceeEEeeeeeeCCCCeEEEEe
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK--YIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~~~lv~ 106 (296)
.+.+..|-.-.+|..... +++++++ .+. ....-.......+|+.+++.+..- .+...++.+.++.....+.||
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344444544555666443 7889898 331 112334456777899999888642 333444555444323668899
Q ss_pred eccCCCCHH----------HHHH--------h-c----------C---CCCHHHHHHHHHHH--------------HHHH
Q 022479 107 EVCTSGNLR----------TYRK--------K-H----------R---HVSIKALKKWSKQV--------------LEGL 140 (296)
Q Consensus 107 e~~~~~sL~----------~~l~--------~-~----------~---~~~~~~~~~i~~ql--------------~~~l 140 (296)
+|++|..+. .+.. . + + .....++..+..+. ....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999994221 1111 0 0 0 00111111111111 1223
Q ss_pred HHHhhCC------CCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 141 EYLHTHE------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 141 ~~LH~~~------~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
.+|+.+. ++++|||+.+.|++++.+ +-+-++||+++..-+.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 3343332 369999999999999999 5699999999987544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0008 Score=56.36 Aligned_cols=32 Identities=22% Similarity=0.324 Sum_probs=26.2
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++++|+|+++.||+++.+.....++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45999999999999998513467999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00066 Score=57.49 Aligned_cols=141 Identities=13% Similarity=0.124 Sum_probs=78.0
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeee----eeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVW----LDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~----~~~~~~~~ 102 (296)
.+.|..|....+|++.. ++..+++|+.... + ...+..|++++..+.+.. +.+++... .....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV----S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC----C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 35677788788998854 3457889987631 2 234555777777764322 33333211 10112456
Q ss_pred EEEeeccCCCCHHH-----H------HHh----cCCCC--------HHHHH------------HHHHHHHHHHHHHhh--
Q 022479 103 NFITEVCTSGNLRT-----Y------RKK----HRHVS--------IKALK------------KWSKQVLEGLEYLHT-- 145 (296)
Q Consensus 103 ~lv~e~~~~~sL~~-----~------l~~----~~~~~--------~~~~~------------~i~~ql~~~l~~LH~-- 145 (296)
++++++++|..+.. . +.. ...+. ..... .....+..++..+.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 78999999876421 0 110 00000 00000 011112233444432
Q ss_pred ---CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 146 ---HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 146 ---~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...+++|+|+.|.||+++.+ +.+.++||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 11239999999999999987 5678999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00072 Score=57.66 Aligned_cols=142 Identities=15% Similarity=0.121 Sum_probs=76.2
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeee----eeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVW----LDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~----~~~~~~~~ 102 (296)
.+.++.|....+|++.. ++..+++|+..... .. ..+..+++++..+.... +.+++... ........
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~---~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV---KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC---CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 35677787788998854 34468889875321 11 23345666666664222 23333211 11112457
Q ss_pred EEEeeccCCCCHH-----H------HHHh----cCCC--------CHHH---HH------------HHHHHHHHHHHHHh
Q 022479 103 NFITEVCTSGNLR-----T------YRKK----HRHV--------SIKA---LK------------KWSKQVLEGLEYLH 144 (296)
Q Consensus 103 ~lv~e~~~~~sL~-----~------~l~~----~~~~--------~~~~---~~------------~i~~ql~~~l~~LH 144 (296)
+++++|++|..+. . .+.. ...+ .... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8899999885431 1 1110 0000 0000 00 00111223444443
Q ss_pred h-----CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 145 T-----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 145 ~-----~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
. ...+++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 2 11239999999999999988 6678999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00015 Score=60.75 Aligned_cols=137 Identities=18% Similarity=0.188 Sum_probs=93.0
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeeccc------------------CCCHHHHHHHHHHHHHHHhcCC-C
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF------------------SEDPVLVNRLHSEVQLLRTLKN-K 85 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------------------~~~~~~~~~~~~e~~~l~~l~~-~ 85 (296)
++-+++.||=|--+.||.+-+. .|.++++|.=..-.. ..-.-..-...+|..+++.+.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4457899999999999999876 478888876322100 0011122335678888888843 2
Q ss_pred -ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 86 -YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 86 -~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
.+.+.+++ ++-++||+.+.|..|...-.- -+.+ .+...+...+..|..+| ++|||++-=||++..
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEec
Confidence 23334433 456778999999887643321 2233 34445666667777899 999999999999998
Q ss_pred CCCceEEeccCCc
Q 022479 165 NIGQVKIGDLGFA 177 (296)
Q Consensus 165 ~~~~~~l~dfg~~ 177 (296)
+ +.++++||--.
T Consensus 238 d-~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 D-DKIVVIDFPQM 249 (465)
T ss_pred C-CCEEEeechHh
Confidence 8 79999999754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0018 Score=55.06 Aligned_cols=74 Identities=19% Similarity=0.203 Sum_probs=45.0
Q ss_pred eeecccCcceEEEeeecC------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeE
Q 022479 30 DLLGSGAVKKVYRAFDQE------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTL 102 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~ 102 (296)
+.|..|-.-.+|++.... .++.+++|+...... ......+|.++++.+....+. +++..+ ++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 446666677888887543 257899999754311 123456788888888654443 333333 21
Q ss_pred EEEeeccCCCCH
Q 022479 103 NFITEVCTSGNL 114 (296)
Q Consensus 103 ~lv~e~~~~~sL 114 (296)
..|++|++|.++
T Consensus 73 ~~v~e~i~G~~l 84 (302)
T cd05156 73 GRIEEFIPSRTL 84 (302)
T ss_pred CchhheeCCCcC
Confidence 236888888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0016 Score=56.40 Aligned_cols=139 Identities=17% Similarity=0.207 Sum_probs=78.8
Q ss_pred eeecccCcceEEEeeecC----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEE
Q 022479 30 DLLGSGAVKKVYRAFDQE----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNF 104 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~l 104 (296)
+.|..|-.-.+|++.... .++.+++|+..... ...+++ .+|..+++.+...++. ++++.+ +. . .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PN-G---R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CC-c---e
Confidence 456667788899986432 24689999876431 222232 6788888888765554 344443 22 1 3
Q ss_pred EeeccCCCCHHHH--------------HHh--c-----CC-CC-HHHHHHHHHHH-----------------HHHHHH--
Q 022479 105 ITEVCTSGNLRTY--------------RKK--H-----RH-VS-IKALKKWSKQV-----------------LEGLEY-- 142 (296)
Q Consensus 105 v~e~~~~~sL~~~--------------l~~--~-----~~-~~-~~~~~~i~~ql-----------------~~~l~~-- 142 (296)
+++|+.+.++... +.+ . .. .. ..++..++.++ ...+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 6888877665311 110 0 00 11 12222222111 111111
Q ss_pred --Hhh--CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 143 --LHT--HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 143 --LH~--~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+.. ...+++|+|+.+.||+++.+.+.+.++||+.+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111 1224999999999999987536899999988764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0058 Score=52.36 Aligned_cols=29 Identities=31% Similarity=0.433 Sum_probs=25.0
Q ss_pred ceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 150 i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+||+|+.+.||+++.+ ....++||+.+..
T Consensus 189 liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 189 VIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 9999999999999976 4568999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00068 Score=60.27 Aligned_cols=165 Identities=21% Similarity=0.249 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 022479 70 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149 (296)
Q Consensus 70 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 149 (296)
.++.-...+++.+.|++......+- .+...+..+|+|++.- ||.+.+..+. +-..... .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~--------------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL--------------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhhcc-chHHHHHhcc-cchhhhc--------------ccc--
Confidence 4556678899999999998887544 4555778889999865 9999887655 3322221 122
Q ss_pred ceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 022479 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 150 i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 229 (296)
+.|- | +++.+| .+++.. .+ ...+++||||+|.++.++..|.-.+.
T Consensus 88 ~~~~-----~--------~~~~td-~~~t~~----~~-----------------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 88 VLHL-----N--------IIYITD-HFLTKY----PS-----------------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ccee-----h--------hhhccc-cccccC----CC-----------------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2221 1 222222 111111 00 01248999999999999999987776
Q ss_pred CCChHHHHHHHHhCCCCCCCCC---------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 230 ECDSVAKIYKKVTGGVKPQALN---------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.....+...-...-...+.... -.++....++..+|+. .|..||...++.+++-|.+..
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 5554444433333222221111 1124556778888986 999999999999998887653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.25 E-value=8.4e-05 Score=73.47 Aligned_cols=215 Identities=16% Similarity=0.060 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHH
Q 022479 66 PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLE 141 (296)
Q Consensus 66 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~ql~~~l~ 141 (296)
+...+....|...++...|+++...+.-....+....+.+++|+.+|.+...+-++ ......-+.....+.+.+..
T Consensus 1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred hHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence 34455666677777778899888777666656667788899999999998887653 22333333333333344444
Q ss_pred HHhhC---CCCceecCCCCCceEEeCCCCceEEeccCCcccc-CCCcccccCCCCCCccCccccccC-CCcchhHHHHHH
Q 022479 142 YLHTH---EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGL 216 (296)
Q Consensus 142 ~LH~~---~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~ 216 (296)
-+|+. |-..+|.++++.|.++..+ -++++.++|+.+.. ......+...+++-|..|++...- ++.++|+|..|+
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 44432 3347999999999999999 48999999999933 333445555666777777766643 666799999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhCCC----CCCCCCCCCChHHHHHHHHHH-hCCCCCCCHHHHhcCcccccc
Q 022479 217 CLLEMVTMEIPYSECDSVAKIYKKVTGGV----KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 217 i~~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l-~~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+|....|..+|-. ..+....+. .....+...|.+.-.....++ ..-..||.-...+..+.|...
T Consensus 1429 ~ly~rs~~n~~fi~------flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIF------FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred HHHHHhcccHHHHH------HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 99999888777632 222222222 222223333333333444444 355667777777665555433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0058 Score=53.65 Aligned_cols=77 Identities=13% Similarity=-0.009 Sum_probs=48.7
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH---HHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP---VLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~ 102 (296)
.+.||.|..-.||++.+. ++.++||.-......... ....+...|.+.|+.+. ..++.+++.+. + ..-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCC
Confidence 578999999999999763 456888886521110010 12444555677776664 23566676655 3 346
Q ss_pred EEEeeccCC
Q 022479 103 NFITEVCTS 111 (296)
Q Consensus 103 ~lv~e~~~~ 111 (296)
+++||++.+
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 678999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0029 Score=55.19 Aligned_cols=85 Identities=22% Similarity=0.312 Sum_probs=52.4
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecc-cCCC-HHHHHHHHHHHHHHHhcC--CC-ceeEEeeeeeeCCCCeEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-FSED-PVLVNRLHSEVQLLRTLK--NK-YIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~~~ 103 (296)
.+.||.|....||++.+...++.++||.-..-. ...+ ....++..-|.+.|+... -| ++.+++.+ ++ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc--HHhh
Confidence 577999999999999885445679988743211 1111 334566777888887764 24 34445433 23 4566
Q ss_pred EEeeccCCC-CHHHH
Q 022479 104 FITEVCTSG-NLRTY 117 (296)
Q Consensus 104 lv~e~~~~~-sL~~~ 117 (296)
+|||+++.. .|++.
T Consensus 110 ~vMEdL~~~~ilR~~ 124 (409)
T PRK12396 110 CVMEDLSDHTILRTA 124 (409)
T ss_pred HHHHhCcccHHHHHH
Confidence 788888553 34443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0033 Score=53.63 Aligned_cols=30 Identities=13% Similarity=0.181 Sum_probs=26.8
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++||+|+.+.|++++.+ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 39999999999999988 7899999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0057 Score=52.73 Aligned_cols=84 Identities=17% Similarity=0.109 Sum_probs=49.8
Q ss_pred eecccCcceEEEeeecCCCcEEEeeeeeeccc--C-CCHHHHHHHHHHHHHHHhcC--CCc-eeEEeeeeeeCCCCeEEE
Q 022479 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--S-EDPVLVNRLHSEVQLLRTLK--NKY-IIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 31 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~-~~~~~~~~~~~e~~~l~~l~--~~~-i~~~~~~~~~~~~~~~~l 104 (296)
.||.|....||++.+...++.++||.-..-.. . .-+...++..-|...|+... -|. +.+++.+ ++ ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc--cccee
Confidence 47999999999999764446899987432111 1 11233556667778887764 243 3344432 23 34567
Q ss_pred EeeccCCC-CHHHHH
Q 022479 105 ITEVCTSG-NLRTYR 118 (296)
Q Consensus 105 v~e~~~~~-sL~~~l 118 (296)
+||+++.. .|++.+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 88988553 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0048 Score=53.20 Aligned_cols=139 Identities=14% Similarity=0.201 Sum_probs=76.6
Q ss_pred eeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEE
Q 022479 30 DLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv 105 (296)
+.|..|=.-.+|++..... +..|++|+..... .. .-.-.+|..+++.+...++. ++++.+ +. . ++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~-~IdR~~E~~il~~l~~~gl~P~~l~~~--~~--G--~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DY-VIDRERELQAIKYLSAAGFGAKLLGVF--GN--G--MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----Ce-EechHHHHHHHHHHHhcCCCCceeEEe--CC--c--Ee
Confidence 5565677777888865432 3478899875321 11 12235688888888765654 334333 22 1 37
Q ss_pred eeccCCCCHHH--------------HHHh--cCC------CC-HHHHHHHHHHH-------------------------H
Q 022479 106 TEVCTSGNLRT--------------YRKK--HRH------VS-IKALKKWSKQV-------------------------L 137 (296)
Q Consensus 106 ~e~~~~~sL~~--------------~l~~--~~~------~~-~~~~~~i~~ql-------------------------~ 137 (296)
.+|+.|.++.. .+.. ... .+ ...+..+..++ +
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88887765421 0111 000 11 11222222111 1
Q ss_pred HHHHHHh-h--CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 138 EGLEYLH-T--HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 138 ~~l~~LH-~--~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+..+. . ...+++|+|+.+.||+++.+.+.++++||+.+..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1112221 1 1224899999999999986546899999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0078 Score=52.80 Aligned_cols=29 Identities=28% Similarity=0.337 Sum_probs=24.5
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++||.|+-+.||+.+.+ .+.++||..+..
T Consensus 228 VfCHNDL~~gNIL~~~~--~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFNQ--GIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecCC--CEEEEEeccccC
Confidence 38999999999997654 699999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.021 Score=48.04 Aligned_cols=136 Identities=17% Similarity=0.171 Sum_probs=68.3
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCCCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.|+.|....+|++. .+++.+.+|+-.... ...+..|.+-|+.|. .-.+.+++++.... +.-+++
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhh-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence 4678889999999986 568889999987221 245777888888884 23455677666443 345899
Q ss_pred eeccCCCC------------HHHHHH-h-cC-------------------CCCHHHHH-------------------HHH
Q 022479 106 TEVCTSGN------------LRTYRK-K-HR-------------------HVSIKALK-------------------KWS 133 (296)
Q Consensus 106 ~e~~~~~s------------L~~~l~-~-~~-------------------~~~~~~~~-------------------~i~ 133 (296)
+||+..+. |...-+ . .+ .-++.+.. .-+
T Consensus 91 le~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~ 170 (288)
T PF03881_consen 91 LEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAEL 170 (288)
T ss_dssp EE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHH
T ss_pred EEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHH
Confidence 99987761 111111 1 00 00000000 011
Q ss_pred HHHHHHHHH-H--hhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 134 KQVLEGLEY-L--HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 134 ~ql~~~l~~-L--H~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
.++++.+.. | |+..|+++||||-..|++++.+ |.+.|.|-..
T Consensus 171 ~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~-g~p~l~DPa~ 215 (288)
T PF03881_consen 171 ERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDAD-GEPVLFDPAC 215 (288)
T ss_dssp HHHHHHHHHCCTTS----EEE-SS-SGGGEEEETT-E-EEE-S---
T ss_pred HHHHHHHHHHhcCCCCCceeeEcCccccceeecCC-CCceeecccc
Confidence 223333333 2 3346679999999999999999 8899888553
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.024 Score=48.70 Aligned_cols=106 Identities=19% Similarity=0.221 Sum_probs=70.7
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
+..+.|+++++..+ ++. .++ .-...++..++.+.+..+.-+..+-+ +-||++...||+++ + |++.|+||.++
T Consensus 297 e~~y~yl~~kdhgt-~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~-fehrnlt~~niLId-~-GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDHGT-PIS-IIK---ADRSEEELSFFWSCISILDILEKKFP-FEHRNLTLDNILID-E-GNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecCCc-eee-eee---cccHHHHHHHHHHHHHHHhhhhhcCC-cccccccccceeee-c-CceEEEEeeee
Confidence 34677888887654 332 122 23466778888888888888877644 89999999999999 5 89999999999
Q ss_pred cccCCCcccccCCCCCCccCccccccCCCcchhHHHHH
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFG 215 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG 215 (296)
+.-... ......++-.|-.+.|.-+...+||-+-
T Consensus 369 Rl~~~q----~~isy~rldhp~lF~G~dd~QFeIYrlM 402 (488)
T COG5072 369 RLSYSQ----GIISYNRLDHPDLFNGVDDYQFEIYRLM 402 (488)
T ss_pred ecccCC----ceeeccccCchhhhcCccceeeeHHHHH
Confidence 843222 1222223344544455556667776543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.046 Score=46.21 Aligned_cols=31 Identities=26% Similarity=0.351 Sum_probs=25.7
Q ss_pred CceecCCCCCceEEeCCC-C---ceEEeccCCccc
Q 022479 149 CIIHRDLNCSNIFINGNI-G---QVKIGDLGFAAI 179 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~-~---~~~l~dfg~~~~ 179 (296)
+++|||+...||++..+. | .++++||..++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 499999999999997763 2 699999987754
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.031 Score=48.75 Aligned_cols=65 Identities=18% Similarity=0.164 Sum_probs=47.8
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCCCceEEeCCCC
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
....++-+|..|.++..+++... .++.-...++.-.+.|+..+ ---+ ++|.|+.|.||++..+.+
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ccceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 34567788899999999988644 34455666666667776554 4457 999999999999987644
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.029 Score=47.49 Aligned_cols=73 Identities=15% Similarity=0.117 Sum_probs=57.6
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
-.+||-++...-+..---+...++..++...-.|+..+++.| |.+- +||.|++-.|+|...+ .+.++|..-+-
T Consensus 358 hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~--LVHADlSEyN~Lw~~g--Kvw~IDVsQsv 431 (531)
T KOG2269|consen 358 HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECL--LVHADLSEYNLLWTPG--KVWVIDVSQSV 431 (531)
T ss_pred ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhh--eeecchhhhhheecCC--ceEEEechhcc
Confidence 456788876654433333334589999999999999999998 7888 9999999999999985 89999986554
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.18 Score=40.72 Aligned_cols=75 Identities=13% Similarity=0.147 Sum_probs=50.3
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc---eeEEeeeeeeCCCCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY---IIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+..|.--..|++.+ ...++.+|+=. ......|..|+.=|+.+...+ +.+++.+ .....+.|+|
T Consensus 21 r~~v~gG~inea~~v~d--g~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylV 89 (286)
T COG3001 21 REEVSGGDINEAWRLRD--GTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLV 89 (286)
T ss_pred ccccCCccccceeEeec--CCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEE
Confidence 35566666667777743 34667788743 333577888988888886555 3344433 3555889999
Q ss_pred eeccCCCCH
Q 022479 106 TEVCTSGNL 114 (296)
Q Consensus 106 ~e~~~~~sL 114 (296)
+||++.+.+
T Consensus 90 le~L~~~~~ 98 (286)
T COG3001 90 LEYLPTGPL 98 (286)
T ss_pred EeeccCCCC
Confidence 999988765
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.13 Score=46.23 Aligned_cols=29 Identities=21% Similarity=0.386 Sum_probs=24.7
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++||+|+.+.||+.+.+ .+.|+||..+..
T Consensus 285 VfCHNDl~~~NiL~~~~--~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK--CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC--CEEEEeeccccc
Confidence 48999999999998754 599999988754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.67 Score=46.32 Aligned_cols=30 Identities=30% Similarity=0.442 Sum_probs=24.4
Q ss_pred ceecCCCCCceEEeCCC-Cce-EEeccCCccc
Q 022479 150 IIHRDLNCSNIFINGNI-GQV-KIGDLGFAAI 179 (296)
Q Consensus 150 i~h~dl~~~nilv~~~~-~~~-~l~dfg~~~~ 179 (296)
++|+|+++.||+++.+. +++ -|+|||-+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999999872 144 5999997754
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.049 Score=45.43 Aligned_cols=51 Identities=25% Similarity=0.365 Sum_probs=37.6
Q ss_pred HHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 129 ~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+...+..+-.++.-++..--.+||+|+.|.|++.++. +.++|+||..|...
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg~~ 184 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCCCc
Confidence 3345555556666655551128999999999999997 79999999988653
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.12 Score=45.85 Aligned_cols=31 Identities=26% Similarity=0.247 Sum_probs=25.1
Q ss_pred CceecCCCCCceEEeCCCC----ceEEeccCCccc
Q 022479 149 CIIHRDLNCSNIFINGNIG----QVKIGDLGFAAI 179 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~----~~~l~dfg~~~~ 179 (296)
.++||||...|||++.+.+ ...|+||..+..
T Consensus 269 VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 269 VLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred ceecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 4999999999999998643 568888877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 296 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-62 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-137
Identities = 123/284 (43%), Positives = 172/284 (60%), Gaps = 6/284 (2%)
Query: 6 SNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED 65
+ + V + GRF ++ +G G+ K VY+ D E +EVAW +++ ++
Sbjct: 8 QDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS 67
Query: 66 PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHRH 123
R E ++L+ L++ I+ Y W + +TE+ TSG L+TY K+ +
Sbjct: 68 ER--QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183
+ IK L+ W +Q+L+GL++LHT P IIHRDL C NIFI G G VKIGDLG A + S
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 184 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243
A ++IGTPE+MAPE+YEE Y E VD+Y+FG+C+LEM T E PYSEC + A+IY++VT
Sbjct: 186 F-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244
Query: 244 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
GVKP + +KV PEVK IE CI Q R S +LL FF E
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-60
Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 15/266 (5%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
+G+G+ + + + +G + W ++ +E L SEV LLR LK+ I+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELKHPNIVRY 70
Query: 91 YSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH-- 144
Y +D + TL + E C G+L K+ +++ + + + Q+ L+ H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 145 -THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE 202
++HRDL +N+F++G VK+GD G A I+ + A + +GTP YM+PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 203 ED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261
Y E DI+S G L E+ + P+ S ++ K+ G K + + E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEI 247
Query: 262 IEKCIA-QPRARPSASELLKDPFFSE 286
I + + + RPS E+L++P E
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-60
Identities = 61/262 (23%), Positives = 121/262 (46%), Gaps = 14/262 (5%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G+ K E+G + ++ +S S EV +L +K+ I+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQ 87
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI--KALKKWSKQVLEGLEYLHTHE 147
+ ++ +L + + C G+L + V + W Q+ L+++H +
Sbjct: 88 YRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEED-Y 205
I+HRD+ NIF+ + G V++GD G A ++ + A + IGTP Y++PE+ E Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265
DI++ G L E+ T++ + E S+ + K+ G ++ ++++ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 266 IA-QPRARPSASELLKDPFFSE 286
PR RPS + +L+ F ++
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-59
Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 21/276 (7%)
Query: 20 DPSGRFGRYSD------LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
DPS + LG G+ +V++ +E+G A + R
Sbjct: 47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR--ARKL 104
Query: 74 SEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKK 131
+EV + ++ + W + L TE+C +L+ + + + +
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTELC-GPSLQQHCEAWGASLPEAQVWG 161
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+ + L L +LH+ ++H D+ +NIF+ G+ K+GD G +G + A G
Sbjct: 162 YLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEG 218
Query: 192 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251
P YMAPEL + Y D++S GL +LE+ + ++ + L
Sbjct: 219 DPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL- 277
Query: 252 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
E+++ + + P+ R +A LL P +
Sbjct: 278 ---SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-58
Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
L+GSG +V++A + +G +V+ ++ + EV+ L L + I+
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHY 69
Query: 91 YSVWLDDQH--------------NTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSK 134
W + L E C G L + +++ + + +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
Q+ +G++Y+H+ + +I+RDL SNIF+ QVKIGD G + GT
Sbjct: 130 QITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLR 186
Query: 195 YMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253
YM+PE Y + VD+Y+ GL L E++ + E +K + + G+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF--- 240
Query: 254 KDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
D + K ++K +++ P RP+ SE+L+ + + + +E
Sbjct: 241 -DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-58
Identities = 73/279 (26%), Positives = 130/279 (46%), Gaps = 16/279 (5%)
Query: 15 PFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 72
+ +G G +VYRA +G+ VA +V++ D
Sbjct: 21 ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADC 79
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKA 128
E+ LL+ L + +I Y+ +++D N LN + E+ +G+L + ++K+ R + +
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AH 187
+ K+ Q+ LE++H+ ++HRD+ +N+FI G VK+GDLG AH
Sbjct: 138 VWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAH 194
Query: 188 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGV 245
S++GTP YM+PE E+ Y DI+S G L EM ++ P+ + ++ + KK+
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 246 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
P + E++ + CI P RP + +
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-56
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 44/303 (14%)
Query: 26 GRYSD------LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
GRY LG G V+ A ++ + A ++RL + ++ EV+ L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA---REKVMREVKAL 57
Query: 80 RTLKNKYIIVCYSVWLDD----------QHNTLNFITEVCTSGNLRTY---RKKHRHVSI 126
L++ I+ ++ WL+ L ++C NL+ + R
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 127 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186
Q+ E +E+LH+ ++HRDL SNIF + VK+GD G + +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174
Query: 187 H-------------SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD 232
+GT YM+PE Y+ VDI+S GL L E++ P+S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231
Query: 233 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291
+ V K L K P ++ ++ P RP A ++++ F +L+
Sbjct: 232 ERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
Query: 292 SEP 294
Sbjct: 291 KTV 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-55
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 19/290 (6%)
Query: 3 AANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF 62
++ D + + G +LG G VY D + +A ++
Sbjct: 2 MRSTEEGDCESDLLEYDYEYDENGD-RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--- 57
Query: 63 SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT-YRKKH 121
D LH E+ L + LK+K I+ + ++ + E G+L R K
Sbjct: 58 -RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKW 114
Query: 122 RHVSIK--ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA- 178
+ + ++KQ+LEGL+YLH + I+HRD+ N+ IN G +KI D G +
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 179 IVGRSHAAHSIIGTPEYMAPE---LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS-V 234
+ G + + GT +YMAPE Y + DI+S G ++EM T + P+ E
Sbjct: 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232
Query: 235 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPF 283
A ++K V P+ + E KAFI KC P R A++LL D F
Sbjct: 233 AAMFKVGMFKVHPEIPESM-SAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-55
Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 43/294 (14%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+LG GA +V +A + + A ++R + + SEV LL +L ++Y++
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-----TILSEVMLLASLNHQYVVR 66
Query: 90 CYSVWLDDQH-----------NTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVL 137
Y+ WL+ ++ +TL E C +G L ++ + + +Q+L
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---------------GR 182
E L Y+H+ IIHRDL NIFI+ + VKIGD G A V G
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 183 SHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 240
S S IGT Y+A E+ + Y E +D+YS G+ EM+ P+S I KK
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 241 VTGGVK--PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 291
+ P + K K I I P RP A LL + + D+
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-53
Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 26/272 (9%)
Query: 28 YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL---HSEVQLL 79
+++ +G G V++ ++ VA + L + ++ + EV ++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLE 138
L + I+ Y + + + E G+L K + + +
Sbjct: 78 SNLNHPNIVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQ----VKIGDLGFAAIVGRSHAAHSIIGTPE 194
G+EY+ P I+HRDL NIF+ K+ D G + H+ ++G +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQ 191
Query: 195 YMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQA 249
+MAPE EE YTE D YSF + L ++T E P+ E + I G++P
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT- 250
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
+ + P ++ IE C + P+ RP S ++K
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-53
Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 21/262 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G+ +V+R D++ G + A +VRL F + E+ L + I+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVP 114
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y + +N E+ G+L K+ + + Q LEGLEYLHT
Sbjct: 115 LYGAVREG--PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--R 170
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA------HSIIGTPEYMAPELYEE 203
I+H D+ N+ ++ + + + D G A + I GT +MAPE+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 204 D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262
VDI+S +L M+ P+++ K + + + P I
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 263 EKCIAQ-PRARPSASELLKDPF 283
++ + + P R SA EL +
Sbjct: 291 QEGLRKEPVHRASAMELRRKVG 312
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-53
Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 19/264 (7%)
Query: 28 YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
+ DL +G+G+ V+RA G +VA + F + VN EV +++ L
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAE--RVNEFLREVAIMKRL 91
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEG 139
++ I++ + L+ +TE + G+L + + + V +G
Sbjct: 92 RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAP 198
+ YLH P I+HR+L N+ ++ VK+ D G + + + ++ S GTPE+MAP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 199 ELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E+ E E D+YSFG+ L E+ T++ P+ + + + + + + +P+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-IPRNLNPQ 267
Query: 258 VKAFIEKCIAQ-PRARPSASELLK 280
V A IE C P RPS + ++
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMD 291
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-51
Identities = 48/265 (18%), Positives = 100/265 (37%), Gaps = 22/265 (8%)
Query: 28 YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
+ L L ++++ Q G ++ +++ +S + E LR
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR--KSRDFNEECPRLRIF 64
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGL 140
+ ++ IT G+L + V K++ + G+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 200
+LHT EP I LN ++ I+ + +I S + + P ++APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVK----FSFQSPGRMYAPAWVAPEA 179
Query: 201 YE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
+ + D++SF + L E+VT E+P+++ ++ K G++P + P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI-SP 238
Query: 257 EVKAFIEKCIAQ-PRARPSASELLK 280
V ++ C+ + P RP ++
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVP 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-51
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 40/280 (14%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYII 88
+ +GSG V++ + +G A + + EV L ++ +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE--QNALREVYAHAVLGQHSHVV 74
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
+S W +D H + E C G+L + + LK QV GL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 145 THEPCIIHRDLNCSNIFINGN------------------IGQVKIGDLGFAAIVGRSHAA 186
+ ++H D+ SNIFI+ KIGDLG V R +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSP 187
Query: 187 HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
G ++A E+ +E+ + DI++ L ++ E D +I +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG---- 243
Query: 245 VKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 283
+ + +V E ++ I P RPSA L+K
Sbjct: 244 -RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 30/286 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 87
+GSG KV++ + E+ A V L ++ +E+ L L+ + I
Sbjct: 15 KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKI 71
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
I Y + DQ+ + + E C + +L ++ KK + + K + K +LE + +H H
Sbjct: 72 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPEL---- 200
I+H DL +N I G +K+ D G A + S S +GT YM PE
Sbjct: 129 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 201 --------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 251
+ + D++S G L M + P+ + + ++K++ + + + +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 252 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
+ +++ ++ C+ + P+ R S ELL P+ ++ +
Sbjct: 245 IP-EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 62/286 (21%), Positives = 123/286 (43%), Gaps = 30/286 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 87
+GSG KV++ + E+ A V L D ++ +E+ L L+ + I
Sbjct: 62 KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
I Y + DQ+ + + E C + +L ++ KK + + K + K +LE + +H H
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED 204
I+H DL +N I G +K+ D G A + S S +G YM PE ++
Sbjct: 176 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 205 ------------YTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 251
+ D++S G L M + P+ + + ++K++ + + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FP 290
Query: 252 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
+ + +++ ++ C+ + P+ R S ELL P+ ++ +
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 30/286 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 87
+GSG KV++ + E+ A V L ++ +E+ L L+ + I
Sbjct: 34 KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKI 90
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
I Y + DQ+ + + E C + +L ++ KK + + K + K +LE + +H H
Sbjct: 91 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED 204
I+H DL +N I G +K+ D G A + S S +GT YM PE ++
Sbjct: 148 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 205 ------------YTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 251
+ D++S G L M + P+ + + ++K++ + + +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FP 262
Query: 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+ + +++ ++ C+ P+ R S ELL P+ ++ +
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-48
Identities = 61/269 (22%), Positives = 122/269 (45%), Gaps = 16/269 (5%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 90
+GSG +V++ ++ G +A Q+R S + R+ ++ +L++ YI+ C
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+ ++ + + E+ + + ++ + + L K + +++ L YL + +
Sbjct: 90 FGTFITN--TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKHGV 146
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------LYEED 204
IHRD+ SNI ++ GQ+K+ D G + + A G YMAPE + D
Sbjct: 147 IHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 263
Y D++S G+ L+E+ T + PY C + ++ KV P + + ++F++
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 264 KC-IAQPRARPSASELLKDPFFSELNDDD 291
C R RP ++LL+ F +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-47
Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 21/276 (7%)
Query: 16 FVEVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 74
+E+D + ++G G KVYRAF G EVA R + + +
Sbjct: 1 LLEIDFAELTLEE---IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
E +L LK+ II V L + + L + E G L + + L W+
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAV 112
Query: 135 QVLEGLEYLHTHEPC-IIHRDLNCSNIFINGNIGQ-------VKIGDLGFAAIVGRSHAA 186
Q+ G+ YLH IIHRDL SNI I + +KI D G A R+
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TK 171
Query: 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245
S G +MAPE+ +++ D++S+G+ L E++T E+P+ D +A Y +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 246 KPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK 280
+ +E C P +RPS + +L
Sbjct: 232 ALPIPSTC-PEPFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-47
Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 28 YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
Y ++ +G GA V +A + +VA Q+ + E++ L +
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKA------FIVELRQLSRV 58
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEG 139
+ I+ Y L N + + E G+L + + + W Q +G
Sbjct: 59 NHPNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 140 LEYLHTHEPC-IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYM 196
+ YLH+ +P +IHRDL N+ + +KI D G A H + G+ +M
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWM 170
Query: 197 APELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQALNKVK 254
APE++E +Y+E D++S+G+ L E++T P+ E A +I V G +P + +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL- 229
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLK 280
+++ + +C ++ P RPS E++K
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-46
Identities = 54/273 (19%), Positives = 111/273 (40%), Gaps = 38/273 (13%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWN-QV---RLSHFSEDPVLVNRLHSEVQLLRTLKNK 85
+L+G G +VY W+ +V + ++ + EV R +++
Sbjct: 39 ELIGKGRFGQVYHGR---------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLH 144
+++ + H L IT +C L + R + + ++ ++++++G+ YLH
Sbjct: 90 NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH------SIIGTPEYMAP 198
I+H+DL N+F + V I D G +I G A G ++AP
Sbjct: 148 AKG--ILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 199 EL----------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 248
E+ + +++ D+++ G E+ E P+ + A I+ ++ G+KP
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMGTGMKPN 262
Query: 249 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
E+ + C A RP+ ++L+
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-46
Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
+GSG+ VY+ G +VA + ++ + + +EV +LR ++ I+
Sbjct: 32 IGSGSFGTVYK------GKWHGDVAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVNIL 83
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
+ Q L +T+ C +L + +K L ++Q G++YLH
Sbjct: 84 LFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPEL--YE 202
IIHRDL +NIF++ + VKIGD G A R SH + G+ +MAPE+ +
Sbjct: 141 --IIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 203 ED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPE 257
+ Y+ D+Y+FG+ L E++T ++PYS ++ +I + V G L+KV+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 258 VKAFIEKCIAQ-PRARPSASELLK 280
+K + +C+ + RPS +L
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILA 281
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-45
Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 17/270 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 90
LG GA V + G +A ++R + + RL ++ +RT+ + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
Y + + E+ + + Y+ K + + L K + +++ LE+LH +
Sbjct: 72 YGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SK 128
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LYE 202
+IHRD+ SN+ IN GQVK+ D G + + A G YMAPE L +
Sbjct: 129 LSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262
+ Y+ DI+S G+ ++E+ + PY + + K+V PQ E F
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 263 EKC-IAQPRARPSASELLKDPFFSELNDDD 291
+C + RP+ EL++ PFF+
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 21/274 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 90
+G GA V + + G +A ++R + D +L ++ ++R+ YI+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTH 146
Y + E+ ++ + Y+ + + L K + ++ L +L
Sbjct: 87 YGALFRE--GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-E 143
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LY 201
IIHRD+ SNI ++ + G +K+ D G + + S A G YMAPE
Sbjct: 144 NLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---PEV 258
+ Y D++S G+ L E+ T PY + +SV +V G PQ N + P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 259 KAFIEKC-IAQPRARPSASELLKDPFFSELNDDD 291
F+ C RP ELLK PF +
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 73/297 (24%), Positives = 132/297 (44%), Gaps = 23/297 (7%)
Query: 3 AANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF 62
A + S G ++ DP F + + +G G+ +V++ D VA + L
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 63 SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH- 121
++ + + E+ +L + Y+ Y +L D L I E G+ +
Sbjct: 61 EDE---IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLLEPGP 115
Query: 122 ---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178
++ +++L+GL+YLH+ + IHRD+ +N+ ++ + G+VK+ D G A
Sbjct: 116 LDETQIATI-----LREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAG 167
Query: 179 -IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK 236
+ ++ +GTP +MAPE+ ++ Y DI+S G+ +E+ E P+SE +
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
++ P L +K F+E C +P RP+A ELLK F S
Sbjct: 228 LFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 2e-43
Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 27/233 (11%)
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKAL 129
+++ + K + + L ++C NL+ + R
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVY--LYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--- 186
Q+ E +E+LH+ ++HRDL SNIF + VK+GD G + +
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTV 223
Query: 187 ----------HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA 235
+GT YM+PE + Y+ VDI+S GL L E++ +S
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 236 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSEL 287
+I V P + K P+ ++ ++ P RP A++++++ F L
Sbjct: 281 RIITDVRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-43
Identities = 71/303 (23%), Positives = 119/303 (39%), Gaps = 51/303 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G V++ + G+ +A + L P + N++ E+Q+L + YI+ Y
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D ++ E G+L KK + + L K S V++GL YL + I+
Sbjct: 98 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIM 154
Query: 152 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 210
HRD+ SNI +N G++K+ D G + + S A+S +GT YM+PE L Y+ D
Sbjct: 155 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 211 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--------------- 255
I+S GL L+EM P D+ A +
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 256 --------------------------PEVKAFIEKCIAQ-PRARPSASELLKDPFFSELN 288
E + F+ KC+ + P R +L+ F +
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332
Query: 289 DDD 291
++
Sbjct: 333 AEE 335
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 20/272 (7%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ R+ + +G GA VY A D G EVA Q+ L + +++N E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVL 137
R KN I+ +L + L + E G+L + I A+ ++ L
Sbjct: 72 RENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECL 126
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYM 196
+ LE+LH+++ +IHRD+ NI + + G VK+ D GF A + + +++GTP +M
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 197 APEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK- 254
APE+ + Y VDI+S G+ +EM+ E PY + + +Y T G P+ N K
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKL 242
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLKDPFFS 285
+ F+ +C+ R SA ELL+ F
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 69/279 (24%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+++GSGA V A+ + +VA ++ L ++ L E+Q + + I+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAMSQCHHPNIVS 77
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS--------KQVLEGLE 141
Y+ ++ L + ++ + G++ K ++VLEGLE
Sbjct: 78 YYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA------IVGRSHAAHSIIGTPEY 195
YLH + IHRD+ NI + + G V+I D G +A + R+ + +GTP +
Sbjct: 136 YLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 196 MAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQAL 250
MAPE+ E+ Y DI+SFG+ +E+ T PY + + + ++
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 251 NKVKD----PEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+K + I C+ + P RP+A+ELL+ FF
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-41
Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 16/270 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP Y +G G+ V A ++ G +VA + L +L N EV ++
Sbjct: 42 DPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIM 96
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
R ++ ++ Y +L L + E G L T ++ + + + VL+
Sbjct: 97 RDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQA 153
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAP 198
L YLH +IHRD+ +I + + G+VK+ D GF A + + S++GTP +MAP
Sbjct: 154 LAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
Query: 199 EL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DP 256
E+ Y VDI+S G+ ++EMV E PY V + + P+ N K P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSP 269
Query: 257 EVKAFIEKCIA-QPRARPSASELLKDPFFS 285
++ F+E+ + P+ R +A ELL PF
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-41
Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 29/286 (10%)
Query: 14 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
++DP+ + LG GA KVY+A ++E G A + E +
Sbjct: 10 HVRRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--- 65
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----SIKAL 129
E+++L T + YI+ + D L + E C G + + I+ +
Sbjct: 66 -EIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHS 188
+Q+LE L +LH+ IIHRDL N+ + G +++ D G +A ++ S
Sbjct: 123 ---CRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDS 176
Query: 189 IIGTPEYMAPE------LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 242
IGTP +MAPE + + Y DI+S G+ L+EM +E P+ E + + + K
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 243 GGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKDPFFS 285
P L E + F++ P RPSA++LL+ PF S
Sbjct: 237 SD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 19/291 (6%)
Query: 2 PAANSNMSDRD-GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
++ D D E F + DP F +G G+ VY A D VA ++ S
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK 120
+ + EV+ L+ L++ I +L + +T + E C
Sbjct: 91 GKQSNEK-WQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVH 147
Query: 121 HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180
+ + + + L+GL YLH+H +IHRD+ NI ++ G VK+GD G A+I+
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM 204
Query: 181 GRSHAAHSIIGTPEYMAPE----LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK 236
A+S +GTP +MAPE + E Y VD++S G+ +E+ + P ++++
Sbjct: 205 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261
Query: 237 IYKKVTGGVKPQALNKVK-DPEVKAFIEKC-IAQPRARPSASELLKDPFFS 285
+Y AL + F++ C P+ RP++ LLK F
Sbjct: 262 LYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 72/271 (26%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
P F + LG G+ VY+A +E G VA QV + ++ + E+ ++
Sbjct: 26 QPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIM 78
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT-YRKKHRHVSIKALKKWSKQVLE 138
+ + +++ Y + + L + E C +G++ R +++ ++ + + L+
Sbjct: 79 QQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMA 197
GLEYLH IHRD+ NI +N G K+ D G A + + A +++IGTP +MA
Sbjct: 137 GLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193
Query: 198 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 255
PE + E Y + DI+S G+ +EM + PY++ + I+ T P K +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPTFRKPELW 251
Query: 256 -PEVKAFIEKC-IAQPRARPSASELLKDPFF 284
F+++C + P R +A++LL+ PF
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-39
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 57/295 (19%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVA----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 85
+G G +V+ + G +VA + S F E +E+ ++++
Sbjct: 43 KQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFRE---------TEIYQTVLMRHE 91
Query: 86 YIIVCYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
I+ + + + IT+ +G+L Y K + K++ K + + GL +L
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150
Query: 144 HT------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGT 192
HT +P I HRDL NI + N G I DLG A ++ +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 193 PEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVA 235
YM PE+ +E M D+YSFGL L E+ ++PY +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 236 KIYKKVTGGV---------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
Y+ + V + + ++ + +C A P +R +A + K
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 69/310 (22%), Positives = 139/310 (44%), Gaps = 31/310 (10%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
M + + S + + DP+G F +L+G+G +VY+ + G A + ++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLN----FITEVCTSGNLR 115
E+ + E+ +L+ + + I Y ++ ++ + E C +G++
Sbjct: 61 GDEEEEIKQ-----EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 116 TYRKKHRHVSIKALKKW----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171
K + ++K ++W +++L GL +LH H+ +IHRD+ N+ + N +VK+
Sbjct: 116 DLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL 170
Query: 172 GDLGFAAIVGRSHA-AHSIIGTPEYMAPE------LYEEDYTEMVDIYSFGLCLLEMVTM 224
D G +A + R+ ++ IGTP +MAPE + Y D++S G+ +EM
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 225 EIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKC-IAQPRARPSASELLKDP 282
P + + ++ L K + ++FIE C + RP+ +L+K P
Sbjct: 231 APPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288
Query: 283 FFSELNDDDS 292
F + ++
Sbjct: 289 FIRDQPNERQ 298
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 76/307 (24%), Positives = 139/307 (45%), Gaps = 29/307 (9%)
Query: 2 PAANSNMSDRDGEPFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA-----W 54
P A + P V VDP RY LG G K + D + A
Sbjct: 18 PGAPAAAPPAKEIPEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK 76
Query: 55 NQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL 114
+ + H ++ E+ + R+L +++++ + + D+ + + E+C +L
Sbjct: 77 SLLLKPH------QREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSL 128
Query: 115 RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174
K+ + ++ + + +Q++ G +YLH + +IHRDL N+F+N + +VKIGD
Sbjct: 129 LELHKRRKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDF 185
Query: 175 GFAAIVGR-SHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD 232
G A V + GTP Y+APE L ++ ++ VD++S G + ++ + P+ E
Sbjct: 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETS 244
Query: 233 SVAKIYKKVTGG--VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289
+ + Y ++ P+ +N P + I+K + P ARP+ +ELL D FF+
Sbjct: 245 CLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
Query: 290 DDSEPSP 296
P
Sbjct: 301 PARLPIT 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-38
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 36/296 (12%)
Query: 27 RYSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
R SDL LG G + + +E G + L F E+ EV+++R
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMV--MKELIRFDEE--TQRTFLKEVKVMRC 63
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGL 140
L++ ++ V D+ LNFITE G LR + ++K + G+
Sbjct: 64 LEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-------------- 186
YLH+ IIHRDLN N + N V + D G A ++
Sbjct: 122 AYLHSM--NIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 187 -HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVTG 243
++++G P +MAPE + Y E VD++SFG+ L E++ + + V G
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 244 GVKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDDDSEPSP 296
+ P +C P RPS +L + L
Sbjct: 239 FLDRYCPPNC-PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 58/327 (17%), Positives = 112/327 (34%), Gaps = 73/327 (22%)
Query: 20 DPSGRFGRYSDLLGSGAVK--KVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 77
G + ++G G V A + G V ++ L S + +V L E+
Sbjct: 22 PEGGCYELL-TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGELH 78
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-----VSIKALKKW 132
+ + + I+ + ++ D L +T G+ + H ++I +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI--- 133
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------- 185
+ VL+ L+Y+H +HR + S+I I+ + G+V + L +
Sbjct: 134 LQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 186 -AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSE----------- 230
+ +++PE+ +++ Y DIYS G+ E+ +P+ +
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 231 --------------------------------CDSVAKIYKKVTGGVKPQALNKVKDPEV 258
+ G ++ P
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPFF 284
F+E+C+ + P ARPSAS LL FF
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 49/291 (16%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ +G G +V+R + G EVA +E+ L+++ I+
Sbjct: 48 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILG 100
Query: 90 CYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-- 145
+ D +++ G+L Y ++ V+++ + K + GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 159
Query: 146 ----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYM 196
+P I HRDL NI + N G I DLG A + A + +GT YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 197 APELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVAKIYK 239
APE+ ++ + + DIY+ GL E+ ++PY + +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 240 KVTGGV---------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
++ V + + + + +C AR +A + K
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 60/336 (17%), Positives = 108/336 (32%), Gaps = 58/336 (17%)
Query: 6 SNMSDRDGEPF-VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF 62
S G+PF VE + R +LG A DQE G V + +F
Sbjct: 57 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYF 113
Query: 63 SEDPV--LVNRLHSEVQLLRTLK------------------------NKYIIVCYSVWLD 96
+E P + ++ EV LR L+ K ++ +
Sbjct: 114 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 173
Query: 97 DQHNTLNFITEVCTSGN-------LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
D F N L ++ H+ + A + + QV+ L LH +
Sbjct: 174 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--G 231
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--AAHSIIGTPEYMAPELYEED--- 204
++H L +I ++ G V + G S PE A +
Sbjct: 232 LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 205 ---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261
T D ++ GL + + ++P ++ D+ + + K V+A
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------QPVRAL 343
Query: 262 IEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+E + R + ++ P + +L + S P
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 379
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 57/295 (19%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVA----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 85
+ +G G +V+R +G VA ++ S F E +E+ L+++
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE---------TELYNTVMLRHE 62
Query: 86 YIIVCYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
I+ + + +H++ IT G+L Y + + + + + GL +L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHL 121
Query: 144 HT------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGT 192
H +P I HRDL NI + N GQ I DLG A + +S + +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 193 PEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVA 235
YMAPE+ +E D + VDI++FGL L E+ + P+ +
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 236 KIYKKVTGGV---------KPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK 280
++ + V + + + +++C P AR +A + K
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-38
Identities = 75/292 (25%), Positives = 136/292 (46%), Gaps = 25/292 (8%)
Query: 15 PFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAW---NQVRLSHFSEDPVLV 69
P V VDP RY LG G K + D + A + L P
Sbjct: 5 PEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQR 59
Query: 70 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 129
++ E+ + R+L +++++ + + D+ + + E+C +L K+ + ++
Sbjct: 60 EKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEA 117
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS 188
+ + +Q++ G +YLH + +IHRDL N+F+N + +VKIGD G A V
Sbjct: 118 RYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV 174
Query: 189 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--V 245
+ GTP Y+APE L ++ ++ VD++S G + ++ + P+ E + + Y ++
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYS 233
Query: 246 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
P+ +N P + I+K + P ARP+ +ELL D FF+ P
Sbjct: 234 IPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 71/307 (23%), Positives = 116/307 (37%), Gaps = 39/307 (12%)
Query: 21 PSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 78
P+ G + + LG+G V R Q+ G +VA Q R ++ R E+Q+
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN---RERWCLEIQI 65
Query: 79 LRTLKNKYIIVCYSVWLDDQHNTLN----FITEVCTSGNLRTYRKKHRHVSI---KALKK 131
++ L + ++ V Q N E C G+LR Y + + ++
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSI 189
+ L YLH + IIHRDL NI + KI DLG+A + +
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 190 IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 248
+GT +Y+APEL E + YT VD +SFG E +T P+ + + KV
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 249 AL------------NKVKDPE-----VKAFIEKCIAQ-----PRARPSASELLKDPFFSE 286
+ + + P + +E+ + R R + + F
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
Query: 287 LNDDDSE 293
L+ S
Sbjct: 304 LDSILSL 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 53/339 (15%), Positives = 101/339 (29%), Gaps = 63/339 (18%)
Query: 6 SNMSDRDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVA--------- 53
S G+PF G R +LG A DQE G
Sbjct: 52 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER 111
Query: 54 ---------------WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98
+R + + R L++ + K +I D
Sbjct: 112 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW 171
Query: 99 HNTLNFITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIH 152
+ F+ S L ++ H+ + A + + QV+ L LH + ++H
Sbjct: 172 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVH 229
Query: 153 RDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL------------ 200
L +I ++ G V + G + + PEL
Sbjct: 230 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGAR---VVSSVSRGFEPPELEARRATISYHRD 285
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEV 258
T D ++ GL + + ++P ++ D+ + + K+ V
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWI--------FRSCKNIPQPV 336
Query: 259 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+A +E + R + ++ P + +L + S P
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 49/276 (17%), Positives = 79/276 (28%), Gaps = 30/276 (10%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
LG G V +G A ++ + E + R + I+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD----REEAQREADMHRLFNHPNILRL 91
Query: 91 YSVWLDDQ--HNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
+ L ++ + + G L + K ++ + + GLE +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII----------GTPE 194
HRDL +NI + GQ + DLG T
Sbjct: 152 --AKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 195 YMAPELYE----EDYTEMVDIYSFGLCLL-EMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
Y APEL+ E D++S G C+L M+ E PY
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
+ + + + P RP LL
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 7e-37
Identities = 46/328 (14%), Positives = 86/328 (26%), Gaps = 47/328 (14%)
Query: 11 RDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVA-------------- 53
+ R + L G V+ D E + A
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105
Query: 54 WNQVR---------LSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104
++ L E+ RL + D
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 105 ITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158
+ + L I AL + Q++ L + ++H
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPD 223
Query: 159 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFG 215
N+FI + G++ +GD+ VG + Y E +T ++ + G
Sbjct: 224 NLFIMPD-GRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 216 LCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD------PEVKAFIEKCIA-Q 268
L + + + +P+ K K P + VK I + +
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340
Query: 269 PRARPSASELLKDPFFSELNDDDSEPSP 296
R R E ++ P F +L ++ S
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLS 368
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-36
Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 25/272 (9%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D+LG GA V+R ++ G A F V+ E ++L+ L +K I+
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVK 71
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KALKKWSKQVLEGLEYLHTH 146
+++ + I E C G+L T ++ + + V+ G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 147 EPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE- 202
I+HR++ NI K+ D G A + S+ GT EY+ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 203 --------EDYTEMVDIYSFGLCLLEMVTMEIP---YSECDSVAKIYKKVTGGVKPQALN 251
+ Y VD++S G+ T +P + ++ K+ G A++
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 252 KVKDPEVKA--FIEKCIAQPRARPSASELLKD 281
V+ E + LL
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 17/266 (6%)
Query: 26 GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY D LG G + VY A D I+VA + E + R EV L
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLS 69
Query: 84 NKYIIVCYSVWLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 142
++ I+ V D+ + ++ E L Y + H +S+ ++ Q+L+G+++
Sbjct: 70 HQNIVSMIDV---DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--AAHSIIGTPEYMAPEL 200
H I+HRD+ NI I+ N +KI D G A + + + ++GT +Y +PE
Sbjct: 127 AHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 201 YE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPE 257
+ E E DIYS G+ L EM+ E P++ +V+ K + V + K
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 258 VKAFIEKCIA-QPRARP-SASELLKD 281
+ I + R + E+ D
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMKDD 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 56/272 (20%), Positives = 100/272 (36%), Gaps = 25/272 (9%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D+LG GA V+R ++ G A F V+ E ++L+ L +K I+
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVK 71
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KALKKWSKQVLEGLEYLHTH 146
+++ + I E C G+L T ++ + + V+ G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 147 EPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE 203
I+HR++ NI K+ D G A + S+ GT EY+ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 204 D---------YTEMVDIYSFGLCLLEMVTMEIP---YSECDSVAKIYKKVTGGVKPQALN 251
Y VD++S G+ T +P + ++ K+ G A++
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 252 KVKDPEVKA--FIEKCIAQPRARPSASELLKD 281
V+ E + LL
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 71/272 (26%), Positives = 107/272 (39%), Gaps = 31/272 (11%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 88
D+LG GA + + +VA ++ FS EVQLLR +I
Sbjct: 30 DVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSF-------ADREVQLLRESDEHPNVI 81
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
+ D Q E+C L+ Y +K H+ ++ +Q GL +LH+
Sbjct: 82 RYFCTEKDRQF--QYIAIELCA-ATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSL 137
Query: 147 EPCIIHRDLNCSNIFI----NGNIGQVKIGDLGFAAIVGRSHAA----HSIIGTPEYMAP 198
I+HRDL NI I + I D G + + + GT ++AP
Sbjct: 138 N--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 199 ELYEED----YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKV 253
E+ ED T VDI+S G +++ P+ + + K
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 254 KDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+D + IEK IA P+ RPSA +LK PFF
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 70/324 (21%), Positives = 115/324 (35%), Gaps = 60/324 (18%)
Query: 2 PAANSNMSDRD-GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVA----WNQ 56
+ + S D G + + ++ G V++A E VA Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPL--QLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQ 58
Query: 57 VRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII--VCYSVWLDDQHNTLNFITEVCTSGNL 114
+ S +E EV L +K++ I+ + L IT G+L
Sbjct: 59 DKQSWQNE---------YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109
Query: 115 RTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--------HEPCIIHRDLNCSNIFINGNI 166
+ K + VS L ++ + GL YLH H+P I HRD+ N+ + N
Sbjct: 110 SDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN- 167
Query: 167 GQVKIGDLGFAAIVGRSHAA---HSIIGTPEYMAPEL------YEEDYTEMVDIYSFGLC 217
I D G A +A H +GT YMAPE+ ++ D +D+Y+ GL
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227
Query: 218 LLEMVTMEIPYS---------------ECDSVAKIYKKV-TGGVKPQALNKV-KDPEVKA 260
L E+ + + S+ + + V +P + K +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 261 F---IEKCIAQ-PRARPSASELLK 280
IE+C AR SA + +
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGE 311
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 13/273 (4%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+LG G+ +V D+ G E A + L EVQLL+ L + I+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMK 90
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y + D + + EV T G L + S + +QVL G+ Y+H +
Sbjct: 91 LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--K 146
Query: 150 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 207
I+HRDL N+ + ++I D G + S IGT Y+APE+ Y E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 264
D++S G+ L +++ P++ + I KKV G + KV K I K
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKV-SESAKDLIRK 264
Query: 265 CIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
+ P R SA + L + +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-34
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 23/293 (7%)
Query: 2 PAANSNMSDRDGEPFVEVDP-SGR-FGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQV 57
+S + R + G FG Y L+G G + VY A D VA +
Sbjct: 8 HHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---L 64
Query: 58 RL--SHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT-EVCTSGNL 114
+L S DPV R+ E + L+ +++ + + + ++ + +L
Sbjct: 65 KLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF---GEIDGQLYVDMRLINGVDL 121
Query: 115 RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174
++ ++ +Q+ L+ H HRD+ NI ++ + + D
Sbjct: 122 AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDF 178
Query: 175 GFAAIVGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC 231
G A+ + +GT YMAPE + T DIY+ L E +T PY
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG- 237
Query: 232 DSVAKIYKKVTGGV-KPQALNKVKDPEVKAFIEKCIA-QPRAR-PSASELLKD 281
D ++ + + + +P + A I + +A P R + +L
Sbjct: 238 DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 14/273 (5%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LGSGA +V D+ +E A +R + S ++L EV +L+ L + I+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEEVAVLKLLDHPNIMK 100
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y + D ++ + E G L + KQVL G+ YLH H
Sbjct: 101 LYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH--N 156
Query: 150 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 207
I+HRDL N+ + +KI D G +A+ +GT Y+APE+ + Y E
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 264
D++S G+ L ++ P+ + +I +KV G V K I++
Sbjct: 217 KCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQ 274
Query: 265 CIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+ + R SA + L+ P+ E+
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 20/270 (7%)
Query: 26 GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL--SHFSEDPVLVNRLHSEVQLLRT 81
RY ++LG G + +V+ A D + +VA V++ + + DP R E Q
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 82 LKNKYIIVCYSV-WLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
L + I+ Y + L +I E LR ++ K + +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGTPEY 195
L + H + IIHRD+ +NI I+ VK+ D G A + S + ++IGT +Y
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 196 MAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKV 253
++PE + D+YS G L E++T E P++ V+ Y+ V P A ++
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 254 KDPEVKAFIEKCIA-QPRARP-SASELLKD 281
++ A + K +A P R +A+E+ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 56/263 (21%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
LG G VY A +++ +A + + + V ++L EV++ L++ I+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRL 74
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
Y + D + I E G + +K + + ++ L Y H+ +
Sbjct: 75 YGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--V 130
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMV 209
IHRD+ N+ + G++KI D G++ S + GT +Y+ PE+ E + E V
Sbjct: 131 IHRDIKPENLLLGSA-GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 210 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-----DPEVKAFIEK 264
D++S G+ E + + P+ E ++ + YK+++ + + I +
Sbjct: 189 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV-------EFTFPDFVTEGARDLISR 240
Query: 265 CI-AQPRARPSASELLKDPFFSE 286
+ P RP E+L+ P+ +
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITA 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 20 DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA-----WNQVRLSHFSEDPVLVNRL 72
+ + +LLG G+ VYRA G+EVA + + +V R+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG------MVQRV 58
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKK 131
+EV++ LK+ I+ Y+ + D + + + E+C +G + Y + + + S +
Sbjct: 59 QNEVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARH 116
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSII 190
+ Q++ G+ YLH+H I+HRDL SN+ + N +KI D G A + +++
Sbjct: 117 FMHQIITGMLYLHSH--GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173
Query: 191 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKP 247
GTP Y++PE + D++S G ++ P+ + D+V KV P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMP 232
Query: 248 QALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 284
L+ E K I + + P R S S +L PF
Sbjct: 233 SFLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 21/280 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVA---------WNQVRLSHFSEDPVLVNRLHSEVQLLR 80
LGSGA +V ++ E A +++E+ LL+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
+L + II + V+ D ++ +TE G L KQ+L G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 141 EYLHTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 198
YLH H I+HRD+ NI N ++ +KI D G ++ + + +GT Y+AP
Sbjct: 160 CYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 199 ELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKD 255
E+ ++ Y E D++S G+ + ++ P+ + I KKV G +
Sbjct: 218 EVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI-S 275
Query: 256 PEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
E K I+ + R +A E L + + ++ ++
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 14/273 (5%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+LG G+ +V + D+ E A + + + + EV+LL+ L + I+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT--STILREVELLKKLDHPNIMK 85
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + D + E+ T G L K + S + KQV G+ Y+H H
Sbjct: 86 LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--N 141
Query: 150 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 207
I+HRDL NI + +KI D G + ++ IGT Y+APE+ Y E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 264
D++S G+ L +++ P+ + I K+V G + + K I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLIRK 259
Query: 265 CIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+ P R +A++ L+ P+ + + + S
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 56/270 (20%), Positives = 116/270 (42%), Gaps = 16/270 (5%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
LG G VY A +++ +A + S ++ V ++L E+++ L++ I+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
Y+ + D + + + E G L +KH + + +++ + L Y H + +
Sbjct: 80 YNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--V 135
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMV 209
IHRD+ N+ + G++KI D G++ S ++ GT +Y+ PE+ E + + E V
Sbjct: 136 IHRDIKPENLLMGYK-GELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 210 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCI- 266
D++ G+ E + P+ + S + ++++ P L K I K +
Sbjct: 194 DLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKLLR 248
Query: 267 AQPRARPSASELLKDPFFSELNDDDSEPSP 296
P R +++ P+ + P
Sbjct: 249 YHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 59/294 (20%), Positives = 101/294 (34%), Gaps = 39/294 (13%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIV 89
+L G VY A D G E A ++ S + + EV ++ L I+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 90 CYSVWLDDQHNTLN-----FITEVCTSGNLRTYRKKHRHV---SIKALKKWSKQVLEGLE 141
S + + + G L + KK S + K Q ++
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI------------ 189
++H +P IIHRDL N+ ++ G +K+ D G A +
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 190 -IGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
TP Y PE+ + E DI++ G L + + P+ E + +I V G
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-EDGAKLRI---VNGK 265
Query: 245 VK-PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
P + + + I + P R S +E++ + + SP
Sbjct: 266 YSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 57/307 (18%), Positives = 109/307 (35%), Gaps = 49/307 (15%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVA-------------WNQVRLSHFSEDPVLVNRLHSEVQL 78
L G K+ +++ A + + +E+Q+
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 79 LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS----- 133
+ +KN+Y + C + + + I E + ++ + + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 134 ---KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
K VL Y+H + I HRD+ SNI ++ N G+VK+ D G + +
Sbjct: 155 CIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKN-GRVKLSDFGESEYM-VDKKIKGSR 211
Query: 191 GTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--- 244
GT E+M PE + VDI+S G+CL M +P+S S+ +++ +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 245 --------------VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELND 289
K N E F++ + P R ++ + LK + ++ N
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331
Query: 290 DDSEPSP 296
+D
Sbjct: 332 EDLREFS 338
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G V++A ++E VA +VRL E P R E+ LL+ LK+K I+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 66
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 149
+ V D L + E C +L+ Y + +K + Q+L+GL + H+
Sbjct: 67 HDVLHSD--KKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--N 121
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 202
++HRDL N+ IN N G++K+ + G A R+ + E Y P++
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLANFGLA----RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------------Y 238
+ Y+ +D++S G E+ P D + +I Y
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 239 KKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288
K +L V + + ++ + P R SA E L+ P+FS+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 20/269 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYI 87
LGSGA +V AF+++ +VA + F+ + + +E+++L+ L + I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
I + + + + + E+ G L ++ + K + Q+L ++YLH +
Sbjct: 203 IKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 148 PCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE----LY 201
IIHRDL N+ + +KI D G + I+G + ++ GTP Y+APE +
Sbjct: 260 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 317
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 258
Y VD +S G+ L ++ P+SE + + ++T G P+ +V +
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV-SEKA 376
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPFFSE 286
++K + P+AR + E L+ P+ +
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 62/312 (19%), Positives = 119/312 (38%), Gaps = 57/312 (18%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLK 83
+Y + +G G+ V++ +++ G VA + S + R E+++L+ LK
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 142
+ ++ V+ L+ + E C + + R V +K + Q L+ + +
Sbjct: 61 HPNLVNLLEVFRRK--RRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 197
H H IHRD+ NI I + +K+ D GFA R S E Y +
Sbjct: 118 CHKHN--CIHRDVKPENILITKH-SVIKLCDFGFA----RLLTGPSDYYDDEVATRWYRS 170
Query: 198 PELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYK-------KVTG 243
PEL + Y VD+++ G C+ E+++ P S+ D + I K +
Sbjct: 171 PELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228
Query: 244 GV------------KPQALNKVK------DPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
P+ + ++ ++ C+ P R + +LL P+F
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288
Query: 285 SELNDDDSEPSP 296
+ + +
Sbjct: 289 ENIREIEDLAKE 300
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 54/297 (18%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
LG G +VY+A D VA ++RL H E P R EV LL+ L+++ II
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVSLLKELQHRNIIEL 98
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
SV + + L+ I E + +L+ Y K+ VS++ +K + Q++ G+ + H+
Sbjct: 99 KSVIHHN--HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR--RC 153
Query: 151 IHRDLNCSNIFIN----GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY 201
+HRDL N+ ++ +KIGD G A R+ T E Y PE+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLA----RAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 202 --EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI------------------ 237
Y+ VDI+S EM+ P SE D + KI
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268
Query: 238 --YKKVTGGVKPQALNKVK----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287
+K+ + + L +V D E + + P R SA L+ P+FS
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 69/302 (22%), Positives = 136/302 (45%), Gaps = 33/302 (10%)
Query: 5 NSNMSDRDGEPFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRL 59
NS S D +P + G Y +G G KV A G EVA ++ +L
Sbjct: 2 NSIASCADEQPHI--------GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL 53
Query: 60 SHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK 119
+P + +L EV++++ L + I+ + V + TL I E + G + Y
Sbjct: 54 -----NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLV 106
Query: 120 KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179
H + K + +Q++ ++Y H I+HRDL N+ ++ + +KI D GF+
Sbjct: 107 AHGRMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDAD-MNIKIADFGFSNE 163
Query: 180 VGRSHAAHSIIGTPEYMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 237
+ G P Y APEL++ + Y VD++S G+ L +V+ +P+ ++ ++
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKEL 222
Query: 238 YKKVTGGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294
++V G P ++ + + +++ + P R + +++KD + + +++D
Sbjct: 223 RERVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
Query: 295 SP 296
Sbjct: 279 PF 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 24/267 (8%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSGA V+ ++ G+E + + ++ +E+++L++L + II +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP---MEQIEAEIEVLKSLDHPNIIKIF 86
Query: 92 SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
V+ D + + + E C G L + + + + +S + + KQ++ L Y H+
Sbjct: 87 EVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 148 PCIIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDY 205
++H+DL NI F + + +KI D G A + + + GT YMAPE+++ D
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP-----EVKA 260
T DI+S G+ + ++T +P++ S+ ++ +K T N + +
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKE----PNYAVECRPLTPQAVD 257
Query: 261 FIEKCIAQ-PRARPSASELLKDPFFSE 286
+++ + + P RPSA+++L +F +
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 55/309 (17%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y++ +G+G+ V++A E EVA +V D NR E+Q++R +K+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQ-----DKRFKNR---ELQIMRIVKH 91
Query: 85 KYII----VCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQV 136
++ YS LN + E + R Y K + + + +K + Q+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 196
L L Y+H+ I HRD+ N+ ++ G +K+ D G A I+ S I + Y
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 197 APELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG------- 243
APEL +YT +DI+S G + E++ + P S D + +I KV G
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEII-KVLGTPSREQI 266
Query: 244 -------------GVKPQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285
++P +KV P+ I + + P AR +A E L PFF
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
Query: 286 ELNDDDSEP 294
EL ++
Sbjct: 327 ELRTGEARM 335
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 22/288 (7%)
Query: 22 SGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
+ G+Y DLLG G+ KV D E A ++ P + E+QLL
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN--LRTYRKKHRHVSIKALKKWSKQVL 137
R L++K +I V +++ + + E C G + + R +A + Q++
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLI 119
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAHSIIGTPE 194
+GLEYLH+ I+H+D+ N+ + G +KI LG A + G+P
Sbjct: 120 DGLEYLHSQ--GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 195 YMAPELY--EEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQA 249
+ PE+ + ++ VDI+S G+ L + T P+ E D++ K+++ + G P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGD 235
Query: 250 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 296
P + ++ + +P R S ++ + +F + + P P
Sbjct: 236 C----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 26/272 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G+ +V + D+ E A + + + + EV+LL+ L + I+ +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT--STILREVELLKKLDHPNIMKLF 87
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D + E+ T G L K + S + KQV G+ Y+H H I+
Sbjct: 88 EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IV 143
Query: 152 HRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMV 209
HRDL NI + +KI D G + ++ IGT Y+APE+ Y E
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKC 203
Query: 210 DIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 260
D++S G V + I P+ + I K+V G + D + K
Sbjct: 204 DVWSAG------VILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKD 255
Query: 261 FIEKCIAQ-PRARPSASELLKDPFFSELNDDD 291
I K + P R +A++ L+ P+ + + ++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 28/281 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKNKYIIV 89
LGSG V + ++ G+E A ++ V+R + EV +LR + + +I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ V+ + L I E+ + G L + + +S + + KQ+L+G+ YLHT +
Sbjct: 80 LHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 150 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I H DL NI + N I +K+ D G A + +I GTPE++APE + E
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 206 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
D++S G L P+ D+ + +T + + +
Sbjct: 196 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANITSVSYDFDEEFFSHTSE- 247
Query: 257 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 296
K FI K + + R R + E L+ P+ + +++ +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 28/267 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ +V A + I A ++ + V+R E++++++L + II Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
+ D+ + + E+CT G L R + K VL + Y H +
Sbjct: 73 ETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VA 128
Query: 152 HRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMV 209
HRDL N F+ + +K+ D G AA + +GTP Y++P++ E Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPEC 188
Query: 210 DIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 260
D +S G V M + P+S + +++ K+ G + V + ++
Sbjct: 189 DEWSAG------VMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSP-QAES 240
Query: 261 FIEKCIAQ-PRARPSASELLKDPFFSE 286
I + + + P+ R ++ + L+ +F +
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 56/292 (19%), Positives = 104/292 (35%), Gaps = 33/292 (11%)
Query: 2 PAANSNMSDRDGEPFVEVDP--SGRF--GRY--SDLLGSGAVKKVYRAFDQE-EGIEVAW 54
A+ G P+ + G G+Y + G + +Y A D+ G V
Sbjct: 52 KGASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVV- 110
Query: 55 NQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV--WLDDQHNTLNFIT-EVCTS 111
++ S D +E Q L + + I+ ++ D + + +I E
Sbjct: 111 --LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG 168
Query: 112 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171
+L+ + + + + + ++L L YLH+ +++ DL NI + Q+K+
Sbjct: 169 QSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKL 222
Query: 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 231
DLG + + + GTP + APE+ T DIY+ G L + +
Sbjct: 223 IDLGAVSRINSFGY---LYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG- 278
Query: 232 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP-SASELLKD 281
V G+ + + I PR R +A E+
Sbjct: 279 RYVD--------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 66/284 (23%), Positives = 125/284 (44%), Gaps = 32/284 (11%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYI 87
LGSGA +V AF+++ +VA + F+ + + +E+++L+ L + I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
I + + + + + E+ G L ++ + K + Q+L ++YLH +
Sbjct: 78 IKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 148 PCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE----LY 201
IIHRDL N+ + +KI D G + I+G + ++ GTP Y+APE +
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNK 252
Y VD +S G V + I P+SE + + ++T G P+ +
Sbjct: 193 TAGYNRAVDCWSLG------VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 253 VKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 295
V + + ++K + P+AR + E L+ P+ + +
Sbjct: 247 VSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 86/347 (24%), Positives = 138/347 (39%), Gaps = 66/347 (19%)
Query: 2 PAANSNMS---DRDGEPFVEVDPSGRFG-------RYSDL--LGSGAVKKVYRAFDQEEG 49
P+A +M D+DG V + G Y+D +G+G+ VY+A + G
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 50 IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII----VCYSVWLDDQHNTLNFI 105
VA +V D NR E+Q++R L + I+ YS LN +
Sbjct: 80 ELVAIKKVLQ-----DKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 106 TEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
+ + R Y + + + + +K + Q+ L Y+H+ I HRD+ N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLL 188
Query: 162 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLL 219
++ + +K+ D G A + R S I + Y APEL DYT +D++S G C+L
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVL 247
Query: 220 -EMVTMEIPY----SECDSVAKIYKKVTG--------------------GVKPQALNKV- 253
E++ + P S D + +I KV G +K KV
Sbjct: 248 AELLLGQ-PIFPGDSGVDQLVEII-KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 305
Query: 254 ---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
PE A + + P AR + E FF EL D + +
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 352
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 54/291 (18%), Positives = 121/291 (41%), Gaps = 35/291 (12%)
Query: 24 RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA----------------------WNQVRL 59
+ +Y+ D +G G+ V A+++ + A +
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 60 SHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK 119
+ + +++ E+ +L+ L + ++ V D + L + E+ G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 120 KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179
+S + + + +++G+EYLH + IIHRD+ SN+ + + G +KI D G +
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNE 186
Query: 180 VGRSHA-AHSIIGTPEYMAPEL---YEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSV 234
S A + +GTP +MAPE + ++ + +D+++ G+ L V + P+ + + +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245
Query: 235 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 284
++ K+ ++K I + + P +R E+ P+
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 53/224 (23%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-------HEPCIIHRDLNC 157
+ E +G+L Y H + + + V GL YLHT ++P I HRDLN
Sbjct: 90 VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 158 SNIFINGNIGQVKIGDLGFAAIVGRS---------HAAHSIIGTPEYMAPELYE------ 202
N+ + + G I D G + + + +AA S +GT YMAPE+ E
Sbjct: 149 RNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 203 --EDYTEMVDIYSFGLCLLEMVT-------------MEIPYSEC----DSVAKIYKKV-T 242
E + VD+Y+ GL E+ ++ + + + V
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR 267
Query: 243 GGVKPQ-----ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
+P+ N + +K IE C Q AR +A +
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 61/343 (17%), Positives = 118/343 (34%), Gaps = 65/343 (18%)
Query: 5 NSNMSDRDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH 61
+ + S + + + +G G+ V A + + A + +
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 62 FSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL--RTYR 118
+ +P V R+ +EV+L++ L + I Y V+ D+Q+ + + E+C G+L +
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNV 121
Query: 119 KKHRHVSIKALKKWS--------------------------------------KQVLEGL 140
A+ +Q+ L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 141 EYLHTHEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIV-----GRSHAAHSIIGTPE 194
YLH I HRD+ N F ++K+ D G + G + + GTP
Sbjct: 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 195 YMAPEL---YEEDYTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGV---KP 247
++APE+ E Y D +S G+ L ++ +P D+ +V +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFEN 297
Query: 248 QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 289
N + P + + + + R A L+ P+ S+ +D
Sbjct: 298 PNYNVL-SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 28/281 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYIIV 89
LGSG V + ++ G+E A ++ V + EV +LR + + II
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ V+ + L I E+ + G L + + +S + + KQ+L+G+ YLHT +
Sbjct: 80 LHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 150 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I H DL NI + N I +K+ D G A + +I GTPE++APE + E
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 206 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
D++S G L P+ D+ + +T + ++ +
Sbjct: 196 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANITAVSYDFDEEFFSQTSE- 247
Query: 257 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 296
K FI K + + R R + E L+ P+ + ++ +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-28
Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLK 83
+Y +L +G G+ V + +++ G VA + S + + R E++LL+ L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLR 82
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEY 142
++ ++ V + E + + + + + ++K+ Q++ G+ +
Sbjct: 83 HENLVNLLEVCKKK--KRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 197
H+H IIHRD+ NI ++ + G VK+ D GFA R+ AA + E Y A
Sbjct: 140 CHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFA----RTLAAPGEVYDDEVATRWYRA 192
Query: 198 PELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKV--------T 242
PEL + Y + VD+++ G CL+ EM E P S+ D + I +
Sbjct: 193 PELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 243 GGVKPQALNKVKDPEVKA-----------------FIEKCIA-QPRARPSASELLKDPFF 284
K V+ PE+K +KC+ P RP +ELL FF
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 285 SELN 288
Sbjct: 311 QMDG 314
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 8e-28
Identities = 70/294 (23%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G VY+A + A ++RL E P R E+ +L+ LK+ I+
Sbjct: 10 IGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 149
Y V L + E +L+ K + Q+L G+ Y H
Sbjct: 66 YDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--R 120
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 202
++HRDL N+ IN G++KI D G A R+ T E Y AP++
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLA----RAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------------Y 238
+ Y+ +DI+S G EMV P SE D + +I Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 239 KKVTGGVKPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288
+P D + K + P R +A + L+ +F E N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 55/296 (18%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 90
+G G VY+A D + I VA ++RL E P R E+ LL+ L + I+
Sbjct: 29 VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVSL 84
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 149
V + L + E +L+ +++ +K + Q+L G+ + H H
Sbjct: 85 IDVIHSE--RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--R 139
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 202
I+HRDL N+ IN + G +K+ D G A R+ T E Y AP++
Sbjct: 140 ILHRDLKPQNLLIN-SDGALKLADFGLA----RAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV----- 245
+ Y+ VDI+S G EM+T + P ++ D + KI+ + G V
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPL 252
Query: 246 ---------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288
+ + + + E + + P R SA + + P+F +L+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 58/292 (19%), Positives = 105/292 (35%), Gaps = 50/292 (17%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 88
+LG G+ V +G VA ++ + E++LL + +I
Sbjct: 21 KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-------IALMEIKLLTESDDHPNVI 72
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNL-------RTYRKKHRHVSIKALKKWSKQVLEGLE 141
Y D+ L E+C NL + + +Q+ G+
Sbjct: 73 RYYCSETTDRF--LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 142 YLHTHEPCIIHRDLNCSNIFIN------------GNIGQVKIGDLGFAAIVGRSHAA--- 186
+LH+ IIHRDL NI ++ ++ I D G + ++
Sbjct: 130 HLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 187 --HSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEIP--YSECDSV 234
++ GT + APEL EE T +DI+S G +++ +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 235 AKIYKKVTGGVKPQALN-KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ I + + + + L+ + E I + I P RP+A ++L+ P F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 27/268 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG GA V R + G+E A + S +L E ++ R L++ I+ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 71
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
++ + ++ T G L S +Q+LE + Y H++ I+
Sbjct: 72 DSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 127
Query: 152 HRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 208
HR+L N+ + VK+ D G A V S A H GTP Y++PE L ++ Y++
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 209 VDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVK 259
VDI++ G V + I P+ + + ++Y ++ G + V E K
Sbjct: 188 VDIWACG------VILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAK 239
Query: 260 AFIEKCIAQ-PRARPSASELLKDPFFSE 286
+ I+ + P+ R +A + LK P+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 31/279 (11%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSGA V+R ++ G + + D V E+ ++ L + +I +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKN---EISIMNQLHHPKLINLH 114
Query: 92 SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ D L I E + G L R + ++ S + + +Q EGL+++H H
Sbjct: 115 DAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKM-SEAEVINYMRQACEGLKHMHEHS-- 169
Query: 150 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 207
I+H D+ NI VKI D G A + T E+ APE + E
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 208 MVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 258
D+++ G L L P++ + + + V A + V E
Sbjct: 230 YTDMWAIGVLGYVLLSGLS------PFAG-EDDLETLQNVKRCDWEFDEDAFSSVSP-EA 281
Query: 259 KAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 296
K FI+ +PR R + + L+ P+ + + + P
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 31/310 (10%)
Query: 1 MPAANSNMSDRDGEPFVEVDPSGRFGRYSDL---LGSGAVKKVYRAFDQEEGIEVAWNQV 57
M + G F+ ++ S +F D+ LG GA V R + G+E A +
Sbjct: 4 MASMTGGQQMGRGSEFM-MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 58 RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY 117
S +L E ++ R L++ I+ + ++ + ++ T G L
Sbjct: 63 NTKKLSARDF--QKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFED 118
Query: 118 RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FINGNIG-QVKIGDLG 175
S +Q+LE + Y H++ I+HR+L N+ + G VK+ D G
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 176 FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI------PY 228
A V S A H GTP Y++PE L ++ Y++ VDI++ G V + I P+
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG------VILYILLVGYPPF 230
Query: 229 SECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ + ++Y ++ G + V E K+ I+ + P+ R +A + LK P+
Sbjct: 231 WD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWI 288
Query: 285 SELNDDDSEP 294
S
Sbjct: 289 CNRERVASAI 298
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 79/306 (25%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----RLHSEVQLLRTLKN--- 84
+G GA VY+A D G VA VR+ + + R EV LLR L+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EVALLRRLEAFEH 73
Query: 85 KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLE 138
++ VC + D + + + E +LRTY + + + +K +Q L
Sbjct: 74 PNVVRLMDVCATSRTDRE-IKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 198
GL++LH + CI+HRDL NI + G VK+ D G A I A ++ T Y AP
Sbjct: 132 GLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV 245
E L + Y VD++S G EM + P SE D + KI+ + G
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFD-LIGLPPEDDWPRD 246
Query: 246 -----------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290
P+ + V + + + + P R SA L+ + +
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD--- 303
Query: 291 DSEPSP 296
E +P
Sbjct: 304 --EGNP 307
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYII 88
+++G G V R ++E G + A V ++ F S + L E + LK+ +I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHV--SIKALKKWSKQVLEGLEYLH 144
+ D L + E +L ++ S + +Q+LE L Y H
Sbjct: 90 ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 145 THEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPE-L 200
+ IIHRD+ + + N VK+G G A +G S +GTP +MAPE +
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 201 YEEDYTEMVDIYSFGL---CLLEMVTMEIPYSEC------DSVAKIYKKVTGGV---KPQ 248
E Y + VD++ G+ LL + ++++ + G P+
Sbjct: 206 KREPYGKPVDVWGCGVILFILL-----------SGCLPFYGTKERLFEGIIKGKYKMNPR 254
Query: 249 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
+ + + K + + + P R + E L P+ E + +
Sbjct: 255 QWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 19/270 (7%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+GA V+R ++ G A V H D V + E+Q + L++ ++ +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRK---EIQTMSVLRHPTLVNLH 220
Query: 92 SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ DD + I E + G L + + + +S ++ +QV +GL ++H +
Sbjct: 221 DAFEDDNEMVM--IYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 275
Query: 150 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 207
+H DL NI F ++K+ D G A + + GT E+ APE +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 264
D++S G+ +++ P+ ++ + + V A + + + + K FI K
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRK 393
Query: 265 CIAQ-PRARPSASELLKDPFFSELNDDDSE 293
+ P R + + L+ P+ + N +
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRD 423
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
++LG G +V++ + G+++A ++ + + +E+ ++ L + +I
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQ 150
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
Y + L + E G L R + + + + KQ+ EG+ ++H
Sbjct: 151 LYDAFESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDT-ILFMKQICEGIRHMHQMY 207
Query: 148 PCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I+H DL NI +N + Q+KI D G A GTPE++APE + +
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 206 TEMVDIYSFG------LCLLEMVTMEIP-YSECDSVAKIYKKVTGGV---KPQALNKVKD 255
+ D++S G L L P + D A+ + + + + +
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLS------PFLGDND--AETLNNILACRWDLEDEEFQDISE 317
Query: 256 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPS 295
E K FI K I + R SASE LK P+ S+ +
Sbjct: 318 -EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 36/286 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVA-----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-K 85
LG G V R + E A E L EV +LR +
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 145
II + + + ++ G L Y + +S K +K + +LE + LH
Sbjct: 85 NIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------ 199
I+HRDL NI ++ + +K+ D GF+ + + GTP Y+APE
Sbjct: 143 LN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199
Query: 200 -LYEEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQA 249
Y + VD++S G V M P+ + + + G
Sbjct: 200 NDNHPGYGKEVDMWSTG------VIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPE 252
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
+ D VK + + + P+ R +A E L PFF + ++
Sbjct: 253 WDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 18/272 (6%)
Query: 20 DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 77
D + G Y D LG G KV Q G +VA + +V ++ E+Q
Sbjct: 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQ 63
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 137
L+ ++ +II Y V + E + G L Y KH V ++ +Q+L
Sbjct: 64 NLKLFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
++Y H H ++HRDL N+ ++ + KI D G + ++ + G+P Y A
Sbjct: 122 SAVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178
Query: 198 PELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKV 253
PE+ Y VDI+S G+ L ++ +P+ + + V ++KK+ GGV P+ LN
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN-- 235
Query: 254 KDPEVKAFIEKCI-AQPRARPSASELLKDPFF 284
V + + P R + ++ + +F
Sbjct: 236 --RSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 59/280 (21%), Positives = 115/280 (41%), Gaps = 28/280 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LGSG V + + G E A ++ S V + EV +LR +++ II
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ ++ + L I E+ + G L + + ++ ++ KQ+L+G+ YLH+
Sbjct: 73 LHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-- 128
Query: 150 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I H DL NI + N ++K+ D G A + + +I GTPE++APE + E
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188
Query: 206 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
D++S G L P+ ++ + ++ + + +
Sbjct: 189 GLEADMWSIGVITYILLSGAS------PFLG-ETKQETLTNISAVNYDFDEEYFSNTSE- 240
Query: 257 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPS 295
K FI + + P+ R + ++ L+ + + +
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 69/321 (21%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
R+ G G V ++ G+ VA +V +DP NR +Q L L +
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLAVLHH 78
Query: 85 KYII----VCYSVWLDDQHNT-LNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQ 135
I+ Y++ D+ + LN + E L R Y ++ +K + Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
++ + LH + HRD+ N+ +N G +K+ D G A + S + I + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 196 MAPELY--EEDYTEMVDIYSFGLCLL-EMVT--------------MEI------------ 226
APEL + YT VDI+S G C+ EM+ EI
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 227 ------------PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 273
S+ + ++ + +A + + + P R
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD---------LLSALLQYLPEERM 307
Query: 274 SASELLKDPFFSELNDDDSEP 294
E L P+F EL+D ++
Sbjct: 308 KPYEALCHPYFDELHDPATKL 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 28/277 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LGSG V + ++ G++ A + R + S V + EV +L+ +++ +I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ V+ + L I E+ G L + + ++ + ++ KQ+L G+ YLH+ +
Sbjct: 79 LHEVYENKTDVIL--ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 150 IIHRDLNCSNI-FINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I H DL NI ++ N+ ++KI D G A + + +I GTPE++APE + E
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 206 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
D++S G L P+ D+ + V+ + + +
Sbjct: 195 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANVSAVNYEFEDEYFSNTSA- 246
Query: 257 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
K FI + + P+ R + + L+ P+ + +
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 38/280 (13%), Positives = 83/280 (29%), Gaps = 32/280 (11%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIV 89
LLG GA +VY A + + L +P ++ L+ +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL-----KKWSKQVLEGLEYLH 144
YS L + E+ + G L +++ K + ++ ++L +E +H
Sbjct: 132 FYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 145 THEPCIIHRDLNCSNIFINGNI----------GQVKIGDLGFAA---IVGRSHAAHSIIG 191
E IIH D+ N + + + DLG + + + +
Sbjct: 190 DCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 192 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
T + E L + + +D + + M+ + + + + +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP---- 303
Query: 251 NKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELND 289
F + + +LL+
Sbjct: 304 ---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 86/295 (29%), Positives = 126/295 (42%), Gaps = 49/295 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN---KY 86
+G GA KV++A D + G VA +VR+ E P+ R EV +LR L+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---EVAVLRHLETFEHPN 75
Query: 87 II----VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGL 140
++ VC D + L + E +L TY + V + +K Q+L GL
Sbjct: 76 VVRLFDVCTVSRTDRETK-LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+H ++HRDL NI + + GQ+K+ D G A I A S++ T Y APE
Sbjct: 134 DFLHSH--RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV-- 245
L + Y VD++S G EM + P S+ D + KI V G
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVA 248
Query: 246 ---------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287
Q + K D K + KC+ P R SA L P+F +L
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 57/297 (19%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 89
LG G VY+ + VA ++RL H E+ P R EV LL+ LK+ I+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR---EVSLLKDLKHANIVT 64
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ + + +L + E +L+ Y +++ +K + Q+L GL Y H
Sbjct: 65 LHDIIHTE--KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY-- 201
++HRDL N+ IN G++K+ D G A R+ + + E Y P++
Sbjct: 120 KVLHRDLKPQNLLIN-ERGELKLADFGLA----RAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV---- 245
DY+ +D++ G EM T P + + + I+ ++ G G+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIF-RILGTPTEETWPGILSNE 232
Query: 246 ----------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288
+ +AL D + + K + + R R SA + +K PFF L
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 64/313 (20%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 89
LG+G VY+ ++ G+ VA +V+L E+ P R E+ L++ LK++ I+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIR---EISLMKELKHENIVR 67
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY------RKKHRHVSIKALKKWSKQVLEGLEYL 143
Y V + N L + E + +L+ Y R + + +K + Q+L+GL +
Sbjct: 68 LYDVIHTE--NKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAP 198
H + I+HRDL N+ IN GQ+K+GD G A R+ + E Y AP
Sbjct: 125 HEN--KILHRDLKPQNLLINKR-GQLKLGDFGLA----RAFGIPVNTFSSEVVTLWYRAP 177
Query: 199 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------- 237
++ Y+ +DI+S G L EM+T + P ++ + + I
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 238 -----YKKVTGGVKPQALNKV--------KDPEVKAFIEKCIA-QPRARPSASELLKDPF 283
Y P+ L +V D + F+ + P R SA + L P+
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 284 FSELNDDDSEPSP 296
F+E S
Sbjct: 297 FAEYYHHASMGGS 309
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 57/297 (19%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----RLHSEVQLLRTLKNKYI 87
LG G VY+A D+ VA +++L H SE +N R E++LL+ L + I
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHPNI 74
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTH 146
I + + ++ + + + +L K + V + +K + L+GLEYLH H
Sbjct: 75 IGLLDAFGHK--SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY 201
I+HRDL +N+ ++ N G +K+ D G A +S + + T + Y APEL
Sbjct: 132 --WILHRDLKPNNLLLDEN-GVLKLADFGLA----KSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 202 --EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKVTG--------GV- 245
Y VD+++ G C+L E++ P+ S+ D + +I+ + G +
Sbjct: 185 FGARMYGVGVDMWAVG-CILAELLLRV-PFLPGDSDLDQLTRIF-ETLGTPTEEQWPDMC 241
Query: 246 -----------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287
L+ + ++ I+ P AR +A++ LK +FS
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 64/313 (20%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 88
+G G +V++A ++ G +VA +V + + E P+ R E+++L+ LK++ ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 81
Query: 89 --VCYS--VWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYL 143
+C + + ++ + + C +L ++ +K+ + +L GL Y+
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAP 198
H + I+HRD+ +N+ I G +K+ D G A + + T Y P
Sbjct: 141 HRN--KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197
Query: 199 ELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKVTG-------- 243
EL E DY +D++ G C++ EM T P +E +A I ++ G
Sbjct: 198 ELLLGERDYGPPIDLWGAG-CIMAEMWTRS-PIMQGNTEQHQLALIS-QLCGSITPEVWP 254
Query: 244 GV--------------KPQAL-----NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 283
V + + + V+DP I+K + P R + + L F
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
Query: 284 FSELNDDDSEPSP 296
F +P P
Sbjct: 315 FWS------DPMP 321
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 30/277 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVC 90
LG G V + + G E A ++ +D + E+ +L K +I
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVINL 94
Query: 91 YSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ V+ + L I E G + + VS + + KQ+LEG+ YLH +
Sbjct: 95 HEVYENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 149 CIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I+H DL NI + +G +KI D G + +G + I+GTPEY+APE L +
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI 210
Query: 206 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
T D+++ G L P+ + + Y ++ + + V
Sbjct: 211 TTATDMWNIGIIAYMLLTHTS------PFVG-EDNQETYLNISQVNVDYSEETFSSVSQ- 262
Query: 257 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
FI+ + P RP+A L + + + ++
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 52/276 (18%), Positives = 109/276 (39%), Gaps = 34/276 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G V+R + V++ + V E+ +L +++ I+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIARHRNILHLH 67
Query: 92 SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + + I E + ++ R ++ + + + QV E L++LH+H
Sbjct: 68 ESFESMEELVM--IFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHN-- 122
Query: 150 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 207
I H D+ NI + +KI + G A + + PEY APE + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 208 MVDIYSFG------LCLLEMVTMEIP-YSECDSVAKIYKKVTGGV---KPQALNKVKDPE 257
D++S G L + P +E + +I + + +A ++ E
Sbjct: 183 ATDMWSLGTLVYVLLSGIN------PFLAETN--QQIIENIMNAEYTFDEEAFKEISI-E 233
Query: 258 VKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 292
F+++ + + ++R +ASE L+ P+ + + S
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 38/298 (12%)
Query: 20 DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHS 74
D Y LLG G V+ + ++VA + R+ +S V
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV-TCPL 83
Query: 75 EVQLLRTLKNK----YIIVCYSVWLDDQHNTLNFITE-VCTSGNLRTYRKKHRHVSIKAL 129
EV LL + +I + + + E + +L Y + +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
+ + QV+ +++ H+ ++HRD+ NI I+ G K+ D G A++
Sbjct: 142 RCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDF 198
Query: 190 IGTPEYMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-- 245
GT Y PE Y ++S G+ L +MV +IP+ +++
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELH 251
Query: 246 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF------SELNDDDSEPSP 296
P ++ P+ A I +C+A P +RPS E+L DP+ LN P+P
Sbjct: 252 FPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAP 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 47/287 (16%)
Query: 27 RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
+Y LG G V G VA Q++ P E+Q+L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQILKAL 81
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 141
+ +I+ V +L + E SG LR + ++HR + L +S Q+ +G+E
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------ 195
YL + +HRDL NI + VKI D G A ++ Y
Sbjct: 142 YLGSR--RCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKD--------YYVVREPG 190
Query: 196 ------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK- 246
APE L + ++ D++SFG+ L E+ T + S ++
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 247 PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 281
+ L +++ EV ++ C P+ RPS S L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 16/267 (5%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
+ LG GA +V A ++ VA V + + P + + E+ + + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
++ ++ Y + E C+ G L + + +++ Q++ G+ YL
Sbjct: 64 HENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPE- 199
H I HRD+ N+ ++ +KI D G A + R + + GT Y+APE
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 200 LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
L ++ E VD++S G+ L M+ E+P+ + + Y K D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 259 KAFIEKC-IAQPRARPSASELLKDPFF 284
A + K + P AR + ++ KD ++
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWY 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 37/298 (12%)
Query: 20 DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHS 74
+ +Y LLGSG VY + + VA + R+S + E P R+
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 95
Query: 75 EVQLLRTLKNK--YIIVCYSVWLDDQHNTLNFITEVCT-SGNLRTYRKKHRHVSIKALKK 131
EV LL+ + + +I + I E +L + + + + +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARS 153
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+ QVLE + + H ++HRD+ NI I+ N G++K+ D G A++ + G
Sbjct: 154 FFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DG 210
Query: 192 TPEYMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQ 248
T Y PE Y ++S G+ L +MV +IP+ + +I + G V Q
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDEEIIR---GQVFFRQ 264
Query: 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF---------SELNDDDSEPSP 296
++ E + I C+A +P RP+ E+ P+ +E++ P P
Sbjct: 265 RVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 61/342 (17%), Positives = 116/342 (33%), Gaps = 84/342 (24%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
+YS LG+G+ V FD E G A +V +DP NR E+ +++ L +
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNR---ELDIMKVLDH 59
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGN------------------------------- 113
II +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 114 --------LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165
L+++ + R + + + + Q+ + ++H+ I HRD+ N+ +N
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSK 177
Query: 166 IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT 223
+K+ D G A + S + + I + Y APEL +YT +D++S G E++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 224 MEIPY----SECDSVAKIYKKVTG--------------------GVKPQALNKV----KD 255
+ P + D + +I ++ G +K + K+
Sbjct: 238 GK-PLFSGETSIDQLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+E+ + +P R + E + PFF L +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVK 337
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
+ + ++ G+LR + +++ H + +K + +++ L+YL IIHRD+ NI
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNIL 147
Query: 162 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLC 217
++ + G V I D AA++ R ++ GT YMAPE++ Y+ VD +S G+
Sbjct: 148 LDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206
Query: 218 LLEMVTMEIPY--SECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCI-AQPRAR 272
E++ PY S +I T V P A E+ + ++K + P R
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 273 PSASELLKD-PFFSELN 288
S +++ P+ +++N
Sbjct: 263 FSQLSDVQNFPYMNDIN 279
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 61/275 (22%), Positives = 109/275 (39%), Gaps = 30/275 (10%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG GA VYR + A ++ + V + +E+ +L L + II
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIK 112
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
++ ++ + E+ T G L + + S + KQ+LE + YLH +
Sbjct: 113 LKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168
Query: 150 IIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 206
I+HRDL N+ + +KI D G + IV ++ GTP Y APE L Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 207 EMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPE 257
VD++S G + I P+ + +++++ ++V
Sbjct: 229 PEVDMWSVG------IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL-N 281
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 291
K + K I P+ R + + L+ P+ + +
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 28/275 (10%)
Query: 24 RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR----LSHFSEDPVLVNRLHSEVQ 77
+YS LGSGA V+ A D+E+ EV ++ L + + ++ E+
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQV 136
+L +++ II ++ + + E SG L + +H + +Q+
Sbjct: 82 ILSRVEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 196
+ + YL IIHRD+ NI I + +K+ D G AA + R ++ GT EY
Sbjct: 140 VSAVGYLRLK--DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 197 APELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNK 252
APE+ Y ++++S G+ L +V E P+ E ++ P ++
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE-------LEETVEAAIHPPYLVS- 248
Query: 253 VKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
E+ + + + P R + +L+ DP+ ++
Sbjct: 249 ---KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 18 EVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 75
++ RY +GSG D+ VA + + + + E
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA-----VKYIERGAAIDENVQRE 66
Query: 76 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 135
+ R+L++ I+ V L H L I E + G L S + + +Q
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
+L G+ Y H+ I HRDL N ++G+ ++KI D G++ S +GTP
Sbjct: 125 LLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 195 YMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------ 246
Y+APE+ ++Y ++ D++S G+ L M+ P+ E + Y+K +
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSI 241
Query: 247 PQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFF 284
P + PE I + +A P R S E+ +F
Sbjct: 242 PDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 28/277 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG GA V R G E A + S +L E ++ R LK+ I+ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 76
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 151
++ H I ++ T G L + S +Q+LE + + H ++
Sbjct: 77 DSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VV 132
Query: 152 HRDLNCSNI-FINGNIG-QVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTE 207
HR+L N+ + G VK+ D G A V G A GTP Y++PE L ++ Y +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 208 MVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 258
VD+++ G V + I P+ + + ++Y+++ G + V E
Sbjct: 193 PVDLWACG------VILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP-EA 244
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
K I K + P R +A+E LK P+ S + S
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 24 RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
G Y + LG G+ KV A + +VA + + + R+ E+ L+
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKL 65
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
L++ +II Y V + + E G L Y + + ++ +++ +Q++ +E
Sbjct: 66 LRHPHIIKLYDVI--TTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY 201
Y H H I+HRDL N+ ++ N VKI D G + I+ + + G+P Y APE+
Sbjct: 123 YCHRH--KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 202 E-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPE 257
+ Y VD++S G+ L M+ +P+ + + + ++KKV V P L+ P
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS----PG 234
Query: 258 VKAFIEKCI-AQPRARPSASELLKDPFF 284
++ I + I A P R + E+ +DP+F
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 59/280 (21%), Positives = 116/280 (41%), Gaps = 18/280 (6%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
+ LG GA +V A ++ VA V + + P + + E+ + + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
++ ++ Y + E C+ G L + + +++ Q++ G+ YL
Sbjct: 64 HENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPEL 200
H I HRD+ N+ ++ +KI D G A + R + + GT Y+APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 201 YE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVTGGVKPQALNKVKDPE 257
+ ++ E VD++S G+ L M+ E+P+ + + Y K+ D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSA 237
Query: 258 VKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 296
A + K + P AR + ++ KD ++++ ++
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-24
Identities = 65/317 (20%), Positives = 117/317 (36%), Gaps = 42/317 (13%)
Query: 2 PAANSNMSDRDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVR 58
P + +++ + Y S +LG G KV + F++ + A +
Sbjct: 37 PPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML- 95
Query: 59 LSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNF--ITEVCTSGNL- 114
+D R EV+L +I+ V+ + + E G L
Sbjct: 96 -----QDCPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 115 -RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FIN-GNIGQVKI 171
R + + + + + K + E ++YLH+ I HRD+ N+ + + +K+
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 205
Query: 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI---- 226
D GFA ++ + TP Y+APE L E Y + D++S G V M I
Sbjct: 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG------VIMYILLCG 259
Query: 227 --P-YSECDSV--AKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASE 277
P YS + ++ G ++V + EVK I + P R + +E
Sbjct: 260 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITE 318
Query: 278 LLKDPFFSELNDDDSEP 294
+ P+ + P
Sbjct: 319 FMNHPWIMQSTKVPQTP 335
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-24
Identities = 68/334 (20%), Positives = 119/334 (35%), Gaps = 79/334 (23%)
Query: 32 LGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G VY+A ++ + A Q+ + S E+ LLR LK+ +I
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------REIALLRELKHPNVIS 82
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA---------LKKWSKQVLEGL 140
V+L + + + +L K HR +K Q+L+G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 141 EYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIVG-----RSHAAHSIIGT 192
YLH + ++HRDL +NI + G G+VKI D+GFA + + ++ T
Sbjct: 142 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 193 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME------------IPYSECDSVAKI- 237
Y APEL YT+ +DI++ G E++T E D + +I
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 238 -------------------YKKVTGGVKPQALNKVK------------DPEVKAFIEKCI 266
+ + + D + ++K +
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318
Query: 267 A-QPRARPSASELLKDPFFSEL---NDDDSEPSP 296
P R ++ + ++DP+F E D
Sbjct: 319 TMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ 352
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-24
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 18/274 (6%)
Query: 18 EVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 75
+ D + G Y D LG G KV + G +VA + +V ++ E
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIRRE 66
Query: 76 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 135
+Q L+ ++ +II Y V + + + E + G L Y K+ + K ++ +Q
Sbjct: 67 IQNLKLFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
+L G++Y H H ++HRDL N+ ++ + KI D G + ++ + G+P Y
Sbjct: 125 ILSGVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNY 181
Query: 196 MAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALN 251
APE+ Y VDI+S G+ L ++ +P+ + D V ++KK+ G+ PQ LN
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN 240
Query: 252 KVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 284
P V + ++ + P R + ++ + +F
Sbjct: 241 ----PSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-24
Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 40/287 (13%)
Query: 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYI 87
+LG G KV F + G + A + D + EV +I
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLL------YDSPKARQ---EVDHHWQASGGPHI 84
Query: 88 IVCYSVWLDDQHNTLNF--ITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
+ V+ + H I E G L R + + + + + + + +++L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 144 HTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 200
H+H I HRD+ N+ + + +K+ D GFA +A + TP Y+APE L
Sbjct: 145 HSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL 201
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTMEI------P-YSECDS--VAKIYKKVTGGV---KPQ 248
E Y + D++S G V M I P YS + +++ G
Sbjct: 202 GPEKYDKSCDMWSLG------VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 249 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
++V + + K I + P R + ++ + P+ ++ P
Sbjct: 256 EWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 23/248 (9%)
Query: 27 RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
++ LG G V G VA +++ S + E+++L++L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSL 99
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 141
++ I+ V L I E G+LR Y +KH+ + L +++ Q+ +G+E
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----MA 197
YL T IHRDL NI + +VKIGD G ++ + + + E A
Sbjct: 160 YLGTK--RYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 198 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
PE L E ++ D++SFG+ L E+ T Y E G Q ++
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVF 270
Query: 257 EVKAFIEK 264
+ ++
Sbjct: 271 HLIELLKN 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 24/271 (8%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
+LG G+ V A + E A + H ++ V + E ++ L + + +
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMSRLDHPFFVKL 95
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
Y + DD+ L F +G L Y +K + ++ +++ LEYLH I
Sbjct: 96 YFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--I 151
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPE-LYEEDYT 206
IHRDL NI +N + ++I D G A ++ + A+S +GT +Y++PE L E+
Sbjct: 152 IHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEK 264
+ D+++ G + ++V P+ + I++K + P+ P+ + +EK
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFPEKF----FPKARDLVEK 265
Query: 265 CI-AQPRARP------SASELLKDPFFSELN 288
+ R L PFF +
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 27/285 (9%)
Query: 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LG G+ + ++ A + + E+ L+ +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEG 64
Query: 85 -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
I+ + V+ D H + E+ G L KK +H S ++++ + ++
Sbjct: 65 HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 144 HTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE- 199
H ++HRDL N+ F + + ++KI D GFA + + + T Y APE
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 200 LYEEDYTEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQAL 250
L + Y E D++S G L C S +I KK+ G + +A
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 251 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
V E K I+ + P R S L + + + + S P
Sbjct: 241 KNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 23/248 (9%)
Query: 27 RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
++ LG G V G VA +++ S + E+++L++L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSL 68
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 141
++ I+ V L I E G+LR Y +KH+ + L +++ Q+ +G+E
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----MA 197
YL T IHRDL NI + +VKIGD G ++ + + E A
Sbjct: 129 YLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 198 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256
PE L E ++ D++SFG+ L E+ T Y E G Q ++
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVF 239
Query: 257 EVKAFIEK 264
+ ++
Sbjct: 240 HLIELLKN 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 48/287 (16%)
Query: 27 RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
+ LG G KV + G VA ++ + + E+ +LRTL
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR---SGWKQEIDILRTL 90
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 142
+++II D +L + E G+LR Y +H + + L +++Q+ EG+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------- 195
LH IHRDL N+ ++ + VKIGD G A V H EY
Sbjct: 150 LHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH---------EYYRVREDG 197
Query: 196 ------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK- 246
APE L E + D++SFG+ L E++T + S ++ G +
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 247 PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 281
+ ++ EV ++ C + RP+ L+
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 35/275 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV----NRLHSEVQLLRTLKN-KY 86
+G G V R + G E A + ++ P + E +LR + +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
II + + + ++ G L Y + +S K + + +LE + +LH +
Sbjct: 162 IITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------- 199
I+HRDL NI ++ N Q+++ D GF+ + + GTP Y+APE
Sbjct: 220 N--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQAL 250
Y + VD+++ G V + P+ + + + G
Sbjct: 277 ETHPGYGKEVDLWACG------VILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEW 329
Query: 251 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ VK I + + P AR +A + L+ PFF
Sbjct: 330 DDRSS-TVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 49/225 (21%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 132
+E ++L+ + +++ + D+ + L + E G + ++ ++ S + +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+ Q++ EYLH+ + +I+RDL N+ I+ G +++ D GFA V ++ GT
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK--GRTWTLCGT 201
Query: 193 PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQA 249
PE +APE + + Y + VD ++ G+ + EM P+ D +IY+K V+G V+ P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSH 260
Query: 250 LNKVKDPEVKAFIEK-CIAQPRAR-----PSASELLKDPFFSELN 288
++K + R +++ +F+ +
Sbjct: 261 F----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 33/295 (11%)
Query: 14 EPFVEVDP---SGRFGRYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDP 66
+P EVDP RF + LG G KV G +VA ++
Sbjct: 8 KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 67 VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VS 125
L E+++LR L ++ I+ + +D N + I E SG+L+ Y K+++ ++
Sbjct: 68 ---ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185
+K K++ Q+ +G++YL + + +HRDL N+ + QVKIGD G +
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKE 181
Query: 186 AHSIIGTPEY----MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYK 239
+++ + APE L + + D++SFG+ L E++T + S K+
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 240 KVTGGVK-PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 281
G + + +N +K+ EV + KC QP R S L++
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-23
Identities = 62/271 (22%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
+LGSGA +V+ + G A ++ S D + L +E+ +L+ +K++ I+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKHENIVTL 71
Query: 91 YSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
++ H + ++ + G L R + + K +QVL ++YLH +
Sbjct: 72 EDIYESTTH--YYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG- 126
Query: 149 CIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 205
I+HRDL N+ ++ ++ I D G + + + + GTP Y+APE L ++ Y
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKPY 184
Query: 206 TEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDP 256
++ VD +S G V I P+ E ++ +K+++K+ G + + + +
Sbjct: 185 SKAVDCWSIG------VITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISE- 236
Query: 257 EVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
K FI + + P R + + L P+
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 50/297 (16%)
Query: 32 LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LG G V A + ++VA ++ + + E ++ + ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88
Query: 89 VCYSVWLDDQHNTLNF----ITEVCTSGNLRTYRKKHRH------VSIKALKKWSKQVLE 138
V L + I G+L + R + ++ L ++ +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY--- 195
G+EYL + IHRDL N + + V + D G + I Y
Sbjct: 149 GMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLS---------RKIYSGDYYRQG 196
Query: 196 ---------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
+A E L + YT D+++FG+ + E++T + PY+ A+IY + GG
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGG 255
Query: 245 VKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDDDSEPSP 296
L + + EV + +C A P+ RPS + L + L+ + P
Sbjct: 256 ---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 52/305 (17%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y + LG G +V+ A + +V ++ PV ++ E+++L L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 85 -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
II + D T + E + + + + ++ ++ + ++L+ L+Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LY 201
H+ I+HRD+ N+ I+ ++++ D G A + + + + PE +
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI-------------------- 237
+ Y +D++S G L M+ + P+ D + +I
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 238 ---YKKVTGGVKPQALNKV--------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285
+ + G + + PE F++K + ++R +A E ++ P+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 286 ELNDD 290
+ D
Sbjct: 325 TVVKD 329
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-22
Identities = 47/232 (20%), Positives = 94/232 (40%), Gaps = 19/232 (8%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
E ++ + +++ + + DD++ L + E G+L + V K
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKW 169
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--A 186
+ ++ +V+ L+ +H+ IHRD+ N+ ++ + G +K+ D G + +
Sbjct: 170 ARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRC 226
Query: 187 HSIIGTPEYMAPEL-----YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241
+ +GTP+Y++PE+ + Y D +S G+ L EM+ + P+ DS+ Y K+
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKI 285
Query: 242 TGGVKPQALNKVKD--PEVKAFIEKCIAQPRAR---PSASELLKDPFFSELN 288
D E K I + R E+ + FF
Sbjct: 286 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 61/281 (21%), Positives = 111/281 (39%), Gaps = 37/281 (13%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 90
+G G+ R + +E A + + E++ LLR ++ II
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFA-----VKIIDKSKRDPTE---EIEILLRYGQHPNIITL 81
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
V+ D ++ + +TE+ G L + + S + + + +EYLH +
Sbjct: 82 KDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--V 137
Query: 151 IHRDLNCSNI-FIN--GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDY 205
+HRDL SNI +++ GN ++I D GFA + + + T ++APE L + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 206 TEMVDIYSFGLCLLEMVTMEI------PY--SECDSVAKIYKKVTGGV---KPQALNKVK 254
DI+S G V + P+ D+ +I ++ G N V
Sbjct: 198 DAACDIWSLG------VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
D K + K + P R +A+ +L+ P+ +
Sbjct: 252 D-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-22
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 32 LGSGAVKKVYRAF----DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LGSGA VY+ ++ I VA ++ L + L E ++ ++ N +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEIL-DEAYVMASVDNPH 78
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+ + L + IT++ G L Y ++H+ ++ + L W Q+ +G+ YL
Sbjct: 79 VCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LY 201
++HRDL N+ + VKI D G A ++G + G P ++MA E +
Sbjct: 136 R--RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 202 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
YT D++S+G+ + E++T PY ++I + G
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKG 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 56/302 (18%), Positives = 109/302 (36%), Gaps = 44/302 (14%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 88
D+LG GA +V + E A + +R+ EV++L + + ++
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI----RSRVFREVEMLYQCQGHRNVL 74
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ ++ + E G++ ++ K RH + + V L++LH
Sbjct: 75 ELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG- 131
Query: 149 CIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSI--------IGTPEYMAP 198
I HRDL NI + + VKI D + + + I G+ EYMAP
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 199 E------LYEEDYTEMVDIYSFG------LC--------LLEMVTMEIPYSECDSVAKIY 238
E Y + D++S G L + + ++
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 239 KKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 294
+ + G + + K I K + + + R SA+++L+ P+ +++ P
Sbjct: 251 ESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
Query: 295 SP 296
+P
Sbjct: 310 TP 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 77/325 (23%), Positives = 127/325 (39%), Gaps = 74/325 (22%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY DL LG G V+ A D + VA ++ DP V E++++R L +
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VL-TDPQSVKHALREIKIIRRLDH 67
Query: 85 KYII------------VCYSVWLDDQHNTLNFITE--------VCTSGNLRTYRKKHRHV 124
I+ + V + N++ + E V G L H
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-----LEEHA 122
Query: 125 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184
+ + Q+L GL+Y+H+ ++HRDL +N+FIN +KIGD G A I+ H
Sbjct: 123 -----RLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PH 174
Query: 185 AAHSIIGTPE-----YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-------------- 223
+H + Y +P L +YT+ +D+++ G EM+T
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 224 ---MEI---PYSE----CDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QP 269
+E + E SV +Y + + L ++ E F+E+ + P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 270 RARPSASELLKDPFFSELNDDDSEP 294
R +A E L P+ S + EP
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEP 319
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 76/335 (22%), Positives = 136/335 (40%), Gaps = 61/335 (18%)
Query: 7 NMSDRDGEPFVEVDPSG-RF---GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLS 60
++S + F + D + + Y +GSGA V A D+ G +VA +LS
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLS 58
Query: 61 HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRT 116
+ + R + E+ LL+ ++++ +I V+ + + +L+
Sbjct: 59 RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQK 117
Query: 117 YRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173
+ + Q+L+GL+Y+H+ ++HRDL N+ +N + ++KI D
Sbjct: 118 IMGLKFSEEKI-----QYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILD 169
Query: 174 LGFAAIVGRSHAAHSI--IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYS 229
G A R A + T Y APE L Y + VDI+S G + EM+T + +
Sbjct: 170 FGLA----RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 230 ECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFIEKCIAQPRA---------------- 271
D + ++ + KVTG + + K+ D K++I+ PR
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADL 285
Query: 272 -----------RPSASELLKDPFFSELNDDDSEPS 295
R +A++ L PFF D + E
Sbjct: 286 LEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 64/317 (20%), Positives = 121/317 (38%), Gaps = 64/317 (20%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY++L +G GA V A+D + VA ++S F E R E+++L ++
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPF-EHQTYCQRTLREIKILLRFRH 84
Query: 85 KYIIVCYSVWLDDQHNTLN---FITE--------VCTSGNLRTYRKKHRHVSIKALKKWS 133
+ II + + + + + + +L + H+ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL-----SNDHI-----CYFL 134
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI---- 189
Q+L GL+Y+H+ ++HRDL SN+ +N +KI D G A + H
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 190 IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGV 245
+ T Y APE L + YT+ +DI+S G L EM++ + + ++ + G
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 246 KPQALNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASEL 278
+ LN + + + + ++ + + R +
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 279 LKDPFFSELNDDDSEPS 295
L P+ + D EP
Sbjct: 312 LAHPYLEQYYDPSDEPI 328
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L+FI ++ G+L + +H S ++ ++ +++ GLE++H +++RDL +NI
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 324
Query: 162 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLL 219
++ + G V+I DLG A + H+ +GT YMAPE Y D +S G L
Sbjct: 325 LDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 220 EMVTMEIPY--SECDSVAKIYKKV-TGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR-- 272
+++ P+ + +I + T V+ P + PE+++ +E + R
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLG 438
Query: 273 ---PSASELLKDPFFSELN 288
A E+ + PFF L+
Sbjct: 439 CLGRGAQEVKESPFFRSLD 457
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 27/261 (10%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G +V+ + + VA R + + + E ++L+ + I+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLI 178
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
V Q + + E+ G+ T+ R + + +K L + G+EYL + C
Sbjct: 179 GVCTQKQPIYI--VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CC 234
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEY----MAPE-LYEED 204
IHRDL N + +KI D G + +AA G + APE L
Sbjct: 235 IHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASG--GLRQVPVKWTAPEALNYGR 291
Query: 205 YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 260
Y+ D++SFG+ L E ++ PY S + + V G P+ V
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLPCPELCP----DAVFR 346
Query: 261 FIEKC-IAQPRARPSASELLK 280
+E+C +P RPS S + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 69 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
V + E +L + + +II + + D Q + I + G L + +K +
Sbjct: 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPV 107
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 188
K ++ +V LEYLH+ + II+RDL NI ++ N G +KI D GFA V ++
Sbjct: 108 AKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--TYT 162
Query: 189 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK 246
+ GTP+Y+APE + + Y + +D +SFG+ + EM+ P+ + K Y+K + ++
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELR 221
Query: 247 -PQALNKVKDPEVKAFIEK-CIAQPRAR----PSASELLKD-PFFSELN 288
P + +VK + + R + +E +K+ P+F E+
Sbjct: 222 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 60/314 (19%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y DL +GSGA V A D G +VA +L + + R + E++LL+ +++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 85 KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----Q 135
+ +I V+ D + + +L + + + L + Q
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DL------GKLMKHEKLGEDRIQFLVYQ 136
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTP 193
+L+GL Y+H IIHRDL N+ +N + ++KI D G A R + + T
Sbjct: 137 MLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA----RQADSEMTGYVVTR 189
Query: 194 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 249
Y APE L YT+ VDI+S G + EM+T + + D + ++ + KVTG +
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 250 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 282
+ +++ E K +++ + R +A E L P
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 283 FFSELNDDDSEPSP 296
+F L+D + EP
Sbjct: 310 YFESLHDTEDEPQV 323
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 78/322 (24%), Positives = 127/322 (39%), Gaps = 66/322 (20%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
+ LG GA V A + G VA ++ F + P+ R E+++L+ K+
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--F-DKPLFALRTLREIKILKHFKH 68
Query: 85 KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----QV 136
+ II +++ D N I E+ + +L HR +S + L Q
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DL------HRVISTQMLSDDHIQYFIYQT 121
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-- 194
L ++ LH +IHRDL SN+ IN N +K+ D G A I+ S A +S +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 195 ---------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI 226
Y APE L Y+ +D++S G L E+ I
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 227 ---PYSECD------SVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARP 273
P+S+ D A+ Y K L K+ +P+ +++ + P R
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
Query: 274 SASELLKDPFFSELNDDDSEPS 295
+A E L+ P+ +D + EP
Sbjct: 299 TAKEALEHPYLQTYHDPNDEPE 320
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 60/314 (19%), Positives = 117/314 (37%), Gaps = 48/314 (15%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVA-------WNQVRLSHFSEDPVLVNRLHSEVQ 77
Y+ + SG+ V D E GI VA + R + D L R+ E++
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
LL + I+ +++ + ++ +TE+ + + + +S + ++ +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
+L GL LH ++HRDL+ NI + N + I D A +
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRW 198
Query: 195 YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQAL 250
Y APE + + +T++VD++S G + EM + + ++ K +V G K + +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258
Query: 251 NKVKDPEVKAFIEKCIAQ----------------------------PRARPSASELLKDP 282
P + ++ ++ P+ R S + L+ P
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 283 FFSELNDDDSEPSP 296
+F L D
Sbjct: 319 YFESLFDPLDLTEG 332
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 60/291 (20%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 32 LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LG G K+++ + Q EV + +H + ++ L +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS----ESFFEAASMMSKLSH 71
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYL 143
K++++ Y V + N L + E G+L TY KK+++ ++I + +KQ+ + +L
Sbjct: 72 KHLVLNYGVCVCGDENIL--VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 144 HTHEPCIIHRDLNCSNIFIN-------GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY- 195
+ +IH ++ NI + GN +K+ D G + V +
Sbjct: 130 EEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------DIL 177
Query: 196 ------MAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 246
+ PE ++ D +SFG L E+ + + P S DS + +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR-- 234
Query: 247 PQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 296
L K E+ I C +P RPS +++D + L D P
Sbjct: 235 -HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLVPRG 282
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 9e-21
Identities = 44/203 (21%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 102 LNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160
L + + G+L T K + + + + +++ ++ +H +HRD+ NI
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNI 206
Query: 161 FINGNIGQVKIGDLGFAAIVGRSHA--AHSIIGTPEYMAPEL------YEEDYTEMVDIY 212
++ N G +++ D G + + +GTP+Y++PE+ + Y D +
Sbjct: 207 LMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 213 SFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG----VKPQALNKVKDPEVKAFIEKCIAQ 268
S G+C+ EM+ E P+ +S+ + Y K+ P + V K I + I
Sbjct: 266 SLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICS 323
Query: 269 PRAR---PSASELLKDPFFSELN 288
R + K PFFS ++
Sbjct: 324 REHRLGQNGIEDFKKHPFFSGID 346
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 9e-21
Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 25/273 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G +VY ++ + VA ++ + L E +++ +K+ ++
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPNLVQLL 282
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
V + ITE T GNL Y ++ VS L + Q+ +EYL
Sbjct: 283 GVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--N 338
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 206
IHR+L N + N VK+ D G + + G ++ AH+ P ++ APE L ++
Sbjct: 339 FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 207 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 263
D+++FG+ L E+ T PY ++++Y+ + + + + + +V +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYR---MERPEGCPEKVYELMR 453
Query: 264 KC-IAQPRARPSASELLK--DPFFSELNDDDSE 293
C P RPS +E+ + + F E + D
Sbjct: 454 ACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 60/314 (19%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V AFD + G+ VA ++ F + + R + E++LL+ +K+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-F-QSIIHAKRTYRELRLLKHMKH 87
Query: 85 KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----Q 135
+ +I V+ ++ N + +T + + +L + V + L Q
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL------NNIVKCQKLTDDHVQFLIYQ 140
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTP 193
+L GL+Y+H+ + IIHRDL SN+ +N + ++KI D G A R A + T
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA----RHTADEMTGYVATR 193
Query: 194 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 249
Y APE L Y + VDI+S G + E++T + D + ++ ++ G +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 250 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 282
L K+ + +I+ P+ R +A++ L
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 283 FFSELNDDDSEPSP 296
+F++ +D D EP
Sbjct: 314 YFAQYHDPDDEPVA 327
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 49/289 (16%)
Query: 32 LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LG G V + ++VA ++L + S+ + SE ++ + +I
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99
Query: 89 VCYSVWLDDQHNTLNF---ITEVCTSGNLRTYRKKHR------HVSIKALKKWSKQVLEG 139
V ++ + I G+L TY R H+ ++ L K+ + G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY---- 195
+EYL +HRDL N + + V + D G + + I Y
Sbjct: 160 MEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLS----KK-----IYSGDYYRQGR 207
Query: 196 --------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 245
+A E L + YT D+++FG+ + E+ T PY ++Y + G
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHG- 265
Query: 246 KPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELND 289
L + +D E+ + C P RP+ S L + L D
Sbjct: 266 --HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 102 LNFITEVCTSGNLRT--YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 159
L + + G+L+ Y ++ ++ GLE LH I++RDL N
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPEN 316
Query: 160 IFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 218
I ++ + G ++I DLG A V +GT YMAPE + E YT D ++ G L
Sbjct: 317 ILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 219 LEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR-- 272
EM+ + P+ + ++ + V P+ ++ P+ ++ + + P R
Sbjct: 376 YEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLG 433
Query: 273 ---PSASELLKDPFFSELN 288
SA E+ + P F +LN
Sbjct: 434 CRGGSAREVKEHPLFKKLN 452
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 27/275 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G +V+ VA ++ S + L E Q+++ L+++ ++ Y
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL-----QEAQVMKKLRHEKLVQLY 328
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V ++ + +TE + G+L + K ++ + L + Q+ G+ Y+
Sbjct: 329 AVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--N 383
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 206
+HRDL +NI + N K+ D G A I + A P ++ APE +T
Sbjct: 384 YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 207 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 263
D++SFG+ L E+ T +PY ++ +V G + + + + +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR---MPCPPECPESLHDLMC 498
Query: 264 KC-IAQPRARPSASELLK--DPFFSELNDDDSEPS 295
+C +P RP+ L + +F+
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 27/275 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G +V+ VA ++ S + L E Q+++ L+++ ++ Y
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL-----QEAQVMKKLRHEKLVQLY 245
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V ++ + +TE + G+L + K ++ + L + Q+ G+ Y+
Sbjct: 246 AVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--N 300
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 206
+HRDL +NI + N K+ D G A I + A P ++ APE +T
Sbjct: 301 YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 207 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 263
D++SFG+ L E+ T +PY ++ +V G + + + + +
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR---MPCPPECPESLHDLMC 415
Query: 264 KC-IAQPRARPSASELLK--DPFFSELNDDDSEPS 295
+C +P RP+ L + +F+
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 61/304 (20%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG G+ VY E VA V + + +E +++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFNCHH 89
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQV 136
++ V Q + I E+ T G+L++Y + R S+ + + + ++
Sbjct: 90 VVRLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY- 195
+G+ YL+ ++ +HRDL N + + VKIGD G R I +Y
Sbjct: 148 ADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMT----RD------IYETDYY 194
Query: 196 ------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 241
M+PE L + +T D++SFG+ L E+ T+ E PY S ++ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFV 253
Query: 242 TGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK------DPFFSELNDDDS 292
G L+K + + + C P+ RPS E++ +P F E++ S
Sbjct: 254 MEG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310
Query: 293 EPSP 296
E +
Sbjct: 311 EENK 314
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 36/170 (21%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--AHSIIGT 192
+++ ++ +H +HRD+ NI ++ G +++ D G + + +GT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 193 PEYMAPEL--------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244
P+Y++PE+ Y D ++ G+ EM + P+ DS A+ Y K+
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHY 285
Query: 245 ---VKPQALNKVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELN 288
+ +++ E + FI++ + P R A + PFF L+
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-20
Identities = 75/337 (22%), Positives = 113/337 (33%), Gaps = 92/337 (27%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAW----NQVRLSHFSEDPVLVNRLHSEVQLL 79
RY LG G V+ A D VA + +ED E++LL
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---------EIKLL 69
Query: 80 RTLK----------NKYIIVCYSVWLDD-QHNTLN-----FITEVCTSGNLRTYRKKHRH 123
+ + I+ LD H N + EV NL KK+ H
Sbjct: 70 QRVNDADNTKEDSMGANHILKL---LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH 125
Query: 124 V--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-----NGNIGQVKIGDLGF 176
+ +K+ SKQ+L GL+Y+H IIH D+ N+ + N+ Q+KI DLG
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 177 AAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT---------MEI 226
A + + I T EY +PE L + DI+S + E++T
Sbjct: 185 ACWYDEHY--TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 227 PYSECDSVAKI------------------------------YKKVTGGVKPQALN---KV 253
+ D +A+I K+ L K
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 254 KDPEVKAF---IEKCIA-QPRARPSASELLKDPFFSE 286
E K + + PR R A L+ P+ +
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-20
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 32 LGSGAVKKVYRAF----DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LGSGA VY+ ++ I VA ++ L + L E ++ ++ N +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEIL-DEAYVMASVDNPH 78
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+ + L + IT++ G L Y ++H+ ++ + L W Q+ +G+ YL
Sbjct: 79 VCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LY 201
++HRDL N+ + VKI D G A ++G + G P ++MA E +
Sbjct: 136 R--RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 202 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
YT D++S+G+ + E++T PY ++I + G
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKG 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 61/320 (19%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D VA +LS ++ R + E+ L++ + +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 85 KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVL 137
K II +V+ ++ + + E+ + NL + H +S Q+L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY-----QML 137
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
G+++LH+ IIHRDL SNI + + +KI D G A G S + T Y A
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 198 PE-LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI---PYSE----CD 232
PE + Y E VDI+S G + EM+ +E P E
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 233 SVAKIYKKVTGGVKPQALNKV---------------KDPEVKAFIEKCIA-QPRARPSAS 276
+ Y + + K+ K + + + K + R S
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 277 ELLKDPFFSELNDDDSEPSP 296
E L+ P+ + D +P
Sbjct: 315 EALQHPYINVWYDPSEAEAP 334
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 70/307 (22%), Positives = 118/307 (38%), Gaps = 65/307 (21%)
Query: 27 RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
+ LG+GA KV A + + VA ++ S + L SE+++L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSY 82
Query: 82 LKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------------ 122
L N I+ + ITE C G+L + ++ R
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 123 HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182
+ ++ L +S QV +G+ +L + IHRDL NI + KI D G
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGL------ 191
Query: 183 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
A I Y MAPE ++ YT D++S+G+ L E+ ++ PY
Sbjct: 192 ---ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 229 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DP 282
+K YK + G + P+ E+ ++ C A P RP+ ++++ +
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 283 FFSELND 289
SE +
Sbjct: 305 QISESTN 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 59/288 (20%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-K 85
LG+GA KV A ++ ++VA ++ + +++ L SE++++ L +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE---KEALMSELKIMSHLGQHE 110
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--------------HVSIKALKK 131
I+ + ITE C G+L + ++ S + L
Sbjct: 111 NIVNLLGACTHGGPVLV--ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+S QV +G+ +L + IHRD+ N+ + KIGD G A I+
Sbjct: 169 FSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG-HVAKIGDFGL---------ARDIMN 216
Query: 192 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 237
Y MAPE +++ YT D++S+G+ L E+ ++ PY +K
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 238 YKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 281
YK V G +P + + ++ C +P RP+ ++
Sbjct: 277 YKLVKDGYQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 46/223 (20%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 32 LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 87
LGSG V++ + I V + + + + + +L + +I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF---QAVTDHMLAIGSLDHAHI 77
Query: 88 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTH 146
+ + L +T+ G+L + ++HR + + L W Q+ +G+ YL H
Sbjct: 78 VRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LYE 202
++HR+L N+ + QV++ D G A ++ P ++MA E ++
Sbjct: 135 --GMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 203 EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
YT D++S+G+ + E++T PY+ +A++ + G
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKG 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 40/272 (14%), Positives = 77/272 (28%), Gaps = 43/272 (15%)
Query: 17 VEVDPSGRF--GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 72
V++ P R GRY G + ++A D +VA V ++
Sbjct: 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQET 78
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI-TEVCTSGNLRTYRKKHRHVSIKALKK 131
S L + + V + E G+L+ S +
Sbjct: 79 LSRTLRLSRIDKPGVARVLDV---VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR 133
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 191
+ + + H + + S + ++ + G V +
Sbjct: 134 AMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAY------------------ 172
Query: 192 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGG-VKP 247
P M DI G L ++ P E +A + G ++P
Sbjct: 173 -PATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225
Query: 248 QALNKVKDPEVKAFIEKCIAQPRARPSASELL 279
+++ ++ A + + SAS LL
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEY 195
GL YLH IIHRD+ NI ++ N KI D G + + ++H + + GT Y
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 196 MAPELYEEDY-TEMVDIYSFGLCLLEMVT------MEIPYSECDSV--AKIYKK---VTG 243
+ PE + + TE D+YSFG+ L E++ +P + A +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 244 GVKPQALNKVKDPEVKAFIE---KCIA-QPRARPSASELLKD 281
V P +K++ ++ F + KC+A RPS ++L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 51/243 (20%), Positives = 107/243 (44%), Gaps = 27/243 (11%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
V + PS +++++G G VY + + I A + + V++
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFL 74
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKW 132
+E +++ + ++ + L + + L + G+LR + R + + ++K L +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA---------AIVGRS 183
QV +G++YL + + +HRDL N ++ VK+ D G A ++ ++
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 184 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 241
A + ++MA E L + +T D++SFG+ L E++T PY + + I +
Sbjct: 191 GAKLPV----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL 245
Query: 242 TGG 244
G
Sbjct: 246 LQG 248
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-19
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 102 LNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 157
L + + G++ + + ++ Q++ GLE+LH II+RDL
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKP 317
Query: 158 SNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFG 215
N+ ++ + G V+I DLG A + GTP +MAPE L E+Y VD ++ G
Sbjct: 318 ENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 216 LCLLEMVTMEIPY---SECDSVAKIYKKV-TGGVK-PQALNKVKDPEVKAFIEKCIA-QP 269
+ L EM+ P+ E ++ ++V V P P K F E + P
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDP 432
Query: 270 RAR-----PSASELLKDPFFSELN 288
R S L P F +++
Sbjct: 433 EKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-19
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG G +VY ++ + VA ++ + L E +++ +K+ ++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPNLVQLL 75
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
V + + ITE T GNL Y ++ VS L + Q+ +EYL
Sbjct: 76 GVCTREPPFYI--ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--N 131
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 206
IHRDL N + N VK+ D G + ++ G ++ AH+ P ++ APE L ++
Sbjct: 132 FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 207 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFI 262
D+++FG+ L E+ T PY ++++Y+ + +P+ +V +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERPEGCP----EKVYELM 245
Query: 263 EKC-IAQPRARPSASELLK--DPFFSELNDDDSE 293
C P RPS +E+ + + F E + D
Sbjct: 246 RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 74/318 (23%), Positives = 124/318 (38%), Gaps = 57/318 (17%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V A+D VA +LS ++ R + E+ L++ + +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 85 KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
K II +V+ ++ + + E+ + + + + H + L Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 199
++LH+ IIHRDL SNI + + +KI D G A G S + T Y APE
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI---------------- 226
+ Y E VDI+S G + EMV +E
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 227 -------PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 278
P + K++ NK+K + + + K + P R S +
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 279 LKDPFFSELNDDDSEPSP 296
L+ P+ + D +P
Sbjct: 354 LQHPYINVWYDPAEVEAP 371
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 139 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEY 195
G+ +LH E IHRD+ +NI ++ KI D G A ++ I+GT Y
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 196 MAPELYEEDYTEMVDIYSFGLCLLEMVT 223
MAPE + T DIYSFG+ LLE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 15/95 (15%)
Query: 138 EGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPE 194
GL YLH H +P IIHRD+ +NI ++ + +GD G A ++ +H ++ GT
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 195 YMAPELYEEDY------TEMVDIYSFGLCLLEMVT 223
++APE Y +E D++ +G+ LLE++T
Sbjct: 201 HIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 71/309 (22%), Positives = 112/309 (36%), Gaps = 70/309 (22%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNK 85
LGSGA KV A I+VA ++ S + L SE++++ L ++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE---REALMSELKMMTQLGSHE 109
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------------------- 123
I+ L I E C G+L Y + R
Sbjct: 110 NIVNLLGACTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 124 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182
++ + L ++ QV +G+E+L +HRDL N+ + VKI D G
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGL------ 218
Query: 183 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
A I+ Y MAPE L+E YT D++S+G+ L E+ ++ PY
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 229 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DP 282
A YK + G +P E+ ++ C R RPS L
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331
Query: 283 FFSELNDDD 291
++ +
Sbjct: 332 QLADAEEAM 340
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 27/226 (11%)
Query: 32 LGSGAVKKVYRAF--DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LGSG V + + ++ VA V+ L + + DP L + L +E +++ L N YI+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 89 ----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
+C + + + E+ G L Y +++RHV K + + QV G++YL
Sbjct: 82 RMIGIC-------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGT--P-EYMAPE- 199
+HRDL N+ + KI D G + A+ + + P ++ APE
Sbjct: 135 ES--NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 200 LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
+ ++ D++SFG+ + E + + PY +++ + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKG 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 51/239 (21%), Positives = 85/239 (35%), Gaps = 39/239 (16%)
Query: 27 RYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
++G G VY + I+ A + + E L+R L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV---EAFLREGLLMRGLN 80
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 142
+ ++ + L + + G+L + R R+ ++K L + QV G+EY
Sbjct: 81 HPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------- 195
L + +HRDL N ++ + VK+ D G A R I EY
Sbjct: 140 LAEQK--FVHRDLAARNCMLDES-FTVKVADFGLA----R------DILDREYYSVQQHR 186
Query: 196 --------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
A E L +T D++SFG+ L E++T PY + + G
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQG 244
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 2 PAANSNMSDRDGEPFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRL 59
N D + + V+ RY L+G G+ +V +A+D+ E VA ++
Sbjct: 31 KVYNDGYDDDNYDYIVKNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK- 88
Query: 60 SHFSEDPVLVNRLHSEVQLLRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNL 114
+N+ EV+LL + KY IV N L + E+ S NL
Sbjct: 89 ----NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFEML-SYNL 142
Query: 115 RTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FINGNIGQVKI 171
+ VS+ +K+++Q+ L +L T E IIH DL NI N +KI
Sbjct: 143 YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202
Query: 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 223
D G + +G+ + I + Y +PE L Y +D++S G L+EM T
Sbjct: 203 VDFGSSCQLGQRI--YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 47/301 (15%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
V + PS +++++G G VY + + I A + + V++
Sbjct: 82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFL 138
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKW 132
+E +++ + ++ + L + + L + G+LR + R + + ++K L +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
QV +G+++L + + +HRDL N ++ VK+ D G A R +
Sbjct: 198 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLA----RD------MYD 244
Query: 193 PEY---------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 235
E+ MA E L + +T D++SFG+ L E++T PY + +
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTF 303
Query: 236 KIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDD 290
I + G + L + + + + KC + RPS SEL+ FS +
Sbjct: 304 DITVYLLQG---RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
Query: 291 D 291
Sbjct: 361 H 361
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 66/304 (21%)
Query: 32 LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 83
LG G +V A +E + VA ++ +D ++ L SE+++++ + K
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGK 145
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 127
+K II D + I E + GNLR Y + R ++ K
Sbjct: 146 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
L + Q+ G+EYL + + IHRDL N+ + N +KI D G A
Sbjct: 204 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA---------R 251
Query: 188 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 233
I Y MAPE L++ YT D++SFG+ + E+ T+ PY
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-P 310
Query: 234 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSEL 287
V +++K + G KP E+ + C A P RP+ +L++ D +
Sbjct: 311 VEELFKLLKEGHRMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366
Query: 288 NDDD 291
+++
Sbjct: 367 TNEE 370
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 66/365 (18%), Positives = 127/365 (34%), Gaps = 103/365 (28%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +G+G+ V A+D+ E VA ++ F ED + R+ E+ +L L +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-F-EDLIDCKRILREIAILNRLNH 111
Query: 85 KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
+++ + + + + E+ S + + + +++ +K +L G++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE------- 194
Y+H+ I+HRDL +N +N + VK+ D G A V +S +
Sbjct: 171 YVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 195 ---------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEI----- 226
Y APE L +E+YTE +D++S G E++ M
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 227 -----------------------------PYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
D + I+ + G + + ++ +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKED 346
Query: 258 VKAFIEKCIAQ---------------------------PRARPSASELLKDPFFSELNDD 290
K +I + P R + +E L PFF E+
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
Query: 291 DSEPS 295
+ E +
Sbjct: 407 EVETN 411
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + + + ++ +++ GL++LH+ I++RDL NI
Sbjct: 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNIL 150
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ + G +KI D G + ++ GTP+Y+APE L + Y VD +SFG+ L
Sbjct: 151 LDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 220 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR-PSA 275
EM+ + P+ +++ P+ L + E K + K +P R
Sbjct: 210 EMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL----EKEAKDLLVKLFVREPEKRLGVR 264
Query: 276 SELLKDPFFSELN 288
++ + P F E+N
Sbjct: 265 GDIRQHPLFREIN 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 62/302 (20%)
Query: 32 LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNK 85
LG GA +V A VA ++ + L SE+++L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKAL 129
++ + I E C GNL TY + R+ ++++ L
Sbjct: 92 NVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 130 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 189
+S QV +G+E+L + + IHRDL NI ++ VKI D G A I
Sbjct: 151 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGL---------ARDI 198
Query: 190 IGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 235
P+Y MAPE +++ YT D++SFG+ L E+ ++ PY
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 236 KIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSELND 289
+ +++ G P PE+ + C +P RP+ SEL++
Sbjct: 259 EFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
Query: 290 DD 291
D
Sbjct: 315 QD 316
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 193
++ L YLH+ I++RDL NI ++ G + + D G + + + GTP
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 194 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 250
EY+APE L+++ Y VD + G L EM+ P+ + A++Y + ++ +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNI 262
Query: 251 NKVKDPEVKAFIEKCIA-QPRAR----PSASELLKDPFFSELN 288
+ +E + R E+ FFS +N
Sbjct: 263 ----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 66/304 (21%)
Query: 32 LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 83
LG GA +V A +E + VA ++ +D ++ L SE+++++ + K
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGK 99
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIK 127
+K II D + I E + GNLR Y + R ++ K
Sbjct: 100 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
L + Q+ G+EYL + + IHRDL N+ + N +KI D G A
Sbjct: 158 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA---------R 205
Query: 188 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 233
I Y MAPE L++ YT D++SFG+ + E+ T+ PY
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-P 264
Query: 234 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSEL 287
V +++K + G KP E+ + C A P RP+ +L++ D +
Sbjct: 265 VEELFKLLKEGHRMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 288 NDDD 291
+++
Sbjct: 321 TNEE 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-18
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 30 DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+ LG G+ V R + + VA ++ S+ + + + EV + +L ++
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHRN 82
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+I Y V L + +TE+ G+L +KH+ H + L +++ QV EG+ YL +
Sbjct: 83 LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGT--P-EYMAPE-L 200
IHRDL N+ + VKIGD G A+ P + APE L
Sbjct: 140 K--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
++ D + FG+ L EM T + P+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-18
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 193
++ L +LH II+RDL NI +N G VK+ D G + H+ GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 194 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 250
EYMAPE L + VD +S G + +M+T P+ ++ K K + + P L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYL 244
Query: 251 NKVKDPEVKAFIEKCIA-QPRAR-----PSASELLKDPFFSELN 288
E + ++K + +R A E+ PFF +N
Sbjct: 245 ----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-18
Identities = 48/197 (24%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G L + + R + + + + +++ LEYLH+ + +++RD+ N+
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLM 137
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ + G +KI D G + + GTPEY+APE L + DY VD + G+ +
Sbjct: 138 LDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 220 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 272
EM+ +P+ ++++ + ++ P+ L PE K+ + + P+ R
Sbjct: 197 EMMCGRLPF-YNQDHERLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGG 251
Query: 273 -PSASELLKDPFFSELN 288
A E+++ FF +N
Sbjct: 252 PSDAKEVMEHRFFLSIN 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-18
Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158
H+ L F+ E G L + + R S + + +++ L+YLH+ + +++RDL
Sbjct: 220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLE 278
Query: 159 NIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 216
N+ ++ + G +KI D G + + GTPEY+APE L + DY VD + G+
Sbjct: 279 NLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 217 CLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR- 272
+ EM+ +P+ D K+++ + ++ P+ L PE K+ + + P+ R
Sbjct: 338 VMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTL----GPEAKSLLSGLLKKDPKQRL 392
Query: 273 ---PS-ASELLKDPFFSELN 288
A E+++ FF+ +
Sbjct: 393 GGGSEDAKEIMQHRFFAGIV 412
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 69/297 (23%)
Query: 32 LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG G KV +A + VA ++ + + + L SE +L+ + + +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE---LRDLLSEFNVLKQVNHPH 87
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------------- 123
+I Y D L I E G+LR + ++ R
Sbjct: 88 VIKLYGACSQDGPLLL--IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 124 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182
+++ L ++ Q+ +G++YL + ++HRDL NI + ++KI D G
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFGL------ 196
Query: 183 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
+ + Y MA E L++ YT D++SFG+ L E+VT+ PY
Sbjct: 197 ---SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 229 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 281
+++ + G +P E+ + +C +P RP +++ KD
Sbjct: 254 PGI-PPERLFNLLKTGHRMERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 193
++ L++LH+ II+RDL NI ++ G +K+ D G + + A+S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 194 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 250
EYMAPE + +T+ D +SFG+ + EM+T +P+ D + + + PQ L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFL 249
Query: 251 NKVKDPEVKAFIEKCIA-QPRAR-----PSASELLKDPFFSELN 288
PE ++ + P R E+ + FFS ++
Sbjct: 250 ----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L+ I + G L T+ + + ++ + +++ LE+LH II+RD+ NI
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENIL 191
Query: 162 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGL 216
++ N G V + D G + + + A+ GT EYMAP++ + + VD +S G+
Sbjct: 192 LDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 217 CLLEMVTMEIPYSECD---SVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPR 270
+ E++T P++ S A+I ++ + PQ + K I++ + P+
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM----SALAKDLIQRLLMKDPK 306
Query: 271 AR-----PSASELLKDPFFSELN 288
R A E+ + FF ++N
Sbjct: 307 KRLGCGPRDADEIKEHLFFQKIN 329
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 37/228 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LGSG V + + +VA ++ SED E Q + L + ++ Y
Sbjct: 16 LGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFF-----QEAQTMMKLSHPKLVKFY 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
V + + +TE ++G L Y R + + L + V EG+ +L +H
Sbjct: 70 GVCSKEYPIYI--VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--QF 125
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MAP 198
IHRDL N ++ + VK+ D G V +Y AP
Sbjct: 126 IHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDD----------QYVSSVGTKFPVKWSAP 174
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
E + Y+ D+++FG+ + E+ ++ ++PY + +++ KV+ G
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQG 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 30 DLLGSGAVKKVYRAFDQEEG---IEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNK 85
+G G V++ + VA ++ + + D V L E +R +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFL-QEALTMRQFDHP 451
Query: 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLH 144
+I+ V ++ + I E+CT G LR++ + + + + +L ++ Q+ L YL
Sbjct: 452 HIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG-TP-EYMAPE-LY 201
+ +HRD+ N+ ++ N VK+GD G + + S + G P ++MAPE +
Sbjct: 509 SK--RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 202 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
+T D++ FG+C+ E++ P+ + ++ G
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENG 608
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 51/281 (18%)
Query: 32 LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA +VY + ++VA + +D E ++ ++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 135
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVLEG 139
I+ C V L + + E+ G+L+++ ++ R +++ L ++ + G
Sbjct: 136 IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEY-- 195
+YL + IHRD+ N + KIGD G A I Y
Sbjct: 194 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAGYYRK 242
Query: 196 ----------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTG 243
M PE E +T D +SFG+ L E+ ++ +PY S ++ + VT
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVTS 301
Query: 244 GVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKD 281
G ++ K+ V + +C QP RP+ + +L+
Sbjct: 302 G---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 53/282 (18%)
Query: 32 LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA +VY + ++VA + +D E ++ ++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 94
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVLEG 139
I+ C V L + + E+ G+L+++ ++ R +++ L ++ + G
Sbjct: 95 IVRCIGVSLQSLPRFI--LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEY-- 195
+YL + IHRD+ N + KIGD G A R I Y
Sbjct: 153 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RD------IYRASYYR 200
Query: 196 -----------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVT 242
M PE E +T D +SFG+ L E+ ++ +PY S ++ + VT
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVT 259
Query: 243 GGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKD 281
G ++ K+ V + +C QP RP+ + +L+
Sbjct: 260 SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ ++ ++ GL +L + II+RDL N+
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 474
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G +KI D G + + GTP+Y+APE + + Y + VD ++FG+ L
Sbjct: 475 LDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 220 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 272
EM+ + P+ E + ++++ + V P+++ E A + + P R
Sbjct: 534 EMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCG 588
Query: 273 -PSASELLKDPFFSELN 288
++ + FF ++
Sbjct: 589 PEGERDIKEHAFFRYID 605
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 66/364 (18%), Positives = 116/364 (31%), Gaps = 109/364 (29%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y +G G+ VY A+D+ VA +++ ED + R+ E+ +L LK+
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 85 KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK------- 134
YII Y + + D + + E+ S +L K ++
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL--------KKLFKTPIFLTEEHIKTIL 135
Query: 135 -QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 193
+L G ++H IIHRDL +N +N + VK+ D G A + + +
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 194 E-----------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 228
E Y APE L +E+YT+ +DI+S G E++ M +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 229 SECDSVAKI-----------------------YK-------KVTGGVKPQALNKVKDPEV 258
+ + + G L + PEV
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312
Query: 259 KAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELNDDD 291
+I+ + R + + L P+ ++
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372
Query: 292 SEPS 295
E
Sbjct: 373 LENF 376
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ ++ ++ GL +L + II+RDL N+
Sbjct: 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 153
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G +KI D G + + GTP+Y+APE + + Y + VD ++FG+ L
Sbjct: 154 LDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 220 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 272
EM+ + P+ E + ++++ + V P+++ E A + + P R
Sbjct: 213 EMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCG 267
Query: 273 -PSASELLKDPFFSELN 288
++ + FF ++
Sbjct: 268 PEGERDIKEHAFFRYID 284
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-17
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 37/228 (16%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG V+ + + +VA +R SE+ + E +++ L + ++ Y
Sbjct: 16 IGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI-----EEAEVMMKLSHPKLVQLY 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 150
V L+ L +TE G L Y + R + + L V EG+ YL C+
Sbjct: 70 GVCLEQAPICL--VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CV 125
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MAP 198
IHRDL N + N +K+ D G V +Y +P
Sbjct: 126 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD----------QYTSSTGTKFPVKWASP 174
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
E Y+ D++SFG+ + E+ + +IPY S +++ + ++ G
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTG 221
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY ++G G+ +V +A+D + VA VR + + E+++L L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLR 151
Query: 84 -----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQV 136
N ++ N + E+ S NL KK++ S+ ++K++ +
Sbjct: 152 KQDKDNTMNVIHMLENFT-FRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
L+ L+ LH + IIH DL NI +K+ D G + + ++ I + Y
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRFY 265
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVT 223
APE + Y +D++S G L E++T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 41/243 (16%)
Query: 18 EVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
E+DP F + LG+G V + + +VA ++ SED + E
Sbjct: 20 EIDPKDLTFLK---ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFI-----EEA 70
Query: 77 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQ 135
+++ L ++ ++ Y V + + ITE +G L Y ++ RH + L + K
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFI--ITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 195
V E +EYL + +HRDL N +N G VK+ D G + V EY
Sbjct: 129 VCEAMEYLESK--QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDD----------EY 175
Query: 196 ------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 241
PE L ++ DI++FG+ + E+ ++ ++PY + ++ + +
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHI 234
Query: 242 TGG 244
G
Sbjct: 235 AQG 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 43/234 (18%)
Query: 32 LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII- 88
LG G V + +++ I+VA ++ D + E Q++ L N YI+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 74
Query: 89 ---VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLH 144
VC Q L + E+ G L + K + + + + QV G++YL
Sbjct: 75 LIGVC-------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY--------- 195
+HRDL N+ + KI D G + +G Y
Sbjct: 128 EK--NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADD--------SYYTARSAGKWP 176
Query: 196 ---MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
APE + ++ D++S+G+ + E ++ + PY + ++ + G
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQG 229
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 60/287 (20%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG GA KV+ A ++ + VA ++ + E +LL L++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEH 78
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 130
I+ Y V D L + E G+L + + H + + +
Sbjct: 79 IVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
+ Q+ G+ YL + +HRDL N + N+ VKIGD G + +
Sbjct: 137 HIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMS---------RDVY 184
Query: 191 GTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 236
T Y M PE + +T D++SFG+ L E+ T + P+ + S +
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTE 243
Query: 237 IYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK 280
+ + +T G + L + + EV + C +P+ R + E+ K
Sbjct: 244 VIECITQG---RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + +K R + ++ +++ L +LH II+RDL N+
Sbjct: 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVL 156
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G K+ D G + + GTP+Y+APE L E Y VD ++ G+ L
Sbjct: 157 LDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 220 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 272
EM+ P+ E ++ +++ + V P L + ++ + P R
Sbjct: 216 EMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL----HEDATGILKSFMTKNPTMRLGSL 270
Query: 273 -PSASELLKD-PFFSELN 288
+ PFF E++
Sbjct: 271 TQGGEHAILRHPFFKEID 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G +V+ A + +VA ++ S + L +E +++TL++ ++ +
Sbjct: 196 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFL-----AEANVMKTLQHDKLVKLH 249
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V + + ITE G+L + K + L +S Q+ EG+ ++
Sbjct: 250 AVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--N 304
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 206
IHRDL +NI ++ + KI D G A I + A P ++ APE + +T
Sbjct: 305 YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 207 EMVDIYSFGLCLLEMVTM-EIPY 228
D++SFG+ L+E+VT IPY
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPY 386
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 9e-17
Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 34/214 (15%)
Query: 32 LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG G V + +++ I+VA +++ + + E Q++ L N YI+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 148
V + L + E+ G L + R + + + + QV G++YL
Sbjct: 401 LIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 455
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------M 196
+HR+L N+ + KI D G + +G Y
Sbjct: 456 NFVHRNLAARNVLLVNR-HYAKISDFGLSKALGA--------DDSYYTARSAGKWPLKWY 506
Query: 197 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
APE + ++ D++S+G+ + E ++ + PY
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 65/303 (21%)
Query: 18 EVDPSG-RFGRYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNR 71
+ LG GA KV+ A +++ + VA ++ + S
Sbjct: 37 HIKRRDIVLKW---ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQD 89
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--------- 122
E +LL L++++I+ + V + + + + E G+L + + H
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLM--VFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 123 ------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176
+ + L + QV G+ YL +HRDL N + + VKIGD G
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGM 204
Query: 177 AAIVGRSHAAHSIIGTPEY-------------MAPE-LYEEDYTEMVDIYSFGLCLLEMV 222
+ R I + +Y M PE + +T D++SFG+ L E+
Sbjct: 205 S----RD------IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 223 TM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASEL 278
T + P+ + S + +T G + L + + PEV A + C +P+ R S ++
Sbjct: 255 TYGKQPWYQL-SNTEAIDCITQG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310
Query: 279 LKD 281
Sbjct: 311 HAR 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G V G +VA ++ ++ +E ++ L++ ++
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQLL 80
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
V ++++ L +TE G+L Y + + L K+S V E +EYL +
Sbjct: 81 GVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--N 137
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP-EYMAPE-LYEEDYTE 207
+HRDL N+ ++ + K+ D G + + P ++ APE L E+ ++
Sbjct: 138 FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFST 193
Query: 208 MVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
D++SFG+ L E+ + +PY + + +V G
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 47/220 (21%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G V + G +VA ++ ++ +E ++ L++ ++
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 250
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHE 147
V ++++ L +TE G+L Y + + L K+S V E +EYL +
Sbjct: 251 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP-EYMAPE-LYEEDY 205
+HRDL N+ ++ + K+ D G + + P ++ APE L E+ +
Sbjct: 309 -NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKF 363
Query: 206 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
+ D++SFG+ L E+ + +PY + + +V G
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG 402
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 75/314 (23%), Positives = 117/314 (37%), Gaps = 71/314 (22%)
Query: 32 LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LG GA +V A +VA ++ +D ++ L SE+++++ +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---LSDLISEMEMMKMIGK 133
Query: 85 -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 127
K II D + I E + GNLR Y + R +S K
Sbjct: 134 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
L + QV G+EYL + + IHRDL N+ + + +KI D G A
Sbjct: 192 DLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGL---------AR 239
Query: 188 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 233
I Y MAPE L++ YT D++SFG+ L E+ T+ PY
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 298
Query: 234 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASEL-------LKDP 282
V +++K + G KP E+ + C A P RP+ +L +
Sbjct: 299 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354
Query: 283 FFSELNDDDSEPSP 296
E+
Sbjct: 355 SNQEMGYYHHHHHH 368
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 23/238 (9%)
Query: 18 EVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLH 73
E++ S + +GSG +V + G + VA ++ +
Sbjct: 45 EIEASRIHIEKI---IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ---RRDFL 98
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKW 132
SE ++ + II V + +TE +G+L T+ + H +I L
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIG 191
+ V G+ YL +HRDL N+ ++ N K+ D G + + AA++ G
Sbjct: 157 LRGVGAGMRYLSDL--GYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTG 213
Query: 192 T--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
P + APE + ++ D++SFG+ + E++ E PY + + V G
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSVEEG 270
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 57/301 (18%), Positives = 100/301 (33%), Gaps = 67/301 (22%)
Query: 27 RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
Y +G GA +V++A E VA ++ ++ E L+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAE 106
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------------- 122
N I+ V + L + E G+L + +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 123 -----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177
+S ++QV G+ YL + +HRDL N + N+ VKI D G +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS 221
Query: 178 AIVGRSHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM 224
+I Y M PE ++ YT D++++G+ L E+ +
Sbjct: 222 ---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 225 -EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK 280
PY + ++ V G L ++ E+ + C P RPS + +
Sbjct: 273 GLQPYYGM-AHEEVIYYVRDG---NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 281 D 281
Sbjct: 329 I 329
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ R + + + +S ++ L YLH II+RDL N+
Sbjct: 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 142
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G +K+ D G + + GTP Y+APE L EDY VD ++ G+ +
Sbjct: 143 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201
Query: 220 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDP-----EVKAFIEKCIA-QPRAR 272
EM+ P+ S + + L +++ P + + ++ + P+ R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
Query: 273 ------PSASELLKDPFFSELN 288
+++ PFF ++
Sbjct: 262 LGCHPQTGFADIQGHPFFRNVD 283
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 39/141 (27%), Positives = 66/141 (46%), Gaps = 5/141 (3%)
Query: 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161
L F+ E G+L + ++ R + + + +S ++ L YLH II+RDL N+
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 185
Query: 162 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 219
++ G +K+ D G + + GTP Y+APE L EDY VD ++ G+ +
Sbjct: 186 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244
Query: 220 EMVTMEIPYSECDSVAKIYKK 240
EM+ P+ S +
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQN 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G +V+ + +VA ++ S D L +E L++ L+++ ++ Y
Sbjct: 21 LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 149
+V + + ITE +G+L + K ++I L + Q+ EG+ ++
Sbjct: 75 AVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MA 197
IHRDL +NI ++ KI D G A ++ + EY A
Sbjct: 130 YIHRDLRAANILVSDT-LSCKIADFGLARLIEDN----------EYTAREGAKFPIKWTA 178
Query: 198 PE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
PE + +T D++SFG+ L E+VT IPY + ++ + + G
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERG 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-16
Identities = 48/231 (20%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 32 LGSGAVKKVYRA---FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
+G G V++ + + VA + + D V L E +R + +I+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFL-QEALTMRQFDHPHIV 79
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHE 147
V ++ + I E+CT G LR++ + ++ + + +L ++ Q+ L YL +
Sbjct: 80 KLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------ 195
+HRD+ N+ ++ N VK+GD G + + S Y
Sbjct: 136 -RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDS----------TYYKASKGKLPIKW 183
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
MAPE + +T D++ FG+C+ E++ P+ + ++ G
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENG 233
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 49/222 (22%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 18 EVDPSG-RFGRYSDLLGSGAVKKVYRA---FDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
E+D + + ++G+G +V ++ I VA +++ + +
Sbjct: 41 ELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFL 94
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKW 132
E ++ + II V + + +TE +G+L ++ +KH ++ L
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIG 191
+ + G++YL +HRDL NI IN N K+ D G + AA++ G
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 192 T--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
P + +PE + +T D++S+G+ L E+++ E PY
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-16
Identities = 48/248 (19%), Positives = 83/248 (33%), Gaps = 53/248 (21%)
Query: 32 LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
LG KVY+ E+ VA ++ E L L++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEFRHEAMLRARLQHPN 73
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 130
++ V DQ ++ I C+ G+L + +
Sbjct: 74 VVCLLGVVTKDQPLSM--IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
Q+ G+EYL +H ++H+DL N+ + + VKI DLG +
Sbjct: 132 HLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLF---------REVY 179
Query: 191 GTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 236
Y MAPE + ++ DI+S+G+ L E+ + PY S
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQD 238
Query: 237 IYKKVTGG 244
+ + +
Sbjct: 239 VVEMIRNR 246
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 67/352 (19%), Positives = 123/352 (34%), Gaps = 101/352 (28%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
+Y + LG GA V+++ D+ G VA ++ ++ R E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 85 -KYIIVCYSVWLDDQHNTLNFITE--------VCTSGNLRTYRKKHRHVSIKALKKWSKQ 135
+ I+ +V D + + + V + L + H + Q
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL-----EPVHK-----QYVVYQ 117
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE- 194
+++ ++YLH+ ++HRD+ SNI +N VK+ D G + + I
Sbjct: 118 LIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 195 ---------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-------- 223
Y APE L YT+ +D++S G L E++
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 224 ---------------------------------------MEIPYSECDSVAKIYKKVTGG 244
+EI S + +K +
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 295
+ P+A + E ++K + P R SA++ LK PF S ++ + EP+
Sbjct: 295 INPKAD---CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 18 EVDPSG-RFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRL 72
E+ PS + +G+G +VY+ ++ + VA ++ + + V
Sbjct: 40 EIHPSCVTRQKV---IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DF 93
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKK 131
E ++ + II V + + ITE +G L + ++ S+ L
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSII 190
+ + G++YL +HRDL NI +N N K+ D G + + A ++
Sbjct: 152 MLRGIAAGMKYLANM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTS 208
Query: 191 GT--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 228
G P + APE + +T D++SFG+ + E++T E PY
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-15
Identities = 44/231 (19%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 32 LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88
LG G +VY + E I VA + ++ + SE +++ L + +I+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPHIV 76
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHE 147
+ ++ I E+ G L Y +++++ + + L +S Q+ + + YL +
Sbjct: 77 KLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------ 195
+HRD+ NI + VK+GD G + + +Y
Sbjct: 133 -NCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDE----------DYYKASVTRLPIKW 180
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 244
M+PE + +T D++ F +C+ E+++ + P+ ++ + + G
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 122 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181
++++ L +S QV +G+E+L + + IHRDL NI ++ VKI D G A +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIY 244
Query: 182 RSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 236
+ ++MAPE +++ YT D++SFG+ L E+ ++ PY +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 237 IYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 281
+++ G P PE+ + C +P RP+ SEL++
Sbjct: 305 FCRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 59/304 (19%), Positives = 108/304 (35%), Gaps = 61/304 (20%)
Query: 14 EPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 70
+ +++ + Y S +LG G KV + F++ + A + +D
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKAR 58
Query: 71 RLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTLNF--ITEVCTSGNL--RTYRKKHRHVS 125
R EV+L R + +I+ V+ + + E G L R + + +
Sbjct: 59 R---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115
Query: 126 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRS 183
+ + K + E ++YLH+ I HRD+ N+ + + +K+ D GFA
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA------ 167
Query: 184 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEI------P-YSECDSV-- 234
E E Y + D++S G V M I P YS
Sbjct: 168 --------------KETTGEKYDKSCDMWSLG------VIMYILLCGYPPFYSNHGLAIS 207
Query: 235 AKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDD 290
+ ++ G ++V + EVK I + P R + +E + P+ +
Sbjct: 208 PGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
Query: 291 DSEP 294
P
Sbjct: 267 PQTP 270
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 54/251 (21%)
Query: 27 RYSDLLGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 83
++ D++G G +V +A ++ A +++ +D E+++L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGH 84
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 127
+ II + L E GNL + +K R +S +
Sbjct: 85 HPNIINLLGACEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 128 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 187
L ++ V G++YL + IHRDL NI + N KI D G + R
Sbjct: 143 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS----RG---- 191
Query: 188 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 233
Y MA E L YT D++S+G+ L E+V++ PY +
Sbjct: 192 ----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T 246
Query: 234 VAKIYKKVTGG 244
A++Y+K+ G
Sbjct: 247 CAELYEKLPQG 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 62/346 (17%), Positives = 115/346 (33%), Gaps = 90/346 (26%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIE-VAW----NQVRLSHFSEDPVLVNRLHSEVQL 78
RY LG G KV D G VA N + + E+ +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---------EINV 69
Query: 79 LRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKK 131
L+ +K NK++ V S W + H + E+ N + K++ + ++
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNF-HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ------------------VKIGD 173
+ Q+ L +LH ++ + H DL NI + + +++ D
Sbjct: 128 MAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 174 LGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--------- 223
G A H +I+ T Y PE + E + + D++S G L E
Sbjct: 186 FGSATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 224 --------MEI-----------------------PYSECDSVAKIYKKVTGGVKPQAL-N 251
+I + E S + K+ +K L +
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
++ ++ + + + P R + +E L PFF+ L ++
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT 349
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 65/340 (19%), Positives = 115/340 (33%), Gaps = 96/340 (28%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIE-VAW----NQVRLSHFSEDPVLVNRLHSEVQL 78
RY D LG GA KV D + G VA N R + E+Q+
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---------EIQV 64
Query: 79 LRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKK 131
L L + + V W + H + + E+ + + K++ + + ++K
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEH-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------------QVKIGD 173
+ Q+ + + +LH+++ + H DL NI + +K+ D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 174 LGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--------- 223
G A H +++ T Y APE + +++ D++S G L+E
Sbjct: 181 FGSATYDDEHH--STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 224 --------MEI-----------------------PYSECDSVAKIYKKVTGGVKP--QAL 250
I + E S + + KP + +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC---KPLKEFM 295
Query: 251 --NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287
V+ + I+K + P R + E LK PFF L
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 63/338 (18%), Positives = 108/338 (31%), Gaps = 92/338 (27%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTL 82
+ +G G +V + A VR + ++ + E +L+ +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI------EADILKKI 88
Query: 83 K----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQV 136
+ N IV Y ++ + I E +L ++ + I+ +K + ++
Sbjct: 89 QNDDINNNNIVKYHGKFM-YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ------------------------VKIG 172
L+ L YL + H DL NI ++ + +K+
Sbjct: 147 LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 173 DLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-------- 223
D G A H SII T +Y APE + + D++SFG L E+ T
Sbjct: 205 DFGCATFKSDYH--GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 224 --------ME-----IPYS-----------------------ECDSVAKIYKKVTGGVKP 247
ME IP + ++ + K P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 284
+K F+ + P RPS +ELLK F
Sbjct: 323 LY-KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 80/400 (20%), Positives = 133/400 (33%), Gaps = 137/400 (34%)
Query: 9 SDRDGEPFVEVDPSGRF---------GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWN-Q 56
D + E + G GRY LG G V+ ++D + VA
Sbjct: 11 DDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV 70
Query: 57 VRLSHFSEDPVLVNRLHSEVQLLRTLKN--------KYIIVCYSVWLDD-QHNTLN---- 103
H++E E++LL++++N + ++ LDD + + +N
Sbjct: 71 KSAEHYTET------ALDEIRLLKSVRNSDPNDPNREMVVQL----LDDFKISGVNGTHI 120
Query: 104 -FITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160
+ EV +L + K ++ + + +KK +QVL+GL+YLHT + IIH D+ NI
Sbjct: 121 CMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENI 178
Query: 161 FI------------------------------------------------NGNIGQVKIG 172
+ N +VKI
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 173 DLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIP---- 227
DLG A V + I T +Y + E L Y DI+S E+ T +
Sbjct: 239 DLGNACWVHKHFT--EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 228 -----YSECDSVAKIYK--------------------------KVTGGVKPQALNKV--- 253
+ D +A I + K +KP L +V
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 254 ----KDPEVKA---FIEKCIA-QPRARPSASELLKDPFFS 285
E F+ + P R +A+E L+ P+ +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 36/196 (18%), Positives = 70/196 (35%), Gaps = 42/196 (21%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
+GSG +Y AF + + A + V++ + L SE++ + + K I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCI-- 96
Query: 91 YSVWLDDQHNTLNFITEVCTSG-------------------NLRTYRKKHRHVSIKALKK 131
W++ + I SG +L+ ++ + +
Sbjct: 97 -KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ 155
Query: 132 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFA----------AIV 180
++L+ LEY+H +E +H D+ +N+ + N QV + D G +
Sbjct: 156 LGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 181 GRSHAAHSIIGTPEYM 196
H GT E+
Sbjct: 214 ENPRKGH--NGTIEFT 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 40/184 (21%), Positives = 68/184 (36%), Gaps = 23/184 (12%)
Query: 26 GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY +GSG+ +Y D G EVA + ++ P L H E ++ + ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQL----HIESKIYKMMQ 62
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEY 142
I ++ N + +L R S+K + + Q++ +EY
Sbjct: 63 GGVGIP--TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 143 LHTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAA--IVGRSH------AAHSIIGT 192
+H+ IHRD+ N + V I D G A R+H ++ GT
Sbjct: 121 IHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 193 PEYM 196
Y
Sbjct: 179 ARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 36/176 (20%), Positives = 66/176 (37%), Gaps = 21/176 (11%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+GSG+ ++Y + + EVA + ++ P L E ++ R L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL----LYESKIYRILQGGTGI-PN 67
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
W N + +L R +S+K + + Q++ +E++H+
Sbjct: 68 VRWFG-VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SF 124
Query: 151 IHRDLNCSNIFI--NGNIGQVKIGDLGFAA--IVGRSH------AAHSIIGTPEYM 196
+HRD+ N + QV I D G A +H ++ GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 15/91 (16%)
Query: 117 YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLG 175
Y + S K + + S ++L+ LEY+H HE +H D+ SN+ +N N QV + D G
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 176 FA----------AIVGRSHAAHSIIGTPEYM 196
A A H GT E+
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCH--DGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 20/90 (22%), Positives = 42/90 (46%), Gaps = 12/90 (13%)
Query: 117 YRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDL 174
+HV S +++ + + ++L+ LE+LH +E +H ++ NIF++ + QV +
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 175 GFAA--------IVGRSHAAHSIIGTPEYM 196
GFA + + G E++
Sbjct: 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 36/187 (19%), Positives = 67/187 (35%), Gaps = 27/187 (14%)
Query: 26 GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
+ +G G ++ + VA ++L +LH E + + L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRA---PQLHLEYRFYKQLG 62
Query: 84 N-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLE 141
+ I Y ++N + + E+ +L R S+K + + Q++ +E
Sbjct: 63 SGDGIPQVYYFGPCGKYNAM--VLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 142 YLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGDLGFAA--IVGRSHA------AHSI 189
Y+H+ +I+RD+ N I N + I D A I + S+
Sbjct: 120 YVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 190 IGTPEYM 196
GT YM
Sbjct: 178 TGTARYM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 23/178 (12%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
+G G+ ++ + +VA S+ P +L E + + L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAP----QLRDEYRTYKLLAGCTGIP-- 69
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 150
+V+ Q N + +L R S+K + +KQ+L ++ +H +
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SL 127
Query: 151 IHRDLNCSNIFI----NGNIGQVKIGDLGFAA--IVGRSHA------AHSIIGTPEYM 196
++RD+ N I + N + + D G + ++ GT YM
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-05
Identities = 50/330 (15%), Positives = 88/330 (26%), Gaps = 67/330 (20%)
Query: 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF----SEDPVLVN 70
PF P+ + R + G G +V++ + VA + +
Sbjct: 12 PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 71 RLHSEVQLLRTLKNKYIIVCYS-----------------------VWLDDQH-------- 99
+ E+ + + L VC W
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 100 ------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHR 153
+ L + E G + + + S+ K Q+ L HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHR 186
Query: 154 DLNCSNIFIN----------GNIGQVKIGDLGF-AAIVGRSHAAHSIIGTPEYM----AP 198
DL+ N+ + N I G +I+ + + G +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246
Query: 199 ELYEEDYTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
+L+ D DIY E PYS + + K+ + + K P
Sbjct: 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK--TKCNTPA 304
Query: 258 VKAFIEKCIAQPRARP---SASELLKDPFF 284
+K K R SA++LL
Sbjct: 305 MKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 8e-04
Identities = 36/263 (13%), Positives = 82/263 (31%), Gaps = 72/263 (27%)
Query: 28 YSDLLGSG-AVKKVYRAFD-----QEEGIEVA----------WNQVRLSHFSEDPVLVNR 71
++ S AV R F QEE ++ + + P ++ R
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110
Query: 72 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL-NFITEVCTSGNLRTYRKKHRHVSIKALK 130
++ E Q R + + Y+V + L + E+ + ++V I +
Sbjct: 111 MYIE-QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL----------RPAKNVLIDGVL 159
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF-INGNIGQVKIGDLGFAAIVGRSHAAHSI 189
K + L+ +++ + ++ IF +N + ++ ++
Sbjct: 160 GSGKTWV-ALDVCLSYK---VQCKMDF-KIFWLN----------------LKNCNSPETV 198
Query: 190 IGTPEYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246
+ M +L + ++T D S I A++ + +
Sbjct: 199 LE----MLQKLLYQIDPNWTSRSDHSS-----------NIKLRIHSIQAELRRLLKSKPY 243
Query: 247 PQAL---NKVKDPEV-KAFIEKC 265
L V++ + AF C
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSC 266
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.33 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.55 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-66 Score=429.66 Aligned_cols=269 Identities=45% Similarity=0.838 Sum_probs=238.0
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
........++|+++.++||+|+||+||+|.++.++..||+|++..... +....+++.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 94 (290)
T 3fpq_A 17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSW 94 (290)
T ss_dssp CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344556778999999999999999999999999999999999986544 455678899999999999999999999998
Q ss_pred eeC--CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 95 LDD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 95 ~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
... ....+|+||||+.||+|.+++...+.+++..+..++.|++.||+|||+++++|+||||||+|||++...+.+||+
T Consensus 95 ~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred eeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 653 236789999999999999999998899999999999999999999999987799999999999998633899999
Q ss_pred ccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
|||+++.... ......+||+.|+|||++.+.++.++|||||||++|+|+||+.||.+......+...+.....+.....
T Consensus 175 DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 175 DLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp CTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred eCcCCEeCCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence 9999986543 334567899999999999888999999999999999999999999887778888888887766666666
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
..++++++||.+||+ ||++|||+.++|+||||++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 678999999999997 9999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=419.50 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=225.0
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|++++++++||||+++++++.++ +.+|+|
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence 478999999999999999999999999999997543211 22357789999999999999999999999655 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
|||+.||+|.+++...+.+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCC
Confidence 999999999999999889999999999999999999999999 9999999999999998 89999999999876432
Q ss_pred -cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 -HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+...... .+...++++++|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dl 264 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD---FPEKFFPKARDL 264 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCcccCHHHHHH
Confidence 23556789999999998775 4899999999999999999999999887666666665554332 344578999999
Q ss_pred HHHHHh-CCCCCCCHHH------HhcCcccccccCCC
Q 022479 262 IEKCIA-QPRARPSASE------LLKDPFFSELNDDD 291 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~------ll~hp~~~~~~~~~ 291 (296)
|.+||+ ||++|||++| +++||||++++|+.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 999997 9999999998 58899999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=418.87 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=222.5
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
+|++.++||+|+||+||+|.++.+|+.||||++....... .+.+.+|++++++++||||+++++++.++ +.+|+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 148 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 148 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 3477899999999999999999999999999997654322 35678999999999999999999999766 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS- 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~- 183 (296)
||||+.||+|.+++..+ .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ |.+||+|||++......
T Consensus 149 vmEy~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCceecCCCC
Confidence 99999999999998764 5999999999999999999999999 9999999999999998 89999999999877543
Q ss_pred cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..............++++++||
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 304 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 34566789999999998764 49999999999999999999999998877666665555544333333445789999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.+||+ ||++|||+.|+|+||||++...+
T Consensus 305 ~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 99997 99999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=405.44 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=203.3
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.+.||+|+||+||+|.++.+|+.||+|+++..... ......++.+|++++++++||||+++++++.++ +.
T Consensus 12 ig~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~ 87 (275)
T 3hyh_A 12 IGNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DE 87 (275)
T ss_dssp --CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred eeCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 3566 7899999999999999999999999999999865432 234457799999999999999999999999655 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+ +|+|.+++...+.+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++...
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC----
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecC
Confidence 99999999 5699999999899999999999999999999999999 9999999999999998 899999999998876
Q ss_pred CCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
........+||+.|+|||++.+. .+.++|||||||++|+|++|+.||.+....+....+..... ..+...+++++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 240 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY---TLPKFLSPGAA 240 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CCCTTSCHHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHH
Confidence 66666678899999999988755 35799999999999999999999987655544444444322 23445689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+||.+||+ ||++|||+.|+++||||+.
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999998 9999999999999999973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=416.83 Aligned_cols=255 Identities=23% Similarity=0.467 Sum_probs=217.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+|+.||||++..... +....+.+.+|++++++++||||+++++++.++ +.+
T Consensus 24 e~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~ 98 (350)
T 4b9d_A 24 EKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSL 98 (350)
T ss_dssp CCE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred cce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEE
Confidence 466 689999999999999999999999999999986654 455678899999999999999999999999765 789
Q ss_pred EEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
|+||||+.||+|.+++... ..+++.+++.++.||+.||+|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccceee
Confidence 9999999999999999743 45799999999999999999999999 9999999999999998 89999999999877
Q ss_pred CCCc-ccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
.... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....++ .....++++
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~s~~~ 253 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--VSLHYSYDL 253 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--CCccCCHHH
Confidence 5432 23456799999999987754 8999999999999999999999999877777666666655432 234568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++||.+||+ ||++|||+.++|+||||++.
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 999999997 99999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-61 Score=420.75 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=223.2
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
+|++.++||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|++++||||+++++++.++ +.+|+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 225 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 225 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEE
Confidence 3478999999999999999999999999999998653322 35678999999999999999999999766 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS- 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~- 183 (296)
||||+.||+|.+++..+ .+++.++..++.||+.||+|||++| |+||||||+|||++.+ |.+||+|||++......
T Consensus 226 VmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccceECCCCC
Confidence 99999999999998765 5999999999999999999999999 9999999999999998 89999999999876543
Q ss_pred cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..............++++++||
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 34566789999999998764 49999999999999999999999999877766666555554433344456789999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.+||+ ||++|||+.|+|+||||++...+
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 99997 99999999999999999976543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=409.61 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=214.5
Q ss_pred CcccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+| ++.++||+|+||+||+|.+. .+++.||+|+++....... ...++.+|++++++++||||+++++++.++ +
T Consensus 25 ~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 99 (304)
T 3ubd_A 25 QF-ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTE--G 99 (304)
T ss_dssp GE-EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEET--T
T ss_pred cc-EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--C
Confidence 45 78999999999999999873 4688999999975433211 123577899999999999999999999765 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.||+|.+++...+.+++.++..++.|++.||+|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceec
Confidence 89999999999999999999889999999999999999999999999 9999999999999999 89999999999865
Q ss_pred CC-CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GR-SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
.. .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+...... .+...++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 253 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---MPQFLSPEA 253 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---CCCcCCHHH
Confidence 33 334556789999999998764 4899999999999999999999999987766666665554332 344579999
Q ss_pred HHHHHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 259 KAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
++||.+||+ ||++||| ++|+++||||++++|+
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 999999997 9999998 5899999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=405.51 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=217.0
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
++++.++||+|+||+||+|.++.+|+.||||+++.... ..+|+.++++++||||+++++++.++ ..+|+
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~i 127 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PWVNI 127 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 44678999999999999999999999999999986533 13699999999999999999999765 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||||+.||+|.+++...+.+++.++..++.|++.||+|||++| |+||||||+|||++.+...+||+|||+++......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999999889999999999999999999999999 99999999999999882369999999998764322
Q ss_pred c------cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 185 A------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 185 ~------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
. ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+....+..........+..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1 2335799999999977654 89999999999999999999999987655555555555544434445567999
Q ss_pred HHHHHHHHHh-CCCCCCCHHHH-------------hcCcccccccCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASEL-------------LKDPFFSELNDDDS 292 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~l-------------l~hp~~~~~~~~~~ 292 (296)
+.+||.+||+ ||++|||+.|+ |+|||+.++..+..
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence 9999999997 99999999997 67999998876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=401.43 Aligned_cols=264 Identities=24% Similarity=0.388 Sum_probs=221.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----Q 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~ 98 (296)
++| ++.++||+|+||+||+|.++.+|+.||||+++.... .....+++.+|+++|++++||||+++++++... .
T Consensus 54 ~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 455 789999999999999999999999999999975432 445567888999999999999999999987543 2
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...+|+||||+.| +|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 131 ~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecceee
Confidence 3679999999975 79999998889999999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCC-----CcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--C
Q 022479 179 IVGR-----SHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--A 249 (296)
Q Consensus 179 ~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 249 (296)
.... .......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+.+..+......+. .
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 6532 223456789999999997654 368999999999999999999999998777666655543321111 0
Q ss_pred --------------------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 250 --------------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 250 --------------------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.....++++.+||.+||. ||++|||+.++|+||||+++..++.+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~ 357 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE 357 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccc
Confidence 011247889999999998 99999999999999999998765544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=394.19 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=199.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC------
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH------ 99 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------ 99 (296)
|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|++++++++||||+++++++.+...
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 467899999999999999999999999999997643 45566789999999999999999999999875432
Q ss_pred ----CeEEEEeeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 100 ----NTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 100 ----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
..+|++|||+.|++|.+++..... .+...++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEc
Confidence 247999999999999999987654 345668899999999999999999 9999999999999999 899999
Q ss_pred ccCCccccCCCcc-------------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022479 173 DLGFAAIVGRSHA-------------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 238 (296)
Q Consensus 173 dfg~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~ 238 (296)
|||+++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++ ||....+.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999987643221 233579999999998775 48999999999999999996 786533333333
Q ss_pred HHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+.....+... ...++...+||.+||+ ||++|||+.++|+||||++++|+..
T Consensus 238 ~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 238 TDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp HHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred HHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 333333222221 1235678899999998 9999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=373.40 Aligned_cols=243 Identities=27% Similarity=0.469 Sum_probs=203.5
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+++++||+|+||+||+|.++. .||||+++... .+....+.|.+|++++++++||||+++++++.+ ..+++||
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVm 110 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVT 110 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEE
Confidence 578999999999999998653 59999987543 356677899999999999999999999998743 4589999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceecccCCc
Confidence 99999999999975 467999999999999999999999999 9999999999999998 79999999999876432
Q ss_pred -cccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---CCCCCCC
Q 022479 184 -HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---ALNKVKD 255 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 255 (296)
......+||+.|+|||++.+ .++.++|||||||++|||+||+.||.+......+...+..+.... .....++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 23445689999999997742 378899999999999999999999998777777776666654322 2334568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+++.+|+.+||+ ||++|||+.++++
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999997 9999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-57 Score=377.77 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=209.6
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.++||+|+||+||+|.+. .++..||||+++.. +....++|.+|++++++++||||+++++++.++ +.
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 89 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 89 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence 57899999999999999864 35788999999743 455678899999999999999999999999654 68
Q ss_pred EEEEeeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 102 LNFITEVCTSGNLRTYRKKH-------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
+++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~-~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC-Cc
Confidence 99999999999999999754 36999999999999999999999999 9999999999999998 79
Q ss_pred eEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 022479 169 VKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~ 243 (296)
+||+|||+++....... .....+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+....+....+..+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986643322 23346889999999776 559999999999999999999 89999987766555554444
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
. .+. .+..+++++.+|+.+||+ ||++|||+.+++. |++++...
T Consensus 247 ~-~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~~~~~ 290 (299)
T 4asz_A 247 R-VLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQNLAKA 290 (299)
T ss_dssp C-CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHH
T ss_pred C-CCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHHHhc
Confidence 3 333 334568999999999997 9999999999965 88776543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=381.10 Aligned_cols=252 Identities=19% Similarity=0.324 Sum_probs=202.3
Q ss_pred CcccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 99 (296)
..|++.++||+|+||+||+|.++ .+++.||+|++..... ..++.+|+++++++ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 33489999999999999999875 4678999999864321 35678899999998 699999999999765
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+.+|+||||+.|++|.+++. .+++.+++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 78999999999999999885 4999999999999999999999999 999999999999998767999999999975
Q ss_pred cCCCc-----------------------------ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCC
Q 022479 180 VGRSH-----------------------------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPY 228 (296)
Q Consensus 180 ~~~~~-----------------------------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~ 228 (296)
..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43211 1234579999999997754 3789999999999999999999999
Q ss_pred CCC-ChHHHHHHHHhC-------------------------------------C--------------CCCCCCCCCCCh
Q 022479 229 SEC-DSVAKIYKKVTG-------------------------------------G--------------VKPQALNKVKDP 256 (296)
Q Consensus 229 ~~~-~~~~~~~~~~~~-------------------------------------~--------------~~~~~~~~~~~~ 256 (296)
... ++.+.+..+... . ..........++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 543 333333222110 0 000011234578
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
++.+||.+||+ ||++|+|++|+|+||||++++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999998 999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=405.90 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=219.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeeccc--CCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.| ++.++||+|+||.||+|.++.+|+.||+|+++.... ............++.+++.++||||+++++++.+. +
T Consensus 189 ddf-~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~ 265 (689)
T 3v5w_A 189 NDF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 265 (689)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HHe-EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--C
Confidence 345 789999999999999999999999999999976432 12233344445567778888999999999999665 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeec
Confidence 89999999999999999999899999999999999999999999999 9999999999999999 89999999999877
Q ss_pred CCCcccccCCCCCCccCccccc-c-CCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHAAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
... .....+||+.|+|||++. + .++.++|+|||||++|+|++|..||.+.. +...+...+.... ...+...++
T Consensus 343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~ 419 (689)
T 3v5w_A 343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSP 419 (689)
T ss_dssp SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCH
Confidence 543 345679999999999875 3 48999999999999999999999997532 2233333333322 223455799
Q ss_pred HHHHHHHHHHh-CCCCCCC-----HHHHhcCcccccccCCC
Q 022479 257 EVKAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDDD 291 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~~ 291 (296)
++++||.+||+ ||.+|++ ++++++||||++++|+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 99999999997 9999998 79999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=375.41 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=203.9
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+.++||+|+||+||+|.++ .++..||||+++.. +....+.|.+|++++++++||||+++++++.++ ..
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 117 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RP 117 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 46799999999999999864 46889999999743 456678899999999999999999999999654 68
Q ss_pred EEEEeeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH---------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI 166 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~ 166 (296)
+++||||+++|+|.+++... +++++.++..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~- 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG- 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC-
Confidence 99999999999999998753 35899999999999999999999999 9999999999999999
Q ss_pred CceEEeccCCccccCCCc---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022479 167 GQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 167 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~ 241 (296)
+.+||+|||+++...... ......+|+.|+|||++.+ .++.++|||||||++|||+| |+.||.+....+.+..+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 899999999998663322 2344678999999997664 59999999999999999999 899999877665555444
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.+ ..+.. +..+++++.+|+.+||+ ||++|||+.++++ +++.+.+.
T Consensus 275 ~g-~~~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~l~~~ 320 (329)
T 4aoj_A 275 QG-RELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHA--RLQALAQA 320 (329)
T ss_dssp HT-CCCCC-CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH--HHHHHHHS
T ss_pred cC-CCCCC-cccccHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHHhhC
Confidence 43 33333 34568999999999997 9999999999988 56655443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=399.55 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=228.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+++|++++||||+++++++.+. ..+
T Consensus 157 ~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 229 (573)
T 3uto_A 157 DHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEM 229 (573)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEE
T ss_pred ccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 455 7899999999999999999999999999999754 334457788999999999999999999999655 789
Q ss_pred EEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~~ 180 (296)
|++|||+.||+|.+++. ..+.+++.++..++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++..+
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999999986 4567999999999999999999999999 9999999999999854 368999999999988
Q ss_pred CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 258 (296)
.........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+...... +.......++++
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 766666677899999999977654 899999999999999999999999987777666666554432 223334568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
++||.+||+ ||.+|||+.++|+||||+...++...
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence 999999998 99999999999999999998877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=370.57 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=205.0
Q ss_pred cceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++.++||+|+||+||+|... .+++.||||+++... +....+.|.+|+.++++++||||+++++++.++ ..
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~ 103 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QP 103 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CE
Confidence 67899999999999999853 357889999997543 234467899999999999999999999999654 67
Q ss_pred EEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 102 LNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
+++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.+
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK 181 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCC
Confidence 99999999999999999642 35899999999999999999999999 9999999999999998
Q ss_pred CCceEEeccCCccccCCC---cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK 240 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 240 (296)
+.+||+|||+++..... .......+|+.|+|||++. +.++.++||||||+++|||+| |..||.+....+....
T Consensus 182 -~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~- 259 (308)
T 4gt4_A 182 -LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM- 259 (308)
T ss_dssp -GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH-
T ss_pred -CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 79999999999865332 2344567899999999765 569999999999999999998 8999998766554444
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+..+..+.. +..++.++.+|+.+||+ ||++|||+.+++++
T Consensus 260 i~~~~~~~~-p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444433333 44568999999999997 99999999999883
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=372.38 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=209.2
Q ss_pred cceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCC
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHN 100 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 100 (296)
+++++||+|+||+||+|.+..+ ++.||+|+++... .....+.+.+|++++++++| |||+++++++.++. .
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-~ 142 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-G 142 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-S
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-C
Confidence 6889999999999999987654 4679999987432 34556789999999999976 89999999986543 5
Q ss_pred eEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
.+++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSE 220 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCC
Confidence 789999999999999999752 34899999999999999999999999 999999999999999
Q ss_pred CCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022479 165 NIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK 239 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~ 239 (296)
+ +.+||+|||+++...... .....++|+.|+|||++. +.++.++|||||||++|||+| |..||.+....+.+..
T Consensus 221 ~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred C-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9 799999999998764322 234456899999999776 559999999999999999998 9999988766666666
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+..+..+.. +..+++++.+|+.+||+ ||++|||+.++++|
T Consensus 300 ~i~~g~~~~~-p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCC-CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6666554444 34568999999999997 99999999999997
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=360.91 Aligned_cols=258 Identities=24% Similarity=0.464 Sum_probs=226.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||.||+|.+..+|+.||+|++..... +....+++.+|++++++++||||+++++++... +.+
T Consensus 15 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 89 (328)
T 3fe3_A 15 GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTL 89 (328)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEE
Confidence 455 789999999999999999999999999999986544 456677899999999999999999999998654 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++||||+.+++|.+++...+.+++.+++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGSS
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecCC
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999999988766
Q ss_pred CcccccCCCCCCccCccccccC-C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.......++++.|+|||++.+. + +.++||||||+++|+|++|..||.+....+........... .+...++++.+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~ 243 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPFYMSTDCEN 243 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHH
Confidence 6666777899999999987654 3 47899999999999999999999887665555555544332 23446899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
|+.+||. ||.+|||++++++||||+....++
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence 9999998 999999999999999999866543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=349.20 Aligned_cols=270 Identities=45% Similarity=0.837 Sum_probs=236.0
Q ss_pred CCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeee
Q 022479 14 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 93 (296)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 93 (296)
.........++++++.++||+|+||+||+|.+..++..||+|++..... +....+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 16 TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp --CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 4555677788888999999999999999999999999999999986544 45667889999999999999999999998
Q ss_pred eeeC--CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 94 WLDD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 94 ~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
+... ....+++||||+.+++|.+++.....+++..++.++.|++.||.|||+.+++++|+||+|+||+++...+.++|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred eccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 8653 24678999999999999999998888999999999999999999999987669999999999999844389999
Q ss_pred eccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
+|||++...... ......+++.|+|||.+.+.++.++|+||||+++|+|++|..||.+................+....
T Consensus 174 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 174 GDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred eeCCCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 999999765433 2344568999999999888899999999999999999999999998788888888777776666666
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
...++++.+|+.+||+ ||.+|||+.++|+||||++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 6778999999999998 9999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=349.85 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=223.5
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+..++| ++.++||+|+||+||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (297)
T 3fxz_A 17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVG-- 89 (297)
T ss_dssp CGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred Chhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----HHHHHHHHHHHhcCCCCCCCeEeEEEEEC--
Confidence 344555 78999999999999999999999999999997654322 45678899999999999999999999765
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+.+++||||+.+++|.+++... .+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQ 165 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCcee
Confidence 6899999999999999999875 4999999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCC-cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGRS-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....................+...+..
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 6443 23445678999999997654 489999999999999999999999998777777766666555544455567899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+.+|+.+||+ ||++|||+.++|+||||+...
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 9999999998 999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=361.56 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=223.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
..|+++++||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ 89 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR--TD 89 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--CE
Confidence 444789999999999999999999999999999986543221 12346788999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC---ceEEeccCCcc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFAA 178 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~---~~~l~dfg~~~ 178 (296)
+++||||+.|++|.+++...+.+++..+..++.|++.||.|||++| ++|+||||+||+++.+.+ .++|+|||++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999999998888999999999999999999999999 999999999999987722 79999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCCh
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDP 256 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (296)
...........++++.|+|||++.+ .++.++|+||||+++|+|++|..||.+....+....+....... .......++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 8766555666789999999997765 58999999999999999999999998876666555554443221 112244688
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+++||.+||. ||.+|||+.++|+||||+..++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 99999999997 9999999999999999997765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=359.29 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=218.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
.++| ++.++||+|+||+||+|.++.+++.||+|+++..... .......+.+|..+++++ +||||+++++++... .
T Consensus 22 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~ 97 (353)
T 3txo_A 22 IDNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--D 97 (353)
T ss_dssp -CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred hhhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--C
Confidence 3455 7899999999999999999999999999999854221 122356678899999988 799999999999655 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.|++|..++...+.+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeec
Confidence 89999999999999999998889999999999999999999999999 9999999999999999 89999999999864
Q ss_pred C-CCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 G-RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
. ........++|+.|+|||++.+. ++.++|+||||+++|+|++|..||.+....+....+...... .+...+..+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~ 251 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---YPTWLHEDA 251 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHH
Confidence 3 23335566899999999977654 899999999999999999999999887766666665554332 334568999
Q ss_pred HHHHHHHHh-CCCCCCCH------HHHhcCcccccccCCC
Q 022479 259 KAFIEKCIA-QPRARPSA------SELLKDPFFSELNDDD 291 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~------~~ll~hp~~~~~~~~~ 291 (296)
.+|+.+||+ ||.+||++ .++++||||++++|+.
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 999999997 99999999 8999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=354.35 Aligned_cols=258 Identities=24% Similarity=0.435 Sum_probs=221.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+|+.||+|+++..... .......+.+|+.++++++||||+++++.+... ..+
T Consensus 5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 80 (337)
T 1o6l_A 5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL 80 (337)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEE
Confidence 345 6899999999999999999999999999999754221 112246678899999999999999999999655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC-
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG- 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~- 181 (296)
++||||+.|++|..++...+.+++..++.++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhccc
Confidence 999999999999999998888999999999999999999999999 9999999999999998 899999999998643
Q ss_pred CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
........++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+.......+..... ..+...++++.+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 234 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKS 234 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHH
Confidence 2334556788999999997764 489999999999999999999999987666555555544432 233456899999
Q ss_pred HHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
||.+||+ ||++|| ++.++++||||+.++|+
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999997 999999 99999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=360.37 Aligned_cols=260 Identities=20% Similarity=0.385 Sum_probs=217.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
.+| ++.++||+|+||+||+|.++.+++.||+|+++..... .....+.+.+|..++.++ +||||+++++++... ..
T Consensus 52 ~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 127 (396)
T 4dc2_A 52 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 127 (396)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred hHc-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence 345 6899999999999999999999999999999865432 233445678899999887 899999999998655 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV- 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~- 180 (296)
+++||||+.|++|..++...+.+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999 89999999999863
Q ss_pred CCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhCCCCCCCCC
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD--------SVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~ 251 (296)
.........++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.... ....+...+.... ...+
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCC
Confidence 33444566789999999997764 48999999999999999999999996321 2233344333322 2234
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCH------HHHhcCcccccccCCC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSA------SELLKDPFFSELNDDD 291 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~------~~ll~hp~~~~~~~~~ 291 (296)
...+.++++||.+||+ ||.+||++ .++++||||++++|+.
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 4568999999999998 99999985 8999999999998853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=352.74 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=222.2
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv 106 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLV 106 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence 4789999999999999999999999999999986543 455567899999999999999999999998655 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~~~~ 183 (296)
|||+.+++|.+++.....+++..+..++.|++.||.|||++| ++|+||||+||+++.+. +.++|+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999999998888999999999999999999999999 99999999999998652 46999999999887655
Q ss_pred cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKAF 261 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 261 (296)
.......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+....... .......++++.+|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 55556789999999997765 58999999999999999999999998876655555555543322 22223468999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
|.+||+ ||++|||+.++|+||||+...
T Consensus 265 i~~~L~~dP~~R~t~~e~l~hp~~~~~~ 292 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKVPWICNRE 292 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred HHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence 999998 999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=351.01 Aligned_cols=261 Identities=21% Similarity=0.361 Sum_probs=222.2
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.+|++.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 345789999999999999999999999999999986543221 11356788999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC----ceEEeccCCc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFA 177 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~----~~~l~dfg~~ 177 (296)
+++||||+.+++|.+++.....+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ + .++|+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence 9999999999999999998888999999999999999999999999 9999999999999887 5 7999999999
Q ss_pred cccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (296)
.............+++.|+|||++. ..++.++||||||+++|+|++|..||.+....+............ .......+
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876555556677999999999776 458999999999999999999999998876665555554443221 11123458
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..+.+|+.+||. ||++|||+.++|+||||+...+
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 899999999997 9999999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=339.26 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=227.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.++.+++.||+|++..... .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (284)
T 3kk8_A 5 SDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SF 79 (284)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CE
Confidence 3455 789999999999999999999999999999986544 455667889999999999999999999998654 68
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~ 179 (296)
.+++|||+.+++|.+++.....+++..+..++.|++.||.+||++| ++|+||+|+||+++.+. +.++|+|||.+..
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 8999999999999999988888999999999999999999999999 99999999999998662 3499999999988
Q ss_pred cCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (296)
...........+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+................. .......+++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 7666555667889999999977654 8999999999999999999999998876666555555544322 2222456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+.+|+.+||+ ||++|||+.++|+||||++..+..+.
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 9999999998 99999999999999999988766543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=340.97 Aligned_cols=257 Identities=23% Similarity=0.413 Sum_probs=213.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.++.++..+|+|++....... ..+.+.+|++++++++||||+++++++.+. ..
T Consensus 21 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 94 (285)
T 3is5_A 21 DDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HN 94 (285)
T ss_dssp HHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeeccccch---hHHHHHHHHHHHHhCCCchHHhHHHheecC--Ce
Confidence 3445 78999999999999999999999999999998654322 256788999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEeccC
Q 022479 102 LNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLG 175 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~dfg 175 (296)
+++||||+.+++|.+++.. +..+++..++.++.|++.||++||++| ++|+||+|+||+++.+ .+.++|+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999988753 467999999999999999999999999 9999999999999542 2689999999
Q ss_pred CccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
++.............+++.|+|||.+.+.++.++|+||||+++|+|++|..||.+....+...................+
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 99877665555667789999999998888999999999999999999999999887666555555554443333334468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+.+.+|+.+||+ ||++|||+.++|+||||++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999998 9999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=348.10 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=222.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|..+++.++||||+++++.+.+. ..+
T Consensus 6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence 345 68999999999999999999999999999997542211 12246678899999999999999999998655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+||||+.|++|.+++.....+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999999987643
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ....++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.........+...... .+...++++.+|
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~l 233 (318)
T 1fot_A 159 V--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---FPPFFNEDVKDL 233 (318)
T ss_dssp C--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHH
T ss_pred c--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHH
Confidence 2 445678999999997664 4899999999999999999999999887766666665554322 334568999999
Q ss_pred HHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 262 IEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 262 i~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+.+||. ||.+|| +++++++||||++++|+.
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 999997 999999 999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=357.19 Aligned_cols=270 Identities=23% Similarity=0.408 Sum_probs=217.5
Q ss_pred eecCCCCCcccceeeeccc--CcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
+.+.+.++.|++.++||+| +||+||+|.++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 3344444445889999999 999999999999999999999986543 456778899999999999999999999999
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
... +.+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+
T Consensus 96 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~ 170 (389)
T 3gni_B 96 IAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLS 170 (389)
T ss_dssp EET--TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEEC
T ss_pred EEC--CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEc
Confidence 765 6899999999999999999875 67999999999999999999999999 9999999999999988 899999
Q ss_pred ccCCccccCCC--------cccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022479 173 DLGFAAIVGRS--------HAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 173 dfg~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~ 241 (296)
|||.+...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+...........
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 99987644211 11223467888999997764 48999999999999999999999998755544443322
Q ss_pred hCCCC-------------------------------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHH
Q 022479 242 TGGVK-------------------------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASE 277 (296)
Q Consensus 242 ~~~~~-------------------------------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ 277 (296)
..... ........++.+.+||.+||+ ||++|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 21110 011223457889999999998 9999999999
Q ss_pred HhcCcccccccCCCCC
Q 022479 278 LLKDPFFSELNDDDSE 293 (296)
Q Consensus 278 ll~hp~~~~~~~~~~~ 293 (296)
+|+||||+.+.+...+
T Consensus 331 ll~hp~f~~~~~~~~~ 346 (389)
T 3gni_B 331 LLNHSFFKQIKRRASE 346 (389)
T ss_dssp HTTSGGGGGC---CCS
T ss_pred HhcCHHHHHHhhcchh
Confidence 9999999999876544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=348.91 Aligned_cols=259 Identities=20% Similarity=0.389 Sum_probs=219.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.++||+|+||.||+|.++.+++.||+|+++.... ......+.+.+|..+++++ +||||+++++++... ..
T Consensus 9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 345 689999999999999999999999999999986543 3455667888999999988 899999999998655 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.|++|..++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 899999999998643
Q ss_pred -CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhCCCCCCCCC
Q 022479 182 -RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 182 -~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~ 251 (296)
........++|+.|+|||++.+ .++.++|+|||||++|+|++|..||... .....+...+.... ...+
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence 2334556789999999997664 5899999999999999999999999642 12233333333322 1233
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCH------HHHhcCcccccccCC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSA------SELLKDPFFSELNDD 290 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~------~~ll~hp~~~~~~~~ 290 (296)
...+.++.+||.+||+ ||++||++ .++++||||++++|+
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 4568999999999998 99999995 899999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=358.29 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=219.2
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.+|+|++..... .....+.+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv 88 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHYLI 88 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEEEE
Confidence 4789999999999999999999999999999986543 344567789999999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.|++|.+.+...+.+++..+..++.||+.||.|||++| ++||||||+||+++.+ .+.++|+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999999998889999999999999999999999999 9999999999999842 268999999999876543
Q ss_pred c-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChHHHH
Q 022479 184 H-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKA 260 (296)
Q Consensus 184 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 260 (296)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+............ .......++++.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2 2345678999999998765 48999999999999999999999998877666665555554332 2222456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
||.+||+ ||++|||+.++|+||||+...
T Consensus 247 li~~~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence 9999998 999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=358.47 Aligned_cols=260 Identities=23% Similarity=0.414 Sum_probs=222.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||+|.++.+++.||+|++....... ....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 15 ~~y-~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 90 (384)
T 4fr4_A 15 DHF-EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDM 90 (384)
T ss_dssp GGE-EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 345 78999999999999999999999999999997543211 12246788999999999999999999999655 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+||||+.|++|..++.....+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeeccC
Confidence 999999999999999999889999999999999999999999999 9999999999999998 8999999999998766
Q ss_pred CcccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.......++|+.|+|||++.+ .++.++|+|||||++|+|++|..||... .............. ...+...+.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~ 245 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQ 245 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCH
Confidence 666677889999999998752 3788999999999999999999999742 23333333333322 223345689
Q ss_pred HHHHHHHHHHh-CCCCCCC-HHHHhcCcccccccCCC
Q 022479 257 EVKAFIEKCIA-QPRARPS-ASELLKDPFFSELNDDD 291 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps-~~~ll~hp~~~~~~~~~ 291 (296)
.+.+||.+||. ||.+||+ ++++++||||++++|++
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~ 282 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA 282 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence 99999999998 9999998 99999999999999853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=352.66 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=220.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.++||+|+||.||+|.++.+|+.||+|+++...... ......+..|..+++++ +||||+++++++.+. ..
T Consensus 17 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~ 92 (345)
T 1xjd_A 17 EDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN 92 (345)
T ss_dssp TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence 455 68999999999999999999999999999998643211 11245677888899877 999999999999655 68
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.|++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 899999999997643
Q ss_pred -CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 -RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 -~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
........++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..+....+..... ..+...+.++.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 246 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAK 246 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccCHHHH
Confidence 2334556789999999997664 489999999999999999999999988666555555544432 23445689999
Q ss_pred HHHHHHHh-CCCCCCCHH-HHhcCcccccccCC
Q 022479 260 AFIEKCIA-QPRARPSAS-ELLKDPFFSELNDD 290 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~-~ll~hp~~~~~~~~ 290 (296)
+||.+||. ||++||++. ++++||||++++|+
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 99999997 999999998 99999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=341.18 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=209.7
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++++++|+||+++++++... ..++
T Consensus 3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 77 (292)
T 3o0g_A 3 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLT 77 (292)
T ss_dssp SE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred Cc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEE
Confidence 45 689999999999999999999999999999986543 344557788999999999999999999999765 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+.++.+..+....+.+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCCc
Confidence 99999998555555555778999999999999999999999999 9999999999999999 89999999999876533
Q ss_pred -cccccCCCCCCccCcccccc-C-CCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhC--CCCCC---------
Q 022479 184 -HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTG--GVKPQ--------- 248 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~i~~~ll~g~~p~-~~~~~~~~~~~~~~~--~~~~~--------- 248 (296)
.......+++.|+|||++.+ . ++.++||||||+++|+|++|..|| .+....+.+...... .....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 23444577899999997754 3 799999999999999999988775 444433333333221 11100
Q ss_pred ---------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 249 ---------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 249 ---------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
......+..+++|+.+||+ ||++|||++++|+||||+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 1112357899999999998 9999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=348.31 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=216.7
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
.-.++| ++.++||+|+||+||+|.++.+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+.
T Consensus 4 ~~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 77 (323)
T 3tki_A 4 PFVEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG-- 77 (323)
T ss_dssp TTTTCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cHhhhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 344566 789999999999999999999999999999975432 22346688999999999999999999998654
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...++||||+.+++|.+++.....+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATV 154 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeeccce
Confidence 789999999999999999988888999999999999999999999999 9999999999999998 8999999999976
Q ss_pred cCCC---cccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 180 VGRS---HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 180 ~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
.... .......+++.|+|||++.+. .+.++||||||+++|+|++|..||..........................
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccC
Confidence 5322 223456789999999977644 47789999999999999999999987655444444444433333333456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
++.+.+|+.+||+ ||.+|||+.++++||||++...
T Consensus 235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 8999999999998 9999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=339.33 Aligned_cols=260 Identities=21% Similarity=0.363 Sum_probs=225.1
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.|++.++||+|+||+||+|.++.++..+|+|++....... .+.+.+|++++++++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch----HHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEE
Confidence 44578999999999999999999999999999998653322 56788999999999999999999998654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE---eCCCCceEEeccCCcccc
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv---~~~~~~~~l~dfg~~~~~ 180 (296)
+||||+.+++|.+++.....+++..++.++.|++.||++||++| ++|+||+|+||++ +.+ +.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARF 159 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccceec
Confidence 99999999999999998888999999999999999999999999 9999999999999 555 79999999999887
Q ss_pred CCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCChHHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEVK 259 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 259 (296)
..........+++.|+|||.+.+.++.++|+||||+++|+|++|..||......+.............. .....++.+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 666666667899999999988888999999999999999999999999887766666665555332211 1124588999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+|+.+||+ ||.+|||+.++|+||||++......
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~ 273 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence 99999998 9999999999999999988665543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=345.32 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=208.3
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.+. +++.||+|++..... +......+.+|++++++++||||+++++++..+ ..
T Consensus 20 ~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 93 (311)
T 3niz_A 20 MEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RC 93 (311)
T ss_dssp SCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SC
T ss_pred Hhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CE
Confidence 3455 78999999999999999986 489999999975433 333457788999999999999999999998544 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++||||+.+ +|.+++.. ...+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAF 169 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEET
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcCceec
Confidence 9999999997 77777665 456999999999999999999999999 9999999999999999 89999999999876
Q ss_pred CCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--CCCCCCCC-----
Q 022479 181 GRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQAL----- 250 (296)
Q Consensus 181 ~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~----- 250 (296)
... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....... ....+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 533 23344578999999997654 479999999999999999999999987655444433322 11111110
Q ss_pred --------------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 251 --------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 251 --------------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
....+.++.+|+.+||+ ||++|||+.++|+||||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 12246789999999998 99999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=345.98 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=192.5
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--CeEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--NTLN 103 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~ 103 (296)
+.+.++||+|+||+||+|.+ +|+.||||+++... ........|+..+.+++||||+++++++.++.. ..+|
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 36789999999999999987 48999999986431 112233456666678899999999999976542 3689
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--------EPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
+||||+++|+|.+++.... +++..+..++.|++.||+|||++ + |+||||||+|||++.+ +.+||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl~~~-~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EEecCCCCCcHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEECCC-CCEEEEeCC
Confidence 9999999999999998654 89999999999999999999987 6 9999999999999999 899999999
Q ss_pred CccccCCCcc-----cccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhCCCCCCC----------C--
Q 022479 176 FAAIVGRSHA-----AHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSE----------C-- 231 (296)
Q Consensus 176 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g~~p~~~----------~-- 231 (296)
+++....... ....+||+.|+|||++.+. ++.++|||||||++|||+||..||.. .
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9987643322 2345799999999987643 56789999999999999999766531 1
Q ss_pred --ChHHHHHHHHhC-CCCCCCCCCC----CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 232 --DSVAKIYKKVTG-GVKPQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 232 --~~~~~~~~~~~~-~~~~~~~~~~----~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
...+.....+.. ...+..+... .+..+.+|+.+||+ ||++|||+.++++ -++.+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~--~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK--TLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH--HHHHHHHC
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHHHHH
Confidence 123344444433 2222222211 12468899999997 9999999999998 45555443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=346.42 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=220.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||+||+|.++.+++.+|+|++... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 76 (321)
T 1tki_A 5 EKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--EEL 76 (321)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEE
T ss_pred hce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEE
Confidence 455 7899999999999999999999999999998743 23356788999999999999999999999665 689
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~~ 180 (296)
++||||+.|++|.+++... ..+++.+++.++.|++.||.|||++| ++|+||||+||+++.+ .+.++|+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999999765 47999999999999999999999999 9999999999999872 279999999999887
Q ss_pred CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 258 (296)
..........+++.|+|||++.+. ++.++||||||+++|+|++|..||.+....+............. ......+.++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 665555566789999999987755 78999999999999999999999988776666655555443321 1123468899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+|+.+||. ||.+|||+.++|+||||++...
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 999999997 9999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=341.33 Aligned_cols=258 Identities=21% Similarity=0.378 Sum_probs=210.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----------------------HHHHHHHHHHHHHHH
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----------------------PVLVNRLHSEVQLLR 80 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 80 (296)
++| ++.++||+|+||.||+|.+..+++.||+|++........ ....+.+.+|+++++
T Consensus 13 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 13 NQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp TTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred cce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 456 689999999999999999999999999999976532111 122467889999999
Q ss_pred hcCCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCce
Q 022479 81 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160 (296)
Q Consensus 81 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ni 160 (296)
+++||||+++++++.+.....+++||||+.+++|.+++. ...+++.+++.++.|++.||+|||++| ++|+||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence 999999999999998765678999999999999987654 456999999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeccCCccccCCCc-ccccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022479 161 FINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA 235 (296)
Q Consensus 161 lv~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~ 235 (296)
+++.+ +.++|+|||++....... ......+++.|+|||.+.+. .+.++||||||+++|+|++|..||.+.....
T Consensus 169 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 169 LVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99998 899999999998765432 23456789999999987654 3678999999999999999999998765544
Q ss_pred HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 236 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
............ ......++++.+|+.+||+ ||++|||+.++++||||+.
T Consensus 248 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 248 LHSKIKSQALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHCCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHhcccCCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 444443333222 2233468999999999998 9999999999999999963
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=350.23 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=221.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
.++| ++.++||+|+||.||+|.++.+++.||+|+++...... ....+.+.+|..++..+ +||+|+++++++... .
T Consensus 19 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 19 LTDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp CTTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred hHHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 3455 68999999999999999999999999999998643211 12246677899999888 799999999998654 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.|++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCccccc
Confidence 89999999999999999998888999999999999999999999999 9999999999999998 89999999999864
Q ss_pred C-CCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 G-RSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~-~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
. ........++|+.|+|||++. +.++.++|+||||+++|+|++|..||.+....+....+...... .+...+.++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---YPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHH
Confidence 3 233455678999999999776 45899999999999999999999999887666555555554322 334568999
Q ss_pred HHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 259 KAFIEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
.+||.+||. ||.+|| +++++++||||+.++|+.
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 999999997 999999 469999999999998853
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=345.06 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=209.2
Q ss_pred CCcccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
++| ++.++||+|+||.||+|.+. .+++.||+|+++.............+.+|+.++++++||||+++++++...
T Consensus 17 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 17 ECF-ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHe-EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 345 78999999999999999874 579999999998654433344456788999999999999999999998654
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++||||+.+++|.+++...+.+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence 789999999999999999998888999999999999999999999999 9999999999999998 8999999999876
Q ss_pred cCC-CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGR-SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
... .......++++.|+|||++. ..++.++|+||||+++|+|++|..||.+.........+..... ..+...+.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~ 247 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL---NLPPYLTQE 247 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---CCCTTSCHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHH
Confidence 432 22344567899999999765 4589999999999999999999999988766655555554432 223456899
Q ss_pred HHHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 258 VKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
+.+|+.+||+ ||.+|| ++.++++||||++++|+
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 9999999997 999999 89999999999998774
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=353.82 Aligned_cols=279 Identities=24% Similarity=0.362 Sum_probs=219.2
Q ss_pred CCCCCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee
Q 022479 9 SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 88 (296)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 88 (296)
....+.........++| ++.++||+|+||+||+|.++.+++.||+|++.... ......+++.+|+.++++++|+||+
T Consensus 12 ~~~~~Q~~~~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv 88 (432)
T 3n9x_A 12 ENLYFQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYII 88 (432)
T ss_dssp CCCCTTCGGGCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhcCCCcceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcc
Confidence 33444556666666777 78999999999999999999999999999997542 2455678899999999999999999
Q ss_pred EEeeeeeeCCC---CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 89 VCYSVWLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 89 ~~~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
++++++..... ..+|+||||+.+ +|.+++.....+++..++.++.||+.||.|||++| ++||||||+||+++.+
T Consensus 89 ~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~ 165 (432)
T 3n9x_A 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD 165 (432)
T ss_dssp CEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT
T ss_pred eEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC
Confidence 99999865432 578999999876 99999998888999999999999999999999999 9999999999999998
Q ss_pred CCceEEeccCCccccCCCc-----------------------ccccCCCCCCccCcccc-c-cCCCcchhHHHHHHHHHH
Q 022479 166 IGQVKIGDLGFAAIVGRSH-----------------------AAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLE 220 (296)
Q Consensus 166 ~~~~~l~dfg~~~~~~~~~-----------------------~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~i~~~ 220 (296)
+.++|+|||+++...... ......+|+.|+|||++ . ..++.++|||||||++|+
T Consensus 166 -~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e 244 (432)
T 3n9x_A 166 -CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244 (432)
T ss_dssp -CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred -CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence 899999999998764322 12456789999999964 3 448999999999999999
Q ss_pred HHhC-----------CCCCCCCCh-----------------HHHHHHH-----------------------HhCCCCCCC
Q 022479 221 MVTM-----------EIPYSECDS-----------------VAKIYKK-----------------------VTGGVKPQA 249 (296)
Q Consensus 221 ll~g-----------~~p~~~~~~-----------------~~~~~~~-----------------------~~~~~~~~~ 249 (296)
|++| .++|.+... .+.+..+ +........
T Consensus 245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (432)
T 3n9x_A 245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324 (432)
T ss_dssp HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence 9984 444433220 1111111 111000000
Q ss_pred -----CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 250 -----LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 250 -----~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
.....++++.+|+.+||+ ||++|||++++|+||||+++.++..++
T Consensus 325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCc
Confidence 012358899999999998 999999999999999999999887654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=353.08 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=209.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.++||+|+||+||+|.++.+|+.||+|++.... .......++.+|+.+++++. |+||+++++++..+....
T Consensus 9 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred Cce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345 78999999999999999999999999999996442 24556678889999999997 999999999998766678
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.+ +|..++..+ .+++..+..++.|++.||+|||+.| ++||||||+||+++.+ +.++|+|||+++...
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred EEEEecccCc-CHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence 9999999986 888888764 6999999999999999999999999 9999999999999999 899999999997653
Q ss_pred CC----------------------cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022479 182 RS----------------------HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 237 (296)
Q Consensus 182 ~~----------------------~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~ 237 (296)
.. ......++|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 11233578999999997754 4899999999999999999999999987776665
Q ss_pred HHHHhCCCCCC--------------------------------------------CCCCCCChHHHHHHHHHHh-CCCCC
Q 022479 238 YKKVTGGVKPQ--------------------------------------------ALNKVKDPEVKAFIEKCIA-QPRAR 272 (296)
Q Consensus 238 ~~~~~~~~~~~--------------------------------------------~~~~~~~~~l~~li~~~l~-~p~~R 272 (296)
..+......+. ......++++.+|+.+||+ ||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 55442211110 0111457899999999998 99999
Q ss_pred CCHHHHhcCcccccccCCCCC
Q 022479 273 PSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 273 ps~~~ll~hp~~~~~~~~~~~ 293 (296)
||++++|+||||+.+.....+
T Consensus 321 ~t~~e~l~Hp~~~~~~~~~~~ 341 (388)
T 3oz6_A 321 ISANDALKHPFVSIFHNPNEE 341 (388)
T ss_dssp CCHHHHTTSTTTTTTCCGGGC
T ss_pred CCHHHHhCCHHHHHhcCCccC
Confidence 999999999999887665544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=348.91 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=221.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|++++++++||||+++++.+.+. ..
T Consensus 40 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 40 LDQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred HHHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 3456 67999999999999999999999999999997543211 12246788999999999999999999998655 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.|++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.. ....++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+....+....+..... ..+...+..+.+
T Consensus 193 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~ 267 (350)
T 1rdq_E 193 GR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---RFPSHFSSDLKD 267 (350)
T ss_dssp SC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTCCHHHHH
T ss_pred CC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHH
Confidence 43 345678999999997654 589999999999999999999999988766655555555432 233456899999
Q ss_pred HHHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
||.+||+ ||.+||+ ++++++||||+.++|+
T Consensus 268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9999998 9999998 9999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=350.63 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=221.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.++.+|+.+|+|++... .......+.+|++++++++|+||+++++++.+. ..
T Consensus 50 ~~~y-~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~ 122 (387)
T 1kob_A 50 YDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YE 122 (387)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SE
T ss_pred ccce-EEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CE
Confidence 3444 7899999999999999999999999999999754 233456788999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~ 179 (296)
+++||||+.+++|.+++... ..+++.++..++.|++.||+|||++| ++|+||||+||+++.+ .+.++|+|||++..
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999999999998754 47999999999999999999999999 9999999999999753 26899999999988
Q ss_pred cCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 257 (296)
...........+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+......... +.......+++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 765555555678999999997764 4899999999999999999999999987766666655554332 22223456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+.+||.+||+ ||++|||+.++|+||||+....+.
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 315 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCcccc
Confidence 9999999998 999999999999999998765443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=352.28 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=213.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHH-HHhcCCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
+.| ++.++||+|+||.||+|.++.+++.||+|+++...... ......+.+|..+ ++.++||||+++++.+... +.
T Consensus 38 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~ 113 (373)
T 2r5t_A 38 SDF-HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DK 113 (373)
T ss_dssp GGE-EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CE
Confidence 344 78999999999999999999999999999998665432 2233455566665 5778999999999998655 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc-
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV- 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~- 180 (296)
+|+||||+.|++|..++...+.+++..++.++.||+.||+|||++| ++||||||+||+++.+ |.++|+|||++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 89999999999864
Q ss_pred CCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.........++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..+....+..... ..+...+..++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~ 267 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSAR 267 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---CCCSSSCHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHH
Confidence 33334566789999999997764 489999999999999999999999988766665555555432 23345689999
Q ss_pred HHHHHHHh-CCCCCCCH----HHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARPSA----SELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~----~~ll~hp~~~~~~~~~ 291 (296)
+||.+||+ ||++||++ .++++||||+.++|++
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 99999997 99999986 6999999999998864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=345.64 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=202.4
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..++| ++.++||+|+||+||++.++.+++.||+|++...... .+.+.+|+.++++++||||+++++++... .
T Consensus 18 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 89 (361)
T 3uc3_A 18 DSDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTP--T 89 (361)
T ss_dssp CTTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred CCCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeC--C
Confidence 34556 7899999999999999999999999999999754332 25577899999999999999999999655 6
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC-CceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~-~~~~l~dfg~~~~ 179 (296)
.+++||||+.+++|.+++...+.+++..++.++.|++.||+|||++| ++||||||+||+++.+. +.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 89999999999999999988888999999999999999999999999 99999999999998762 2499999999986
Q ss_pred cCCCcccccCCCCCCccCccccccC-CCcc-hhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCCCCCCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEED-YTEM-VDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 254 (296)
...........+++.|+|||++.+. ++.+ +||||||+++|+|++|+.||.+... .......+.............
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 5444445566789999999976544 5444 8999999999999999999976432 233333333332222223346
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++++.+||.+||+ ||.+|||+.++++||||.+.
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 8999999999998 99999999999999999654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=347.75 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=204.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
...|++.++||+|+||+||+|.++.+++.||+|+++... ..+.+.+|+.++++++|+||+++++++... ..+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeE
Confidence 344578999999999999999999999999999997432 235678899999999999999999999654 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC---CCCceEEeccCCccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAI 179 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~---~~~~~~l~dfg~~~~ 179 (296)
++||||+.+++|.+++...+.+++.+++.++.|++.||.|||++| ++|+||||+||+++. + +.++|+|||++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPD-APLKIADFGLSKI 200 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTT-CCEEECCCC----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCC-CCEEEccCccccc
Confidence 999999999999999998888999999999999999999999999 999999999999975 4 7999999999987
Q ss_pred cCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCCCCCCCh
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKVKDP 256 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 256 (296)
...........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+..........+...... .......+.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765544556678999999997765 48999999999999999999999998766665555555443322 122244688
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
++.+|+.+||+ ||++|||+.++|+||||.....+.
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 316 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch
Confidence 99999999998 999999999999999998776543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=346.29 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=210.8
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
...++| ++.++||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.++++++|+||+++++++...
T Consensus 31 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (329)
T 3gbz_A 31 TSIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-- 105 (329)
T ss_dssp -CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--
T ss_pred cchhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--
Confidence 344556 689999999999999999999999999999975533 334456778999999999999999999999765
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----CCceEEeccC
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIGDLG 175 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~----~~~~~l~dfg 175 (296)
..+++||||+.+ +|.+++...+.+++..++.++.||+.||+|||++| ++|+||||+||+++.+ .+.++|+|||
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 789999999986 99999999888999999999999999999999999 9999999999999643 1469999999
Q ss_pred CccccCCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCC
Q 022479 176 FAAIVGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QAL 250 (296)
Q Consensus 176 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 250 (296)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+.........+ ...
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 99876432 22344567899999997764 37999999999999999999999999877766666554331111 100
Q ss_pred -------------------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 251 -------------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 251 -------------------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
....++++.+|+.+||+ ||++|||+.++|+||||++.+|+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 01157889999999998 999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=362.04 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=223.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+++.||+|++....... .....+.+|++++++++||||+++++++.+. ..+
T Consensus 22 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 96 (486)
T 3mwu_A 22 ERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDS--SSF 96 (486)
T ss_dssp HHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEE
Confidence 344 78999999999999999999999999999997543211 1246788999999999999999999998654 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~dfg~~~~~ 180 (296)
++||||+.+++|.+.+.....+++..++.++.|++.||.|||++| ++||||||+||+++.+ .+.++|+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999999999988888999999999999999999999999 9999999999999643 257999999999887
Q ss_pred CCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVK 259 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 259 (296)
..........+++.|+|||++.+.++.++||||||+++|+|++|..||.+....+.+........... ......+++++
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 66655666789999999999988899999999999999999999999998777666666555543322 22234689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+||.+||+ ||.+|||+.++|+||||+......
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence 99999998 999999999999999999876554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=341.63 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=202.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+|++++++++||||+++++++..+ +.
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 77 (317)
T 2pmi_A 4 SSQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTE--NK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TE
T ss_pred ccce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--Ce
Confidence 3455 6799999999999999999999999999999765422 2235677899999999999999999998554 78
Q ss_pred EEEEeeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 102 LNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
+++||||+.+ +|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||
T Consensus 78 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFG 153 (317)
T ss_dssp EEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCS
T ss_pred EEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCc
Confidence 9999999995 899888753 35899999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCC--
Q 022479 176 FAAIVGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQ-- 248 (296)
Q Consensus 176 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~-- 248 (296)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876533 23445578999999997754 4799999999999999999999999887766555444321 10000
Q ss_pred ---------------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 249 ---------------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 249 ---------------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
......+.++.+|+.+||+ ||++|||+.++|+||||+++.+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 0112357899999999998 99999999999999999999887665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=343.84 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=222.5
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
..|++.+.||+|+||.||+|.++.+|+.||+|+++....... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--TD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CE
Confidence 445789999999999999999999999999999986543221 11356788999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC----ceEEeccCCc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFA 177 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~----~~~l~dfg~~ 177 (296)
+++||||+.+++|.+++.....+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ + .++|+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~-~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDK-NIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCT-TSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecC-CCCcCCEEEccCccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999987 5 7999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (296)
.............+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+............ .......+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 88766555566678999999997764 58999999999999999999999998866655555544432221 11123468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
..+.+|+.+||. ||++|||+.++++||||...++.
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 899999999998 99999999999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=361.92 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=223.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC---------HHHHHHHHHHHHHHHhcCCCceeEEee
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED---------PVLVNRLHSEVQLLRTLKNKYIIVCYS 92 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 92 (296)
.+..|++.++||+|+||+||+|.++.+++.+|+|++........ ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 33445789999999999999999999999999999986543211 123567889999999999999999999
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC--ceE
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG--QVK 170 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~--~~~ 170 (296)
++.+. ..+++||||+.+++|.+++.....+++..+..++.||+.||+|||++| ++||||||+||+++.+.. .++
T Consensus 114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 99654 789999999999999999988888999999999999999999999999 999999999999987721 699
Q ss_pred EeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-C
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-A 249 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 249 (296)
|+|||++.............+++.|+|||++.+.++.++||||||+++|+|++|..||.+....+.+........... .
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 999999988776666667789999999999888899999999999999999999999998776666655555433221 1
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.....++++++||.+||+ ||.+|||+.++|+||||++....
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 123468999999999998 99999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=351.75 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=213.6
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++..+ ..
T Consensus 8 i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 83 (336)
T 3h4j_B 8 IGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TD 83 (336)
T ss_dssp ETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence 3566 7899999999999999999999999999999753221 111235688999999999999999999998655 68
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+++||||+ +++|.+++...+.+++.+++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTT
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceecc
Confidence 99999999 5689999988888999999999999999999999999 9999999999999998 899999999998876
Q ss_pred CCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
........++++.|+|||++.+. .+.++||||||+++|+|++|..||.+....... ..+.. .....+...++++.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~~i~~--~~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-KKVNS--CVYVMPDFLSPGAQ 236 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-CCCCS--SCCCCCTTSCHHHH
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-HHHHc--CCCCCcccCCHHHH
Confidence 66666677899999999988765 378999999999999999999999764321111 10011 11223445689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+|+.+||+ ||.+|||+.++++||||+.-
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999998 99999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=340.54 Aligned_cols=262 Identities=22% Similarity=0.396 Sum_probs=212.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++|+||+++++++... ..+
T Consensus 3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (311)
T 4agu_A 3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL 77 (311)
T ss_dssp CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence 355 68999999999999999999999999999987543 2556677888999999999999999999999665 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++||||+.+++|..++.....+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC-
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccC
Confidence 999999999999999988888999999999999999999999999 9999999999999998 8999999999987653
Q ss_pred C-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CC------------
Q 022479 183 S-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GV------------ 245 (296)
Q Consensus 183 ~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~------------ 245 (296)
. .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+........ ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 22345578899999997754 4799999999999999999999999887666554433221 00
Q ss_pred -----CCCCC---------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 246 -----KPQAL---------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 246 -----~~~~~---------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..... ....+..+.+|+.+||+ ||.+|||++++|+||||+++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 00000 12357789999999998 9999999999999999999876643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=338.67 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=208.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-CHHHHHHHHHHHHHHHhc---CCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~ 98 (296)
++| ++.++||+|+||+||+|.+..+++.||+|++....... .......+.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 9 SRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp -CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred cce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 455 78999999999999999999999999999997643211 111123444566665555 5999999999987653
Q ss_pred C---CeEEEEeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 99 H---NTLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 99 ~---~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
. ..+++++||+.+ +|.+++..... +++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEECS
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEee
Confidence 2 258999999985 99999987654 999999999999999999999999 9999999999999998 8999999
Q ss_pred cCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCC
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQAL 250 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 250 (296)
||++.............+++.|+|||++. ..++.++||||||+++|+|++|..||.+....+......... .....+
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998876665566678899999999765 558999999999999999999999998877666655544321 111100
Q ss_pred ----------------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 251 ----------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 251 ----------------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
....++++.+|+.+||+ ||++|||+.++|+||||++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~ 306 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence 12357889999999998 99999999999999999986544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=361.27 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=218.7
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
.|++.++||+|+||+||+|.++.++..+|+|++....... .....+.+|+.++++++||||+++++++... ..+++
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 113 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYL 113 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 3578999999999999999999999999999998654321 2246788999999999999999999999654 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEeccCCccccCC
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~dfg~~~~~~~ 182 (296)
||||+.+++|.+++.....+++..++.++.|++.||+|||++| ++||||||+||+++.+ .+.++|+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999988888999999999999999999999999 9999999999999764 24699999999988776
Q ss_pred CcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 261 (296)
........+++.|+|||++.+.++.++||||||+++|+|++|..||.+....+............. ......++.+.+|
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 666667789999999999888899999999999999999999999998776666655555443321 2223468999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
|.+||+ ||.+|||+.++|+||||+...
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccCc
Confidence 999998 999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=352.22 Aligned_cols=260 Identities=19% Similarity=0.283 Sum_probs=216.3
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
-|++.++||+|+||+||+|.++.+++.||+|+++...... ......+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~l 146 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYM 146 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 3478999999999999999999999999999997532100 00123477899999999999999999999655 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||||+.|++|.+++... .+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEeeccCC
Confidence 99999999999998765 5999999999999999999999999 9999999999999999 899999999998765433
Q ss_pred --ccccCCCCCCccCccccccC-----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCCh
Q 022479 185 --AAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDP 256 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (296)
.....++|+.|+|||++.+. ++.++|+||||+++|+|++|..||.+.+..+....+......... .....+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 23467899999999977533 678999999999999999999999886665555544432211111 1234689
Q ss_pred HHHHHHHHHHh-CCCC--CCCHHHHhcCcccccccCCC
Q 022479 257 EVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~--Rps~~~ll~hp~~~~~~~~~ 291 (296)
++++||.+||. +|++ ||+++++++||||++++|+.
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 99999999997 8888 99999999999999998874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=355.05 Aligned_cols=263 Identities=20% Similarity=0.321 Sum_probs=218.0
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
-+++.++||+|+||.||+|.++.+|+.||+|+++..... .......+.+|..++.+++|+||+++++.+.+. +.+|+
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~l 138 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NYLYL 138 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEE
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence 347899999999999999999999999999999753211 111234578899999999999999999999655 78999
Q ss_pred EeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 105 ITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||||+.|++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheeccCC
Confidence 99999999999999864 47999999999999999999999999 9999999999999998 89999999999876543
Q ss_pred cc--cccCCCCCCccCccccc--------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCCC
Q 022479 184 HA--AHSIIGTPEYMAPELYE--------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQALN 251 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~--------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 251 (296)
.. ....++|+.|+|||++. +.++.++|+|||||++|+|++|+.||.+....+....+.... .......
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 32 33468999999999775 348899999999999999999999998866655554444321 1112223
Q ss_pred CCCChHHHHHHHHHHhCCCCC---CCHHHHhcCcccccccCCCCC
Q 022479 252 KVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~~p~~R---ps~~~ll~hp~~~~~~~~~~~ 293 (296)
...++++++||++||.+|.+| |+++++++||||++++|++-.
T Consensus 296 ~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp -CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred cCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 456899999999999988887 699999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=337.43 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=216.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+...++||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.++++++|+||+++++++... ..+++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 120 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVL 120 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence 3567899999999999999998999999999975432 2246788999999999999999999998765 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC-c
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-H 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-~ 184 (296)
|||+.+++|.+++... .+++..+..++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 121 ~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc
Confidence 9999999999988754 5999999999999999999999999 9999999999999998 89999999999876443 2
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
......+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+........................++.+.+++.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 3445678999999997764 489999999999999999999999987766655555544443333334456889999999
Q ss_pred HHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 264 KCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+||+ ||++|||+.++++||||.....
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred HHccCChhhCcCHHHHhcChhhccCCC
Confidence 9998 9999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=339.53 Aligned_cols=264 Identities=22% Similarity=0.341 Sum_probs=203.7
Q ss_pred CCcccc-eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 23 GRFGRY-SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 23 ~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
++| ++ .++||+|+||+||+|.+..+++.||+|++..... .....+.+|+++++++ +|+||+++++++.+. +
T Consensus 12 ~~y-~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~ 84 (316)
T 2ac3_A 12 DVY-QLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--D 84 (316)
T ss_dssp TSC-EECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred eeE-EecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--C
Confidence 455 45 5889999999999999999999999999975432 2246788999999985 799999999999765 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc---eEEeccCCc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ---VKIGDLGFA 177 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~---~~l~dfg~~ 177 (296)
.+++||||+.+++|.+++.....+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +. ++|+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHP-NQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCS-SSSCSEEECCTTCC
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccC-CCcCceEEEEccCc
Confidence 89999999999999999998888999999999999999999999999 9999999999999877 44 999999998
Q ss_pred cccCCC--------cccccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCCh----------
Q 022479 178 AIVGRS--------HAAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---------- 233 (296)
Q Consensus 178 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---------- 233 (296)
...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 765321 11223458899999997753 378899999999999999999999976432
Q ss_pred ----HHHHHHHHhCCCCCCC--CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCCCC
Q 022479 234 ----VAKIYKKVTGGVKPQA--LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296 (296)
Q Consensus 234 ----~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 296 (296)
...+...+........ .....+.++.+|+.+||. ||.+|||+.++|+||||++..++...++|
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 311 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP 311 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence 1223333333221111 113458899999999998 99999999999999999998887777665
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=345.12 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=211.5
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+..++| ++.+.||+|+||+||+|.++.+|+.||+|++.... ......+++.+|++++++++|+||+++++++.....
T Consensus 22 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 22 EVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp CCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 444555 78999999999999999999999999999996543 245667889999999999999999999999865421
Q ss_pred ----CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 100 ----NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 100 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
..+|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg 173 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFG 173 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeee
Confidence 4569999999 7799999887 45999999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------ 247 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------ 247 (296)
++...... .....+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 174 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 174 LARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99876432 344577899999997654 58999999999999999999999999877666555443321110
Q ss_pred ----------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 ----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 ----------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++.+.+|+.+||. ||++|||+.++|+||||+.+..+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 320 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence 01123357899999999998 99999999999999999998776554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=358.85 Aligned_cols=259 Identities=23% Similarity=0.430 Sum_probs=212.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||+|.++.+|+.||+|+++.... ........+.+|+.++++++||||+++++++... ..+
T Consensus 148 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 148 NEF-EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred HHc-EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 344 789999999999999999999999999999985432 1233456678899999999999999999999765 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+++|..++.....+++..+..++.|++.||+|||+ +| ++||||||+||+++.+ +.++|+|||++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceecc
Confidence 9999999999999999988889999999999999999999998 89 9999999999999998 899999999997643
Q ss_pred C-CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 R-SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
. .......++|+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+...... .+...++++.
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~ 377 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---FPRTLGPEAK 377 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHH
Confidence 2 33345578999999999775 45899999999999999999999999887665555555544332 3344689999
Q ss_pred HHHHHHHh-CCCCCC-----CHHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARP-----SASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~~ 291 (296)
+||.+||+ ||.+|| ++.++++||||++++|+.
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 99999998 999999 999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=359.74 Aligned_cols=259 Identities=26% Similarity=0.370 Sum_probs=207.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---- 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 98 (296)
++| ++.++||+|+||+||+|.+..+++.||+|++..... .....+++.+|+.++++++|+||+++++++....
T Consensus 62 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 62 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 455 689999999999999999999999999999975432 4566778899999999999999999999986542
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...+|+||||+.++ |.+.+.. .+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++.
T Consensus 139 ~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~ 212 (464)
T 3ttj_A 139 FQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR 212 (464)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC-
T ss_pred CCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeee
Confidence 24689999999885 5555543 4899999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------- 248 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 248 (296)
............+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..++.....+.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 8766555666789999999997654 589999999999999999999999998776666555443211110
Q ss_pred ------------C-------CCCC-----------CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 249 ------------A-------LNKV-----------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 249 ------------~-------~~~~-----------~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
. .+.. .++++.+|+.+||+ ||++|||+.++|+||||+.+..+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 0 0000 04568999999998 99999999999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=352.72 Aligned_cols=261 Identities=20% Similarity=0.325 Sum_probs=217.4
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
-+++.++||+|+||+||+|.++.+++.||+|+++...... ......+.+|..++..++|+||+++++.+.+. ..+|+
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~l 151 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NNLYL 151 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEE
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CEEEE
Confidence 3478999999999999999999999999999997532111 11123478899999999999999999999655 78999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 105 ITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||||+.|++|.+++.. .+.+++..++.++.|++.||.|||++| ++||||||+|||++.+ +.+||+|||++......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhcccC
Confidence 9999999999999987 578999999999999999999999999 9999999999999999 89999999999776443
Q ss_pred cc--cccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCCCCC
Q 022479 184 HA--AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKV 253 (296)
Q Consensus 184 ~~--~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 253 (296)
.. ....++|+.|+|||++. +.++.++|+||||+++|+|++|+.||.+....+....+.... .........
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 22 33467999999999764 348999999999999999999999998876665555544321 111111233
Q ss_pred CChHHHHHHHHHHh-CCCC--CCCHHHHhcCcccccccCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~--Rps~~~ll~hp~~~~~~~~~ 291 (296)
.++++++||.+||. +|++ |++++++++||||++++|+.
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 68999999999996 7777 99999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=361.78 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=225.3
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
.|++.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.++++++||||+++++++.+. ..+++
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 103 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYL 103 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEE
Confidence 3478999999999999999999999999999997654321 22357788999999999999999999998654 78999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe---CCCCceEEeccCCccccC
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~---~~~~~~~l~dfg~~~~~~ 181 (296)
|+||+.+++|.+++.....+++..++.++.|++.||.|||++| ++||||||+||+++ .+ +.++|+|||++....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKD-ANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTT-CCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCC-CcEEEEeeeeeEEcc
Confidence 9999999999999998889999999999999999999999999 99999999999995 44 789999999998876
Q ss_pred CCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 260 (296)
.........+++.|+|||++.+.++.++||||||+++|+|++|..||.+....+............. ......++++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 6555566678999999999888899999999999999999999999998777666666655543322 222346899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
||.+||+ ||.+|||+.++|+||||+...++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 9999998 99999999999999999987663
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=356.65 Aligned_cols=255 Identities=23% Similarity=0.406 Sum_probs=220.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++++.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.++++++||||+++++++... ..+
T Consensus 16 ~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 91 (476)
T 2y94_A 16 GHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI 91 (476)
T ss_dssp TTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 455 7899999999999999999999999999999754321 112356788999999999999999999998655 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++||||+.+++|.+++...+.+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhccc
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999999988766
Q ss_pred CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.......++++.|+|||++.+. .+.++||||||+++|+|++|..||.+.........+..... ..+...++++.+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVIS 245 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---CCCTTCCHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---CCCccCCHHHHH
Confidence 5556667899999999987754 36899999999999999999999987665555444444322 223456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
|+.+||+ ||.+|||+.++++||||+..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999998 99999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=346.40 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=212.2
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
|++.++||+|+||+||+|.++.+++.||+|++....... .....+.+.+|+.++++++||||+++++++.+. ..+|+
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 103 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GMLYM 103 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEE
Confidence 478999999999999999999999999999997543211 111256788999999999999999999998765 78999
Q ss_pred EeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCcc
Q 022479 105 ITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAA 178 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~ 178 (296)
||||+.|++|.+++.. +..+++..++.++.|++.||+|||++| ++|+||||+||+++.+. +.++|+|||++.
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999887754 335899999999999999999999999 99999999999998652 349999999998
Q ss_pred ccCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCC
Q 022479 179 IVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD 255 (296)
Q Consensus 179 ~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (296)
....... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .............. .......+
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 7754332 445678999999997764 48999999999999999999999998743 33333333332221 11123468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.++.+||.+||. ||++|||+.++|+||||+...+
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence 899999999998 9999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=335.41 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=206.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.+ .+++.+|+|++..... +......+.+|++++++++||||+++++++... ..++
T Consensus 3 ~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (288)
T 1ob3_A 3 KY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLV 76 (288)
T ss_dssp SE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEE
T ss_pred cc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEE
Confidence 45 6799999999999999998 5789999999975432 222246678899999999999999999998654 6899
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+.+ +|.+++.. .+.+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI 152 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccCc
Confidence 99999987 88888875 367999999999999999999999999 9999999999999998 8999999999987643
Q ss_pred C-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCC----------
Q 022479 183 S-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKP---------- 247 (296)
Q Consensus 183 ~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~---------- 247 (296)
. .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+........ ....
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2 22334567999999997754 4799999999999999999999999887766655544331 1100
Q ss_pred --------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 248 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 248 --------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.......++++.+|+.+||+ ||++|||+.++|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01112357899999999998 99999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=344.62 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=214.5
Q ss_pred Ccccc--eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 24 RFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~--~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++.+ .++||+|+||.||+|.+..+|+.||+|+++.. .....+.+.+|++++++++|+||+++++++... ..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--ND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 34444 57899999999999999999999999999854 234467889999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC-CCCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~-~~~~~~l~dfg~~~~ 179 (296)
+++||||+.+++|.+++.. ...+++..+..++.|++.||+|||++| ++|+||||+||++.. +.+.++|+|||++..
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 9999999999999888864 456999999999999999999999999 999999999999953 226899999999988
Q ss_pred cCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (296)
...........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+....... .......+++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 766555566679999999997764 48889999999999999999999999877777666666554322 1222346899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+.+||.+||+ ||.+|||+.++|+||||++..+
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 9999999998 9999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=339.25 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=212.7
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--KYIIVCYSVWLDD 97 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~ 97 (296)
+..++.|++.++||+|+||+||++.+. +++.||+|++..... .....+.+.+|+.++++++| +||+++++++...
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 344565689999999999999999885 588999999986543 56667889999999999987 9999999998655
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++||| +.+++|.+++.....+++.++..++.|++.||.|||++| ++||||||+||+++. +.++|+|||++
T Consensus 82 --~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~--~~~kl~DFG~a 154 (343)
T 3dbq_A 82 --QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIA 154 (343)
T ss_dssp --SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSS
T ss_pred --CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC--CcEEEeecccc
Confidence 78999999 566799999999889999999999999999999999999 999999999999974 68999999999
Q ss_pred cccCCCcc---cccCCCCCCccCccccc------------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 022479 178 AIVGRSHA---AHSIIGTPEYMAPELYE------------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 242 (296)
Q Consensus 178 ~~~~~~~~---~~~~~~~~~~~aPE~~~------------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~ 242 (296)
........ .....+++.|+|||++. +.++.++||||||+++|+|++|..||.+............
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 87643322 33457899999999764 3478899999999999999999999987544433333344
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
........+...+..+.+|+.+||+ ||.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 3333344455567899999999998 9999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=354.67 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=200.6
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.++||+|+||+||+|.++.+++.||+|++.... .+....+++.+|+.++++++|+||+++++++....
T Consensus 52 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTE-EECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 4556 78999999999999999999999999999996432 25566788999999999999999999999986442
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccch
Confidence 257899999985 589999998888999999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCc----------------------------ccccCCCCCCccCcccc-c-cCCCcchhHHHHHHHHHHHHh-----
Q 022479 179 IVGRSH----------------------------AAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLEMVT----- 223 (296)
Q Consensus 179 ~~~~~~----------------------------~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~i~~~ll~----- 223 (296)
...... .....++|+.|+|||++ . ..++.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 764221 12334679999999964 3 448999999999999999998
Q ss_pred ------CCCCCCCCCh--------------------HHHHHHHH--hCCCC--------------------------CCC
Q 022479 224 ------MEIPYSECDS--------------------VAKIYKKV--TGGVK--------------------------PQA 249 (296)
Q Consensus 224 ------g~~p~~~~~~--------------------~~~~~~~~--~~~~~--------------------------~~~ 249 (296)
|+++|.+... .+.+..+. .+... ...
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6777765331 11111111 01000 001
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.....++++.+||.+||. ||++|||++++|+||||+++.++..+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 112347899999999998 99999999999999999999876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=329.19 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=222.4
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC-----CHHHHHHHHHHHHHHHhcC-CCceeEEeeeee
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-----DPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWL 95 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 95 (296)
.++| ++.++||+|++|.||+|.++.+|+.||+|+++...... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 16 YENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4555 68999999999999999999999999999997643211 1234567889999999995 999999999985
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.. ..+++||||+.+++|.+++.....+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||
T Consensus 95 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg 169 (298)
T 1phk_A 95 TN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFG 169 (298)
T ss_dssp CS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCT
T ss_pred cC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEeccc
Confidence 54 789999999999999999998888999999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCcccccCCCCCCccCccccc-------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
.+.............+++.|+|||++. ..++.++|+||||+++|+|++|..||....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 998876555556667899999999763 3478899999999999999999999987766655555554433322
Q ss_pred C-CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 249 A-LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 249 ~-~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
. .....+..+.+|+.+||+ ||.+|||+.++++||||++..++.
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence 1 123468899999999998 999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=328.02 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=223.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||++.++.+++.+|+|++..... ......+.+.+|+.++++++|+||+++++++... +.
T Consensus 14 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 89 (294)
T 2rku_A 14 RRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DF 89 (294)
T ss_dssp TEEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred ccce-EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CE
Confidence 3444 789999999999999999999999999999975543 2455677899999999999999999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++|||+.+++|.+++.....+++.+++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCceecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CC-cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RS-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. .......+++.|+|||.+.+ ..+.++|+||||+++|+|++|..||......+.......... ..+...+..+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 243 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAA 243 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHH
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---CCccccCHHHH
Confidence 32 22344568899999997664 488999999999999999999999987665555444433322 23345688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+++.+||+ ||++|||+.++++||||.....+...
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~ 278 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence 99999998 99999999999999999987665544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=344.02 Aligned_cols=258 Identities=23% Similarity=0.405 Sum_probs=211.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC--CCceeEEeeeeeeCCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 100 (296)
++.|++.++||+|+||+||++.+.. ++.||+|++..... +....+.+.+|+.+++++. |+||+++++++... .
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--C
Confidence 4445889999999999999999875 89999999986543 5666788999999999997 49999999988655 6
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++||| +.+++|.+++.....+++.++..++.||+.||.|||++| ++||||||+||+++. +.++|+|||++...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~--~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEESS--SCEEECCCSSSCCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEEC--CeEEEEecCccccc
Confidence 7999999 567799999998889999999999999999999999999 999999999999953 68999999999876
Q ss_pred CCCc---ccccCCCCCCccCcccccc------------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC
Q 022479 181 GRSH---AAHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 181 ~~~~---~~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 4322 2345678999999997753 488899999999999999999999987544433333333333
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.....+...+.++.+|+.+||+ ||++|||+.++|+||||+....+
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 3333445558899999999998 99999999999999999866543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=345.25 Aligned_cols=271 Identities=21% Similarity=0.335 Sum_probs=219.0
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC-CCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
+....+.|++.++||+|+||+||+|.++.+++.+|+|++...... .+....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 333334447899999999999999999999999999999754321 1234467899999999999999999999999654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHH
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKK----------------------------------------HRHVSIKALKKWSKQVL 137 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~----------------------------------------~~~~~~~~~~~i~~ql~ 137 (296)
..+++||||+.+++|.+++.. ...+++..++.++.|++
T Consensus 101 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 101 --QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp --SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred --CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 789999999999999998852 11236778889999999
Q ss_pred HHHHHHhhCCCCceecCCCCCceEEeCCC-CceEEeccCCccccCCCc-----ccccCCCCCCccCccccc---cCCCcc
Q 022479 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYMAPELYE---EDYTEM 208 (296)
Q Consensus 138 ~~l~~LH~~~~~i~h~dl~~~nilv~~~~-~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~---~~~~~~ 208 (296)
.||+|||++| ++|+||+|+||+++.+. ..++|+|||++....... ......+++.|+|||.+. ..++.+
T Consensus 179 ~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 179 SALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999999 99999999999998761 289999999998653321 234556899999999775 458899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 209 ~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+||||||+++|+|++|..||.+....+.............. .....++++.+|+.+||+ ||.+|||+.++|+||||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999988777777776665443222 122358899999999998 9999999999999999999
Q ss_pred ccCCCCC
Q 022479 287 LNDDDSE 293 (296)
Q Consensus 287 ~~~~~~~ 293 (296)
+.+.-..
T Consensus 337 ~~~~~~~ 343 (345)
T 3hko_A 337 FSDKIYK 343 (345)
T ss_dssp TSSCSSC
T ss_pred ChHhhEe
Confidence 8876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=334.38 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=222.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+.|++.++||+|+||.||++.+..+++.+|+|++..... ......+.+.+|+.++++++|+||+++++++.+. +.++
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 117 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVF 117 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEE
Confidence 344789999999999999999999999999999985533 2456677899999999999999999999998654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
++|||+.+++|.+++.....+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCceecccC
Confidence 99999999999999998888999999999999999999999999 9999999999999998 89999999999876432
Q ss_pred -cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 -HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+.......... ......+..+.+|
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 271 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAASL 271 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHHH
Confidence 23444568899999997664 488999999999999999999999987665555554444332 2334568899999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+.+||+ ||++|||+.++++||||.....+..
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence 999998 9999999999999999988765543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=334.55 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=202.1
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l 104 (296)
|++.++||+|+||+||+|.++.+|+.||+|++..... ..........|+..+.++ +|+||+++++++.+. ..+++
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 4678999999999999999999999999999864432 333344445555555555 999999999999655 78999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 105 ITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+ +.++|+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecccC
Confidence 99999 4588887765 456999999999999999999999999 9999999999999998 79999999999887666
Q ss_pred cccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.......+++.|+|||++.+.++.++||||||+++|+|++|..|+.+... ...+.....+.......++++.+|+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCCCcccccCCCHHHHHHHH
Confidence 55666678999999999888899999999999999999999776654322 22233333333334456899999999
Q ss_pred HHHh-CCCCCCCHHHHhcCccccc
Q 022479 264 KCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+||+ ||++|||+.++|+||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 9998 9999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=344.97 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=211.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD------ 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 97 (296)
..|++.++||+|+||+||+|.+..+|+.||+|++...... ..+|++++++++|+||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3347899999999999999999999999999999754322 23699999999999999999988543
Q ss_pred ------------------------------CCCeEEEEeeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH
Q 022479 98 ------------------------------QHNTLNFITEVCTSGNLRTYR----KKHRHVSIKALKKWSKQVLEGLEYL 143 (296)
Q Consensus 98 ------------------------------~~~~~~lv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~ql~~~l~~L 143 (296)
...++++||||+.+ +|.+.+ ..+..+++..++.++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23458999999996 665554 4567899999999999999999999
Q ss_pred hhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHH
Q 022479 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEM 221 (296)
Q Consensus 144 H~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~l 221 (296)
|++| ++||||||+||+++...+.++|+|||++.............+++.|+|||.+.+ .++.++|||||||++|+|
T Consensus 158 H~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 9999 999999999999985448999999999988766656666788999999997654 389999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhCCCCC--------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCC
Q 022479 222 VTMEIPYSECDSVAKIYKKVTGGVKP--------------------------QALNKVKDPEVKAFIEKCIA-QPRARPS 274 (296)
Q Consensus 222 l~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps 274 (296)
++|..||.+....+.+..++.....+ ...+...++++.+|+.+||+ ||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 99999999877777666554321110 00223457889999999998 9999999
Q ss_pred HHHHhcCcccccccC
Q 022479 275 ASELLKDPFFSELND 289 (296)
Q Consensus 275 ~~~ll~hp~~~~~~~ 289 (296)
+.++|+||||+++..
T Consensus 316 ~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 316 PYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHTSGGGHHHHH
T ss_pred HHHHhcCHHHHHHHh
Confidence 999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=335.43 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=194.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+++||+|+||+||+|.++.+++.||+|++... ....+.+|+.+++++. ||||+++++++.+. ...++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence 47899999999999999999999999999743 1356778999999997 99999999999655 78999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccccCCC-c
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRS-H 184 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~~~~-~ 184 (296)
|+.+++|.+++.....+++.+++.++.|++.||+|||++| ++||||||+||+++.+. ..++|+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999999999999889999999999999999999999999 99999999999998762 27999999999866433 2
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhCCCCCCCC--CCCCC
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYKKVTGGVKPQAL--NKVKD 255 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~--~~~~~ 255 (296)
.....++++.|+|||++.+ .++.++||||||+++|+|++|..||.+... .......+..+...... ....+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 2345567999999997764 489999999999999999999999975332 23344444443221111 12358
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+++.+|+.+||. ||.+|||+.++++||||++.....+.
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~ 283 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence 899999999998 99999999999999999987655443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=339.61 Aligned_cols=255 Identities=23% Similarity=0.418 Sum_probs=217.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----HHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++.++||+|++|.||+|.++.+|+.||||++........ ....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 174 (365)
T 2y7j_A 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS--SF 174 (365)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS--SE
T ss_pred ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC--CE
Confidence 678999999999999999998999999999976532212 23456788999999999 799999999988654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
.++||||+.|++|.+++.....+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCcccccC
Confidence 9999999999999999998888999999999999999999999999 9999999999999998 899999999998876
Q ss_pred CCcccccCCCCCCccCcccccc-------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCC
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKV 253 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 253 (296)
.........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+................... ....
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 6555666789999999997642 3788999999999999999999999876665555554444332211 1134
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+..+.+|+.+||+ ||++|||+.++|+||||+.
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 57889999999998 9999999999999999973
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=340.06 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=210.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.+.||+|+||+||+|.++.+|+.||+|+++.... ...+|++++.++ +||||+++++++.+. ..
T Consensus 22 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~ 90 (342)
T 2qr7_A 22 DGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--KY 90 (342)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--SE
T ss_pred ccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CE
Confidence 345 689999999999999999999999999999975432 124577788887 799999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC---ceEEeccCCcc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFAA 178 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~---~~~l~dfg~~~ 178 (296)
+|+||||+.|++|.+++...+.+++..+..++.|++.||.|||++| ++||||||+||++..+.+ .++|+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999998888999999999999999999999999 999999999999865423 59999999998
Q ss_pred ccCCC-cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhCCCCC--CCCCC
Q 022479 179 IVGRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGGVKP--QALNK 252 (296)
Q Consensus 179 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~--~~~~~ 252 (296)
..... ......++++.|+|||++.+. ++.++|+||||+++|+|++|..||.+. .....+...+..+... .....
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 76433 334556789999999987654 888999999999999999999999753 2334444444332221 12234
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..++++.+||.+||. ||++|||+.++++||||.+...
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 568999999999997 9999999999999999977543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=339.56 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=215.8
Q ss_pred Ccccce-eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCe
Q 022479 24 RFGRYS-DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 24 ~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 101 (296)
.+|.+. ++||+|+||+||+|.++.+++.||+|+++.... .......+.+|+.+++++. |+||+++++++... ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--Ce
Confidence 344455 899999999999999999999999999986543 2233567889999999995 69999999998654 78
Q ss_pred EEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC---CCCceEEeccCC
Q 022479 102 LNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGF 176 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~---~~~~~~l~dfg~ 176 (296)
+++||||+.+++|.+++.. ...+++.+++.++.|++.||++||++| ++|+||+|+||+++. + +.++|+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~-~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPL-GDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTB-CCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCC-CcEEEeeCcc
Confidence 9999999999999998854 367999999999999999999999999 999999999999987 4 7999999999
Q ss_pred ccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCC
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVK 254 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 254 (296)
+.............+++.|+|||++. ..++.++|+||||+++|+|++|..||.+....+........... +.......
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 98876655556678899999999776 45899999999999999999999999887766665555544332 22223456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+..+.+|+.+||+ ||.+|||++++|+||||+.++|+.-
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 8999999999998 9999999999999999999988653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=332.29 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=221.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|++|+||+|.++.+++.||+|++...... ......+.+|++++++++|+||+++++++... ..++
T Consensus 23 ~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 97 (287)
T 2wei_A 23 RY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFY 97 (287)
T ss_dssp HE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred cc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEE
Confidence 44 7899999999999999999999999999999765432 22356788999999999999999999998654 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~~~ 181 (296)
+++||+.+++|.+++.....+++.+++.++.|++.||.+||++| ++|+||+|+||+++.+. +.++|+|||++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999988888999999999999999999999999 99999999999997642 479999999998776
Q ss_pred CCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-CCCCCChHHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEVKA 260 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 260 (296)
.........+++.|+|||.+.+.++.++|+||||+++|+|++|..||.+....+.............. .....+.++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55444445678899999988888999999999999999999999999887666555555444332221 12346899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
++.+||. ||++|||+.++|+||||++..++
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence 9999998 99999999999999999988765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=352.67 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=207.0
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC----CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE----DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
|++.++||+|+||+||+|.++.+++.||+|++....... .......+.+|+.++++++||||+++++++.. ..
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~ 213 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---ED 213 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---SE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---Cc
Confidence 368899999999999999999999999999998654321 12223457899999999999999999998743 45
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~ 179 (296)
+++||||+.+++|.+++.....+++.+++.++.|++.||+|||++| ++||||||+||+++.+. ..++|+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 8999999999999999988888999999999999999999999999 99999999999997651 3599999999998
Q ss_pred cCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC--CCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKV 253 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 253 (296)
..........++++.|+|||++. ..++.++||||||+++|+|++|..||.+......+...+........ ....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 76665566678999999999874 34778999999999999999999999865544444444444332211 1234
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.++.+.+|+.+||+ ||++|||+.++|+||||++.++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 58899999999998 9999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=328.23 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=216.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.+.||+|++|.||+|.++.+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+. ...+
T Consensus 8 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (276)
T 2yex_A 8 DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 81 (276)
T ss_dssp HE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ce-EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEE
Confidence 44 689999999999999999999999999999975432 23457788999999999999999999998665 7889
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+|+||+.+++|.+++.....+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCCC
Confidence 99999999999999988888999999999999999999999999 9999999999999998 89999999999765322
Q ss_pred ---cccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 184 ---HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 184 ---~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
.......+++.|+|||.+.+. .+.++|+||||+++|+|++|..||..........................++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 223445688999999987654 367899999999999999999999875544333333333333223334568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.+|+.+||. ||.+|||+.++++||||++.....
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 999999998 999999999999999998765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=358.17 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=218.6
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|++++++++|+||+++++.+.+. ..+|+|
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV 262 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 262 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEEEE
Confidence 478999999999999999999999999999997543211 11245678899999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.|++|.+++...+ .+++..++.++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccceecccC
Confidence 99999999999998754 3999999999999999999999999 9999999999999998 89999999999887655
Q ss_pred cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
......++|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.. ....+...+.... ...+...+++++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--ccCCccCCHHHH
Confidence 55556789999999997765 48999999999999999999999997643 2344444444322 223455689999
Q ss_pred HHHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 260 AFIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 260 ~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
+||.+||+ ||.+|| ++.++++||||++++|+
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 99999997 999999 89999999999998874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=339.78 Aligned_cols=265 Identities=21% Similarity=0.370 Sum_probs=213.6
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-- 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 98 (296)
..++| ++.++||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.++++++|+||+++++++....
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 15 EVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp BGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 44566 689999999999999999999999999999865543 2222356778999999999999999999987643
Q ss_pred ----CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 99 ----HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 99 ----~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
...+++||||+.+ +|.+.+.. ...+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~D 167 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLAD 167 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECC
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEcc
Confidence 3578999999997 66666554 467999999999999999999999999 9999999999999998 8999999
Q ss_pred cCCccccCC-----CcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--CC
Q 022479 174 LGFAAIVGR-----SHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GG 244 (296)
Q Consensus 174 fg~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~--~~ 244 (296)
||++..... ........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+............ ..
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999987642 222344567899999997754 379999999999999999999999988766555443332 22
Q ss_pred CCCCCCCCC---------------------------CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 245 VKPQALNKV---------------------------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 245 ~~~~~~~~~---------------------------~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+...... .++.+.+|+.+||+ ||++|||+.++|+||||.....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 222221111 25679999999998 9999999999999999988766654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=330.60 Aligned_cols=260 Identities=21% Similarity=0.378 Sum_probs=217.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||+||+|.+..+++.+|+|++...... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 9 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 345 7899999999999999999999999999999754321 122246788999999999999999999998655 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++|||+.+++|.+++.....+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCc
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999998865543
Q ss_pred CcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ......+++.|+|||.+.+. .+.++|+||||+++|+|++|..||......+.......... ..+...+..+.+|
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---TFPDFVTEGARDL 237 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCHHHHHH
T ss_pred c-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---CCCCcCCHHHHHH
Confidence 2 23445788999999977654 78899999999999999999999987665555544444322 2344568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+.+||+ ||++|||+.++++||||+......+.
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 270 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCccCccc
Confidence 999998 99999999999999999987766554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=331.72 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=200.7
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 104 (296)
-+++.++||+|+||+||+|.+..+|+.||+|+++.... .....+.+.++...++.++||||+++++++..+ ...++
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~l 83 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVWI 83 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEEE
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEEE
Confidence 34789999999999999999999999999999975432 233444555666668888999999999999655 67999
Q ss_pred EeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 105 ITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 105 v~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
||||+.+ +|.+++. .+..+++..++.++.|++.||+|||++ | ++|+||||+||+++.+ +.++|+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence 9999986 7777664 357899999999999999999999998 9 9999999999999998 7999999999987
Q ss_pred cCCCcccccCCCCCCccCcccc----c-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELY----E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS-VAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~----~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 253 (296)
...........+++.|+|||.+ . ..++.++|+||||+++|+|++|..||..... ........... .+......
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADK 238 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCCCCTTT
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CCCccccc
Confidence 7665555556789999999975 2 3488899999999999999999999986443 34444444443 33444455
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.+.++.+|+.+||+ ||++|||+.++++||||+......
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~ 277 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccc
Confidence 68999999999998 999999999999999998765443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=341.22 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=216.1
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||++.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++... ..+++|
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 109 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 109 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEE
Confidence 478999999999999999999999999999998542 456678899999999999999999999998765 689999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|||+.+++|.+++...+.+++..+..++.|++.||+|||+. | ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCcccccc-
Confidence 99999999999999888899999999999999999999996 9 9999999999999998 89999999999765322
Q ss_pred ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---------------------------
Q 022479 185 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--------------------------- 236 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~--------------------------- 236 (296)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 2334578999999997764 489999999999999999999999976443221
Q ss_pred --------------HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 237 --------------IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 237 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
....+.....+.......+.++.+|+.+||+ ||.+|||+.++|+||||+...++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 1112222223333344568899999999998 999999999999999999877654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=331.28 Aligned_cols=263 Identities=21% Similarity=0.366 Sum_probs=217.6
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC--HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
|++.+.||+|+||+||+|.++.+++.+|+|+++....... ....+.+.+|+.++++++||||+++++++... ..++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 84 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TDVV 84 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--CeEE
Confidence 3789999999999999999999999999999986543221 12356788999999999999999999998654 6899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC----ceEEeccCCccc
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFAAI 179 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~----~~~l~dfg~~~~ 179 (296)
++|||+.+++|.+++.....+++.+++.++.|++.||.+||++| ++|+||+|+||+++.+ + .++|+|||.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDK-NVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecC-CCCCCceEEEeccccee
Confidence 99999999999999998888999999999999999999999999 9999999999999877 4 799999999987
Q ss_pred cCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (296)
...........+++.|+|||.+. +.++.++|+||||+++|+|++|..||.+....+............ .......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76555555567899999999776 458899999999999999999999998866655554444332211 1112345889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+.+|+.+||. ||.+|||+.++++||||+.+.+...+
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 278 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR 278 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence 9999999998 99999999999999999998776543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=332.63 Aligned_cols=262 Identities=28% Similarity=0.496 Sum_probs=217.8
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
++..++| ++.+.||+|+||.||+|.++.+++.+|+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 88 (302)
T 2j7t_A 15 LDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHD- 88 (302)
T ss_dssp SCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred cCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-
Confidence 4455555 789999999999999999999999999999975422 2356788999999999999999999998655
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 89 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 164 (302)
T 2j7t_A 89 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVS 164 (302)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHHH
T ss_pred -CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCCC
Confidence 689999999999999998875 567999999999999999999999999 9999999999999988 79999999987
Q ss_pred cccCC-CcccccCCCCCCccCcccc------ccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 178 AIVGR-SHAAHSIIGTPEYMAPELY------EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 178 ~~~~~-~~~~~~~~~~~~~~aPE~~------~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
..... ........+++.|+|||.+ ...++.++|+||||+++|+|++|..||......................
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence 54321 1123345688899999976 3448889999999999999999999998877766666666655444444
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
....+.++.+++.+||. ||.+|||+.++++||||+.+.+.
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 55668999999999998 99999999999999999988764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=331.39 Aligned_cols=264 Identities=23% Similarity=0.411 Sum_probs=216.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||++.+..+++.+|+|+++.............+.+|+.++++++|+||+++++++.......+
T Consensus 5 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 455 7899999999999999999999999999999765432223346788999999999999999999999876656789
Q ss_pred EEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++||||+.++ |.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeecccccccc
Confidence 9999999986 7677664 457999999999999999999999999 9999999999999998 89999999999876
Q ss_pred CC---CcccccCCCCCCccCccccccC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 181 GR---SHAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 181 ~~---~~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
.. ........+++.|+|||++.+. .+.++||||||+++|+|++|..||.+....+.......... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~ 236 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---AIPGDC 236 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---CCCSSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC---CCCCcc
Confidence 43 2223345688999999977643 47799999999999999999999987655544444433322 233456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
++.+.+|+.+||. ||.+|||+.++++||||++.....+.+
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 277 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCC
Confidence 8999999999998 999999999999999999887766553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=334.77 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=216.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| ++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|++++++++||||+++++++... ...
T Consensus 54 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 129 (348)
T 1u5q_A 54 KLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTA 129 (348)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred hhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeE
Confidence 344 678999999999999999999999999999975432 2344567889999999999999999999999765 689
Q ss_pred EEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.| +|.+++. ....+++.++..++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++....
T Consensus 130 ~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSS
T ss_pred EEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCceecC
Confidence 999999985 7777765 4667999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.. ....+++.|+|||++. +.++.++||||||+++|+|++|..||.+......+......... .......++.
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 281 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-ALQSGHWSEY 281 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCCCTTSCHH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCCCCCHH
Confidence 32 3457899999999763 45889999999999999999999999887777766666555433 3334556899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+.+|+.+||+ ||++|||+.++++||||....
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999998 999999999999999997654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=335.85 Aligned_cols=257 Identities=18% Similarity=0.346 Sum_probs=211.8
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 100 (296)
.++| ++.++||+|+||+||+|.+..+++.||+|+++... .+.+.+|+.++++++ |+||+++++++.+....
T Consensus 35 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 4455 68999999999999999999999999999997432 366889999999997 99999999999876668
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
..+++|||+.+++|.+++.. +++.+++.++.|++.||+|||++| ++|+||||+||+++.+...++|+|||++...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 89999999999999988864 899999999999999999999999 9999999999999977348999999999887
Q ss_pred CCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHh------------CCC
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVT------------GGV 245 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~------------~~~ 245 (296)
..........+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ..+.+..... ...
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 66555666778999999997654 48999999999999999999999995432 2222221111 000
Q ss_pred C----------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 246 K----------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 246 ~----------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
. ........++++.+||.+||+ ||++|||+.++|+||||+.+.+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~ 330 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC---
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccCC
Confidence 0 001112258899999999998 999999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=330.00 Aligned_cols=257 Identities=26% Similarity=0.525 Sum_probs=214.9
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
...+| ++.++||+|+||.||+|.++.+|+.||+|++..... .+.+.+|+.++++++|+||+++++++... .
T Consensus 27 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 97 (314)
T 3com_A 27 PEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKN--T 97 (314)
T ss_dssp ---CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred chhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeC--C
Confidence 34455 689999999999999999999999999999975421 35678899999999999999999999765 6
Q ss_pred eEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.+++|.+++. ....+++..++.++.|++.||.+||+.| ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~ 174 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccchh
Confidence 8999999999999999987 4667999999999999999999999999 9999999999999998 8999999999977
Q ss_pred cCCC-cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGRS-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..........................+..
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T 3com_A 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDN 254 (314)
T ss_dssp CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHH
Confidence 6443 22344568899999997664 489999999999999999999999988776666655555544333344556899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+.+|+.+||. ||.+|||+.++++||||+...+
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999999998 9999999999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=336.25 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=214.0
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..++| ++.++||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++|+||+++++++.+. .
T Consensus 23 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 97 (331)
T 4aaa_A 23 SMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--K 97 (331)
T ss_dssp CGGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred hhhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--C
Confidence 34456 67999999999999999999999999999997543 3566677888999999999999999999999665 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++||||+.+++|..++.....+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceee
Confidence 89999999999999998888888999999999999999999999999 9999999999999998 79999999999776
Q ss_pred CCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-----------
Q 022479 181 GRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----------- 246 (296)
Q Consensus 181 ~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------- 246 (296)
... .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+...........
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 432 22345578899999997765 4789999999999999999999999887766655544321100
Q ss_pred --------CCC---------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 247 --------PQA---------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 247 --------~~~---------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
... .....++.+.+|+.+||+ ||++|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 000 011357899999999998 999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=332.22 Aligned_cols=261 Identities=25% Similarity=0.507 Sum_probs=213.7
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
.+..++| ++.++||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 20 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3455555 789999999999999999999999999999975432 135678899999999 799999999998764
Q ss_pred C----CCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 98 Q----HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 98 ~----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
. ...+++||||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEE
Confidence 2 46899999999999999999864 57999999999999999999999999 9999999999999988 89999
Q ss_pred eccCCccccCCC-cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC
Q 022479 172 GDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 244 (296)
Q Consensus 172 ~dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 244 (296)
+|||++...... .......+++.|+|||.+. ..++.++||||||+++|+|++|..||.+..............
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999999876432 2233456889999999764 348889999999999999999999998876666555544443
Q ss_pred CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 245 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+.......+..+.+||.+||. ||.+|||+.++++||||++...
T Consensus 251 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 251 -APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp -CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred -cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 3333445568999999999997 9999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=338.25 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=216.6
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ- 98 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 98 (296)
+..++| ++.++||+|+||.||+|.+..+++.||+|++... ........+.+|++++++++|+||+++++++....
T Consensus 24 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 24 DVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp CCTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cccccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 344566 7899999999999999999999999999999743 24556678899999999999999999999886542
Q ss_pred --CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 99 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 99 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
...+++|+||+.+ +|.+++... .+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||+
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~ 174 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGL 174 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTT
T ss_pred cccceEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCcc
Confidence 2468999999986 898888765 5999999999999999999999999 9999999999999998 8999999999
Q ss_pred ccccCCCcc----cccCCCCCCccCccccc-c-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---
Q 022479 177 AAIVGRSHA----AHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--- 247 (296)
Q Consensus 177 ~~~~~~~~~----~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--- 247 (296)
+........ .....+++.|+|||++. + .++.++||||||+++|+|++|..||.+....+.+..+......+
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 987643322 23457899999999654 3 37999999999999999999999998766555444333211000
Q ss_pred -------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 -------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 -------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++++.+|+.+||+ ||++|||+.++|+||||+.+..+..+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~ 326 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccc
Confidence 00112357899999999998 99999999999999999998654443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=328.23 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=212.8
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+. ..++++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 84 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYLV 84 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEEE
Confidence 4789999999999999999999999999999985432 2235688999999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE---eCCCCceEEeccCCccccCC
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv---~~~~~~~~l~dfg~~~~~~~ 182 (296)
|||+.+++|.+++...+.+++..+..++.|++.||.+||++| ++|+||+|+||++ +.+ +.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC
Confidence 999999999999988888999999999999999999999999 9999999999999 555 7999999999876543
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 260 (296)
. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+................. .......+..+.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 2334468899999997765 48899999999999999999999998766555554444443221 2223456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
|+.+||+ ||++|||+.++++||||++...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999998 9999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=336.06 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=211.3
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.++| ++.++||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|++++++++|+||+++++++... .
T Consensus 9 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 85 (346)
T 1ua2_A 9 AKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--S 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--T
T ss_pred hccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--C
Confidence 3455 689999999999999999999999999999976433221 12235678999999999999999999998544 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.+ +|..++... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEeccccee
Confidence 78999999997 888887754 46899999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCC-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC--CCCCC----
Q 022479 180 VGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQAL---- 250 (296)
Q Consensus 180 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~---- 250 (296)
.... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+..... ....+
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 6433 23445678999999997754 378899999999999999999999988777666655544211 11110
Q ss_pred -------------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 251 -------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 251 -------------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
....+.++.+||.+||. ||++|||+.++|+||||++..++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 12346889999999998 9999999999999999998776653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=327.52 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=207.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||++.++.+|+.||+|++...... .....+.+.+|+.++++++|+||+++++++... ..+
T Consensus 11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred ccE-EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 455 7899999999999999999999999999999754221 112356788999999999999999999998654 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++++||+.+++|.+++.....+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCC
Confidence 999999999999999998888999999999999999999999999 9999999999999998 7999999999987765
Q ss_pred CcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
........+++.|+|||.+.+. .+.++|+||||+++|+|++|..||................. ..+...+..+.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---YIPEYLNRSVAT 240 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---cCchhcCHHHHH
Confidence 5445556788999999987765 35799999999999999999999987655444443333321 233446889999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++.+||+ ||.+|||+.++++||||++.
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999998 99999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=341.83 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=200.1
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.++||+|+||+||+|.+..+|+.||+|++.... .+.....++.+|+.++++++|+||+++++++....
T Consensus 28 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3566 68999999999999999999999999999997543 24556778889999999999999999999986431
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...++++++++ +++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++.+ +.++|+|||++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeecccc
Confidence 25679999998 5689888876 56999999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 247 (296)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 180 RHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 875432 334578999999997654 58899999999999999999999999877666554443211110
Q ss_pred -------------C-------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 248 -------------Q-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 248 -------------~-------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
. ......++.+.+|+.+||. ||.+|||+.++|+||||+.+..++.++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 325 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 325 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC
Confidence 0 0012347889999999998 999999999999999999987766553
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=336.03 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=218.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--N 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~ 100 (296)
++| ++.++||+|+||.||+|.+..+++.||+|+++.... .+......+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 12 DRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred CcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 445 789999999999999999999999999999975433 345667789999999999999999999998865432 2
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
..++||||+.+++|.+++...+.+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCcccc
Confidence 56999999999999999998888999999999999999999999999 9999999999999999 89999999999866
Q ss_pred CCCc----ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCC
Q 022479 181 GRSH----AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVK 254 (296)
Q Consensus 181 ~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (296)
.... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+....+...........+ .......
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 4322 2233568999999997764 48999999999999999999999999877777766666654433 2223446
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+.++.+++.+||+ ||.+||++.+++.|+|++.......
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 8999999999997 9999999999999999987655443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=341.36 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=201.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHH-HhcCCCceeEEeeeeee--
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLD-- 96 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~-- 96 (296)
...+.|+.+.++||+|+||+||++.++.+|+.||+|++... ..+.+|+.++ +..+|+||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 34455654458999999999999999999999999999632 3456788876 45589999999998854
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEe
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIG 172 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~ 172 (296)
.....+|+||||+.|++|.+++...+ .+++.+++.++.|++.||.|||++| ++||||||+||+++.+ .+.++|+
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence 23467899999999999999998643 5999999999999999999999999 9999999999999972 2789999
Q ss_pred ccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhCCCC-
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA----KIYKKVTGGVK- 246 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~----~~~~~~~~~~~- 246 (296)
|||++............++|+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... ...........
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 9999987765555566788999999998764 58999999999999999999999997543211 12222222221
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+.......+.++.+||.+||. ||++|||+.++++||||....
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 112223468999999999997 999999999999999998644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=342.05 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=209.9
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----CCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----HNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~ 101 (296)
|++.++||+|+||+||+|.++.+|+.||||++..... ...+|++++++++|+||+++++++.... ..+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4678999999999999999999999999999975422 1236999999999999999998886432 235
Q ss_pred EEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 102 LNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
+++||||+.+ +|...+. ....+++..++.++.||+.||+|||++| ++||||||+|||++.+.+.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7899999997 5554443 4577999999999999999999999999 9999999999999976467899999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC---------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--------- 246 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------- 246 (296)
+............+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..++.....
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 87755555556678999999997654 4899999999999999999999999987766666554432100
Q ss_pred -----CCC------------CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 247 -----PQA------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 247 -----~~~------------~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
... .....+.++.+||.+||. ||.+|||+.++++||||+++.++..
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 000 122347899999999998 9999999999999999999876643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=326.90 Aligned_cols=259 Identities=20% Similarity=0.357 Sum_probs=219.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||+||+|.+..+++.||+|++...... .......+.+|++++++++|+||+++++++.+. +.+
T Consensus 14 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 89 (284)
T 2vgo_A 14 DDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI 89 (284)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhc-eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence 455 7899999999999999999999999999999754221 111246788999999999999999999998654 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++|||+.+++|.+++...+.+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCcc
Confidence 999999999999999998888999999999999999999999999 9999999999999988 8999999999876543
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+.......... ..+...+..+.++
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDL 242 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHH
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---CCCCcCCHHHHHH
Confidence 3 2344578899999997664 488999999999999999999999987666555544443322 2334568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+.+||+ ||.+|||+.++++||||+.......
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~ 274 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhccccC
Confidence 999998 9999999999999999997665443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=341.74 Aligned_cols=259 Identities=26% Similarity=0.353 Sum_probs=204.0
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
.++| ++.++||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 3455 689999999999999999999999999999985432 4566778899999999999999999999986543
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC-
T ss_pred cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecc
Confidence 1378999999987 7877776 35899999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-------- 248 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 248 (296)
.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+...........+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 87765544556678999999997664 489999999999999999999999998777666555544322110
Q ss_pred ------------CC-------------C------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 249 ------------AL-------------N------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 249 ------------~~-------------~------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.. + ...+.++.+|+.+||+ ||++|||+.++|+||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 0 0014578999999998 9999999999999999987644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=338.14 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=211.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+| ++.++||+|+||+||+|.++.+++.||+|+++....... ......+.+|+.++++++|+||+++++++...
T Consensus 25 ~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-- 101 (335)
T 3dls_A 25 KY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-- 101 (335)
T ss_dssp HE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred ce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC--
Confidence 44 789999999999999999999999999999986543211 11234567899999999999999999998654
Q ss_pred CeEEEEeeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.++ +|.+++.....+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecccce
Confidence 7899999998766 99999999889999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcccccCCCCCCccCccccccC-C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
............+++.|+|||++.+. + +.++||||||+++|+|++|..||...... .......+...+.
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAAIHPPYLVSK 249 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTCCCCSSCCCH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------HhhccCCCcccCH
Confidence 87666556667789999999977654 3 78899999999999999999999753221 1112223444689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++.+|+.+||+ ||++|||+.++++||||+..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999998 99999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=336.92 Aligned_cols=251 Identities=25% Similarity=0.446 Sum_probs=203.7
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC-------
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH------- 99 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 99 (296)
++.++||+|+||.||+|.++.+|+.||+|+++... .....+.+.+|++++++++||||+++++++.+...
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 67899999999999999999999999999998543 33446788999999999999999999998865432
Q ss_pred ------------------------------------------------CeEEEEeeccCCCCHHHHHHhcC---CCCHHH
Q 022479 100 ------------------------------------------------NTLNFITEVCTSGNLRTYRKKHR---HVSIKA 128 (296)
Q Consensus 100 ------------------------------------------------~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~ 128 (296)
..++++|||+.+++|.+++.... ..+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 24899999999999999998754 355667
Q ss_pred HHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-------------ccccCCCCCCc
Q 022479 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-------------AAHSIIGTPEY 195 (296)
Q Consensus 129 ~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~ 195 (296)
++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++....... ......+++.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999999 9999999999999988 899999999998765432 23345689999
Q ss_pred cCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCC
Q 022479 196 MAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 273 (296)
Q Consensus 196 ~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rp 273 (296)
+|||.+.+ .++.++||||||+++|+|++|..|+. ..............+.. ....++.+.+|+.+||+ ||++||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCCcCC
Confidence 99997764 58999999999999999999877653 22223333333322211 12236788999999998 999999
Q ss_pred CHHHHhcCcccccc
Q 022479 274 SASELLKDPFFSEL 287 (296)
Q Consensus 274 s~~~ll~hp~~~~~ 287 (296)
|+.++|+||||+++
T Consensus 319 s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 319 EATDIIENAIFENL 332 (332)
T ss_dssp CHHHHHHSTTCCCC
T ss_pred CHHHHhhchhhhcC
Confidence 99999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=336.75 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=206.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.++.+++.||+|++..... ......+.+|++++++++|+||+++++++... ..++
T Consensus 3 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (324)
T 3mtl_A 3 TY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT 76 (324)
T ss_dssp SE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEE
T ss_pred ce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEE
Confidence 45 689999999999999999999999999999975432 11122345799999999999999999998655 6899
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSI 152 (324)
T ss_dssp EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC--
T ss_pred EEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCcccccccC
Confidence 99999986 88888775 456999999999999999999999999 9999999999999999 8999999999976543
Q ss_pred C-cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC--CCCCCCCC------
Q 022479 183 S-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQALN------ 251 (296)
Q Consensus 183 ~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~------ 251 (296)
. .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+........ ......+.
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 22344567899999997654 4799999999999999999999999887666555444332 11111111
Q ss_pred -------------------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 252 -------------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 252 -------------------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
...++++.+|+.+||+ ||.+|||+.++|+||||.++......
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence 1347889999999998 99999999999999999998776544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=328.49 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=206.2
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.....+++.++||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|++++++++|+||+++++++... .
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--P 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--T
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--C
Confidence 3334447899999999999999976 488999999975543 456677899999999999999999999998544 6
Q ss_pred eEEEEeeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
.+++||||+.+++|.+++..... +++..++.++.|++.||+|||++|++++||||||+||+++.+ +.++|+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCC
Confidence 78999999999999999987553 999999999999999999999998779999999999999998 89999999999
Q ss_pred cccCCCc-ccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
....... ......+++.|+|||++.+. ++.++||||||+++|+|++|..||.+....+............ ..+...+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 265 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-CCCTTSC
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCccCC
Confidence 7654332 23446789999999977644 8899999999999999999999998876666555554444333 3344568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc--Cccccc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK--DPFFSE 286 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~--hp~~~~ 286 (296)
+++.+|+.+||+ ||.+|||+.++++ .++++.
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999998 9999999999998 344443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=362.27 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=221.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
+.| ++.++||+|+||.||+|.++.+++.||+|+++...... ....+.+..|..++..+ +|++|++++.++.+. ..
T Consensus 341 ~~f-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 341 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp TTE-EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred cce-EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 345 67899999999999999999999999999998542211 12245677889999887 799999999988544 78
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+|+||||+.|++|..++...+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeeccc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999 899999999998643
Q ss_pred -CCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 -RSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 -~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
........++|+.|+|||++. ..++.++|+||||+++|+|++|..||.+.+..+....+..... ..+...+.++.
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---CCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHH
Confidence 333455678999999999776 4589999999999999999999999998766555555554432 23345789999
Q ss_pred HHHHHHHh-CCCCCCCH-----HHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARPSA-----SELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~-----~~ll~hp~~~~~~~~~ 291 (296)
+||.+||+ ||++||++ +++++||||+.++|+.
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 99999997 99999998 9999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=340.05 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=211.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC--
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN-- 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 100 (296)
++| ++.++||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.++++++|+||+++++++......
T Consensus 42 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 42 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccE-EEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 455 679999999999999999999999999999975432 556678899999999999999999999998654321
Q ss_pred --eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 101 --TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 101 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
.+++||||+.+ +|.+++. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 119 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC-
T ss_pred ceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccc
Confidence 24899999985 7877764 35999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
..... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+.+.........+
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 65433 344567999999997664 58999999999999999999999998877666555443321110
Q ss_pred -------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 -------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 -------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++.+.+|+.+||+ ||++|||+.++|+||||+.+..+.++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 336 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 336 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccc
Confidence 00112357899999999998 99999999999999999988665443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=332.64 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=210.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+..|++.++||+|+||+||+|.+..+++.||+|++........ .+.+.+|++++++++|+||+++++++.......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch---HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3445789999999999999999999999999999976543222 4667799999999999999999999887766689
Q ss_pred EEEeeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE----eCCCCceEEeccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGDLG 175 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv----~~~~~~~~l~dfg 175 (296)
++||||+.+++|.+++..... +++.+++.++.|++.||+|||++| ++|+||||+||++ +.+ +.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEEccCC
Confidence 999999999999999986433 999999999999999999999999 9999999999998 555 679999999
Q ss_pred CccccCCCcccccCCCCCCccCccccc---------cCCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYE---------EDYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVT 242 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~Di~slG~i~~~ll~g~~p~~~~----~~~~~~~~~~~ 242 (296)
++.............+++.|+|||++. ..++.++||||||+++|+|++|..||... ...+.......
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 998876666666677899999999764 45889999999999999999999999632 22333444433
Q ss_pred CCCCC----------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcc
Q 022479 243 GGVKP----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 243 ~~~~~----------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~ 283 (296)
..+.. .......+..+.+|+.+||+ ||++|||+.++|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32211 01111224578899999998 9999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=336.12 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=209.0
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC----CCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
|++.+.||+|+||.||+|.++.+++.||+|++...... ........+.+|++++++++|+||+++++++... .
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 88 (322)
T 2ycf_A 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---D 88 (322)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC---c
Confidence 37899999999999999999999999999999754321 1122345688999999999999999999988543 3
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l~dfg~~~~ 179 (296)
+++||||+.+++|.+++.....+++..++.++.|++.||.|||++| ++|+||+|+||+++.+. ..++|+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999999999999998888999999999999999999999999 99999999999998762 2499999999988
Q ss_pred cCCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALNKV 253 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 253 (296)
...........+++.|+|||++. ..++.++||||||+++|+|++|..||........+...+....... .....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence 76544444556899999999763 4488999999999999999999999976543333333333322111 11234
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+..+.+|+.+||. ||++|||+.++|+||||++..+
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 58899999999998 9999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=335.10 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=206.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-----CCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----NKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~ 97 (296)
++.|++.++||+|+||+||+|.+..+++.||+|+++. .....+.+..|+.+++++. |+||+++++.+...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 3445789999999999999999999999999999973 3445667788999999997 99999999999765
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC-----------
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----------- 164 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~----------- 164 (296)
..+++||||+ +++|.+++.... .+++.+++.++.||+.||+|||++| ++||||||+||+++.
T Consensus 109 --~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 --DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp --TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred --CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence 6899999999 889999998654 5999999999999999999999999 999999999999974
Q ss_pred -------------CCCceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 022479 165 -------------NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSE 230 (296)
Q Consensus 165 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~ 230 (296)
..+.++|+|||++...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 1278999999999875433 345678999999997654 589999999999999999999999987
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------C--------------------CCCCCChHHHHHHHHHHh
Q 022479 231 CDSVAKIYKKVTGGVKPQ-----------------------A--------------------LNKVKDPEVKAFIEKCIA 267 (296)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~-----------------------~--------------------~~~~~~~~l~~li~~~l~ 267 (296)
....+............. . .....++.+.+|+.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 665554433322111100 0 001123678899999998
Q ss_pred -CCCCCCCHHHHhcCcccc
Q 022479 268 -QPRARPSASELLKDPFFS 285 (296)
Q Consensus 268 -~p~~Rps~~~ll~hp~~~ 285 (296)
||++|||+.++|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=350.55 Aligned_cols=257 Identities=22% Similarity=0.363 Sum_probs=215.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|++++++++||||+++++.+... ..+|+|
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV 263 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLV 263 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEEEE
Confidence 367899999999999999999999999999997543211 12245688899999999999999999998654 789999
Q ss_pred eeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 106 TEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
|||+.|++|..++... ..+++..++.++.||+.||.|||++| ++||||||+||+++.+ |.++|+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeecceeeecc
Confidence 9999999999998763 46999999999999999999999999 9999999999999998 899999999998765
Q ss_pred CCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 182 RSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 182 ~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.... ....++|+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.. ....+...+.... ...+...+.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccCH
Confidence 4332 344589999999997765 48999999999999999999999997642 2334444433322 123345689
Q ss_pred HHHHHHHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 257 EVKAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
.+.+||.+||+ ||++||+ ++++++||||++++|+
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 99999999997 9999995 5899999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=330.21 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---- 97 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 97 (296)
.++| ++.++||+|+||+||+|.++.+++.||+|++... +....+.+.+|++++++++|+||+++++++...
T Consensus 10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4566 6899999999999999999999999999999753 455677899999999999999999999887432
Q ss_pred --------CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCce
Q 022479 98 --------QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169 (296)
Q Consensus 98 --------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~ 169 (296)
....+++||||+.+ +|.+++.. +.+++..++.++.|++.||+|||++| ++|+||+|+||+++.+.+.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 23688999999985 99998875 45999999999999999999999999 99999999999998654799
Q ss_pred EEeccCCccccCCC----cccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 022479 170 KIGDLGFAAIVGRS----HAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 170 ~l~dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~ 243 (296)
+|+|||++...... .......+++.|+|||.+. ..++.++|+||||+++|+|++|+.||.+....+........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876432 1233345688999999664 45889999999999999999999999887765554444332
Q ss_pred CCCC---------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 244 GVKP---------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 244 ~~~~---------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
.... .......+.++.+|+.+||+ ||++|||+.++|+||||+.+.++..+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~ 319 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence 1110 01113468899999999998 999999999999999999999998776
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=324.44 Aligned_cols=263 Identities=26% Similarity=0.485 Sum_probs=222.0
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
.....++..+| ++.++||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.++++++|+||+++++.+
T Consensus 14 ~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 14 QNLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp TTCEECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcCCCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34445666666 679999999999999999999999999999986543 22357788999999999999999999998
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
... ..+++||||+.+++|.+++.. +.+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 90 ~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Df 163 (303)
T 3a7i_A 90 LKD--TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADF 163 (303)
T ss_dssp EET--TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCC
T ss_pred ecC--CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeec
Confidence 765 689999999999999999876 45999999999999999999999999 9999999999999998 89999999
Q ss_pred CCccccCCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 175 GFAAIVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 175 g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
|.+....... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||................. .....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 241 (303)
T 3a7i_A 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--PTLEG 241 (303)
T ss_dssp TTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCCS
T ss_pred ccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--CCCcc
Confidence 9997764432 2344568899999997664 488999999999999999999999987666555554444332 23344
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..+..+.+|+.+||. ||.+|||+.++++||||.....
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 568999999999997 9999999999999999976543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=326.75 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=192.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 11 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (278)
T 3cok_A 11 EDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYV 86 (278)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEE
T ss_pred ccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeE
Confidence 455 78999999999999999999899999999997543211 12246788999999999999999999998654 789
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceeecc
Confidence 9999999999999999865 67999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 182 RSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 182 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.............. .....+...+.++.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 240 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADYEMPSFLSIEAK 240 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---SCCCCCTTSCHHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---cccCCccccCHHHH
Confidence 322 2334568899999997764 488899999999999999999999976543332222111 11223445688999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+|+.+||+ ||++|||+.++++||||.......
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 273 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence 99999998 999999999999999998765443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=336.58 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=208.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----CCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----HNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~ 101 (296)
|++.++||+|+||+||+|.+..+++ +|+|++...... ..+|++++++++|+||+++++++.... ...
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4789999999999999999987665 888887644321 226999999999999999999986543 234
Q ss_pred EEEEeeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 102 LNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+++||||+.++.+... ......+++..++.++.|++.||+|||++| ++||||||+||+++...+.++|+|||++.
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 7899999998644333 234667999999999999999999999999 99999999999999433899999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------- 247 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 247 (296)
............+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+......+
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 8765555566778999999997754 48999999999999999999999999877766666554321110
Q ss_pred -----------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 -----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 -----------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++++.+|+.+||+ ||.+|||+.++++||||+++.+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 01122357899999999998 99999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=332.77 Aligned_cols=265 Identities=25% Similarity=0.300 Sum_probs=203.3
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-- 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 98 (296)
..++| ++.++||+|+||+||+|.++.+|+.||+|++...... ...+.++++.++.++|+||+++++++....
T Consensus 21 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTE-EEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34466 6899999999999999999999999999998654322 234567888889999999999999986532
Q ss_pred ---CCeEEEEeeccCCCCHH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHh--hCCCCceecCCCCCceEEeCCCCceE
Q 022479 99 ---HNTLNFITEVCTSGNLR---TYRKKHRHVSIKALKKWSKQVLEGLEYLH--THEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 99 ---~~~~~lv~e~~~~~sL~---~~l~~~~~~~~~~~~~i~~ql~~~l~~LH--~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
...+++||||+.++.+. .+......+++..++.++.|++.||.+|| ++| ++|+||||+||+++...+.++
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 22488999999985332 23345678999999999999999999999 889 999999999999997338999
Q ss_pred EeccCCccccCCCcccccCCCCCCccCcccccc-C-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP- 247 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~- 247 (296)
|+|||++.............+++.|+|||++.+ . ++.++||||||+++|+|++|..||.+................+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999988766655666778999999997643 3 7999999999999999999999998877666555444321110
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 ----------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 ----------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......+.++.+|+.+||+ ||.+|||+.++|+||||+++..+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 00011135789999999998 99999999999999999999877654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=323.06 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=216.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||.||++.++.+++.+|+|++..... .....+.+.+|+.++++++|+||+++++++.+.....+
T Consensus 6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 6 EDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 455 789999999999999999999999999999986543 45667889999999999999999999998877666889
Q ss_pred EEEeeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CCceecCCCCCceEEeCCCCceEEeccC
Q 022479 103 NFITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHE---PCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
++||||+.+++|.+++... ..+++..++.++.|++.||++||+.+ .+++|+||+|+||+++.+ +.++|+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg 161 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG 161 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCc
Confidence 9999999999999998753 34999999999999999999999977 239999999999999988 899999999
Q ss_pred CccccCCCcc-cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 176 FAAIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 176 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
.+........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+.......... + .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~-~~~~~ 239 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-R-RIPYR 239 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-C-CCCTT
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-c-cCCcc
Confidence 9987643321 233467889999997764 488999999999999999999999987665544444444332 2 23345
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+.++.+++.+||+ ||++|||+.++++|+|+.+-..
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 68999999999998 9999999999999999887554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=320.48 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=204.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++.++||+|+||+||+|.+..+++.||+|++..... .......+.+|+..+.++ +||||+++++++.+. ..+++|
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~lv 89 (289)
T 1x8b_A 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLIQ 89 (289)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEEE
T ss_pred hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEEE
Confidence 678999999999999999999999999999986533 334456788899999999 999999999999665 689999
Q ss_pred eeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----------------
Q 022479 106 TEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---------------- 165 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~---------------- 165 (296)
|||+.+++|.+++... ..+++.+++.++.|++.||.|||++| ++|+||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999764 67999999999999999999999999 9999999999999843
Q ss_pred --CCceEEeccCCccccCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022479 166 --IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 166 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~ 241 (296)
...++|+|||.+...... ....+++.|+|||.+.+. .+.++||||||+++|+|++|..|+...... ..+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----HEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----HHH
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----HHH
Confidence 147999999999876543 234588999999977654 557999999999999999999887553322 222
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.....+ ..+...++++.+|+.+||+ ||++|||+.++++||||.+..
T Consensus 241 ~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 241 RQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 232222 3344568999999999998 999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=322.13 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=213.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.++++++||||+++++++... +.+
T Consensus 11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 86 (294)
T 4eqm_A 11 ERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DCY 86 (294)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SEE
T ss_pred ccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--CeE
Confidence 445 789999999999999999999999999999975433 3566778899999999999999999999998544 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++||||+.|++|.+++...+.+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence 999999999999999998888999999999999999999999999 9999999999999998 8999999999987644
Q ss_pred Cc--ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC--CCCCCCChH
Q 022479 183 SH--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALNKVKDPE 257 (296)
Q Consensus 183 ~~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 257 (296)
.. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.................. ......+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 2334568999999997665 488899999999999999999999998777666666665543321 223446899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+.+++.+||+ ||.+||+..+.+.+.|..-.
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 9999999997 99999966666665554433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=328.17 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=213.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---H 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~ 99 (296)
++| ++.++||+|+||+||+|.+..+|+.||+|++... ........+.+|+.++++++|+||+++++++.... .
T Consensus 11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 11 SDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 445 7899999999999999999999999999999642 24556677889999999999999999999875432 3
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...++++||+.+ +|.+++... .+++..+..++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred ceEEEEEeccCc-cHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEecccccc
Confidence 678999999985 898888764 5999999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCCcc-----------cccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 022479 180 VGRSHA-----------AHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 180 ~~~~~~-----------~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
...... .....+++.|+|||++. ..++.++|+||||+++|+|++|..||.+................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 643211 22346789999999754 45889999999999999999999999887655444332221100
Q ss_pred CC-----------------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 247 PQ-----------------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 247 ~~-----------------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
+. ......++++.+|+.+||+ ||++|||+.++|+||||+.+.++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence 00 0012457899999999998 99999999999999999998876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=336.62 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=205.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc------CCCceeEEeeeeeeCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL------KNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 99 (296)
|++.++||+|+||+||+|.+..+++.||+|++.. .......+.+|+++++.+ +|+||+++++.+...
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 171 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-- 171 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--
Confidence 4789999999999999999999999999999974 344456777888888887 567999999998665
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc--eEEeccC
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLG 175 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~--~~l~dfg 175 (296)
..++++|||+.+ +|.+++.... .+++..++.++.||+.||+|||++| ++||||||+||+++.+ +. ++|+|||
T Consensus 172 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEECCCT
T ss_pred CeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEeecc
Confidence 789999999975 8988887653 4999999999999999999999999 9999999999999988 55 9999999
Q ss_pred CccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-------
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------- 247 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 247 (296)
++...... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+
T Consensus 248 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 248 SSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp TCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 99765432 344678999999997654 58999999999999999999999998877666554443221000
Q ss_pred -------------------------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHH
Q 022479 248 -------------------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASE 277 (296)
Q Consensus 248 -------------------------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ 277 (296)
.......++.+.+||.+||+ ||++|||+.+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 00112336789999999998 9999999999
Q ss_pred HhcCcccccccCCC
Q 022479 278 LLKDPFFSELNDDD 291 (296)
Q Consensus 278 ll~hp~~~~~~~~~ 291 (296)
+|+||||++.....
T Consensus 406 ~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 406 ALRHPWLRRRLPKP 419 (429)
T ss_dssp HHTSTTTC------
T ss_pred HhCChhhccCCCCC
Confidence 99999999865433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=324.68 Aligned_cols=263 Identities=29% Similarity=0.417 Sum_probs=212.9
Q ss_pred CCcccceeeecccCcceEEEeeec-CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeeeeee--
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ-EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLD-- 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-- 96 (296)
++| ++.+.||+|+||+||+|.+. .+++.||+|+++...... .....+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 11 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred hce-eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 455 78999999999999999985 678999999997654321 1112344566666655 89999999998862
Q ss_pred -CCCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEec
Q 022479 97 -DQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 173 (296)
Q Consensus 97 -~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~d 173 (296)
.....+++|+||+.+ +|.+++.... .+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECS
T ss_pred cCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEEec
Confidence 234678999999985 9999988643 4999999999999999999999999 9999999999999998 8999999
Q ss_pred cCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC------
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------ 246 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------ 246 (296)
||++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||.+....+...........
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99998776555555677899999999765 45899999999999999999999999887766655554431100
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 247 ------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 247 ------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
........+..+.+|+.+||. ||.+|||+.++++||||+++.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 011123457899999999998 9999999999999999999887654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=331.89 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=205.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC-------CCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-------EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
++| ++.++||+|+||.||+|.+.. |+.||+|++...... .+....+.+.+|++++++++||||+++++++.
T Consensus 22 ~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 22 SPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp CSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred cce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 445 789999999999999999875 999999999654322 23455688999999999999999999999886
Q ss_pred eC---CCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 96 DD---QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 96 ~~---~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
.. ....+++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEE
T ss_pred eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCEEE
Confidence 53 33578999999996 77777664 447999999999999999999999999 9999999999999988 89999
Q ss_pred eccCCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ- 248 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 248 (296)
+|||++.............+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+...........+.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999987655555556678899999997654 489999999999999999999999988766555544432111100
Q ss_pred ----------------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 249 ----------------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 249 ----------------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
......++.+.+|+.+||+ ||.+|||+.++|+||||+.+..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0112347889999999998 99999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=335.39 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=211.9
Q ss_pred CCcccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
++| ++.++||+|+||+||++.+. .+++.||+|+++...........+.+.+|+.+++++ .|+||+++++++...
T Consensus 54 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 54 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred cce-EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 345 78999999999999999884 579999999997543211122234566799999999 699999999998665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.+++|.+++.....+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK 207 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCe
Confidence 689999999999999999998888999999999999999999999999 9999999999999998 899999999997
Q ss_pred ccCCC--cccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhCCCCCCCC
Q 022479 179 IVGRS--HAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSEC---DSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 179 ~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~ 250 (296)
..... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||... .....+......... ..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CC
Confidence 65332 22334578999999998764 3788999999999999999999999642 223333333333222 22
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
+...+..+.+||.+||. ||++|| ++.++++||||++++|+
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 34468899999999997 999999 99999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=320.04 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=204.6
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEeec
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV 108 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 108 (296)
..+||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++... ..+++++||
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 100 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQ 100 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEe
Confidence 458999999999999999999999999997542 33457788999999999999999999999665 689999999
Q ss_pred cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-
Q 022479 109 CTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH- 184 (296)
Q Consensus 109 ~~~~sL~~~l~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~- 184 (296)
+.+++|.+++... ..+++..++.++.|++.||.+||++| ++|+||+|+||+++...+.++|+|||.+.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999999864 25678999999999999999999999 99999999999999843899999999998764322
Q ss_pred ccccCCCCCCccCccccccC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhCCCCCCCCCCCCChHHHH
Q 022479 185 AAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......+++.|+|||++.+. ++.++|+||||+++|+|++|..||.......... ........ .......+.++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 257 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAKA 257 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-CCCCTTSCHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-ccccccCCHHHHH
Confidence 23445688999999977542 7889999999999999999999997644333222 22121222 2234456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
|+.+||. ||++|||+.++|+||||+......
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 9999998 999999999999999998765443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=322.47 Aligned_cols=268 Identities=23% Similarity=0.394 Sum_probs=212.1
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC--CCceeEEee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYIIVCYS 92 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~ 92 (296)
.+..+...++.|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+.+|+.++++++ |+||+++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 33444555565688999999999999999986 488999999976543 4566788999999999997 599999999
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
++... ..++++|| +.+++|.+++.....+++..++.++.|++.||.|||++| ++|+||+|+||+++. +.++|+
T Consensus 96 ~~~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~--~~~kL~ 168 (313)
T 3cek_A 96 YEITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLI 168 (313)
T ss_dssp EEECS--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEEC
T ss_pred EeecC--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC--CeEEEe
Confidence 88655 68999999 567799999998889999999999999999999999999 999999999999975 689999
Q ss_pred ccCCccccCCCcc---cccCCCCCCccCcccccc------------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022479 173 DLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 237 (296)
Q Consensus 173 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~ 237 (296)
|||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 9999987643321 234568999999997653 5788999999999999999999999875444333
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.................+.++.+++.+||+ ||++|||+.++|+||||+....+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence 333333333333444558899999999998 9999999999999999987665544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=337.87 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=190.9
Q ss_pred eeeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 29 SDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
+++||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.++++++||||+++++++.......+++||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 679999999999999965 4688999999975432 24577899999999999999999999876678999999
Q ss_pred eccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE----eCCCCceEEec
Q 022479 107 EVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGD 173 (296)
Q Consensus 107 e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv----~~~~~~~~l~d 173 (296)
||+.+ +|.+++... ..+++..++.++.||+.||+|||++| ++||||||+||++ +.+ +.++|+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER-GRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT-TCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC-CcEEEEE
Confidence 99986 777776532 24999999999999999999999999 9999999999999 444 7999999
Q ss_pred cCCccccCCC----cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 022479 174 LGFAAIVGRS----HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---------VAKIY 238 (296)
Q Consensus 174 fg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---------~~~~~ 238 (296)
||++...... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999876432 22344678999999997764 389999999999999999999999965432 12222
Q ss_pred HHHh--CCCCCCCCC---------------------------------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCc
Q 022479 239 KKVT--GGVKPQALN---------------------------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDP 282 (296)
Q Consensus 239 ~~~~--~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp 282 (296)
.+.. +......+. ...++.+.+||.+||+ ||.+|||+.++|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 2211 111111100 1126788999999998 999999999999999
Q ss_pred ccccccCCCC
Q 022479 283 FFSELNDDDS 292 (296)
Q Consensus 283 ~~~~~~~~~~ 292 (296)
||.+..++..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9998766543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=328.94 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=210.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC---
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--- 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 99 (296)
++| .+.+.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.++++++|+||+++++++.....
T Consensus 24 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 24 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 455 67999999999999999999999999999997543 245667889999999999999999999999865432
Q ss_pred -CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 -NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..++++|||+.+ +|.+++.. .+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCTT
T ss_pred ceeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeeccccc
Confidence 245999999985 88776643 5999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-----------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----------- 245 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 245 (296)
..... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+.+........
T Consensus 175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 75432 334567899999997654 488999999999999999999999987665554443322100
Q ss_pred -----------------CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 246 -----------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 246 -----------------~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.........++++.+|+.+||. ||++|||+.++|+||||+.+..+.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 0011123458899999999998 99999999999999999988765544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=325.51 Aligned_cols=259 Identities=26% Similarity=0.503 Sum_probs=192.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||++.+..+++.||+|++..... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 88 (303)
T 2vwi_A 15 DDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DEL 88 (303)
T ss_dssp CCC-EEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESS--SCE
T ss_pred hhh-hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCc
Confidence 344 789999999999999999998999999999875432 23356788999999999999999999998655 679
Q ss_pred EEEeeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 103 NFITEVCTSGNLRTYRKK--------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEEEec
Confidence 999999999999999874 456999999999999999999999999 9999999999999998 89999999
Q ss_pred CCccccCCCc------ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC
Q 022479 175 GFAAIVGRSH------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 175 g~~~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
|.+....... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654321 1234568899999997763 5899999999999999999999999876665555544443322
Q ss_pred C-------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 247 P-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 247 ~-------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
. .......+.++.+|+.+||+ ||.+|||+.++++||||++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 1 11123457899999999998 99999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=343.95 Aligned_cols=254 Identities=20% Similarity=0.199 Sum_probs=198.8
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHH---HHHHhcCCCceeEEe------
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV---QLLRTLKNKYIIVCY------ 91 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~------ 91 (296)
...+.|++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+ +.+++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 3344557899999999999999999999999999999864332 334567888999 556666899999888
Q ss_pred -eeeeeCCC----------C-----eEEEEeeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhCCC
Q 022479 92 -SVWLDDQH----------N-----TLNFITEVCTSGNLRTYRKKHRHVSI-------KALKKWSKQVLEGLEYLHTHEP 148 (296)
Q Consensus 92 -~~~~~~~~----------~-----~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~i~~ql~~~l~~LH~~~~ 148 (296)
+++..++. . ..+++|||+ +++|.+++...+.+++ ..++.++.|++.||+|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 44433311 1 378999999 5699999987555555 788889999999999999999
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCcccccc------------CCCcchhHHHHHH
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGL 216 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~ 216 (296)
++||||||+||+++.+ +.+||+|||++..... ......+ +.|+|||++.+ .++.++||||||+
T Consensus 227 -ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp -EECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999998 8999999999986543 2334566 89999997653 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 217 CLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 217 i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
++|+|++|+.||.+.......... .......++++.+|+.+||+ ||++|||+.++++||||+.+..
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI-------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG-------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhh-------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 999999999999754322111111 11123468999999999998 9999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=325.57 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=190.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHH-HHHhcCCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.+.||+|+||.||+|.++.+|+.||+|+++... .......+..|+. +++.++|+||+++++++... ..
T Consensus 22 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~ 95 (327)
T 3aln_A 22 EDL-KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GD 95 (327)
T ss_dssp CSE-EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SE
T ss_pred HHh-hehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cc
Confidence 344 77999999999999999999999999999997542 2334445555555 77778999999999999765 68
Q ss_pred EEEEeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 102 LNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.++||||+.+ +|.+++.. ...+++..+..++.|++.||.+||+. | ++|+||+|+||+++.+ +.++|+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEccCC
Confidence 9999999997 78777763 56799999999999999999999999 9 9999999999999998 899999999
Q ss_pred CccccCCCcccccCCCCCCccCccccc-----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC-
Q 022479 176 FAAIVGRSHAAHSIIGTPEYMAPELYE-----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 249 (296)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 249 (296)
++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||.+................+..
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 998775544444457889999999873 34889999999999999999999999764432222221222211111
Q ss_pred --CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 250 --LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 250 --~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.....+..+.+|+.+||. ||++|||+.++++||||....+.+.
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHH
Confidence 123468899999999998 9999999999999999998876653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=331.27 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=214.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH-------------HHHHHHHHHHHHHHhcCCCceeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP-------------VLVNRLHSEVQLLRTLKNKYIIV 89 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~ 89 (296)
++| ++.++||+|+||.||+|.+ +++.||+|++......... ...+.+.+|+.++++++|+||++
T Consensus 31 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 31 NDY-RIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TTE-EEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred Cce-EEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 355 7899999999999999998 7999999999865332111 11277889999999999999999
Q ss_pred EeeeeeeCCCCeEEEEeeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCce
Q 022479 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY------RKK--HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNI 160 (296)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~ni 160 (296)
+++++.+. +.+++||||+.+++|.++ +.. ...+++..++.++.|++.||.|||+ +| ++|+||+|+||
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 99998665 789999999999999988 665 6789999999999999999999999 99 99999999999
Q ss_pred EEeCCCCceEEeccCCccccCCCcccccCCCCCCccCccccccC--CCc-chhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022479 161 FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YTE-MVDIYSFGLCLLEMVTMEIPYSECDSVAKI 237 (296)
Q Consensus 161 lv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~-~~Di~slG~i~~~ll~g~~p~~~~~~~~~~ 237 (296)
+++.+ +.++|+|||.+...... ......+++.|+|||.+.+. ++. ++|+||||+++|+|++|..||.........
T Consensus 184 l~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99998 79999999999876443 34456788999999987754 444 899999999999999999999876663444
Q ss_pred HHHHhCCCCCCCC-----------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 238 YKKVTGGVKPQAL-----------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 238 ~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
...+......... ....+.++.+|+.+||+ ||.+|||+.++++||||++..++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 4444443221111 14568999999999998 99999999999999999987754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=327.05 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=206.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| +++++||+|+||+||+|.+..+++.+|+|++... +....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 10 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (310)
T 3s95_A 10 SDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL 82 (310)
T ss_dssp GGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred hHe-eccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence 345 6799999999999999999999999999998532 566678899999999999999999999999765 689
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+++|.+++.. ...+++.++..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence 999999999999999987 567999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCccc---------------ccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Q 022479 182 RSHAA---------------HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-----KIYKK 240 (296)
Q Consensus 182 ~~~~~---------------~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~-----~~~~~ 240 (296)
..... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 32221 14568999999997765 48999999999999999999999986422110 00111
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
... ..+..+++.+.+++.+||+ ||++|||+.++++ |++.+.
T Consensus 240 ~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 240 LDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp HHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred ccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 111 1123457889999999998 9999999999998 766553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=319.82 Aligned_cols=259 Identities=23% Similarity=0.414 Sum_probs=194.8
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.+.||+|+||+||+|.++.+|+.||+|++..... .....+.+..+..+++.++|+||+++++++... ..
T Consensus 24 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~ 98 (318)
T 2dyl_A 24 INDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TD 98 (318)
T ss_dssp GGGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--Cc
Confidence 3455 578999999999999999999999999999975432 233344555666678889999999999998655 68
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+++||||+ ++.+..+... ...+++..++.++.|++.||.|||++ | ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchh
Confidence 99999999 4466555543 56799999999999999999999995 9 9999999999999998 7999999999987
Q ss_pred cCCCcccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhCCCCCCCCCC
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 252 (296)
...........+++.|+|||.+. ..++.++||||||+++|+|++|..||...... +.................
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 65544455567899999999763 34788999999999999999999999874443 334444444332222233
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..+.++.+|+.+||+ ||.+|||+.++++||||+.+..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 468999999999998 9999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=322.82 Aligned_cols=262 Identities=19% Similarity=0.298 Sum_probs=192.0
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
....|++.+.||+|+||+||+|.+..++. .||+|+++.... .....+.+.+|++++++++|+||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 33444789999999999999999887765 899999975433 3344678999999999999999999999987653
Q ss_pred CC----eEEEEeeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 99 HN----TLNFITEVCTSGNLRTYRKKHR------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 99 ~~----~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
.. ..++++||+.+++|.+++.... .+++.+++.++.|++.||+|||++| ++|+||||+||+++.+ +.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~-~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-CC
Confidence 21 2489999999999999986432 5999999999999999999999999 9999999999999998 89
Q ss_pred eEEeccCCccccCCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 022479 169 VKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~ 243 (296)
++|+|||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+........
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999987643322 223345678999997764 48999999999999999999 99999876655554444433
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCC-------HHHHhcCcccccccCC
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPS-------ASELLKDPFFSELNDD 290 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps-------~~~ll~hp~~~~~~~~ 290 (296)
. ... .....++++.+|+.+||+ ||++||| +++++.|||+....++
T Consensus 256 ~-~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 256 N-RLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp C-CCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred C-CCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 3 222 234468999999999998 9999999 7778889998876554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=335.06 Aligned_cols=258 Identities=15% Similarity=0.171 Sum_probs=190.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc--CCCceeEEe-------eeeee
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL--KNKYIIVCY-------SVWLD 96 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~ 96 (296)
+++.++||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.+ +|||+++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 5789999999999999999999999999999986533 1344566777885544444 699988755 33332
Q ss_pred CCC---------------CeEEEEeeccCCCCHHHHHHh-cCCCCHHHH------HHHHHHHHHHHHHHhhCCCCceecC
Q 022479 97 DQH---------------NTLNFITEVCTSGNLRTYRKK-HRHVSIKAL------KKWSKQVLEGLEYLHTHEPCIIHRD 154 (296)
Q Consensus 97 ~~~---------------~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~------~~i~~ql~~~l~~LH~~~~~i~h~d 154 (296)
++. ..+++||||+. ++|.+++.. +..++...+ ..++.|++.||+|||++| ++|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCc
Confidence 221 34899999999 699999986 334555555 677799999999999999 99999
Q ss_pred CCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 022479 155 LNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSEC 231 (296)
Q Consensus 155 l~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~ 231 (296)
|||+|||++.+ +.++|+|||++....... ....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.
T Consensus 220 ikp~NIll~~~-~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPD-GRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTT-SCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCC-CCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999998 899999999998765432 13455699999997764 4899999999999999999999999764
Q ss_pred ChHHHH-HHH---HhC-C-CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 232 DSVAKI-YKK---VTG-G-VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 232 ~~~~~~-~~~---~~~-~-~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
...... ... ... . ..........++.+.+|+.+||+ ||++|||+.++|+||||+++.+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 221000 000 000 0 00111113458999999999998 99999999999999999988764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=315.33 Aligned_cols=254 Identities=32% Similarity=0.514 Sum_probs=204.1
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD------ 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 97 (296)
+| ++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.++++++||||+++++.+.+.
T Consensus 7 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 7 DF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cc-hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 44 6789999999999999999999999999999642 44567889999999999999999999988653
Q ss_pred -----CCCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEE
Q 022479 98 -----QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 98 -----~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
....+++||||+.+++|.+++... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEEE
Confidence 236789999999999999999854 46888999999999999999999999 9999999999999998 89999
Q ss_pred eccCCccccCCC---------------cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022479 172 GDLGFAAIVGRS---------------HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234 (296)
Q Consensus 172 ~dfg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 234 (296)
+|||.+...... .......+++.|+|||.+.+ .++.++|+||||+++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999999765421 12234567889999997764 48899999999999999998 66543333
Q ss_pred HHHHHHHhCCC--CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 235 AKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 235 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
......+.... .+.......+..+.+++.+||+ ||.+|||+.++++||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 33444433322 1223344457789999999998 9999999999999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=321.41 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=205.0
Q ss_pred cccceeeecccCcceEEEeee-cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc------eeEEeeeeeeC
Q 022479 25 FGRYSDLLGSGAVKKVYRAFD-QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY------IIVCYSVWLDD 97 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~ 97 (296)
.|++.++||+|+||+||+|.+ +.+++.||+|+++. .....+.+.+|++++++++|++ ++++++++...
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 347899999999999999998 56789999999973 2445677889999999987654 89999988655
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----------
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---------- 165 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~---------- 165 (296)
..+++||||+ +++|.+++...+ .+++..++.++.|++.||+|||++| ++|+||||+||+++.+
T Consensus 90 --~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 --GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred --CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 6899999999 779999988765 6899999999999999999999999 9999999999999873
Q ss_pred --------CCceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022479 166 --------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK 236 (296)
Q Consensus 166 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~ 236 (296)
.+.++|+|||++...... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||...+..+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 257999999999875432 344578999999997664 589999999999999999999999987655443
Q ss_pred HHHH--HhCCCCC---------------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCC
Q 022479 237 IYKK--VTGGVKP---------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPS 274 (296)
Q Consensus 237 ~~~~--~~~~~~~---------------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps 274 (296)
.... .....+. .......++++.+|+.+||+ ||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 3222 1111110 00011124678899999998 9999999
Q ss_pred HHHHhcCcccccccC
Q 022479 275 ASELLKDPFFSELND 289 (296)
Q Consensus 275 ~~~ll~hp~~~~~~~ 289 (296)
+.++++||||+.+..
T Consensus 323 ~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 323 LREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTTSGGGGGGGC
T ss_pred HHHHhcCHHHHHHhc
Confidence 999999999998764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=322.59 Aligned_cols=264 Identities=19% Similarity=0.295 Sum_probs=185.5
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
.....++|..+.++||+|+||+||+|.++.+|+.||+|++... .. ........++.++|+|++++++++...
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PK---ARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HH---HHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3344556643356899999999999999999999999999642 21 222334456778999999999988652
Q ss_pred --CCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEE
Q 022479 98 --QHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKI 171 (296)
Q Consensus 98 --~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l 171 (296)
....+++||||+.+++|.+++.... .+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ .+.++|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEE
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEE
Confidence 2356899999999999999998653 6999999999999999999999999 9999999999999864 246999
Q ss_pred eccCCccccCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhCC--C
Q 022479 172 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI---YKKVTGG--V 245 (296)
Q Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~---~~~~~~~--~ 245 (296)
+|||++...... ......+++.|+|||++.+. ++.++||||||+++|+|++|..||......... ...+... .
T Consensus 173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp CCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred eccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 999999866432 23445678999999987644 888999999999999999999999754332211 1111111 1
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
.+.......++++.+|+.+||+ ||.+|||+.++|+||||+.......
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 1112223468999999999998 9999999999999999987654433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=325.61 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=202.8
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CC-----ceeEEeeeeeeCC
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NK-----YIIVCYSVWLDDQ 98 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~ 98 (296)
.|++.++||+|+||+||+|.++.+++.||+|+++. .......+.+|+.+++.++ |+ +++++.+.+...
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 34789999999999999999999999999999973 3445677788999988885 44 488999988665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--CCCCceecCCCCCceEEeC-CCCceEEec
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHT--HEPCIIHRDLNCSNIFING-NIGQVKIGD 173 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~--~~~~i~h~dl~~~nilv~~-~~~~~~l~d 173 (296)
..+++||||+.+ +|.+++... ..+++..++.++.|++.||.|||+ .| ++||||||+||+++. +.+.++|+|
T Consensus 129 -~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 -NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp -TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEECC
T ss_pred -CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEEe
Confidence 689999999976 999998764 469999999999999999999995 57 999999999999964 226899999
Q ss_pred cCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC----
Q 022479 174 LGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---- 248 (296)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---- 248 (296)
||++...... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+.
T Consensus 205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999876533 345678999999997664 589999999999999999999999998776665554433211000
Q ss_pred ------------------------------CCCCC---------------------------CChHHHHHHHHHHh-CCC
Q 022479 249 ------------------------------ALNKV---------------------------KDPEVKAFIEKCIA-QPR 270 (296)
Q Consensus 249 ------------------------------~~~~~---------------------------~~~~l~~li~~~l~-~p~ 270 (296)
..+.. ..+++.+||.+||+ ||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00000 01378999999998 999
Q ss_pred CCCCHHHHhcCcccccccC
Q 022479 271 ARPSASELLKDPFFSELND 289 (296)
Q Consensus 271 ~Rps~~~ll~hp~~~~~~~ 289 (296)
+|||+.++|+||||++..+
T Consensus 363 ~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp TSCCHHHHTTSGGGCC---
T ss_pred hCCCHHHHhcCcccccCCC
Confidence 9999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=319.55 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=209.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
++| ++.++||+|+||+||++.+..+++ .||+|+++... .....+.+.+|+.++++++|+||+++++++.+.
T Consensus 49 ~~y-~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 122 (325)
T 3kul_A 49 SRI-HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-- 122 (325)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--
T ss_pred hHe-EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 344 789999999999999999976554 59999997432 455677899999999999999999999998544
Q ss_pred CeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.+++|.+++... ..+++.++..++.|++.||+|||+.| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCccc
Confidence 6789999999999999999754 67999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+....+........ .... ...
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~ 277 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLP-APM 277 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCC-CCT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCC-CCC
Confidence 7643321 22234567899999776 448999999999999999999 99999876665555444433 3222 234
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..+.++.+|+..||. ||++|||+.++++ .++.+-...+
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l~~~~~ 316 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDALIRSPE 316 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHSCC
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHhCcc
Confidence 568999999999997 9999999999998 6665544433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=314.46 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=202.2
Q ss_pred CCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.+.+++.++||+|+||+||+|. +..+++.||+|++... .....+.+.+|++++++++|+||+++++++....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3445889999999999999998 5668999999998743 4566778999999999999999999999987655
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++||||+.+++|.+++... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccCccc
Confidence 56789999999999999999864 35999999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHH
Q 022479 178 AIVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------------AKI 237 (296)
Q Consensus 178 ~~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~---------------~~~ 237 (296)
........ .....++..|+|||.+. ..++.++||||||+++|+|++|..||...... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87643321 22334566799999766 45899999999999999999999998642211 122
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
........... .+..+++++.+|+.+||+ ||++|||+.++++
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCC-CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23333332222 344568999999999998 9999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=320.75 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=211.1
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH--HHHHHHHHHHHHHHhcC--CCceeEE
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP--VLVNRLHSEVQLLRTLK--NKYIIVC 90 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~ 90 (296)
+....+.....|++.++||+|+||+||+|.+..+++.||+|++......... .....+.+|+.++++++ |+|++++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3344444455558899999999999999999999999999999765432100 11244667999999996 5999999
Q ss_pred eeeeeeCCCCeEEEEeeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCce
Q 022479 91 YSVWLDDQHNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169 (296)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~ 169 (296)
++++..+ ..+++++|++.+ ++|.+++...+.+++..++.++.|++.||+|||++| ++|+||+|+||+++.+.+.+
T Consensus 114 ~~~~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 114 LDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEEECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEE
T ss_pred EEEEecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCE
Confidence 9998655 689999999976 799999998888999999999999999999999999 99999999999999444899
Q ss_pred EEeccCCccccCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC
Q 022479 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
+|+|||++...... ......+++.|+|||.+.+. .+.++||||||+++|+|++|..||.... . .... .
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~---~~~~---~ 259 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E---IIRG---Q 259 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HHHC---C
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---h---hhcc---c
Confidence 99999999876543 23445689999999977643 3678999999999999999999997532 1 1122 1
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.......++++.+|+.+||+ ||++|||+.++++||||++...+
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 22344568999999999998 99999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=324.87 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=209.4
Q ss_pred CCCCcccceeeecccCcceEEEee-----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
.....+++.++||+|+||+||+|. +..+++.||+|+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 333444789999999999999998 56678999999997432 345567899999999999 789999999998
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCC---------------------------------------------------
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRH--------------------------------------------------- 123 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------- 123 (296)
.+.. ..+++||||+.+++|.+++.....
T Consensus 96 ~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 96 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp CSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 6543 568999999999999999986543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc---c
Q 022479 124 ---------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---A 185 (296)
Q Consensus 124 ---------------~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~---~ 185 (296)
+++..++.++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++....... .
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccchh
Confidence 899999999999999999999999 9999999999999988 799999999998653322 2
Q ss_pred cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022479 186 AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263 (296)
Q Consensus 186 ~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 263 (296)
.....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.................. .+...++++.+++.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-CCCCCCHHHHHHHH
Confidence 33345678899999765 458999999999999999998 9999987665555555555544333 33456899999999
Q ss_pred HHHh-CCCCCCCHHHHhcC
Q 022479 264 KCIA-QPRARPSASELLKD 281 (296)
Q Consensus 264 ~~l~-~p~~Rps~~~ll~h 281 (296)
+||+ ||.+|||+.++++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9998 99999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=329.46 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=199.4
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC--------CCceeEEeeeee
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--------NKYIIVCYSVWL 95 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~ 95 (296)
..|++.++||+|+||+||+|.+..+++.||+|+++. .....+.+.+|+.++++++ |+||+++++.+.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 334789999999999999999999999999999973 3455678889999999996 778999999886
Q ss_pred eC--CCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCCC----
Q 022479 96 DD--QHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNI---- 166 (296)
Q Consensus 96 ~~--~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~~---- 166 (296)
.. ....+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ | ++||||||+||+++.+.
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhh
Confidence 32 34689999999955 555555443 5699999999999999999999998 9 99999999999998762
Q ss_pred --------------------------------------------CceEEeccCCccccCCCcccccCCCCCCccCccccc
Q 022479 167 --------------------------------------------GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 202 (296)
Q Consensus 167 --------------------------------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~ 202 (296)
..++|+|||.+...... .....+|+.|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence 27999999999876533 34457899999999776
Q ss_pred c-CCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHH--hCCCCC-------------------C------
Q 022479 203 E-DYTEMVDIYSFGLCLLEMVTMEIPYSECD------SVAKIYKKV--TGGVKP-------------------Q------ 248 (296)
Q Consensus 203 ~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~------~~~~~~~~~--~~~~~~-------------------~------ 248 (296)
+ .++.++|||||||++|+|++|..||.... ....+.... .+..+. .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 4 48999999999999999999999997533 112221111 111100 0
Q ss_pred ------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 249 ------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 249 ------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
......+..+.+||.+||+ ||++|||+.++|+||||+.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0011123568899999998 9999999999999999973
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=319.18 Aligned_cols=255 Identities=19% Similarity=0.317 Sum_probs=203.2
Q ss_pred CcccceeeecccCcceEEEeeecCCC-cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc------eeEEeeeeee
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY------IIVCYSVWLD 96 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~ 96 (296)
..|++.++||+|+||+||+|.+..++ +.||+|+++. .....+.+.+|+.++++++|++ ++.+.+++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 34478999999999999999998776 6899999963 3445677888999999997655 7888888765
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE------------
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI------------ 162 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv------------ 162 (296)
. ..+++||||+. +++.+++... ..+++.+++.++.||+.||+|||++| ++|+||||+||++
T Consensus 94 ~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 H--GHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp T--TEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred C--CeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 5 68999999995 4666666554 46999999999999999999999999 9999999999999
Q ss_pred -------eCCCCceEEeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022479 163 -------NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 234 (296)
Q Consensus 163 -------~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 234 (296)
+.+ +.++|+|||++...... .....+++.|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 169 ~~~~~~~~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKN-TSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESC-CCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCC-CcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 455 79999999999875433 34457899999999765 45899999999999999999999999876654
Q ss_pred HHHHHHHh--CCCCCC---------------------------------------CCCCCCChHHHHHHHHHHh-CCCCC
Q 022479 235 AKIYKKVT--GGVKPQ---------------------------------------ALNKVKDPEVKAFIEKCIA-QPRAR 272 (296)
Q Consensus 235 ~~~~~~~~--~~~~~~---------------------------------------~~~~~~~~~l~~li~~~l~-~p~~R 272 (296)
+....... ...+.. ......+.++.+|+.+||+ ||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 43332211 111000 0001113478899999998 99999
Q ss_pred CCHHHHhcCcccccccCCC
Q 022479 273 PSASELLKDPFFSELNDDD 291 (296)
Q Consensus 273 ps~~~ll~hp~~~~~~~~~ 291 (296)
||+.++|+||||+++++++
T Consensus 326 pt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp CCHHHHTTSGGGGGCCHHH
T ss_pred cCHHHHhcChhhcCCChhh
Confidence 9999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=320.97 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=203.8
Q ss_pred ccceeeecccCcceEEEeeec-------CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
++++++||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368999999999999999864 345679999997542 355677899999999999 899999999998544
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceE
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nil 161 (296)
..+|+||||+.+++|.+++.... .++..++..++.|++.||+|||++| ++||||||+||+
T Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 67999999999999999998643 4789999999999999999999999 999999999999
Q ss_pred EeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022479 162 INGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAK 236 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~ 236 (296)
++.+ +.++|+|||++....... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+.
T Consensus 236 l~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9998 899999999998664322 233345677899999765 458999999999999999999 9999987654443
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...+.....+. .+..++.++.+|+.+||+ ||.+|||+.++++
T Consensus 315 -~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 315 -FKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp -HHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33444433332 334568999999999998 9999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=312.89 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=203.1
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..++| ++.++||+|+||.||+|.+..+++.||+|++..... .+....+.+.+|+.++++++||||+++++++... .
T Consensus 32 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~ 107 (309)
T 2h34_A 32 QFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--G 107 (309)
T ss_dssp --CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--T
T ss_pred EeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--C
Confidence 34556 789999999999999999999999999999975432 3456678899999999999999999999998765 6
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+++++||+.+++|.+++.....+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC----
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCccc
Confidence 89999999999999999998888999999999999999999999999 9999999999999998 89999999998766
Q ss_pred CCCc--ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC-CCCCCCCCCCh
Q 022479 181 GRSH--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (296)
.... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.... .....+.... .+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCH
Confidence 4332 2334568899999997764 4888999999999999999999999875443 3334344332 23334455789
Q ss_pred HHHHHHHHHHh-CCCCCC-CHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARP-SASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rp-s~~~ll~ 280 (296)
++.+++.+||+ ||++|| |++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999998 999999 8888876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=308.34 Aligned_cols=251 Identities=18% Similarity=0.328 Sum_probs=213.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.+. ++.+|+|+++.... +....+.+.+|+.++++++||||+++++++.......++
T Consensus 11 ~y-~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 11 QL-NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GC-EEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred Hh-HHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 45 68999999999999999875 88999999986533 456667899999999999999999999999776557889
Q ss_pred EEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++|||+.+++|.+++.... .+++.+++.++.|++.||+|||+++++++|+||+|+||+++.+ +.++++|||+.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeeec
Confidence 9999999999999998765 4899999999999999999999988779999999999999988 799999888775432
Q ss_pred CCcccccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.....+++.|+|||.+.+. .+.++||||||+++|+|++|..||.+................+.. +...+++
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-PPGISPH 239 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC-CTTCCHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC-CCCCCHH
Confidence 2334678899999977643 333799999999999999999999987777766666666554443 4456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+.+++.+||+ ||++|||+.++++ .++.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~--~L~~l 268 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVP--ILEKM 268 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH--HHHHh
Confidence 9999999998 9999999999998 55544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=310.40 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=205.3
Q ss_pred CCCCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
-..+++++.++||+|+||.||+|. +..+++.||+|+++.... ......+.+|+.++++++|+||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 334566889999999999999998 567899999999975432 2235678899999999999999999999987
Q ss_pred CCCCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.....++++|||+.+++|.+++. ....+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEECccc
Confidence 76678999999999999999995 4567999999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCc----ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCC--------------CChHHH
Q 022479 176 FAAIVGRSH----AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSE--------------CDSVAK 236 (296)
Q Consensus 176 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~--------------~~~~~~ 236 (296)
++....... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..|+.. ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 998765432 2334456778999997764 488899999999999999999887632 223334
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
............ .....++.+.+|+.+||+ ||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLP-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCC-CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 444444444333 334568999999999998 9999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=310.89 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=200.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+..++.+++.++||+|+||+||++.+.. .+|+|+++.... .....+.+.+|+.++++++|+||++++++.. .
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~ 91 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYST---A 91 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---S
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---C
Confidence 3334444789999999999999997653 599999976543 5666788999999999999999999998652 2
Q ss_pred CeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.+++|.+++.. ...+++.+++.++.|++.||++||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceecc
Confidence 468899999999999999864 457999999999999999999999999 9999999999999999 899999999997
Q ss_pred ccCC---CcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC---C
Q 022479 179 IVGR---SHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---Q 248 (296)
Q Consensus 179 ~~~~---~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~ 248 (296)
.... ........+++.|+|||.+. ..++.++||||||+++|+|++|..||.+....+............ .
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 6543 22233456899999999764 347889999999999999999999998877766666665554332 2
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.....+++.+.+|+.+||+ ||.+|||+.++++ .+.++
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~l 286 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA--EIEEL 286 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence 2334568999999999998 9999999999998 44443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=306.11 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=205.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHH---HHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV---NRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.++| ++.++||+|+||+||+|.+..+++.||+|++............ +.+.+|+.++++++|+||+++++++...
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 18 DNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp STTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3455 7899999999999999999999999999999765543333332 6789999999999999999999988443
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc-----eEEe
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIG 172 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~-----~~l~ 172 (296)
.+++|||+.+++|.+++.. ...+++..++.++.|++.||+|||++|++++|+||||+||+++.+ +. ++|+
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVA 171 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEEC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeC
Confidence 3689999999999888764 457999999999999999999999998779999999999999877 44 9999
Q ss_pred ccCCccccCCCcccccCCCCCCccCccccc---cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhCCCCC
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--IYKKVTGGVKP 247 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~ 247 (296)
|||++..... ......+++.|+|||.+. ..++.++||||||+++|+|++|..||........ ..........
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 248 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR- 248 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC-
T ss_pred CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC-
Confidence 9999986543 244467899999999873 2378899999999999999999999976443222 2333333333
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.......++.+.+++.+||+ ||.+|||+.++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33445568999999999998 9999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=310.04 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=203.3
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.....+++.+.||+|+||+||++.+. ++..||+|+++.... . .+.+.+|++++++++|+||+++++++... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 92 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--R 92 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--C---HHHHHHHHHHHhcCCCCCEeeEEEEEecC--C
Confidence 33344478999999999999999876 577899999985433 2 35688999999999999999999998544 7
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.+++|.+++.. ...+++.+++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEcccccccc
Confidence 89999999999999999986 567999999999999999999999999 9999999999999998 7999999999987
Q ss_pred cCCCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 180 VGRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 180 ~~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
...... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||......+...... .... ...+...+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~-~~~~~~~~ 247 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLR-LYRPHLAS 247 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC-CCCCTTCC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccC-CCCCCcCC
Confidence 643221 22334567899999776 558999999999999999998 999998766555544443 3322 23344568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+.+.+++.+||+ ||.+|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999998 99999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=308.30 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=196.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||++.+. ++.+|+|+++...........+.+.+|++++++++||||+++++++... ..+
T Consensus 7 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 7 AEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL 81 (271)
T ss_dssp TSE-EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhe-eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence 345 68999999999999999875 8899999997654433344467889999999999999999999998654 678
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCC-ceecCCCCCceEEeCC-------CCceEEecc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC-IIHRDLNCSNIFINGN-------IGQVKIGDL 174 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-i~h~dl~~~nilv~~~-------~~~~~l~df 174 (296)
++||||+.+++|.+++.. ..+++..++.++.|++.||++||++|.. ++|+||+|+||+++.+ .+.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999998864 4699999999999999999999999832 7799999999999862 368999999
Q ss_pred CCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
|.+....... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+................. .....
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPST 238 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC-CCCTT
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC-CCCcc
Confidence 9998765432 234568899999997764 48999999999999999999999999877666666555554433 33455
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.++.+.+++.+||+ ||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 68999999999998 99999999999973
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=318.19 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=210.8
Q ss_pred CcccceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
..+++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.++++++||||+++++++...
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 122 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG- 122 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence 34478999999999999999987 356899999997432 455678899999999999999999999998554
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecC
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 154 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~d 154 (296)
..+++||||+.+++|.+++... ..+++.+++.++.|++.||.|||++| ++|+|
T Consensus 123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~D 199 (343)
T 1luf_A 123 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 199 (343)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred -CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 6799999999999999999763 56999999999999999999999999 99999
Q ss_pred CCCCceEEeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 022479 155 LNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYS 229 (296)
Q Consensus 155 l~~~nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~ 229 (296)
|||+||+++.+ +.++|+|||++....... ......+++.|+|||.+. +.++.++|+||||+++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 99999999988 799999999997654322 233445678899999765 458999999999999999999 999998
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 230 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+....+........ ... ..+...+..+.+|+.+||+ ||.+|||+.++++ .|+++....+
T Consensus 279 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYVRDG-NIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHHHTT-CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTTC---
T ss_pred CCChHHHHHHHhCC-CcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHHHhhhh
Confidence 76655544444333 222 2344568999999999998 9999999999998 6766655443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=322.99 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=204.8
Q ss_pred ccceeeecccCcceEEEee-----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+++.++||+|+||+||+|. +..+++.||+|+++... .......+.+|+.++++++|+||+++++++... .
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 147 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 147 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence 4789999999999999999 44567899999996432 355566788999999999999999999998554 6
Q ss_pred eEEEEeeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC--CceEE
Q 022479 101 TLNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKI 171 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~--~~~~l 171 (296)
..++||||+.+++|.+++... ..+++.+++.++.|++.||+|||++| ++||||||+||+++.+. ..++|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEE
Confidence 789999999999999999864 35899999999999999999999999 99999999999998541 35999
Q ss_pred eccCCccccCC---CcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCC
Q 022479 172 GDLGFAAIVGR---SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK 246 (296)
Q Consensus 172 ~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 246 (296)
+|||++..... ........+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....+.... +.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCC
Confidence 99999975422 22334456788999999765 558999999999999999998 9999987655544444 444333
Q ss_pred CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 247 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 247 ~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
.. .....+..+.+|+.+||+ ||.+|||+.+++++.++.
T Consensus 305 ~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 MD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 234568999999999998 999999999999986654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=324.39 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=205.0
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-----------CCceeEE
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----------NKYIIVC 90 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~ 90 (296)
.++| ++.++||+|+||+||+|.+..+++.||+|++.. +....+.+.+|+.++++++ |+||+++
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 3455 789999999999999999999999999999973 3444567888999998886 7899999
Q ss_pred eeeeeeCC--CCeEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhC-CCCceecCCCCCceEEeCC
Q 022479 91 YSVWLDDQ--HNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 91 ~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~-~~~i~h~dl~~~nilv~~~ 165 (296)
++++.... ...+++++|++ +++|.+++.. ...+++..+..++.||+.||+|||++ | ++|+||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99987542 24789999999 7799999886 34599999999999999999999998 9 9999999999999633
Q ss_pred -----CCceEEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC------h
Q 022479 166 -----IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD------S 233 (296)
Q Consensus 166 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~------~ 233 (296)
.+.++|+|||++...... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 147999999999876543 334578999999997765 48999999999999999999999997543 1
Q ss_pred HHHHHHHHh--CCCCC-------------------------------------CCCCCCCChHHHHHHHHHHh-CCCCCC
Q 022479 234 VAKIYKKVT--GGVKP-------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARP 273 (296)
Q Consensus 234 ~~~~~~~~~--~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rp 273 (296)
...+..... +..+. .......+.++.+||.+||+ ||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 122222111 10000 00111235678899999998 999999
Q ss_pred CHHHHhcCcccccccCCCCC
Q 022479 274 SASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 274 s~~~ll~hp~~~~~~~~~~~ 293 (296)
|+.++|+||||++.....+.
T Consensus 327 t~~ell~hp~f~~~~~~~~~ 346 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTLGMEEI 346 (373)
T ss_dssp CHHHHHTCGGGTTCTTCTTC
T ss_pred CHHHHhhChhhhcccCcccc
Confidence 99999999999987655443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=315.67 Aligned_cols=244 Identities=18% Similarity=0.241 Sum_probs=198.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 101 (296)
++| ++.++||+|+||+||+|.+..+++.||+|++..... .+.+.+|+++++++ +|+||+++++++... ..
T Consensus 9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~ 79 (330)
T 2izr_A 9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KY 79 (330)
T ss_dssp TTE-EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TE
T ss_pred CCe-EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--Cc
Confidence 445 789999999999999999999999999999975433 23577899999999 999999999998765 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc-----eEEeccC
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIGDLG 175 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~-----~~l~dfg 175 (296)
.++||||+ +++|.+++.. ...+++..+..++.|++.||+|||++| ++||||||+||+++.+ +. ++|+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg 155 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCCT
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEcc
Confidence 99999999 8899999986 467999999999999999999999999 9999999999999987 55 9999999
Q ss_pred CccccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhCC
Q 022479 176 FAAIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGG 244 (296)
Q Consensus 176 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~--~~~~~~~~~~~~ 244 (296)
++........ .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ........+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 9987643221 245678999999997765 48999999999999999999999998632 222222222111
Q ss_pred ---CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 245 ---VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 245 ---~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..........+ ++.+++..||+ ||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111122234 99999999998 9999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=317.33 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=201.1
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH--HHHHHHHHHHHHHHhc----CCCceeEEeeeeeeC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP--VLVNRLHSEVQLLRTL----KNKYIIVCYSVWLDD 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~ 97 (296)
..|++.++||+|+||.||+|.+..+++.||+|+++........ .....+.+|+.+++++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 3347899999999999999999999999999999765432111 1233456789999998 899999999998654
Q ss_pred CCCeEEEEeec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 98 QHNTLNFITEV-CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 98 ~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
+..++++|+ +.+++|.+++.....+++..++.++.|++.||.|||++| ++|+||+|+||+++.+.+.++|+|||+
T Consensus 111 --~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 111 --EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred --CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 678889999 788999999998888999999999999999999999999 999999999999994338999999999
Q ss_pred ccccCCCcccccCCCCCCccCccccccC-C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
+...... ......+++.|+|||.+.+. . +.++||||||+++|+|++|+.||.... . ..... .......
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~---~~~~~---~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---E---ILEAE---LHFPAHV 256 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HHHTC---CCCCTTS
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---H---Hhhhc---cCCcccC
Confidence 9876543 23455688999999977643 3 458999999999999999999997531 1 11121 1233456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+..+.+++.+||+ ||++|||+.++++||||+....+.
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 8999999999998 999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=315.61 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=210.9
Q ss_pred ceecCCCCCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 022479 16 FVEVDPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91 (296)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 91 (296)
...+-...+| ++.++||+|+||.||+|. +..+++.||+|++... .....+.+.+|++++++++|+||++++
T Consensus 16 ~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 16 DPTIFEERHL-KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp -CCBCCGGGE-EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhchhhh-hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 3334344455 789999999999999998 5678999999999743 455567899999999999999999999
Q ss_pred eeeeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
+++.......+++||||+.+++|.+++.. ...+++..++.++.|++.||++||++| ++|+||||+||+++.+ +.++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~k 167 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVK 167 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEE
Confidence 99887666889999999999999999986 456999999999999999999999999 9999999999999998 8999
Q ss_pred EeccCCccccCCCcc----cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCCh------------
Q 022479 171 IGDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS------------ 233 (296)
Q Consensus 171 l~dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~------------ 233 (296)
|+|||++........ .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 999999987643322 2334567789999977654 78999999999999999999999854322
Q ss_pred --HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 234 --VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
................ ....++.+.+|+.+||+ ||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp CHHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHhhcccCCCC-CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1233344444433333 44568999999999998 9999999999977
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=304.66 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=207.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|+||+||++.++ ++..||+|+++.... . .+.+.+|++++++++||||+++++++... ..+
T Consensus 8 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (268)
T 3sxs_A 8 EEI-TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--S---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPI 78 (268)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSE
T ss_pred hhe-eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--c---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--Cce
Confidence 344 78999999999999999876 467899999975433 2 35688999999999999999999998544 779
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+++|.+++... ..+++.+++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEECC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceecc
Confidence 9999999999999999764 45999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCcc--cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... .....+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||................ . ...+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 233 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-R-LYRPHLASDT 233 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-C-CCCCTTSCHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-C-CCCCCcChHH
Confidence 4322 233445678999997765 48899999999999999999 999998766655555444332 2 2334456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+.+++..||+ ||.+|||+.++++ .++.+..
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~--~L~~l~~ 264 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLS--SIEPLRE 264 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHH--HHGGGCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH--HHHHhhh
Confidence 9999999998 9999999999999 4444443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=305.98 Aligned_cols=243 Identities=22% Similarity=0.397 Sum_probs=203.6
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.+.||+|+||+||++.+. +++.||+|++..... . .+.+.+|++++++++||||+++++++.+. ..+++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 83 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 83 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred ceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--C---HHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEE
Confidence 368999999999999999987 477899999975433 2 35688999999999999999999998554 679999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|||+.+++|.+++.. ...+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccccccc
Confidence 999999999999975 456899999999999999999999999 9999999999999988 799999999998664322
Q ss_pred --ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......+++.|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+....... .... ..+...+..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRL-YKPRLASTHVYQ 238 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCC-CCCTTSCHHHHH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccC-CCCCcCCHHHHH
Confidence 233345567899999776 558999999999999999999 9999987665554444433 3222 234446899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcC
Q 022479 261 FIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~h 281 (296)
++.+||+ ||.+|||+.++++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999998 99999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=308.10 Aligned_cols=260 Identities=29% Similarity=0.526 Sum_probs=202.8
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
....++| ++.++||+|+||.||+|.+..+|+.||+|++..... .+......+.+|+.++++++|+||+++++++...
T Consensus 28 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 104 (310)
T 2wqm_A 28 YNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED- 104 (310)
T ss_dssp TSSGGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-
T ss_pred cccccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-
Confidence 3344555 789999999999999999999999999999975432 2456678899999999999999999999999765
Q ss_pred CCeEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
..++++|||+.+++|.+++.. ...+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Df 180 (310)
T 2wqm_A 105 -NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDL 180 (310)
T ss_dssp -TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC
T ss_pred -CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEec
Confidence 689999999999999998864 567999999999999999999999999 9999999999999988 89999999
Q ss_pred CCccccCCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCC
Q 022479 175 GFAAIVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 175 g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 251 (296)
|++....... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.. ........+.....+....
T Consensus 181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 260 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT
T ss_pred cceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc
Confidence 9987664322 2334567899999997654 58899999999999999999999997532 3334444444444343444
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
...+.++.+|+.+||+ ||.+|||+.++++ .++.+
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l 295 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM 295 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 5568999999999998 9999999999998 55544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=312.42 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=206.9
Q ss_pred CCCcccceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
..+.+++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3445578999999999999999873 456889999997432 45667889999999999999999999999854
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCCCcee
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHRH------------------------VSIKALKKWSKQVLEGLEYLHTHEPCIIH 152 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~ql~~~l~~LH~~~~~i~h 152 (296)
. ..+++||||+.+++|.+++..... +++.+++.++.|++.||+|||++| ++|
T Consensus 98 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 98 D--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred C--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 4 679999999999999999986543 899999999999999999999999 999
Q ss_pred cCCCCCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHh-CCCC
Q 022479 153 RDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIP 227 (296)
Q Consensus 153 ~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~-g~~p 227 (296)
+||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+. ++.++||||||+++|+|++ |..|
T Consensus 174 ~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 174 RDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999998 8999999999987643322 2334467789999976644 8999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 228 YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
|.+..... ....+....... .....++.+.+++.+||+ ||.+|||+.+++++
T Consensus 253 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPER-LFNLLKTGHRME-RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGG-HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHH-HHHHhhcCCcCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 98755443 334444433322 334568999999999998 99999999999983
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=313.25 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=215.5
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEee
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYS 92 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 92 (296)
........|++.+.||+|+||+||+|.++ .+++.||+|++.... .......+.+|+.++++++|+||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33444444578999999999999999876 357889999997432 3455667899999999999999999999
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv 162 (296)
++... ...++||||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||+|+||++
T Consensus 96 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli 171 (322)
T 1p4o_A 96 VVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 171 (322)
T ss_dssp EECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred EEccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE
Confidence 98544 6789999999999999998752 45799999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKI 237 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~ 237 (296)
+.+ +.++|+|||++....... ......+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+..
T Consensus 172 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 172 AED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp CTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 998 899999999997654322 123344578899999776 458999999999999999999 89999876655544
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC------cccccccCCCCC
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD------PFFSELNDDDSE 293 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h------p~~~~~~~~~~~ 293 (296)
........ . ......+..+.+|+.+||+ ||.+|||+.+++++ ++|+++.+....
T Consensus 251 ~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~ 311 (322)
T 1p4o_A 251 RFVMEGGL-L-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311 (322)
T ss_dssp HHHHTTCC-C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred HHHHcCCc-C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccc
Confidence 44433332 2 2334568999999999998 99999999999986 788776655443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=316.74 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=211.2
Q ss_pred CCCCCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
.-.++|+++.++||+|+||+||++. +..+++.||+|+++.. ......+.+.+|++++++++|+||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 3456787899999999999997764 4557899999999754 24566778999999999999999999999998
Q ss_pred eCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 96 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 96 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
+.....+++||||+.+++|.+++.... +++.+++.++.|++.||++||+.| ++|+||+|+||+++.+ +.++|+|||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg 179 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFG 179 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGG
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCcc
Confidence 876688999999999999999998765 999999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCcc----cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHH
Q 022479 176 FAAIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS--------------VAK 236 (296)
Q Consensus 176 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~--------------~~~ 236 (296)
++........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..... ...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987654322 233456778999997765 488899999999999999999999964321 112
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
....+...... ......+.++.+|+.+||+ ||.+|||+.++++ +|+.+.
T Consensus 260 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~ 309 (318)
T 3lxp_A 260 LTELLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVH 309 (318)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred HHHHHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHH
Confidence 23333333332 2344568999999999998 9999999999997 666553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=325.93 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=207.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++.|++.++||+|+||+||+|.++.+|+.||+|++........ .+.+.+|++++++++|+||+++++++.......
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch---HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34455889999999999999999999999999999976543222 466778999999999999999999988776668
Q ss_pred EEEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE----eCCCCceEEecc
Q 022479 102 LNFITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGDL 174 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv----~~~~~~~~l~df 174 (296)
+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++| ++||||||+||++ +.+ +.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~DF 160 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDF 160 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEECCG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEEecC
Confidence 899999999999999987643 3999999999999999999999999 9999999999998 555 67999999
Q ss_pred CCccccCCCcccccCCCCCCccCccccc---------cCCCcchhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHH
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYE---------EDYTEMVDIYSFGLCLLEMVTMEIPYSE----CDSVAKIYKKV 241 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~Di~slG~i~~~ll~g~~p~~~----~~~~~~~~~~~ 241 (296)
|++.............+++.|+|||++. ..++.++||||||+++|+|++|..||.. ....+......
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9998876665566678999999999765 3477899999999999999999999963 23344444544
Q ss_pred hCCCCCC----------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 242 TGGVKPQ----------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 242 ~~~~~~~----------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...+... ......+..+.+++.+||+ ||++||++.++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 4432210 0111224578899999998 9999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=312.72 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=208.2
Q ss_pred CCcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
++| ++.+.||+|+||+||+|.+ ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 23 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 23 NRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 445 7899999999999999984 4568899999997442 345567899999999999 99999999999855
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHR------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
. ...++||||+.+++|.+++.... .+++..++.++.|++.||+|||++| ++|+||+|+
T Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 174 (313)
T 1t46_A 99 G--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (313)
T ss_dssp S--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred C--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccc
Confidence 4 67899999999999999998654 4899999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+...
T Consensus 175 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred eEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999998 8999999999987654322 23344567899999665 458999999999999999999 9999987665
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
................ ....+..+.+++.+||+ ||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp SHHHHHHHHHTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHhccCCCCCC-cccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5555555554433322 34468999999999998 9999999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.69 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=204.3
Q ss_pred ccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 99 (296)
+++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 36899999999999999997 3456789999997432 233457889999999999 899999999998654
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCC
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR-----------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 156 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~ 156 (296)
..+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++| ++|+||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik 199 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 199 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 67999999999999999998643 3799999999999999999999999 9999999
Q ss_pred CCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 022479 157 CSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSEC 231 (296)
Q Consensus 157 ~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~ 231 (296)
|+||+++.+ +.++|+|||++........ .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+.
T Consensus 200 p~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999998 8999999999976643222 23344577899999765 558999999999999999998 99999877
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 232 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.........+........ ....++++.+|+.+||. ||.+|||+.++++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCSHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 665666666665544333 34468999999999998 99999999999993
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=316.73 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=206.2
Q ss_pred cccceeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
.++++++||+|+||+||+|.+.. .+..||+|+++.. ........+.+|+++++++ +|+||+++++++..
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34789999999999999998643 3467999999754 2456678899999999999 99999999999855
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCce
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ni 160 (296)
. ..+++||||+.+++|.+++.... .+++.+++.++.|++.||+|||++| ++||||||+||
T Consensus 147 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 222 (382)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred C--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence 4 67899999999999999998653 4999999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEeccCCccccCCC---cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022479 161 FINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVA 235 (296)
Q Consensus 161 lv~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~ 235 (296)
+++.+ +.++|+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....
T Consensus 223 ll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 223 LVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99998 89999999999876443 22334456778999997654 48999999999999999999 99999875544
Q ss_pred HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 236 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+...+........ ....++++.+|+.+||+ ||++|||+.+++++
T Consensus 301 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44444444433333 34568999999999998 99999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=306.28 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=202.9
Q ss_pred CCccccee-eecccCcceEEEee--ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSD-LLGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~-~lg~g~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
.+| ++.+ .||+|+||+||++. .+.+++.||+|+++.... +....+.+.+|++++++++||||+++++++. .
T Consensus 16 ~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~-- 89 (291)
T 1xbb_A 16 KLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICE-A-- 89 (291)
T ss_dssp GGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S--
T ss_pred hhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C--
Confidence 344 5666 99999999999994 466789999999975532 3455678999999999999999999999883 2
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++||||+.+++|.+++...+.+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCccee
Confidence 568899999999999999999888999999999999999999999999 9999999999999998 7999999999987
Q ss_pred cCCCcc----cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 180 VGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 180 ~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+. ...+.....+. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~ 244 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMG-CPAG 244 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCC-CCTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCC-CCCC
Confidence 644322 122345678999997764 47889999999999999999 9999987655443 44444433332 3345
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+..+.+++.+||+ ||.+|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999998 9999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=330.48 Aligned_cols=256 Identities=27% Similarity=0.340 Sum_probs=193.3
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
+...+.-+.+.++||+|+||+|+. ....+++.||||++..... ..+.+|+++++++ +||||+++++.+.+.
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 333333346799999999999764 3345789999999964332 2245799999999 799999999988655
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----CCceEEe
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIG 172 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~----~~~~~l~ 172 (296)
..+++||||+.+ +|.+++.... .+++..+..++.|++.||.|||++| ++||||||+||+++.+ ...++|+
T Consensus 91 --~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 91 --QFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp --TEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred --CEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 689999999976 9999987643 4556677899999999999999999 9999999999999632 1368899
Q ss_pred ccCCccccCCC----cccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 022479 173 DLGFAAIVGRS----HAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 173 dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~ 243 (296)
|||++...... .......+|+.|+|||++. ..++.++|||||||++|+|++ |..||........ .....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~ 243 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLG 243 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTT
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhc
Confidence 99999876432 2234467899999999875 346779999999999999999 9999965433322 22222
Q ss_pred CCCC--CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 244 GVKP--QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 244 ~~~~--~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.... .......+..+.+|+.+||+ ||.+|||+.++++||||..+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 2221 11122234568899999998 9999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=315.08 Aligned_cols=246 Identities=25% Similarity=0.279 Sum_probs=197.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--CCe
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--HNT 101 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 101 (296)
..+++.++||+|+||+||+|.+. ++.||+|+++.. ........+|+.++++++||||+++++++.... ...
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 33478999999999999999775 789999999643 233445567899999999999999999987654 345
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCceecCCCCCceEEeCCCCceEE
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH----------EPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~----------~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
+++||||+.+++|.+++.... +++..++.++.|++.||+|||+. + ++|+||||+||+++.+ +.++|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CCEEE
T ss_pred EEEEEecCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-CeEEE
Confidence 799999999999999998754 99999999999999999999999 8 9999999999999998 89999
Q ss_pred eccCCccccCCCcc---cccCCCCCCccCcccccc------CCCcchhHHHHHHHHHHHHhCCCCCCCCC----------
Q 022479 172 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECD---------- 232 (296)
Q Consensus 172 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~i~~~ll~g~~p~~~~~---------- 232 (296)
+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999977644322 333568999999997764 35668899999999999999999996432
Q ss_pred -----hHHHHHHHHhCCCCCCCCCC-----CCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 233 -----SVAKIYKKVTGGVKPQALNK-----VKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 233 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.................... ..+.++.+|+.+||+ ||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22333333333222222111 113459999999998 9999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.91 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=204.8
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||+|.++.+++.||+|+++.. ........+.+|++++++++||||+++++++... ..+++|
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 190 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIV 190 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEEE
Confidence 36789999999999999999989999999998743 2355567788999999999999999999998544 678999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|||+.+++|.+++... ..+++..+..++.|++.||+|||++| ++||||+|+||+++.+ +.++|+|||++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence 9999999999999764 46999999999999999999999999 9999999999999998 899999999997654321
Q ss_pred cc---ccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 185 AA---HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 185 ~~---~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
.. ....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.. ..+..+.... .+..+++++.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~l~ 345 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EFVEKGGRLP-CPELCPDAVF 345 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HHHHTTCCCC-CCTTCCHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCC-CCCCCCHHHH
Confidence 11 1123456799999776 458899999999999999998 99999876654443 3344433322 2345689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+|+.+||+ ||++|||+.++++
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 99999998 9999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=310.24 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=201.7
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecC---CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEe
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 91 (296)
.+..+....+.+++.++||+|+||+||+|.+.. ++..||+|+++.... .....+.+.+|+.++++++||||++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 444455555666889999999999999998765 566899999976533 456677899999999999999999999
Q ss_pred eeeeeCCCC---eEEEEeeccCCCCHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE
Q 022479 92 SVWLDDQHN---TLNFITEVCTSGNLRTYRK------KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 92 ~~~~~~~~~---~~~lv~e~~~~~sL~~~l~------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv 162 (296)
+++.+.... ..++++||+.+++|.+++. ....+++..++.++.|++.||.|||++| ++|+||+|+||++
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli 180 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML 180 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE
Confidence 998765432 5699999999999999984 3456999999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCc---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKI 237 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~ 237 (296)
+.+ +.++|+|||++....... ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.......
T Consensus 181 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 181 RDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp CTT-SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 998 799999999997664322 1223446778999997654 48999999999999999999 89999876555444
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
...... ..+. .....++.+.+++.+||. ||.+|||+.+++++
T Consensus 260 ~~~~~~-~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHG-HRLK-QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTT-CCCC-CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcC-CCCC-CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444333 2222 234468999999999998 99999999999983
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=313.60 Aligned_cols=259 Identities=19% Similarity=0.227 Sum_probs=205.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 100 (296)
+..|++.++||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 33447899999999999999999999999999999753 455677899999999999999999999988643 335
Q ss_pred eEEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 101 TLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
..++|+||+.+++|.+++.. ...+++.+++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++|+|||.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEecCc
Confidence 78999999999999998875 567999999999999999999999999 9999999999999988 7999999999
Q ss_pred ccccCCCcc----------cccCCCCCCccCccccccC----CCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 022479 177 AAIVGRSHA----------AHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKKV 241 (296)
Q Consensus 177 ~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-~~~~~~~ 241 (296)
+........ .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||...... .......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 876532111 1223468899999987643 588999999999999999999999531100 0112222
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...... ......+.++.+++.+||+ ||.+|||+.++++ .|..+..+.
T Consensus 261 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~L~~~~~~~ 308 (317)
T 2buj_A 261 QNQLSI-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS--QLEALQPPA 308 (317)
T ss_dssp HCC--C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTCCCC
T ss_pred hccCCC-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHH--HhhhcCCCC
Confidence 222211 1223458899999999998 9999999999999 555554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=306.00 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=196.9
Q ss_pred CCCCCceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHH-HhcCCCceeE
Q 022479 11 RDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIV 89 (296)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~ 89 (296)
+.+.++......++|+.+.++||+|+||.||+|.++.+++.||+|+++.. ..+.+|+.++ +..+|+||++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~ 75 (299)
T 3m2w_A 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVR 75 (299)
T ss_dssp CCCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCC
T ss_pred cccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchh
Confidence 34455666666778865558999999999999999999999999999732 3456788887 6669999999
Q ss_pred Eeeeeee--CCCCeEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 90 CYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 90 ~~~~~~~--~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
+++++.. .....+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++| ++|+||+|+||+++.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 153 (299)
T 3m2w_A 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSK 153 (299)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSS
T ss_pred HHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecC
Confidence 9998865 23467999999999999999998754 6999999999999999999999999 9999999999999983
Q ss_pred --CCceEEeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC
Q 022479 166 --IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 166 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~ 243 (296)
.+.++|+|||++..... ..++.++|+||||+++|+|++|..||.+.............
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 213 (299)
T 3m2w_A 154 RPNAILKLTDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213 (299)
T ss_dssp STTCCEEECCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred CCCCcEEEecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence 27899999999875432 23578899999999999999999999764332211110000
Q ss_pred CCC-CCCCC----CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 244 GVK-PQALN----KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 244 ~~~-~~~~~----~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
... ..... ...+.++.+|+.+||+ ||.+|||+.++++||||++......
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 000 00011 3458899999999998 9999999999999999987764433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=304.74 Aligned_cols=245 Identities=27% Similarity=0.484 Sum_probs=205.5
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee---------
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--------- 96 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 96 (296)
|++.++||+|+||.||+|.+..+++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 367899999999999999999899999999997542 346689999999999999999998754
Q ss_pred -----CCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCce
Q 022479 97 -----DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 169 (296)
Q Consensus 97 -----~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~ 169 (296)
.....++++|||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-CCE
Confidence 1235689999999999999999753 67999999999999999999999999 9999999999999998 799
Q ss_pred EEeccCCccccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
+|+|||++.............+++.|+|||.+.+ .++.++|+||||+++|+|++|..|+... ...........
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~--- 235 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGI--- 235 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTC---
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhccc---
Confidence 9999999988766555556678999999997764 4899999999999999999999887532 22233333322
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.....+..+.+++.+||. ||.+|||+.++++|.+.-.-.
T Consensus 236 -~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 234568899999999998 999999999999987654433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=304.28 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=194.4
Q ss_pred CCcccceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
...|++.++||+|+||+||+|.+..+ +..+|+|+++.. ......+.+.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 34447899999999999999998654 456999988643 245667789999999999999999999998732
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECcccccc
Confidence 56889999999999999998643 6999999999999999999999999 9999999999999988 899999999998
Q ss_pred ccCCCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 179 IVGRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 179 ~~~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
....... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+......... .. ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~-~~~~~~ 242 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RL-PMPPNC 242 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC-CCCTTC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CC-CCCCCC
Confidence 7644322 22334567899999776 458899999999999999997 999998766555444443332 22 234456
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+.+++.+||. ||++|||+.++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999998 9999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=309.04 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=204.2
Q ss_pred CCcccceeeecccCcceEEEeeec-------CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
++| ++.+.||+|+||+||+|.+. .++..||+|+++... .......+.+|+++++++ +||||+++++++
T Consensus 35 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 35 DKL-TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHe-EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 444 78999999999999999875 356789999997432 455677899999999999 899999999998
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
... ..+++||||+.+++|.+++.... .+++.+++.++.|++.||+|||++| ++|+||||+
T Consensus 111 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 186 (334)
T 2pvf_A 111 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 186 (334)
T ss_dssp CSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred ccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccc
Confidence 554 68999999999999999998654 3899999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++|+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+...
T Consensus 187 NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999988 8999999999987654322 233456778999997654 48999999999999999999 9999987655
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+... .+....... .....+.++.+++.+||+ ||.+|||+.+++++
T Consensus 266 ~~~~~-~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFK-LLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHH-HHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHH-HHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44433 333333222 334568999999999998 99999999999983
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=312.17 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=202.5
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEE--EeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEV--AWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 99 (296)
++| ++.+.||+|+||.||+|.++.++..+ ++|.++... .....+.+.+|+++++++ +||||+++++++...
T Consensus 25 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 98 (327)
T 1fvr_A 25 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 98 (327)
T ss_dssp GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred HHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--
Confidence 445 68999999999999999998888765 899887432 233456788999999999 899999999999665
Q ss_pred CeEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 163 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~ 163 (296)
..+++||||+.+++|.+++.... .+++.+++.++.|++.||+|||++| ++|+||+|+||+++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 176 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc
Confidence 68999999999999999997654 7999999999999999999999999 99999999999999
Q ss_pred CCCCceEEeccCCccccCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022479 164 GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~ 241 (296)
.+ +.++|+|||++.............+++.|+|||.+.+. ++.++||||||+++|+|++ |..||.+....+. ...+
T Consensus 177 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-~~~~ 254 (327)
T 1fvr_A 177 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKL 254 (327)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHG
T ss_pred CC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-HHHh
Confidence 88 79999999999765443334445567899999977654 7999999999999999998 9999987655443 3333
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
....... .....++.+.+|+.+||. ||.+|||+.+++++
T Consensus 255 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4333222 234468999999999998 99999999999884
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=317.11 Aligned_cols=266 Identities=16% Similarity=0.181 Sum_probs=199.8
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecC---CCcEEEeeeeeecccCCCH--H-----HHHHHHHHHHHHHhcCCCc
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDP--V-----LVNRLHSEVQLLRTLKNKY 86 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~--~-----~~~~~~~e~~~l~~l~~~~ 86 (296)
...+..+..|++.++||+|+||+||+|.+.. ++..+|+|++......... . ....+.+|+..++.++|+|
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3334444455789999999999999999987 7889999999754210000 0 1123567888899999999
Q ss_pred eeEEeeeeeeC--CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 87 IIVCYSVWLDD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 87 i~~~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
|+++++++... ....+++||||+ +++|.+++...+.+++.+++.++.|++.||+|||++| ++|+||||+||+++.
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGY 186 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEES
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEcc
Confidence 99999998762 247899999999 8899999988778999999999999999999999999 999999999999998
Q ss_pred CCC--ceEEeccCCccccCCCcc--------cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCC-C
Q 022479 165 NIG--QVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC-D 232 (296)
Q Consensus 165 ~~~--~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~-~ 232 (296)
+ + .++|+|||++........ .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+. .
T Consensus 187 ~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 187 K-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp S-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred C-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 7 5 999999999977643211 2345789999999977654 899999999999999999999999542 2
Q ss_pred hHHHHH---HHHhCCCCC----CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 233 SVAKIY---KKVTGGVKP----QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 233 ~~~~~~---~~~~~~~~~----~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
...... .......+. .......+.++.+++.+||+ ||++|||+.++++ .|++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~ 327 (345)
T 2v62_A 266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPHG 327 (345)
T ss_dssp CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTTC
T ss_pred ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhccC
Confidence 222111 111111111 01112468899999999998 9999999999988 555443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=311.34 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=208.4
Q ss_pred CCCCcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
.....|++.++||+|+||+||+|.+ ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3334447899999999999999984 4567899999997542 345567889999999999 689999999998
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
.... ..++++|||+.+++|.+++..... +++..++.++.|++.||.|||++| ++|+||+|+
T Consensus 101 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~ 177 (316)
T 2xir_A 101 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 177 (316)
T ss_dssp CCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccc
Confidence 6543 568999999999999999987553 899999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+...
T Consensus 178 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 178 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 9999988 7999999999986643221 23345677899999765 458999999999999999998 9999987665
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.......+....... .....++.+.+++.+||+ ||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555555444443322 334468999999999998 99999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=304.26 Aligned_cols=244 Identities=15% Similarity=0.169 Sum_probs=198.6
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCCeEE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++++ +|++++++++++... ...+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 82 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNV 82 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeE
Confidence 34789999999999999999999999999999875432 23467899999999 799999999888554 7899
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc-----eEEeccCCc
Q 022479 104 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIGDLGFA 177 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~-----~~l~dfg~~ 177 (296)
+||||+ +++|.+++... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.+ +. ++|+|||++
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCS-SSTTTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccC-CCCCCCeEEEEECccc
Confidence 999999 88999999864 46999999999999999999999999 9999999999999876 44 999999999
Q ss_pred cccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCC-
Q 022479 178 AIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGG- 244 (296)
Q Consensus 178 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~- 244 (296)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.. ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87644322 344568999999997764 48999999999999999999999997632 222222211111
Q ss_pred -CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 245 -VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 245 -~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..........++++.+++..||+ ||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111223468999999999998 9999999999977
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.05 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=208.1
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee---
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--- 96 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 96 (296)
...++| ++.++||+|+||+||+|.+..+|+.||+|++... ......+.+.+|++++++++||||+++++++..
T Consensus 11 ~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 11 QTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 344566 7899999999999999999999999999998753 245667889999999999999999999988643
Q ss_pred -CCCCeEEEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC--ceE
Q 022479 97 -DQHNTLNFITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG--QVK 170 (296)
Q Consensus 97 -~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~--~~~ 170 (296)
......++||||+.|++|.+++.... .+++..++.++.|++.||+|||++| ++|+||+|+||+++.+.+ .++
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEE
Confidence 22467899999999999999998644 6999999999999999999999999 999999999999997621 489
Q ss_pred EeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------
Q 022479 171 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-------- 241 (296)
Q Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~-------- 241 (296)
|+|||.+.............+++.|+|||.+. +.++.++||||||+++|+|++|..||.+...........
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99999998876665566678899999999776 458999999999999999999999997543222110000
Q ss_pred ------hCC-------CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 242 ------TGG-------VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 242 ------~~~-------~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
.+. ..+.......++.+.+|+.+||. ||++|||+.++++||||+.++
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000 00111122245789999999998 999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=310.82 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=198.4
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEE----EeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeee
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEV----AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 93 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 93 (296)
.+-..++| ++.++||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++|+||++++++
T Consensus 10 ~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 10 RILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp EECCGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred hhcCHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 33445566 67999999999999999988777765 666654322 23345778999999999999999999999
Q ss_pred eeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 94 WLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
+... ..+++++|+.+++|.+++.. ...+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+
T Consensus 86 ~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~ 159 (327)
T 3poz_A 86 CLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKIT 159 (327)
T ss_dssp EESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEEC
T ss_pred EecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEc
Confidence 8754 37889999999999999876 567999999999999999999999999 9999999999999998 899999
Q ss_pred ccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 022479 173 DLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 173 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
|||++........ .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+..... +...+......
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~ 238 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCCC
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-HHHHHHcCCCC
Confidence 9999987644322 22334577899999765 458999999999999999999 999998755443 33444443332
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
. .....+..+.+++.+||+ ||.+|||+.+++++
T Consensus 239 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 P-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp C-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred C-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2 234468899999999998 99999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=315.80 Aligned_cols=247 Identities=20% Similarity=0.339 Sum_probs=194.1
Q ss_pred CCcccceeeecccCcceEEEeeec---CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
.+| .+.++||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 45 ~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 118 (373)
T 2qol_A 45 TNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-- 118 (373)
T ss_dssp GGC-CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hhc-eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--
Confidence 345 67999999999999999876 457789999997532 455677899999999999999999999998544
Q ss_pred CeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++||||+.+++|.+++... ..+++.++..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCcccc
Confidence 6889999999999999999864 46999999999999999999999999 9999999999999998 899999999998
Q ss_pred ccCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 179 IVGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 179 ~~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
....... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.... +....... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~~-~~~ 273 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLP-PPM 273 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEECC-CCT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC-CCc
Confidence 7643221 12223467899999776 458999999999999999998 9999987665544443 33332222 233
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+.++.+++.+||+ ||.+||++.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 468899999999998 9999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=303.02 Aligned_cols=248 Identities=20% Similarity=0.349 Sum_probs=204.7
Q ss_pred CCcccceeeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
++|+.+.+.||+|+||+||+|.+. .++..||+|+++.. ......+.+.+|++++++++||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---C
Confidence 455444459999999999999854 46788999999754 245667889999999999999999999999832 4
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.+++|.+++.. ...+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccceee
Confidence 68999999999999999864 456999999999999999999999999 9999999999999988 8999999999987
Q ss_pred cCCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 180 VGRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 180 ~~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
...... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+.... +.....+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~-~~~~ 237 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRME-CPPE 237 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCC-CCTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCC-CCCC
Confidence 643322 22334578899999776 448999999999999999998 9999987665554443 33333322 3345
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.++++.+++.+||. ||.+|||+.+++++
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68999999999998 99999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=309.43 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=188.2
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeee-
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLD- 96 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 96 (296)
++..+..|++.++||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 333444458899999999999999999999999999998654 4555678899999999996 9999999998853
Q ss_pred -----CCCCeEEEEeeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 97 -----DQHNTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 97 -----~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
.....+++++||+.| +|.+++.. .+.+++.+++.++.|++.||+|||++|++++|+||||+||+++.+ +.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SC
T ss_pred ccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CC
Confidence 233568999999975 88888764 567999999999999999999999988679999999999999998 79
Q ss_pred eEEeccCCccccCCCccc-------------ccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 022479 169 VKIGDLGFAAIVGRSHAA-------------HSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSEC 231 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 231 (296)
++|+|||++......... ....+++.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876543221 1345788999999762 34788999999999999999999999764
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 232 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
...... ... .........+..+.+|+.+||+ ||.+|||+.++++|
T Consensus 257 ~~~~~~----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 257 AKLRIV----NGK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hHHHhh----cCc-ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332211 111 1122234457889999999998 99999999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=304.48 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=206.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
..-+++.++||+|+||+||+|.++.++..+|+|++... ....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 84 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCE
Confidence 34447899999999999999999999999999999743 22357788999999999999999999998544 679
Q ss_pred EEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++||||+.+++|.+++... ..+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCccceec
Confidence 9999999999999999863 45999999999999999999999999 9999999999999988 79999999999876
Q ss_pred CCCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
..... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||.+..... ....+....... .....++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~ 239 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRME-RPEGCPE 239 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCCC-CCTTCCH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhccCCCC-CCCCCCH
Confidence 54322 22334567899999776 458999999999999999999 999998755433 333444433332 3345689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.+.+|+.+||. ||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999998 9999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=320.58 Aligned_cols=244 Identities=21% Similarity=0.371 Sum_probs=201.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||++.++ ++.||+|+++... ..+.+.+|++++++++|+||+++++++.... ..+++|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv 265 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 265 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEE
T ss_pred eEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEE
Confidence 367899999999999999875 7899999997542 2467889999999999999999999986543 478999
Q ss_pred eeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.+++|.+++...+. +++..+..++.|++.||+|||+++ ++||||+|+||+++.+ +.++|+|||++......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCccccccc
Confidence 999999999999986543 799999999999999999999999 9999999999999998 89999999999865432
Q ss_pred cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. ....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.... +..+.... .+..+++++.+|
T Consensus 343 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~-~p~~~~~~l~~l 418 (450)
T 1k9a_A 343 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMD-APDGCPPAVYDV 418 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCC-CCTTCCHHHHHH
T ss_pred c--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC-CCCcCCHHHHHH
Confidence 2 2235678999999765 458999999999999999998 9999987655444433 34433333 344568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+.+||+ ||.+|||+.++++ .++++
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~--~L~~i 443 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLRE--QLEHI 443 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH--HHHHH
Confidence 999998 9999999999987 44443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=310.51 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=199.3
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcE----EEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIE----VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
..++| ++.++||+|+||+||+|.+..+++. +|+|++..... ......+.+|+.++++++|+||+++++++..
T Consensus 11 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (325)
T 3kex_A 11 KETEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86 (325)
T ss_dssp CTTTE-EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB
T ss_pred CHhHc-eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 34455 7899999999999999999888876 66666543321 1123456789999999999999999998742
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
...++|+||+.+++|.+++... +.+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||
T Consensus 87 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg 160 (325)
T 3kex_A 87 ---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFG 160 (325)
T ss_dssp ---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCS
T ss_pred ---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCC
Confidence 5689999999999999998864 57999999999999999999999999 9999999999999988 899999999
Q ss_pred CccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCC
Q 022479 176 FAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 176 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (296)
++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.. ..+...... ..
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~-~~ 238 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEKGERL-AQ 238 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHHTTCBC-CC
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCC-CC
Confidence 9987643322 23345677999999776 558999999999999999999 99999875544433 333333322 22
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
....+.++.+++.+||+ ||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33457889999999998 99999999999884
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=300.50 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=200.1
Q ss_pred CcccceeeecccCcceEEEeeecC---CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
..+++.++||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+ .
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---E 85 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---S
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---C
Confidence 334789999999999999998643 34569999987542 35556889999999999999999999998743 3
Q ss_pred eEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++|||+.+++|.+++... ..+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCCCcc
Confidence 468999999999999999764 46999999999999999999999999 9999999999999998 7999999999987
Q ss_pred cCCCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 180 VGRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 180 ~~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
...... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||......+.......... . ......+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~ 240 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-L-PKPDLCP 240 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-C-CCCTTCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-C-CCCCCCC
Confidence 644321 23345677899999776 458999999999999999998 9999976554444433333322 2 2234468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+.+.+++.+||. ||.+|||+.+++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999998 99999999999983
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=310.31 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=207.7
Q ss_pred cccceeeecccCcceEEEeeecCCCc-----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGI-----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 98 (296)
.+++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 34789999999999999999876654 79999987432 345567899999999999 899999999998544
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH--------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
..+++||||+.+++|.+++... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.
T Consensus 123 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 -GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199 (333)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEG
T ss_pred -CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECC
Confidence 6799999999999999998742 35899999999999999999999999 999999999999999
Q ss_pred CCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022479 165 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK 239 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~ 239 (296)
+ +.++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+.........
T Consensus 200 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 G-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp G-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred C-CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 8 7999999999986533221 22344567899999765 458999999999999999998 9999987665555555
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
......... .+...+..+.+++.+||+ ||.+|||+.++++ +++++
T Consensus 279 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~ 324 (333)
T 2i1m_A 279 LVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQ 324 (333)
T ss_dssp HHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHH
Confidence 555443332 234468999999999998 9999999999998 55443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=305.30 Aligned_cols=246 Identities=21% Similarity=0.343 Sum_probs=199.3
Q ss_pred ccceeeecccCcceEEEeeecCCC-------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEG-------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
+++.++||+|+||+||+|.++.++ ..||+|++.... ....+.+.+|+.++++++|+||+++++++..+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG- 84 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence 378999999999999999998776 469999986542 23357789999999999999999999998654
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc--------e
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--------V 169 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~--------~ 169 (296)
+..++||||+.+++|.+++..... +++..++.++.|++.||.|||++| ++|+||||+||+++.+ +. +
T Consensus 85 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 -DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPFI 160 (289)
T ss_dssp -TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCEE
T ss_pred -CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-Cccccccccee
Confidence 678999999999999999987554 999999999999999999999999 9999999999999988 55 9
Q ss_pred EEeccCCccccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC
Q 022479 170 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
+|+|||.+...... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..|+.................
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~-- 235 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH-- 235 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC--
Confidence 99999998765432 22346778999997764 489999999999999999995544433333344443333322
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
..+...+.++.+|+.+||+ ||.+|||+.++++ .|+.+-
T Consensus 236 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~ 274 (289)
T 4fvq_A 236 -QLPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLF 274 (289)
T ss_dssp -CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhc
Confidence 2223347789999999998 9999999999999 444443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=298.42 Aligned_cols=242 Identities=22% Similarity=0.403 Sum_probs=202.8
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.+.||+|+||.||++.+. +++.||+|++..... . .+.+.+|++++++++||||+++++++... ..++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 81 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred eeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEE
Confidence 368999999999999999986 578899999975433 2 35788999999999999999999998554 678999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 106 TEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
|||+.+++|.+++... ..+++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEccccccccccccc
Confidence 9999999999999864 56899999999999999999999999 9999999999999988 799999999998764321
Q ss_pred --ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......+++.|+|||.+. ..++.++|+||||+++|+|++ |..||......+..... ...... ..+...+..+.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~~-~~~~~~~~~l~~ 236 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRL-YKPRLASTHVYQ 236 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCC-CCCTTSCHHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCcC-CCCccCcHHHHH
Confidence 123345677899999776 458899999999999999999 89999876555444443 333322 233446899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhc
Q 022479 261 FIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+||+ ||.+|||+.++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 9999998 9999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=321.74 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=208.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||.||++.++.++..||+|+++.... ..+.+.+|+.++++++|+||+++++++... ..+++||
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 295 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 295 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEEE
Confidence 678999999999999999998899999999975432 256788999999999999999999998554 6789999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++.......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeecccceeccCCc
Confidence 999999999999863 45899999999999999999999999 9999999999999988 799999999998764322
Q ss_pred --ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 185 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 185 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+ +...+....... .+..+++.+.+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~l~~ 450 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRME-RPEGCPEKVYE 450 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCCCCCHHHHH
Confidence 122334567899999776 458999999999999999999 999998765443 344444443332 23456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 261 FIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
|+.+||+ ||.+|||+.++++ .|+.+-.
T Consensus 451 li~~cl~~dP~~RPs~~el~~--~L~~~~~ 478 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ--AFETMFQ 478 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH--HHHTSCS
T ss_pred HHHHHcCcChhHCcCHHHHHH--HHHHHHh
Confidence 9999998 9999999999988 5555543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=305.81 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=201.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
..+++||+|+||+||+|.+ +++.+|+|++............+.+.+|+.++++++||||+++++++... ...+++|
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 109 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVY 109 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEE
Confidence 4569999999999999976 58899999997654334455678899999999999999999999998554 6789999
Q ss_pred eccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 107 EVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 107 e~~~~~sL~~~l~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
||+.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence 99999999999873 456999999999999999999999999 9999999999999988 89999999999876432
Q ss_pred cc---cccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhCCCC---------CC
Q 022479 184 HA---AHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVTGGVK---------PQ 248 (296)
Q Consensus 184 ~~---~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~---~~~~~~~~~~~---------~~ 248 (296)
.. .....+++.|+|||.+.+.++.++|+||||+++|+|++|..||....... .+......... ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 22 33456889999999888888999999999999999999999997543221 22222221110 01
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
......+..+.+++.+||. ||.+|||+.++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112234678999999998 9999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=303.44 Aligned_cols=239 Identities=26% Similarity=0.452 Sum_probs=191.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||++.+. ++.||+|++.. ....+.+.+|++++++++||||+++++++. +..+
T Consensus 9 ~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~ 75 (307)
T 2eva_A 9 EI-EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL----NPVC 75 (307)
T ss_dssp GE-EEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTE
T ss_pred He-eeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcE
Confidence 44 68999999999999999875 78899999863 223577889999999999999999999874 3478
Q ss_pred EEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh---CCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 104 FITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHT---HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ql~~~l~~LH~---~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
+||||+.+++|.+++.... .++...+..++.|++.||+|||+ +| ++|+||||+||+++.+...++|+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 9999999999999998654 47899999999999999999999 78 9999999999999988324899999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..............+.. ....+
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (307)
T 2eva_A 154 CDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-BTTCC
T ss_pred cccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-ccccC
Confidence 765432 233468999999997765 48999999999999999999999997543 22233333333333332 34468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+.+++.+||+ ||++|||+.++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999998 9999999999988
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=301.71 Aligned_cols=247 Identities=20% Similarity=0.308 Sum_probs=199.8
Q ss_pred ccceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++++++||+|+||+||+|.+..+++ .+|+|++... ......+.+.+|+.++++++|+||+++++++.... ...
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLP 98 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCC
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCc
Confidence 3567999999999999998755444 7999998642 24556788999999999999999999999986543 445
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++++||+.+++|.+++.. ...+++.++..++.|++.||+|||++| ++|+||||+||+++.+ +.++|+|||++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDIL 175 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCccccc
Confidence 889999999999999986 567899999999999999999999999 9999999999999998 899999999997653
Q ss_pred CC-----cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 182 RS-----HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 182 ~~-----~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
.. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..|+............+....... .....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-QPEYCP 254 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-CCTTCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-CCccch
Confidence 32 12333456788999997765 489999999999999999995555433333334444444443322 344468
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+.+++.+||+ ||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999998 9999999999988
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=308.50 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=202.2
Q ss_pred CCcccceeeecccCcceEEEee-----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
++| ++.+.||+|+||+||+|. +..+++.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 30 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 30 KNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGC-EEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhe-EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 344 789999999999999998 45678899999996332 455567889999999999999999999998654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQ 168 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~ 168 (296)
...++||||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.+ ...
T Consensus 106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcce
Confidence 6789999999999999999865 34899999999999999999999999 9999999999999843 146
Q ss_pred eEEeccCCccccCCC---cccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhC
Q 022479 169 VKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~ 243 (296)
++|+|||++...... .......+++.|+|||.+. +.++.++||||||+++|+|++ |..||......+. ...+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-HHHHhc
Confidence 999999998754322 1223345688999999765 458999999999999999998 9999987655444 444444
Q ss_pred CCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 244 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
..... .....+..+.+++.+||+ ||.+|||+.++++|.|+.
T Consensus 261 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 261 GGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 33322 334568999999999998 999999999999987754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=304.95 Aligned_cols=245 Identities=20% Similarity=0.339 Sum_probs=196.3
Q ss_pred ccceeeecccCcceEEEeeecCCC----cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
+.+.++||+|+||+||+|.++.++ ..||+|+++... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 120 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKP 120 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CCC
Confidence 367899999999999999887553 459999987432 45556788999999999999999999999854 378
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 102 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++||||+.+++|.+++... ..+++.+++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCCcchhh
Confidence 99999999999999999764 67999999999999999999999999 9999999999999998 89999999999876
Q ss_pred CCCcc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCC
Q 022479 181 GRSHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254 (296)
Q Consensus 181 ~~~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (296)
..... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+..... ........ ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~-~~~~ 275 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPT-PMDC 275 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCC-CTTC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HCCCcCCC-cccC
Confidence 43221 22234567899999776 458999999999999999999 99999876655444443 33322222 3346
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+..+.+++.+||+ ||++||++.++++
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999997 9999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=313.19 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=202.3
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW 94 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 94 (296)
+...+......|++.++||+|+||+||+|.++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34445555555578999999999999999975 68999999886542 23467789999999999999999999998
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceE
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 170 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~ 170 (296)
... +.+++||||+.+++|.+++.... .+++.+++.++.|++.||+|||++| ++|+||+|+||+++.+ +.++
T Consensus 105 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~k 179 (321)
T 2qkw_B 105 DER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPK 179 (321)
T ss_dssp CCT--TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEE
T ss_pred cCC--CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEE
Confidence 544 67899999999999999886543 5899999999999999999999999 9999999999999998 8999
Q ss_pred EeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHH
Q 022479 171 IGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA------KIYKK 240 (296)
Q Consensus 171 l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~------~~~~~ 240 (296)
|+|||++....... ......+++.|+|||.+. +.++.++||||||+++|+|++|+.||.+....+ .....
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99999997653321 223345788999999765 558999999999999999999999996533211 11111
Q ss_pred HhCCCCCC--------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 241 VTGGVKPQ--------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 241 ~~~~~~~~--------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
........ ......+..+.+++.+||+ ||++|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111110 0111124678899999998 99999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=302.10 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=199.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
...++| ++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.++++++|+++++.+..+... .
T Consensus 6 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~ 77 (296)
T 3uzp_A 6 RVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-G 77 (296)
T ss_dssp EETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-T
T ss_pred eeccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-C
Confidence 334566 789999999999999999999999999999875433 23578899999999998877766665443 3
Q ss_pred CeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe---CCCCceEEeccC
Q 022479 100 NTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDLG 175 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~---~~~~~~~l~dfg 175 (296)
...+++|||+ +++|.+++. ....+++..++.++.|++.||+|||++| ++|+||||+||+++ .+ +.++|+|||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg 153 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDFG 153 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGT-TCEEECCCT
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCC-CeEEEeeCC
Confidence 7889999999 889999997 3567999999999999999999999999 99999999999995 55 799999999
Q ss_pred CccccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH
Q 022479 176 FAAIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYKK 240 (296)
Q Consensus 176 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~------~~~~~~~ 240 (296)
++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+... ...+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 9987644322 245578999999997765 489999999999999999999999975321 1122221
Q ss_pred HhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 241 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.... .........++++.+++..||+ ||.+|||+.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 KMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHS-CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccCC-chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111 1111223468899999999998 9999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=302.60 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=195.6
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
....++| ++.++||+|+||+||+|.+..+++.||+|++..... ...+.+|+.++++++|++++..+..+...
T Consensus 5 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 5 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp ------C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred cccCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 3445666 789999999999999999999999999999765433 23477899999999998888777666543
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEE---eCCCCceEEecc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDL 174 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv---~~~~~~~~l~df 174 (296)
....+++|||+ +++|.+++.. ...+++..+..++.|++.||.|||++| ++|+||||+||++ +.+ +.++|+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~Df 152 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEECCC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEecC
Confidence 37889999999 8899999884 567999999999999999999999999 9999999999999 566 79999999
Q ss_pred CCccccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH
Q 022479 175 GFAAIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYK 239 (296)
Q Consensus 175 g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~------~~~~~~ 239 (296)
|++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+... ......
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 99987644322 234568999999997664 588999999999999999999999975322 111211
Q ss_pred HHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 240 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..... .........++++.+|+..||+ ||++|||+.++++
T Consensus 233 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 233 KKMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHS-CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccccc-hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11111 1111123458899999999998 9999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=306.31 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=202.9
Q ss_pred CCcccceeeecccCcceEEEee----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.+.+++.++||+|+||.||++. +..+++.||+|++... .....+.+.+|++++++++|+||+++++++....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 4445789999999999999998 4667999999999753 3455678999999999999999999999987665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++|+||+.+++|.+++... ..+++.+++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCcch
Confidence 56789999999999999999875 46999999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCcc----cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHH
Q 022479 178 AIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---------------VAKI 237 (296)
Q Consensus 178 ~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---------------~~~~ 237 (296)
........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..... ...+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87654322 223445677999997764 488999999999999999999998853211 0112
Q ss_pred HHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
...+....... ....++.++.+|+.+||+ ||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23333332222 234568999999999998 9999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=316.08 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=190.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
.++++.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+++++ +||||+++++.+... .
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 82 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTD--R 82 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecC--C
Confidence 3455567899999999999865 34579999999987432 34567899999876 899999999988544 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--------
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVS-------IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-------- 165 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-------- 165 (296)
.+++||||+.+ +|.+++....... +..++.++.|++.||+|||++| ++||||||+||+++.+
T Consensus 83 ~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 83 FLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred eEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence 89999999975 9999998754332 2245679999999999999999 9999999999999753
Q ss_pred ----CCceEEeccCCccccCCCcc-----cccCCCCCCccCcccccc--------CCCcchhHHHHHHHHHHHHh-CCCC
Q 022479 166 ----IGQVKIGDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT-MEIP 227 (296)
Q Consensus 166 ----~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~i~~~ll~-g~~p 227 (296)
.+.++|+|||++........ .....+++.|+|||++.+ .++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 24899999999987654321 234578999999997653 47889999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCC----CCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 228 YSECDSVAKIYKKVTGGVKPQALNK----VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
|.+..... ............... ..+.++.+|+.+||+ ||.+|||+.++++||||..
T Consensus 240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 97654433 222333222211111 124789999999998 9999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=304.35 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=203.8
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 93 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 93 (296)
..+++....+++.++||+|+||+||+|.+..++ ..+|+|.+... .+....+.+.+|+.++++++|+||++++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 345555566688999999999999999875433 35888888642 245667889999999999999999999998
Q ss_pred eeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 94 WLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
+.... ...+++|||+.+++|.+++.. ...+++..++.++.|++.||++||++| ++|+||||+||+++.+ +.++|+
T Consensus 95 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~ 170 (298)
T 3f66_A 95 CLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVA 170 (298)
T ss_dssp ECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEEC
T ss_pred EEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEEC
Confidence 65443 678899999999999999975 456899999999999999999999999 9999999999999998 899999
Q ss_pred ccCCccccCCCcc-----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCC
Q 022479 173 DLGFAAIVGRSHA-----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV 245 (296)
Q Consensus 173 dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 245 (296)
|||++........ .....+++.|+|||.+. ..++.++|+||||+++|+|++ |.+||.+....+........ .
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-~ 249 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-R 249 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-C
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-C
Confidence 9999986643221 22344567899999776 458999999999999999999 66777665544444433333 2
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
. ...+...++.+.+++.+||+ ||.+|||+.++++
T Consensus 250 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 R-LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 22344568999999999998 9999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=304.83 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=197.7
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEE----EeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeee
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEV----AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 93 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 93 (296)
.+-..++| ++.++||+|+||+||+|.+..+++.+ ++|.+.... .....+.+.+|+.++++++||||++++++
T Consensus 10 ~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 10 RILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp EECCTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred cccCHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 34445566 68999999999999999998888766 555554322 22335778899999999999999999999
Q ss_pred eeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 94 WLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
+... ..+++++++.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+
T Consensus 86 ~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL~ 159 (327)
T 3lzb_A 86 CLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKIT 159 (327)
T ss_dssp EESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEEC
T ss_pred EecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEEc
Confidence 8654 37889999999999999876 567999999999999999999999999 9999999999999998 899999
Q ss_pred ccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCC
Q 022479 173 DLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 173 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+....+. ...+......
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~~~~~ 238 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL 238 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCC
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCC
Confidence 9999987643322 22334567899999766 458999999999999999999 9999987554443 3334443332
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
. .....+.++.+++.+||+ ||.+|||+.++++
T Consensus 239 ~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 P-QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp C-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 234468899999999998 9999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=311.81 Aligned_cols=255 Identities=17% Similarity=0.176 Sum_probs=193.3
Q ss_pred CCCcccceeeecccCcceEEEeeecCC-----CcEEEeeeeeecccCCC--HHH-----HHHHHHHHHHHHhcCCCceeE
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSED--PVL-----VNRLHSEVQLLRTLKNKYIIV 89 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~--~~~-----~~~~~~e~~~l~~l~~~~i~~ 89 (296)
.+..|++.++||+|+||+||+|.++.+ ++.||+|++........ ... ......++..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 333447899999999999999998764 58899999875421000 000 011334555667788999999
Q ss_pred EeeeeeeCC--CCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe--C
Q 022479 90 CYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--G 164 (296)
Q Consensus 90 ~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~--~ 164 (296)
+++++.... ...+++||||+ |++|.+++... ..+++.++..++.|++.||+|||++| ++||||||+||+++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCC
Confidence 999987643 25689999999 88999999865 67999999999999999999999999 99999999999999 6
Q ss_pred CCCceEEeccCCccccCCCcc--------cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022479 165 NIGQVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA 235 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~ 235 (296)
+ +.++|+|||++........ .....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.....
T Consensus 190 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 P-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp T-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred C-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 6 7999999999977643222 1334589999999977654 8999999999999999999999997532221
Q ss_pred HHHHHHhC----CC----CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 236 KIYKKVTG----GV----KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 236 ~~~~~~~~----~~----~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
........ .. .........+.++.+++..||. ||++||++.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111110 00 0011123458999999999998 9999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=300.68 Aligned_cols=246 Identities=21% Similarity=0.370 Sum_probs=195.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.+.||+|++|+||++.+. |+.||+|+++... ..+.+.+|++++++++|+|++++++++.+.. ..+
T Consensus 21 ~~y-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 90 (278)
T 1byg_A 21 KEL-KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 90 (278)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred hhc-eEEeEEecCCCceEEEEEEc--CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cce
Confidence 344 78999999999999999774 8899999997432 2567889999999999999999999875443 578
Q ss_pred EEEeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++++||+.+++|.+++..... +++..++.++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeeccccccc
Confidence 999999999999999986543 899999999999999999999999 9999999999999988 79999999998765
Q ss_pred CCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... .....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||......+. ...+...... ......++.+
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~l 243 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVEKGYKM-DAPDGCPPAV 243 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-HHHHTTTCCC-CCCTTCCHHH
T ss_pred ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCCCC-CCcccCCHHH
Confidence 433 22335678899999776 458999999999999999998 9999987554333 3333333332 2344568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+++.+||+ ||.+|||+.++++ .++.+
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~--~L~~i 271 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE--QLEHI 271 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH--HHHHH
Confidence 999999998 9999999999987 54443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=301.27 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=199.9
Q ss_pred CCCcccceeeecccCcceEEEeeecC-CC--cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQE-EG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.++| ++.++||+|+||+||+|.+.. ++ ..||+|+++..... .....+.+.+|++++++++|+||+++++++..+
T Consensus 17 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 17 EKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp GGGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred hhHe-eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 3455 789999999999999998643 33 36899999754332 345567899999999999999999999998654
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..++++||+.+++|.+++.. ...+++..+..++.|++.||.+||++| ++|+||+|+||+++.+ +.++|+|||++
T Consensus 94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLM 168 (291)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTC
T ss_pred --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEcccccc
Confidence 38899999999999999876 357999999999999999999999999 9999999999999988 79999999999
Q ss_pred cccCCCcc----cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCC
Q 022479 178 AIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALN 251 (296)
Q Consensus 178 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (296)
........ .....++..|+|||.+.+. ++.++|+||||+++|+|++ |..||.+....+............ ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 247 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-PRP 247 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-CCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-CCC
Confidence 87644322 2234567789999977644 7889999999999999999 999998876655555544443332 334
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
...+.++.+++.+||. ||.+|||+.++++ +|++....+
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~~~ 286 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPTD 286 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC---
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhCccc
Confidence 4568999999999998 9999999999998 666655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=317.46 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=204.9
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||+||++.++. +..||+|+++.... ..+.+.+|++++++++||||+++++++. ...+++|
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv 260 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYII 260 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred eEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEE
Confidence 3678999999999999998864 67899999975432 2567899999999999999999999874 2568999
Q ss_pred eeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.+++|.+++... ..++...+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCC
Confidence 9999999999999753 36899999999999999999999999 9999999999999998 89999999999876432
Q ss_pred c--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
. ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+......... .... +..+++++.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~-~~~~~~~l~ 415 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPR-PENCPEELY 415 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCC-CTTSCHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCCHHHH
Confidence 1 122334567899999776 558999999999999999999 999998876665555444432 2222 344689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+|+.+||+ ||++|||+.++++ .++++.
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~--~L~~~~ 443 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS--VLDDFY 443 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH--HHHTSS
T ss_pred HHHHHHccCChhHCcCHHHHHH--HHHHHH
Confidence 99999998 9999999999988 444443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=309.52 Aligned_cols=247 Identities=18% Similarity=0.281 Sum_probs=197.6
Q ss_pred CCCCCcccceeeecccCcceEEEeeecC--------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeE--
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQE--------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV-- 89 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-- 89 (296)
+..++.|++.+.||+|+||+||+|.+.. .++.||+|++... ..+.+|++++++++|+|+++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~ 108 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKW 108 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhh
Confidence 4444555889999999999999999987 4889999999743 35778999999999999887
Q ss_pred -------------EeeeeeeCCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecC
Q 022479 90 -------------CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 154 (296)
Q Consensus 90 -------------~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~d 154 (296)
+++++... ...+++||||+ +++|.+++... ..+++.+++.++.|++.||+|||++| ++|+|
T Consensus 109 ~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~D 184 (352)
T 2jii_A 109 KKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGN 184 (352)
T ss_dssp HHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSC
T ss_pred hhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCC
Confidence 45555442 37899999999 88999999875 78999999999999999999999999 99999
Q ss_pred CCCCceEEeCCCC--ceEEeccCCccccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh
Q 022479 155 LNCSNIFINGNIG--QVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT 223 (296)
Q Consensus 155 l~~~nilv~~~~~--~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~ 223 (296)
|||+||+++.+ + .++|+|||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++
T Consensus 185 ikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 185 VTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999988 6 899999999977643221 233478999999997765 58999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHH---hCCCCCCC----CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 224 MEIPYSECD-SVAKIYKKV---TGGVKPQA----LNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 224 g~~p~~~~~-~~~~~~~~~---~~~~~~~~----~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
|..||.... ....+.... ........ .....+.++.+|+.+||+ ||++|||+.++++
T Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 999997643 333332222 12111111 112358999999999998 9999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=302.61 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=192.0
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeC--CC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYSVWLDD--QH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~--~~ 99 (296)
+-+++.++||+|+||+||++.+ +++.||+|++.... ...+.+|.+++.. ++||||+++++.+... ..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 3347899999999999999977 58999999986431 2445567777766 7999999999987653 23
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCceecCCCCCceEEeCCCCceEE
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH--------THEPCIIHRDLNCSNIFINGNIGQVKI 171 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~~~i~h~dl~~~nilv~~~~~~~~l 171 (296)
..+++||||+.+++|.+++... .+++..++.++.|++.||+||| +++ ++|+||||+||+++.+ +.++|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SCEEE
T ss_pred ceeEEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CCEEE
Confidence 5689999999999999999654 5999999999999999999999 889 9999999999999998 79999
Q ss_pred eccCCccccCCCcc-----cccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhC----------CCCCC
Q 022479 172 GDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTM----------EIPYS 229 (296)
Q Consensus 172 ~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g----------~~p~~ 229 (296)
+|||++........ .....+++.|+|||.+.+. ++.++||||||+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999976543222 2334789999999977653 34689999999999999999 88885
Q ss_pred CC----ChHHHHHHHHhCCC-CCCCCC----CCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 230 EC----DSVAKIYKKVTGGV-KPQALN----KVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 230 ~~----~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.. .............. .+.... ...+.++.+|+.+||+ ||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 42 22233333332222 221111 1234679999999998 9999999999997
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=296.16 Aligned_cols=243 Identities=23% Similarity=0.414 Sum_probs=201.8
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.+| ++.+.||+|+||+||+|.+. ++..||+|+++.... . .+.+.+|++++++++|+||+++++++.. +..
T Consensus 13 ~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 82 (279)
T 1qpc_A 13 ETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--S---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI 82 (279)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred Hhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--c---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCc
Confidence 344 78999999999999999876 467899999975432 2 4678899999999999999999998743 458
Q ss_pred EEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++|||+.+++|.+++.... .+++.++..++.|++.||++||++| ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcccccc
Confidence 89999999999999987543 6999999999999999999999999 9999999999999988 89999999999876
Q ss_pred CCCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
..... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.... +...... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~ 237 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRM-VRPDNCPE 237 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCC-CCCTTCCH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCC-CCcccccH
Confidence 54322 23345677899999776 448899999999999999999 9999987665544443 3333322 23345689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
++.+++.+||. ||++|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999998 9999999999988
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=307.59 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=199.5
Q ss_pred eecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
.++...+..|++.++||+|+||+||+|.++ +++.||+|++........ ...+.+|++++++++|+||+++++++..
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG---ELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C---CCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH---HHHHHHHHHHHHhccCCCccceEEEEec
Confidence 334444444578999999999999999865 589999999975432211 2358899999999999999999999865
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CCCceecCCCCCceEEeCCCCce
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTH---EPCIIHRDLNCSNIFINGNIGQV 169 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~~~i~h~dl~~~nilv~~~~~~~ 169 (296)
. ...++||||+.+++|.+++.... .+++..++.++.|++.||+|||++ | ++|+||+|+||+++.+ +.+
T Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~ 173 (326)
T 3uim_A 99 P--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEA 173 (326)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCE
T ss_pred C--CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCE
Confidence 4 67889999999999999998643 499999999999999999999999 8 9999999999999998 899
Q ss_pred EEeccCCccccCCCc--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh
Q 022479 170 KIGDLGFAAIVGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVT 242 (296)
Q Consensus 170 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~----~~~~~~~~~~~ 242 (296)
+|+|||++....... ......+++.|+|||.+. +.++.++||||||+++|+|++|..||... ...........
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998764322 234455899999999775 45899999999999999999999999521 11011111111
Q ss_pred CCCCCCCCC------------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcc
Q 022479 243 GGVKPQALN------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 283 (296)
Q Consensus 243 ~~~~~~~~~------------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~ 283 (296)
......... ...+..+.+++.+||+ ||.+|||+.++++|-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111111100 1113678999999998 9999999999999643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.11 Aligned_cols=241 Identities=22% Similarity=0.348 Sum_probs=199.8
Q ss_pred eeecccCcceEEEeee--cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFD--QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
++||+|+||+||+|.+ +.+++.||||+++.... +....+.+.+|++++++++|+||+++++++.. ..+++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEE
Confidence 5899999999999954 55678999999976433 34456789999999999999999999998843 45889999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc--
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-- 185 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~-- 185 (296)
|+.+++|.+++.....+++..+..++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++........
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-----
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCccccccCcccc
Confidence 9999999999998889999999999999999999999999 9999999999999998 7999999999987643221
Q ss_pred --cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+. ...+....... .+..++.++.+|
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-~~~i~~~~~~~-~p~~~~~~l~~l 604 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMG-CPAGCPREMYDL 604 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCC-CCCCCCHHHHHH
Confidence 222345678999997764 58999999999999999998 9999988665544 44444443332 334568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhc
Q 022479 262 IEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~ 280 (296)
+..||+ ||++||++.++++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 999998 9999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=310.25 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=195.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD 96 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 96 (296)
......+++.++||+|+||+||+|.+..+ +..+|+|.++.. .+....+.+.+|+.++++++||||+++++++..
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 33444456789999999999999987543 346889988642 244557889999999999999999999998754
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 175 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg 175 (296)
.. ...++||||+.+++|.+++... ..+++.++..++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||
T Consensus 162 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DFG 237 (373)
T 3c1x_A 162 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFG 237 (373)
T ss_dssp CS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred CC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeecc
Confidence 43 5778999999999999999854 46899999999999999999999999 9999999999999998 899999999
Q ss_pred CccccCCCc-----ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCC
Q 022479 176 FAAIVGRSH-----AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ 248 (296)
Q Consensus 176 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 248 (296)
++....... ......+++.|+|||.+. +.++.++||||||+++|+|++ |.+||.+....+..... ..+...
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~- 315 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRL- 315 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCC-
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCC-
Confidence 997653321 122345677899999776 458999999999999999999 77888765544433333 333222
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
..+..+++.+.+++.+||+ ||++|||+.+++++
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2344568999999999998 99999999999883
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=315.24 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=196.7
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||++.++. +..||+|+++.... . .+.+.+|++++++++||||+++++++.+ ..+++|
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred ceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEE
Confidence 3678999999999999999875 46799999975432 2 3578899999999999999999998843 568999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.+++|.+++.. +..+++.++..++.|++.||+|||+++ ++||||+|+||+++.+ +.++|+|||++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccceecCCC
Confidence 999999999999974 356999999999999999999999999 9999999999999988 79999999999876432
Q ss_pred c--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
. ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+..... ..+..... +..+++.+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~-~~~~~~~l~ 411 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPC-PPECPESLH 411 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCC-CTTSCHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCC-CCCCCHHHH
Confidence 2 122344567899999765 558999999999999999999 99999886665544443 44333222 345689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhc
Q 022479 260 AFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+|+.+||+ ||++|||++++++
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 99999998 9999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=316.10 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=201.2
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.+.|.+++..+..+... ...
T Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~-~~~ 77 (483)
T 3sv0_A 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVE-GDY 77 (483)
T ss_dssp TTTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEE-TTE
T ss_pred CCcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEee-CCE
Confidence 3455 7899999999999999999999999999998755432 3467899999999886555444444332 378
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEe---CCCCceEEeccCCc
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDLGFA 177 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~---~~~~~~~l~dfg~~ 177 (296)
.++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++| |+||||||+|||++ .+ +.++|+|||++
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~-~~vkL~DFGla 153 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRA-NQVYIIDFGLA 153 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGT-TCEEECCCTTC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCC-CeEEEEeCCcc
Confidence 89999999 8899999985 567999999999999999999999999 99999999999994 55 79999999999
Q ss_pred cccCCCcc--------cccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhCC-
Q 022479 178 AIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGG- 244 (296)
Q Consensus 178 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~---~~~~~~~~~~~- 244 (296)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+... ...+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 87644322 225678999999997664 589999999999999999999999976432 11111111110
Q ss_pred -CCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc----------CcccccccCC
Q 022479 245 -VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK----------DPFFSELNDD 290 (296)
Q Consensus 245 -~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~----------hp~~~~~~~~ 290 (296)
.........++.++.+|+..||+ ||++||++.+|++ ++|+..++|+
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 01111123458899999999998 9999999998865 5777666665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=301.31 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=187.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHH--HHhcCCCceeEEeeeeee---C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL--LRTLKNKYIIVCYSVWLD---D 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~---~ 97 (296)
++| ++.++||+|+||+||++.+ +++.||+|++.... ...+..+.++ +..++|+||+++++.+.. .
T Consensus 13 ~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 13 DNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred HHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 455 7899999999999999966 58999999997432 1233334444 456899999999875432 2
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCceecCCCCCceEEeCCCCc
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---------EPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~---------~~~i~h~dl~~~nilv~~~~~~ 168 (296)
....+++||||+.+++|.+++.... .++..++.++.|++.||+|||+. | ++|+||||+||+++.+ +.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-GT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-SC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-Cc
Confidence 3356799999999999999998765 58999999999999999999999 8 9999999999999998 89
Q ss_pred eEEeccCCccccCCC---------cccccCCCCCCccCcccccc--------CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 022479 169 VKIGDLGFAAIVGRS---------HAAHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVTMEIPYSEC 231 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~i~~~ll~g~~p~~~~ 231 (296)
++|+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999876432 11224468999999998764 3567899999999999999997666321
Q ss_pred C-----------------hHHHHHHHHhCCCCCCCCCCC------CChHHHHHHHHHHh-CCCCCCCHHHHhc------C
Q 022479 232 D-----------------SVAKIYKKVTGGVKPQALNKV------KDPEVKAFIEKCIA-QPRARPSASELLK------D 281 (296)
Q Consensus 232 ~-----------------~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~-~p~~Rps~~~ll~------h 281 (296)
. ..................+.. .+.++.+||.+||+ ||++|||+.++++ +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1 112222222222211121211 23479999999998 9999999999955 6
Q ss_pred cccccccCCCCC
Q 022479 282 PFFSELNDDDSE 293 (296)
Q Consensus 282 p~~~~~~~~~~~ 293 (296)
+|-++-...++.
T Consensus 319 ~~~~~~~~~~~~ 330 (336)
T 3g2f_A 319 IWERNKSVSPTA 330 (336)
T ss_dssp CCCC--------
T ss_pred HHHhcccCCCcc
Confidence 776665555544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=304.45 Aligned_cols=247 Identities=17% Similarity=0.192 Sum_probs=194.0
Q ss_pred CceecCCCCCcccceeeecccCcceEEEee-----ecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC---CCc
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKY 86 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~ 86 (296)
+...+...+..|++.++||+|+||+||+|. +..+++.||+|+++... ...+.+|++++++++ |++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhh
Confidence 344455555666889999999999999994 66779999999997432 345667777777776 899
Q ss_pred eeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceE
Q 022479 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 87 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nil 161 (296)
++++++.+... +..++||||+.+++|.+++.. ...+++..++.++.|++.||+|||++| ++||||||+||+
T Consensus 129 iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIl 204 (365)
T 3e7e_A 129 FMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFI 204 (365)
T ss_dssp BCCEEEEEECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEE
T ss_pred hhhhheeeecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEE
Confidence 99999998655 678999999999999999973 567999999999999999999999999 999999999999
Q ss_pred EeC-----------CCCceEEeccCCccccC---CCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCC
Q 022479 162 ING-----------NIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEI 226 (296)
Q Consensus 162 v~~-----------~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~ 226 (296)
++. + +.++|+|||++.... ........++|+.|+|||++.+. ++.++||||||+++|+|++|+.
T Consensus 205 l~~~~~~~~~~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp ECGGGTCC------C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccCcccccccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 988 6 799999999996542 33345566799999999977654 8999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 227 PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
||....... ............++.+.+++..|++ +|.+|++..+.+.
T Consensus 284 pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 284 MKVKNEGGE-------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CCEEEETTE-------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ccccCCCCc-------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 996432110 0001111122346789999999998 9999865444444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.27 Aligned_cols=240 Identities=20% Similarity=0.357 Sum_probs=196.3
Q ss_pred eeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
.+||+|+||.||+|.++ .++..||||+++.... ....+.+.+|++++++++|+||+++++++.. +.+++|||
T Consensus 342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E 415 (613)
T 2ozo_A 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVME 415 (613)
T ss_dssp EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS---STTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEE
Confidence 38999999999999875 3567799999975422 2335778999999999999999999999854 45899999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc-
Q 022479 108 VCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA- 185 (296)
Q Consensus 108 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~- 185 (296)
|+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCce
Confidence 9999999999875 456999999999999999999999999 9999999999999998 8999999999987643221
Q ss_pred ---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 186 ---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 186 ---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
.....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+.... +..+.... .+..+++++.+
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~-~p~~~~~~l~~ 570 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRME-CPPECPPELYA 570 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCC-CCTTCCHHHHH
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCC-CCCcCCHHHHH
Confidence 12233467899999776 558999999999999999998 9999988766554444 44443332 33456899999
Q ss_pred HHHHHHh-CCCCCCCHHHHhc
Q 022479 261 FIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~~ll~ 280 (296)
|+..||+ ||++||++.++++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 9999998 9999999999966
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.84 Aligned_cols=259 Identities=22% Similarity=0.404 Sum_probs=202.5
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
.+....-+++.++||+|+||+||++.+.. .+|+|+++.... .....+.+.+|+.++++++|+||+++++++...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 101 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP- 101 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-
Confidence 33333344789999999999999998753 499999876432 122234567899999999999999999998755
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++++||+.+++|.+++...+ .+++..++.++.|++.||++||++| ++|+||+|+||+++ + +.++|+|||++
T Consensus 102 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg~~ 176 (319)
T 2y4i_B 102 -PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFGLF 176 (319)
T ss_dssp -SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred -CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecCCc
Confidence 67999999999999999998654 7999999999999999999999999 99999999999998 4 69999999998
Q ss_pred cccCC------CcccccCCCCCCccCcccccc----------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022479 178 AIVGR------SHAAHSIIGTPEYMAPELYEE----------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 241 (296)
Q Consensus 178 ~~~~~------~~~~~~~~~~~~~~aPE~~~~----------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~ 241 (296)
..... ........+++.|+|||.+.+ .++.++||||||+++|+|++|..||........... +
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~ 255 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-M 255 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-h
Confidence 65432 122333457889999997653 368899999999999999999999987655544444 4
Q ss_pred hCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 242 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
.....+.......+.++.+++.+||. ||++|||+.++++ .|+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~ 304 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRN 304 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC----
T ss_pred ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhh
Confidence 44444444444568899999999998 9999999999998 666665543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=299.23 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=193.4
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc--CCCceeEEee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL--KNKYIIVCYS 92 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~ 92 (296)
+........+.|++.++||+|+||.||++.+. ++.||+|++.... .....+|.+++... +|+||+++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 33444444445588999999999999999875 8999999996431 13334455555544 8999999999
Q ss_pred eeeeCCC--CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCceecCCCCCceEE
Q 022479 93 VWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--------EPCIIHRDLNCSNIFI 162 (296)
Q Consensus 93 ~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------~~~i~h~dl~~~nilv 162 (296)
.+..... ..+++||||+.+++|.+++... .+++..++.++.|++.||+|||++ | ++|+||||+||++
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill 175 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILV 175 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEE
Confidence 9876543 6789999999999999999765 599999999999999999999998 8 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCcc-----cccCCCCCCccCccccccC-CCc------chhHHHHHHHHHHHHhC------
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED-YTE------MVDIYSFGLCLLEMVTM------ 224 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~------~~Di~slG~i~~~ll~g------ 224 (296)
+.+ +.++|+|||++........ .....+++.|+|||++.+. ... ++||||||+++|+|++|
T Consensus 176 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 176 KKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp CTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 998 7999999999976643222 2245789999999977654 333 38999999999999999
Q ss_pred ----CCCCCCC----ChHHHHHHHHhCCC-CCCCCC----CCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 225 ----EIPYSEC----DSVAKIYKKVTGGV-KPQALN----KVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 225 ----~~p~~~~----~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
..||... .............. .+.... ..++.++.+|+.+||+ ||.+|||+.++++|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7777542 12233333332222 222111 1235679999999998 99999999999983
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=316.97 Aligned_cols=246 Identities=22% Similarity=0.374 Sum_probs=203.1
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
+++.++||+|+||.||++.++. +..||||+++.... . .+.+.+|++++++++|+||+++++++.+ ..+++|
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred hhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEe
Confidence 3678999999999999999875 46799999975432 2 3578899999999999999999998844 568999
Q ss_pred eeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.+++|.+++.. +..+++.++..++.||+.||+|||+++ ++||||+|+|||++.+ +.++|+|||++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEcccccceecCCC
Confidence 999999999999974 356999999999999999999999999 9999999999999988 79999999999876432
Q ss_pred c--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022479 184 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259 (296)
Q Consensus 184 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (296)
. ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.... +..+.... ....++..+.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~-~~~~~~~~l~ 494 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMP-CPPECPESLH 494 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCC-CCTTCCHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC-CCCCCCHHHH
Confidence 1 122334567899999665 558999999999999999999 9999988665554444 44433322 2345689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+||.+||+ ||++|||+.++++ +|+++
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~--~L~~~ 521 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQA--FLEDY 521 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHHH--HHHHH
Confidence 99999998 9999999999998 44443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=299.14 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=201.9
Q ss_pred CceecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHh--cCCCceeEEee
Q 022479 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYS 92 (296)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~ 92 (296)
+........+.+++.+.||+|+||+||++.+ +++.||+|++.... ...+.+|.++++. ++|+||+++++
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 3333333334457899999999999999987 48999999986431 3567788888888 78999999999
Q ss_pred eeeeCCC--CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCceecCCCCCceEE
Q 022479 93 VWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH--------THEPCIIHRDLNCSNIFI 162 (296)
Q Consensus 93 ~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~~~i~h~dl~~~nilv 162 (296)
++..... ..+++||||+.+++|.+++... .+++.+++.++.|++.||+||| +.+ ++|+||||+||++
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll 180 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV 180 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEE
Confidence 9876542 3789999999999999999865 5999999999999999999999 888 9999999999999
Q ss_pred eCCCCceEEeccCCccccCCCc-----ccccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhC------
Q 022479 163 NGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTM------ 224 (296)
Q Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g------ 224 (296)
+.+ +.++|+|||++....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|
T Consensus 181 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 181 KKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp CTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 998 799999999997764433 23445789999999987654 23689999999999999999
Q ss_pred ----CCCCCCCC----hHHHHHHHHhCC-CCCCCCC----CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 225 ----EIPYSECD----SVAKIYKKVTGG-VKPQALN----KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 225 ----~~p~~~~~----~~~~~~~~~~~~-~~~~~~~----~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
..||.... ........+... ..+.... ...+..+.+|+.+||+ ||++|||+.++++ .++.+
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~--~L~~i 334 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK--TLSQL 334 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH--HHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH--HHHHH
Confidence 78886532 234444444332 2222221 1123578999999997 9999999999998 44444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=313.93 Aligned_cols=253 Identities=21% Similarity=0.235 Sum_probs=189.5
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-Cce---------eEE
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYI---------IVC 90 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i---------~~~ 90 (296)
...+.++++++||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.+.| .+. +..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 334444678999999999999999999999999999874322 123345778899999999987 211 110
Q ss_pred eee------------eeeCC---CCeEEEEeeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 022479 91 YSV------------WLDDQ---HNTLNFITEVCTSGNLRTYRKK-------HRHVSIKALKKWSKQVLEGLEYLHTHEP 148 (296)
Q Consensus 91 ~~~------------~~~~~---~~~~~lv~e~~~~~sL~~~l~~-------~~~~~~~~~~~i~~ql~~~l~~LH~~~~ 148 (296)
... +.... ...++++|+.. +++|.+++.. ...+++..+..++.|++.||+|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111 11111 12456666665 4589888741 335778889999999999999999999
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCCCCCCccCcccc----------cc-CCCcchhHHHHHHH
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY----------EE-DYTEMVDIYSFGLC 217 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~-~~~~~~Di~slG~i 217 (296)
++||||||+|||++.+ +.+||+|||++...... ....++ +.|+|||++ .+ .++.++|||||||+
T Consensus 232 -iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp -EECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred -cccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999 79999999998876543 344566 999999976 22 27789999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 218 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 218 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+|+|++|+.||............ . ......++.+.+|+.+||+ ||++||++.++++||||+.+.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~-~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI-F------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG-G------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH-H------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 99999999999764432211111 1 1112458999999999998 999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=313.62 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=200.9
Q ss_pred ccceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+++.++||+|+||+||+|.+..+ +..+|+|+++.. ......+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 465 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 465 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cce
Confidence 36789999999999999988654 456889988643 245666889999999999999999999998743 458
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence 9999999999999999864 46999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCcc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 182 RSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 182 ~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+........... ..+..+++.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPT 620 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--CCCTTCCHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCccccHH
Confidence 4322 22334567899999776 458999999999999999997 99999887666555555444322 233456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
+.+|+.+||. ||.+|||+.++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999998 9999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.84 Aligned_cols=249 Identities=18% Similarity=0.205 Sum_probs=191.7
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC----CCHHHHHHHHHHHHHHHhcC---------CCce
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLK---------NKYI 87 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------~~~i 87 (296)
..++| ++.++||+|+||+||+|.+ +|+.||+|+++..... ......+.+.+|+.+++.++ |+|+
T Consensus 18 ~~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 18 PTEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp CHHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred ccccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 34555 6899999999999999987 5899999999876431 12233467888999998886 7777
Q ss_pred eEEeeeeeeC----------------------------CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 022479 88 IVCYSVWLDD----------------------------QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139 (296)
Q Consensus 88 ~~~~~~~~~~----------------------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~ 139 (296)
+++.+++... ....+|+||||+.++++.+.+.. ..+++.+++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 7777654321 14789999999999976555544 568999999999999999
Q ss_pred HHHHh-hCCCCceecCCCCCceEEeCCCC--------------------ceEEeccCCccccCCCcccccCCCCCCccCc
Q 022479 140 LEYLH-THEPCIIHRDLNCSNIFINGNIG--------------------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 198 (296)
Q Consensus 140 l~~LH-~~~~~i~h~dl~~~nilv~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aP 198 (296)
|+||| ++| ++||||||+|||++.+ + .+||+|||+++..... ...+|+.|+||
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred HHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence 99999 999 9999999999999987 5 8999999999876532 34789999999
Q ss_pred cccccCCCcchhHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHh-CCCCCCCC----CCCCChHHHHHHHHHHh-CCCC
Q 022479 199 ELYEEDYTEMVDIYSFGLC-LLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL----NKVKDPEVKAFIEKCIA-QPRA 271 (296)
Q Consensus 199 E~~~~~~~~~~Di~slG~i-~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~l~~li~~~l~-~p~~ 271 (296)
|++.+..+.++||||||++ .+++++|..||.+..........+. ........ ....++++.+||++||+ |
T Consensus 247 E~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 9988777999999998777 6778889999854221122222222 11111111 11246789999999998 6
Q ss_pred CCCHHHHh-cCcccc
Q 022479 272 RPSASELL-KDPFFS 285 (296)
Q Consensus 272 Rps~~~ll-~hp~~~ 285 (296)
|+.++| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=285.20 Aligned_cols=230 Identities=16% Similarity=0.150 Sum_probs=185.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||.||+|.+..+++.||+|++..... .+....+.+.+|+..+++++|+||+++++++... +.+
T Consensus 31 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 106 (286)
T 3uqc_A 31 GRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGG 106 (286)
T ss_dssp TTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred CcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcE
Confidence 455 789999999999999999999999999999975433 3456678899999999999999999999998765 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+||||+.|++|.+++..+ ....++..++.|++.||+|||++| ++|+||||+||+++.+ +.++|++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEecc-------
Confidence 9999999999999999653 466678899999999999999999 9999999999999998 899998543
Q ss_pred CcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhCCCC-CCCCCCCCChHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY---KKVTGGVK-PQALNKVKDPEV 258 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~l 258 (296)
|++| .+.++||||||+++|+|++|+.||.+......+. ........ +.......+.++
T Consensus 175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 2222 5889999999999999999999998644321110 00011000 011223468899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.+|+.+||+ ||++| |+.++++ .++.+..
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~--~L~~~~~ 265 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLN--LMQQATA 265 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHH--HHHHHHC
T ss_pred HHHHHHHcccCCccC-CHHHHHH--HHHHHhc
Confidence 999999997 99999 9999998 5555443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=319.35 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=198.5
Q ss_pred CCcccceeeecccCcceEEEeeecC-CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC-
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN- 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 100 (296)
++| ++.++||+|+||+||++.+.. +++.||+|++... .+......+.+|++++++++||||+++++++......
T Consensus 80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 445 789999999999999999876 6899999998643 2456677889999999999999999999998765321
Q ss_pred --eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 101 --TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 101 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..|+||||+.|++|.+++.. .+++.+++.++.|++.||.|||++| |+||||||+||+++.+ .++|+|||++.
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--cEEEEecccch
Confidence 26999999999999988765 6999999999999999999999999 9999999999999875 89999999998
Q ss_pred ccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
..... ....+|+.|+|||++.+..+.++||||||+++|+|++|..||.+... ............++.+
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY 297 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred hcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence 76543 45578999999998887789999999999999999999998864211 0001111111135789
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+||.+||+ ||.+||+..+.+.|+|+..
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999998 9999999999999988754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-34 Score=263.51 Aligned_cols=190 Identities=12% Similarity=0.032 Sum_probs=135.7
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC------CHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------DPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
+..-.+.|+.|....+.....|+.+++|++....... .+...+++.+|+++|+++ .|+||+++++++.++ .
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~ 315 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--Q 315 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--S
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--C
Confidence 3344667777777777777789999999997643211 233456799999999999 799999999998655 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+||||||++|++|.+.+..++++++. .++.||+.||+|+|++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~ 389 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESC
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeC
Confidence 899999999999999999999888875 47889999999999999 9999999999999998 89999999999876
Q ss_pred CCC-cccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCC
Q 022479 181 GRS-HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTME 225 (296)
Q Consensus 181 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~ 225 (296)
... ......++|+.|+|||++.+....++|+|++|++++++.++.
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 433 234456789999999999988888999999999988776653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=215.33 Aligned_cols=185 Identities=19% Similarity=0.236 Sum_probs=142.4
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC----HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
..++||+|+||+||++. ..++.+++|+......... ....+++.+|++++++++|+||+++..++... ...+
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~ 415 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNKR 415 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTTE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--CccE
Confidence 35799999999999994 4578899998765433211 12345689999999999999999544444434 4569
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+++++|.+++.. +..++.|++.+|.|||++| ++||||||+||+++. .++|+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCc
Confidence 99999999999999886 5689999999999999999 999999999999998 8999999999887553
Q ss_pred cc--------cccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCC
Q 022479 184 HA--------AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 184 ~~--------~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~ 229 (296)
.. .....+|+.|+|||++.. .++...|+|+..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 22 134578999999998874 37778899999988888877776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-25 Score=183.13 Aligned_cols=150 Identities=19% Similarity=0.253 Sum_probs=116.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-----H---------HHHHHHHHHHHHHHhcCCCcee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----P---------VLVNRLHSEVQLLRTLKNKYII 88 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~---------~~~~~~~~e~~~l~~l~~~~i~ 88 (296)
+.++.++++||+|++|.||+|.+ .+|+.||+|+++....... . .....+.+|+.++++++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34445679999999999999999 7899999999964321100 0 24567899999999999 4 5
Q ss_pred EEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCc
Q 022479 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 168 (296)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~ 168 (296)
++.+.+.. +..++||||++|++|.+ +. ......++.|++.||.+||++| ++|+||||+||+++ + +.
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~ 230 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EG 230 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-Cc
Confidence 55554432 35699999999999987 42 1245579999999999999999 99999999999999 6 89
Q ss_pred eEEeccCCccccCCCcccccCCCCCCccCccccc
Q 022479 169 VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 202 (296)
Q Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~ 202 (296)
++|+|||++.... .+.|||.+.
T Consensus 231 vkl~DFG~a~~~~------------~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVEVG------------EEGWREILE 252 (282)
T ss_dssp EEECCCTTCEETT------------STTHHHHHH
T ss_pred EEEEECCCCeECC------------CCCHHHHHH
Confidence 9999999997532 356777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=160.84 Aligned_cols=144 Identities=18% Similarity=0.178 Sum_probs=109.9
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcE--EEeeeeeecccCC--------------------CHHHHHHHHHHHHHHH
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFSE--------------------DPVLVNRLHSEVQLLR 80 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~--~avK~~~~~~~~~--------------------~~~~~~~~~~e~~~l~ 80 (296)
+.++++.+.||+|+||.||+|.+..+|+. ||||+++...... .......+.+|+..++
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 34457889999999999999998677888 9999976432110 0122346889999999
Q ss_pred hcCCCce--eEEeeeeeeCCCCeEEEEeeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCCCcee
Q 022479 81 TLKNKYI--IVCYSVWLDDQHNTLNFITEVCTS-G----NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH-THEPCIIH 152 (296)
Q Consensus 81 ~l~~~~i--~~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~~~i~h 152 (296)
++.|+++ ..++.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.+|| ++| ++|
T Consensus 126 ~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivH 194 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVH 194 (258)
T ss_dssp HHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EEC
T ss_pred HHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 9988764 223321 246899999943 3 67766443 235577889999999999999 999 999
Q ss_pred cCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 153 RDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 153 ~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS---SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC---cEEEEECcccccC
Confidence 999999999987 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.6e-18 Score=145.44 Aligned_cols=143 Identities=15% Similarity=0.137 Sum_probs=101.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccC------------C-CH-----HHHHHHHHHHHHHHhcCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------------E-DP-----VLVNRLHSEVQLLRTLKNK 85 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------------~-~~-----~~~~~~~~e~~~l~~l~~~ 85 (296)
..|+++.+||+|++|.||+|.+. +|+.||||+++..... . .. ...-....|+..|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34578999999999999999985 5999999997642110 0 00 1111234677788888655
Q ss_pred ceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC
Q 022479 86 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 165 (296)
Q Consensus 86 ~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~ 165 (296)
++....-+... ..++||||+.|.+|..+.. .+....++.|++.+|.+||++| +|||||||.|||++.+
T Consensus 174 gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE 241 (397)
T ss_dssp TCSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE
T ss_pred CCCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC
Confidence 44222111111 2378999999988865432 2244678899999999999999 9999999999999887
Q ss_pred CC----------ceEEeccCCcccc
Q 022479 166 IG----------QVKIGDLGFAAIV 180 (296)
Q Consensus 166 ~~----------~~~l~dfg~~~~~ 180 (296)
+ .+.++||+-+-..
T Consensus 242 -gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 -KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp -ECSSCTTSEEEEEEECCCTTCEET
T ss_pred -CCcccccccccceEEEEeCCcccC
Confidence 4 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.3e-12 Score=105.10 Aligned_cols=139 Identities=15% Similarity=0.088 Sum_probs=104.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCCCeEEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 105 (296)
++...++.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..+.+++++.... ...|+|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv 88 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred eeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEE
Confidence 56788888999999999654 6889999987532111 134778999999885 45566777776543 678999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-------------------------------------- 147 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-------------------------------------- 147 (296)
|||++|.+|.+.+. +......++.++.++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 22233577889999999999810
Q ss_pred -------------------CCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 148 -------------------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 148 -------------------~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 238999999999999875 4667999997754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=6.2e-11 Score=97.16 Aligned_cols=134 Identities=14% Similarity=0.108 Sum_probs=93.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce--eEEeeeeeeCCCCeEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQHNTLNF 104 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~l 104 (296)
.+..+.+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.++ .+++.....+ ...++
T Consensus 23 ~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~ 92 (264)
T 1nd4_A 23 DWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 92 (264)
T ss_dssp EEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence 4333334566699999964 457789999976431 1346778888888865443 4466665433 56899
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE------------------------------------- 147 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------------------------------------- 147 (296)
||||++|.+|. .. ..+. ..++.+++..|+.||+..
T Consensus 93 v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998884 11 1222 356677777888887643
Q ss_pred -------------------CCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 148 -------------------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 148 -------------------~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++++|+|++|.||+++.+ +.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 129999999999999876 5667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.3e-10 Score=100.07 Aligned_cols=145 Identities=12% Similarity=0.148 Sum_probs=103.0
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeee--ecccCCCHHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCC-CeEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVR--LSHFSEDPVLVNRLHSEVQLLRTLKN--KYIIVCYSVWLDDQH-NTLN 103 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~-~~~~ 103 (296)
.+.|+.|.+..+|++... +..+++|+.. .... ......+.+|+.+++.+.. ..+.+++..+.+... ...|
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 577999999999999754 5678888876 3221 1123467789999999974 345666666543321 3578
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------------------------------------- 146 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------- 146 (296)
+||||++|..+.+. .-..++..+...++.+++.+|+.||+.
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 89999999877431 122467888889999999999999972
Q ss_pred -------------------CCCceecCCCCCceEEeCCCC-ceEEeccCCcccc
Q 022479 147 -------------------EPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV 180 (296)
Q Consensus 147 -------------------~~~i~h~dl~~~nilv~~~~~-~~~l~dfg~~~~~ 180 (296)
.++++|+|+++.||+++.+.+ .+.++||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 134999999999999997732 3689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.2e-11 Score=99.27 Aligned_cols=187 Identities=16% Similarity=0.146 Sum_probs=121.8
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCce--eEEeeeeeeCCC-CeEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYI--IVCYSVWLDDQH-NTLNF 104 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~~~-~~~~l 104 (296)
.+.++.|....+|++. ..+++|+.. .......+.+|..+++.+. +..+ .+++........ ...|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3558999999999883 468888854 2344677889999999884 3332 233322211111 23478
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE------------------------------------- 147 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------------------------------------- 147 (296)
||++++|.++..... ..++..+...++.+++..++.||+..
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 899999998865333 24678888888889988888888611
Q ss_pred -------------------CCceecCCCCCceEEeCC-CCceEEeccCCccccCCCcccccCCCCCCccCccccc-----
Q 022479 148 -------------------PCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE----- 202 (296)
Q Consensus 148 -------------------~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~----- 202 (296)
++++|+|+++.||+++.+ .+.+.++||+.+.................-.+|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 248999999999999984 2578999999986543211111111000001222111
Q ss_pred -cCC---------CcchhHHHHHHHHHHHHhCCCCC
Q 022479 203 -EDY---------TEMVDIYSFGLCLLEMVTMEIPY 228 (296)
Q Consensus 203 -~~~---------~~~~Di~slG~i~~~ll~g~~p~ 228 (296)
+.. ....+.|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=6.8e-08 Score=79.48 Aligned_cols=136 Identities=14% Similarity=0.127 Sum_probs=95.6
Q ss_pred eeecccCcc-eEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVK-KVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~-~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
+.+..|..+ .||+......+..+++|+-... ....+.+|...|+.+.. -.+-+++.++.++ ...++||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEE
Confidence 345556555 6899988777888999987632 24567889999998853 2344556665444 57899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH----------------------------------------- 146 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~----------------------------------------- 146 (296)
+++|.++.+..... ......+..++...|+.||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99999887765432 122344556666666666621
Q ss_pred ---------------CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 147 ---------------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 147 ---------------~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.++++|+|+.+.||+++.+ +.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 1137999999999999987 5778999998865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.8e-07 Score=78.56 Aligned_cols=138 Identities=20% Similarity=0.106 Sum_probs=92.6
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC---ceeEEeeeeeeCCCCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.++.|....+|++ +..+++|+-. .......+.+|..+++.+.+. .+.+++.... ......+++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEE
Confidence 356788888899988 5678888843 334567889999999999753 2334444433 223557799
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--------------------------------------- 146 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------------------------------------- 146 (296)
|++++|.++....- ..++..+...++.++...|+.||+.
T Consensus 92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99999988865321 1234445555555555555555532
Q ss_pred -------------------CCCceecCCCCCceEEeC---CCCceEEeccCCcccc
Q 022479 147 -------------------EPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIV 180 (296)
Q Consensus 147 -------------------~~~i~h~dl~~~nilv~~---~~~~~~l~dfg~~~~~ 180 (296)
.++++|+|+++.||+++. +...+.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 223799999999999997 3234589999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.9e-06 Score=75.00 Aligned_cols=80 Identities=16% Similarity=0.182 Sum_probs=47.9
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeeccc-CCC--HHHHHHHHHHHHHHHhcCC--Cce-eEEeeeeeeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SED--PVLVNRLHSEVQLLRTLKN--KYI-IVCYSVWLDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~--~~~~~~~~~e~~~l~~l~~--~~i-~~~~~~~~~~~~~~~ 102 (296)
.+.||.|..+.||++....+++.+++|....... ... ....+++..|.++++.+.. +.. .+++.. +. ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Ccc
Confidence 5789999999999998766678899998653211 000 0113456678888887742 333 344432 23 235
Q ss_pred EEEeeccCCC
Q 022479 103 NFITEVCTSG 112 (296)
Q Consensus 103 ~lv~e~~~~~ 112 (296)
++|||++.+.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7899999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.26 E-value=2.8e-05 Score=60.71 Aligned_cols=133 Identities=16% Similarity=0.165 Sum_probs=91.4
Q ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcccccCC
Q 022479 113 NLRTYRKK-HRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190 (296)
Q Consensus 113 sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (296)
||.+.++. +.+++++++|.++.|.+.+|..+ ++.. -...=+.|..|++..+ |.|.+.+ ..+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence 78888874 67899999999999999998886 3223 2344556799999999 8887764 1111 1
Q ss_pred CCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHhC--
Q 022479 191 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-- 268 (296)
Q Consensus 191 ~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-- 268 (296)
....+.|||......+.+.=|||||+++|..+--..|=. .+...++.+.+||..|..+
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~~~~ 158 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMANTVE 158 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTTCCC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHhccc
Confidence 122466888766566788999999999999987444321 1233588899999998752
Q ss_pred ------------------------CCCCCCHHHHhc
Q 022479 269 ------------------------PRARPSASELLK 280 (296)
Q Consensus 269 ------------------------p~~Rps~~~ll~ 280 (296)
+..|++..++++
T Consensus 159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp --------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccccCcCCHHHHHH
Confidence 346788888876
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.7e-06 Score=69.60 Aligned_cols=82 Identities=7% Similarity=-0.005 Sum_probs=49.9
Q ss_pred eeee-cccCcceEEEeeec--C----CCcEEEeeeeeecc---cCCCHHHHHHHHHHHHHHHhcCC---CceeEEeeeee
Q 022479 29 SDLL-GSGAVKKVYRAFDQ--E----EGIEVAWNQVRLSH---FSEDPVLVNRLHSEVQLLRTLKN---KYIIVCYSVWL 95 (296)
Q Consensus 29 ~~~l-g~g~~~~v~~~~~~--~----~~~~~avK~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~ 95 (296)
.+.| +.|....+|++... . ++..+++|...... ... ...+.+|+.+++.+.. -.+.+++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 4677 88888999988653 0 26678899865432 101 1345667777777742 23445555543
Q ss_pred eCC-CCeEEEEeeccCCCCH
Q 022479 96 DDQ-HNTLNFITEVCTSGNL 114 (296)
Q Consensus 96 ~~~-~~~~~lv~e~~~~~sL 114 (296)
+.. ....++|||+++|.++
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 221 1345789999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.4e-05 Score=64.05 Aligned_cols=31 Identities=26% Similarity=0.435 Sum_probs=26.8
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 349999999999999877 6899999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=6.9e-05 Score=62.76 Aligned_cols=75 Identities=16% Similarity=0.123 Sum_probs=55.1
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC---CceeEEeeeeeeCCCCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---KYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.|+.|....+|++.. ++..+++|+.... ....+.+|+..|+.+.. ..+.+++.+.... ...++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 46789999999999965 4678889987632 14567888888888842 4456666655433 578999
Q ss_pred eeccCCCCH
Q 022479 106 TEVCTSGNL 114 (296)
Q Consensus 106 ~e~~~~~sL 114 (296)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00021 Score=62.48 Aligned_cols=31 Identities=19% Similarity=0.390 Sum_probs=26.7
Q ss_pred CCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 148 ~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
++++|||+.+.||+++.+ + +.++||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSS-C-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCC-C-CEEEeCcccccC
Confidence 349999999999999987 4 999999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00019 Score=59.30 Aligned_cols=74 Identities=15% Similarity=0.021 Sum_probs=50.0
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCC---ceeEEeeeeeeCCCCeEEEE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~~~lv 105 (296)
.+.+|.|..+.||++... +|+.+++|+-...... ....+.+|+..|+.+... .+.+++.+ +. -+++
T Consensus 20 v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~lv 88 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTLA 88 (288)
T ss_dssp EEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEEE
T ss_pred EEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceEE
Confidence 467899999999999765 5889999986533221 124577899999988532 22333332 22 3678
Q ss_pred eeccCCCC
Q 022479 106 TEVCTSGN 113 (296)
Q Consensus 106 ~e~~~~~s 113 (296)
|||+.+..
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 89987764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00027 Score=58.82 Aligned_cols=71 Identities=13% Similarity=-0.053 Sum_probs=41.8
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e 107 (296)
.+.|+.|....+|++ ..+++|+...... . .....+|..+++.+....+. +++... + ..-+++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~--~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----E-YINRANEAVAAREAAKAGVSPEVLHVD--P--ATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T--TTCCEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----c-eeCHHHHHHHHHHHHHcCCCCceEEEE--C--CCCEEEEe
Confidence 567889999999998 4588898764211 0 11124577777766433333 333322 3 22356899
Q ss_pred cc-CCCCH
Q 022479 108 VC-TSGNL 114 (296)
Q Consensus 108 ~~-~~~sL 114 (296)
|+ .|.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00041 Score=58.53 Aligned_cols=32 Identities=22% Similarity=0.365 Sum_probs=26.8
Q ss_pred CceecCCCCCceEEeCC---CCceEEeccCCcccc
Q 022479 149 CIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIV 180 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~---~~~~~l~dfg~~~~~ 180 (296)
+++|||+.+.||+++.+ .+.+.++||+.+..-
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999874 147899999988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00025 Score=59.50 Aligned_cols=142 Identities=17% Similarity=0.137 Sum_probs=73.6
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce--eEEeeee----eeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVW----LDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~----~~~~~~~~ 102 (296)
.+.|+.|....+|++... +..+++|+...... ...+..|+.+++.+....+ .+++... ...-....
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCC------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 356778888899998654 34688998864211 1234456666666642222 2222110 00011456
Q ss_pred EEEeeccCCCCHH-----H------HH----HhcCC--------CCHHHHHH---------------HHHHHHHHHHHHh
Q 022479 103 NFITEVCTSGNLR-----T------YR----KKHRH--------VSIKALKK---------------WSKQVLEGLEYLH 144 (296)
Q Consensus 103 ~lv~e~~~~~sL~-----~------~l----~~~~~--------~~~~~~~~---------------i~~ql~~~l~~LH 144 (296)
+++++|++|..+. . .+ ..... .....-.. +...+...+..+.
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8899999886431 1 11 10000 11110000 0011333444444
Q ss_pred hC-----CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 145 TH-----EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 145 ~~-----~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.. .++++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 21 1239999999999999986 4568999997754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.001 Score=57.15 Aligned_cols=140 Identities=16% Similarity=0.242 Sum_probs=79.2
Q ss_pred eeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCCC
Q 022479 29 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN 100 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 100 (296)
.+.|..|-...+|++.... +++.+++|+.... . .. ...+.+|.++++.+...++ .++++.+ +.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~-- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L-QG---VDSLVLESVMFAILAERSLGPQLYGVF--PE-- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--
Confidence 3567778888899987642 3578999986321 1 11 3445588888888854333 3444443 32
Q ss_pred eEEEEeeccCCCCHHH--------------HHHh--------cCCCC--HHHHHHHHHHHHH------------------
Q 022479 101 TLNFITEVCTSGNLRT--------------YRKK--------HRHVS--IKALKKWSKQVLE------------------ 138 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~--------------~l~~--------~~~~~--~~~~~~i~~ql~~------------------ 138 (296)
. +|+||++|.+|.. .+.. +.... ..++..+..++-.
T Consensus 126 g--~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 G--RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp E--EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred c--cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 1 7899998865421 1111 11122 3455555544322
Q ss_pred -HHHH----Hhh--CCCCceecCCCCCceEEeCC---CCceEEeccCCccc
Q 022479 139 -GLEY----LHT--HEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAI 179 (296)
Q Consensus 139 -~l~~----LH~--~~~~i~h~dl~~~nilv~~~---~~~~~l~dfg~~~~ 179 (296)
.+.. |.. ...+++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 222 22249999999999999875 25899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=57.39 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=46.4
Q ss_pred eeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCCC
Q 022479 29 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN 100 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 100 (296)
.+.|+.|....+|++.... +++.+++|+.... .. ...+.+|..+++.+...++ .++++.+ +.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--
Confidence 3678888889999997642 2578999988431 11 1334468888887754444 3455443 32
Q ss_pred eEEEEeeccCCCC
Q 022479 101 TLNFITEVCTSGN 113 (296)
Q Consensus 101 ~~~lv~e~~~~~s 113 (296)
.++++|++|.+
T Consensus 148 --g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 --GRLEEYIPSRP 158 (429)
T ss_dssp --EEEECCCCEEE
T ss_pred --CEEEEEeCCcc
Confidence 26889988744
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=57.83 Aligned_cols=75 Identities=17% Similarity=0.142 Sum_probs=46.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e 107 (296)
.+.|+.|-...+|++.....+..+++|+...... ...+ ..+|..+++.+...++. ++++.+ + +. .|++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~----~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~--~G--~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD----EIIN-REREKKISCILYNKNIAKKIYVFF--T--NG--RIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC----SCSC-HHHHHHHHHHHTTSSSBCCEEEEE--T--TE--EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh----hhcC-HHHHHHHHHHHHhcCCCCCEEEEe--C--Ce--EEEE
Confidence 4678888889999997754457899998743211 0011 24788889888765553 455544 3 22 3899
Q ss_pred ccCCCCH
Q 022479 108 VCTSGNL 114 (296)
Q Consensus 108 ~~~~~sL 114 (296)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.01 Score=49.70 Aligned_cols=140 Identities=13% Similarity=0.112 Sum_probs=75.3
Q ss_pred eeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeee---eeeCCCCeEEE
Q 022479 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSV---WLDDQHNTLNF 104 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~---~~~~~~~~~~l 104 (296)
+.|+ |....+|++... +|+.+++|....... + ...+..|..+++.+.... +.+++.. .........++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 4466 778889988643 466799999863221 2 234556777777764222 2333322 00001245678
Q ss_pred EeeccCCCCHH-----HH------HH------hc------CCCCHHHH----------------------HHHHHHHHHH
Q 022479 105 ITEVCTSGNLR-----TY------RK------KH------RHVSIKAL----------------------KKWSKQVLEG 139 (296)
Q Consensus 105 v~e~~~~~sL~-----~~------l~------~~------~~~~~~~~----------------------~~i~~ql~~~ 139 (296)
++++++|..+. .. +. .. ...+.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999885431 11 11 00 01121111 1111222222
Q ss_pred HHHHhh--CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 140 LEYLHT--HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 140 l~~LH~--~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+..+.. ..++++|||+++.||+++ + .+.++||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 222211 233389999999999998 4 799999987754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.013 Score=49.44 Aligned_cols=31 Identities=16% Similarity=0.360 Sum_probs=27.1
Q ss_pred CceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 149 ~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
+++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGG-GCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCC-CeEEEEECCCCeeC
Confidence 49999999999999977 68999999887654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0024 Score=54.61 Aligned_cols=74 Identities=15% Similarity=0.064 Sum_probs=41.0
Q ss_pred eeeecccCcceEEEeeecCC--------CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCC
Q 022479 29 SDLLGSGAVKKVYRAFDQEE--------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQH 99 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~ 99 (296)
.+.|+.|..-.+|++..... +..+++|+...... . ......|..+++.+...++ .++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----c-eecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 46678888889999876431 26788888753211 0 1123467777777753333 3444332 2
Q ss_pred CeEEEEeeccCCCC
Q 022479 100 NTLNFITEVCTSGN 113 (296)
Q Consensus 100 ~~~~lv~e~~~~~s 113 (296)
-+++++|++|.+
T Consensus 109 --~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 --GGRIEEWLYGDP 120 (369)
T ss_dssp --TEEEEECCCSEE
T ss_pred --CcEEEEEecCCc
Confidence 256899998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.72 E-value=1.1 Score=34.99 Aligned_cols=114 Identities=7% Similarity=0.001 Sum_probs=75.9
Q ss_pred CCCceeEEeeeeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhCCCCceecCCCCCceE
Q 022479 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE-YLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 83 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~-~LH~~~~~i~h~dl~~~nil 161 (296)
.||++ +. .+-. ..+.+.+.++.-.++.-...+. .++..+.++++.+|+.... ++ .. -.|--|+|+|++
T Consensus 48 ~~~~f-~~-~I~~--~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~--r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI-VR-DIDV--SEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--AR--RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS-EE-EEEE--CSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SS--SEECCCCGGGEE
T ss_pred cCCCC-Ce-EEEE--eCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hC--ceeEEEeCceEE
Confidence 56777 33 2332 2367777777664443333444 3789999999999888666 43 34 588999999999
Q ss_pred EeCCCCceEEeccCCccccCCCcccccCCCCCCccCccccccCCCcchhH-HHHHHHHHHHHhCCCCCC
Q 022479 162 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDI-YSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di-~slG~i~~~ll~g~~p~~ 229 (296)
++.+ +.+++.-.|+-....+.. ....|. -..=|++..++.++..|.
T Consensus 117 f~~~-~~p~i~hRGi~~~lpP~e---------------------~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRA-LEPFFLHVGVKESLPPDE---------------------WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTT-CCEEESCCEETTTBSSCS---------------------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCC-CcEEEEEcCCcccCCCCC---------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999 899999888765432211 111233 366778888888877763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.4 Score=37.25 Aligned_cols=116 Identities=9% Similarity=0.056 Sum_probs=77.3
Q ss_pred cCCCceeEEeeeeeeCCCCeEEEEeeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCce
Q 022479 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 160 (296)
Q Consensus 82 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ni 160 (296)
..+|++++.- +... .+.+.+.++.-..+ +... +. ..+....++++.+|+....+++ . -.|--|+|+|+
T Consensus 42 ~~~~~Fl~~~-I~e~--eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~--~--r~tf~L~P~NL 110 (215)
T 4ann_A 42 QHSPYFIDAE-LTEL--RDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNR--T--RYTFVLAPDEL 110 (215)
T ss_dssp SCCTTBCCEE-EEEC--SSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGG--S--SEECCCSGGGE
T ss_pred ccCCcccceE-EEEc--ccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhc--C--ceEEEEecceE
Confidence 3578888663 3322 25677666655432 3332 33 3789999999999998774443 3 48899999999
Q ss_pred EEeCCCCceEEeccCCccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 022479 161 FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYS 229 (296)
Q Consensus 161 lv~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 229 (296)
+++.+ +.++++-.|+...+.+. ..+...=.-..=|++..+++++..|.
T Consensus 111 ~f~~~-~~p~i~~RGik~~l~P~--------------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRD-GLPIAKTRGLQNVVDPL--------------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTT-SCEEESCCEETTTBSCC--------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCC-CCEEEEEccCccCCCCC--------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999 79999988875543221 11222223366788888899888773
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.33 E-value=0.36 Score=41.58 Aligned_cols=30 Identities=17% Similarity=0.299 Sum_probs=24.9
Q ss_pred ceecCCCCCceEEeC-----CCCceEEeccCCccc
Q 022479 150 IIHRDLNCSNIFING-----NIGQVKIGDLGFAAI 179 (296)
Q Consensus 150 i~h~dl~~~nilv~~-----~~~~~~l~dfg~~~~ 179 (296)
++|+|+.+.||++.. ..+.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 789999999999943 225799999999865
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.17 E-value=0.1 Score=46.01 Aligned_cols=63 Identities=8% Similarity=-0.034 Sum_probs=16.8
Q ss_pred ceeeecccCcceEEEeeecCCCcEEEe------eeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 022479 28 YSDLLGSGAVKKVYRAFDQEEGIEVAW------NQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL 95 (296)
Q Consensus 28 ~~~~lg~g~~~~v~~~~~~~~~~~~av------K~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 95 (296)
+.+.|| ||.||++.......+||+ |..+.... +.+....+.++..+.+..+|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~--~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV--SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc--cccccccccccccccccccccccCCCcceEE
Confidence 456676 999999988765567888 65543222 2334456778888898999999988876543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.55 E-value=0.5 Score=41.06 Aligned_cols=75 Identities=15% Similarity=0.059 Sum_probs=45.4
Q ss_pred eeeecccCcceEEEeeecCC-------CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCCC
Q 022479 29 SDLLGSGAVKKVYRAFDQEE-------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN 100 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 100 (296)
.+.|..|-.-.+|++..... ++.+++|+..... .. .-...+|..+++.+...++ .++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GK-FYDSKVELDVFRYLSNINIAPNIIADF--P--- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C---
Confidence 46677788888999876521 5789999865321 11 1123467777877753333 3334322 2
Q ss_pred eEEEEeeccCCCCH
Q 022479 101 TLNFITEVCTSGNL 114 (296)
Q Consensus 101 ~~~lv~e~~~~~sL 114 (296)
-+.|++|++|.+|
T Consensus 145 -~~~I~efI~G~~l 157 (424)
T 3mes_A 145 -EGRIEEFIDGEPL 157 (424)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CCEEEEEeCCccC
Confidence 2568999998653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 296 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-78 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-50 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-13 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 6e-78
Identities = 122/271 (45%), Positives = 170/271 (62%), Gaps = 6/271 (2%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
V + GRF ++ +G G+ K VY+ D E +EVAW +++ ++ R E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEA 59
Query: 77 QLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
++L+ L++ I+ Y W + +TE+ TSG L+TY K+ + + IK L+ W +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 194
Q+L+GL++LHT P IIHRDL C NIFI G G VKIGDLG A + R+ A ++IGTPE
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPE 178
Query: 195 YMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254
+MAPE+YEE Y E VD+Y+FG+C+LEM T E PYSEC + A+IY++VT GVKP + +KV
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
PEVK IE CI Q R S +LL FF
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 9e-59
Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 16/277 (5%)
Query: 13 GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 72
E F + DP F +G G+ VY A D VA ++ S + +
Sbjct: 5 AELFFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDI 62
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 132
EV+ L+ L++ I +L + + E C + + +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+ L+GL YLH+H +IHRD+ NI ++ G VK+GD G A+I+ + +S +GT
Sbjct: 121 THGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGT 174
Query: 193 PEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 248
P +MAPE+ Y VD++S G+ +E+ + P ++++ +Y P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA 233
Query: 249 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ + F++ C+ + P+ RP++ LLK F
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-58
Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 15/264 (5%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G+G+ + + + +G + W ++ +E L SEV LLR LK+ I+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKHPNIVR 67
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHT 145
Y +D + TL + E C G+L + K+ +++ + + + Q+ L+ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 146 HEPC---IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPELY 201
++HRDL +N+F++G VK+GD G A I+ + A + +GTP YM+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 202 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260
Y E DI+S G L E+ + P+ S ++ K+ G K + + E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 261 FIEKCIAQ-PRARPSASELLKDPF 283
I + + RPS E+L++P
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-57
Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 14/268 (5%)
Query: 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 79
DP ++ R+ + +G GA VY A D G EVA Q+ L + + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVM 71
Query: 80 RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
R KN I+ +L L + E G+L + + ++ L+
Sbjct: 72 RENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQA 128
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAP 198
LE+LH++ +IHRD+ NI + + G VK+ D GF A + +++GTP +MAP
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 199 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257
E + + Y VDI+S G+ +EM+ E PY + + +Y T G +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPFF 284
+ F+ +C+ R SA ELL+ F
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-56
Identities = 56/259 (21%), Positives = 112/259 (43%), Gaps = 12/259 (4%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG G VY A +++ +A + + E + ++L EV++ L++ I+
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y + D + I E G + +K + + ++ L Y H+
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEM 208
+IHRD+ N+ + G++KI D G++ S ++ GT +Y+ PE+ E + E
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 268
VD++S G+ E + + P+ E ++ + YK+++ + I + +
Sbjct: 185 VDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH 241
Query: 269 -PRARPSASELLKDPFFSE 286
P RP E+L+ P+ +
Sbjct: 242 NPSQRPMLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-56
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 19/278 (6%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 77
+++P + LG GA KVY+A ++E + A + E + E+
Sbjct: 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEID 61
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQV 136
+L + + I+ + + + L + E C G + + R ++ ++ KQ
Sbjct: 62 ILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 137 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEY 195
L+ L YLH + IIHRDL NI + G +K+ D G +A R+ S IGTP +
Sbjct: 120 LDALNYLHDN--KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 196 MAPELY------EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
MAPE+ + Y D++S G+ L+EM +E P+ E + + + K A
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
K F++KC+ + AR + S+LL+ PF +
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 73/307 (23%), Positives = 127/307 (41%), Gaps = 51/307 (16%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG+G V++ + G+ +A +L H P + N++ E+Q+L + YI+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y + D ++ E G+L KK + + L K S V++GL YL +
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 208
I+HRD+ SNI +N G++K+ D G + + S A+S +GT YM+PE L Y+
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDS----------------------------------- 233
DI+S GL L+EM P D+
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 234 ------VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
+ ++ + P+ + V E + F+ KC+ + P R +L+ F
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
Query: 287 LNDDDSE 293
+ ++ +
Sbjct: 304 SDAEEVD 310
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-53
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 20/278 (7%)
Query: 15 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 74
PFVE + LG GA +V A ++ VA V + + P +
Sbjct: 2 PFVE-----DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKK 52
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 134
E+ + + L ++ ++ Y + E C+ G L + + +++
Sbjct: 53 EICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 110
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIG 191
Q++ G+ YLH I HRD+ N+ ++ +KI D G A + R + + G
Sbjct: 111 QLMAGVVYLHGI--GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 192 TPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
T Y+APEL E + E VD++S G+ L M+ E+P+ + + Y
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
K D A + K + + P AR + ++ KD ++++
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 1e-53
Identities = 59/287 (20%), Positives = 115/287 (40%), Gaps = 15/287 (5%)
Query: 17 VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 74
VEV + Y + LGSGA V+R ++ G + + + + +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK----YTVKN 75
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWS 133
E+ ++ L + +I + + D + I E + G L + +S + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGT 192
+Q EGL+++H H I+H D+ NI VKI D G A + T
Sbjct: 134 RQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 193 PEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQAL 250
E+ APE+ + E D+++ G+ +++ P++ D + + + +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 251 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
PE K FI+ + + PR R + + L+ P+ + + + P
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 25 FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
G+ + +GSG+ VY+ + VA + ++ + + +EV +LR
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKT 61
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 141
++ I++ Q L +T+ C +L + + L ++Q +G++
Sbjct: 62 RHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAP 198
YLH IIHRDL +NIF++ + VKIGD G A + R SH + G+ +MAP
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 199 ELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254
E+ Y+ D+Y+FG+ L E++T ++PYS ++ +I V G L+KV+
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 255 D---PEVKAFIEKCIAQ-PRARPSASELLK 280
+K + +C+ + RP ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 2e-53
Identities = 59/286 (20%), Positives = 114/286 (39%), Gaps = 15/286 (5%)
Query: 17 VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 74
VE+ Y + LG+GA V+R ++ G A V H S+ +
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRK 72
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWS 133
E+Q + L++ ++ + + DD + I E + G L +H +S ++
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 134 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFAAIVGRSHAAHSIIGT 192
+QV +GL ++H + +H DL NI ++K+ D G A + + GT
Sbjct: 131 RQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 193 PEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQAL 250
E+ APE+ E + D++S G+ +++ P+ + + + +
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248
Query: 251 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 295
+ K FI K + P R + + L+ P+ + N +
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 5e-53
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 12/272 (4%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
D+LG+GA +V A D+ VA + + +E+ +L +K+ I+
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE---GSMENEIAVLHKIKHPNIVA 71
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
++ H L I ++ + G L + + + + QVL+ ++YLH +
Sbjct: 72 LDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--DLG 127
Query: 150 IIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP-ELYEEDYT 206
I+HRDL N+ ++ I D G + + + GTP Y+AP L ++ Y+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKC 265
+ VD +S G+ ++ P+ + + + + + K FI
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 266 IAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
+ + P R + + L+ P+ + D
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (431), Expect = 4e-52
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 20/278 (7%)
Query: 25 FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-----EDPVLVNRLHSEVQ 77
+ Y ++LG G V R + E A + ++ E L EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 137
+LR + I+ + + ++ G L Y + +S K +K + +L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
E + LH I+HRDL NI ++ + +K+ D GF+ + + GTP Y+A
Sbjct: 121 EVICALHKL--NIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 198 PELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 250
PE+ E Y + VD++S G+ + ++ P+ + + ++G + +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 251 NKVK-DPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286
VK + + + QP+ R +A E L PFF +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-50
Identities = 54/269 (20%), Positives = 112/269 (41%), Gaps = 16/269 (5%)
Query: 25 FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
+ +Y + LG G V+R + V++ D VLV + E+ +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKK---EISILNIA 58
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 141
+++ I+ + + + L I E + ++ ++ + + + QV E L+
Sbjct: 59 RHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 142 YLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 200
+LH+H I H D+ NI +KI + G A + + PEY APE+
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 201 YEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEV 258
++ D + D++S G + +++ P+ + I + + K E
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPFFSE 286
F+++ + + ++R +ASE L+ P+ +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 56/280 (20%), Positives = 115/280 (41%), Gaps = 14/280 (5%)
Query: 27 RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTL 82
Y + LGSG V + ++ G++ A ++ S V + EV +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 142
++ +I + V+ + + I E+ G L + + ++ + ++ KQ+L G+
Sbjct: 71 QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY- 127
Query: 143 LHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 199
+ H I H DL NI + N ++KI D G A + + +I GTPE++APE
Sbjct: 128 -YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 200 LYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE 257
+ + D++S G+ +++ P+ + +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 258 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
K FI + + + P+ R + + L+ P+ + + S
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 63/276 (22%), Positives = 120/276 (43%), Gaps = 20/276 (7%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
++ +LG G+ V A + E A + H ++ V + E ++ L + +
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMSRLDHPF 69
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
+ Y + DD+ L F +G L Y +K + ++ +++ LEYL H
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL--H 125
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPE-LYE 202
IIHRDL NI +N + ++I D G A ++ + A+S +GT +Y++PE L E
Sbjct: 126 GKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262
+ + D+++ G + ++V P+ + I++K+ + K P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL-EYDFPEKF-FPKARDLV 241
Query: 263 EKCIAQ-PRARPSASE------LLKDPFFSELNDDD 291
EK + R E L PFF + ++
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-47
Identities = 60/270 (22%), Positives = 111/270 (41%), Gaps = 20/270 (7%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN--RLHSEVQLLRT 81
+Y LLGSG VY + + VA V S+ L N R+ EV LL+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 82 LKNKYI-IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 140
+ + + ++ W + + + + +L + + + + + + QVLE +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 141 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 200
+ H ++HRD+ NI I+ N G++K+ D G A++ + GT Y PE
Sbjct: 124 RHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEW 180
Query: 201 Y--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
+ ++S G+ L +MV +IP+ + + + V E
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSEC 231
Query: 259 KAFIEKCIAQ-PRARPSASELLKDPFFSEL 287
+ I C+A P RP+ E+ P+ ++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-46
Identities = 55/270 (20%), Positives = 109/270 (40%), Gaps = 20/270 (7%)
Query: 32 LGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LGSG V + + Q + VA ++ + DP L + L +E +++ L N YI+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + + + E+ G L Y +++RHV K + + QV G++YL
Sbjct: 73 MIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--N 127
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH----AAHSIIGTPEYMAPE-LYEED 204
+HRDL N+ + KI D G + + A ++ APE +
Sbjct: 128 FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
++ D++SFG+ + E + +++ + G + E+ +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNL 245
Query: 265 CIAQ-PRARPSASEL---LKDPFFSELNDD 290
C RP + + L++ ++ +N+
Sbjct: 246 CWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-46
Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 35/296 (11%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYII 88
D LG G VY+A D+ VA +++L H SE + E++LL+ L + II
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ + ++ + + + + ++ +K + L+GLEYL H+
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL--HQH 119
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEED--Y 205
I+HRDL +N+ ++ N G +K+ D G A G + A++ + T Y APEL Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 206 TEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK----------------------K 240
VD+++ G L E++ S+ D + +I++ K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 295
G+ + ++ I+ P AR +A++ LK +FS
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 57/266 (21%), Positives = 117/266 (43%), Gaps = 12/266 (4%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+LG G+ KV+ A ++ A ++ D + + + L ++ ++
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + ++ L F+ E G+L + + + ++ +++ GL++LH+
Sbjct: 68 MFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--G 123
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPE-LYEEDYTE 207
I++RDL NI ++ + G +KI D G A + GTP+Y+APE L + Y
Sbjct: 124 IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
VD +SFG+ L EM+ + P+ +++ + + + E K + K
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFV 239
Query: 268 Q-PRARPSA-SELLKDPFFSELNDDD 291
+ P R ++ + P F E+N ++
Sbjct: 240 REPEKRLGVRGDIRQHPLFREINWEE 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-45
Identities = 57/297 (19%), Positives = 113/297 (38%), Gaps = 28/297 (9%)
Query: 17 VEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
+++ + Y S +LG G KV + F++ + A ++ +
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---------KAR 52
Query: 74 SEVQ-LLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKA 128
EV+ R + +I+ V+ + L + E G L + + + + +
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAA 186
+ K + E ++YLH+ I HRD+ N+ +K+ D GFA ++
Sbjct: 113 ASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 187 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVT 242
+ TP Y+APE+ E Y + D++S G+ + ++ P+ +A + ++
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 243 GGVK--PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 296
G P EVK I + P R + +E + P+ + P
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 3e-45
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 16/268 (5%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY ++LG G + +V+ A D +VA +R + DP R E Q L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALN 65
Query: 84 NKYIIVCYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
+ I+ Y + + E LR ++ K + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA----AHSIIGTPEYMA 197
+ H + IIHRD+ +NI I+ VK+ D G A + S ++IGT +Y++
Sbjct: 126 FSHQN--GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 198 PELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-VKPQALNKVKD 255
PE + D+YS G L E++T E P++ V+ Y+ V + P A ++
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 256 PEVKAFIEKCIAQ-PRARP-SASELLKD 281
++ A + K +A+ P R +A+E+ D
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 8e-45
Identities = 64/269 (23%), Positives = 119/269 (44%), Gaps = 18/269 (6%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG+G+ +V+ + G A ++ V + E +L + + +II
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ + D Q + I + G L + +K + K ++ +V LEYLH
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--SKD 124
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 208
II+RDL NI ++ N G +KI D GFA V +++ GTP+Y+APE + + Y +
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYNKS 181
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 268
+D +SFG+ + EM+ P+ + + K Y+K+ + +VK + + I +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238
Query: 269 ------PRARPSASELLKDPFFSELNDDD 291
+ ++ P+F E+ +
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 17/270 (6%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LLG G KV ++ G A +R V +E ++L+ ++ ++
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ L F+ E G L + + R + + + + +++ LE + H
Sbjct: 70 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE--YLHSRD 125
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE-EDYTE 207
+++RD+ N+ ++ + G +KI D G A + GTPEY+APE+ E DY
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
VD + G+ + EM+ +P+ ++++ + + PE K+ + +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 241
Query: 268 Q-PRARPS-----ASELLKDPFFSELNDDD 291
+ P+ R A E+++ FF +N D
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 19/267 (7%)
Query: 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 78
+DPS + +GSG V+ + +VA +R SE+ E ++
Sbjct: 2 IDPS-EL-TFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE-----DFIEEAEV 53
Query: 79 LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVL 137
+ L + ++ Y V L+ + + E G L Y R + + + L V
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEY 195
EG+ YL E C+IHRDL N + N +K+ D G V + ++ ++
Sbjct: 112 EGMAYLE--EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
Query: 196 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 254
+PE Y+ D++SFG+ + E+ + E S +++ + ++ G + ++
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLA 227
Query: 255 DPEVKAFIEKCIAQ-PRARPSASELLK 280
V + C + P RP+ S LL+
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-44
Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 19/255 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+G G V G +VA ++ ++ +E ++ L++ ++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ------AFLAEASVMTQLRHSNLVQ 64
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 147
V ++++ L +TE G+L Y + + L K+S V E +EYL
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--G 121
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 206
+HRDL N+ ++ + K+ D G + + ++ APE L E+ ++
Sbjct: 122 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFS 178
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266
D++SFG+ L E+ + + + +V G K A + P V ++ C
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCW 237
Query: 267 AQ-PRARPSASELLK 280
RPS +L +
Sbjct: 238 HLDAAMRPSFLQLRE 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (380), Expect = 1e-43
Identities = 59/271 (21%), Positives = 114/271 (42%), Gaps = 16/271 (5%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYII 88
++G G +VY + G A + + L + L+ T +I+
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ L+FI ++ G+L + +H S ++ ++ +++ GLE++H
Sbjct: 71 CMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-- 126
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YT 206
+++RDL +NI ++ G V+I DLG A + H+ +GT YMAPE+ ++ Y
Sbjct: 127 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYD 184
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 266
D +S G L +++ P+ + + K L PE+++ +E +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 267 AQ-PRARPS-----ASELLKDPFFSELNDDD 291
+ R A E+ + PFF L+
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-43
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 48/307 (15%)
Query: 27 RYSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y+D ++G+G+ VY+A + G VA +V +D NR E+Q++R L +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDH 72
Query: 85 KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVL 137
I+ YS LN + + R Y + + + + +K + Q+
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 138 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 197
L Y+H+ I HRD+ N+ ++ + +K+ D G A + R S I + Y A
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 198 PELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247
PEL DYT +D++S G L E++ + + V ++ + + P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 248 ------------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELN 288
+ PE A + + P AR + E FF EL
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 289 DDDSEPS 295
D + +
Sbjct: 311 DPNVKLP 317
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-43
Identities = 57/264 (21%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ LG+G +V+ + +VA ++ S D +E L++ L+++ ++
Sbjct: 19 ERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHE 147
Y+V + + ITE +G+L + K + +I L + Q+ EG+ ++
Sbjct: 73 LYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 148 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAP-ELYEED 204
IHRDL +NI ++ + KI D G A ++ A ++ AP +
Sbjct: 129 -NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
+T D++SFG+ L E+VT + ++ + + G + + E+ +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRL 245
Query: 265 CIAQ-PRARPSASELLK--DPFFS 285
C + P RP+ L + FF+
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-43
Identities = 53/278 (19%), Positives = 108/278 (38%), Gaps = 23/278 (8%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 77
E+ R LG G +V+ VA ++ S + E Q
Sbjct: 13 EIPRE-SL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-----AFLQEAQ 64
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQ 135
+++ L+++ ++ Y+V + +TE + G+L + + +++ + L + Q
Sbjct: 65 VMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP 193
+ G+ Y+ +HRDL +NI + N K+ D G A ++ A
Sbjct: 122 IASGMAYVERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 194 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252
++ APE +T D++SFG+ L E+ T ++ +V G + +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 253 VKDPEVKAFIEKCIAQ-PRARPSASELLK--DPFFSEL 287
+ + +C + P RP+ L + +F+
Sbjct: 239 C-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-43
Identities = 59/258 (22%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQ-VRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+LGSGA VY+ EG +V ++ + P + E ++ ++ N ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 148
+ L T+ IT++ G L Y ++H+ ++ + L W Q+ +G+ YL
Sbjct: 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE-LYEED 204
++HRDL N+ + VKI D G A ++G + + A ++MA E +
Sbjct: 131 RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 205 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 264
YT D++S+G+ + E++T + ++I + G + +V + K
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVK 248
Query: 265 CIAQ-PRARPSASELLKD 281
C +RP EL+ +
Sbjct: 249 CWMIDADSRPKFRELIIE 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-43
Identities = 51/274 (18%), Positives = 106/274 (38%), Gaps = 22/274 (8%)
Query: 32 LGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG G V + + + I+VA ++ D + E Q++ L N YI+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMMREAQIMHQLDNPYIVR 73
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
V Q L + E+ G L + K + + + + QV G++YL
Sbjct: 74 LIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMAPE-LYEE 203
+HRDL N+ + KI D G + +G + + + ++ APE +
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 204 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 263
++ D++S+G+ + E ++ + ++ + G + + + PE+ A +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMS 246
Query: 264 KCIAQ-PRARPSASEL---LKDPFFSELNDDDSE 293
C RP + ++ ++S + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-42
Identities = 64/315 (20%), Positives = 118/315 (37%), Gaps = 50/315 (15%)
Query: 17 VEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 74
VE +Y L +G G +V++A ++ G +VA +V + + E
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--FPITALR 58
Query: 75 EVQLLRTLKNKYIIVCYSVWLDDQH------NTLNFITEVCTSGNLRTYRKKHRHVSIKA 128
E+++L+ LK++ ++ + ++ + + C ++
Sbjct: 59 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 118
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH- 187
+K+ + +L GL Y+H I+HRD+ +N+ I + G +K+ D G A + +
Sbjct: 119 IKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQP 175
Query: 188 ----SIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIY 238
+ + T Y PE L E DY +D++ G + EM T +E +A I
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 239 --------------------------KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRA 271
K VK + V+DP I+K + P
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 272 RPSASELLKDPFFSE 286
R + + L FF
Sbjct: 296 RIDSDDALNHDFFWS 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 13/272 (4%)
Query: 17 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 76
V + PS +++++G G VY + + V+ + D V++ +E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 77 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQ 135
+++ + ++ + L + + L + G+LR + + H ++K L + Q
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-----RSHAAHSII 190
V +G++ +HRDL N ++ VK+ D G A + H
Sbjct: 139 VAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 191 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
++MA E L + +T D++SFG+ L E++T P + I + G +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
+ + KC RPS SEL+
Sbjct: 256 PEYC-PDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 8e-42
Identities = 40/259 (15%), Positives = 92/259 (35%), Gaps = 15/259 (5%)
Query: 31 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 90
++G+G +V + G + ++ SE ++ + +I
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92
Query: 91 YSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
V + ITE +G+L ++ R+ ++ L + + G++YL
Sbjct: 93 EGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--N 148
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS------IIGTPEYMAPELYE- 202
+HRDL NI +N N K+ D G + + + + + APE +
Sbjct: 149 YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262
+T D++S+G+ + E+++ + + + + + +
Sbjct: 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLM 266
Query: 263 EKCIAQ-PRARPSASELLK 280
C + RP +++
Sbjct: 267 LDCWQKDRNHRPKFGQIVN 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-41
Identities = 64/291 (21%), Positives = 113/291 (38%), Gaps = 38/291 (13%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ +G G VY+A ++ G VA ++RL +E + + E+ LL+ L + I+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--VPSTAIREISLLKELNHPNIVK 65
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEP 148
V + L + E + + + +K + Q+L+GL + H+H
Sbjct: 66 LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED--Y 205
++HRDL N+ IN G +K+ D G A G + T Y APE+ Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 206 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK----------- 254
+ VDI+S G EMVT + + ++++ P +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 255 ---------------DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 289
D + ++ + + + P R SA L PFF ++
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-41
Identities = 55/255 (21%), Positives = 106/255 (41%), Gaps = 17/255 (6%)
Query: 32 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 91
LG+G V + +VA ++ SED E +++ L ++ ++ Y
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLY 65
Query: 92 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 150
V + + ITE +G L Y ++ RH + L + K V E +EYL +
Sbjct: 66 GVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QF 121
Query: 151 IHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAPELYE-EDYTE 207
+HRDL N +N G VK+ D G + V ++ + PE+ ++
Sbjct: 122 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 208 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 267
DI++FG+ + E+ ++ E + ++ + + G++ + +V + C
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWH 239
Query: 268 Q-PRARPSASELLKD 281
+ RP+ LL +
Sbjct: 240 EKADERPTFKILLSN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 23/279 (8%)
Query: 30 DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+LG+GA KV+ + G A ++ + + +E Q+L ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 146
+V + L+ I + G L T+ + + ++ + +++ LE+LH
Sbjct: 90 FLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 147 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPELY--- 201
II+RD+ NI ++ N G V + D G + + A+ GT EYMAP++
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEV 258
+ + + VD +S G+ + E++T P+ E +S A+I +++ P +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263
Query: 259 KAFIEKCIAQ-PRARPS-----ASELLKDPFFSELNDDD 291
K I++ + + P+ R A E+ + FF ++N DD
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 3e-41
Identities = 61/282 (21%), Positives = 114/282 (40%), Gaps = 21/282 (7%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 77
E++ + LG G +VY ++ + VA ++ ED + V E
Sbjct: 13 EMERT-DI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 65
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQ 135
+++ +K+ ++ V + ITE T GNL Y + VS L + Q
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 136 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP 193
+ +EYL + IHRDL N + N VK+ D G + ++ A
Sbjct: 124 ISSAMEYLE--KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 194 EYMAP-ELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 252
++ AP L ++ D+++FG+ L E+ T + ++++Y+ + + +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240
Query: 253 VKDPEVKAFIEKCIAQ-PRARPSASELLK--DPFFSELNDDD 291
+V + C P RPS +E+ + + F E + D
Sbjct: 241 C-PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 3e-41
Identities = 54/288 (18%), Positives = 101/288 (35%), Gaps = 31/288 (10%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY +GSG+ +Y D G EVA + +LH E ++ + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP------QLHIESKIYKMMQ 60
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
I W + + + E+ + R S+K + + Q++ +EY+
Sbjct: 61 GGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 144 HTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRS--------HAAHSIIGTP 193
H+ IHRD+ N + V I D G A + ++ GT
Sbjct: 120 HSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----P 247
Y + + + + D+ S G L+ +P+ + K K K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 248 QALNKVKDPEVKAFIEKCIA-QPRARPSAS---ELLKDPFFSELNDDD 291
+ L K E ++ C + + +P S +L ++ F + D
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 5e-41
Identities = 65/296 (21%), Positives = 123/296 (41%), Gaps = 40/296 (13%)
Query: 27 RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
+Y + +G G V++A ++E VA +VRL E + + E+ LL+ LK+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKH 60
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 144
K I+ + V D+ TL + E C + + + + + +K + Q+L+GL + H
Sbjct: 61 KNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 145 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELY-- 201
+ ++HRDL N+ IN N G++K+ + G A G +S + T Y P++
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 202 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------------- 245
+ Y+ +D++S G E+ P + V K++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 246 -----------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 289
+ + + ++ + P R SA E L+ P+FS+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-40
Identities = 53/260 (20%), Positives = 109/260 (41%), Gaps = 18/260 (6%)
Query: 30 DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+G G V++ + + VA ++ + + E +R + +
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHT 145
I+ V ++ + I E+CT G LR++ + + + + +L ++ Q+ L YL
Sbjct: 70 IVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-- 124
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPE-LYE 202
+HRD+ N+ ++ N VK+GD G + + S + A ++MAPE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262
+T D++ FG+C+ E++ + + + ++ G + P + + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLM 242
Query: 263 EKCIAQ-PRARPSASELLKD 281
KC A P RP +EL
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-40
Identities = 64/310 (20%), Positives = 115/310 (37%), Gaps = 46/310 (14%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY+ +G GA V A+D + VA ++ E R E+++L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFR 64
Query: 84 NKYIIVCYSVWLDDQHNTLN--FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
++ II + + ++ +L K +H+S + + Q+L GL+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLK 123
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMA 197
Y+H+ ++HRDL SN+ +N +KI D G A + H + T Y A
Sbjct: 124 YIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 198 PELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 247
PE+ + YT+ +DI+S G L EM++ + + ++ + P
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 248 --------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286
L D + ++K + P R + L P+ +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 287 LNDDDSEPSP 296
D EP
Sbjct: 301 YYDPSDEPIA 310
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 61/272 (22%), Positives = 114/272 (41%), Gaps = 24/272 (8%)
Query: 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
++ D++G G +V +A +++G+ + R+ ++ E+++L L +
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHP 71
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----------------SIKALK 130
I+ + + L E GNL + +K R + S + L
Sbjct: 72 NIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 131 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 190
++ V G++YL + IHRDL NI + N KI D G +
Sbjct: 131 HFAADVARGMDYLS--QKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGR 187
Query: 191 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249
+MA E L YT D++S+G+ L E+V++ + A++Y+K+ G + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 250 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
D EV + +C + P RPS +++L
Sbjct: 248 PLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 35/290 (12%)
Query: 30 DLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYI 87
+G GA KV++A D + G VA +VR+ E P+ R + ++ L T ++ +
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 88 IVCYSVWLD---DQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYL 143
+ + V D+ L + E + V + +K Q+L GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 144 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 202
H+H ++HRDL NI + + GQ+K+ D G A I A S++ T Y APE L +
Sbjct: 133 HSH--RVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 203 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD------- 255
Y VD++S G EM + + V ++ K + P + +D
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 256 -----------------PEVKAFIEKCIAQ-PRARPSASELLKDPFFSEL 287
K + KC+ P R SA L P+F +L
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-40
Identities = 52/274 (18%), Positives = 106/274 (38%), Gaps = 22/274 (8%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 73
E+ PS R ++G+G +VY+ ++ + VA ++ + +
Sbjct: 3 EIHPS-CVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFL 57
Query: 74 SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKW 132
E ++ + II V + + ITE +G + R+K S+ L
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 133 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG----RSHAAHS 188
+ + G++Y +HRDL NI +N N K+ D G + ++ ++
Sbjct: 116 LRGIAAGMKY--LANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 189 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247
+ APE + +T D++SFG+ + E++T S ++ K + G +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 248 QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
+ + +C Q RP ++++
Sbjct: 233 PTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-40
Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 19/262 (7%)
Query: 30 DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 86
+ LG G+ V R + + VA ++ S P ++ EV + +L ++
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRN 72
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 145
+I Y V L + +TE+ G+L +KH+ H + L +++ QV EG+ YL
Sbjct: 73 LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE- 128
Query: 146 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMAPE-L 200
IHRDL N+ + VKIGD G + ++ + + APE L
Sbjct: 129 -SKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 201 YEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 259
++ D + FG+ L EM T + P+ + ++K G + ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC-PQDIY 245
Query: 260 AFIEKCIAQ-PRARPSASELLK 280
+ +C A P RP+ L
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRD 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (350), Expect = 1e-39
Identities = 49/300 (16%), Positives = 110/300 (36%), Gaps = 51/300 (17%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYII 88
LG G +V+ A + +V ++ PV ++ E+++L L+ II
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
+ D T + E + + + ++ ++ ++ + ++L+ L+Y H+
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YT 206
I+HRD+ N+ I+ ++++ D G A + + + + PEL + Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 207 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT------------------------ 242
+D++S G L M+ + P+ ++
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 243 -----------GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290
+ PE F++K + ++R +A E ++ P+F + D
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 38/283 (13%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKN-KY 86
+LGSGA KV A QV + E D L SE++++ L + +
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 87 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------------- 123
I+ + I E C G+L Y + R
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 124 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--- 180
++ + L ++ QV +G+E+L +HRDL N+ + VKI D G A +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSD 217
Query: 181 GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 238
+ ++MAPE L+E YT D++S+G+ L E+ ++ PY A Y
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
K + G K E+ ++ C A R RPS L
Sbjct: 278 KLIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 73/305 (23%), Positives = 123/305 (40%), Gaps = 42/305 (13%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
Y DL +GSGA V A D G +VA ++ SE R + E++LL+ +++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRH 76
Query: 85 KYIIVCYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 142
+ +I V+ D+ + +F + G KH + ++ Q+L+GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 143 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY- 201
+H HRDL N+ +N + ++KI D G A + T Y APE+
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADSEM--TGYVVTRWYRAPEVIL 191
Query: 202 -EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------------- 247
YT+ VDI+S G + EM+T + + D + ++ + + P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 248 ---------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 291
++ P +EK + R +A E L P+F L+D +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 292 SEPSP 296
EP
Sbjct: 312 DEPQV 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 3e-38
Identities = 53/269 (19%), Positives = 116/269 (43%), Gaps = 18/269 (6%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
LG+G+ +V +E G A + + +E ++L+ + +++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
+ D+ + L + E G + ++ ++ S + ++ Q++ EYLH+
Sbjct: 106 LEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL--D 161
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 208
+I+RDL N+ I+ G +++ D GFA V ++ GTPE +APE + + Y +
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKA 218
Query: 209 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 268
VD ++ G+ + EM P+ D +IY+K+ G K + + ++K + +
Sbjct: 219 VDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSG-KVRFPSHF-SSDLKDLLRNLLQV 275
Query: 269 ------PRARPSASELLKDPFFSELNDDD 291
+ +++ +F+ +
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (336), Expect = 5e-38
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 38/287 (13%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ +G G VY+A + G A ++RL ED + + E+ +L+ LK+ I+
Sbjct: 8 EKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 90 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 149
Y V + L + E + + K + Q+L G+ Y H +
Sbjct: 65 LYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRR 120
Query: 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED--YT 206
++HRDL N+ IN G++KI D G A G I T Y AP++ Y+
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 207 EMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-----------------------K 240
+DI+S G EMV + SE D + +I++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 241 VTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 286
V + ++ K D + K + P R +A + L+ +F E
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 9e-38
Identities = 52/288 (18%), Positives = 98/288 (34%), Gaps = 43/288 (14%)
Query: 27 RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
Y +G GA +V++A E VA ++ ++ + E L+
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD---MQADFQREAALMAE 72
Query: 82 LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH------------------ 123
N I+ V + + + E G+L + +
Sbjct: 73 FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 124 ------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177
+S ++QV G+ YL +HRDL N + N VKI D G +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIADFGLS 187
Query: 178 AIV---GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 233
+ A + +M PE ++ YT D++++G+ L E+ + + +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
++ V G E+ + C ++ P RPS + +
Sbjct: 248 HEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 36/280 (12%)
Query: 30 DLLGSGAVKKVYRAFD-------QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 82
LG GA +V A +VA ++ +D ++ L SE+++++ +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---LSDLISEMEMMKMI 75
Query: 83 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSI 126
I+ L I E + GNLR Y + R +S
Sbjct: 76 GKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 127 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--- 183
K L + QV G+EYL IHRDL N+ + + +KI D G A +
Sbjct: 135 KDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYY 191
Query: 184 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 242
+ ++MAPE L++ YT D++SFG+ L E+ T+ V +++K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 243 GGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKD 281
G + + E+ + C P RP+ +L++D
Sbjct: 252 EGHRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 70/306 (22%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 27 RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
RY +L +GSGA V AFD + G+ VA ++ + + R + E++LL+ +K+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKH 76
Query: 85 KYIIVCYSVWLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 141
+ +I V+ + ++ +L K + + Q+L GL+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLK 135
Query: 142 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY 201
Y+H+ IIHRDL SN+ +N ++KI D G A + T Y APE+
Sbjct: 136 YIHSA--DIIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 190
Query: 202 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA---------- 249
Y + VDI+S G + E++T + D + ++ + P A
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 250 ------------------LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDD 290
+ +P +EK + R +A++ L +F++ +D
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 291 DSEPSP 296
D EP
Sbjct: 311 DDEPVA 316
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 37/302 (12%)
Query: 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRL 72
EV + S LG G+ VY + E VA V + +
Sbjct: 16 EVARE-KI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE---RIEF 70
Query: 73 HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-------- 124
+E +++ +++ V Q I E+ T G+L++Y + R
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 125 --SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182
S+ + + + ++ +G+ YL+ + +HRDL N + + VKIGD G +
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYE 185
Query: 183 S---HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 238
+ + +M+PE L + +T D++SFG+ L E+ T+ + S ++
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 239 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK------DPFFSELNDDD 291
+ V G + + + C P+ RPS E++ +P F E++
Sbjct: 246 RFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304
Query: 292 SE 293
SE
Sbjct: 305 SE 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-36
Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 34/278 (12%)
Query: 30 DLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 84
LG GA +V A VA ++ + L SE+++L + +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGH 75
Query: 85 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKA 128
+V L I E C GNL TY + R+ ++++
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 129 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HA 185
L +S QV +G+E+L + IHRDL NI ++ VKI D G A + +
Sbjct: 136 LICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVR 192
Query: 186 AHSIIGTPEYMA-PELYEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 243
++MA +++ YT D++SFG+ L E+ + PY + +++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 244 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
G + +A + PE+ + C P RP+ SEL++
Sbjct: 253 GTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-36
Identities = 62/303 (20%), Positives = 111/303 (36%), Gaps = 51/303 (16%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 89
+ +G G +V+R + G EVA +E+ L+++ I+
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILG 61
Query: 90 CYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-- 145
+ D L +++ G+L Y ++ V+++ + K + GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120
Query: 146 ----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-----SHAAHSIIGTPEYM 196
+P I HRDL NI + N G I DLG A A + +GT YM
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 197 APELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT------- 242
APE+ ++ + + DIY+ GL E+ + Y +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 243 --------GGVKPQALNKVKDPE----VKAFIEKCIAQ-PRARPSASELLKDPFFSELND 289
++P N+ + E + + +C AR +A + K S+L+
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ 297
Query: 290 DDS 292
+
Sbjct: 298 QEG 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 6e-36
Identities = 37/292 (12%), Positives = 86/292 (29%), Gaps = 32/292 (10%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
Y +G G+ ++ + +VA + +L E + + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP------QLRDEYRTYKLLA 58
Query: 84 NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 143
I + + + ++ R S+K + +KQ+L ++ +
Sbjct: 59 GCTGIPNV-YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 144 HTHEPCIIHRDLNCSNIFINGNI----GQVKIGDLGFAAIVG--------RSHAAHSIIG 191
H +++RD+ N I + + D G ++ G
Sbjct: 118 HEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIPYSECDSVAKIYKKVTGG---V 245
T YM+ + + + D+ + G + + + + + + Y+++
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK--DPFFSELNDDDSEP 294
+ L E ++ A P L LN + E
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-34
Identities = 63/284 (22%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 27 RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 81
+ LG+GA KV A + + VA ++ S + L SE+++L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE---REALMSELKVLSY 82
Query: 82 LKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------- 123
L N I+ ITE C G+L + ++ R
Sbjct: 83 LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 124 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-- 180
+ ++ L +S QV +G+ +L + IHRDL NI + KI D G A +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHG-RITKICDFGLARDIKN 197
Query: 181 -GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKI 237
+ ++MAPE ++ YT D++S+G+ L E+ ++ V +K
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 238 YKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 280
YK + G + + E+ ++ C P RP+ ++++
Sbjct: 258 YKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 55/318 (17%)
Query: 26 GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 83
RY +L +GSGA V A+D VA ++ ++ R + E+ L++ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN 74
Query: 84 NKYIIVCYSVWLDDQH----NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 139
+K II +V+ + + + E+ + + + + H + + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSYLLYQMLCG 131
Query: 140 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 199
+++LH+ IIHRDL SNI + + +KI D G A G S + T Y APE
Sbjct: 132 IKHLHSA--GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 200 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP----------- 247
+ Y E VDI+S G + EMV +I + D + + K + P
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 248 ----------------------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASEL 278
NK+K + + + K + P R S +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 279 LKDPFFSELNDDDSEPSP 296
L+ P+ + D +P
Sbjct: 309 LQHPYINVWYDPAEVEAP 326
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 2e-27
Identities = 66/334 (19%), Positives = 117/334 (35%), Gaps = 66/334 (19%)
Query: 26 GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQ 77
RY LG G V+ A D VA VR E +L ++
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 78 LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN---LRTYRKKHRHVSIKALKKWSK 134
++ +I+ + N ++ + G + +HR + + +K+ SK
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 135 QVLEGLEYLHTHEPCIIHRDLNCSNIFIN-----GNIGQVKIGDLGFAAIVGRSHAAHSI 189
Q+L GL+Y+H IIH D+ N+ + N+ Q+KI DLG A + +
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNS 189
Query: 190 IGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYS---------ECDSVAKIYK 239
I T EY +PE L + DI+S + E++T + + + D +A+I +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 240 KV------------------------------------TGGVKPQALNKVKDPEVKAFIE 263
+ + +K + E+ F+
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 264 KCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 296
+ PR R A L+ P+ + + P
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 5e-13
Identities = 30/192 (15%), Positives = 62/192 (32%), Gaps = 7/192 (3%)
Query: 30 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR-TLKNKYII 88
L+G G V+ + E+ E ++ H S V R + ++ +++
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 89 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 148
L + E K+ V ++ + +LE + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR-- 122
Query: 149 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 208
I+H DL+ N+ ++ + I D + VG + + + Y
Sbjct: 123 GIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGWREILERDVRNII-TYFSRTYRTE 179
Query: 209 VDIYSFGLCLLE 220
DI S +L+
Sbjct: 180 KDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.35 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-63 Score=411.60 Aligned_cols=264 Identities=45% Similarity=0.852 Sum_probs=234.5
Q ss_pred cCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-
Q 022479 19 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD- 97 (296)
Q Consensus 19 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 97 (296)
....+||+++.++||+|+||+||+|.++.+++.||+|++..... +....+.+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 45677898999999999999999999999999999999986544 455677899999999999999999999998653
Q ss_pred -CCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 98 -QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 98 -~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
....+|+||||+++++|.+++.....+++.+++.++.|++.||+|||+++++|+||||||+|||++...+.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 2367899999999999999999888999999999999999999999998877999999999999976447999999999
Q ss_pred ccccCCCcccccCCCCCCccCccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
++..... ......||+.|+|||++.+.++.++|||||||++|+|++|+.||.+......+...+..+..+.......++
T Consensus 162 a~~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 162 ATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp GGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ceeccCC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 9865433 344568999999999998889999999999999999999999998877888888888777666666666789
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
++++|+.+||+ ||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999998 999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-61 Score=401.02 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=224.9
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
++..+| ++.++||+|+||+||+|.++.+|+.||+|+++...... .+.+.+|++++++++||||+++++++.++
T Consensus 17 dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~-- 89 (293)
T d1yhwa1 17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVG-- 89 (293)
T ss_dssp CTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred Cccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH----HHHHHHHHHHHHhCCCCCEeeEeEEEEEC--
Confidence 445566 67999999999999999999999999999998653322 46788999999999999999999999766
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
+.+|+||||+.|++|.+++..+ .+++.+++.++.||+.||+|||++| ++||||||+|||++.+ +.+||+|||++..
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQ 165 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhhee
Confidence 7899999999999999987764 5999999999999999999999999 9999999999999998 8999999999987
Q ss_pred cCCC-cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
.... ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+.............+...+++
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 245 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence 6443 345566799999999977654 89999999999999999999999998887777777766655544455567999
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
+++||.+||+ ||++|||+.|+|+||||+.-
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999998 99999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=399.99 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=216.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+.| ++.++||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|++++++++||||+++++++.++ +.+
T Consensus 5 ~dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~ 78 (271)
T d1nvra_ 5 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 78 (271)
T ss_dssp TEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred cce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--cee
Confidence 345 789999999999999999999999999999976532 23346788999999999999999999999766 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+||||+.+++|.+++...+.+++.+++.++.|++.||+|||++| ++||||||+|||++.+ +.+||+|||+++....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeecc
Confidence 999999999999999988889999999999999999999999999 9999999999999998 8999999999987632
Q ss_pred C---cccccCCCCCCccCccccccC-C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 183 S---HAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 183 ~---~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
. ......+||+.|+|||++.+. + +.++|||||||++|+|++|+.||..........................+++
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence 2 224456799999999987654 4 5679999999999999999999987665555555555544444444556899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
+.+|+.+||+ ||++|||++++|+||||++
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 9999999998 9999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=397.78 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=223.8
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
.+++.+.| ++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE 81 (288)
T ss_dssp SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 34555656 78999999999999999999999999999997542 22356788999999999999999999999766
Q ss_pred CCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
+.+++||||+.+++|.+++.. .+.+++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 82 --~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~ 156 (288)
T d2jfla1 82 --NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGV 156 (288)
T ss_dssp --TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTT
T ss_pred --CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechh
Confidence 789999999999999998764 567999999999999999999999999 9999999999999998 8999999999
Q ss_pred ccccCCC-cccccCCCCCCccCccccc------cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCC
Q 022479 177 AAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 249 (296)
Q Consensus 177 ~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 249 (296)
+...... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.........
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9765332 2244567999999999763 33788999999999999999999999988777777777776655444
Q ss_pred CCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 250 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 250 ~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+...++++++||.+||+ ||++|||+.++|+||||+.
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 455678999999999998 9999999999999999973
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-60 Score=392.20 Aligned_cols=252 Identities=21% Similarity=0.391 Sum_probs=217.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.| ++.+.||+|+||+||+|.++.+++.||+|++...... +....+.+.+|++++++++||||+++++++.++ +.+|
T Consensus 7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred He-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence 45 6899999999999999999999999999999754321 122356788999999999999999999999765 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
+||||+.+++|.+++...+.+++.++..++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCCC
Confidence 99999999999999998888999999999999999999999999 9999999999999998 89999999999876543
Q ss_pred cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+....+..... ..+...++++++|+
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---TFPDFVTEGARDLI 235 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHH
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHHHH
Confidence 34456789999999987755 89999999999999999999999987665554444433322 23445689999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCccccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+||+ ||++|||+.|+|+||||..
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99998 9999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-60 Score=395.35 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=219.3
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.||||++....... ....+.+.+|++++++++||||+++++++.++ +.+|+|
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~iv 86 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG 86 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEEE
Confidence 378999999999999999999999999999997543211 22356789999999999999999999999655 789999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC--
Q 022479 106 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-- 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~-- 183 (296)
|||+.|++|.+++...+.+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCCc
Confidence 999999999999999889999999999999999999999999 9999999999999998 89999999999876432
Q ss_pred -cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 184 -HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 184 -~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..... ..+...++++++|
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---DFPEKFFPKARDL 240 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---CCCTTCCHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---CCCccCCHHHHHH
Confidence 23445679999999998765 489999999999999999999999988666655555544432 2334568999999
Q ss_pred HHHHHh-CCCCCCCHHH------HhcCcccccccCCC
Q 022479 262 IEKCIA-QPRARPSASE------LLKDPFFSELNDDD 291 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~------ll~hp~~~~~~~~~ 291 (296)
|.+||+ ||++|||++| +++||||++++|+.
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 999998 9999999998 57899999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-59 Score=393.87 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=203.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
..|++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.++++++||||+++++++.++ +.+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 3347899999999999999999999999999999865432 2245688999999999999999999999655 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC--CCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~--~~~~~~l~dfg~~~~~~ 181 (296)
+||||+.|++|.+++...+.+++.++..++.||+.||+|||++| ++||||||+||++.. +.+.+||+|||++....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999889999999999999999999999999 999999999999964 23789999999998876
Q ss_pred CCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCChHHH
Q 022479 182 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVK 259 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 259 (296)
........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+........ ......++++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 66566677899999999987654 89999999999999999999999988766665555555443322 22345689999
Q ss_pred HHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 260 AFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 260 ~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
+|+.+||+ ||++|||+.|+++||||+.-.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999998 999999999999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=393.70 Aligned_cols=264 Identities=20% Similarity=0.346 Sum_probs=223.8
Q ss_pred cccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCC--CHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 25 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 25 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+|+++++||+|+||+||+|.++.+|+.||+|+++...... .....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 88 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TDV 88 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 4478999999999999999999999999999998654422 223467889999999999999999999999655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCC---CceEEeccCCccc
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAI 179 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~---~~~~l~dfg~~~~ 179 (296)
|+||||+.|++|.+++...+.+++..++.++.|++.||+|||+++ ++||||||+||+++.+. ..+|++|||++..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999999998889999999999999999999999999 99999999999998762 2599999999988
Q ss_pred cCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (296)
...........+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+....... .......+.+
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 876666677789999999998775 48999999999999999999999999877666665555543322 1222346889
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+++||.+||+ ||++|||++++|+||||+..++...
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence 9999999998 9999999999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=387.58 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=205.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||+||+|.++.+|+.||+|++..... +....+.+.+|++++++++||||+++++++.+.....+|+||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 689999999999999999999999999999986644 456677899999999999999999999999876667899999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCC---CceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 107 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEP---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 107 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~---~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+++. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccceee
Confidence 99999999998863 5679999999999999999999998641 39999999999999998 8999999999987
Q ss_pred cCCCc-ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChH
Q 022479 180 VGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
..... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..... + ..+...+++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~s~~ 241 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-R-RIPYRYSDE 241 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-C-CCCTTSCHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-C-CCCcccCHH
Confidence 65432 3445678999999998765 489999999999999999999999987665554444444332 2 234456899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCccc
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFF 284 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~ 284 (296)
+.+|+.+||+ ||++|||+.|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999998 99999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.6e-59 Score=397.03 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=226.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
.++| ++.++||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.++ +.
T Consensus 25 l~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 97 (350)
T d1koaa2 25 LDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NE 97 (350)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TE
T ss_pred ccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 3456 7899999999999999999999999999999754 334467889999999999999999999999765 78
Q ss_pred EEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~ 179 (296)
+|+||||+.|++|.+++. ..+.+++.++..++.||+.||.|||++| ++||||||+|||++.+ .+.+||+|||++..
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999985 4567999999999999999999999999 9999999999999753 37899999999998
Q ss_pred cCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChH
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE 257 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (296)
...........+|+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+....... .......+++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 8776666778899999999987654 8899999999999999999999999877766666665554332 2223446899
Q ss_pred HHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 258 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 258 l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
+++||.+||. ||++|||+.|+|+||||+...++..
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence 9999999998 9999999999999999998776543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-59 Score=397.19 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=223.2
Q ss_pred ccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 105 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 105 (296)
|++.++||+|+||+||+|.++.+|+.||+|+++.. .......+.+|++++++++||||+++++++.++ ..+|+|
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 104 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLI 104 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 47899999999999999999999999999999754 233456788999999999999999999999655 789999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC-CCCceEEeccCCccccCCC
Q 022479 106 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 106 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~-~~~~~~l~dfg~~~~~~~~ 183 (296)
|||+.|++|.+++.. +.++++.+++.++.||+.||+|||++| ++||||||+|||++. +.+.+||+|||++......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999988765 447999999999999999999999999 999999999999983 2379999999999988766
Q ss_pred cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCChHHHHH
Q 022479 184 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAF 261 (296)
Q Consensus 184 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 261 (296)
.......+++.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+...... +.......++++.+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 666677899999999977654 899999999999999999999999987777766666665443 233344578999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
|.+||+ ||++|||+.++|+||||+....+
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 999998 99999999999999999875443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-58 Score=389.54 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=223.0
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+..+| +..++||+|+||+||+|.++.+|+.||||+++.... .+....+.+.+|++++++++||||+++++++.++ +
T Consensus 13 p~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 88 (309)
T d1u5ra_ 13 PEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--H 88 (309)
T ss_dssp HHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--T
T ss_pred cHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--C
Confidence 33455 568999999999999999999999999999986543 2345567899999999999999999999999765 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.+++|..++...+.+++.+++.++.|++.||.|||++| ++||||||+|||++.+ +.+||+|||++...
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSS
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeeccccccc
Confidence 89999999999999888888888999999999999999999999999 9999999999999998 89999999999875
Q ss_pred CCCcccccCCCCCCccCccccc----cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 181 GRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
.. .....||+.|+|||++. +.++.++|||||||++|+|++|..||.+....+.+.......... ......++
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~ 241 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSE 241 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCTTSCH
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-CCCCCCCH
Confidence 43 34467999999999764 347889999999999999999999999877777777666665433 33445689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++++||.+||+ ||.+|||++++|+||||..-
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99999999998 99999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=397.14 Aligned_cols=260 Identities=28% Similarity=0.491 Sum_probs=217.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+.| ++.++||+|+||+||+|.++.+|+.||+|+++... ......++.+|+.++++++||||+++++++.++ ..+
T Consensus 6 d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 6 DDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEE
T ss_pred cCC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 345 67899999999999999999999999999997543 334457889999999999999999999999765 689
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
|+||||+.|++|.+++...+.+++..++.++.|++.||.|||+ +| |+||||||+|||++.+ +.+||+|||+|....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCccccC
Confidence 9999999999999999988889999999999999999999997 59 9999999999999998 899999999998764
Q ss_pred CCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH------------------------
Q 022479 182 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK------------------------ 236 (296)
Q Consensus 182 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~------------------------ 236 (296)
.. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....
T Consensus 157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 32 2345689999999997765 599999999999999999999999975432211
Q ss_pred -----------------HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCC
Q 022479 237 -----------------IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS 292 (296)
Q Consensus 237 -----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~ 292 (296)
..........+.......+.++.+|+.+||+ ||++|||++|+|+||||+..+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccc
Confidence 1111222222333334457899999999998 9999999999999999998776554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=390.24 Aligned_cols=257 Identities=24% Similarity=0.437 Sum_probs=223.1
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.| ++.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.++++++||||+++++++.+. +.+|
T Consensus 6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 6 DF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hc-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 45 68999999999999999999999999999998643211 12356788999999999999999999999665 7899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC-
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR- 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~- 182 (296)
+||||+.||+|..++...+.+++..++.++.||+.||+|||++| ++||||||+|||++.+ |.+||+|||+++....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999 9999999999999999 8999999999987643
Q ss_pred CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.......+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.+..+....+..... ..+...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---CCCccCCHHHHHH
Confidence 334556789999999998764 499999999999999999999999998776555555544432 2344578999999
Q ss_pred HHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 262 IEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 262 i~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
|.+||+ ||++|++ ++++++||||++++|+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 999998 9999994 9999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-58 Score=388.35 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=222.3
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.++++++||||+++++++.++ ..+|+||
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 83 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIM 83 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeEe
Confidence 7899999999999999999999999999999754321 112356788999999999999999999999665 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCccc
Q 022479 107 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 186 (296)
Q Consensus 107 e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~~ 186 (296)
||+.|++|..++.....+++..++.++.||+.||+|||++| ++||||||+|||++.+ |.+||+|||++...... .
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~--~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--T 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--B
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEeccc--c
Confidence 99999999999999999999999999999999999999999 9999999999999998 89999999999887543 3
Q ss_pred ccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022479 187 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 265 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (296)
...+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+..... ..+...++++++++.+|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---RFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHH
Confidence 456899999999987755 89999999999999999999999998776666666555533 23345689999999999
Q ss_pred Hh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 266 IA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 266 l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
|. ||.+|+ |++++++||||++++|+
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 97 999996 99999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-57 Score=377.19 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=225.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-----HHHHHHHHHHHHHHHhcC-CCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----PVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 96 (296)
.+| ++.++||+|+||+||+|.++.+|+.||||+++....... ....+++.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 355 789999999999999999999999999999987554322 234567889999999997 9999999999965
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
+ +.+|+||||+.+++|.+++...+++++.+++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||+
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~ 156 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGF 156 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchh
Confidence 5 789999999999999999998889999999999999999999999999 9999999999999988 8999999999
Q ss_pred ccccCCCcccccCCCCCCccCcccccc-------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-C
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-Q 248 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~ 248 (296)
+.............+|+.|.|||.+.+ .++.++||||+||++|+|++|+.||.+....+....+..+.... .
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 998876656666789999999997642 26789999999999999999999999887777666666654432 2
Q ss_pred CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 249 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 249 ~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
......|+++++|+.+||+ ||++|||++++|+||||+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 2233568999999999998 99999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-57 Score=391.32 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=216.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeeccc--CCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+.| ++.++||+|+||+||+|.++.+|+.||+|++..... ...........+++++++.++||||+++++++.++ +
T Consensus 4 ddy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 4 NDF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HhC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence 345 789999999999999999999999999999975432 12223333445567788888999999999998655 7
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.|++|.+++.....+++..++.++.||+.||+|||++| ++||||||+|||++.+ |.+||+|||++...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeec
Confidence 89999999999999999999899999999999999999999999999 9999999999999998 89999999999877
Q ss_pred CCCcccccCCCCCCccCccccc-c-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... .....+||+.|+|||++. + .++.++|||||||++|+|++|+.||.+....+...-.......+...+...++++
T Consensus 158 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 158 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 544 345568999999999775 3 3789999999999999999999999764332221111122223333455679999
Q ss_pred HHHHHHHHh-CCCCCCC-----HHHHhcCcccccccCC
Q 022479 259 KAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD 290 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps-----~~~ll~hp~~~~~~~~ 290 (296)
++||.+||+ ||++||| ++++++||||++++|.
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 999999998 9999999 7999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-57 Score=387.53 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=222.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++.+|+.||||+++..... .....+.+.+|++++++++||||+++++++... ..+
T Consensus 41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 116 (350)
T d1rdqe_ 41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL 116 (350)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccc
Confidence 466 6899999999999999999999999999999754321 122356788999999999999999999999655 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
++|+||+.+++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeeccc
Confidence 999999999999999998889999999999999999999999999 9999999999999998 8999999999988754
Q ss_pred CcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 183 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 183 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+...... .+...++++.+|
T Consensus 194 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l 268 (350)
T d1rdqe_ 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---FPSHFSSDLKDL 268 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTCCHHHHHH
T ss_pred c--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---CCccCCHHHHHH
Confidence 3 3456789999999977654 899999999999999999999999887766666665555332 234568999999
Q ss_pred HHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 262 IEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 262 i~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
|.+||+ ||.+|+ |++++++||||++++|+
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 999997 999994 99999999999998874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=382.67 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=216.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHH-HhcCCCceeEEeeeeeeCCCCeE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
.| ++.++||+|+||+||+|.++.+|+.||||+++......... .+.+..|..++ +.++||||+++++++.+. +.+
T Consensus 3 dy-~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~-~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~ 78 (320)
T d1xjda_ 3 DF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-VECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENL 78 (320)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC-HHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred Ce-EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHH-HHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Cce
Confidence 45 68999999999999999999999999999997643221222 34455666655 478999999999999665 789
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
|+||||+.+|+|.+++.....+++.+++.++.||+.||+|||++| ++||||||+|||++.+ +.++|+|||++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhccc
Confidence 999999999999999999889999999999999999999999999 9999999999999998 8999999999987643
Q ss_pred -CcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022479 183 -SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 260 (296)
Q Consensus 183 -~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (296)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+..... ..+...++++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~d 232 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKD 232 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHH
Confidence 333445678999999997765 589999999999999999999999988766555555444422 233456899999
Q ss_pred HHHHHHh-CCCCCCCHH-HHhcCcccccccCC
Q 022479 261 FIEKCIA-QPRARPSAS-ELLKDPFFSELNDD 290 (296)
Q Consensus 261 li~~~l~-~p~~Rps~~-~ll~hp~~~~~~~~ 290 (296)
||.+||+ ||++|||+. ++++||||++++|+
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 9999997 999999996 89999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=380.44 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=212.5
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCC-HHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
.++||+|+||+||+|.++.+|+.||||+++....... ....+.+.+|+.++++++||||+++++++..+ +.+|+|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehhh
Confidence 6899999999999999999999999999976543222 22345788999999999999999999999655 67999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc-cc
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AA 186 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~-~~ 186 (296)
|+.++++......+..+++.+++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||.+....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence 9999888877777788999999999999999999999999 9999999999999998 899999999998765433 34
Q ss_pred ccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCC--CCCCCC------------
Q 022479 187 HSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQAL------------ 250 (296)
Q Consensus 187 ~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~------------ 250 (296)
....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.... ......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45678999999997653 37899999999999999999999999877776665544321 110000
Q ss_pred -----------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 251 -----------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 251 -----------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
....++++.+|+.+||+ ||++|||++|+|+||||++...+.+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~ 292 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence 11346889999999998 99999999999999999987765544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=380.29 Aligned_cols=255 Identities=19% Similarity=0.282 Sum_probs=219.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++++.||+|+||+||+|.++.+|+.||+|+++... .....+.+|+++|++++||||+++++++.++ +.+
T Consensus 5 ~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~ 76 (321)
T d1tkia_ 5 EKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EEL 76 (321)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEE
T ss_pred cce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 456 68999999999999999999999999999997542 2245688999999999999999999999765 789
Q ss_pred EEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC-CCceEEeccCCcccc
Q 022479 103 NFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIV 180 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~-~~~~~l~dfg~~~~~ 180 (296)
|+||||+.|++|.+++...+ .+++.+++.++.||+.||.|||++| ++||||||+||+++.+ ...++|+|||++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999999998654 7999999999999999999999999 9999999999999854 248999999999887
Q ss_pred CCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCCChHH
Q 022479 181 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEV 258 (296)
Q Consensus 181 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 258 (296)
..........+++.|+|||...+. ++.++|||||||++|+|++|..||.+....+....+....... .......++++
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 666556667889999999976644 8999999999999999999999999877766666665554332 11223468899
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
++||.+||. ||++|||+.++|+||||+..
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999998 99999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=379.29 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=209.2
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee--
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD-- 96 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 96 (296)
...+.|..++++||+|+||+||+|.++.+++.||||+++.. ..+.+|+.++.++ +||||+++++++.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 33457754457899999999999999999999999999732 4566799886554 89999999999865
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEe
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIG 172 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~ 172 (296)
.....+|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++| ++||||||+||+++.+ .+.+||+
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence 3346799999999999999999864 46999999999999999999999999 9999999999999863 2579999
Q ss_pred ccCCccccCCCcccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--- 248 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 248 (296)
|||+++...........++|+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..................
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999987766667778899999999988754 89999999999999999999999976544333222222211111
Q ss_pred --CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccccc
Q 022479 249 --ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 288 (296)
Q Consensus 249 --~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~ 288 (296)
......++++.+||.+||+ ||++|||+.++++||||.+-.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 1112357899999999998 999999999999999997543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=368.79 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=210.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCH--HHHHHHHHHHHHHHhcC--CCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP--VLVNRLHSEVQLLRTLK--NKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 98 (296)
++| +++++||+|+||+||+|.++.+|+.||||++......... ....++.+|+.++++++ ||||+++++++.++
T Consensus 4 ~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 4 SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 455 7899999999999999999999999999999764432111 11234668999999997 89999999999655
Q ss_pred CCeEEEEeeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
+.+++||||+.+ +++.+++.....+++.+++.++.||+.||+|||++| ++||||||+||+++.+.+.++|+|||++
T Consensus 82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence 789999999976 588888988889999999999999999999999999 9999999999999976579999999999
Q ss_pred cccCCCcccccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
...... ......||+.|+|||++.+. .+.++|||||||++|+|++|+.||.+.. +..... ...+...+
T Consensus 159 ~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~---~~~~~~~s 228 (273)
T d1xwsa_ 159 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---VFFRQRVS 228 (273)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC---CCCSSCCC
T ss_pred eecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc---cCCCCCCC
Confidence 876443 34456799999999987643 4567899999999999999999997532 122222 22344579
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
+++++||.+||+ ||++|||++|+|+||||+++..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 999999999998 9999999999999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=366.20 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=210.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.+..+|+.||+|+++.... ......++.+|++++++++||||+++++++.++ ..+|
T Consensus 3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~ 77 (298)
T d1gz8a_ 3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY 77 (298)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence 45 678999999999999999999999999999975432 233356788999999999999999999999766 7899
Q ss_pred EEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+.++.+..... ....+++..++.++.|++.||+|||++| |+||||||+||+++.+ +.+||+|||.+.....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCC
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccC
Confidence 9999998755544333 3456999999999999999999999999 9999999999999988 7999999999987654
Q ss_pred C-cccccCCCCCCccCcccccc-C-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC--CCC-------
Q 022479 183 S-HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QAL------- 250 (296)
Q Consensus 183 ~-~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~------- 250 (296)
. .......+++.|+|||.+.. . .+.++|+||||+++|+|++|+.||.+.+..+.+.........+ ...
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 3 33445678999999996543 3 6889999999999999999999999877766665544321110 000
Q ss_pred -----------------CCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 251 -----------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 251 -----------------~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
....+.++.+|+++||+ ||++|||+.|+|+||||+++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 11236789999999998 99999999999999999988665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=366.92 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=211.9
Q ss_pred CCcccceeeecccCcceEEEeeecCC-CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc---CCCceeEEeeeeeeC-
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDD- 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~- 97 (296)
++| ++.++||+|+||+||+|.+..+ ++.||||+++....... ....+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 7 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 455 7899999999999999999665 67799999976543211 122344566666555 899999999988642
Q ss_pred --CCCeEEEEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 98 --QHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 98 --~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
....+++++||+.++++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.++|+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecch
Confidence 3357899999999987754443 4567999999999999999999999999 9999999999999998 89999999
Q ss_pred CCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC-------
Q 022479 175 GFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------- 246 (296)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------- 246 (296)
|.+.............+|+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9998876666677788999999999765 45899999999999999999999999987776665554332110
Q ss_pred -----------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 247 -----------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 247 -----------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
........++.+.+|+.+||+ ||++|||+.|+|+||||+++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k 303 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence 011123357889999999998 999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=361.69 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=204.1
Q ss_pred eeecccCcceEEEeeec--CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEee
Q 022479 30 DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 30 ~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
++||+|+||+||+|.++ .+++.||||+++.... +....+++.+|++++++++||||+++++++.. +..++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEE
Confidence 57999999999999754 4568899999975432 45566789999999999999999999998843 35789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc--
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-- 185 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~-- 185 (296)
|+++|+|.+++.....+++.++..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||+++.......
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhcccccccc
Confidence 9999999999999899999999999999999999999999 9999999999999998 8999999999987643222
Q ss_pred --cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....+|+.|+|||.+. +.++.++||||||+++|+|++ |+.||.+.... .+...+..+..+.. +..+++++.+|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~~~~-p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGC-PAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCC-CTTCCHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHHcCCCCCC-CcccCHHHHHH
Confidence 23346789999999776 448999999999999999998 89999886654 44445555444333 34568999999
Q ss_pred HHHHHh-CCCCCCCHHHH---hcCcccccc
Q 022479 262 IEKCIA-QPRARPSASEL---LKDPFFSEL 287 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~l---l~hp~~~~~ 287 (296)
+.+||+ ||++|||+.++ |+|+|++-+
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 999997 99999999998 467766543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-55 Score=363.08 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=213.9
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++.+|+.||||+++.... ..+++.+|++++++++||||+++++++.++ ..++++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv~ 92 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 92 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEEEe
Confidence 678999999999999999999999999999875432 246789999999999999999999999654 6889999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||++| ++||||||+|||++.+ +.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceeecCCCC
Confidence 99999999999875 357899999999999999999999999 9999999999999998 799999999998764432
Q ss_pred c--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 185 A--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 185 ~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
. .....+++.|+|||++. +.++.++||||||+++|+|++|..||....+...+...+..+..+.. +...++++.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-PEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC-CccchHHHHHH
Confidence 2 23345788999999765 55899999999999999999977776655666667777766655444 34568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 262 IEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+.+||+ ||++|||+.++++ +|+.+.++.
T Consensus 249 i~~cl~~dP~~Rps~~ei~~--~L~~~~~~~ 277 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ--AFETMFQES 277 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH--HHHHTTSSS
T ss_pred HHHHcCCCHhHCcCHHHHHH--HHHHHHHhC
Confidence 999998 9999999999987 777665543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=359.85 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=204.6
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| +++++||+|+||+||+|..+ ..||||+++.... +....+.+.+|++++++++||||+++++++.+ ..+
T Consensus 8 ~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 8 GQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp TCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred ccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 445 67999999999999999764 3599999976543 34457889999999999999999999998643 458
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+++ ++||||||+|||++.+ +.+||+|||++....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeecc
Confidence 999999999999999975 467999999999999999999999999 9999999999999999 899999999997764
Q ss_pred CC---cccccCCCCCCccCcccccc----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---CCC
Q 022479 182 RS---HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---ALN 251 (296)
Q Consensus 182 ~~---~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 251 (296)
.. .......+|+.|+|||++.. .++.++||||||+++|+|+||+.||.+......+...+..+.... ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 32 22345678999999997752 378899999999999999999999998777776666665543322 234
Q ss_pred CCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 252 KVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 252 ~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
..+++++.+|+.+||+ ||++|||+.+++++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4568999999999997 99999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-54 Score=357.20 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=213.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--N 100 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~ 100 (296)
++| ++.+.||+|+||+||+|.+..+|+.||+|+++.... .+......+.+|++++++++||||+++++++..... .
T Consensus 7 drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 456 789999999999999999999999999999985433 356667789999999999999999999999876432 4
Q ss_pred eEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcccc
Q 022479 101 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 180 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~ 180 (296)
.+|+||||+.|++|.+++...+.+++.++..++.|++.||+|||++| ++||||||+||+++.+ +..+++|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhhh
Confidence 58999999999999999999889999999999999999999999999 9999999999999999 79999999998765
Q ss_pred CCC----cccccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC-CCCCCCC
Q 022479 181 GRS----HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVK 254 (296)
Q Consensus 181 ~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (296)
... .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.....+.....+ .......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 332 234456789999999987654 8999999999999999999999999888777777777765543 3334557
Q ss_pred ChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 255 DPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 255 ~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
|+++.+||.+||+ ||.+||+..+.|.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 8999999999998 999999444444566654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-54 Score=367.26 Aligned_cols=257 Identities=19% Similarity=0.361 Sum_probs=213.1
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCC
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH 99 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 99 (296)
..++| ++.++||+|+||+||+|.++.+|+.||+|+++... .+++.+|+.+|++++ ||||+++++++.....
T Consensus 33 ~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 33455 78999999999999999999999999999997432 356889999999995 9999999999877666
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++||||+.+++|..+. ..+++.+++.++.||+.||.|||++| |+||||||+|||++.+.+.++|+|||++..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeeccccccee
Confidence 7899999999999987653 46999999999999999999999999 999999999999997645799999999988
Q ss_pred cCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---C-----------
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---G----------- 243 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~---~----------- 243 (296)
...........+|+.|+|||.+.+ .++.++||||+||++++|++|..||....+.......+. +
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 776666677788999999997653 379999999999999999999999975443322111110 0
Q ss_pred CC---------------------CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCC
Q 022479 244 GV---------------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 290 (296)
Q Consensus 244 ~~---------------------~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~ 290 (296)
.. .........++++.+||++||. ||++|||++|+|+||||+.+.|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 00 0011112357889999999998 99999999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-54 Score=361.16 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=209.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
++| ++.++||+|+||+||+|.++ +|+.||||+++.... +....+++.+|+.++++++||||+++++.+..+ +..
T Consensus 2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 75 (286)
T d1ob3a_ 2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL 75 (286)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--Cce
Confidence 366 67999999999999999986 789999999976543 223356788999999999999999999999665 679
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 103 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+++++++.++.+..+....+.+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+|++|||.+.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceeccc
Confidence 999999999888877777888999999999999999999999999 9999999999999998 8999999999987654
Q ss_pred Cc-ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC------------
Q 022479 183 SH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------------ 247 (296)
Q Consensus 183 ~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------ 247 (296)
.. ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+....+.+.+.......+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 32 2344568889999997653 37899999999999999999999998877666555433211000
Q ss_pred --------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 248 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 248 --------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.......+..+.+|+.+||+ ||++|||++|+|+||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01112346789999999998 9999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=365.69 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=207.7
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--- 98 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 98 (296)
..+| ++.++||+|+||+||+|.++.+|+.||||+++.... +....+.+.+|+++|++++||||+++++++...+
T Consensus 17 ~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 3566 689999999999999999999999999999975432 5566788999999999999999999999987543
Q ss_pred -CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+|+||||+ +.+|..++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++++|||++
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccccce
Confidence 23679999999 4577776654 56999999999999999999999999 9999999999999999 89999999999
Q ss_pred cccCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC---------
Q 022479 178 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--------- 246 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------- 246 (296)
...... .....+++.|+|||++.+ ..+.++|||||||++|+|++|..||.+.+....+.........
T Consensus 169 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 169 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred eccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 876543 345678999999997653 3789999999999999999999999887655544332221100
Q ss_pred -------------------CCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 247 -------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 247 -------------------~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
........++++.+||.+||. ||++|||+.++|+||||+.+.++..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~ 313 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc
Confidence 011123357899999999998 99999999999999999998765444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=363.96 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=210.5
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----CC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----QH 99 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~ 99 (296)
.| +..++||+|+||+||+|.++.+|+.||||++...... ..+|++++++++|+||+++++++... ..
T Consensus 21 ~Y-~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred Cc-EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 45 5689999999999999999999999999999765322 23699999999999999999988643 23
Q ss_pred CeEEEEeeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 100 NTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
.++++||||+.++.+... ......+++.+++.++.||+.||+|||++| |+||||||+|||++.+...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccc
Confidence 468999999988644333 345667999999999999999999999999 999999999999998745899999999
Q ss_pred ccccCCCcccccCCCCCCccCccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCC--------
Q 022479 177 AAIVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-------- 246 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------- 246 (296)
+.............+++.|+|||.+. ..++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 98876666666778999999999654 34899999999999999999999999887766655544321000
Q ss_pred ----------C--------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCC
Q 022479 247 ----------P--------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 291 (296)
Q Consensus 247 ----------~--------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~ 291 (296)
+ .......++++.+|+.+||+ ||++|||+.|+|+||||+++..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 0 01122357899999999998 999999999999999999886543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=354.98 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=214.2
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.++++++|+||+++++++... ..++
T Consensus 3 ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 77 (292)
T d1unla_ 3 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLT 77 (292)
T ss_dssp SE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred CC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--ccee
Confidence 55 789999999999999999999999999999976543 445578899999999999999999999999665 7889
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCC
Q 022479 104 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 183 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~ 183 (296)
++++++.+++|..++...+.+++..++.++.|++.||+|||++| |+||||||+||+++.+ +.++|+|||.+......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccCC
Confidence 99999999999999998889999999999999999999999999 9999999999999998 79999999999887554
Q ss_pred cc-cccCCCCCCccCccccccC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhC---CC------------
Q 022479 184 HA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GV------------ 245 (296)
Q Consensus 184 ~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~---~~------------ 245 (296)
.. .....+++.|.|||.+.+. ++.++|||||||++|+|++|+.||....+.......+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 33 3334456778899966543 689999999999999999999987544443333322211 11
Q ss_pred ------------CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 246 ------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 246 ------------~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
.........++.+.+|+.+||+ ||++|||++|+|+||||+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0111122346789999999998 9999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=355.31 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=206.7
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++.++||+|+||+||+|.++ ++..||||+++.... . .+.+.+|++++++++||||+++++++.+ +.++
T Consensus 14 ~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~ 83 (272)
T d1qpca_ 14 TL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--S---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83 (272)
T ss_dssp GE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred He-EEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--C---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeE
Confidence 44 78999999999999999986 578899999975432 2 4678999999999999999999998743 4578
Q ss_pred EEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+||||+.+|+|.+++.. ...+++.++..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||+++...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEcc
Confidence 99999999999987653 336999999999999999999999999 9999999999999998 899999999998775
Q ss_pred CCc--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 182 RSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 182 ~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... ......+++.|+|||++. +.++.++||||||+++|+|+||..|+........+...+..+..+.. +..+++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-cccChHHH
Confidence 432 234456888999999776 45899999999999999999965555444455555555555544433 34568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhc--Cccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLK--DPFFSE 286 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~--hp~~~~ 286 (296)
.+|+.+||+ ||++|||++++++ |+||..
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999998 9999999999998 788753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=361.09 Aligned_cols=261 Identities=21% Similarity=0.368 Sum_probs=209.1
Q ss_pred CCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--
Q 022479 21 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-- 98 (296)
Q Consensus 21 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 98 (296)
..++| ++.++||+|+||+||+|.++.+|+.||||++..... ......++.+|+.+|++++|+|++++++.+....
T Consensus 8 ~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 8 EVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp BGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 35677 689999999999999999999999999999876543 2333567789999999999999999999886532
Q ss_pred ----CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEecc
Q 022479 99 ----HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 174 (296)
Q Consensus 99 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~df 174 (296)
...++++|||+.++.+.........+++..++.++.|++.||.|||++| |+||||||+|||++.+ +.++++||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~df 161 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 161 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCC
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEeeec
Confidence 2468999999998877766667788999999999999999999999999 9999999999999999 89999999
Q ss_pred CCccccCCC-----cccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--CCC
Q 022479 175 GFAAIVGRS-----HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGV 245 (296)
Q Consensus 175 g~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~--~~~ 245 (296)
|++...... ......++|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+......... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999765422 22334568999999997653 478999999999999999999999987766555443322 222
Q ss_pred CCCCCCC---------------------------CCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 246 KPQALNK---------------------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 246 ~~~~~~~---------------------------~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+..... ..++.+.+||.+||+ ||++|||++|+|+||||+.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 2111111 125677899999998 99999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-53 Score=355.86 Aligned_cols=246 Identities=19% Similarity=0.321 Sum_probs=194.5
Q ss_pred ccceeeecccCcceEEEeeecCCCc---EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeE
Q 022479 26 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 26 ~~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 102 (296)
+++.++||+|+||+||+|.++.+++ .||+|++... .+....+.+.+|++++++++||||+++++++..+ ..+
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEE
Confidence 3789999999999999999987765 4777777533 2456677899999999999999999999998554 679
Q ss_pred EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 103 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 103 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
++||||+.+|+|.+++.. .+.+++.++..++.|++.||+|||+++ ++||||||+|||++.+ +.+||+|||+++...
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccceEcc
Confidence 999999999999998876 457999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCcc------cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 182 RSHA------AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 182 ~~~~------~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
.... .....+++.|+|||.+. +.++.++|||||||++|+|+| |..||.+....+... .+..+..+.. +..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~-~i~~~~~~~~-~~~ 257 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-AIEQDYRLPP-PMD 257 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCCCC-CTT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCC-Ccc
Confidence 3222 12235688999999766 458999999999999999998 899998766554444 4444433333 334
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
++.++.+|+.+||+ ||++|||+.+++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 68999999999997 99999999999873
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=352.89 Aligned_cols=252 Identities=20% Similarity=0.375 Sum_probs=208.1
Q ss_pred ccee-eecccCcceEEEeeecC--CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSD-LLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~-~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.+.+ +||+|+||+||+|.++. ++..||||+++.. .+....+++.+|++++++++||||+++++++.. +.+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence 3566 49999999999998754 3457999999743 245667889999999999999999999998853 3589
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhcccc
Confidence 99999999999998764 467999999999999999999999999 9999999999999998 8999999999987644
Q ss_pred Ccc----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHA----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
... .....+++.|+|||++. +.++.++||||||+++|+|+| |..||.+....+. ...+..+..+.. +..+++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-~~~i~~~~~~~~-p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMEC-PPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-HHHHHTTCCCCC-CTTCCH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCC-CCcCCH
Confidence 322 23446788999999776 458999999999999999998 9999988765544 444455444433 345689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHH---hcCcccccccC
Q 022479 257 EVKAFIEKCIA-QPRARPSASEL---LKDPFFSELND 289 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~l---l~hp~~~~~~~ 289 (296)
++.+|+..||+ ||++|||+.++ |+|+|+.-...
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 99999999997 99999999988 56788754333
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=350.23 Aligned_cols=242 Identities=22% Similarity=0.420 Sum_probs=193.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.+.||+|+||+||+|.++ +++.||||+++.... . .+.+.+|++++++++||||+++++++..+ +.+++||
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp EEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--c---HHHHHHHHHHHHhcCCCCcccccceeccC--CceEEEE
Confidence 68999999999999999986 467899999975432 2 35788999999999999999999999655 6799999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCcc
Q 022479 107 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 185 (296)
Q Consensus 107 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||+++.......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccCCCc
Confidence 99999999998865 466899999999999999999999999 9999999999999998 7999999999987644322
Q ss_pred --cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022479 186 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 261 (296)
Q Consensus 186 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (296)
.....+|+.|+|||++. +.++.++||||||+++|+|+|+ .+||... ....+...+..+..+.. +..+++++.+|
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~~~~-p~~~~~~l~~l 234 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYK-PRLASTHVYQI 234 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHTCCCCC-CTTSCHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhcCCCCC-ccccCHHHHHH
Confidence 33456789999999776 4589999999999999999995 5556554 44444444444443333 34568999999
Q ss_pred HHHHHh-CCCCCCCHHHHhcC
Q 022479 262 IEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 262 i~~~l~-~p~~Rps~~~ll~h 281 (296)
+.+||+ ||++|||++++++|
T Consensus 235 i~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHH
Confidence 999998 99999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=360.92 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=206.2
Q ss_pred CcccceeeecccCcceEEEeeecCCCc-----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGI-----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
+| +++++||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 38 ~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 38 NL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred He-EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 44 688999999999999999865543 68999886432 233456788999999998 899999999999655
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH-----------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 154 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~d 154 (296)
+.+++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+++ |+|||
T Consensus 114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD 189 (325)
T d1rjba_ 114 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD 189 (325)
T ss_dssp --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred --CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 6799999999999999999754 24899999999999999999999999 99999
Q ss_pred CCCCceEEeCCCCceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 022479 155 LNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYS 229 (296)
Q Consensus 155 l~~~nilv~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~ 229 (296)
|||+||+++.+ +.+||+|||+++....... .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.
T Consensus 190 lKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999 8999999999976643322 23455789999999765 558999999999999999998 899998
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 230 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+......+...+.....+.. +..+++++++||.+||+ ||++|||+++|++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCC-CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87766777777777655443 34568999999999998 99999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=357.94 Aligned_cols=266 Identities=23% Similarity=0.369 Sum_probs=209.5
Q ss_pred CCCCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC
Q 022479 20 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH 99 (296)
Q Consensus 20 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 99 (296)
+.+.+| ++.++||+|+||+||+|.++.+|+.||||++.... .....+++.+|+.+|++++|||++++++++.....
T Consensus 5 ~i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 5 DVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CcCCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 344566 78999999999999999999999999999997432 45566788999999999999999999999865432
Q ss_pred --CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 100 --NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 100 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
...+++++++.+++|.+++... .+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a 156 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLA 156 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccCce
Confidence 1233445667788999999765 5999999999999999999999999 9999999999999998 89999999999
Q ss_pred cccCCCc----ccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC----
Q 022479 178 AIVGRSH----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---- 247 (296)
Q Consensus 178 ~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---- 247 (296)
....... ......+++.|+|||++.. .++.++||||+||++|+|++|..||.+....+...........+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 7664322 2345568899999997643 36889999999999999999999998765544433322110000
Q ss_pred ------------------------CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCC
Q 022479 248 ------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE 293 (296)
Q Consensus 248 ------------------------~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~ 293 (296)
.......++++.+|+.+||+ ||++|||++++|+||||+.......+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~ 307 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence 00112346789999999998 99999999999999999976664433
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=344.27 Aligned_cols=244 Identities=21% Similarity=0.380 Sum_probs=206.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.| ++.++||+|+||+||+|.++ +++.||||+++.... . .+.+.+|++++++++||||+++++++.++ +.++
T Consensus 5 ~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~ 75 (258)
T d1k2pa_ 5 DL-TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 75 (258)
T ss_dssp CC-CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEE
T ss_pred HC-EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--C---HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Confidence 44 68999999999999999985 678999999986543 2 35788999999999999999999998654 7899
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+.+|+|..++.. ...+++..+..++.|++.||+|||++| ++||||||+||+++.+ +.+||+|||++.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccC
Confidence 99999999999998654 567999999999999999999999999 9999999999999998 8999999999976543
Q ss_pred Ccc--cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 183 SHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 183 ~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... .....+++.|+|||.+. +.++.++||||||+++|+|+| |+.||.+....+ +...+..+..+. .+...++++
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~-~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQGLRLY-RPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHTTCCCC-CCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HHHHHHhCCCCC-CcccccHHH
Confidence 322 33356788999999766 558999999999999999998 899998876554 444455544433 345568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 259 KAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+|+.+||+ ||++|||++++++|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999997 99999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=360.22 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=211.3
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC---C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---H 99 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~ 99 (296)
.+| ++.++||+|+||+||+|.++.+|+.||||+++.... +....+++.+|++++++++|+|++++++++.... .
T Consensus 18 ~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 18 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp TTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 455 789999999999999999999999999999975432 4555678899999999999999999999886432 2
Q ss_pred CeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 100 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 100 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
...+++++++.|++|.+++.. +.+++.+++.++.||+.||+|||++| ++||||||+||+++.+ +.++++|||.+..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----C
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhcc
Confidence 344556777889999998865 46999999999999999999999999 9999999999999999 8999999999976
Q ss_pred cCCCcccccCCCCCCccCcccccc--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCC---------
Q 022479 180 VGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------- 248 (296)
Q Consensus 180 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 248 (296)
.... .....+++.|+|||...+ ..+.++|||||||++|+|++|..||.+.+.......+......+.
T Consensus 171 ~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 5433 344567889999996543 368899999999999999999999987665554443322211100
Q ss_pred -------------------CCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccCCCCCC
Q 022479 249 -------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP 294 (296)
Q Consensus 249 -------------------~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~~~~~~ 294 (296)
......++++.+||.+||. ||++|||+.|+|+||||+++..++.++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 0012357889999999998 999999999999999999987766654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=344.29 Aligned_cols=257 Identities=20% Similarity=0.331 Sum_probs=203.1
Q ss_pred ecCCCCCcccceeeecccCcceEEEeeecCCC----cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeee
Q 022479 18 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 93 (296)
Q Consensus 18 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 93 (296)
++++. .| .+.++||+|+||+||+|.++.++ ..||||+++... +......+.+|++++++++||||++++++
T Consensus 3 ei~~~-~~-~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPS-CV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTT-TE-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHH-He-EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34443 35 56899999999999999987654 469999986432 45556778999999999999999999999
Q ss_pred eeeCCCCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 94 WLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
+.+. ..++++|||+.++++.+++.. ...+++.++..++.|++.||+|||+++ ++||||||+|||++.+ +.+||+
T Consensus 78 ~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~ 152 (283)
T d1mqba_ 78 ISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVS 152 (283)
T ss_dssp ECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEEC
T ss_pred EecC--CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEc
Confidence 9654 678999999999999887765 467999999999999999999999999 9999999999999999 899999
Q ss_pred ccCCccccCCCc----ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCC
Q 022479 173 DLGFAAIVGRSH----AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 247 (296)
Q Consensus 173 dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 247 (296)
|||+++...... ......+|+.|+|||++. +.++.++||||||+++|+|++|..|+........+...+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999998764322 223345788999999766 458999999999999999999766655545555666666665554
Q ss_pred CCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 248 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 248 ~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
... ...+.++.+|+.+||+ ||++|||+.++++ .+..+
T Consensus 233 ~~~-~~~~~~l~~li~~cl~~~p~~RPt~~eil~--~L~~l 270 (283)
T d1mqba_ 233 PTP-MDCPSAIYQLMMQCWQQERARRPKFADIVS--ILDKL 270 (283)
T ss_dssp CCC-TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH--HHHHH
T ss_pred CCc-hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH--HHHHH
Confidence 443 3468999999999997 9999999999988 44443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=359.54 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=213.6
Q ss_pred CCcccceeeecccCcceEEEeee---cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 98 (296)
.+| ++.++||+|+||+||+|.+ +.+|+.||+|+++......+....+.+.+|++++++++| |||+++++.+.+.
T Consensus 24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 445 7899999999999999986 446899999999765432233335667889999999977 7999999998665
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
..+++++||+.+++|.+++...+.+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.++|+|||++.
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK 177 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchh
Confidence 689999999999999999999888999999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCC--cccccCCCCCCccCcccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhCCCCCCCC
Q 022479 179 IVGRS--HAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQAL 250 (296)
Q Consensus 179 ~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 250 (296)
..... .......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.. ....+......... ..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CC
Confidence 76432 22445678999999997653 36789999999999999999999996543 33333333333222 22
Q ss_pred CCCCChHHHHHHHHHHh-CCCCCC-----CHHHHhcCcccccccCC
Q 022479 251 NKVKDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD 290 (296)
Q Consensus 251 ~~~~~~~l~~li~~~l~-~p~~Rp-----s~~~ll~hp~~~~~~~~ 290 (296)
+...++++.+|+.+||+ ||++|| +++|+++||||++++|+
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 33468999999999998 999999 58999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=360.23 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=199.7
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----C
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----Q 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~ 98 (296)
.+| ++.++||+|+||+||+|.++.+|+.||||++..... +.....++.+|+.++++++||||+++++++... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 455 789999999999999999999999999999986543 455667899999999999999999999998654 2
Q ss_pred CCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCcc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 178 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~ 178 (296)
...+|+||||+.++++... ...+++..++.++.|++.||.|||+.| ++||||||+||+++.+ +.++++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred CceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhh
Confidence 3689999999988655433 346899999999999999999999999 9999999999999999 799999999998
Q ss_pred ccCCCcccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCC------------
Q 022479 179 IVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV------------ 245 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------ 245 (296)
...........++|+.|+|||++.+ .+++++||||+||++++|++|+.||.+.+.............
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 8776666677788999999997664 589999999999999999999999987665444333221100
Q ss_pred ----------CCCCC----------C-------CCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccccC
Q 022479 246 ----------KPQAL----------N-------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 289 (296)
Q Consensus 246 ----------~~~~~----------~-------~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~~~ 289 (296)
..... . ...++++.+|+.+||. ||++||||+|+|+||||+...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 00000 0 0114578899999998 9999999999999999997543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=345.86 Aligned_cols=251 Identities=21% Similarity=0.352 Sum_probs=202.9
Q ss_pred CcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
+| ++++.||+|+||+||+|.++.+ +.||||+++.... + .+.+.+|+.++++++|+||+++++++.+ +.++
T Consensus 18 ~~-~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~ 87 (285)
T d1fmka3 18 SL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 87 (285)
T ss_dssp GE-EEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred HE-EEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--C---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCeE
Confidence 45 7899999999999999998754 5799999975433 2 3678999999999999999999998743 4578
Q ss_pred EEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccC
Q 022479 104 FITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 181 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~ 181 (296)
+||||+.+|+|..++.. ...+++.++..++.|++.||+|||++| ++||||||+||+++.+ +.+||+|||+++...
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIE 164 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC---
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhcc
Confidence 99999999999888753 457999999999999999999999999 9999999999999998 899999999998764
Q ss_pred CCc--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHH
Q 022479 182 RSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 258 (296)
Q Consensus 182 ~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (296)
... ......+++.|+|||.+. +.++.++||||||+++|+|++|..||............+........ +..+++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CcccCHHH
Confidence 322 233456889999999765 55899999999999999999976665544555555555555544433 44568999
Q ss_pred HHHHHHHHh-CCCCCCCHHHHhc--Cccccccc
Q 022479 259 KAFIEKCIA-QPRARPSASELLK--DPFFSELN 288 (296)
Q Consensus 259 ~~li~~~l~-~p~~Rps~~~ll~--hp~~~~~~ 288 (296)
.+|+.+||+ ||++|||+++++. ++||....
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999998 9999999999998 78887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=337.54 Aligned_cols=246 Identities=23% Similarity=0.413 Sum_probs=194.5
Q ss_pred CcccceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
+| +++++||+|+||+||+|.+..++ ..||+|+++.. ......+.+.+|++++++++||||+++++++.+ +
T Consensus 8 ~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 8 RI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 80 (273)
T ss_dssp GE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred He-EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 44 78999999999999999886543 45788887532 245667789999999999999999999998843 5
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||+++.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhhee
Confidence 68999999999999988764 557999999999999999999999999 9999999999999999 7999999999987
Q ss_pred cCCCc--ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCC
Q 022479 180 VGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 255 (296)
Q Consensus 180 ~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
..... ......+|+.|+|||.+. +.++.++||||||+++|+|++ |.+||.+....+..... ..+..+.. +..++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~-~~~~~ 235 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPM-PPNCP 235 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCC-CTTCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCC-CCCCC
Confidence 64322 233456788999999776 558999999999999999998 89999876665544444 44433333 34568
Q ss_pred hHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 256 PEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 256 ~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+++.+||.+||. ||++|||+.++++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999998 99999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=344.10 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=198.0
Q ss_pred CCcccceeeecccCcceEEEeeecCCCc----EEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ 98 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 98 (296)
+.| ++.++||+|+||+||+|.+..+|+ +||+|+++... +....+.+.+|++++++++||||+++++++.++
T Consensus 9 ~dy-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHC-EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 345 679999999999999999988776 47777775332 233467789999999999999999999998654
Q ss_pred CCeEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCc
Q 022479 99 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 177 (296)
Q Consensus 99 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~ 177 (296)
..+++++++.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla 158 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLA 158 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHH
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccc
Confidence 47788899999999887765 567999999999999999999999999 9999999999999999 79999999999
Q ss_pred cccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCC
Q 022479 178 AIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK 252 (296)
Q Consensus 178 ~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (296)
+....... .....+|+.|+|||++. +.++.++||||||+++|+|+| |..||.+....+ +...+..+..+.. +.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~~~~~~~~-p~ 236 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ-PP 236 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHHHTCCCCC-CT
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCCCC-Cc
Confidence 87644322 23345789999999765 558999999999999999998 889998755443 3444444433333 34
Q ss_pred CCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 253 VKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 253 ~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+++++.+|+.+||. ||++|||+.++++|
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 468999999999998 99999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=336.42 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=198.0
Q ss_pred CcccceeeecccCcceEEEeeecCC---CcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 100 (296)
.| ++.+.||+|+||.||+|.+..+ ...||||+++..... .....+++.+|++++++++||||+++++++.+ .
T Consensus 9 d~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 9 DL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred He-EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 34 7899999999999999986432 246899999765432 34556789999999999999999999999854 3
Q ss_pred eEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 101 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
.+++||||+.++++.+.+.. .+.+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||+++.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhh
Confidence 57899999999999887654 457999999999999999999999999 9999999999999999 7999999999987
Q ss_pred cCCCcc----cccCCCCCCccCccccccC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCC
Q 022479 180 VGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV 253 (296)
Q Consensus 180 ~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (296)
...... .....++..|+|||.+.+. ++.++||||||+++|+|+| |..||.+....+...........+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC-CTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC-ccc
Confidence 644322 2234467789999977654 8889999999999999998 89999987777666666555544433 344
Q ss_pred CChHHHHHHHHHHh-CCCCCCCHHHHhcCcccc
Q 022479 254 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 285 (296)
Q Consensus 254 ~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~ 285 (296)
.++++.+|+.+||. ||++|||+.++++ +|+
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~--~L~ 270 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLL 270 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH--HHH
Confidence 68999999999998 9999999999975 554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=341.43 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=197.4
Q ss_pred CcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD 97 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 97 (296)
+| ++.++||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|...+.++ +|+||+.+++.+.++
T Consensus 14 ~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 14 RL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HE-EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 45 789999999999999998653 45789999987432 344566778888888777 688999998887654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceE
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 161 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nil 161 (296)
. ..++++|||+.+|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||
T Consensus 90 ~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NIL 166 (299)
T d1ywna1 90 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 166 (299)
T ss_dssp T-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred C-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcccee
Confidence 3 6789999999999999998643 34899999999999999999999999 999999999999
Q ss_pred EeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 022479 162 INGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 236 (296)
Q Consensus 162 v~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g-~~p~~~~~~~~~ 236 (296)
++.+ +.+||+|||+++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++| ..||.+....+.
T Consensus 167 l~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9998 899999999997654322 2334578999999997764 489999999999999999986 568877666666
Q ss_pred HHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 237 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
+...+..+..+.. +...++++.+|+.+||+ ||++|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666665554433 44568999999999998 99999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=335.81 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=196.0
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEEEEe
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 106 (296)
++.++||+|+||+||+|.++ |..||||+++.+. ..+.+.+|++++++++||||+++++++.++. +.+++||
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 80 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT 80 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEE
Confidence 67899999999999999885 7889999997432 2467889999999999999999999886543 5689999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCCCc
Q 022479 107 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 184 (296)
Q Consensus 107 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~~~ 184 (296)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.+ +.++++|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecCCC-
Confidence 999999999998653 35899999999999999999999999 9999999999999999 89999999999876443
Q ss_pred ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022479 185 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 262 (296)
Q Consensus 185 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 262 (296)
.....++..|+|||.+. +.++.++||||||+++|+|+| |++||...... .+...+..+..+... ...++++++|+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-~~~~~i~~~~~~~~~-~~~~~~~~~li 233 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAP-DGCPPAVYEVM 233 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHTTTCCCCCC-TTCCHHHHHHH
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCC-ccCCHHHHHHH
Confidence 33346788999999765 568999999999999999998 78888765443 444445555444443 44689999999
Q ss_pred HHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 263 EKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 263 ~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+||. ||++|||+.++++ +++.+
T Consensus 234 ~~cl~~dP~~Rps~~~l~~--~L~~i 257 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLRE--QLEHI 257 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHHcccCHhHCcCHHHHHH--HHHHH
Confidence 99998 9999999999998 55544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-50 Score=339.49 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=206.9
Q ss_pred CCcccceeeecccCcceEEEeeec-----CCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
++| ++.+.||+|+||+||+|..+ .+++.||||+++.. ......+++.+|++++++++|+|++++++++...
T Consensus 13 ~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 13 NNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 345 78999999999999999865 35678999998743 2455678899999999999999999999999654
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceec
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHR 153 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~ 153 (296)
..+++++||+.+++|.+++... ..++...+..++.|++.||+|||+++ ++||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 6789999999999999998643 24889999999999999999999999 9999
Q ss_pred CCCCCceEEeCCCCceEEeccCCccccCCC---cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCC-CCC
Q 022479 154 DLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTME-IPY 228 (296)
Q Consensus 154 dl~~~nilv~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~-~p~ 228 (296)
||||+||+++.+ +.+||+|||++...... .......+++.|+|||.+.+ .++.++||||||+++|+|++|. +||
T Consensus 165 DlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 165 DLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999998 79999999999765332 22334567889999997664 5899999999999999999985 677
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCcccccc
Q 022479 229 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 287 (296)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~~ 287 (296)
.+....+.. ..+..+..+.. +..+++++.+|+.+||+ ||++|||+.+|++ +|+.+
T Consensus 244 ~~~~~~e~~-~~v~~~~~~~~-p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVI-YYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM 299 (301)
T ss_dssp TTSCHHHHH-HHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred CCCCHHHHH-HHHHcCCCCCC-CccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence 776555544 44454443333 44568999999999998 9999999999987 66654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=340.42 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=201.8
Q ss_pred CcccceeeecccCcceEEEeeecCCCcE--EEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCCC
Q 022479 24 RFGRYSDLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN 100 (296)
Q Consensus 24 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 100 (296)
.| +++++||+|+||+||+|.++.+|.. ||||.++... .....+.+.+|+++++++ +||||+++++++.+. +
T Consensus 11 ~~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 84 (309)
T d1fvra_ 11 DI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 84 (309)
T ss_dssp GC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred Hc-EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--C
Confidence 44 6789999999999999999888775 5666665332 233456789999999999 799999999999765 7
Q ss_pred eEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeC
Q 022479 101 TLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING 164 (296)
Q Consensus 101 ~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~ 164 (296)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 899999999999999998643 57999999999999999999999999 999999999999999
Q ss_pred CCCceEEeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHh
Q 022479 165 NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKKVT 242 (296)
Q Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~-~p~~~~~~~~~~~~~~~ 242 (296)
+ +.+||+|||++.............++..|+|||.+. +.++.++||||||+++|+|++|. +||.+.. ...+...+.
T Consensus 163 ~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~~~~~i~ 240 (309)
T d1fvra_ 163 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP 240 (309)
T ss_dssp G-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHGG
T ss_pred C-CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-HHHHHHHHH
Confidence 9 799999999998766555555567899999999776 45899999999999999999975 5676544 444555555
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
.+..+.. +...++++.+||.+||+ ||++|||++++++|
T Consensus 241 ~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444433 33468999999999997 99999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=336.54 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=201.5
Q ss_pred cceeeecccCcceEEEeeecCCC---cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCeEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 103 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 103 (296)
.+.++||+|+||+||+|.+..++ ..||||.++.. .+....+++.+|++++++++||||+++++++...+ ..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceE
Confidence 45789999999999999986543 35899998642 25666788999999999999999999999886543 5789
Q ss_pred EEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEeccCCccccCC
Q 022479 104 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 182 (296)
Q Consensus 104 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~~~~ 182 (296)
+||||+++++|.+++.. ...++...+..++.|++.||.|||+++ ++||||||+|||++.+ +.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEecccchhhccc
Confidence 99999999999998874 446778899999999999999999999 9999999999999998 7999999999987643
Q ss_pred Ccc-----cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCCh
Q 022479 183 SHA-----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 256 (296)
Q Consensus 183 ~~~-----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
... .....+++.|+|||.+. +.++.++||||||+++|+|++|..||............+..+..+.. +..+++
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~-p~~~~~ 261 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPD 261 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC-CTTCCH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-cccCcH
Confidence 221 22346788999999765 56899999999999999999988887655444445555555544443 345689
Q ss_pred HHHHHHHHHHh-CCCCCCCHHHHhcC
Q 022479 257 EVKAFIEKCIA-QPRARPSASELLKD 281 (296)
Q Consensus 257 ~l~~li~~~l~-~p~~Rps~~~ll~h 281 (296)
++.+|+.+||+ ||++|||+.|+++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999997 99999999999997
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=330.40 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=202.1
Q ss_pred CCcccceeeecccCcceEEEeeecCCC-------cEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEG-------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW 94 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 94 (296)
++| +++++||+|+||.||+|.+..++ ..||+|+++... .......+.+|...+.++ +||||+++++++
T Consensus 13 ~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 13 DRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 355 68999999999999999876544 479999997543 455567888999999888 799999999999
Q ss_pred eeCCCCeEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 95 LDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
.++ ..+++||||+.+|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+
T Consensus 89 ~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 89 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp CSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 654 7899999999999999999754 35899999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
|||++.+ +.+||+|||++....... ......+++.|+|||.+. +.++.++||||||+++|+|++ |.+||.+...
T Consensus 165 NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999 899999999998764322 234456788999999765 569999999999999999998 7888876554
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
..+...+..+..+.. +...++++.+|+.+||+ ||.+|||+.++++
T Consensus 244 -~~~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 -EELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -HHHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHcCCCCCC-CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 455566666555444 44568999999999998 9999999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=330.85 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=210.4
Q ss_pred CCcccceeeecccCcceEEEeeecC-----CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD 97 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 97 (296)
.+| +++++||+|+||+||+|.++. ++..||||+++... .......+.+|++++++++|+||+++++++..+
T Consensus 20 ~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 20 EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHe-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 455 679999999999999998753 35789999997432 445567799999999999999999999998544
Q ss_pred CCCeEEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCC
Q 022479 98 QHNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 98 ~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~ 167 (296)
..+++||||+.+|+|.+++... ..++...+..++.|++.||.|||+++ ++||||||+|||++.+ +
T Consensus 96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~-~ 170 (308)
T d1p4oa_ 96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-F 170 (308)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-C
T ss_pred --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-c
Confidence 6789999999999999987532 34788999999999999999999999 9999999999999998 7
Q ss_pred ceEEeccCCccccCCCcc---cccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 022479 168 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVT 242 (296)
Q Consensus 168 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g-~~p~~~~~~~~~~~~~~~ 242 (296)
.+||+|||+++....... .....+++.|+|||.+. +.++.++|+||||+++|+|+|| ..||.+....+... .+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~-~i~ 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-FVM 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH-HHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH-HHH
Confidence 999999999986643322 33346789999999766 4588899999999999999998 57787765555444 444
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc------CcccccccCC
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK------DPFFSELNDD 290 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~------hp~~~~~~~~ 290 (296)
.+..+.. +...++.+.+|+.+||+ ||++|||++++++ +|+|+++...
T Consensus 250 ~~~~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~ 303 (308)
T d1p4oa_ 250 EGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 303 (308)
T ss_dssp TTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred hCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCC
Confidence 4433333 34468999999999998 9999999999998 7888765543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=331.30 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=210.2
Q ss_pred CCcccceeeecccCcceEEEeee-----cCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD 96 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 96 (296)
++| +++++||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+++++ +||||+++++++.+
T Consensus 23 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 23 NRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 344 5799999999999999975 3467889999997532 345567889999999999 69999999999965
Q ss_pred CCCCeEEEEeeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCC
Q 022479 97 DQHNTLNFITEVCTSGNLRTYRKKHR------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 158 (296)
Q Consensus 97 ~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~ 158 (296)
. ..++++|||+.+++|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+
T Consensus 99 ~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 99 G--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp S--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred C--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 4 67999999999999999987533 5899999999999999999999999 999999999
Q ss_pred ceEEeCCCCceEEeccCCccccCCCc---ccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022479 159 NIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS 233 (296)
Q Consensus 159 nilv~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 233 (296)
||+++.+ +.++++|||.+....... ......+++.|+|||.+. +.++.++||||||+++|+|+| |.+||.+...
T Consensus 175 NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999998 899999999998765432 234457789999999766 558999999999999999999 6666766666
Q ss_pred HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhcCccccc
Q 022479 234 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 286 (296)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~hp~~~~ 286 (296)
.+.+...+..+..+... ...++.+.+||.+||+ ||++|||++++++ .++.
T Consensus 254 ~~~~~~~i~~~~~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~ 304 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSP-EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEK 304 (311)
T ss_dssp SHHHHHHHHHTCCCCCC-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHHHhcCCCCCCc-ccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence 66666666666554433 4468999999999998 9999999999997 5543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=328.43 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=194.5
Q ss_pred CCCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCCCe
Q 022479 22 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 22 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 101 (296)
+++| ++.++||+|+||+||+|.+..+|+.||||++...... .++.+|++++++++|++++..+..+... ...
T Consensus 6 g~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~ 77 (299)
T d1ckia_ 6 GNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 77 (299)
T ss_dssp TTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTE
T ss_pred CCEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCE
Confidence 4566 7899999999999999999999999999998765432 3467899999999888766665554433 268
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC--CCceEEeccCCccc
Q 022479 102 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAI 179 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~--~~~~~l~dfg~~~~ 179 (296)
.++||||+.++.+.........+++..+..++.|++.||+|||++| ++||||||+||+++.. ...++++|||++..
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 8999999966444444455678999999999999999999999999 9999999999998643 24799999999987
Q ss_pred cCCCc--------ccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhC--CC
Q 022479 180 VGRSH--------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK---VTG--GV 245 (296)
Q Consensus 180 ~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~---~~~--~~ 245 (296)
..... ......+|+.|+|||.+.+ .++.++|||||||++|+|++|+.||............ ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 64322 2334578999999997765 4899999999999999999999999764433222111 110 11
Q ss_pred CCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHH---hcCcccc
Q 022479 246 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL---LKDPFFS 285 (296)
Q Consensus 246 ~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~l---l~hp~~~ 285 (296)
+........|+++.+++..||+ ||++||+++++ |+|+|.+
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1122234468999999999998 99999998754 6677654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=319.22 Aligned_cols=243 Identities=25% Similarity=0.321 Sum_probs=187.2
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCC--CeEEE
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--NTLNF 104 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~l 104 (296)
.+.+.||+|+||+||+|.+ +|+.||||+++... ........|+..+++++||||+++++++.+... ..+++
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4689999999999999976 58999999986432 112223345555667899999999999986543 36899
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------CCCCceecCCCCCceEEeCCCCceEEeccCC
Q 022479 105 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 176 (296)
Q Consensus 105 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~--------~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~ 176 (296)
||||+.+++|.+++... .+++.++..++.|++.||+|||+ +| |+||||||+||+++.+ +.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~-~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTT-SCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCC-CCeEEEecCc
Confidence 99999999999999875 48999999999999999999997 47 9999999999999998 8999999999
Q ss_pred ccccCCCc-----ccccCCCCCCccCccccccC-------CCcchhHHHHHHHHHHHHhCCCCCCCC-------------
Q 022479 177 AAIVGRSH-----AAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSEC------------- 231 (296)
Q Consensus 177 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~i~~~ll~g~~p~~~~------------- 231 (296)
+....... ......+|+.|+|||++.+. ++.++|||||||++|+|+||..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98764332 23345789999999987643 466899999999999999998876321
Q ss_pred -ChHHHHHHHHhCCC-CCCCCCCC----CChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 232 -DSVAKIYKKVTGGV-KPQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 232 -~~~~~~~~~~~~~~-~~~~~~~~----~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
.............. .+...... ....+.+|+.+||+ ||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 12333333333322 22221111 12458899999998 9999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-46 Score=313.78 Aligned_cols=246 Identities=15% Similarity=0.183 Sum_probs=195.2
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNT 101 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 101 (296)
++| +++++||+|+||+||+|.+..+|+.||+|+++.... .+.+.+|++.++.++| +|++.+++++... ..
T Consensus 5 ~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~ 75 (293)
T d1csna_ 5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LH 75 (293)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TE
T ss_pred Cce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--Cc
Confidence 445 899999999999999999999999999999865432 1346678899999976 7888888887554 78
Q ss_pred EEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCC----CCceEEeccCC
Q 022479 102 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIGDLGF 176 (296)
Q Consensus 102 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~----~~~~~l~dfg~ 176 (296)
.++||||+ +++|.+++.. +..++..++..++.|++.||+|||++| ++||||||+||+++.+ .+.++|+|||+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccce
Confidence 89999998 5689888875 457999999999999999999999999 9999999999999752 26899999999
Q ss_pred ccccCCC--------cccccCCCCCCccCcccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHh--
Q 022479 177 AAIVGRS--------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVT-- 242 (296)
Q Consensus 177 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i~~~ll~g~~p~~~~~---~~~~~~~~~~-- 242 (296)
++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ..........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 9876432 12334578999999997765 49999999999999999999999997532 2222221111
Q ss_pred CCCCCCCCCCCCChHHHHHHHHHHh-CCCCCCCHHHHhc
Q 022479 243 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 280 (296)
Q Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~-~p~~Rps~~~ll~ 280 (296)
............|+++.+++..|++ +|++||+++.+.+
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111222233468899999999998 9999999887755
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-46 Score=320.71 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=199.4
Q ss_pred CCcccceeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcC-----------CCceeEEe
Q 022479 23 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----------NKYIIVCY 91 (296)
Q Consensus 23 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~ 91 (296)
+|| ++.++||+|+||+||+|.++.+|+.||||+++.. ....+.+.+|++++++++ |+||++++
T Consensus 13 ~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 455 7899999999999999999999999999999743 344567788998888875 47899999
Q ss_pred eeeeeCCCCeEEEEeeccCCCCH-HHH--HHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceecCCCCCceEEeCCCC
Q 022479 92 SVWLDDQHNTLNFITEVCTSGNL-RTY--RKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIG 167 (296)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~sL-~~~--l~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~i~h~dl~~~nilv~~~~~ 167 (296)
+++........++++++...+.. ... ......+++..++.++.|++.||+|||+ .| |+||||||+|||++.+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCc
Confidence 88866555667777777655533 222 2345679999999999999999999998 88 999999999999986521
Q ss_pred -----ceEEeccCCccccCCCcccccCCCCCCccCccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCh------HH
Q 022479 168 -----QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS------VA 235 (296)
Q Consensus 168 -----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~------~~ 235 (296)
.++++|||.+...... .....+++.|+|||++. ..++.++|+||+||++++|++|+.||..... .+
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 4999999999765432 34567899999999655 4589999999999999999999999964321 11
Q ss_pred HHHHH--HhCCC-------------------CCCC------------------CCCCCChHHHHHHHHHHh-CCCCCCCH
Q 022479 236 KIYKK--VTGGV-------------------KPQA------------------LNKVKDPEVKAFIEKCIA-QPRARPSA 275 (296)
Q Consensus 236 ~~~~~--~~~~~-------------------~~~~------------------~~~~~~~~l~~li~~~l~-~p~~Rps~ 275 (296)
.+... ..+.. .... .....++++.+|+.+||+ ||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111 00100 0000 001124678999999998 99999999
Q ss_pred HHHhcCcccccccCCCCCCCC
Q 022479 276 SELLKDPFFSELNDDDSEPSP 296 (296)
Q Consensus 276 ~~ll~hp~~~~~~~~~~~~~~ 296 (296)
.|+|+||||++....++...|
T Consensus 323 ~e~L~Hp~f~~~~~~~~~~~p 343 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGMEEIRVP 343 (362)
T ss_dssp HHHHTCGGGTTCTTCTTCCCT
T ss_pred HHHhcCcccCCCCCcccCCCC
Confidence 999999999988777666544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1e-25 Score=175.74 Aligned_cols=166 Identities=17% Similarity=0.205 Sum_probs=122.1
Q ss_pred cceeeecccCcceEEEeeecCCCcEEEeeeeeecccC--------------CCHHHHHHHHHHHHHHHhcCCCceeEEee
Q 022479 27 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--------------EDPVLVNRLHSEVQLLRTLKNKYIIVCYS 92 (296)
Q Consensus 27 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 92 (296)
.++++||+|+||+||+|.+. +|+.||||+++..... ...........|...+.++.|.++...++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 47899999999999999885 6899999987642210 00122344567889999999999887765
Q ss_pred eeeeCCCCeEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCCCceecCCCCCceEEeCCCCceEEe
Q 022479 93 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 172 (296)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~i~h~dl~~~nilv~~~~~~~~l~ 172 (296)
.. . .+++|||+.+..+.+ ++......++.|++.++++||++| ++||||||+|||++.+ .++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEEC
T ss_pred ec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEE
Confidence 43 2 368999999876542 455667789999999999999999 9999999999999975 58999
Q ss_pred ccCCccccCCCcccccCCCCCCccC------ccccccCCCcchhHHHHHHH
Q 022479 173 DLGFAAIVGRSHAAHSIIGTPEYMA------PELYEEDYTEMVDIYSFGLC 217 (296)
Q Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~a------PE~~~~~~~~~~Di~slG~i 217 (296)
|||.+.....+.... |.. .+.+.+.++.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999997764332111 111 11223457888999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=4e-07 Score=72.46 Aligned_cols=137 Identities=16% Similarity=0.096 Sum_probs=84.3
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCCCeEEEEee
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITE 107 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e 107 (296)
.+..+.++.+.||++. .+++.+++|......... ...+.+|...+..+.. -.+.+++.....+ ...++||+
T Consensus 19 ~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~ 90 (263)
T d1j7la_ 19 VKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMS 90 (263)
T ss_dssp EECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred EEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEE
Confidence 3333334456899885 457778888876443221 2345678888777742 2234444444333 67889999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q 022479 108 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT------------------------------------------ 145 (296)
Q Consensus 108 ~~~~~sL~~~l~~~~~~~~~~~~~i~~ql~~~l~~LH~------------------------------------------ 145 (296)
+++|.++....... .....++.++.+.++.||+
T Consensus 91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 99998875433211 1122334444444555542
Q ss_pred ---------------CCCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 146 ---------------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 146 ---------------~~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..++++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence 12248999999999999976 5667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.25 E-value=1.7e-06 Score=68.33 Aligned_cols=75 Identities=15% Similarity=0.037 Sum_probs=47.5
Q ss_pred eeecccCc-ceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCc--eeEEeeeeeeCCCCeEEEEe
Q 022479 30 DLLGSGAV-KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVWLDDQHNTLNFIT 106 (296)
Q Consensus 30 ~~lg~g~~-~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~lv~ 106 (296)
+.+..|.. +.||++... .+..+++|....... ..+.+|...++.+.... +.+++....++ ...+++|
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEE
T ss_pred EEcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEE
Confidence 34555554 678998754 466788888654322 23566777777775433 34455544333 5788999
Q ss_pred eccCCCCH
Q 022479 107 EVCTSGNL 114 (296)
Q Consensus 107 e~~~~~sL 114 (296)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.17 E-value=4.1e-06 Score=70.62 Aligned_cols=81 Identities=17% Similarity=0.200 Sum_probs=47.1
Q ss_pred eeeecccCcceEEEeeecCCCcEEEeeeeeecc-c-CC-CHHHHHHHHHHHHHHHhcC-C-C-ceeEEeeeeeeCCCCeE
Q 022479 29 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-F-SE-DPVLVNRLHSEVQLLRTLK-N-K-YIIVCYSVWLDDQHNTL 102 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~-~~-~~~~~~~~~~e~~~l~~l~-~-~-~i~~~~~~~~~~~~~~~ 102 (296)
.+.||.|..-.||++.+..+++.+++|.-.... . .. -....++...|.+.|+.+. + | .+.+++.. ++ ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC--CCC
Confidence 457899999999999988778899998643210 0 00 0112344556888887763 2 2 33444433 33 345
Q ss_pred EEEeeccCCCC
Q 022479 103 NFITEVCTSGN 113 (296)
Q Consensus 103 ~lv~e~~~~~s 113 (296)
+++||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 67899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.0018 Score=54.00 Aligned_cols=74 Identities=15% Similarity=0.122 Sum_probs=47.1
Q ss_pred eeeecccCcceEEEeeecC-------CCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCCC
Q 022479 29 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHN 100 (296)
Q Consensus 29 ~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~ 100 (296)
.+.|+.|-.=.+|++.... .++.+++++..... . .....+|..+++.+...++. ++++.+ ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~---~idr~~E~~i~~~ls~~gl~Pkll~~~--~~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---T---ESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---C---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---h---hhHHHHHHHHHHHHHhCCCCCeEEEEc--CC--
Confidence 3678888888889987643 24568788875221 1 12345788888888644554 555554 32
Q ss_pred eEEEEeeccCCCCH
Q 022479 101 TLNFITEVCTSGNL 114 (296)
Q Consensus 101 ~~~lv~e~~~~~sL 114 (296)
..|++|+.|.++
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 457899887644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0092 Score=48.04 Aligned_cols=133 Identities=14% Similarity=0.116 Sum_probs=71.2
Q ss_pred ceEEEeeecCCCcEEEeeeeeecccCCCHHHHHHHHHHHHHHHhcCCCce--eEEeee---eeeCCCCeEEEEeeccCCC
Q 022479 38 KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSV---WLDDQHNTLNFITEVCTSG 112 (296)
Q Consensus 38 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~---~~~~~~~~~~lv~e~~~~~ 112 (296)
=.||++... +|..+++|+...... + .+++..|+..+..+....+ ...... .........+.++++..|.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999764 588899999764322 2 3456667777777753222 111111 0001124567788888775
Q ss_pred CH-----HHH------HH------hc------CC-------------------CCH---HHHHHHHHHHHHHHHHHh-hC
Q 022479 113 NL-----RTY------RK------KH------RH-------------------VSI---KALKKWSKQVLEGLEYLH-TH 146 (296)
Q Consensus 113 sL-----~~~------l~------~~------~~-------------------~~~---~~~~~i~~ql~~~l~~LH-~~ 146 (296)
.+ ..+ +. .. .. ++. ......+.++...+..+- +.
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 32 111 10 00 01 111 122233334444433331 11
Q ss_pred -CCCceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 147 -EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 147 -~~~i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
..+++|+|+.+.||+++.+ ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeCC---ceEEechhccc
Confidence 1238999999999999743 45899997754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.35 E-value=0.0047 Score=49.51 Aligned_cols=29 Identities=34% Similarity=0.466 Sum_probs=25.9
Q ss_pred ceecCCCCCceEEeCCCCceEEeccCCccc
Q 022479 150 IIHRDLNCSNIFINGNIGQVKIGDLGFAAI 179 (296)
Q Consensus 150 i~h~dl~~~nilv~~~~~~~~l~dfg~~~~ 179 (296)
++|+|+.++||+++.+ ...-++||+.+..
T Consensus 185 iIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cccCCcchhhhhcccc-cceeEeccccccc
Confidence 9999999999999987 5778999998754
|